coronaviruses implicated cause respiratory gastrointestinal infections since isolation severe acute respiratory syndrome coronavirus sarscov<NUMBER> guangdong china <NUMBER> <NUMBER> middle east respiratory syndrome coronavirus merscov saudi arabia <NUMBER> <NUMBER> coronaviruses enveloped positive singlestranded rna viruses originated bats indeed sarscov<NUMBER> merscov transmitted initially humans market civets dromedary camels respectively <NUMBER> humans sarscov<NUMBER> infects ciliated bronchial epithelial cells type ii pneumocytes using angiotensinconverting enzyme <NUMBER> ace<NUMBER> receptor merscov utilises dipeptidyl peptidase<NUMBER> dpp<NUMBER> receptor infect unciliated bronchial epithelial cells type ii pneumocytes <NUMBER> recently novel coronavirus subsequently named severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> isolated wuhan china december <NUMBER> causes disease termed coronavirus disease <NUMBER> covid<NUMBER> <NUMBER> subsequently worldwide pandemic resulted <NUMBER> million people infected almost <NUMBER> deaths <NUMBER> countries time writing <NUMBER> notably sarscov<NUMBER> also appears infect ciliated bronchial epithelial cells type ii pneumocytes predominantly via ace<NUMBER> receptor structurally similar sarscov<NUMBER> <NUMBER> akin previous coronavirus outbreaks sarscov<NUMBER> likely originated bat outbreak initiated animaltohuman transmission markets wild animals sold <NUMBER> <NUMBER> whilst prevalence diabetes people infected sarscov<NUMBER> relatively low compared population prevalence diabetes chinese italian cohorts <NUMBER> <NUMBER> people diabetes appear develop severe forms disease data uk suggest diagnosis diabetes major risk factor hospital admission people covid<NUMBER> <NUMBER> <NUMBER> patients hospitalised covid<NUMBER> february april <NUMBER> underlying diabetes <NUMBER> see table <NUMBER> indeed onethird people dying covid<NUMBER> uk underlying diagnosis diabetes regrettably odds inhospital death people type <NUMBER> type <NUMBER> diabetes t<NUMBER>d <NUMBER> <NUMBER> compared people without diabetes adjusting confounding variables <NUMBER> moreover time writing underlying diagnosis diabetes commonest underlying health condition amongst died covid<NUMBER> uk <NUMBER> people diabetes infected sarscov<NUMBER> china italy also required greater use intensive care unit icu support andor mechanical ventilation higher mortality rate people without diabetes <NUMBER> indeed studies usa china report diabetes independent predictor death people covid<NUMBER> mortality <NUMBER> higher patient population people without diabetes <NUMBER> moreover recently published analysis people diabetes hospitalised covid<NUMBER> france found <NUMBER> people attained primary outcome measure mechanical ventilation andor death within <NUMBER> days hospitalisation covid<NUMBER> interestingly authors study reported high body mass index independently associated primary outcome <NUMBER> fact around <NUMBER> people hospitalised covid<NUMBER> usa underlying diabetes hyperglycaemia fourfold greater mortality <NUMBER> therefore would appear diabetes may act marker poor metabolic health turn increases risk severe disease infected sarscov<NUMBER> several highrisk medical conditions associated diabetes including hypertension obesity ischaemic heart disease chronic renal disease undoubtedly increased mortality people diabetes covid<NUMBER> possibly due association conditions poor outcomes covid<NUMBER> hypertension ischaemic heart disease obesity <NUMBER> commonly observed people diabetes see fig <NUMBER> therefore mortality association may confounded relationship however considerable biology links poor outcomes higher mortality people diabetes covid<NUMBER> review discuss likely biological interactions diabetes covid<NUMBER> potential impact diabetes medications covid<NUMBER> severity health outcomes article based previously conducted studies contain studies human participants animals performed authors diabetes associated poorer health outcomes result multisystem involvement association multiple cardiovascular renal comorbidities making leading cause death worldwide <NUMBER> diabetes results inflammatory condition hyperglycaemia triggers generation proinflammatory cytokines resulting oxidative stress thereby tissue inflammation moreover diabetes associated relative immunodeficiency result impaired macrophage neutrophil function reduced lymphocyte proliferation complement activation dysfunction <NUMBER> result fig <NUMBER> complex relationship diabetes coronavirus disease <NUMBER> covid<NUMBER> mortality may confounded association diabetes risk factors increased mortality persons covid<NUMBER> including obesity hypertension increasing age proinflammatory state chronic respiratory disease ethnicity vitamin deficiency copd chronic obstructive pulmonary disease proinflammatory immunodeficient state higher morbidity mortality previously associated several bacterial viral infections people diabetes <NUMBER> <NUMBER> predictably uncontrolled glycaemia previously associated worse outcomes people diabetes sarscov<NUMBER> <NUMBER> merscov <NUMBER> disease outbreaks however remains debate whether hyperglycaemia acts exacerbate infection simply consequence stress response results coronavirus infection owing high prevalence people diabetes covid<NUMBER> requiring hospitalisation andor icu support must specific mechanisms affect people diabetes infected sarscov<NUMBER> <NUMBER> given understanding mechanism sarscov<NUMBER> merscov review potential role ace<NUMBER> dpp<NUMBER> receptors pathogenesis sarscov<NUMBER> people diabetes ace<NUMBER> receptor widely expressed within epithelial cells respiratory tract tubular epithelial cells renal tract mucosal cells gastrointestinal tract arterial venous endothelial cells cardiac myocytes pancreatic bcells <NUMBER> <NUMBER> within respiratory system ace<NUMBER> converts angiotensin ii angiotensin therefore inhibition ace<NUMBER> leads elevated concentrations angiotensin ii thereby generating proinflammatory response stimulating aldosterone secretion collectively actions enhance local vascular permeability renal fluid retention thus engendering respiratory distress <NUMBER> sarscov<NUMBER> enters host cell utilising envelope spike glycoprotein surface bind ace<NUMBER> enzyme turn modulates enzymes activity potentiating cell damage respiratory failure <NUMBER> consequently hypokalaemia noted feature people critically ill covid<NUMBER> believed result renal potassium wasting excess aldosterone secretion moreover early normalisation serum potassium predictor improved prognosis people critically unwell covid<NUMBER> <NUMBER> interestingly one recent study concluded sarscov<NUMBER> may cause acute kidney injury via ace<NUMBER> receptor virus detected within human glomerular cells autopsy <NUMBER> people diabetes hyperglycaemia earlier stages covid<NUMBER> may worsen disease outcomes hyperglycaemia induces glycosylation ace<NUMBER> receptor promoting cellular linkage sarscov<NUMBER> virus therefore promoting infection host cell causing higher disease severity <NUMBER> moreover early correction hyperglycaemia reverse process may improve disease outcomes leading many authors argue case tight glycaemic control priority care people diabetes covid<NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> addition enhanced ace<NUMBER> receptor glycosylation upregulation ace<NUMBER> receptor expression may enhance ability sarscov<NUMBER> enter infect host cell result safety concerns surrounding use many medications commonly used people diabetes including ace inhibitors angiotensinreceptor blockers ibuprofen thiazolidinediones appear increase expression ace<NUMBER> <NUMBER> nevertheless little evidence currently supports discontinuation routine practice current guidance supports continuation medications <NUMBER> <NUMBER> however study possibly harmful effect frequently utilised medications people diabetes cardiovascular disease warranted <NUMBER> genetic analyses ace<NUMBER> gene provide explanation poorer health outcomes seen people covid<NUMBER> diabetes ace<NUMBER> enzyme expressed ace<NUMBER> gene x chromosome <NUMBER> interestingly expression ace<NUMBER> linked development t<NUMBER>d expression single nucleotide polymorphism g<NUMBER>a ace<NUMBER> gene also increases risk developing t<NUMBER>d <NUMBER> <NUMBER> theoretically increased expression ace<NUMBER> specific ace<NUMBER> polymorphisms may result greater disease severity increased binding potential sarscov<NUMBER> virus one study observed asian men greater expression ace<NUMBER> white african american counterparts <NUMBER> implying may explain population differences observed covid<NUMBER> severity additionally cao colleagues observed east asian populations higher ace<NUMBER> receptor tissue expression may explain differences susceptibility response sarscov<NUMBER> <NUMBER> however investigation potential risk factor warranted <NUMBER> may lead therapeutic targets interest role ace<NUMBER> people diabetes comes studies identifying receptor pancreatic bcells <NUMBER> recent observations greater incidence rates diabetic ketoacidosis reported people without underlying diagnosis diabetes associated high mortality rate <NUMBER> diabetic ketoacidosis setting likely results destruction pancreatic bcells following sarscov<NUMBER> entry cell via ace<NUMBER> receptor indeed people insulintreated diabetes covid<NUMBER> appear greater insulin resistance require significantly higher insulin doses <NUMBER> may simply reflect severity infection inducing considerable catecholamine response generates greater insulin resistance direct mechanism sarscov<NUMBER> impairs bcell function latter argument supported previous study conducted sarscov<NUMBER> outbreak observed approximately <NUMBER> nondiabetic patients sarscov<NUMBER> infection developed diabetes inpatient although <NUMBER> participants diabetes followup <NUMBER> years later authors reason sarscov<NUMBER> binds ace<NUMBER> receptor pancreatic bcells resulting damage islet cells impairs insulin release <NUMBER> relative hypoinsulinaemia thought cause higher incidence hyperglycaemia diabetic ketoacidosis patients <NUMBER> result many argue tighter blood glucose control essential improve health outcomes people diabetes <NUMBER> <NUMBER> <NUMBER> <NUMBER> interest dpp<NUMBER> receptors started finding merscov virus targeted receptor enter subsequently infect host cell <NUMBER> antibodies directed dpp<NUMBER> inhibit infection host cells merscov virus <NUMBER> course dpp<NUMBER> enzyme plays critical role glucose metabolism degrading incretin hormones glucagonlike peptide<NUMBER> glp<NUMBER> glucosedependent insulinotropic polypeptide resulting reduced insulin secretion <NUMBER> however dpp<NUMBER> also known cluster differentiation<NUMBER> cd<NUMBER> plays additional immunomodulatory role activating cells maintaining lymphocyte function <NUMBER> recent studies observed dpp<NUMBER>cd<NUMBER> molecule also interacts s<NUMBER> domain sarscov<NUMBER> viral spike glycoprotein <NUMBER> addition initially reported interaction ace<NUMBER> receptor <NUMBER> moreover structural similarities sarscov<NUMBER> merscov sarscov<NUMBER> viruses <NUMBER> <NUMBER> however results mixed studies support interaction sarscov<NUMBER> cells expressing dpp<NUMBER> cells expressing ace<NUMBER> <NUMBER> nevertheless remains potential role dpp<NUMBER> inhibitors treatment people covid<NUMBER> leading call studies explore potential therapeutic avenue <NUMBER> <NUMBER> drugs within class medication inhibit sodiumglucose cotransporter<NUMBER> sglt<NUMBER> protein proximal convoluted tubule thereby preventing reuptake sodium glucose promote urinary excretion <NUMBER> use medications associated significant improvements glycaemic control body weight reduced progression renal disease <NUMBER> <NUMBER> since introduction <NUMBER> prescribing usage increased dramatically amongst commonly used drugs treating t<NUMBER>d <NUMBER> strong rationale use sglt<NUMBER> inhibitors potential treatment people covid<NUMBER> firstly use medications promotes diuresis natriuresis improves heart failure outcomes <NUMBER> <NUMBER> additionally use appears selectively reduce interstitial fluid volume without significantly affecting intravascular fluid volume <NUMBER> collectively actions may improve covid<NUMBER> health outcomes discussed covid<NUMBER> locally increases vascular permeability within lung thereby increasing interstitial fluid volume consequently inducing respiratory distress <NUMBER> secondly use sglt<NUMBER> inhibitors associated shift myocardial renal metabolism carbohydrate andor lipids ketones energyefficient may improve myocardial renal function <NUMBER> thirdly sglt<NUMBER> inhibitors also believed exert antiinflammatory effect reducing serum leptin tumour necrosis factoralpha tnfa interleukin <NUMBER> il<NUMBER> levels increasing serum adiponectin level <NUMBER> given proinflammatory state associated diabetes <NUMBER> reducing inflammatory markers may result improved morbidity mortality associated covid<NUMBER> indeed use sglt<NUMBER> inhibitors appears associated favourable cardiovascular general health outcomes making attractive therapeutic option people diabetes covid<NUMBER> result studies establish whether drugs improve covid<NUMBER> outcomes people without diabetes would important dare<NUMBER> trial phase iii randomised doubleblind placebocontrolled trial aims establish whether dapagliflozin <NUMBER> mg reduces disease progression complications allcause mortality people covid<NUMBER> <NUMBER> interestingly study participants diagnosis diabetes requirement diagnosis either hypertension t<NUMBER>d atherosclerotic cardiovascular disease heart failure chronic renal disease participate <NUMBER> unaware clinical trials investigating use medications time writing however major concerns surrounding use sglt<NUMBER> inhibitors people diabetes covid<NUMBER> concerns due increased risk diabetic ketoacidosis associated use sglt<NUMBER> inhibitors result increased urinary glucose excretion reversal insulinglucagon ratio precipitates ketosis <NUMBER> given increased risk ketoacidosis people covid<NUMBER> discussed therefore potential harm associated use sglt<NUMBER> inhibitors current recommendation withhold drugs illness keeping sick day rules <NUMBER> <NUMBER> moreover sglt<NUMBER> inhibitors promote renal ace<NUMBER> activity thus potential use medications may promote sarscov<NUMBER> infectivity <NUMBER> however trials date demonstrate data required await outcome dare<NUMBER> trial anticipation investigate benefits potential risks associated use dapagliflozin discussed considerable interest dpp<NUMBER> receptor therapeutic target people covid<NUMBER> result potential interaction receptor infect host cell <NUMBER> whilst currently available clinical data support studies underway examine impact dpp<NUMBER> inhibition covid<NUMBER> outcomes people diabetes aim observational retrospective casecontrol study italy compare clinical biochemical outcomes people diabetes treated dpp<NUMBER> inhibitor sitagliptin people diabetes treated sitagliptin <NUMBER> objective randomised openlabel trial compare measures glycaemic control inflammation chest xray findings insulintreated patients t<NUMBER>d without dpp<NUMBER> inhibitor linagliptin <NUMBER> time writing clinical trials dpp<NUMBER> inhibitors found glucagonlike peptide<NUMBER> endogenous peptide secreted distal small bowel response glucose ingestion stimulate insulin release bcells pancreas subsequently degraded dpp<NUMBER> enzyme glp<NUMBER> analogues act directly stimulate pancreatic insulin secretion associated improved glycaemic control body weight reduced progression renal disease <NUMBER> <NUMBER> glp<NUMBER> analogues may interact covid<NUMBER> disease process two key processes upregulation ace<NUMBER> receptors antiinflammatory effects rats use glp<NUMBER> analogue liraglutide associated upregulation ace<NUMBER> receptors cardiopulmonary system <NUMBER> liver <NUMBER> secondly use glp<NUMBER> analogues known improve metabolic health generally least partly reducing endovascular inflammation <NUMBER> indeed one preclinical trial found use liraglutide rats associated reduced inflammatory measures including macrophage infiltration reduced tnfa il<NUMBER> levels <NUMBER> however paucity evidence human studies area <NUMBER> aware ongoing trials examining potential impact medications covid<NUMBER> outcomes time writing review covid<NUMBER> worldwide pandemic resulted extraordinary number infections deaths worldwide people diabetes particularly vulnerable develop severe forms disease possibly due clustering risk factors hypertension ischaemic heart disease chronic renal disease common pathways appear exist may explain susceptibility patient population covid<NUMBER> medications commonly used people diabetes may interact pathways however little known date whether interactions lead clinical harm benefit indeed whether impact although recent analysis people diabetes hospitalised france covid<NUMBER> demonstrated association need mechanical ventilation death within <NUMBER> days glucoselowering therapies metformin insulin <NUMBER> safe trials exploring medications welcomed hope shed light rapidly evolving area time great uncertainty whilst continue rapidly learn novel disease funding funding sponsorship received study publication article authorship named authors meet international committee medical journal editors icmje criteria authorship article take responsibility integrity work given approval version published nawaz nothing disclose marc evans received financial support consultancy novartis merck sharp dohme corp novo nordisk served speakers bureau novartis lilly boehringer lngelheim merck sharp dohme corp novo nordisk janssen takeda marc evans also editorinchief diabetes therapy compliance ethics guidelines article based previously conducted studies contain studies human participants animals performed authors data availability data sharing applicable article datasets generated analyzed current study open access article licensed creative commons attributionnoncommercial <NUMBER> international license permits noncommercial use sharing adaptation distribution reproduction medium format long give appropriate credit original authors source provide link creative commons licence indicate changes made images third party material article included articles creative commons licence unless indicated otherwise credit line material material included articles creative commons licence intended use permitted statutory regulation exceeds permitted use need obtain permission directly copyright holder view copy licence visit httpcreativecommonsorglicensesbync<NUMBER> january <NUMBER> facing unprecedented outbreak coronavirus disease <NUMBER> covid<NUMBER> caused novel coronavirus severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER>which become global catastrophe data early months <NUMBER> suggest people covid<NUMBER> comorbidities prevalent diabetes cardiovascular disease hypertension <NUMBER> significant association worse outcomes seen people comorbidities <NUMBER> studies also shown covid<NUMBER> associated hyperglycaemia particularly elderly type <NUMBER> diabetes <NUMBER> view many uncertainties covid<NUMBER> faculty representatives primary specialist care developed consensus document management diabetes people risk confirmed covid<NUMBER> use primary specialist care brief practical recommendations authored group convened virtually recommendations based queries emphasised important clinicians questions raised colleagues social media recommendations guided using focusedliterature review clinical decision making manage ment diabetes already complex normal circumstances recommend clinicians follow guidelines management people diabetes however recommendations authored group add existing guidelines considering specific points management patients diabetes covid<NUMBER> disease risk metabolic disease diabetes primary risk factor development severe pneumonia septic course due virus infections occurs around <NUMBER> patients <NUMBER> <NUMBER> diabetes identified major contributor disease severity mortality middle east respiratory syndrome merscov <NUMBER> evidence epidemiological observations regions heavily affected sarscov<NUMBER> reports centers disease control prevention cdc national health centres hospitals showed risk fatal outcome covid<NUMBER> <NUMBER> higher patients diabetes diabetes <NUMBER> several hypotheses explain increased incidence severity covid<NUMBER> infection people diabetes general people forms diabetes increased risk infection defects innate immunity affecting phagocytosis neutrophil chemotaxis cellmediated immunity however high frequency diabetes serious cases covid<NUMBER> could potentially reflect higher prevalence type <NUMBER> diabetes older people furthermore diabetes older age associated cardiovascular disease could help explain association fatal outcomes least two specific mechanisms might play role covid<NUMBER> infection first gain entry target cells sarscov<NUMBER> virus hijacks endocrine pathway plays crucial role blood pressure regulation metabolism inflammation <NUMBER> angiotensinconvertingenzyme <NUMBER> ace<NUMBER> identified receptor coronavirus spike protein ace<NUMBER> protective effects primarily regarding inflammation covid<NUMBER> infection reduces ace<NUMBER> expression inducing cellular damage hyperinflammation respiratory failure <NUMBER> acute hyperglycaemia shown upregulate ace<NUMBER> expression cells might facilitate viral cell entry however chronic hyperglycaemia known downregulate ace<NUMBER> expression making cells vulnerable inflammatory damaging effect virus furthermore expression ace<NUMBER> pancreatic β cells lead direct effect β cell function <NUMBER> <NUMBER> <NUMBER> although findings verified humans suggest diabetes might risk factor severe form covid<NUMBER> disease also infection could induce new onset diabetes <NUMBER> <NUMBER> <NUMBER> potential β cell damage caused virus leading insulin deficiency supported observation italian colleagues coauthors recommen dations reported frequent cases severe diabetic ketoacidosis dka time hospital admission another important observation coauthors various centres different countries affected covid<NUMBER> tremendous insulin requirement patients severe course infection extent covid<NUMBER> plays direct role high insulin resistance unclear according personal experiences coauthors personal view extent insulin resistance patients diabetes seems dispro portionate compared critical illness caused conditions second potential mechanism might explain link covid<NUMBER> diabetes involves dipeptidyl peptidase<NUMBER> dpp<NUMBER> enzyme commonly targeted pharmacologically people type <NUMBER> diabetes cell studies dpp<NUMBER> identified functional receptor human coronaviruserasmus medical center hcovemc virus responsible mers <NUMBER> antibodies directed dpp<NUMBER> inhibited hcovemc infection primary cells dpp<NUMBER> enzyme ubiquitously expressed type ii transmembrane glycoprotein plays major role glucose insulin metabolism also increases inflammation type <NUMBER> diabetes <NUMBER> whether mechanisms also apply covid<NUMBER> whether diabetes treatment dpp<NUMBER> inhibitors clinical practice influences course infection currently unknown mechanisms translate sarscov<NUMBER> use agents could reduce dpp<NUMBER> concentrations could provide thera peutic opportunities treatment covid<NUMBER> <NUMBER> clinical relevance aforementioned mechanisms currently uncertain healthcare practitioners aware implications patients diabetes compiled simple flowchart metabolic screening management patients covid<NUMBER> diabetes risk metabolic disease includes recommendations regarding need primary prevention diabetes well avoidance severe sequelae diabetes triggered unidentified poorly managed diabetes figure furthermore special considerations antidiabetes drugs commonly used patients type <NUMBER> diabetes view covid<NUMBER> presented panel people diabetes yet infected sarscov<NUMBER> virus intensify metabolic control needed means primary prevention covid<NUMBER> disease includes continuation strict abidance adequate control blood pressure lipids wherever possible remote consultations using connected health models utilised reduce exposure also encouraged follow general advice cdc state local governments hand washing physical distancing patients without diabetes particularly high risk metabolic disease contracted viral infection need monitored new onset diabetes might triggered virus patients covid<NUMBER> disease diabetes require continuous reliable glycaemic control suggested flowchart older patients refers aged <NUMBER> ardsacute respiratory distress syndrom cgmcontinous glucose measurement fgmflash glucose measurement hba <NUMBER>c haemoglobin <NUMBER>c tirtime range target concentrations lower plasma glucose adjusted <NUMBER> mmoll <NUMBER> mgdl frail patients †hba <NUMBER>c testing might possible time previous measurements available allow differentiation chronic acute decompensation patients type <NUMBER> diabetes components metabolic syndrome including hypertension dyslipidaemia therefore continuation appropriate antihypertensive lipidlowering regimen patients crucial importance treatment ace inhibitors angiotensin <NUMBER> receptor blockers could increase expression ace<NUMBER> could accelerate entry virus cells <NUMBER> however sarscov<NUMBER> might impair protective ace<NUMBER>mas receptor pathway increase deleterious angiotensin<NUMBER> activity use ace inhibitors angiotensin <NUMBER> receptor blockers could protect severe lung injury following infection basis currently available evidence recommend patients continue antihypertensive regimens including ace inhibitors angiotensin <NUMBER> receptors view endorsed recent position statement european society cardiology heart failure society america american college cardiology american heart association strongly recommended continuation treatment ace inhibitors angiotensin <NUMBER> receptor blockers <NUMBER> statins shown restore reduction ace<NUMBER> induced high lipids low density lipoprotein lipoproteina <NUMBER> pleiotropic antiinflammatory effects statins attributed upregulation ace<NUMBER> however although believe modulation ace<NUMBER> expression associated infection mortality rates covid<NUMBER> statins discontinued longterm benefits potential tipping balance towards cytokine storm rebound rises interleukinil<NUMBER> il<NUMBER>ß discontinued given close links diabetes cardiovascular disease recommend control lipid concentrations patients covid<NUMBER> certain subgroups people diabetes might require specific consideration elevated hemo globin <NUMBER>c people type <NUMBER> diabetes compromises immune function rendering susceptible infectious disease individuals need intense monitoring supportive therapy reduce risk metabolic decompensation including dka particular taking sodium glucose cotransporter <NUMBER> inhibitors sglt<NUMBER> according expertise coauthors increase prevalence severe dka covid<NUMBER> positive patients established type <NUMBER> diabetes observed might part delayed hospital admission thus making patients type <NUMBER> diabetes aware complication reeducating typical symptoms homemeasurement urine blood ketones acute behaviour guidelines liberal early inquiry professional medical advice sick day rules crucial patients undergone transplantation islets pancreas kidney immunosuppressive therapy particularly increased risk additionally potential effect coronavirus infection pancreatic function group unknown monitoring recurrence insulin requirement insulin independent transplant important increasing number patients type <NUMBER> diabetes concomitant fatty liver disease probably increased risk pronounced inflammatory response including socalled cytokine storm patients considered increased risk severe covid<NUMBER> disease therefore screening hyperinflammation using laboratory trends eg increasing ferritin decreasing platelet counts highsensitivity creactive protein erythrocyte sedimentation rate crucial importance might also help identify subgroups patients immuno suppression steroids immunoglobulins selective cytokine blockade could improve outcome majority patients type <NUMBER> diabetes living conditions overweight obesity body mass index • dehydration lactic acidosis probably occur patients dehydrated patients stop taking drug follow sick day rules • illness renal function carefully monitored high risk chronic kidney disease acute kidney injury • include canagliflozin dapagliflozin empagliflozin • risk dehydration diabetic ketoacidosis illness patients stop taking drugs follow sick day rules • patients avoid initiating therapy respiratory illness • renal function carefully monitored acute kidney injury glucagonlike peptide<NUMBER> receptor agonists • include albiglutide dulaglutide exenatideextended release liraglutide lixisenatide semaglutide • dehydration likely lead serious illness patients closely monitored • adequate fluid intake regular meals encouraged • include alogliptin linagliptin saxagliptin sitagliptin • drugs generally well tolerated continued insulin • insulin therapy stopped • regular selfmonitoring bloodglucose every <NUMBER> hours encouraged continuous glucose monitoring • carefully adjust regular therapy appropriate reach therapeutic goals according diabetes type comorbidities health status connected health models telemedicine used continue regular reviews selfmanagement education programmes virtually ensure patients adherent therapy important determinant lung volume respiratory mechanics oxygenation mechanical ventilation especially supine position therefore patients obesity diabetes could specific risk ventilatory failure complications mechanical ventilation clinical experience young patients obesity covid<NUMBER> supports notion furthermore individuals obesity diabetes altered innate adaptive immune response characterised state chronic lowgrade inflammation higher concentrations proinflammatory leptin lower antiinflammatory adiponectin <NUMBER> additionally obesity often associated physical inactivity leading aggravated insulin resistance condition per se impairs immune response microbial agents including macrophage activation inhibition proinflammatory cytokines leads dysregulation immune response contributing complications associated obesity <NUMBER> furthermore sarscov<NUMBER> induce longterm metabolic alterations patients infected virus reported previously sars virus <NUMBER> therefore careful cardiometabolic monitoring patients survived severe covid<NUMBER> disease might necessary importantly also bring attention subgroup people diabetes work healthcare professionals given covid<NUMBER> might preva lent among sick currently diagnosed healthcare professionals diabetes deployed away front line clinical duties possible cases possible desirable highgrade protection increased protection used provision elective surgical proceduresincluding metabolic surgeryis postponed many hospitals around world increase capacity inpatient beds acute care however postponing elective metabolic surgery outbreak covid<NUMBER> advisable regardless issues hospital capacity patients type <NUMBER> diabetes obesity increased risk complications covid<NUMBER> <NUMBER> compounding potential negative influence surgical stress recovery period furthermore although specific data available plausible concerns pneumoperitoneum use haemostatic instruments laparoscopy far common approach used metabolic surgery ability reduce morbidity mortality might lead viral aerosolisation thus increasing risk transmission virus patients staff whether patients type <NUMBER> diabetes metabolic surgery protected adverse outcomes covid<NUMBER> relative peers undergone surgical treatment simply better glycaemic control remains unclear <NUMBER> however metabolic surgery could induce nutritional deficiencies including reduced absorption vitamins micronutrients play important roles regulation immune stress response <NUMBER> although data yet suggest patients metabolic surgery greater risk infection complications covid<NUMBER> patients receive particular attention close monitoring although optimising glycaemic control reduce risk severe covid<NUMBER> disease important specific considerations around treatment modality made panel lactic acidosis associated metformin euglycaemic moderate hyperglycaemic diabetic ketoacidosis associated sglt<NUMBER> inhibitors rare events however recommend drugs discontinued patients severe symptoms covid<NUMBER> reduce risk acute metabolic decompensation <NUMBER> importantly discontinuing drugs recommended prophylactically outpatients diabetes without symptoms infection absence evidence serious course covid<NUMBER> furthermore present convincing evidence exists suggest dpp<NUMBER> inhibitors discontinued analyses affected patients various diabetes treatments covid<NUMBER> could allow elucidation effects dpp<NUMBER> inhibitors <NUMBER> importantly drugs discontinued alternative treatment choicein cases option feasibleis insulin <NUMBER> given multiple stresses associated covid<NUMBER> including limited respiratory failure defects insulin secretion frequent occurrence diarrhoea sepsis patients require identified references publication searches pubmed articles published apr <NUMBER> <NUMBER> apr <NUMBER> <NUMBER> using combinations terms coronavirus covid<NUMBER> sarscov<NUMBER> ncov diabetes risk factors severe acute respiratory syndrome acute respiratory distress syndrome comorbidities reviewed guidelines management covid<NUMBER> published american diabetes assiciation us centers disease control prevention added articles searches authors personal files also reviewed relevant references cited retrieved articles articles published english italian chinese included final reference list generated basis relevance topics covered publication aim emphasising multiple challenges healthcare professionals practitioners intensive care staff might face management patients diabetes risk covid<NUMBER> providing practical recommendations care vulnerable subgroup insulin especially since many cases reported high insulin consumption need managed intravenous infusion <NUMBER> considerable care required fluid balance risk excess fluid exacerbate pulmonary oedema severely inflamed lung furthermore potassium balance needs considered carefully context insulin treatment hypokalaemia common feature covid<NUMBER> possibly associated hyperaldosteronism induced high concentrations angiotensin <NUMBER> could exacerbated following initiation insulin <NUMBER> realise recommendations reflections based expert opinion awaiting outcome randomised clinical trials executing clinical trials challenging circumstances proven feasible covid<NUMBER> pandemic trial networks provide evidencebased therapies arising <NUMBER> investigating subgroups diabetes relate covid<NUMBER> outcomes important particular investigating various management approaches would particularly effective managing diabetes covid<NUMBER> context <NUMBER> novel coronavirus sarscov<NUMBER> originating wuhan china spread rapidly around world march <NUMBER> th <NUMBER> world health organisation declared coronavirus disease covid<NUMBER> pandemic <NUMBER> virus devastating consequences global scale <NUMBER> people diabetes susceptible adverse outcomes death respiratory tract infections <NUMBER> influenza h<NUMBER>n<NUMBER> <NUMBER> severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> <NUMBER> middle east respiratory syndrome coronavirus merscov infection <NUMBER> diabetes particularly patients aged <NUMBER> years older strongly associated increased risk infection complications <NUMBER> <NUMBER> unclear susceptibility infection people diabetes due chronic inflammatory state associated alterations glucose metabolism dysregulation immune system due renal vascular cardiovascular complications frequently associated diabetes increasing age <NUMBER> understanding health impact covid<NUMBER> people diabetes evolving clear community management diabetes directly indirectly impacted covid <NUMBER> order minimise transmission risk healthcare workers patients consumers public health policies focussed early detection selfisolation positive cases infection control precautions minimising face face contact use telemedicine <NUMBER> aimed review impact covid<NUMBER> people living diabetes australia provide practical recommendations management diabetes outpatient setting undertook search pubmed medline embase google scholar using key words diabetes coronavirus sars mers management studies full text english versions included reviewed literature epidemiology pathophysiology covid<NUMBER> relevant people diabetes recommendations summarised addition expert guidance based following topic areas diabetes specific general prevention logistical considerations <NUMBER> severeacuterespiratorysyndrome coronavirus sarscov<NUMBER> outbreak believed originated zoonotic source huanan wholesale seafood market wuhan city china <NUMBER> highly contagious sarscov<NUMBER> rapidly spread throughout china worldwide persontoperson spread main mode transmission <NUMBER> since initial detection <NUMBER> million laboratory confirmed cases globally largest burden morbidity mortality arising european cities united states <NUMBER> whilst ages susceptible children significantly less affected <NUMBER> reported cases occurring individuals age <NUMBER> years <NUMBER> majority cases <NUMBER> appear affect individuals <NUMBER> <NUMBER> years disease severity appears worsen age underlying comorbid conditions <NUMBER> <NUMBER> incidence diabetes covid<NUMBER> cases china varied <NUMBER> <NUMBER> however largescale data suggest incidence may order <NUMBER> <NUMBER> refer appendix <NUMBER> discrepancies may attributed incomplete data due lack testing comorbid analysis cases death comparison diabetes reported approximately <NUMBER> chinese population prior covid<NUMBER> <NUMBER> <NUMBER> therefore based early prevalence studies china appears people diabetes significantly likely infected covid<NUMBER> people diabetes increased risk severe infection <NUMBER> <NUMBER> large china cohort study <NUMBER> individuals mortality rate patients diabetes significantly higher people without diabetes <NUMBER> vs <NUMBER> respectively p<NUMBER> <NUMBER> <NUMBER> mortality increased people one coexisting comorbid condition <NUMBER> important consideration given diabetes commonly associated multiple organ systems including renal cardiovascular complications <NUMBER> laboratory confirmed cases china february <NUMBER> mortality highest people <NUMBER> years case fatality rate cfr <NUMBER> comorbidities cfr cardiovascular disease <NUMBER> diabetes <NUMBER> hypertension <NUMBER> chronic respiratory disease <NUMBER> cancer <NUMBER> vs patients comorbid condition cfr <NUMBER> <NUMBER> additionally population based data england national health service revealed diabetes prevalent one four <NUMBER> patients died hospital tested positive covid<NUMBER> <NUMBER> <NUMBER>th april <NUMBER> <NUMBER> cumulative confirmed cases total <NUMBER> deaths reported australia <NUMBER> total cases <NUMBER> admitted hospital <NUMBER> admitted patients required intensive care unit icu admission ventilatory support diabetes prevalent comorbidity among hospitalised cases admitted icu followed cardiovascular disease <NUMBER> <NUMBER> patients respectively diabetes also commonly reported comorbid condition among sarscov<NUMBER> associated death <NUMBER> fatalities diabetes <NUMBER> median age sarscov<NUMBER> deaths <NUMBER> years interquartile range <NUMBER> <NUMBER> years indicating frailty associated increased severity infection mortality <NUMBER> consistent international reports <NUMBER> however stringent social distancing measures expanded testing criteria federal government led sharp decrease incidence new covid<NUMBER> cases australia since beginning april <NUMBER> see figure <NUMBER> insert figure <NUMBER> severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> enveloped single stranded positivesense rna virus believed subgenus sarscov<NUMBER> distantly related merscov <NUMBER> coronaviruses largest genome rna viruses typically <NUMBER> <NUMBER> kilobases enclosed within nucleocapsid <NUMBER> bound coronavirus envelope spike glycoproteins give virus distinctive halo appearance electron microscope <NUMBER> <NUMBER> aside giving coronavirus characteristic name spike glycoprotein receptor binding domains rbds bind angiotensinconvertingenzyme <NUMBER> ace<NUMBER> surface receptors high affinity mediating viral entry host cell enhancing pathogenicity sarscov<NUMBER> <NUMBER> <NUMBER> figure <NUMBER> upon binding ace<NUMBER> sarscov<NUMBER> invades host cell endocytosis leading subsequent regulation surface ace<NUMBER> receptor <NUMBER> ace<NUMBER> type membrane bound receptor single active site abundant mucosal epithelial cells within lung alveolar tissue well heart kidney intestine blood vessels <NUMBER> <NUMBER> ace<NUMBER> also endogenous inhibitor reninangiotensin system ras degradation angiotensin ii angiotensin <NUMBER> <NUMBER> figure <NUMBER> angiotensin <NUMBER> subsequently binds proteincoupled receptor mas exerts vasodilatory antithrombotic antiproliferative antioxidative effects <NUMBER> see figure <NUMBER> insert figure <NUMBER> <NUMBER> ace<NUMBER> inhibition reninangiotensin system healthy individuals circulating ace<NUMBER> low <NUMBER> however circulating ace<NUMBER> increased individuals diabetes hypertension nephropathy <NUMBER> <NUMBER> ascribed compensatory mechanism account overactivity angiotensin ii ras people diabetes <NUMBER> importantly currently clinical data humans indicate change ace<NUMBER> activity alters susceptibility sarscov<NUMBER> infection many people cardiovascular complications nephropathy due diabetes prescribed ace inhibitors acei angiotensin ii receptor blockers arbs cardiovascular <NUMBER> renoprotective effects <NUMBER> <NUMBER> recently speculation use acei arbs may upregulate ace<NUMBER> <NUMBER> binding angiotensin ii angiotensin type <NUMBER> receptor map kinasephosphotase signalling pathways activated reduce ace<NUMBER> mrna gene expression activity <NUMBER> inhibiting formation angiotensin ii acei blocks negative feedback loop resulting increased ace<NUMBER> see figure <NUMBER> others suggest angiotensin ii binds <NUMBER> receptor mediates internalisation ace<NUMBER> degradation lysosomes process inhibited arb losartan <NUMBER> whilst animal studies demonstrated upregulation ace<NUMBER> gene expression response ace inhibition <NUMBER> <NUMBER> normotensive models used studies failed investigate whether increased ace<NUMBER> gene expression correlated increased ace<NUMBER> activity animal studies contradictorily shown increase ace<NUMBER> gene expression activity levels acei arbs <NUMBER> <NUMBER> date human studies shown evidence upregulation ace<NUMBER> activity patients acei arbs <NUMBER> <NUMBER> thus ongoing use usual ace inhibitors blood pressure management patients diabetes continues supported australian diabetes society ads well international bodies <NUMBER> characterised chronic lowgrade inflammatory state induced excess adipose tissue <NUMBER> elevated levels tumour necrosis factor tnfa interleukin il<NUMBER> creactive protein plasminogen activator inhibitor reactive oxygen species ros demonstrated adipose tissue obese mice <NUMBER> <NUMBER> inflammatory cytokines believed inhibit insulin signalling serine phosphorylation insulin receptor substrate via activation iҡβα kinase β ikkβ cjun nterminal kinase jnk<NUMBER> mediators <NUMBER> activated ikkβ also results transcription various inflammatory genes <NUMBER> addition pathogenesis insulin resistance type <NUMBER> diabetes increased proinflammatory macrophages cytokines chemokines proteases contribute development diabetes related retinopathy nephropathy neuropathy cardiovascular disease <NUMBER> individuals diabetes increased risk infection due dysregulation innate humoral immune system previous studies demonstrated hyperglycaemia upregulates adhesion molecules intracellular cell adhesion molecule<NUMBER> vascular cell adhesion molecule<NUMBER> eselectin cd<NUMBER>b endothelial cells neutrophils <NUMBER> <NUMBER> believed diminish neutrophil chemotaxis sites infection <NUMBER> acute hyperglycaemia also impairs neutrophil phagocytosis bactericidal activity <NUMBER> <NUMBER> <NUMBER> respiratory burst capacity <NUMBER> <NUMBER> formation granular elastase myeloperoxidase extracellular traps leading susceptibility infection <NUMBER> acute hyperglycaemia also associated reduced complement fixation opsonization microorganisms <NUMBER> isolated individuals diabetes reported <NUMBER> inflammatory mediators important inducing adaptive immune response therefore may explain increased susceptibility invading pathogens people diabetes <NUMBER> evidence suggests insulin treatment may restore immune function improving chemotaxis phagocytosis bactericidal capacities neutrophils <NUMBER> <NUMBER> thereby supporting importance adequate blood glucose management covid<NUMBER> zhu et al utilized retrospective longitudinal multicentered cohort study investigate relationship plasma glucose levels covid<NUMBER> outcome <NUMBER> patients diabetes <NUMBER> found inpatient plasma glucose levels <NUMBER>mmoll associated adverse outcomes death covid<NUMBER> hazard ratio hr adjusted age gender comorbidities site effect allcause mortality well managed type <NUMBER> diabetes mellitus t<NUMBER>dm group blood glucose <NUMBER>mmoll compared suboptimally managed t<NUMBER>dm group blood glucose <NUMBER>mmoll <NUMBER> <NUMBER>ci <NUMBER> p <NUMBER> <NUMBER> prevalence acute respiratory distress syndrome acute heart injury also lower well managed t<NUMBER>dm group hr <NUMBER> <NUMBER> ci <NUMBER> p <NUMBER> <NUMBER> <NUMBER> ci <NUMBER> p <NUMBER> respectively <NUMBER> however authors access prehospital data therefore unable determine associations prehospital glycemic status natural history covid<NUMBER> investigate active inpatient management hyperglycaemia improved covid<NUMBER> adverse outcomes patients stress hyperglycaemia without previous history diabetes associated increase covid<NUMBER> disease severity mortality seen established diabetes <NUMBER> additionally individuals increased levels raised inflammatory biomarkers hypercoagulopathy well leukocytosis neutrophilia also comparable seen patients established diabetes <NUMBER> <NUMBER> suggesting perhaps hyperglycaemia may reflect consequences counterregulatory state severe covid<NUMBER> infection <NUMBER> similar outcomes observed retrospective studies usa among hospitalized patients covid<NUMBER> diabetes andor uncontrolled hyperglycaemia fourfold increase mortality rate without <NUMBER> vs <NUMBER> p<NUMBER> patients diabetes andor uncontrolled hyperglycaemia survived discharged hospital significant increase length stay compared counterparts median <NUMBER> vs <NUMBER> days p <NUMBER> <NUMBER> glucose index tyg severity mortality covid<NUMBER> <NUMBER> found tyg index levels significantly higher severe cases death group controlling confounding variables tyg index positively associated arterial stiffness nephric microvascular damage coronary artery disease however direct marker metabolic control <NUMBER> whilst substantial evidence suggest strong association hyperglycaemia irrespective diabetes status poorer prognosis difficult prove cause effect based available observational studies interventional studies required draw definitive conclusions projected global economy contract sharply approximately three percent surpassing <NUMBER> global financial crisis <NUMBER> australia unemployment rates expected rise <NUMBER> almost doubled rates february year <NUMBER> australian government responded quickly stimulus packages almost <NUMBER> billion dollars providing financial support businesses employees education providers community services including jobkeeper jobseeker packages <NUMBER> according department agriculture approximately <NUMBER> australias food supply sourced locally australia producing substantially food consumes <NUMBER> despite uncertainties around impacts covid<NUMBER> initially triggered panic buying stockpiling staple goods resulting temporary disruption supermarket supply <NUMBER> unclear impact social isolation home schooling financial instability healthy eating behaviours glycaemia management disruption work school social routine may lead stress emotional eating highcalorie high glycaemic index foods <NUMBER> legislative changes also introduced legalise electronic prescriptions home delivery medications vulnerable patients isolation <NUMBER> hospitals converted majority face face outpatient appointments telehealth consultations main provider telehealth consultations reporting increased usage <NUMBER> consultations <NUMBER> day <NUMBER> use telehealth management diabetes prior pandemic well documented evidence support improved glycaemic management <NUMBER> <NUMBER> patient satisfaction <NUMBER> compared conventional health services although longterm outcomes telehealth lacking short intermediate term improvement hyperglycaemia patient engagement makes telehealth viable way deliver health care periods pandemic natural disasters however potential barriers telehealth internet connectivity age fear lack support use technology access devices patient preference facetoface encounters patients hearing andor vision impairments <NUMBER> increasing use insulin pump therapy cgm devices telemonitoring diabetes management improved help support individuals diabetes avoid prolong hyperglycaemia complications increase technology also greatly complement telehealth providing invaluable realtime data improve patient engagement contact covid<NUMBER> pandemic beyond clinicians access uploaded reports remotely assist people diabetes remotely leading collaborative decision making improve outcomes including reducing hypo hyperglycaemia <NUMBER> people diabetes likely experience severe infection death covid<NUMBER> frailty preexisting comorbid conditions underlying immune system dysfunction may contribute poorer outcomes suggest continuation usual care people diabetes incorporating telehealth larger focus sick day management early detection testing sarscov<NUMBER> permissible increased blood glucose testing account changes daily routine diet mental health health  enough household items groceries hand prepared required quarantine period time  write phone numbers doctor diabetes educator local pharmacy  write list usual medications doses  <NUMBER>day supply insulin diabetes medications unlikely event quarantined  ensure supply insulin pump consumables continuous glucose monitoring device  patients type <NUMBER> diabetes sufficient supply ketone testing strips glucagon prescribed doctor  engage diabetes team pump supplier learn upload pump data diabetes nurse educator endocrinologist doctor isolation  continue monitor blood glucose level bgl glucose management unsatisfactory bgls consistently <NUMBER> mmoll less <NUMBER> mmoll speak doctor diabetes nurse educator assistance medication adjustments  ketone levels checked every <NUMBER> hours bgls <NUMBER> mmoll call doctor immediately raised ketones  experience hypo bgl less <NUMBER> mmoll eat <NUMBER> g simple carbohydrates <NUMBER> jelly beans ½ full strength soft drink recheck bgl <NUMBER> minutes ensure levels rising  develop sick day management plan doctor diabetes nurse educator people type <NUMBER> diabetes  continue monitor blood glucose level bgl glucose control unsatisfactory bgls consistently <NUMBER> mmoll less <NUMBER> mmoll speak doctor diabetes nurse educator assistance medication adjustments  experience hypo bgl less <NUMBER> mmoll eat <NUMBER> g simple carbohydrates <NUMBER> jelly beans ½ full strength soft drink recheck bgl <NUMBER> minutes ensure levels rising  continue taking usual oral medications insulin prescribed doctor  unwell nausea vomiting unable tolerate oral intake stop taking sglt inhibitor empagliflozin dapagliflozin ertugliflozin prevent ketoacidosis  develop sick day management plan doctor diabetes nurse educator information system dear sir today’s reports global number confirmed cases covid<NUMBER> surpassed <NUMBER> number known cases increasing several thousand every day march <NUMBER> <NUMBER> publicly characterized covid<NUMBER> pandemic issue serious concern deserves momentous attention coronaviruses family viruses cause respiratory illnesses cause illness animals seven known types coronaviruses cause illness humans coronavirus sarscov<NUMBER> severe acute respiratory syndromecoronavirus<NUMBER> one viruses – causes illness currently known coronavirus disease<NUMBER> covid<NUMBER> though still learning exactly puts someone greater risk developing severe illness covid<NUMBER> early information indicates older patients chronic medical conditions hypertension diabetes cardiocerebrovascular diseases may higher risk <NUMBER> <NUMBER> <NUMBER> infection caused covid<NUMBER> likely disturb metabolic regulation diabetic patients covid<NUMBER> may face altered immune response background already compromised health status owing diabetesrelated complications andor aging important findings patients hyperglycemia viral infection significant worsening symptoms implies greater morbidity patients compared without diabetes <NUMBER> however pathophysiology association remains uncertain known whether hyperglycemia changes virulence infection virus modifies glycemic metabolism know diabetic patients susceptible infection impact glucose metabolism <NUMBER> dm disorder glucose metabolism chronic inflammatory condition characterized multiple changes lipid carbohydrate protein profiles <NUMBER> inflammatory processes due hyperglycemia leads increased synthesis glycosylation end products ages activates macrophages cells immune system increase oxidative stress promote synthesis proinflammatory cytokines besides stimulating synthesis adhesion molecules facilitate inflammation tissues <NUMBER> inflammatory process complications might provide higher propensity infections greater severity conditions another important issue inflammatory immune response occur diabetic patients acquire viral infection well whether virus interferes insulin secretion glycemic control stage biological mechanism relationship covid<NUMBER> diabetes known association severity cases death pronounced need develop hypothesis explain causal path underlying severe clinical presentation covid<NUMBER> infection subsequent death diabetic patients biochemical tests also essential clarify molecular pathophysiology involved association covid<NUMBER> dm substantial public health importance deserves proper attention since large diverse population affected globally nowadays comorbidity poses relevant threat human health prospective welldesigned studies elucidate biological mechanism best clinical management association urgently neededhomephilipphiliphomenewcastleacuktranslational clinical research institute medical school framlington place newcastle upon tyne ne<NUMBER> <NUMBER>hu ukdear sirit useful see review published journal diabetes covid <NUMBER> infection <NUMBER> highlight people diabetes death rate perhaps around four times background population note suggested <NUMBER> deaths chinawuhan people diabetes <NUMBER> clearly important understand whythere confounders form associations risk factors dying covid<NUMBER> infection notably age cardiovascular disease cannot explain excess need understand better mitigate riskit reported deaths occurring context pneumonitis <NUMBER> particularly onset adult respiratory distress syndrome ards condition excess fluid alveoli blocks gas exchange air bloodpeople diabetes many cardiovascular disease cvd without diabetes permeable vasculature identified since <NUMBER>s albumin lead kidneys micro macroalbuminuria even prior late blush retina intravenous fluorescence marker injection <NUMBER> leaky vasculature associated vascular inflammation metabolic syndrome steatohepatitis well cvd per seit would seem far stretch absence research yet assume prior enhancement vascular permeability could account increased rate ards death people diabetes particularly type <NUMBER> diabetes also cvdaside research would suggest already albuminuria routine yearly test people diabetes higher liver enzyme markers alt perhaps diabetes associated dyslipidaemia low hdl cholesterol take particular steps selfisolateit unclear fast vascular inflammation ameliorated improved blood glucose control nearly glucoselowering medications reduce microalbuminuria time tight glucose control infected persons insulin would meanwhile seem sensible poor glucose control known interfere leukocytelymphocyte function <NUMBER>yours sincerelyphilip hometranslational clinical research institute newcastle university ukreferences<NUMBER>guptarghoshasinghakmisraaclinical considerations patients diabetes times covid<NUMBER>diabetes metabolic syndr clin res rev<NUMBER>e<NUMBER>joint commission report whochina joint mission coronavirus disease <NUMBER> covid<NUMBER> <NUMBER> february <NUMBER> available httpswwwwhointdocsdefaultsourcecoronavirusewhochinajointmissiononcovid<NUMBER>finalreportpdf accessed <NUMBER> march <NUMBER>the novel coronavirus pneumonia emergency response epidemiology team epidemiological characteristics outbreak <NUMBER> novel coronavirus diseases covid<NUMBER> — china <NUMBER> china cdc weekly <NUMBER> <NUMBER>x <NUMBER> available httpsgithubcomcmriversncovblobmastercovid<NUMBER>pdf china cvd weekly accessed <NUMBER> march <NUMBER>raskmadsenckingglvascular complications diabetes mechanisms injury protective factorscell metab<NUMBER>pozzilli p signore e leslie rdg infections immunity diabetes alberti kgmm zimmet p defronzo ra ed international textbook diabetes second edition chichester john wiley <NUMBER> <NUMBER> guptariteshfortis cdoc hospital chirag enclaverenin angiotensin system blockade covid<NUMBER> diseasedear editorwe recently published article highlighting special concerns managing patients diabetes times covid<NUMBER> pandemic<NUMBER> concerns use angiotensin converting enzyme ace inhibitors angiotensin receptor blockers arbs clarified publication<NUMBER> summarising current evidence regard try arrive reasonable conclusionin absence vaccine antiviral drug covid<NUMBER> infection several therapeutic approaches studied one approach use inhibitors renin angiotensin system namely ace inhibitors arbs hand concern raised fact patients agents might increased risk infection severe acute respiratory syndrome coronavirus<NUMBER> sars cov<NUMBER>angiotensin converting enzyme<NUMBER> ace<NUMBER> receptor sars cov<NUMBER> well coronaviruses expressed type <NUMBER> alveolar epithelial cells endothelium sglycoprotein surface coronavirus binds ace<NUMBER> leads conformational change sglycoprotein allows proteolytic digestion host cell proteases tmprss<NUMBER> ultimately leading internalization virion<NUMBER> viral sglycoprotein tmprss<NUMBER> ace<NUMBER> inhibition potential targets therapy possibly vaccine developmentas ace<NUMBER> essential coronavirus infection blockade thought beneficial preventingtreating infection retrospective analysis found reduced rates death endotracheal intubation patients viral pneumonia continued ace inhibitors<NUMBER> mice coronavirus induced lung injury showed improvement treated losartan<NUMBER> far cvid<NUMBER> infection concerned data ras activation effect blockade limited present hypokalaemia could marker ras activation high incidence hypokalaemia reported patients covid<NUMBER> infection<NUMBER>despite small studies suggesting benefit drugs acting ras data albeit scarce animal models human studies treatment ace inhibitors arb could cause regulation ace<NUMBER> ibuprofen thiazolidinediones also shown same<NUMBER> <NUMBER> increased expression ace<NUMBER> could theoretically increase risk infection sars cov<NUMBER> could concern people diabetes already elevated risk infections many factors however currently evidence support hypothesis view lack robust evidence either benefit harm reasonable patients continue using ace inhibitors arb recommended european society cardiology council hypertension european society hypertension<NUMBER> <NUMBER>references<NUMBER>guptarghoshasinghakmisraaclinical considerations patients diabetes times covid<NUMBER> epidemicdiabetes metab syndr<NUMBER> mar <NUMBER>fanglkarakiulakisgrothmare patients hypertension diabetes mellitus increased risk covid<NUMBER> infectionlancet respir med<NUMBER> mar <NUMBER>s<NUMBER>hoffmannmkleineweberhkrügernmüllermdrostencpöhlmannsthe novel coronavirus <NUMBER> <NUMBER>ncov uses sarscoronavirus receptor ace<NUMBER> cellular protease tmprss<NUMBER> e ntry target cellsbiorxiv<NUMBER>henryczaizafounmstockeghamandesarroligaacwhitehdimpact angiotensinconverting enzyme inhibitors statins viral pneumoniaproc bayl univ med cent<NUMBER>yangpguhzhaozwangwcaoblaicyangxzhanglduanyzhangschenwzhenwcaimpenningerjmjiangcwangxangiotensinconverting enzyme <NUMBER> ace<NUMBER> mediates influenza h<NUMBER>n<NUMBER> virusinduced acute lung injurysci rep<NUMBER>chen li x song q hu c su f daij ye huangj zhang x hypokalemia clinical implications patients coronavirus disease <NUMBER> covid<NUMBER> medrxiv preprint doi <NUMBER>lixczhangjzhuojlthe vasoprotective axes reninangiotensin system physiological relevance therapeutic implications cardiovascular hypertensive kidney diseasespharmacol res<NUMBER>qiaowwangcchenbzhangfliuyluqguohyancsunhhugyinxibuprofen attenuates cardiac fibrosis streptozotocininduced diabetic ratscardiology<NUMBER>zhangwxuyzliubwuryangyyxiaoxqzhangxpioglitazone upregulates angiotensin converting enzyme <NUMBER> expression insulinsensitive tissues rats highfat dietinduced nonalcoholic steatohepatitisscientific world journal<NUMBER>position statement esc council hypertension aceinhibitors angiotensin receptor blockers mar <NUMBER> <NUMBER> httpswwwescardioorgcouncilscouncilonhypertensionchtnewspositionstatementoftheesccouncilonhypertensiononaceinhibitorsandang<NUMBER>esh statement covid<NUMBER> march <NUMBER> <NUMBER> httpswwweshonlineorgspotlightseshstatementoncovid<NUMBER>accessed <NUMBER> march <NUMBER> coronaviruses covs enveloped viruses positive singlestranded rna virus widely distributed humans animals cause respiratory infections humans <NUMBER> nowadays ongoing pandemic covid<NUMBER> caused novel coronavirus syndromecoronavirus<NUMBER> sarscov<NUMBER> emerging rapidly evolving situation <NUMBER> april <NUMBER> <NUMBER> <NUMBER> cases <NUMBER> deaths total confirmed around world suggesting overall death rate covid<NUMBER> <NUMBER> although sarscov<NUMBER> sarscov share similarities phylogeny clinical trials new type coronavirus seems higher spread lower mortality <NUMBER> study reported sarscov<NUMBER> invades cells predicated receptor angiotensin converting enzyme <NUMBER> ace<NUMBER> <NUMBER> blocking reninangiotensin system prevent newonset diabetes reduce risk diabetes complications <NUMBER> du et al <NUMBER> found elderly <NUMBER> years old showed higher risk suffering disease especially severe complications patients experience entering managed antonio secchi intensive care unit icu finding indicated complications may risk factor adverse consequences recent metaanalysis reported hypertension diabetes copd cardiovascular disease cerebrovascular disease major risk factors patients covid<NUMBER> impact risk factors covid<NUMBER> mortality explored <NUMBER> therefore metaanalysis first aims explore possible clinical mortality diabetes covid<NUMBER> analyze diabetes patients infected sarscov<NUMBER> exposed worst clinical prognostic risk evaluate reliability evidence result may help government formulate prevention policies respond outbreak covid<NUMBER> ultimately contributing better clinical management patients covid<NUMBER> diabetes preferred reporting items metaanalyses prisma guidelines used determined include studies involving covid<NUMBER> sarscov<NUMBER> diabetes find relevant primitive articles performed comprehensive retrieval databases involving medline via pubmed embase web science following words also reviewed reference lists based recognized literature find additional eligible studies first screened titles abstracts articles publications may involve data concerning covid<NUMBER> sarscov<NUMBER> diabetes primitive studies carefully examined nation restrictions study inclusion criteria follows <NUMBER> studies reporting data covid<NUMBER> nonsurvivors survivors laboratoryconfirmed covid<NUMBER> patients <NUMBER> studies limited mankind contained original data published english appeared form either abstract fulltext exclusion criteria follows <NUMBER> duplicate studies letters case reports abstracts reviews <NUMBER> research focusing morbidity rather mortality collected following information study publication year first authors name sample size age dead group alive group assessed quality involved research newcastleottawa scale <NUMBER> metaanalysis conducted via review manager <NUMBER> calculating <NUMBER> index evaluate heterogeneity <NUMBER> values <NUMBER> <NUMBER> <NUMBER> <NUMBER> considered homogeneous low moderate high heterogeneous levels respectively <NUMBER> value <NUMBER> random effects model rem would applied <NUMBER> value <NUMBER> fixed effects model fem would applied pooled odds ratios ors different studies corresponding <NUMBER> confidence intervals cis used estimate relationship diabetes mortality patients covid<NUMBER> sensitivity analysis repeated impact study evaluated deleting different individual studies time total <NUMBER> potentially relevant articles identified using search strategy databases <NUMBER> reference lists four hundred sixty studies remained ruling duplicates screening titles abstracts <NUMBER> research articles satisfy inclusion criteria ruled scanning main body reserving <NUMBER> records another seven articles excluded finally nine qualified articles met eligibility criteria <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> steps document retrieval shown fig <NUMBER> meanwhile common characteristic included studies listed table <NUMBER> metaanalysis involved <NUMBER> cases <NUMBER> dead <NUMBER> alive overall published <NUMBER> one study <NUMBER> reported settings icu isolation wards articles high quality nos score less <NUMBER> outcome forest plot connection diabetes mortality patients covid<NUMBER> shown fig <NUMBER> results showed close relationship diabetes mortality covid<NUMBER> pooled <NUMBER> <NUMBER> ci <NUMBER> p <NUMBER> pooled data calculated fem heterogeneity appeared studies chose age subgroup significant difference age ≥ <NUMBER> subgroup age <NUMBER> subgroup <NUMBER> <NUMBER> ci <NUMBER> p <NUMBER> <NUMBER> <NUMBER> ci <NUMBER> p <NUMBER> respectively fig <NUMBER> result insufficient data impact age stratification mortality covid<NUMBER> carried meanwhile study demonstrated heterogeneity <NUMBER> <NUMBER> upon eliminating impact yuans study wangs study results significantly affected pooled outcomes <NUMBER> dropped <NUMBER> <NUMBER> therefore assumed studies yuan et al wang et al may sources heterogeneity metaanalysis sensitivity analysis results showed ors ranged <NUMBER> <NUMBER> ci <NUMBER> <NUMBER> <NUMBER> ci <NUMBER> risk publication bias analyzed beggs test p <NUMBER> eggers regression test p <NUMBER> indicating significant publication bias metaanalysis metaanalysis suggested mortality patients covid<NUMBER> significantly related diabetes <NUMBER> <NUMBER> ci <NUMBER> p <NUMBER> meanwhile value <NUMBER> <NUMBER> <NUMBER> <NUMBER> p <NUMBER> indicated heterogeneity exists studies addition sensitivity analysis revealed excluding single study rem converted fem total outcomes still held confident validity data obtained study showing powerful correlation diabetes mortality patients covid<NUMBER> despite unclear pathophysiology observed severe fatal cases covid<NUMBER> occur elderly patients potential complications especially diabetes <NUMBER> according reports diabetes high blood glucose levels important predictors severity death patients infected different viruses involving sarscov merscov <NUMBER> <NUMBER> study found elderly patients chronic diseases including diabetes higher risk severe covid<NUMBER> infection death <NUMBER> insulin resistance promotes synthesis endglycosylation products stimulates production proinflammatory cytokines oxidative stress adhesion molecules resulting higher likelihood infection worse prognosis <NUMBER> infection leads destruction pancreatic beta cells decreased pancreatic insulin content changes hosts ability respond normally glucose tolerance tests <NUMBER> previous study suggested sars coronavirus uses ace<NUMBER> receptor enter damage islet cells cause acute diabetes <NUMBER> relevant study exploring role ace<NUMBER> covid<NUMBER> diabetic patients recent metaanalysis retrieved data <NUMBER> chinese patients diagnosed sarscov<NUMBER> infection found prevalence diabetes <NUMBER> <NUMBER> metaanalysis explored possible mortality diabetes covid<NUMBER> therefore metaanalysis results found significant relationship diabetes mortality covid<NUMBER> pooled <NUMBER> <NUMBER> ci <NUMBER> p <NUMBER> may contribute better clinical management patients covid<NUMBER> diabetes compared younger patients patients aged <NUMBER> showed higher risk initial complications severe symptoms prone multiple organ involvement death <NUMBER> similarly feng et al <NUMBER> recruited <NUMBER> covid<NUMBER> patients three different cities china survival rate patients <NUMBER> years old significantly lower young patients factors leading poor health include physiological changes aging multiple agerelated complications study held opinion older peoples suspicion detection threshold sars<NUMBER> lower temperature decline pulmonary function shortness breath <NUMBER> management began diagnosis classification elderly order achieve appropriate level care simultaneously age subgroup analysis results indicated significant difference age ≥ <NUMBER> subgroup age <NUMBER> subgroup however chose threshold age stratification <NUMBER> years old age ≥ <NUMBER> subgroup would <NUMBER> <NUMBER> ci <NUMBER> p <NUMBER> research impact age stratification mortality covid<NUMBER> diabetic patients carried first attempt use metaanalysis prove whether mortality patients covid<NUMBER> related diabetes time study limitations first due inadequate data access information diabetes duration time diagnoses diabetes type diabetes medications complications thus cannot conduct risk stratification subgroup analysis within diabetic population second obtained information regarding age gender covid<NUMBER> patients factors might influence accuracy results bmi <NUMBER> measurements instruments detection sarscov<NUMBER> meanwhile populations included study mainly asian populations conclusions even important cannot extended automatically caucasian populations finally patients diagnosed covid<NUMBER> may multiple chronic diseases simultaneously hypertension cardiovascular disease cerebrovascular disease copd may affect accuracy results meanwhile samples quite enough largescale studies needed metaanalysis showed diabetes increases mortality patients covid<NUMBER> results indicated disturbance blood glucose covid<NUMBER> patients importantly metaanalysis grades reliability evidence basic clinical research diabetes dysfunction covid<NUMBER> patients clinical considerations patients diabetes times covid<NUMBER> pandemic dear sir todays reports global number confirmed cases covid<NUMBER> surpassed <NUMBER> number known cases increasing several thousand every day march <NUMBER> <NUMBER> publicly characterized covid<NUMBER> pandemic issue serious concern deserves momentous attention coronaviruses family viruses cause respiratory illnesses cause illness animals seven known types coronaviruses cause illness humans coronavirus sarscov<NUMBER> severe acute respiratory syndromecoronavirus<NUMBER> one viruses e causes illness currently known coronavirus disease<NUMBER> covid <NUMBER> though still learning exactly puts someone greater risk developing severe illness covid<NUMBER> early information indicates older patients chronic medical conditions hypertension diabetes cardiocerebrovascular diseases may higher risk <NUMBER>e<NUMBER> infection caused covid<NUMBER> likely disturb metabolic regulation diabetic patients covid<NUMBER> may face altered immune response background already compromised health status owing diabetesrelated complications andor aging important findings patients hyperglycemia viral infection significant worsening symptoms implies greater morbidity patients compared without diabetes <NUMBER> however pathophysiology association remains uncertain known whether hyperglycemia changes virulence infection virus modifies glycemic metabolism know diabetic patients susceptible infection impact glucose metabolism <NUMBER> dm disorder glucose metabolism chronic inflammatory condition characterized multiple changes lipid carbohydrate protein profiles <NUMBER> inflammatory processes due hyperglycemia leads increased synthesis glycosylation end products ages activates macrophages cells immune system increase oxidative stress promote synthesis proinflammatory cytokines besides stimulating synthesis adhesion molecules facilitate inflammation tissues <NUMBER> inflammatory process complications might provide higher propensity infections greater severity conditions another important issue inflammatory immune response occur diabetic patients acquire viral infection well whether virus interferes insulin secretion glycemic control stage biological mechanism relationship covid<NUMBER> diabetes known association severity cases death pronounced need develop hypothesis explain causal path underlying severe clinical presentation covid<NUMBER> infection subsequent death diabetic patients biochemical tests also essential clarify molecular pathophysiology involved association covid<NUMBER> dm substantial public health importance deserves proper attention since large diverse population affected globally nowadays comorbidity poses relevant threat human health prospective welldesigned studies elucidate biological mechanism best clinical management association urgently needed useful see review published journal diabetes covid <NUMBER> infection <NUMBER> highlight people diabetes death rate perhaps around four times background population note suggested <NUMBER>e<NUMBER> deaths chinawuhan people diabetes <NUMBER> clearly important understand confounders form associations risk factors dying covid<NUMBER> infection notably age cardiovascular disease cannot explain excess need understand better mitigate risk reported deaths occurring context pneumonitis <NUMBER> <NUMBER> particularly onset adult respiratory distress syndrome ards condition excess fluid alveoli blocks gas exchange air blood people diabetes many cardiovascular disease cvd without diabetes permeable vasculature identified since <NUMBER>s albumin lead kidneys microand macroalbuminuria even prior late blush retina intravenous fluorescence marker injection <NUMBER> leaky vasculature associated vascular inflammation metabolic syndrome steatohepatitis well cvd per se would seem far stretch absence research yet assume prior enhancement vascular permeability could account increased rate ards death people diabetes particularly type <NUMBER> diabetes also cvd aside research would suggest already albuminuria routine yearly test people diabetes higher liver enzyme markers alt perhaps diabetes associated dyslipidaemia low hdl cholesterol take particular steps selfisolate unclear fast vascular inflammation ameliorated improved blood glucose control nearly glucoselowering medications reduce microalbuminuria time tight glucose control infected persons insulin would meanwhile seem sensible poor glucose control known interfere leukocytelymphocyte function <NUMBER> dear editor recently published article highlighting special concerns managing patients diabetes times covid<NUMBER> pandemic <NUMBER> concerns use angiotensin converting enzyme ace inhibitors angiotensin receptor blockers arbs clarified publication <NUMBER> summarising current evidence regard try arrive reasonable conclusion absence vaccine antiviral drug covid<NUMBER> infection several therapeutic approaches studied one approach use inhibitors renin angiotensin system namely ace inhibitors arbs hand concern raised fact patients agents might increased risk infection severe acute respiratory syndrome coronavirus<NUMBER> sars cov<NUMBER> angiotensin converting enzyme<NUMBER> ace<NUMBER> receptor sars cov<NUMBER> well coronaviruses expressed type <NUMBER> alveolar epithelial cells endothelium sglycoprotein surface coronavirus binds ace<NUMBER> leads conformational change sglycoprotein allows proteolytic digestion host cell proteases tmprss<NUMBER> ultimately leading internalization virion <NUMBER> viral sglycoprotein tmprss<NUMBER> ace<NUMBER> inhibition potential targets therapy possibly vaccine development ace<NUMBER> essential coronavirus infection blockade thought beneficial preventingtreating infection retrospective analysis found reduced rates death endotracheal intubation patients viral pneumonia continued ace inhibitors <NUMBER> mice coronavirus induced lung injury showed improvement treated losartan <NUMBER> far cvid<NUMBER> infection concerned data ras activation effect blockade limited present hypokalaemia could marker ras activation high incidence hypokalaemia reported patients covid<NUMBER> infection <NUMBER> despite small studies suggesting benefit drugs acting ras data albeit scarce animal models human studies treatment ace inhibitors arb could cause regulation ace<NUMBER> <NUMBER> ibuprofen thiazolidinediones also shown <NUMBER> <NUMBER> increased expression ace<NUMBER> could theoretically increase risk infection sars cov<NUMBER> could concern people diabetes already elevated risk infections many factors however currently evidence support hypothesis view lack robust evidence either benefit harm reasonable patients continue using ace inhibitors arb recommended european society cardiology council hypertension european society hypertension <NUMBER> <NUMBER> clusters pneumonia caused severe acute respiratory syndrome coronavirus<NUMBER> sarscov<NUMBER> emerged wuhan china early december <NUMBER> rapid spreading sarscov<NUMBER> occurred throughout globe present june <NUMBER> <NUMBER> <NUMBER> confirmed cases including <NUMBER> deaths reported across <NUMBER> countries <NUMBER> huge outbreak occurred february <NUMBER> <NUMBER> result superspreading event within religious group daegu southern south korea <NUMBER> confirmed cases <NUMBER> deaths reported south korea june <NUMBER> <NUMBER> <NUMBER> although fatality rate coronavirus disease <NUMBER> cov lower severe acute respiratory syndrome caused severe acute respiratory syndrome coronavirus<NUMBER> sarscov<NUMBER> middle east respiratory syndrome mers caused middle east respiratory syndromerelated coronavirus merscov absolute number fatalities result covid<NUMBER> extremely high high prevalence covid<NUMBER> <NUMBER> severity disease varies asymptomatic infection mild selflimiting upper respiratory tract illness severe pneumonia respiratory failure multiorgan dysfunction death although large majority cases mild severe fatal many people covid<NUMBER> comorbidities diabetes cardiovascular disease hypertension <NUMBER> <NUMBER> <NUMBER> diabetic patients strongly suggested severe outcomes higher mortality due covid<NUMBER> without diabetes <NUMBER> thus diabetic community urgently needs know covid<NUMBER> effects patients diabetes special precautions taken management covid<NUMBER> pandemic report aims describe association diabetes covid<NUMBER> provides official suggestions korean diabetes association kda covid<NUMBER> outbreak people diabetes increased risk serious infection <NUMBER> diabetes identified major contributor disease severity fatality h<NUMBER>n<NUMBER> pandemic influenza virus infection mers <NUMBER> <NUMBER> currently available data come hospitalized cohorts reported prevalence diabetes covid<NUMBER> ranging <NUMBER> <NUMBER> worldwide <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> small number nationwide studies available recent populationbased cohort study using korean health insurance review assessment service hira data among <NUMBER> covid<NUMBER> patients <NUMBER> <NUMBER> diabetes korea unpublished data data studies across china estimated population prevalence diabetes covid<NUMBER> patients approximately <NUMBER> <NUMBER> higher prevalence diabetes general population <NUMBER> <NUMBER> according report centers disease control prevention cdc united states <NUMBER> covid<NUMBER> patients diabetes <NUMBER> summarize reports diabetes one common comorbidities covid<NUMBER> infection still unclear whether people diabetes susceptible covid<NUMBER> infection disease severity mortality patients diabetes higher patients without diabetes among covid<NUMBER> several studies twocenter retrospective study performed hospitals wuhan showed higher proportion intensive care unit icu admissions <NUMBER> vs <NUMBER> p <NUMBER> fatal cases <NUMBER> vs <NUMBER> p<NUMBER> identified covid<NUMBER> patients diabetes sexand agematched patients without diabetes <NUMBER> another retrospective multicenter study <NUMBER> cases covid<NUMBER> china found subjects type <NUMBER> diabetes mellitus required medical interventions significantly higher mortality <NUMBER> vs <NUMBER> adjusted hazard ratio hr <NUMBER> nondiabetic individuals <NUMBER> singlecenter study conducted korea mortality significantly higher patients diabetes <NUMBER> without diabetes <NUMBER> <NUMBER> study based nationwide surveillance data among <NUMBER> fatal cases covid<NUMBER> <NUMBER> found diabetes korea <NUMBER> according nationwide populationbased cohort study conducted korea prevalence diabetes among covid<NUMBER> patients hospitalized received oxygen supply applied mechanical ventilator died <NUMBER> <NUMBER> <NUMBER> <NUMBER> respectively unpublished data metaanalysis <NUMBER> patients <NUMBER> studies also showed diabetes associated composite poor outcomes including mortality severe covid<NUMBER> acute respiratory distress syndrome ards need icu care disease progression risk ratio <NUMBER> <NUMBER> <NUMBER> p<NUMBER> <NUMBER> <NUMBER> <NUMBER> results suggest association diabetes poor prognosis increased mortality covid<NUMBER> publications investigated association diabetes severity patients covid<NUMBER> shown fig <NUMBER> several suggested mechanisms might play role association diabetes covid<NUMBER> fig <NUMBER> uncontrolled hyperglycemia reported significant predictor severity fatality different viral diseases including sarscov <NUMBER> pandemic influenza <NUMBER> merscov infection <NUMBER> <NUMBER> observational study conducted france longterm glycemic control assessed using glycosylated hemoglobin hba<NUMBER>c associated covid<NUMBER> severity <NUMBER> although admission plasma glucose significantly associated primary outcome tracheal intubation mechanical ventilation death within <NUMBER> days admission age sexadjusted nonlinear models predictor severity covid <NUMBER> multivariable models <NUMBER> hba<NUMBER>c also predictor covid <NUMBER> severity single center study korea <NUMBER> retrospective multicenter study conducted china showed wellcontrolled blood glucose assessed using glycemic variability associated markedly lower mortality individuals diabetes metab j <NUMBER> httpsedmjorg poorly controlled blood glucose adjusted hr <NUMBER> hospitalization adjusting age sex covid<NUMBER> severity comorbidities side effects patients covid<NUMBER> preexisting type <NUMBER> diabetes mellitus <NUMBER> single center study italy reported group treated insulin infusion better glycemic control less severe covid<NUMBER> <NUMBER> findings provide clinical evidence uncontrolled hyperglycemia hospitalization associated poor outcomes covid<NUMBER> patients diabetes prospective controlled studies needed clarify effect hyperglycemia prognosis covid<NUMBER> diabetes might associated immune system impairment may affect inflammatory response pathogens poorly controlled diabetes linked inhibited lymphocyte proliferative responses different stimuli <NUMBER> impaired macrophage neutrophil functions <NUMBER> furthermore bactericidal activity following stimulation decreased bacterial phagocytosis killing mechanisms reduced diabetic patients <NUMBER> demonstrated respiratory burst monocytes patients poorly controlled disease hyperglycemia severely impaired compared patients wellcontrolled disease healthy people <NUMBER> influenza virus infection replication significantly increased pulmonary epithelial cells exposed high glucose concentrations <NUMBER> lowgrade chronic inflammation common feature subjects type <NUMBER> diabetes mellitus creactive protein crp wellestablished marker development inflammation tumor necrosis factor α inflammatory marker interleukin <NUMBER> strongly associated diabetes <NUMBER> cytokines play key role promoting atherosclerosis therefore cardiovascular disease <NUMBER> interestingly ards patients covid<NUMBER> driven severe hypoxemia despite relatively wellpreserved lung mechanics <NUMBER> preexisting proinflammatory state could accentuate hyperinflammatory response cytokine storm believed responsible ards well multiorgan dysfunction covid<NUMBER> <NUMBER> comorbidities diabetes might cause susceptibility covid<NUMBER> diabetic patients common demographics comorbidities diabetes older age male sex cardiovascular disease hypertension obesity associated poor outcomes covid<NUMBER> <NUMBER> <NUMBER> retrospective singlecenter study conducted korea reported age independent risk factor severe outcomes patients diabetes <NUMBER> study assessing prognostic value clinical biological features age microvascular macrovascular diabetic complications treated obstructive sleep apnea dyspnea increased aspartate transaminase crp decreased estimated glomerular filtration rate platelet count independently associated risk early death patients diabetes hospitalized covid<NUMBER> <NUMBER> obesity also known independent risk factor severity covid<NUMBER> patients <NUMBER> angiotensinconverting enzyme <NUMBER> ace<NUMBER> protein important element regulation blood pressure metabolism inflammation also identified receptor coronavirus spike protein sarscov<NUMBER> enters cell binding ace<NUMBER> <NUMBER> experimental evidence downregulation ace<NUMBER> diabetes <NUMBER> might reduce entry virus cells furthermore ace<NUMBER> expressed pancreatic beta cells sarscov<NUMBER> might enter islets cells cause betacell dysfunction <NUMBER> hand ace<NUMBER> suggested protective effect inflammationinduced damage ang<NUMBER> formed angii ace<NUMBER> exerts inhibitory effects inflammation vascular cellular growth mechanisms acting via mas receptor <NUMBER> downregulation ace<NUMBER> diabetes might make cells vulnerable inflammation following viral infection dipeptidyl peptidase<NUMBER> dpp<NUMBER> inhibitors one frequently used medications patients type <NUMBER> diabetes mellitus vitro experiments dpp<NUMBER> identified functional receptor merscov entry cell <NUMBER> antibodies directed dpp<NUMBER> inhibited merscov infection primary cells <NUMBER> dpp<NUMBER> may also role entry route sarscov<NUMBER> although proven yet vitro treatment dpp<NUMBER> inhibitors block entry coronavirus cells <NUMBER> hand dpp<NUMBER> enzyme known involved immune system increases inflammation type <NUMBER> diabetes mellitus <NUMBER> whether dpp<NUMBER> enzyme also plays role association diabetes covid<NUMBER> currently unknown based mounting evidence supporting effect proper glycemic control prognosis covid<NUMBER> intensified glycemic control recommended covid<NUMBER> patients diabetes infection sarscov<NUMBER> might trigger stress conditions increased secretion stress hormones cortisol catecholamines result elevation blood glucose extreme glycemic excursion practice cases acute hyperglycemic crisis reported covid<NUMBER> patients diabetes <NUMBER> <NUMBER> case report successful management highrisk patients type <NUMBER> diabetes mellitus diabetic ketoacidosis using telehealth <NUMBER> thought pandemic health providers diabetic patients required minimize contact may even quarantined telehealth could provide alternative support preventing acute complications controlling sever hyperglycemia people diabetes infected sarscov<NUMBER> also recommended maintain optimal glycemic control part primary prevention covid<NUMBER> covid<NUMBER> patients without diabetes need monitored new onset diabetes viral infection trigger onset diabetes <NUMBER> covid<NUMBER> patients hyperglycemia diagnosed diabetes hospitalization single center study <NUMBER> also covid<NUMBER> pandemic social distancing decrease attendances hospital facilities limited access patients remote consultations easy miss urgent situations diabetic complications diabetic foot acute coronary syndrome severe diabetic retinopathy therefore doctors healthcare providers patients need alert regards development deterioration diabetic complications metformin recommended firstline treatment choice one frequently prescribed medications type <NUMBER> diabetes mellitus metformin contraindicated people concomitant sepsis severe impairment hepatic renal function covid<NUMBER> patients vulnerable dehydration multiorgan failure patients follow sick day rule metformin stopped severe renal hepatic dysfunction confirmed careful monitoring renal function needed illness euglycemic ketoacidosis rarely reported type <NUMBER> diabetes mellitus treated sodiumglucose cotransporter<NUMBER> sglt<NUMBER> inhibitor sglt<NUMBER> inhibitors discontinued patients renal dysfunction severe sarscov<NUMBER> infection dehydrated risk ketoacidosis however prophylactic discontinuation medications recommended patients mild symptoms without symptomsorgan failure previously described dpp<NUMBER> inhibitor suggested protective role mers <NUMBER> lack evidence sarscov<NUMBER> binding dpp<NUMBER> dpp<NUMBER> inhibitors glucagonlike peptide<NUMBER> receptor agonists may exert antiinflammatory actions human subjects successfully used control glucose levels hospitalized patients <NUMBER> study using korean national insurance claim data analyzed <NUMBER> confirmed covid<NUMBER> subjects dm showed use dpp<NUMBER> inhibitor associated better clinical outcomes patients covid<NUMBER> <NUMBER> however whether dpp<NUMBER> inhibitors influence course covid<NUMBER> remains unclear insufficient secretion insulin result beta cell dysfunction develop patients multiple stresses triggered covid<NUMBER> intensive glucose control use insulin feasible treatment insulin infusion showed better glycemic control less severe covid<NUMBER> retrospective study <NUMBER> possibility extreme blood excursion patients severe covid<NUMBER> risk hypoglycemia carefully monitored insulin use good glycemic control important improving outcomes patients covid<NUMBER> antidiabetic medications effectively control blood glucose beneficial effect covid<NUMBER> prognosis antidiabetic medications suggested immunemodulating effects expected additional benefits neither proven yet larger cohort studies needed prove specific antidiabetic medication beneficial independent glycemic control covid<NUMBER> patients regarding association covid<NUMBER> ace<NUMBER> increased risk sarscov<NUMBER> infection due elevated expression ace<NUMBER> patients treated ace inhibitors angiotensin ii receptor blockers arbs hypothesized controversy whether reninangiotensin aldosterone system raas inhibitors harmful protective respect covid<NUMBER> positive test covid<NUMBER> risk severe covid<NUMBER> increased patients take raas inhibitors <NUMBER> retrospective singlecenter study conducted korea also showed use arb ace inhibitor medications associated critical outcome showed protective effects acute cardiac injury odds ratio <NUMBER> p<NUMBER> diabetic patients covid<NUMBER> <NUMBER> study korea using national insurance claim data also showed effect raas blockade clinical outcomes covid<NUMBER> patients diabetes <NUMBER> metaanalysis <NUMBER> studies involving <NUMBER> covid<NUMBER> cases raas inhibitor exposure associated higher risk covid<NUMBER> among covid<NUMBER> put mask visit medical institution avoid crowds avoid contacting someone fever respiratory symptoms avoid personal contact home much possible always wipe table doorknob keyboard frequently touched practice blood sugar management make sure keep oral medication insulin administration strict usual conduct check selfmonitoring blood sugar frequently waking morning <NUMBER> hours meals conduct selfmonitoring blood sugar least twice day result consistently higher usual visit doctor use phone helpline limit sugar eating three meals balance diets eat enough vegetables take enough protein well drink plenty water prevent infection exercise necessary order maintain immunity certain amount minimum <NUMBER> minutes aerobic exercises regularly every day home resistance exercise twice week contact community healthcare center symptoms cough phlegm fever contact doctor sudden blood sugar increase difficult visit doctor consult phone helpline allowed temporarily diabetes metab j <NUMBER> httpsedmjorg fection raas inhibitor exposure also associated higher risk severe outcomes mortality contrary raas inhibitor exposure associated lower risk mortality compared nonraas inhibitor antihypertensive drugs <NUMBER> <NUMBER> confidence interval ci <NUMBER> <NUMBER> p<NUMBER> <NUMBER> strongly recommended patients taking ace inhibitors arbs withdraw current treatment regimens covid<NUMBER> possibility patients diabetes typically immunosuppressive condition develop serious covid<NUMBER> kda would like make official suggestions regarding covid<NUMBER> epidemiological emergency kda suggests patients diabetes particularly <NUMBER> years old opportunity tested hospitalized symptoms first detected situation nationwide spread already suspected beyond local infection preferential screening hospitalization high risk groups elderly patients diabetes progress serious condition decrease entire death toll number deaths aged older population prevent development serious illness would efficient response covid<NUMBER> kda also provides covid<NUMBER> prevention guidelines patients diabetes table <NUMBER> people diabetes health providers aware likely develop serious illness otherwise healthy people follow strict prevention guidelines particular patients diabetes aged <NUMBER> years highrisk group require special care difficult situation important measure blood sugar closely strictly maintain life style kda suggests refraining going visiting crowded areas ensuring good hand washing maintaining cough etiquette avoiding touching face unwashed hands putting mask visiting medical institution avoiding contacting someone fever respiratory symptoms kda also recommends avoiding personal contact home much possible always wiping frequently touched surfaces tables doorknob keyboard blood sugar management kda suggests taking oral medications administering insulin strictly usual selfmonitoring blood sugar frequently selfmonitoring blood sugar performed least twice day waking morning <NUMBER> hours meals result consistently higher usual patients visit doctor use phone helpline proper nutrition therapy also important sugar consumption limited regular three meals balanced diet essential sufficient vegetable protein consumption also recommended kda also recommends drinking plenty water prevent infection exercise necessary order maintain immunity certain amount minimum <NUMBER> minutes regular aerobic exercise recommended every day home regular resistance exercises also recommended least twice week contacting community healthcare center needed symptoms cough phlegm fever immediate contact doctor also needed blood sugar levels reveal sudden consistent increase difficult visit doctor consult phone helpline allowed temporarily close attention timely adequate care essential prevention proper treatment covid<NUMBER> diabetic patients expanding knowledge covid<NUMBER> developing medications sarscov<NUMBER> infection conducting studies identifying unanswered questions pathogenic pathway risk factors effects antidiabetic medications covid<NUMBER> outcomes best practice managing diabetes pandemic essential future another infectious disease pandemic prepare nationwide remote monitoring couching system diabetic patients soon possible kda spare effort closely cooperating health authorities patients diabetes overcome current difficulties related covid<NUMBER> potential conflict interest relevant article reported junghyun noh httpsorcidorg<NUMBER> inkyung jeong httpsorcidorg<NUMBER>x kun ho yoon httpsorcidorg<NUMBER> n u c r p <NUMBER> prevalence t<NUMBER>d <NUMBER> <NUMBER> data reported laboratoryconfirmed sarscov<NUMBER> infections united states february <NUMBER>march <NUMBER> <NUMBER> tabulated centers disease control <NUMBER> subjects completed case information revealed prevalence rates diabetes <NUMBER> <NUMBER> <NUMBER> nonhospitalized hospitalized requiring intensive care unit icu admission vs hospitalized icu respectively <NUMBER> among hospitalized sarscov<NUMBER> positive patients assessed single health care centre new york march <NUMBER>april <NUMBER> <NUMBER> prevalence diabetes <NUMBER> sarscov<NUMBER> population <NUMBER> however prevalence rates diabetes <NUMBER> vs <NUMBER> obesity <NUMBER> vs <NUMBER> greater hospitalized vs nonhospitalized subgroups respectively furthermore bmi<NUMBER> among risk factors predictive need hospitalization <NUMBER> pancreatic injury determined assessment plasma levels amylase lipase reported <NUMBER> patients hospitalized sarscov<NUMBER>associated pneumonia china <NUMBER> subjects also exhibited moderate increases plasma glucose <NUMBER> emerging putative association pancreatic injury sarscov<NUMBER> consistent expression ace<NUMBER> exocrine endocrine pancreas <NUMBER> obesity also risk factor increasing severity sarscov<NUMBER>related illness analysis <NUMBER> consecutive icu admissions single center lille france february <NUMBER>april <NUMBER> <NUMBER> revealed greater rates obesity severe obesity among sarscov<NUMBER> patients relative historical nonsarscov<NUMBER> controls <NUMBER> frequency obesity <NUMBER> observational study compared <NUMBER> historical control group icu subjects nonsarscov<NUMBER> illness requirement intubation mechanical ventilation higher subjects obesity related observations reported retrospective analysis <NUMBER> sarscov<NUMBER> subjected presenting emergency room single medical center new york march <NUMBER>april <NUMBER> <NUMBER> individuals obesity severe obesity <NUMBER> years old likely require acute medical care admission intensive care unit <NUMBER> consistent findings great proportion <NUMBER> critically ill patients sarscov<NUMBER> admitted icus march <NUMBER>april <NUMBER> <NUMBER> england wales northern ireland reported bmi <NUMBER> relative critically ill historical controls hospitalized icu <NUMBER> viral pneumonia <NUMBER> moreover progressive increase bmi associated greater mortality subjects sarscov<NUMBER> infection relative bmimatched hospitalized icu controls viral pneumonia acute viral respiratory infection linked rapid development transient insulin resistance otherwise healthy euglycemic normal weight overweight individuals <NUMBER> moreover infection severe illness medications glucocorticoids impair insulin sensitivity often necessitates adjustment glucoselowering medications insulin dosage hospital worldwide infectious diseases contribute excess mortality individuals diabetes <NUMBER> mortality increased older patients diabetes retrospective analysis people french intensive care units hospitalized pulmonary invasive pneumococcal infection <NUMBER> nevertheless studies show differences corrected age comorbidities plasma biomarker responses hospitalization outcomes people diabetes hospitalized intensive care unit sepsis <NUMBER> diagnosis diabetes linked increased susceptibility adverse outcomes associated bacterial mycotic parasitic viral infections <NUMBER> attributed combination dysregulated innate immunity maladaptive inflammatory responses <NUMBER> pulmonary systemic coronavirus infection including sarscov<NUMBER> may complicated secondary bacterial infection n u c r p <NUMBER> reflecting compromise epithelial barrier function lungs gastrointestinal tract substantial number subjects diabetes increased risk infection due concomitant immunosuppression associated history solid organ transplantation <NUMBER> primary site energy absorption gut plays important role metabolic homeostasis production metabolically active gut hormones interaction microbiota via potential capacity contribute gluconeogenesis <NUMBER> moreover healthy gut essential absorption action several glucoselowering medications including widely used metformin <NUMBER> delivered orally treatment t<NUMBER>d potential clinical relevance dpp<NUMBER> ace<NUMBER> tmprrss<NUMBER> substantially expressed beyond lung within epithelial tissues including small large bowel enterocytes <NUMBER> <NUMBER> <NUMBER> experimental inoculation merscov murine gut human dpp<NUMBER> transgenic mice produces lethal infection associated progressive systemic viral dissemination <NUMBER> initial reports describing clinical symptoms <NUMBER> hospitalized sarscov<NUMBER> patients china reported low rate <NUMBER> gastrointestinal complaints consistent potential importance enterocyte viral entry symptoms gut inflammation including nausea vomiting diarrhea reported severely ill individuals mers <NUMBER> notably subjects sarscov<NUMBER> may present gastrointestinal distress without symptoms pulmonary infection <NUMBER> subset individuals also exhibit clinical evidence liver injury glucose levels higher severely ill patients <NUMBER> whether oral absorption medications t<NUMBER>d actions drugs liver might impaired proportion infected subjects t<NUMBER>d gastrointestinal dysfunction determined ace<NUMBER> <NUMBER> amino acid transmembrane carboxypeptidase enzyme functional coronavirus s<NUMBER> subunit receptor cleaves last amino acid angiotensin ii figure <NUMBER> generates vasodilatory ang<NUMBER> collectively modulating often opposing actions angiotensin ii angiotensin converting enzyme ace angiotensin mas receptors example reduction ace<NUMBER> activity context unopposed ace<NUMBER> action may lead augmented signaling angiotensin receptors figure <NUMBER> increased aldosterone possibly increased blood pressure hypokalemia physiological actions ace<NUMBER> relevant metabolism mediated part expression blood vessels pancreas renal tubular epithelium via enzymatic generation angiotensin<NUMBER> may antagonize actions angiotensin ii figure <NUMBER> <NUMBER> within pancreas ace<NUMBER> expression described acinar cells within subsets islet cells <NUMBER> gain loss ace<NUMBER> function preclinical studies reveals physiological pharmacological roles ace<NUMBER> dependent independent ang<NUMBER> glucose control cell function renal physiology blood pressure atherosclerosis amelioration experimental diabetes <NUMBER> nevertheless importance ace<NUMBER> glucose control independent angiotensin pathway humans conclusively established ace<NUMBER> expression lung detected low levels studies may upregulated context sarscov<NUMBER> infection type <NUMBER> pneumocytes potentially serving key cell type n u c r p <NUMBER> facilitating pulmonary inflammation <NUMBER> however ace<NUMBER> highly expressed several extrapulmonary tissues including gut <NUMBER> multiple often beneficial roles cardiometabolic physiology including potential therapeutic activities heart pancreas kidney potential biological importance clinical relevance use drugs hmg coareductase inhibitors medications blocking components reninangiotensinaldosterone system raas ace inhibitors angiotensin receptor blockers context hypertension cardiovascular renal disease diabetes active sarscov<NUMBER> infection reviewed <NUMBER> levels urinary ace<NUMBER> protein enzymatic activity increased subjects t<NUMBER>d <NUMBER> t<NUMBER>d <NUMBER> values urinary ace<NUMBER>creatinine ratios correlate positively fasting blood glucose hemoglobin a<NUMBER>c <NUMBER> however whether ace<NUMBER> mechanistically linked development dysglycemia complications people diabetes uncertain ace<NUMBER> also highly expressed human small large intestine <NUMBER> ace<NUMBER> mrna transcripts upregulated duodenal biopsies taken individuals treated ace inhibitors <NUMBER> expression ace<NUMBER> rna protein well ang<NUMBER> upregulated jejunal enterocytes isolated rats streptozotocininduced diabetes <NUMBER> whether hyperglycemia andor insulin deficiency similarly regulates ace<NUMBER> expression human tissues studied ace<NUMBER> also cleave metabolically active substrates addition angiotensin including apelin<NUMBER> desarg<NUMBER>bradykinin neurotensin<NUMBER> βcasomorphin dynorphin <NUMBER> ghrelin <NUMBER> cellassociated proteases mprss<NUMBER> disintegrin metalloproteinase adam<NUMBER> cleave ace<NUMBER> however tmprss<NUMBER> predominantly facilitates sars spike proteindriven cellular entry <NUMBER> described dpp<NUMBER> membranetethered ace<NUMBER> enzyme cleaved yield soluble circulating form ace<NUMBER> however biological importance sace<NUMBER> remains uncertain extracellular domain ace<NUMBER> sace<NUMBER> bind sarscov <NUMBER> sarscov<NUMBER> <NUMBER> raising possibility exploring pharmacological administration recombinant sace<NUMBER> therapeutic approach sequester block coronavirus cellular entry <NUMBER> rats streptozotocininduced diabetes exhibit reduced pulmonary expression ace<NUMBER> mrna treatment diabetic rats glp<NUMBER>r agonist liraglutide twice daily <NUMBER> days increased pulmonary ace ace<NUMBER> mrna expression associated increased surfactant protein expression lung upregulated circulating levels angiotensin<NUMBER> <NUMBER> notably liraglutide effect glucose control insulin levels model consistent possibility direct augmentation pulmonary glp<NUMBER>r signaling rather indirect glp<NUMBER> actions islet hormones contributes restoration pulmonary reninangiotensin system similarly administration dpp<NUMBER> inhibitor linagliptin daily liraglutide twice daily <NUMBER> weeks attenuated cardiac fibrosis prevented ang iimediated reduction cardiac ace<NUMBER> activity rats angiiinduced hypertension <NUMBER> however putative pathophysiological significance findings context experimental coronavirus infection explored tmprss<NUMBER> serine protease highly expressed within lung gastrointestinal tissues including stomach small large bowel pancreas liver tmprss<NUMBER> cleaves activates influenza influenza b virus hemagglutinin envelope glycoproteins thereby enabling viral membrane infusion infectivity human airway cells type <NUMBER> pneumocytes <NUMBER> tmprss<NUMBER> also cleaves activates spike protein sarscov merscov enabling virusmembrane fusion indeed genetic n u c r p <NUMBER> inactivation tmprss<NUMBER> mice attenuates extent lung damage inflammation induced experimental infection merscov sarscov <NUMBER> importance tmprss<NUMBER> viral pathogenicity also revealed studies employing tmprss<NUMBER> inhibitors camostat mesylate attenuates sarscov<NUMBER> infection human lung cells cultured ex vivo <NUMBER> camostat mesylate improved japan treatment pancreatitis short term use <NUMBER> days reduced urinary protein excretion evident <NUMBER> days <NUMBER> subjects nephrotic syndrome secondary diabetic kidney disease without coexistent pancreatitis <NUMBER> little information informing whether regulation tmprss<NUMBER> expression activity regulated glucose dysregulated context experimental clinical diabetes dpp<NUMBER> originally identified tcell activation antigen cluster differentiation cd<NUMBER> widely expressed <NUMBER> amino acid cell surface endopeptidase interacts cellular proteins adenosine deaminase ada caveolin<NUMBER> generate intracellular signals governing immune responses <NUMBER> dpp<NUMBER> also cleaves wide range peptide hormones chemokines bioactive immunomodulatory proteins figure <NUMBER> <NUMBER> commonly position <NUMBER> alanine proline resulting inactivation peptide action switching peptide receptor affinity <NUMBER> dpp<NUMBER> like ace<NUMBER> also shed cell membrane circulates <NUMBER> amino acid soluble moiety sdpp<NUMBER> containing amino acid residues <NUMBER> retains catalytic activity sdpp<NUMBER> exerts proinflammatory activity alone association factor xa independent catalytic actions interacting cellassociated caveolin<NUMBER> proteinase activated receptor <NUMBER> macrophages lymphocytes <NUMBER> circulating dpp<NUMBER> activity levels sdpp<NUMBER> increased humans hepatitis c miscellaneous viral infections <NUMBER> however sdpp<NUMBER> levels lower measured <NUMBER> subjects merscov infection <NUMBER> similarly circulating sdpp<NUMBER> levels also reduced humans primary hiv infection <NUMBER> within human respiratory tract immunoreactive dpp<NUMBER> localized immune endothelial cells pleural mesothelium lymphatics type <NUMBER> type <NUMBER> pneumocytes <NUMBER> increased dpp<NUMBER> rna protein expression detected pneumocytes subjects history smoking lung disease including chronic obstructive pulmonary disease <NUMBER> <NUMBER> membraneassociated human dpp<NUMBER> also functional coronavirus receptor <NUMBER> interacting merscov spike glycoprotein s<NUMBER> b domain binding dpp<NUMBER> merscov protein cleaved activated tmprss<NUMBER> cathepsin l facilitating viral entry <NUMBER> human neutralizing antibodies directed receptorbinding domain rbd merscov spike protein block viral binding human dpp<NUMBER> thereby inhibiting merscov infection <NUMBER> similarly recombinant human ada blocks spike protein s<NUMBER> binding dpp<NUMBER> inhibits merscov infection cells transfected human dpp<NUMBER> <NUMBER> studies examining <NUMBER> different bat cell lines ex vivo demonstrate susceptibility resistance merscov infection correlates presence absence cell surfaceexpressed dpp<NUMBER> antidpp<NUMBER> antibodies blocked acute viral infection susceptible bat cells dosedependent manner <NUMBER> naturally occurring dpp<NUMBER> polymorphisms described alter amino acid sequence dpp<NUMBER> diminish binding merscov subunit <NUMBER> protein specific dpp<NUMBER> isoforms variants associated reduced viral cell entry <NUMBER> mouse dpp<NUMBER> bind coronavirus spike protein subunits due differential glycosylation mouse vs human dpp<NUMBER> c c e p e n u c r p <NUMBER> protein key amino acid differences mediating differential glycosylation localized positions <NUMBER> <NUMBER> <NUMBER> <NUMBER> substitutions amino acids a<NUMBER>l t<NUMBER>r human mouse dpp<NUMBER> using crisprcas<NUMBER> gene editing sufficient confer murine susceptibility merscov viral infection replication <NUMBER> resulting infected mice exhibiting severe lung injury features respiratory distress syndrome similarly transgenic mice engineered express human dpp<NUMBER> become susceptible lethal coronavirus infection merscov <NUMBER> high fat dietfed transgenic mice expressing human dpp<NUMBER> infected merscov exhibit severe prolonged disease unresolved pulmonary inflammation delayed recovery associated dysregulated cellular immune cytokine responses despite apparently similar levels viral replication clearance <NUMBER> humanized hdpp<NUMBER> mice may represent useful preclinical models assessment antiviral therapeutics studies administering two human antibodies regn<NUMBER> regn<NUMBER> demonstrate interruption interaction merscov spike protein hdpp<NUMBER> attenuated lung pathology mice experimental merscov infection <NUMBER> surprisingly transgenic mice overexpressing hdpp<NUMBER> exhibited relative resistance merscov infection exemplified less lung inflammation reduced rates mortality intriguingly hdpp<NUMBER> transgenic higher levels hdpp<NUMBER> expression mice also exhibited increased circulating levels sdpp<NUMBER> administration recombinant sdpp<NUMBER> attenuated lung histopathology reduced titers virus recovered lung tissue <NUMBER> small study <NUMBER> subjects hospitalized korea circulating levels sdpp<NUMBER> lower human subjects merscov relative healthy controls <NUMBER> levels sdpp<NUMBER> found effective partial suppression viral merscov entry cells ex vivo much higher circulating levels sdpp<NUMBER> human subjects hence whether sdpp<NUMBER> exhibits therapeutic potential use soluble decoy receptor figure <NUMBER> binding partially sequestering circulating merscov requires investigation intriguingly merscov strains point mutations rbd viral spike protein isolated outbreak south korean subjects strains exhibit reduced binding human dpp<NUMBER> decreased viral entry cells ex vivo <NUMBER> however pathophysiological significance implications findings requires analysis early studies examining immunological properties dpp<NUMBER> often used nonselective dpp<NUMBER> inhibitors however highly selective dpp<NUMBER> inhibitors developed treatment t<NUMBER>d <NUMBER> administration dpp<NUMBER> inhibitor sitagliptin <NUMBER> days healthy human subjects effect circulating leukocytes including lymphocyte cell subsets levels <NUMBER> different plasma cytokines levels dozen cytokines released stimulation peripheral blood mononuclear cells lipopolysaccharide anticd<NUMBER> antibody different sitagliptintreated subjects <NUMBER> similarly sitagliptin administration <NUMBER> weeks hiv men women without aidsdefining illness diabetes effect viral rna load cd<NUMBER> cell count rantes levels soluble tnf receptor ii concentrations however levels total stromal cellderived factor<NUMBER> also known cxcl<NUMBER> declined sitagliptintreated subjects <NUMBER> immunological consequences sitagliptin therapy <NUMBER> weeks also studied <NUMBER> hiv men women impaired glucose tolerance simultaneously treated chimeric antigen receptor cell therapy sitagliptin treatment associated reduced circulating levels creactive protein cxc motif chemokine <NUMBER> <NUMBER> larger study randomized <NUMBER> hiv subjects stable antim n u c r p <NUMBER> retroviral therapy without diabetes ≥<NUMBER>μl cd<NUMBER> cells either sitagliptin placebo <NUMBER> weeks differences observed primary study endpoint levels soluble cd<NUMBER> circulating marker monocyte activation <NUMBER> levels cxcl<NUMBER> decreased however levels inflammatory biomarkers scd<NUMBER> il<NUMBER> high sensitivity creactive protein crp sdpp<NUMBER> stnfri stnfrii levels total cd<NUMBER> cd<NUMBER> counts different sitagliptintreated subjects <NUMBER> similarly small open label nonrandomized observational study <NUMBER> subjects t<NUMBER>d initiated sitagliptin levels cd<NUMBER>cd<NUMBER> cells nk th<NUMBER> cells plasma cytokine levels different <NUMBER> year therapy <NUMBER> consistent lack major effect dpp<NUMBER> inhibitors immune function administration either dpp<NUMBER> inhibitor vildagliptin glucosidase inhibitor acarbose compared cross design several weeks <NUMBER> individuals t<NUMBER>d differential effect either drug detected plasma levels il<NUMBER> crp difference relative production inflammatory cytokines human mononuclear cells isolated study subjects stimulated ex vivo <NUMBER> hence available evidence support clinically meaningful alterations markers immune function administration dpp<NUMBER> inhibitors human subjects without t<NUMBER>d dpp<NUMBER> inhibitors widely used clinically therapy t<NUMBER>d act selectively inhibit catalytic activity cellassociated circulating sdpp<NUMBER> used people t<NUMBER>d dpp<NUMBER> inhibitors produce <NUMBER> inhibition dpp<NUMBER> activity <NUMBER>h period <NUMBER> hence residual dpp<NUMBER> enzyme activity always present within tissues circulation subjects treated dpp<NUMBER> inhibitors extensive preclinical studies using highly selective dpp<NUMBER> inhibitors demonstrated evidence impaired celldependent immune responses <NUMBER> despite initial concerns surrounding potential safety dpp<NUMBER> inhibitors <NUMBER> major safety concerns related infections compromised immune function <NUMBER> years clinical experience populationbased cohort study subjects t<NUMBER>d assessed data uk clinical practice research datalink found increased risk pneumonia <NUMBER> subjects treated dpp<NUMBER> inhibitors compared <NUMBER> individuals treated noninsulin glucose lowering agents <NUMBER> findings consistent metaanalysis multiple dpp<NUMBER> inhibitor trials encompassing <NUMBER> study participants t<NUMBER>d treated dpp<NUMBER> inhibitor compared <NUMBER> controls studies ranging <NUMBER> <NUMBER> weeks <NUMBER> increased risk infection detected subjects treated dpp<NUMBER> inhibitors consistent findings results large trials examining safety saxagliptin alogliptin sitagliptin linagliptin humans t<NUMBER>d risk cardiovascular renal disease reveal clinically relevant safety concerns related infections immune inflammatory disorders <NUMBER> metformin exerts antiinflammatory actions preclinical studies reduces circulating biomarkers inflammation people t<NUMBER>d <NUMBER> metformin also used successfully nonhospitalized subjects stable hepatitis hiv infections however scant information immunomodulatory actions metformin context coronavirus infection several reports studying antibody titres small number individuals suggested immune responses influenza vaccination modestly impaired metformintreated subjects however clinical significance observations uncertain <NUMBER> <NUMBER> metformin used caution n u c r p <NUMBER> unstable hospitalized patients discontinued people concomitant sepsis severe impairment hepatic renal function although dpp<NUMBER> serves coreceptor subset coronaviruses little data informing whether structurally distinct small molecule dpp<NUMBER> enzyme inhibitors might sterically interfere modify binding merscov subunits dpp<NUMBER> dpp<NUMBER> activity also potentially modulates levels bioactivity multiple immunomodulatory chemokines cytokines figure <NUMBER> <NUMBER> however preclinical studies mice genetic chemical reduction dpp<NUMBER> activity setting dietinduced inflammation reveal dysregulation tissue systemic inflammatory markers despite complete absence marked reduction dpp<NUMBER> activity <NUMBER> available evidence insufficient determine impact sustained partial reduction dpp<NUMBER> activity achieved clinically subjects t<NUMBER>d treated dpp<NUMBER> inhibitors clinical outcomes humans active coronavirus infection individuals active sarscov<NUMBER> infection clinically significant volume depletion systemic sepsis reduction renal function may necessitate adjustment dose dpp<NUMBER> inhibitors <NUMBER> circulating glp<NUMBER> levels induced lipopolysaccharide animals humans <NUMBER> increased human subjects sepsis critical illness correlate illness severity mortality <NUMBER> <NUMBER> multiple preclinical studies demonstrate glp<NUMBER>r agonists attenuate pulmonary inflammation reduce cytokine production preserve lung function mice rats experimental lung injury <NUMBER> <NUMBER> <NUMBER> notably glp<NUMBER>r agonism reduces pulmonary type <NUMBER> immune cytokine responses extent lung injury mice following infection respiratory syncytial virus isolated child severe lower respiratory tract infection <NUMBER> results several large studies examining cardiovascular safety glp<NUMBER>r agonists reveal imbalances rates inflammatory disorders severe infections <NUMBER> <NUMBER> <NUMBER> <NUMBER> liraglutide shown safe effective used acute perioperative control blood glucose adult human subjects undergoing elective cardiovascular surgery <NUMBER> similarly twice daily exenatide appears safe effective used alone combination basal insulin blood glucose management noncritically ill hospitalized patients t<NUMBER>d treated general medicine surgery wards <NUMBER> glp<NUMBER>r agonists explored glucoselowering agents perioperative period intensive care unit generally proven safe effective blood glucose management <NUMBER> however total number subjects studied small duration therapy limited although glp<NUMBER> safely lowers blood glucose short term studies ventilated patients critical illness <NUMBER> insufficient experience safety use glp<NUMBER>r agonists critically ill subjects make therapeutic recommendations use agents context coronavirus infection <NUMBER> exenatidebased formulations stopped subjects deteriorating kidney function insulin extensively used decades control glucose critically ill hospitalized subjects diabetes emerging use continuous glucose monitoring may lower rates hypoglycemia associated insulin use hospital including subjects critical illness <NUMBER> intriguingly selective loss insulin action murine immune cells shown attenuate antiinflammatory cell response experimental influenza infection <NUMBER> moreover insulin exerts n u c r p <NUMBER> antiinflammatory actions humans reduces biomarkers inflammations hospitalized individuals critical illness <NUMBER> amongst available agents treatment acute illness complicated diabetes insulin extensively used agent human subjects bacterial viral infections hospitalized critically ill patients however little information surrounding potential benefits risks insulin context acute coronavirus infection sulfonylureas increase risk hypoglycemia best avoided hospitalized subjects severe medical illness although sglt<NUMBER> inhibitors generally well tolerated outpatient setting cardioprotective notably context heart failure sarscov<NUMBER> infection may associated anorexia dehydration rapid deterioration clinical status hence symptomatic individuals t<NUMBER>d active sarscov<NUMBER> infection may heightened risk volume depletion euglycemic ketoacidosis accordingly available evidence suggests reevaluation discontinuation agents unwell ambulatory individuals sglt<NUMBER> inhibitors routinely discontinued unstable patients severe sarscov<NUMBER> infection upon admission hospital <NUMBER> available information indicate increased susceptibility coronavirus infections children adults type <NUMBER> diabetes t<NUMBER>d people t<NUMBER>d may find interruption normal daily activities changes type frequency exercise alteration diet routines may alter glucose control necessitating reexamination insulin requirements many instances interactions health care providers may facilitated telephone email well telemedicine interactions including uploading glucose data facilitating adjustment insulin regimens rise blood glucose marked change <NUMBER>h glucose patterns may early harbinger impending clinical infection individuals prompting frequent blood glucose ketone monitoring areas disruption medication supply chains may require additional vigilance regular communication pharmacies insurance companies health care providers individual patients use medications acetaminophen may introduce error technologies used glucometer readings continuous glucose monitoring systems <NUMBER> despite limitations access health care providers individuals unstable kidney function active retinopathy may need seen diabetes clinic assessment appropriate therapy available evidence implicates diabetes obesity important risk factors impacting clinical severity coronavirus infections including sarscov<NUMBER> ace<NUMBER> dpp<NUMBER> important physiological regulators glucose homeostasis little compelling clinical evidence drugs targeting ace<NUMBER>or dpp<NUMBER>related pathways produce differential harm benefit context human coronavirus infections soluble decoy receptors ace<NUMBER> antisera directed ace<NUMBER> may promising investigational interventions block cellular coronavirus entry however metabolic consequences investigational agents carefully studied requires ongoing scrutiny dpp<NUMBER> inhibitors glp<NUMBER>r agonists may exert antiinflammatory actions human subjects successfully used control glucose hospitalized patients however insufficient experience agents suggest might safely replace insulin critically ill subjects c c e p e n u c r p <NUMBER> coronavirus infection hence extensive historical experience use insulin bolstered increasing adoption continuous glucose monitoring supports ongoing use insulin agent choice management severely ill subjects diabetes coronavirus infections insufficient experience diabetes pregnancy subjects sarscov<NUMBER> make tailored therapeutic recommendations however modified screening guidelines gestational diabetes proposed context sarscov<NUMBER> individuals limited access regular clinics <NUMBER> expression ace<NUMBER> within exocrine endocrine pancreas highlights need vigilance consideration whether pancreatic inflammation reported individuals sarscov<NUMBER> infection may contribute exacerbation development diabetes subset acutely ill patients hospitalized individuals deteriorating renal function use sglt<NUMBER> inhibitors exenatide reconsidered discontinued metformin sulfonylurea dosing may also need reduced stopped rapid flow new clinical information stemming sarscov<NUMBER> epidemic requires ongoing scrutiny understand prudent use risks benefits individual glucoselowering agents related medications commonly used subjects diabetes risk hospitalized coronavirusrelated infections moreover current pandemic highlights importance opportunities continuing expanding innovative delivery diabetes care use wearable portable monitoring devices regular communication people diabetes health care providers c c e p e n u c r p <NUMBER>  ace<NUMBER> dpp<NUMBER> coronavirus receptors  ace<NUMBER> dpp<NUMBER> control inflammation cardiometabolic physiology  dpp<NUMBER> merscov sarscov<NUMBER> receptor  dpp<NUMBER> inhibitors meaningfully modify immune response human subjects  sarscov<NUMBER> hospitalizations common people diabetes obesity  acute sarscov<NUMBER> illness requires reevaluation medications used type <NUMBER> diabetes  insulin glucoselowering therapy choice acute coronavirusrelated illness hospital ace<NUMBER> ace<NUMBER> camostat mesylate tmprss<NUMBER> sace<NUMBER> sarscov<NUMBER> spike protein rbd angiotensin <NUMBER> angiotensin <NUMBER> angiotensin ii <NUMBER> angiotensin <NUMBER> ang <NUMBER> nep ace dipeptidyl peptidase<NUMBER> substrates coronavirus disease <NUMBER> covid <NUMBER> emergency public health incident happening nearly <NUMBER> countries regions affecting <NUMBER> <NUMBER> <NUMBER> patients worldwide <NUMBER> <NUMBER> deaths <NUMBER> april <NUMBER> <NUMBER> severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> causes symptoms majority cases common fever cough shortness breath fatigue muscle pain <NUMBER> highresolution computed tomography ct allows accurate evaluation lung lesions thus enabling us better understand pathogenesis disease <NUMBER> acute respiratory distress syndrome ards respiratory failure sepsis acute cardiac injury heart failure common critical complications exacerbation covid<NUMBER> <NUMBER> growing body evidence suggests notable impact comorbidities chronic diseases clinical outcomes patients covid<NUMBER> infection according coronavirus reports centers disease control prevention us department health human services patients type <NUMBER> diabetes mellitus metabolic syndrome may <NUMBER> times greater risk death infected covid<NUMBER> <NUMBER> <NUMBER> laboratoryconfirmed hospitalized patients <NUMBER> hospitals <NUMBER> <NUMBER> reported least one comorbidity <NUMBER> prevalent comorbidity covid<NUMBER> hypertension <NUMBER> followed diabetes <NUMBER> report drawn considerable attention covid<NUMBER> coexisting disorders patients presence coexisting illness found common among severe patients <NUMBER> covid<NUMBER> patients underlying risk factors associated mortality including male gender advanced age presence comorbidities including hypertension diabetes mellitus cardiovascular diseases cerebrovascular diseases <NUMBER> major comorbidities fatality cases include hypertension diabetes coronary heart disease cerebral infarction chronic bronchitis <NUMBER> notable diabetes demonstrated potential risk factor close association mortality <NUMBER> covid<NUMBER> places huge burden healthcare facilities especially regarding patients comorbidities intensive care required approximately <NUMBER> polymorbid covid<NUMBER>infected patients hospitalization associated case fatality rate cfr greater <NUMBER> <NUMBER> special attention efforts protect reduce transmission applied susceptible populations including children healthcare providers elderly people <NUMBER> given higher mortality higher proportion critically ill adult covid<NUMBER> patients diabetes good inpatient glycemic control particularly important comprehensive treatment covid<NUMBER> individualized blood glucose target goals treatment strategies made according specific circumstances covid<NUMBER> patients diabetes <NUMBER> <NUMBER> recent metaanalysis included <NUMBER> covid<NUMBER> patients nine studies covid<NUMBER> significantly correlated several metabolic diseases indicating hypertension diabetes coronary heart disease may exert profound effect progression covid<NUMBER> <NUMBER> adverse effects glucose lipid metabolism disorders immune system make patients vulnerable various infections however evidence worsening covid<NUMBER> patients diabetes compared nondiabetes required conclusions consolidated elucidate risk severity comorbidity diabetes patients infected covid<NUMBER> retrospective study carried investigate clinical features radiographic laboratory tests complications treatments clinical outcomes covid<NUMBER> patients without diabetes included <NUMBER> hospitalized patients ≥ <NUMBER> years old laboratoryconfirmed covid<NUMBER> hubei provincial hospital integrated traditional chinese western medicine <NUMBER> january <NUMBER> <NUMBER> march <NUMBER> covid<NUMBER> diagnosed basis world health organization whos interim guidance confirmed case covid<NUMBER> defined positive result highthroughput sequencing realtime reversetranscriptase polymerase chain reaction rtpcr assay nasal pharyngeal swab specimens total <NUMBER> diabetic <NUMBER> nondiabetic patients randomly selected information recent exposure history clinical symptoms signs laboratory findings admission extracted electronic medical records determined presence radiologic abnormality basis documentation description medical charts major disagreement two reviewers resolved consultation third reviewer laboratory assessments consisted following complete blood count blood glucose lipids coagulation testing assessment liver renal function measures electrolytes creactive protein procalcitonin pct lactate dehydrogenase creatine kinase blood gas analysis detection inflammation markers divided cases two groups group patients covid<NUMBER> type <NUMBER> diabetes based guidelines prevention control type <NUMBER> diabetes china <NUMBER> edition <NUMBER> group covid<NUMBER> patients without diabetes medical data processed team experienced clinicians reviewed abstracted data data entered computerized database checked core data missing requests clarification sent coordinators subsequently contacted attending clinicians laboratory confirmation sarscov<NUMBER> performed hubei provincial hospital integrated chinese western medicine rtpcr assays performed accordance protocol established categorical variables described frequency rates percentages continuous variables described using mean median interquartile range iqr values means continuous variables compared using independent group ttests data normally distributed otherwise mannwhitney u test used proportions categorical variables compared using χ <NUMBER> test although fisher exact test used data limited statistical analyses performed using statistical package social sciences spss version <NUMBER> software spss inc unadjusted comparisons twosided p value less <NUMBER> considered statistically significant analyses adjusted multiple comparisons given potential type error findings interpreted exploratory descriptive shown table <NUMBER> <NUMBER> <NUMBER> patients type <NUMBER> diabetes <NUMBER> <NUMBER> patients without diabetes enrolled median age patients <NUMBER> years iqr <NUMBER> total <NUMBER> female fever body temperature ≥ <NUMBER> ºc present <NUMBER> patients admission developed <NUMBER> hospitalization common symptoms cough <NUMBER> fatigue <NUMBER> shortness breath <NUMBER> sputum <NUMBER> myalgia arthralgia <NUMBER> diarrhea <NUMBER> among overall population <NUMBER> least one coexisting glucoselipid metabolism disorder diabetes hypertension coronary heart disease cerebrovascular disease admission hospitalization body temperature diabetic patients lower nondiabetic patients <NUMBER> ºc iqr <NUMBER> vs <NUMBER> ºc iqr <NUMBER> p <NUMBER> <NUMBER> ºc iqr <NUMBER> vs <NUMBER> ºc iqr <NUMBER> p <NUMBER> <NUMBER> profile may attributed impaired immune response diabetic patients furthermore fatigue <NUMBER> vs <NUMBER> p <NUMBER> chills <NUMBER> vs <NUMBER> p <NUMBER> symptoms differed among diabetic nondiabetic patients since diabetic patients prone fatigue long time due energy metabolism disorders infection sarscov<NUMBER> may become less sensitive symptoms fatigue diabetes promotes detrimental proinflammatory state <NUMBER> may cause chill symptoms pronounced present study showed significant differences comorbidities diabetic covid<NUMBER> patients versus nondiabetic patients including hypertension <NUMBER> vs <NUMBER> p <NUMBER> coronary heart disease <NUMBER> vs <NUMBER> p <NUMBER> chronic renal disease <NUMBER> vs <NUMBER> p <NUMBER> well established hypertension coronary heart disease chronic renal disease coexist diabetes leading higher risk morbidity mortality covid<NUMBER> diabetic patients patients related glucose lipid dysfunctions angiotensinconverting enzyme <NUMBER> ace<NUMBER> receptor overexpresses multiple organs lung kidney liver facilitates receptorbinding domain spike protein sarscov<NUMBER> bound cell receptor ace<NUMBER> <NUMBER> several lines evidence suggest diabetes risk factor progression prognosis covid<NUMBER> <NUMBER> <NUMBER> study enhanced hypothesis nonetheless prevalence cerebrovascular disease hepatitis b infection cancer chronic obstructive pulmonary disease copd history comparable two groups radiologic data admission shown table <NUMBER> <NUMBER> ct scans performed time admission <NUMBER> showed abnormal results ct abnormality found seven <NUMBER> patients <NUMBER> without diabetes six <NUMBER> patients <NUMBER> diabetes common patterns chest cts groundglass opacity <NUMBER> vs <NUMBER> p <NUMBER> bilateral patchy shadowing <NUMBER> vs <NUMBER> p <NUMBER> among diabetic patients comparison nondiabetic patients consistent recent reports <NUMBER> suggest severe lung injury diabetic covid<NUMBER> patients table <NUMBER> shows laboratory findings admission blood glucose <NUMBER> mmol·l <NUMBER> iqr <NUMBER> vs <NUMBER> mmol·l <NUMBER> iqr <NUMBER> blood lowdensity lipoprotein cholesterol ldlc <NUMBER> regarding hematological parameters admission lymphocytopenia present <NUMBER> patients thrombocytopenia present <NUMBER> leukopenia present <NUMBER> presence lymphocytopenia suggested viral infection patients differences hematological parameters diabetic nondiabetic covid<NUMBER> groups levels inflammatory parameters erythrocyte sedimentation rate esr <NUMBER> creactive protein <NUMBER> elevated difference two covid<NUMBER> groups without diabetes difference proinflammatory cytokines procalcitonin pct tumor necrosis factor tnf interleukins ils forth two covid<NUMBER> groups blood biochemical parameters alanine aminotransferase alt aspartate aminotransferase ast blood urea nitrogen bun creatinine forth showed laboratory abnormalities suggesting less abnormal liver renal myocyte functions levels immunity parameters showed similar negative results although immunoglobulin iga positive change serum iga important role protection mucociliary areas acts barrier pathogenic organisms antigens even allergens <NUMBER> combination covid<NUMBER> diabetes different effect immune status covid<NUMBER> without diabetes glucose lipid metabolism disorders may increase immune response findings suggest diabetic patients covid<NUMBER> likely show abnormal blood coagulation function clinical practice inflammatory storm blood coagulation abnormal early stage result inflammationactivating plasmin subsequently hypoxiainduced molecules activate thrombin directly progressive inflammation activation monocytemacrophages also secretes number tissue factors activating exogenous coagulation pathway leads overall hypercoagulable state <NUMBER> compared nondiabetic cases diabetic cases much lower po <NUMBER> table <NUMBER> shows primary composite end point event occurred <NUMBER> <NUMBER> <NUMBER> patients including eight patients <NUMBER> admitted icu eight patients <NUMBER> underwent mechanical ventilation one patient experienced invasive noninvasive mechanical ventilation nine patients <NUMBER> died median duration hospitalization <NUMBER> iqr <NUMBER> among <NUMBER> patients diabetes tendency toward severe prognosis observed even though statistical significance clinical outcomes diabetic nondiabetic groups including primary composite end point event <NUMBER> vs <NUMBER> p <NUMBER> median duration hospitalization <NUMBER> vs <NUMBER> p <NUMBER> incidence admission icu <NUMBER> vs <NUMBER> p <NUMBER> discharge hospital <NUMBER> vs <NUMBER> p <NUMBER> death <NUMBER> vs <NUMBER> p <NUMBER> hospitalization <NUMBER> vs <NUMBER> p <NUMBER> majority patients <NUMBER> received intravenous antibiotic therapy <NUMBER> received antiviral therapy <NUMBER> received systemic glucocorticoids <NUMBER> received antifungal medication <NUMBER> received mechanical ventilation <NUMBER> treated traditional chinese medicine <NUMBER> treated acupuncture noninvasive mechanical ventilation initiated diabetic patients nondiabetic patients <NUMBER> vs <NUMBER> p <NUMBER> table <NUMBER> hospital admission patients received diagnosis ards <NUMBER> acute kidney injury <NUMBER> septic shock <NUMBER> heart failure <NUMBER> physician patient entered disseminated intravascular coagulation dic stage clinical data <NUMBER> diabetic patients <NUMBER> given glucocorticoids accounting <NUMBER> diabetic patients <NUMBER> nondiabetic patients given glucocorticoids accounting <NUMBER> nondiabetic patients p <NUMBER> according retrospective study patients ards covid<NUMBER> showed lower mortality among receiving glucocorticoids <NUMBER> covid<NUMBER> patients benefit glucocorticoids treatment reduce autoimmunity cytokine toxicity <NUMBER> retrospective study blood glucose monitored every covid<NUMBER> patient treatment glucocorticoids due outbreak isolation management therefore could analyze impact glucocorticoids glucose level covid<NUMBER> patients without diabetes due insufficient clinical data limitation study although glucocorticoids unavoidably affect blood glucose level evidence administration glucocorticoids worsens covid<NUMBER> future influence glucocorticoids covid<NUMBER> patients diabetes investigated retrospective study provides first direct evidence supporting high frequency coexistence type <NUMBER> diabetes hypertension coronary heart disease chronic renal disease patients covid<NUMBER> new finding strongly supports proposed novel concept glucolipid metabolic disease glmd integrated strategy treatment whole spectrum metabolic diseases underlying sarscov<NUMBER> infection <NUMBER> recognized disorders metabolism glucose lipids act initial trigger potent driving force development progress various metabolic diseases including type <NUMBER> diabetes mellitus dyslipidemia nonalcoholic fatty liver disease hypertension atherosclerosis cardiovascular complications metabolism lipids glucose highly coordinated process physiological diseased conditions impairment signals corresponding metabolism either lipids glucose common mechanism also key mechanism underlying pathogenesis glmd <NUMBER> another novel finding present study potentiated severity covid<NUMBER> patients metabolic comorbidities although several previous studies reported diabetes one common comorbidities patients sarscov<NUMBER> infection <NUMBER> <NUMBER> <NUMBER> pathophysiological consequence close association diabetes covid<NUMBER> progression still remains elusive analysis highlights markedly promoted morbidity diabetes patients covid<NUMBER> infection frequency degree abnormalities radiologic examinations diabetic covid<NUMBER> patients notably higher control group without diabetes addition disruption homeostatic control glucose metabolism blood pressure severe diabetic covid<NUMBER> patients diabetes related metabolic disorders consistently documented one key risk factors severe outcomes patients infected types coronavirus middle east respiratory syndrome coronavirus merscov <NUMBER> <NUMBER> sarsassociated coronavirus sarscov <NUMBER> thus data present study demonstrate diabetes associated metabolic complications crucial contributor enhanced morbidity mortality covid<NUMBER> patients conceptional construction glmd great relevance clinical management covid<NUMBER> one hand data suggest maintenance homeostasis glucose lipid metabolism via optimal clinical management covid<NUMBER> patients mandatory furthermore evidence infection another member coronavirus familynamely sarscovhas demonstrated binding sarscov receptor ace<NUMBER> pancreas results islet damage notable decrease release insulin thereby causing shortterm hyperglycemia even onset diabetes <NUMBER> furthermore sarscovevoked diabeteslike traits markedly potentiate progression multipleorgan failure via positive feedback loop therefore tight control parameter set glucose lipid metabolism may key optimal clinical outcomes covid<NUMBER> patients without history diabetes andor metabolic diseases hand diabetes attained epidemic proportions worldwide according estimated data international diabetes federation <NUMBER> million people diabetes mellitus <NUMBER> individuals type <NUMBER> diabetes mellitus <NUMBER> hence powerful integrated approaches launched comprehensive prevention glmd significant importance marked reduction morbidity mortality caused covid<NUMBER> emerging infectious diseases present study may possess limitations first retrospective study conducted historical cohorts recorded events already occurred thus information relevant risk factors potentially profound influence progression covid<NUMBER> may included database subsequent analysis therefore measurement impact diabetes complications clinical outcomes would accurate prospective study second sample size relatively small therefore findings observed present study warrant validation future study large sampling size conclusion diabetes coexisting metabolic disorders within spectrum glmd significantly boost morbidity covid<NUMBER> patients therefore findings deliver least two important messages clinical management covid<NUMBER> first optimal management metabolic hemostasis glucose lipids key ensuring better clinical outcomes second increased clinical vigilance warranted covid<NUMBER> patients glmd form fundamental chronic conditions novel coronavirus pandemic worldwide public health concern <NUMBER> progressive public health emergency global significance <NUMBER> first case reported wuhan province china <NUMBER> december <NUMBER> unexplained lower respiratory infections <NUMBER> disease rapid human human transmission capacity varied fatality due acute respiratory distress syndrome ards multiorgan failure serious complications <NUMBER> viruses termed severe acute respiratory syndromecoronavirus<NUMBER> sarscov<NUMBER> similar one caused sars outbreak <NUMBER> large family singlestranded rna viruses ssrna isolated different animal species <NUMBER> according recent estimates <NUMBER> population suggested healthy carriers coronavirus viruses responsible <NUMBER> <NUMBER> acute respiratory infections <NUMBER> primarily covid<NUMBER> patients fever myalgia fatigue dry cough time admission <NUMBER> although patients thought favorable prognosis older patients chronic underlying conditions like diabetes hypertension coronary heart diseases etc show worse outcomes <NUMBER> <NUMBER> patients severe illness develop dyspnea hypoxemia within <NUMBER>week onset disease might quickly progress ards endorgan failure <NUMBER> various studies reported clinical characteristics patients covid<NUMBER> need management intensive care units old age comorbidities particularly hypertension diabetes believed risk factors disease severity death sarscov<NUMBER> infected patients <NUMBER> <NUMBER> <NUMBER> another study also reported comorbid hypertension common followed diabetes coronary heart disease <NUMBER> several studies demonstrated higher prevalence diabetes covid<NUMBER> patients however effect prevalence diabetes severity disease needs exploration understanding association might helpful early vigilant monitoring better management covid<NUMBER> patients high risk leading ards organ failure death thus metaanalysis aim assess association diabetes hypertension severity disease systematic literature review followed preferred reporting items systematic review metaanalysis prisma guidelines extension scoping reviews <NUMBER> searched pubmed medline cochrane march <NUMBER> <NUMBER> using keywords covid<NUMBER> diabetes <NUMBER> novel coronavirus diabetes <NUMBER> novel coronavirus hypertension covid<NUMBER> hypertension also searched grey literature using google scholar reference list eligible articles studies describing prevalence diabetes hypertension according disease severity included excluded duplicate publications reviews editorials case reports letters metaanalysis protocols studies language english studies reporting required data first author rp searched data screened article eligibility senior author na double checked included articles dispute resolved consensus two reviewers rp ns assessed quality data included studies using national institute health nih quality assessment tools <NUMBER> preferred nih tool comprehensive widely accepted exhaustive assessment data quality rated overall quality included studies good fair poor incorporated metaanalysis results data inputted standardized data extraction table excel independently checked second reviewer ns accuracy following variables extracted name first author year publication study design age gender current smoking number patients severe nonsevere condition comorbidities hypertension diabetes included studies designated severe group respiratory distress rr ≥ <NUMBER> beatsminute resting state mean oxygen saturation ≤ <NUMBER> arterial blood oxygen partial pressure pao<NUMBER>oxygen concentration fio<NUMBER> ≤ <NUMBER> mmhg <NUMBER> performed exploratory metaanalysis understand magnitude direction effect estimate odds ratios ors calculated presented respective <NUMBER> confidence intervals cis mantelhaenszel randomeffects metaanalysis using dersimonian laird method used pool ors <NUMBER> heterogeneity studies assessed using χ <NUMBER>based cochrans q statistic p<NUMBER> considered presence heterogeneity isquared <NUMBER> statistics <NUMBER> representing moderate heterogeneity <NUMBER> forest plot produced studies grouped according design publication bias assessed total number studies less ten <NUMBER> systematic search yielded total <NUMBER> publications <NUMBER> studies <NUMBER> studies found using keyword covid<NUMBER> diabetes <NUMBER> studies keyword <NUMBER> novel coronavirus diabetes <NUMBER> studies term covid<NUMBER> hypertension <NUMBER> studies keyword <NUMBER> novel coronavirus hypertension two studies found sources removing duplicates <NUMBER> articles found potential publications screening application predefined inclusion exclusion criteria total seven studies included metaanalysis included studies conducted china prevalence diabetes hypertension reported survivors nonsurvivors two studies icu care nonicu care patients two studies prevalence diabetes hypertension severe nonsevere patients reported three studies among seven included studies three cohort studies <NUMBER> <NUMBER> <NUMBER> four caseseries <NUMBER> <NUMBER> <NUMBER> <NUMBER> studies enrolled total <NUMBER> patients including <NUMBER> males <NUMBER> females demographic characteristics subjects included studies provided table <NUMBER> assessed quality data included studies using nih quality assessment tools quality assessment indicated included studies acceptable quality papers clearly stated research question objective study population clearly specified defined subjects selected similar populations detailed result quality assessment provided supplementary file <NUMBER> figure <NUMBER>c recent evidence sarscov<NUMBER> suggest presence comorbidities increase mortality risk covid<NUMBER> patients diabetes one important components predict adverse outcomes <NUMBER> thus present metaanalysis conducted assess association diabetes disease severity covid<NUMBER> patients present metaanalysis based data <NUMBER> studies covid<NUMBER> patients present metaanalysis demonstrated prevalence diabetes lower survivors nonsurvivors covid<NUMBER> patients however difference diabetes prevalence patients requiring requiring icu care additionally positive association diabetes disease severity found several studies demonstrated higher prevalence diabetes covid<NUMBER> patients however effect prevalence diabetes severity disease needs exploration recent metaanalysis comorbidities suggested diabetes one prevalent comorbidities <NUMBER>±<NUMBER> <NUMBER> ci <NUMBER> covid<NUMBER> patients however significant difference found diabetes severe nonsevere group <NUMBER> another similar metaanalysis demonstrated pooled prevalence diabetes <NUMBER> <NUMBER>ci <NUMBER> <NUMBER> metaanalysis reported proportions diabetes patients covid<NUMBER> <NUMBER> incidences diabetes two folds higher icusevere cases nonicusevere counterparts <NUMBER> retrospective study showed <NUMBER> severe patients diabetes cardiovascular diseases significantly higher mild group <NUMBER> caseseries reported <NUMBER> covid<NUMBER> patients comorbid diabetes mellitus <NUMBER> although pathophysiology involved comorbidity remains unexplained several hypotheses suggested blood glucose level suggested play essential role pathogenesis infectious diseases immune system diabetes patients might altered abnormal blood glucose level resulting dysregulation reduced responses immune components consequently patients susceptible sarscov<NUMBER> various types bacteria <NUMBER> another hypothesis states human pathogenic coronaviruses sarscov sarscov<NUMBER> bind target cells angiotensinconverting enzyme <NUMBER> ace<NUMBER> expressed epithelial cells lung intestine kidney blood vessels expression ace<NUMBER> significantly increased diabetes patients treated ace inhibitors angiotensin ii typei receptor blockers use thiazolidinediones ibuprofen also increased ace<NUMBER> consequently increased expression ace<NUMBER> would facilitate infection covid<NUMBER> <NUMBER> present metaanalysis showed hypertension lower survivors nonsurvivors covid<NUMBER> patients additionally positive association hypertension disease severity icu care found recent metaanalysis demonstrated hypertension prevalent comorbidity <NUMBER>±<NUMBER> <NUMBER> ci <NUMBER> covid<NUMBER> patients additionally higher risk hypertension found severe group compared nonsevere group <NUMBER> <NUMBER> ci <NUMBER> <NUMBER> according another metaanalysis pooled prevalence hypertension people infected sarscov<NUMBER> estimated <NUMBER> <NUMBER>ci <NUMBER> <NUMBER> metaanalysis reported proportions hypertension patients covid<NUMBER> <NUMBER> incidence hypertension two folds higher icusevere cases nonicusevere counterparts <NUMBER> understanding disease establish risk stratification patients authors contributed significantly manuscript funding research receive specific grant funding agencies public commercial notforprofit sectors n number gence current novel coronavirus pandemic sarscov<NUMBER> covid<NUMBER> wuhan china become rapidly apparent known preceding comorbidities much likely develop lifethreatening complications pneumonia acute respiratory distress syndrome unexpectedly diabetes identified posing particular adverse risk along chronic renal coronary heart disease surrogate risk indicators obesity hypertension actual susceptibility infection diabetes may argued infection acquired likely severe prolonged determined number factors including duration diabetes presence diabetesrelated complications level glycaemic control suboptimal blood glucose levels compounded adverse vicious cycle response infection increase vulnerability adverse outcome comprehensive review immune system may disturbed diabetes relevant chapter infection diabetes joslins diabetes mellitus <NUMBER> recommended example studies described reporting defects cellmediated immunity diminished lymphocyte transformation response people poorlycontrolled diabetes impaired leucocyte function first line defence secondary bacterial infection demonstrated observation reduced phagocytic activity increasing levels blood glucose <NUMBER> disturbances immune function likely significant impact outcome covid<NUMBER> infection complicated diabetes furthermore suggested increased glucose concentrations airway secretions may expose pulmonary epithelial cells greater viral replication consequent pneumonitis <NUMBER> although criticism levelled concerning transparency early coronavirus epidemic experience china several preliminary clinical epidemiological papers summarised recent practical diabetes editorial <NUMBER> achieved rapid publication <NUMBER> primarily listing diabetes simply adverse comorbidity prevalent severe cases nonsurvivors early reports covid<NUMBER> infection included observations <NUMBER> critically ill adult patients coronavirus pneumonia admitted icu wuhan jin yintan hospital diabetes found twice number individuals died compared survived <NUMBER> vs <NUMBER> <NUMBER> outcome since replicated wider scale <NUMBER> hospitals across china <NUMBER> total <NUMBER> patients established covid<NUMBER> infection diabetes present <NUMBER> cases overall recorded significantly greater proportion severe compared nonsevere disease <NUMBER> vs <NUMBER> small sample analysis <NUMBER> fatalities reported diabetes <NUMBER> cases <NUMBER> reports wuhan since published continued indication diabetes risk factor progression prognosis covid<NUMBER> infection one study <NUMBER> observed <NUMBER> cases diabetes without comorbidities nonetheless individuals much higher risk developing severe pneumonia excessive release inflammatory biomarkers increased hypercoagulability inflammatory storm associated rapid deterioration illness significantly higher mortality rate analysis <NUMBER> <NUMBER> patients predictors fatal outcome included older age presence underlying diseases onset secondary infection elevated inflammatory markers <NUMBER> fatal cases five <NUMBER> patients died myocardial damage described fulminant myocarditis consequent cytokine storm working central london junior doctor <NUMBER> hong kong flu pandemic one recollects deaths young individuals often attributed viral myocarditis salutary reflection diabetes exploded modern age barely recognised clinical issue <NUMBER> years ago western world university hospital padua epicentre outbreak italy <NUMBER> reports <NUMBER> patients dying covid<NUMBER> infection diabetes compared matched population prevalence <NUMBER> preliminary estimates usa <NUMBER> based data <NUMBER> persons confirmed covid<NUMBER> disease diabetes proved significant medical comorbidity <NUMBER> total <NUMBER> hospitalised <NUMBER> admitted icu far data uk limited however office national statistics reported <NUMBER> england wales <NUMBER> dying covid<NUMBER> infection least one preexisting condition including diabetes specifically statistics nhs england <NUMBER> period <NUMBER> march <NUMBER> may <NUMBER> record <NUMBER> covid<NUMBER> deaths hospital <NUMBER> <NUMBER> diabetes comparable proportion new york city diabetes identified <NUMBER> patients hospitalised covid<NUMBER> infection <NUMBER> parallels drawn current coronavirus pandemic global spanish influenza pandemic <NUMBER> years ago concept managing comorbidities postwar malnutrition would foremost mind time diabetes however much consideration swine flu pandemic <NUMBER> contingency planning management guidelines issued <NUMBER> <NUMBER> even recognised people diabetes potentially six times likely require hospitalisation influenza epidemic <NUMBER> however circumstances different natural innate covid<NUMBER> immunity population preventative vaccination programme yet developed recognising people may seriously vulnerable infection uk government identified certain groups primarily potential immune deficiency severe respiratory conditions advised selfisolate home <NUMBER> weeks although diabetes included list people diabetes nonetheless encouraged take particular care precautionary measures social distancing relative selfisolation principles diabetes management infection remain relevant sickday rules circumstances people diabetes may well feel anxious concerns diabetes control availability medical supplies access expert advice guidance people diabetes made available online organisations diabetes uk <NUMBER> jdrf <NUMBER> similarly health care professionals specialist bodies including association british clinical diabetologists <NUMBER> us endocrine society jointly university leeds <NUMBER> international perspective national diabetes foundation india <NUMBER> latest <NUMBER> march <NUMBER> clinical guide management people diabetes coronavirus pandemic issued jointly royal college physicians abcd nhs <NUMBER> national diabetes inpatient covid response team provided advice <NUMBER> maintaining essential elements diabetes service collating shared experience learn unprecedented circumstances education programmes selfmanagement especially event acute illness returning desired dividend specialist advice must continue available people difficulties diabetes control instance immediate facility need place initiate insulin therapy type <NUMBER> diabetes previously bordering edge acceptable control maximum oral hypoglycaemic agents swine flu pandemic fiveto <NUMBER>fold increase new case insulin demand anticipated assumed need arise pandemic important data analysed due course time writing peak rate infected numbers hospitalised sadly casefatalities uk yet reached measures still place suppress virus transmission lessen pressures nhs inevitably questions concerning easing current restrictions raise issues whether sufficient acquired immunity population present indication still low proportion whether achieved effective vaccination programme developed possible countries speedier response initiated outset epidemic better position see restrictions lifted gained previous experience former sarscov merscov coronavirus pandemics singapore cited exemplary model management wellprepared terms preplanning rapid implementation control measures quarantining infected individuals family along early school closure workplace distancing <NUMBER> based personal observation visitor time everyone airport arrival entry public buildings subject infrared thermal scanning febrile individuals immediately isolated rigorous contact tracing seemingly effective measure missed opportunity uk furthermore addition extensive antigen testing infected persons particular asymptomatic contacts appeared crucial early success controlling outbreak thereby facilitating earlier return postepidemic normality albeit small secondary wave relapse attributed returning nationals since similarly reported china present uncertainty prevails particularly recognised vulnerable groups diabetes without reliable antibody test many people unsure immune status indeed recovered overt coronavirus infection degree duration immunity infection uncertain yet specific data respect diabetes available immune response infection different diabetes many questions present waiting addressed diabetes potential composite comorbidity extent outcome determined additional renal cardiovascular considerations differing levels glycaemic control medication influenced outcome drugs metformin sglt<NUMBER> inhibitors discontinued hospitalisation advised consequence proportion patients needed immediate conversion insulin statins improve antiinflammatory response like nonsteroidals possibly reverse ace<NUMBER> inhibitors adversely affect outcome answers awaited considerable interest meanwhile pandemic takes course focus moves towards exit strategy current restrictions far untested almost impossible configure without risking infection yet unaffected illness taken extra precaution vulnerable including diabetes individuals remain risk requiring level continued care probably safe effective vaccine becomes available suggestions mooted differential phased release easy answer much learnt experience pandemic eventually settle unlikely last knowledge gained used prepare well advance future contingency ever extra burden diabetes event overwhelming contagious disease must constantly addressed coronavirus syndrome coronavirus <NUMBER> sarscov<NUMBER> covid<NUMBER> pandemic exerts major universal impact human population although case fatality rates previous coronaviruses middle eastern respiratory syndrome coronavirus merscov sarscov <NUMBER> <NUMBER> considerably higher sarscov<NUMBER> around <NUMBER> sarscov<NUMBER> transmitted much rapidly could confined certain regions resulting quickly evolving pandemic <NUMBER> <NUMBER> april <NUMBER> <NUMBER> people worldwide tested positive sarscov<NUMBER> <NUMBER> died covid<NUMBER> <NUMBER> day <NUMBER> persons tested positive <NUMBER> fatalities noted austria <NUMBER> moreover <NUMBER> covid patients hospitalized <NUMBER> intensive care units <NUMBER> invasively ventilated sars sarscov<NUMBER> enter body angiotensin converting enzyme <NUMBER> ace<NUMBER> mers uses dipeptidyl peptidaseiv dpp<NUMBER> receptor <NUMBER> <NUMBER> enzyme expression patterns change diabetes albeit different ways making receptor proteins unlikely explanation elevated risk <NUMBER> <NUMBER> instead research focus shifting towards impairment immune response diabetes cause risk elevation <NUMBER> <NUMBER> first published case series described diabetes among commonly related diseases arterial hypertension obesity coronary heart disease risk factor either covid<NUMBER> severe clinical course mortality <NUMBER> <NUMBER> <NUMBER> reason remains unclear risk population pattern strikingly similar previous fatal coronavirus outbreaks zoonotic origin sars mers <NUMBER> <NUMBER> several investigations demonstrated higher susceptibility infectious diseases diabetes patients particularly bacterial origin probably owing dysregulated immune response <NUMBER> diabetes patients comprise significant proportion hospitalized covid<NUMBER> patients across chinese provinces diabetes prevalence <NUMBER> even <NUMBER> reported covid<NUMBER> patients <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> italy prevalence diabetes hospitalized covid<NUMBER> patients <NUMBER> moderately exceeding local overall diabetes prevalence <NUMBER> roughly reflecting people aged <NUMBER> years <NUMBER> thus appears diabetes patients exhibit slightly elevated susceptibility sarscov<NUMBER> infection different picture however seen diabetes related disease severity report china showed patients diabetes higher prevalence cardiovascular disease <NUMBER> vs <NUMBER> less fever <NUMBER> vs <NUMBER> compared patients without diabetes <NUMBER> notably diabetes patients presented higher inflammatory serum markers including lactate dehydrogenase ldh creactive protein crp ferritin ddimer lower lymphocyte counts pronounced computer tomography ct imaging pathologies indicating severe overall particularly lung involvement <NUMBER> ddimer levels strongly linked higher mortality covid<NUMBER> <NUMBER> significantly higher patients diabetes indicating disposition hypercoagulable state <NUMBER> one first reports covid<NUMBER> patients revealed diabetes patients higher risk need intensive care usually means invasive ventilation report <NUMBER> intensive care unit patients diabetes compared <NUMBER> overall hospitalized covid<NUMBER> population hence diabetes confers similar increase noted risk populations hypertension cardiovascular disease <NUMBER> comprehensive report <NUMBER> patients china showed prevalence diabetes <NUMBER> overall covid<NUMBER> population however <NUMBER> severe disease <NUMBER> moreover <NUMBER> patients experiencing primary composite end point ie admission intensive care unit use mechanical ventilation death diabetes roughly <NUMBER>fold enrichment critically affected patients recent metaanalysis calculated odds ratio <NUMBER> diabetes patients admitted intensive care unit <NUMBER> accordingly diabetes significantly associated development acute respiratory distress syndrome ards hazard ratio <NUMBER> <NUMBER> summary pooled ratio diabetes among covid<NUMBER> patients severe course compared favorable course <NUMBER> indicating significantly elevated risk <NUMBER> similar picture evolved looking <NUMBER> covid<NUMBER> fatalities prevalence diabetes twofold increased nonsurviving compared surviving covid<NUMBER> population china italy <NUMBER> <NUMBER> data mirror higher mortality rates diabetes patients sars mers <NUMBER> moreover presence diabetic complications potentiates diabetesrelated mortality <NUMBER> note plasma glucose levels diabetes independent predictors mortality morbidity patients sars <NUMBER> yet evaluated current covid<NUMBER> season conclusion diabetes much increases risk sarscov<NUMBER> infection significantly enhances covid<NUMBER> severity mortality role acute glycemic control covid<NUMBER> manifestation clinical outcomes studied yet however influenza vitro animal data suggest among negative effects hyperglycemia facilitates local viral replication lungs impairs antiviral immune response <NUMBER> <NUMBER> therefore acute glycemic management could play important role limiting viral replication disease duration patients diabetes cardiac injury defined blood levels cardiac biomarkers highsensitivity troponin <NUMBER>th percentile upper reference limit significantly associated mortality covid<NUMBER> patients <NUMBER> patients cardiac injury compared without significantly higher prevalence diabetes <NUMBER> vs <NUMBER> multivariable adjusted cox proportional hazard regression revealed cardiac injury ards diabetes independent mortality risk factor data indicate adverse outcome diabetes patients due higher rate cardiac pulmonary complications <NUMBER> unfortunately available data differentiate type <NUMBER> type <NUMBER> diabetes covid<NUMBER> making difficult compare contribution preexisting metabolic syndrome occurs patients t<NUMBER>dm hyperglycemia without concomitant metabolic disturbances retrospective data infection rates diabetes suggest people t<NUMBER>dm greater risk infectious disease general death rates similar t<NUMBER>dm compared matched control groups people diabetes types significantly increased mortality infectious diseases <NUMBER> however data stratified type pathogen eg bacterial viral currently available viruses might trigger islet autoimmunity hence diabetes development <NUMBER> exploring data covid<NUMBER> patients diabetes showed <NUMBER> insulin therapy admission additional <NUMBER> received insulin therapy admission indicating poor glycemic control disease <NUMBER> earlier study sars found higher fasting blood glucose levels even absence severe disease glucocorticoid therapy <NUMBER> moreover strong immunostaining sarscov even sars cov<NUMBER> receptor ace<NUMBER> langerhans islets suggests potential direct damage insulinsecreting cells sars corona viruses <NUMBER> chronic subclinical inflammation diabetes part disturbed immune response sarscov<NUMBER> infection cytokine storm occurs severe disease indicated eg elevated interleukin il<NUMBER> serum levels <NUMBER> higher diabetes patients along enhanced disease severity indicating pronounced cytokine storm <NUMBER> however unknown whether treatment il<NUMBER> blockade beneficial effect outcome covid<NUMBER> patients diabetes <NUMBER> covid<NUMBER> pandemic driving significant changes healthcare system disrupting current best practices diabetic limb preservation leaving large numbers patients without care <NUMBER> impact covid<NUMBER> diabetes complications difficult quantify since data lacking ongoing season however one analysis cardiac catheter laboratory implied significant delay time onset stemi symptoms coronary intervention compared previous year notably time first medical contact <NUMBER> another potential complication particularly vulnerable disruptions healthcare provision limb preservation patients chronic wounds peripheral arterial disease substitutional options direct specialist contact authors make case triage systems enable reduction inhospital visits nonlifethreatening wounds allocating patients less severe problems office visits even telemedical care remote monitoring <NUMBER> yet validated approach could free valuable resources hospitals urgent treatment indications data acute complications pandemicrelated healthcare crises eg diabetic ketoacidosis hypoglycemia almost exist hopefully generated aftermath sarscov<NUMBER> may allow planning comparable future events case series <NUMBER> <NUMBER> patients suffered least one episode hypoglycemia <NUMBER> mgdl ie <NUMBER> mmoll <NUMBER> aside seeking achieve individual glucose metabolic targets currently special recommendations people diabetes regarding covid<NUMBER> complications <NUMBER> initial impact covid<NUMBER> glycemic control seems akin infectious disease states acute inflammatory response leads insulin resistance subsequent hyperglycemia turn necessitates intensification preexisting diabetes therapy <NUMBER> retrospective study wuhan china <NUMBER> <NUMBER> blood glucose measurements hospitalized patients covid<NUMBER> abnormal <NUMBER> illustrates necessity proactive approach diabetes care patients despite blood sugar main focus moreover approximately <NUMBER> patients t<NUMBER>dm either start intensify insulin therapy course hospital admission <NUMBER> regarding optimal treatment covid<NUMBER> patients diabetes physicians refer <NUMBER> guidelines austrian diabetes society österreichische diabetes gesellschaft ödg insufficient glycemic control shown negatively affect outcomes several diseases leading increased length hospitalization rate complications mortality antidiabetic therapy initiated intensified patients repeatedly preprandial blood glucose values <NUMBER> mgdl <NUMBER> mmoldl target glucose depends several patient factors particularly comorbidities generally lies <NUMBER> <NUMBER> mgdl preprandially severe signs covid<NUMBER> owing wellestablished efficacy safety profile insulin therapy choice patients preferably multiple daily injections intensive care units continuous intravenous infusion syringe pump dose suggestions respective passages ödg guidelines recommended <NUMBER> concomitant medication reviewed every hospitalized patient admission metformin sodium glucose transporter sglt<NUMBER> inhibitors extensively used type <NUMBER> diabetes grave potentially lifethreatening adverse effects acute sickness temporarily discontinued covid<NUMBER> might prudent withhold ace inhibitors angiotensin receptor blockers arb acute illness due increased risk acute kidney injury selected diabetes patients <NUMBER> <NUMBER> however general stop reninangiotensinaldosterone inhibitors covid<NUMBER> based considerations potential upregulate sarscov<NUMBER> receptor ace<NUMBER> recommended <NUMBER> physicians treating patients diabetes outside hospital setting aware impact social distancing quarantine measures may glycemic control calling people stay home likely reduce amount physical exercise compared usual daily routine reliable empirical data topic one expect calorie balance increase period proportion subjects aspects may lead deterioration glycemic control patients particularly type <NUMBER> diabetes advised increase frequency blood glucose measurements covid<NUMBER> furthermore reeducated recognition handling diabetic ketoacidosis since infection one frequent triggers <NUMBER> covid<NUMBER> also impacted many treatment facilities patients diabetes order minimize potential spreading many hospitals reduced outpatient clinic capacities bare minimum emergencies additionally many licensed physicians adopted similar strategies seeking minimize direct patient visits offices depending duration measures may leave huge proportion diabetes patients insecure state inability get routine check option intensify potentially insufficient therapy insufficient glucose control potential provoke numerous acute chronic complications healthcare systems deal covid<NUMBER> pandemic telemedicine could reasonable approach least partly mitigate problem uncontrolled diabetes widespread use flash glucose monitoring fgm continuous glucose monitoring cgm enables physician get insights complete daily glucose profiles minimum time investment patient approach especially suitable experienced type <NUMBER> diabetes patients since insulin dose might easily adjustable without need face face contact type <NUMBER> diabetes however option limited use fgm cgm commonly used population yet however metaanalyses found benefits telemedicine type <NUMBER> type <NUMBER> diabetes modest affect clinically relevant end points <NUMBER> <NUMBER> <NUMBER> however telemedicine improved instruments could complement personal contact standard diabetes management notably access insulin oral antidiabetics glucose management supplies compromised sarscov<NUMBER> pandemic yet region <NUMBER> diabetes patients prone severe clinical course covid<NUMBER> significantly increased mortality hence diabetes patients particularly comorbidities must urged comply social isolation preventive measures covid<NUMBER> infection moreover patients must made aware hyperglycemia stress infection counselled adapt glucose lowering therapy telemedicine methodologies including interdisciplinary counselling diabetologists nutritionists wound managers must established including compensation models addition data privacy issues occurring telemedicine must solved cooperation healthcare providers promote security diabetes patients pandemic maintaining optimal glucose control moreover strategies developed restrictions caused pandemic crisis potential become novel standards diabetes treatment future treatment diabetic complications particularly foot care delivered safety conditions order prevent later amputations moreover covid<NUMBER> pandemic used systematically collect data patients diabetes order learn future epidemics overall covid<NUMBER> pandemic crisis used establish innovative management strategies patients diabetes coronavirus disease <NUMBER> covid<NUMBER> new disease within four months origin wuhan china spread two hundred countries around world affecting <NUMBER> people caused <NUMBER> deaths april <NUMBER> <NUMBER> <NUMBER> march <NUMBER> <NUMBER> world health organization declared covid<NUMBER> pandemic alarming levels spread severity inaction <NUMBER> covid<NUMBER> caused severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> sufficiently genetically divergent closely related severe acute respiratory syndrome coronavirus sarscov considered new humaninfecting betacoronavirus <NUMBER> mainly affects respiratory tract illness ranges severity asymptomatic mild severe critical disease although current estimate case fatality rate covid<NUMBER> <NUMBER> <NUMBER> patients may become severe critically ill requiring icu care mechanical ventilation <NUMBER> since covid<NUMBER> new disease knowledge disease still incomplete evolving many casecontrol studies shown patients covid<NUMBER> underlying diabetes mellitus develop severe clinical course also increased mortality however studies small sample size data heterogenous conflicting addition data prevalence diabetes patients covid<NUMBER> also clear hence metaanalysis conducted primary objective exploring relationship underlying diabetes severity mortality covid<NUMBER> disease secondary objective determining prevalence diabetes patients covid<NUMBER> since metaanalysis therefore institutional board ethics committee approval required prisma preferred reporting items systematic reviews metaanalyses moose metaanalysis observational studies epidemiology guidelines consulted stages design analysis reporting metaanalysis <NUMBER> <NUMBER> <NUMBER> protocol metaanalysis registered international prospective register systematic reviews prospero vide registration number crd<NUMBER> available full nihr national institute health research website httpswwwcrdyorkacukprosperodisplayrecordphprecordid<NUMBER> three authors ak saa sk independently searched screened selected studies according search inclusion exclusion criteria pubmed database searched papers english language using following keywords <NUMBER>ncov ncov<NUMBER> novel coronavirus <NUMBER> sarscov<NUMBER> covid<NUMBER> coronavirus coronavirus covid<NUMBER> corona virus since first report covid<NUMBER> disease published december <NUMBER> <NUMBER> <NUMBER> limited search articles published since january <NUMBER> <NUMBER> last search performed april <NUMBER> <NUMBER> since high likelihood duplicate publications covid<NUMBER> <NUMBER> especially set patients reported english well chinese languages hence restricted search papers published english language reason restricted search pubmed database search databases addition included study carefully evaluated study setting author list exclude duplicate publication inclusion exclusion criteria studies follows <NUMBER> studies english language pubmed database <NUMBER> study design casecontrol categorized patients two groups depending severity clinical course mortality patients covid<NUMBER> ie composite endpoint studies without categorization included study data diabetes mellitus group <NUMBER> study observational retrospective prospective interventional studies controlled uncontrolled drug trials excluded <NUMBER> study included least <NUMBER> patients covid<NUMBER> <NUMBER> participants adult patients covid<NUMBER> studies describing exclusively pediatric population excluded however studies adult pediatric patients included studies describing exclusively pregnant women also excluded following data extracted study date online publication pmid number study setting total number patients demographic data number patients composite endpoint number patients diabetes mellitus among patients without composite endpoint studies missing data corresponding authors studies contacted request provide missing data primary outcome interest occurrence composite endpoint purpose study labelled severe clinical course defined occurrence one two endpoints depending studys <NUMBER> <NUMBER> iii american thoracic society guidelines <NUMBER> patients features severe clinical course categorized good clinical course secondary outcome interest study prevalence diabetes mellitus patients covid<NUMBER> assessment quality studies including risk bias national institute health nih tool casecontrol studies used tool developed jointly national heart lung blood institute nhlbi research triangle institute international <NUMBER> uses composite score twelve domains domain scored <NUMBER> <NUMBER> depending response yes respectively studies categorized good quality scored ≥<NUMBER> points fair quality scored <NUMBER> points poor quality scored <NUMBER> points categorical data displayed n continuous data mean sd study reported data median iqr range method described wan et al used calculate mean sd <NUMBER> study prevalence diabetes mellitus patients covid<NUMBER> pooled proportion <NUMBER> confidence interval ci taken effect size first raw proportion study extracted transformed freemantukey double arcine method stabilize variance <NUMBER> pooled proportion obtained using dersimonianlaird random effects model <NUMBER> study association diabetes mellitus composite endpoint severe clinical course pooled odds ratio <NUMBER> ci taken effect size performed metaanalysis using generic inverse variance approach dersimonianlaird random effects model <NUMBER> p value <NUMBER> used show statistically significant association metaanalysis subgrouped according composite endpoint severe disease mortality assess heterogeneity among studies <NUMBER> statistic calculated <NUMBER> value <NUMBER> indicated substantial heterogeneity take care heterogeneity among studies calculate conservative result odds ratios pooled using random effects model explore source heterogeneity metaregression analysis done using age type composite endpoint severity versus mortality country study china versus others number patients quality score quality type good versus fair covariates addition heterogeneity among studies ≥<NUMBER> sensitivity analysis also performed identifying removing outlier studies evaluated publication bias visual inspection funnel plot begg <NUMBER> egger <NUMBER> tests funnel plot symmetrical p value begg egger tests <NUMBER> significant publication bias considered exist metaanalysis however publication bias found trim fill analysis duval tweedie <NUMBER> used evaluate number missing studies recalculation pooled odds ratio done addition missing hypothetical studies using keywords <NUMBER>ncov ncov<NUMBER> novel coronavirus <NUMBER> sarscov<NUMBER> covid<NUMBER> coronavirus coronavirus covid<NUMBER> corona virus limiting entrez date <NUMBER>jan<NUMBER> <NUMBER>apr<NUMBER> initially <NUMBER> publications english language retrieved pubmed database screened relevance figure <NUMBER> carefully going abstracts full texts needed publications <NUMBER> potentially relevant studies selected evaluated detail potential inclusion <NUMBER> studies excluded following reasons <NUMBER> <NUMBER> studies comparative data covid<NUMBER> patients without composite endpoint <NUMBER> <NUMBER> studies small less <NUMBER> participants <NUMBER> <NUMBER> studies diabetes one comparative factors <NUMBER> <NUMBER> study duplicate publication hence remaining <NUMBER> studies included qualitative well quantitative synthesis metaanalysis figure <NUMBER> study characteristics <NUMBER> included studies given table <NUMBER> online publication date studies pubmed database february <NUMBER> <NUMBER> april <NUMBER> <NUMBER> twenty <NUMBER> <NUMBER> studies single centres remaining <NUMBER> <NUMBER> multicentre studies studies <NUMBER> <NUMBER> mainland china remaining <NUMBER> studies two <NUMBER> usa one <NUMBER> france total included patients <NUMBER> <NUMBER> <NUMBER> reported mainland china <NUMBER> <NUMBER> usa <NUMBER> <NUMBER> france median number patients included studies <NUMBER> iqr <NUMBER> quality study assessed using nih tool casecontrol studies <NUMBER> results shown table <NUMBER> scores follows <NUMBER> score <NUMBER> studies <NUMBER> <NUMBER> score <NUMBER> studies <NUMBER> <NUMBER> score <NUMBER> study <NUMBER> twelve domains assessed tool three domains studies given <NUMBER> score sample size justification blinding assessors adjusting confounding variables thus <NUMBER> studies <NUMBER> judged good quality scores ≥<NUMBER> remaining <NUMBER> study <NUMBER> judged fair quality scores <NUMBER> none included study judged poor single study fair quality paper published cdc usa covid<NUMBER> cases reported us <NUMBER> thus registry data rather hospitalbased study table <NUMBER> shows characteristics included patients total number patients <NUMBER> proportion males <NUMBER> <NUMBER> thus male female ratio approximately <NUMBER> <NUMBER> pooled mean age <NUMBER>±<NUMBER> years <NUMBER> patients <NUMBER> <NUMBER> patients composite endpoint labelled severe clinical course reasons composite endpoint mortality <NUMBER> studies <NUMBER> <NUMBER> patients severity <NUMBER> studies <NUMBER> <NUMBER> patients <NUMBER> studies severity composite endpoint reasons follows predefined criteria <NUMBER> studies icu requirement versus requirement <NUMBER> studies invasive ventilation requirement versus requirement <NUMBER> studies progressive disease versus stable disease <NUMBER> studies refractory disease versus responsive disease <NUMBER> study ards versus ards <NUMBER> study diabetes present <NUMBER> patients total <NUMBER> patients covid<NUMBER> pooled prevalence diabetes calculated <NUMBER> <NUMBER> ci <NUMBER> using freemantukey double arcine transformation dersimonianlaird random effects model figure <NUMBER> however heterogeneity among studies substantial <NUMBER> value <NUMBER> explore source heterogeneity metaregression analyses done using age type composite endpoint severity versus mortality country study china versus others number patients quality score quality type good versus fair covariates supplementary table <NUMBER> supplementary figure <NUMBER> results metaregression showed proportion diabetes patients covid<NUMBER> influenced age studies higher patient age higher proportion diabetes p<NUMBER> type composite endpoint studies reporting mortality endpoint higher proportion diabetes p<NUMBER> country study studies outside china higher proportion diabetes p<NUMBER> influence number patients studies quality score studies subgroup analysis revealed proportion diabetes mellitus china <NUMBER> <NUMBER> ci <NUMBER> countries china mainly usa <NUMBER> <NUMBER> ci <NUMBER> high heterogeneity data shown sensitivity analysis also done excluding <NUMBER> outlier studies revealed pooled prevalence diabetes <NUMBER> <NUMBER> ci <NUMBER> patients covid<NUMBER> acceptable <NUMBER> value <NUMBER> supplementary figure <NUMBER> <NUMBER> included studies metaanalysis <NUMBER> used severity composite endpoint <NUMBER> used mortality composite endpoint presence diabetes found significantly associated severe covid<NUMBER> pooled odds ratio <NUMBER> <NUMBER> ci <NUMBER> p<NUMBER> well mortality due covid<NUMBER> pooled odds ratio <NUMBER> <NUMBER> ci <NUMBER> p<NUMBER> combine pooled odds ratio composite endpoints labelled severe clinical course <NUMBER> <NUMBER> ci <NUMBER> p<NUMBER> figure <NUMBER> mortality endpoint heterogeneity among studies low <NUMBER> <NUMBER> severity endpoint heterogeneity among studies substantial <NUMBER> <NUMBER> thus combined heterogeneity also substantial <NUMBER> <NUMBER> explore source heterogeneity metaregression analyses done using age type composite endpoint severity versus mortality country study china versus others number patients quality score quality type good versus fair covariates supplementary table <NUMBER> supplementary figure <NUMBER> results metaregression showed odds ratio influenced age studies higher patients age lower odds ratio p<NUMBER> addition found cdc study usa <NUMBER> good quality registry data significantly influenced outcome metaanalysis mainly responsible significant heterogeneity hence sensitivity analysis performed excluding study revealed significant combined pooled odds ratio <NUMBER> <NUMBER> ci <NUMBER> p<NUMBER> <NUMBER> value <NUMBER> acceptable heterogeneity supplementary figure <NUMBER> main outcome metaanalysis ie association diabetes mellitus severe clinical course covid<NUMBER> publication bias evaluated visual inspection funnel plot begg egger tests <NUMBER> <NUMBER> funnel plot figure <NUMBER> found mildly asymmetric beggs rank correlation test funnel plot asymmetry kendalls τ <NUMBER> well eggers regression test funnel plot asymmetry z <NUMBER> statistically significant p<NUMBER> hence trim fill analysis duval tweedie <NUMBER> used evaluate number missing studies recalculated pooled odds ratio addition missing hypothetical studies recalculated pooled odds ratio association diabetes mellitus severe clinical course covid<NUMBER> <NUMBER> <NUMBER> ci <NUMBER> p<NUMBER> supplementary figure <NUMBER> redrawn funnel plot addition four missing hypothetical studies symmetrical supplementary figure <NUMBER> adjusting heterogeneity well publication bias corrected pooled odds ratio diabetes mellitus associated severe clinical course covid<NUMBER> ieboth mortality severity still significant <NUMBER> figure <NUMBER> summarise results metaanalysis <NUMBER> studies <NUMBER> patients found diabetes mellitus significantly associated mortality risk covid<NUMBER> pooled odds ratio <NUMBER> <NUMBER> ci <NUMBER> p<NUMBER> low heterogeneity <NUMBER> <NUMBER> addition diabetes mellitus associated severe covid<NUMBER> including risk ards icu requirement invasive ventilatory requirement pooled odds ratio <NUMBER> <NUMBER> ci <NUMBER> p<NUMBER> combined pooled odds ratio diabetics developing severe covid<NUMBER> dying due ie composite endpoint <NUMBER> <NUMBER> ci <NUMBER> p<NUMBER> adjusting heterogeneity among studies well publication bias corrected pooled odds ratio diabetes associated severe clinical course covid<NUMBER> still significantly high <NUMBER> <NUMBER> ci <NUMBER> p<NUMBER> secondary outcome also calculated pooled prevalence diabetes mellitus patients covid<NUMBER> <NUMBER> <NUMBER> ci <NUMBER> uncorrected <NUMBER> <NUMBER> ci <NUMBER> adjusting heterogeneity many strengths metaanalysis first best knowledge first large metaanalysis specific influence diabetes severity covid<NUMBER> well mortality addition also studied prevalence diabetes among covid<NUMBER> patients second included large number studies patient population sixteen thousand spanning three continents third included large studies <NUMBER> patients thus study contributed robust data diabetescovid<NUMBER> association without increasing heterogeneity fourth avoided including duplicate studies limiting search single database limiting search english articles carefully going included articles study setting author list fifth synthesizing results taken care heterogeneity well publication bias appropriate statistical tools first discussing secondary outcome metaanalysis determined corrected pooled prevalence diabetes mellitus covid<NUMBER> patients close <NUMBER> higher prevalence usa china results prevalence similar large chinese nationwide study <NUMBER> patients shown prevalence diabetes covid<NUMBER> patients <NUMBER> <NUMBER> another small metaanalysis <NUMBER> chinese studies <NUMBER> patients fadini et al <NUMBER> also reported prevalence diabetes covid<NUMBER> patients <NUMBER> study well previous studies indicate prevalence diabetes patients covid<NUMBER> range <NUMBER> similar population prevalence diabetes general population china usa <NUMBER> <NUMBER> respectively <NUMBER> <NUMBER> thus metaanalysis supports previously held notion susceptibility diabetic population covid<NUMBER> infection might increased similar nondiabetic population <NUMBER> primary important outcome metaanalysis study association diabetes mortality severity covid<NUMBER> disease found diabetic patients covid<NUMBER> twice likely develop severe covid<NUMBER> disease twice likely die due odds ratio close <NUMBER> severity well mortality thus patients covid<NUMBER> diabetes likely develop ards need icu care need invasive ventilation vulnerable succumb results similar two small metaanalyses fadini et al <NUMBER> studies <NUMBER> patients wang et al <NUMBER> studies <NUMBER> patients gave odds ratio <NUMBER> <NUMBER> respectively diabetic patients developing adverse disease due sarscov<NUMBER> infection <NUMBER> <NUMBER> another systematic review <NUMBER> studies singh et al also suggested diabetes determinant severity mortality covid<NUMBER> patients <NUMBER> however metaanalysis largest <NUMBER> studies conclusively shown association diabetes covid<NUMBER> mortality well severity whether diabetes independent determinant severity studied guo et al casecontrol study china <NUMBER> compared diabetic nondiabetic covid<NUMBER> patients found even absence comorbidities diabetics higher risk severe pneumonia uncontrolled inflammatory response higher levels tissue injuryrelated enzymes higher hypercoagulable state found serum levels inflammatory biomarkers creactive protein ddimer il<NUMBER> serum ferritin coagulation index significantly higher diabetic patients compared without suggesting patients diabetes susceptible inflammatory storm leads worsening covid<NUMBER> <NUMBER> pathogenesis increased mortality severity covid<NUMBER> patients diabetes still unclear severe acute respiratory syndrome sars outbreak <NUMBER> middle east respiratory syndrome mers outbreaks <NUMBER> <NUMBER> also resulted increased severity fatality patients diabetes mellitus <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> previous outbreaks also caused coronaviruses namely sarscov merscov respectively elucidate mechanism enhanced disease severity diabetics following merscov infection kulcsar et al <NUMBER> used animal model mice made susceptible merscov infection expressing human dipeptidyl peptidase <NUMBER> dpp<NUMBER> type <NUMBER> diabetes induced administering highfat diet upon infection merscov diabetic mice prolonged phase severe disease delayed recovery independent viral titres histological examination revealed diabetic mice delayed prolonged systemic inflammation fewer inflammatory monocytemacrophages cd<NUMBER> cells lower levels chemokine ligand <NUMBER> cxc motif chemokine <NUMBER> expression lower levels tumor necrosis factor alpha tnfα interleukin il <NUMBER> il <NUMBER>b arginase <NUMBER> expression higher levels il <NUMBER>a expression data suggested increased disease severity observed diabetes likely due dysregulated immune response resulted severe prolonged lung pathology <NUMBER> since patients diabetes multiple immune dysregulations phagocytic cell dysfunction inhibition neutrophil chemotaxis impaired tcell mediated immune response altered cytokine production ineffective microbial clearance <NUMBER> dysregulated immune responses may result cytokine profile resembling secondary haemophagocytic lymphohistiocytosis patients severe sarscov<NUMBER> infection characterised increased il <NUMBER> il <NUMBER> granulocytecolony stimulating factor interferonγ inducible protein <NUMBER> monocyte chemoattractant protein <NUMBER> macrophage inflammatory protein <NUMBER>α tnfα <NUMBER> <NUMBER> addition type <NUMBER> diabetes mellitus coronavirus infection also shared pathogenic pathways therapeutic implications <NUMBER> two coronavirus receptors angiotensin converting enzyme <NUMBER> ace<NUMBER> dpp<NUMBER> also transducers metabolic pathways regulating glucose homeostasis renal cardiovascular physiology inflammation dpp<NUMBER> inhibitors widely used subjects type <NUMBER> diabetes effect lowering blood glucose levels however effects dpp<NUMBER> inhibition immune response patients diabetes still controversial completely understood <NUMBER> two recent metaanalyses shown dpp<NUMBER> inhibitors increased risk various infections <NUMBER> <NUMBER> third metaanalysis showed increased risk infections dpp<NUMBER> inhibitors <NUMBER> whether dpp<NUMBER> inhibitors increase susceptibility severity sarscov<NUMBER> infection needs studied future trials results metaanalysis three major implications current covid<NUMBER> pandemic first since diabetes lead severe covid<NUMBER> prevention diabetics imperative responsibility treating physicians advice diabetic patients take extraprecautions social distancing hand hygiene protect coronavirus infection <NUMBER> second increased vigilance outpatient clinics diabetes covid<NUMBER> threshold testing infection diabetic patients lowered <NUMBER> third patient covid<NUMBER> comorbid diabetes taken potentially serious even though may show mild symptoms presentation patients need extra monitoring threshold hospital icu admission also needs lowered results metaanalysis also implications india often called diabetes capital world according <NUMBER> estimate age standardised diabetes prevalence southeast asia including india among ages <NUMBER> years estimated <NUMBER> <NUMBER> ci <NUMBER> actual number people diabetes india <NUMBER> million <NUMBER> <NUMBER> drivers type <NUMBER> diabetes south asia include genetic epigenetic factors intrauterine early life factors high carbohydrate dietary patterns increase physical inactivity <NUMBER> factors increase prevalence diabetes also major factors causation obesity hypertension metabolic syndrome fatty liver cardiovascular cerebrovascular diseases resultant increase morbidity mortality fact diabetes along cardiovascular disease chronic kidney disease accounted <NUMBER> <NUMBER> <NUMBER> deaths respectively south asia <NUMBER> current covid<NUMBER> pandemic metaanalysis well multiple studies shown covid<NUMBER> particularly severe patients comorbidities increased hospitalization icu ventilatory requirements <NUMBER> <NUMBER> huge population burden diabetes india urgent strong measures taken flatten curve covid<NUMBER> pandemic india lead disastrous consequences overburdening already stretched healthcare system india especially elderly population india comorbidities diabetes hypertension cardiac diseases need special protection enumerated preceding paragraph blood sugars need better controlled health condition need better monitored even face lockdown measures teleconsultation telemedicine <NUMBER> metaanalysis two limitations shown diabetes associated covid<NUMBER> severity mortality however cannot said whether diabetes acting independent factor responsible severity mortality confounding factor many conditions elderly age hypertension cardiovascular disease obesity often coexist diabetes comorbidities shown associated severe covid<NUMBER> mortality spite limitation implication metaanalysis remain unchanged diabetic need protected covid<NUMBER> need extra care infected second limitation metaanalysis able document role glycemic control severity mortality covid<NUMBER> shown previously poor glycemic control terms high hba<NUMBER>c significantly associated increased risk various infections <NUMBER> <NUMBER> however none included studies covid<NUMBER> metaanalysis evaluated glycemic control one factors associated severity andor mortality needs explored trials conclusion shown metaanalysis presence underlying diabetes patients covid<NUMBER> associated twofold increased risk mortality well twofold increased risk severity covid<NUMBER> necessitates enhanced prevention covid<NUMBER> diabetics increased vigilance patients diabetes covid<NUMBER> lower threshold monitoring hospitalization icu care diabetics develop infection results metaanalysis emphasizes need investigation pathogenic mechanism relationship diabetes covid<NUMBER> explore therapeutic implications none authors declare conflicts interest author contributions ak designed study ak saa sk searched screened selected articles ak ps nb extracted data articles ak ps performed data analysis interpretation ak drafted manuscript authors contributed writing editing manuscript aa supervised study since first reported case december <NUMBER> <NUMBER> wuhan china cases coronavirus <NUMBER> disease quickly escalated global pandemic levels within month present <NUMBER> months later number confirmed cases surpasses <NUMBER> million reported across <NUMBER> countries regions world <NUMBER> <NUMBER> virus responsible covid<NUMBER> named sarscov<NUMBER> previously described humans animals reported january <NUMBER> isolation bronchoalveolar fluid patients <NUMBER> <NUMBER> new betacoronavirus shares high percentage genomic similarities sarscov coronavirus responsible severe acute respiratory syndrome sars outbreak <NUMBER> <NUMBER> among respiratory syndromes caused betacoronaviruses humans sarscov<NUMBER> infection higher basic reproduction number compared sarscov middle east respiratory syndrome merscov representing greater threat international public health <NUMBER> preliminary estimates mortality rates indicate sarscov<NUMBER> infection less often fatal mersand sarscov respiratory infections <NUMBER> <NUMBER> <NUMBER> respectively <NUMBER> <NUMBER> <NUMBER> however evidenced higher reproduction rate covid<NUMBER> outbreak already caused higher total number deaths coronavirus respiratory syndromes cases covid<NUMBER> estimated around <NUMBER> million around world may <NUMBER>th <NUMBER> <NUMBER> deaths <NUMBER> sars outbreak <NUMBER> cases across <NUMBER> countries <NUMBER> total deaths <NUMBER> mers outbreak <NUMBER> confirmed cases reported <NUMBER> countries total <NUMBER> deaths <NUMBER> <NUMBER> <NUMBER> ongoing challenge number confirmed cases increasing exponentially epidemiological data characterizing covid<NUMBER> patients valuable helping control spread treatment disease considered respiratory virus evident invades many organs beside upper lower respiratory tract cause multisystemwide disease characteristics unique organ invades date studies describing comorbidities related covid<NUMBER> report correlations distinctive underlying diseases one first reports describing clinical features hospitalized covid<NUMBER> patients published february <NUMBER> huang et al found <NUMBER> <NUMBER> patients health issues common diabetes cardiovascular disease hypertension chronic obstructive pulmonary disease <NUMBER> high incidence diabetes throughout world makes truly worrisome pandemic spread subsequent studies broader data collection confirmed observations study including <NUMBER> patients <NUMBER> <NUMBER> manifesting severe symptoms common comorbidities hypertension <NUMBER> diabetes <NUMBER> heart disease <NUMBER> cerebrovascular disease <NUMBER> <NUMBER> hypertension diabetes also common comorbidities third study included <NUMBER> patients prevalence <NUMBER> <NUMBER> respectively also correlated severity clinical outcome disease <NUMBER> study <NUMBER> patients wang et al found <NUMBER> <NUMBER> patients underlying conditions notably number much higher <NUMBER> amongst patients intensive care unit <NUMBER> addition among cases negative outcome yang et al described group <NUMBER> nonsurvivors <NUMBER> <NUMBER> cerebrovascular diseases <NUMBER> diabetes <NUMBER> systematic review including eight different studies encompassing total <NUMBER> confirmed cases yang et al found common comorbidities among covid<NUMBER> patients hypertension <NUMBER> diabetes <NUMBER> patients underlying respiratory diseases amounted <NUMBER> <NUMBER> summary report chinese center disease control <NUMBER> cases largest case load date informs us overall fatality sarscov<NUMBER> <NUMBER> percentage <NUMBER> diabetes <NUMBER> sum evidence diabetes per se makes likely one gets infected sarscov<NUMBER> inconclusive lacking altogether lack information group people get infected symptoms diabetic condition makes likely infection severe therefore result hospitalizations hospitalized diabetic patients need intensive care diabetes patients spend longer time hospital discharged patients diabetes likely die nondiabetic patients generalized immunological findings viral infections diabetic patients known diabetic patients especially uncontrolled glycemia higher risk contract infections trend correlates tightly glycated hemoglobin levels clinical practice higher incidence foot infections yeast infections urinary tract infections surgical site infections commonly seen diabetic patients <NUMBER> <NUMBER> <NUMBER> <NUMBER> several host factors explain observation ranging local changes bacterial colonization systemic alterations immune response instance cytokine release macrophages tcells disturbed diabetes also impairs neutrophil recruitment <NUMBER> alteration innate immune responses humoral innate immunity observed vitro diabetic patients <NUMBER> <NUMBER> <NUMBER> nonobese diabetic mice basal levels interferonα ifnα type interferon reduced compared prediabetic mice ifnγ production cd<NUMBER> cells impaired <NUMBER> similarly persons either type <NUMBER> type <NUMBER> diabetes t<NUMBER>dm t<NUMBER>dm respectively ifnα production dendritic cells reduced <NUMBER> impaired dendritic cell functions together reduced activation natural killer cells compromise proper adaptative immune responses fig <NUMBER> adipose tissue t<NUMBER>dm mouse models human patients regulatory antiinflammatory macrophages m<NUMBER> regulatory cells treg change profile proinflammatory macrophages m<NUMBER> th<NUMBER> th<NUMBER> cd<NUMBER> cells <NUMBER> delayed activation th<NUMBER> response late hyperinflammatory reaction regular findings diabetes <NUMBER> alternations immune profile likely contribute reasons patients dm higher incidence severity infections type ifn plays crucial role cd<NUMBER> cells differentiation antiviral response <NUMBER> dendritic cells necessary element induce type ifndependent polarization cd<NUMBER> cells follicular helper cells tfh vital immune humoral responses viral infections <NUMBER> interestingly cd<NUMBER> cell polarization tfh happens ifn exposure early stages infection exposure delayed stages promotes differentiation th<NUMBER> cells <NUMBER> mentioned reduced levels ifnα production dendritic cells feature found t<NUMBER>dm t<NUMBER>dm patients may favor th<NUMBER> differentiation detriment tfh sarscov responsible <NUMBER> outbreak able suppress induction type ifn dendritic cells inhibiting transcription factor irf<NUMBER> interferon regulatory transcription factor<NUMBER> <NUMBER> seem case sarscov<NUMBER> <NUMBER> fact lokugamage colleagues show sarscov<NUMBER> much sensitive type ifn priming sarscov measured reduced viral protein replication vero e<NUMBER> cells <NUMBER> reduced basal levels type ifn observed diabetic patients offer additional explanation increased risk severity covid<NUMBER> human ifnα<NUMBER>b vapor inhalation adjuvant treatment recommended guidelines treatment coronaviruses china <NUMBER> least two ongoing clinical trials nct<NUMBER> chictr<NUMBER> evaluating two different type ifns ifnβ<NUMBER>b ifnα<NUMBER>b respectively combination antiviral drugs treatment covid<NUMBER> investigatorinitiated openlabel study human recombinant ifnα nasal drops seemed effectively prevent infection medical personnel likely exposed sarscov<NUMBER> indicating ifnα inhalation promise protecting susceptible healthy people coronavirus pandemic underlining importance ifn disease <NUMBER> report replicated would hugely significant advance fighting disease according <NUMBER> national diabetes statistics report elaborated published cdc <NUMBER> us adults age <NUMBER> diabetes corresponding <NUMBER> total population additionally prevalence diabetes increases age <NUMBER> adults <NUMBER> <NUMBER> years age diabetes number increases <NUMBER> age range <NUMBER> years <NUMBER> people <NUMBER> <NUMBER> even though elderly individuals dm get infections similar common infections found younger dm patients agerelated immune senescence additional component already compromised cellmediated immunity seen diabetic persons several different aspects immune response altered aging changes tcell mediated response studied best described due gradual thymic involution aging production naive cells decreased resulting limited diversity tcell receptors apt recognize new antigens even though total number cells mostly unaltered age higher prevalence memory lymphocytes older individuals detriment naive cells <NUMBER> characteristic one reasons elderly persons adequate immune response previously exposed antigens poorer response exposed new ones decreased number naive cells however one aspect tcell system altered aging expression il<NUMBER> receptor il<NUMBER>r signal transduction decreased aging <NUMBER> number steps tcell maturation activation also affected one factor particularly interesting context diabetes association type ifns tcell differentiation survival previously mentioned type ifns produced dendritic cells crucial element cd<NUMBER> cells case sarscov sarscov<NUMBER> uses ectopeptidase ace<NUMBER> entry site human host cells ace<NUMBER> part reninangiotensin system responsible termination angiotensin signal promoting conversion angiotensin ii ang ii angiotensin <NUMBER> ang <NUMBER> ang ii acts angiotensin receptor <NUMBER> at<NUMBER> results vasoconstriction sympathetic nervous stimulation ang <NUMBER> hand acts angiotensin receptor <NUMBER> at<NUMBER> opposite effects inducing vasodilation ace<NUMBER> expressed throughout respiratory epithelium nasal oral mucosa epithelium alveoli diabetic patients higher risk infection complications covid<NUMBER> result several factors dampened antiviral response reduced interferon production common feature seen persons diabetes additionally diabetic patients may vulnerable sarscov<NUMBER> infection due elevated ace<NUMBER> expression finally diabetesrelated subclinical pulmonary dysfunction microvascular disease may aggravating factors contribute severity respiratory symptoms associated covid<NUMBER> differentiation antiviral response dendritic cells present antigen molecules antigenspecific cells clonal expansion lymphocytes subsequent differentiation effector cells later establish tcell memory elderly individuals process compromised li colleagues <NUMBER> found even though expression ifn receptor elements intracellular signaling jakstat pathway change age type ifn response still diminished activated naive cd<NUMBER> cells older individuals rather decreased expression components ifn response found upregulation inhibitory elements thus cd<NUMBER> cells elderly persons considered resistant tnf contributing impaired cellmediate immune response may represent additional burden elderly individuals dm since described ifnα production dendritic cells reduced t<NUMBER>dm may therapeutic implications aside bacterial yeast infections correlation diabetes prevalence severity viral respiratory infections also well described people either t<NUMBER>dm t<NUMBER>dm reported higher risk serious complications common flu <NUMBER> caused different influenza viruses members myxovirus family according centers disease control prevention cdc around <NUMBER> patients hospitalized due common flurelated complications diabetes <NUMBER> swine flu pandemic caused outbreak influenza virus subtype h<NUMBER>n<NUMBER> ah<NUMBER>n<NUMBER> showed similar numbers canadian study <NUMBER> hospitalized patients pcrconfirmed influenza ah<NUMBER>n<NUMBER> found diabetes triples risk hospitalization hospitalized diabetic patients quadruple risk admitted intensive care <NUMBER> diabetes plasma glucose levels also correlated severity mortality sars patients <NUMBER> retrospective analysis yang et al compared data <NUMBER> patients found fasting plasma glucose levels higher sarspositive patients patients nosars pneumonia interestingly patients died sars infection plasma glucose levels even higher similarly <NUMBER> patients negative outcome sars infection history diabetes percentage significantly higher recovered infection <NUMBER> particular interest right kulcsar colleagues studied severity merscov infection mouse model diabetes induced highfat diet <NUMBER> results show severe prolonged acute phase infection diabetic mice impaired cd<NUMBER> cell recruitment lungs altered cytokine profiles elevated il<NUMBER> similar inflammatory response observed covid<NUMBER> patients well low cd<NUMBER> cell counts seen together disproportionally high number th<NUMBER> cells mentioned previously one characteristic cellmediate response aging decreased il<NUMBER> production signaling also favors cd<NUMBER> cell differentiation th<NUMBER> cells <NUMBER> addition inflammatory profile accentuated diabetes may go long way towards explaining severity covid<NUMBER> diabetic patients <NUMBER> oftenneglected characteristic diabetes effects lungs one common finding diabetic patients abnormalities small vessels thickening capillary basement membrane affects many organs tissues condition known diabetic microangiopathy microvascular disease important factor determine prognosis diabetic patients frequently affects kidneys eyes skin muscle another important target however particularly relevant discussion lungs alveolar diabetic microangiopathy usually presents subclinical pulmonary dysfunction normal conditions fig <NUMBER> since alveolar microvasculature structured large physiological reserve however even otherwise healthy diabetic patients restriction lung volume diffusing capacity found t<NUMBER>dm t<NUMBER>dm <NUMBER> crosssectional study <NUMBER> patients peak oxygen uptake pulmonary blood flow diffusing capacity capillary blood volume found significantly reduced nonsmoking t<NUMBER>dm patients exercise functional impairment correlated directly glycemic control measured hba<NUMBER>c levels extrapulmonary microangiopathy retinopathy neuropathy microalbuminuria aggravated obesity <NUMBER> study obese diabetic animals foster colleagues found extensive fat deposits lungs septal lipofibroblasts interstitial matrix alveolar macrophages correlated alterations interstitial environment presented increased number interstitial cells matrix collagen reduced capillary volume thickening capillary basement membrane <NUMBER> intracellular lipid droplets macrophages hallmark feature classical m<NUMBER> activation caused profound cellular metabolic shift towards aerobic glycolysis decreased mitochondrial respiration <NUMBER> diabetes case stimulates macrophage activation response sterile inflammation may profound consequences proper inflammatory response infections discussed another point concern diabetic patients regarding pulmonary function bronchomotor tone control ventilation since autonomic neuropathy common finding present <NUMBER> patients <NUMBER> impaired noradrenergic innervation bronchioles occurs diabetic patients autonomic neuropathy despite apparent normality respiratory functions <NUMBER> loss autonomic innervation however may alter respiratory response endogenous exogenous stimuli plausible damage negative impact course prognosis respiratory infections even though disturbance immune response may explain higher risk infection worse outcome diabetic patients influenza relationship diabetes respiratory infections caused coronaviruses merscov sarscov sarscov<NUMBER> may complicated first step process viral infection attachment virus targeted cells seven known human coronaviruses capable infecting cells respiratory system hcovoc<NUMBER> hcov<NUMBER>e first described <NUMBER>s thought cause common cold <NUMBER> sarscov identified <NUMBER> <NUMBER> hcovnl<NUMBER> hcovhku<NUMBER> <NUMBER> associated weak respiratory infections <NUMBER> merscov described <NUMBER> <NUMBER> sarscov<NUMBER> responsible ongoing covid<NUMBER> pandemic coronaviruses cellular attachment targeting mediated glycoprotein called spike glycoprotein found enveloped surface virus interaction glycoprotein specific molecular targets found host cells allows viral adhesion ultimately cellular infection targets identified human coronaviruses interestingly membranebound exopeptidases aminopeptidase n apn metalloprotease mediates attachment hcov<NUMBER>e host cells <NUMBER> angiotensinconverting enzyme <NUMBER> ace<NUMBER> responsible hydrolysis angiotensin ii angiotensin <NUMBER> coreceptor sarscov hcovnl<NUMBER> <NUMBER> <NUMBER> finally dipeptidyl peptidase <NUMBER> dpp<NUMBER> transmembrane glycoprotein allows attachment merscov human host cells sarscov<NUMBER> <NUMBER> <NUMBER> different studies suggest besides sarscov hcovnl<NUMBER> ace<NUMBER> also host coreceptor sarscov<NUMBER> fig <NUMBER> vitro studies using hela cells without human ace<NUMBER> expression zhou et al showed novel <NUMBER> coronavirus infect cells express ace<NUMBER> <NUMBER> furthermore wrapp et al reported binding kinetics sarscov<NUMBER> human ace<NUMBER> showing strong specific binding affinity <NUMBER>x higher compared sarscov <NUMBER> association ace<NUMBER> expression sarscov<NUMBER> infection vulnerability seems clear two different mouse models diabetes ace<NUMBER> expression levels increased different organs including lungs <NUMBER> <NUMBER> recently similar finding described humans well <NUMBER> phenomewide mendelian randomization study investigating factors causally correlate pulmonary ace<NUMBER> expression rao et al found increased ace<NUMBER> expression consistent causal link t<NUMBER>dm traits significant correlations also found t<NUMBER>dm well inflammatory bowel disease er breast lung cancer asthma <NUMBER> supporting finding study <NUMBER> covid<NUMBER> patients chen et al reported diabetes negatively affects viral clearance measured sarscov<NUMBER> qrtpcr <NUMBER> angiotensin prohormone activated angiotensin ii angiotensinconverting enzyme ace angiotensin ii acts agonist receptor angiotensin receptor type <NUMBER> at<NUMBER> ace<NUMBER> hand promotes conversion angiotensin ii angiotensin <NUMBER> fig <NUMBER> longer capable activating at<NUMBER> instead binds activates angiotensin receptor type <NUMBER> at<NUMBER> at<NUMBER> activation responsible major cardiovascular effects attributed angiotensin ii inducing vasoconstriction aldosterone synthesis secretion renal tubular sodium reuptake at<NUMBER> activity promotes vasodilation natriuresis <NUMBER> controlling ratio angiotensin ii angiotensin <NUMBER> ace<NUMBER> responsible balancing opposing roles at<NUMBER> at<NUMBER> mouse model sarscov infection reduced pulmonary ace<NUMBER> expression <NUMBER> disturbance observed animals injected viral spike protein alone indicating binding ace<NUMBER> spike protein enough downregulation interestingly model acute lung failure could mitigated reninangiotensin antagonists <NUMBER> olfactory gustation impairment affect around <NUMBER> diabetic patients <NUMBER> <NUMBER> based patient histories altered taste smell sensing also clinical feature covid<NUMBER> cases altered chemosensation may symptom appears certain chemoreceptor cells taste smell somehow affected sarscov<NUMBER> infection chemoreceptor cells smell modified neuronal cells located distal superior portion nasal cavity encompassing superior nasal conche nasal septum distal nasal ends cells project cilia nasal cavity sense discriminate airborne chemicals however different singlecell rnaseq studies indicate ace<NUMBER> expression nasal epithelium found exclusively nonneuronal cells <NUMBER> <NUMBER> observation suggests sarscov<NUMBER>related anosmia may caused infection support stem cells olfactory epithelium note taste buds contain taste receptor cells trcs embedded within lingual epithelium fungiform foliate circumvallate papillae dispersed across soft palate nasopharynx larynx upper bronchi proximal esophagus <NUMBER> murine tissue ace<NUMBER> expressed fungiform circumvallate papillae throughout tongue epithelium immense relevance sarscov<NUMBER> ace<NUMBER> present membranes type saltsensing type ii sweet bitter sensing trcs <NUMBER> therefore highly likely sarscov<NUMBER> also gains entry trcs sites fig <NUMBER> far ascertain current literature topic evidence immune cells residing within taste buds normal conditions <NUMBER> <NUMBER> therefore capacity direct early action immune cells taste buds clear virus low allowing virus replicate unimpeded potentially shed cause infection lower pharynx direct infection trcs within enclosed space taste bud would also likely disturb signaling machinery trcs impacting neurotransmitter signals diminishing synthesis neurotransmitters causing unregulated neurotransmitter release inability clear neurotransmitters adequately leading desensitization receptors disturbance sensory afferent neurons receptors besides serving viral reservoirs hypothesize trcs may involved serving sentinels inflammatory response sarscov<NUMBER> propose early loss taste predicts brisk ifn response virus clearing virus oral nasal cavities faster patient recovery innate immune nodlike receptor pyrin <NUMBER>nlrp inflammasome <NUMBER> trcs likely activated response sarscov<NUMBER> infection several viral components original sarscov known sensed dangerassociated a<NUMBER>b<NUMBER> show <NUMBER>molecular patterns damps nlrp<NUMBER> inflammasome <NUMBER> nlrp activates caspase<NUMBER> converts procytokines il<NUMBER>ß il<NUMBER> active forms activated cytokines recruit innate immune cells site infection cause production ifnγ direct evidence inflammation ifn taste linked wellknown clinical observation ifn therapy reported cause altered taste smell <NUMBER> mice two ifnα receptor subunits ifnar<NUMBER> ifnar<NUMBER> downstream jak kinases jak<NUMBER> tyk<NUMBER> transcription factors stat<NUMBER> stat<NUMBER> irf<NUMBER> expressed normal trcs lpsinduced systemic inflammation increases cleaved caspase levels trc death within taste buds <NUMBER> furthermore increased death trcs could increased viral shedding loss taste therefore may associated weak immune response virus use ifnbased therapies <NUMBER> <NUMBER> described may preventing virus gaining ideal replication target clearing virus approximately <NUMBER> million people diagnosed diabetes usa vast majority patients get covid<NUMBER> infection managed home regards inpatients one retrospective study confirmed covid<NUMBER> adults <NUMBER> deaths discharges recorded pointofcare blood glucose test results bgs transmitted stored mortality rate <NUMBER> <NUMBER> diabetes andor uncontrolled hyperglycemia patients compared <NUMBER> remaining <NUMBER> patients without diabetes hyperglycemia <NUMBER> hyperglycemia per se clearly associated increased mortality underline necessity good glucose control retrospective analysis <NUMBER> hospitalized covid<NUMBER> without preexisting t<NUMBER>dm patients wellcontrolled blood glucose maintaining levels within range <NUMBER> <NUMBER> mmoll associated significant reduction composite adverse outcomes death <NUMBER> attention nutrition adequate protein intake important mineral vitamin intake need continue vitamin c particular may role covid<NUMBER> prevention shown infections <NUMBER> hydration maintained treatment acetaminophen humidifier use continuation cpap sleep apnea continue seems reasonable antihyperglycemic agents known result volume depletion sodium glucose transporter<NUMBER> sglt<NUMBER> inhibitors hypoglycemia chlorpropamide avoided care also taken use glucagonlike receptor<NUMBER> glp<NUMBER>r agonists dose reduction discontinuation altogether may needed prevent nausea abdominal distress dehydration patients eating drinking little patients gastrointestinal symptoms directly caused invasion virus gut dipeptidyl peptidase<NUMBER> dpp<NUMBER> inhibitors see discussion weak antihyperglycemic agents first line glucose lowering drugs probably stopped anyone indications volume depletion reduced kidney function nonhospitalized patients t<NUMBER>dm well t<NUMBER>dm patients using insulin measure blood glucose urinary ketones frequently especially fever increasing hyperglycemia occur true infections frequent changes dosage correctional boluses par course order maintain normal glucose levels hospitalized patients severe covid<NUMBER> symptoms concomitant diabetes need escalating frequency blood glucose monitoring infection signs worsen subcutaneous insulin via basalbolus regimen possible hospitalized patients continuous insulin drip icu setting preferred methods control blood glucose levels oral agents especially metformin sglt<NUMBER> inhibitors likely stopped biguanides metformin one use patients t<NUMBER>dm prediabetes known increase lactic acid production gut normally cleared liver however recently described two independent groups human gut epithelium contains transmembranal ace<NUMBER> site covid<NUMBER> infection supports viral replication spread <NUMBER> <NUMBER> therefore expectation would endogenous lactic acid levels already high gut well organs due infection could make risk lactic acidosis likely presence metformin might also implications lung function acidosis would impede metabolism cellular function infected alveolar cells lymphocytes time vulnerability see discussion reiterate drug use might facilitate dehydration would seem unwise increasing thrombosis especially venous thromboses micro vascular thromboses many organs including pulmonary vasculature <NUMBER> hypercoagulable state low platelets <NUMBER> reported occur extremely sick covid<NUMBER> patients dehydration would seriously detrimental conditions specific conundrums sarscov<NUMBER> management setting diabetes chloroquine cq hydroxychloroquine hcq much discussion use cq hcq therapy covid<NUMBER> worth remembering hcq approved treatment though first line diabetes since <NUMBER> india used malaria prophylaxis treating autoimmune arthritis rheumatoid arthritis systemic lupus erythematosus sle patients appeared reduced risk t<NUMBER>dm though conditions risk may reduced reasons besides use drugs less obesity attention nutrition instance found hcq treatment led less insulin requirements t<NUMBER>dm without altering cpeptide levels would imply hcq reduces clearance insulin increases secretion <NUMBER> clinical case reports use t<NUMBER>dm would seem bear improved glycemic control setting reduced insulin requirements also reported condition additionally reports cq improves insulin sensitivity activation akt would result greater glucose uptake glycogen synthesis <NUMBER> additional piece puzzle relates adiponectin found use hcq cq leads increased adiponectin levels circulation welldescribed favorable effects glucose uptakeutilization insulinsensitizing effects adiponectin also antiinflammatory antiapoptotic effects one could hypothesize would added benefits covid<NUMBER> indeed viral infection <NUMBER> regards antiinflammatory properties hcq use leads significant decrease production proinflammatory markers cytokines successful disease modifying antiinflammatory agent autoimmune diseases based vitro studies changes ph acidic intracellular organelles including endosomeslysosomes essential membrane fusion believed agents could effective tools sarscov data vitro work seemed indicate hcq might cytotoxic sarscov<NUMBER> <NUMBER> clinical trials using hcq reported either benefit increased mortality due cardiotoxicity use hcq without azithromycin <NUMBER> many studies still ongoing give clarity use agents sarscov<NUMBER> decreasing certain cytokines andor lowering intracellular ph organelles might result diminished autophagy might detrimental one wants accelerate clearance virus b angiotensin converting enzyme inhibitors angiotensin type <NUMBER> receptor blockers raas inhibitors diabetes hypertension kidney disease coexist many patients prescribed raas inhibitors wellproven beneficial effects protecting kidney myocardium lowering blood pressure ace<NUMBER> expression lung increased diabetes stated clear membranebound ace<NUMBER> necessary sarscov<NUMBER> spike protein attachment actually increased suggestions literature raas inhibitors increase ace<NUMBER> paucity data suggest effect lungspecific nasalspecific expression transmembranal ace<NUMBER> vaduganathan et al written thorough review topic raas inhibitors patients sarscov<NUMBER> infection <NUMBER> short however european society cardiology council hypertension american college cardiology american heart association heart failure society america american society hypertension released similar statements advising discontinuing medications sudden withdrawal cardiorenal stable patients already severe stress infection could lead clinical instability decompensation reason response mere hypothetical concerns c dpp <NUMBER> inhibitors great interest virology membrane bound human mouse dpp<NUMBER> functional coreceptor merscov <NUMBER> though sarscov<NUMBER> dpp<NUMBER> also known cd<NUMBER> type ii transmembrane glycoprotein expressed many tissues including immune cells nonciliated bronchial epithelial cells also shed cell membranes therefore present circulation last <NUMBER> decades subject much research ability cleave alanine proline penultimate position peptides chemokines bioactive compounds resulting either inactivation activation substrates dpp<NUMBER> well known diabetes researchers medical practitioners inactivates wellstudied gutderived incretins glp<NUMBER> glucosedependent insulinotropic polypeptide gip released enteroendocrine cells response food gut glp<NUMBER>r agonists mentioned routine treatments t<NUMBER>dm management additionally use lead weight loss incretin action specific receptors beta cells islet langerhans responsible <NUMBER> secreted insulin eating <NUMBER> <NUMBER> levels active full length glp<NUMBER> gip increased dpp activity eliminated consequence dpp inhibitors routine though first line oral agents managing t<NUMBER>dm improving insulin secretion dpp<NUMBER> also plays role immune regulation activating cells upregulating cd<NUMBER> expression nfkb pathway chemotaxis modulation cell adhesion apoptosis <NUMBER> expression higher visceral adipose subcutaneous tissue directly correlates adipocyte inflammation insulin resistance despite activity cytokines plasma levels <NUMBER> plasma cytokines unchanged fourweek treatment sitagliptin dpp<NUMBER> inhibitor <NUMBER> another inhibitor vildagliptin affect ex vivo cytokine response function lymphocytes taken t<NUMBER>dm patients <NUMBER> review literature support meaningful changes immune function dpp inhibition humans therefore likely play role treating covid<NUMBER> additionally despite dpp<NUMBER> coreceptor merscov data forthcoming point dpp<NUMBER> inhibitors saxagliptin sitagliptin vildagliptin sterically interfering modifying merscov binding subunits dpp<NUMBER> <NUMBER> use dpp<NUMBER> coronavirus seems simply due coronavirus hitching ride abundant target epithelial cells unrelated dpp<NUMBER>s proteolytic activity hmgcoa reductase inhibitors many t<NUMBER>dm patients taking statins control ldl levels prevent atherosclerotic heart disease fact american college cardiology american heart association american diabetes association issued recommendations anyone aged <NUMBER> older diabetes prescribed statins continued covid<NUMBER> infection hmgcoa reductase inhibitors upregulate ace<NUMBER> part function reducing endothelial dysfunction many pleiotropic effects independent lipidlowering effects class compounds based observational studies may actually reduce mortality hospitalized patients influenza pneumonias acute lung injury <NUMBER> also anecdotal evidence sierra leone statins beneficial ebola outbreak proposed agents potential role managing patients severe covid<NUMBER> <NUMBER> e steroids use steroid use exacerbate hyperglycemia high cytokine crp levels routine findings sarscov<NUMBER> steroids used severely ill patients suppress cytokine storm however shown decrease mortality theoretically might even slow viral clearance even setting adult respiratory distress syndrome sarscov<NUMBER> evidence suggest provide therapeutic benefit national institute allergy infectious diseases issued guidelines steroid use certain circumstances covid<NUMBER> <NUMBER> use intranasal steroids fluticasone allergies also discontinued data emerges say otherwise yet reported intranasal steroids enhance viral replication olfactory epithelium whether people use consistent basis likely get infected theoretical reasons may individuals diabetes increased risk infections acquired generally get severe infections much greater increase mortality compared nondiabetic patients certainly proving rule sarscov<NUMBER> also transpires <NUMBER> coronavirus coreceptors ace<NUMBER> dpp<NUMBER> wellestablished actors within metabolic inflammatory pathways renal cardiovascular physiology front center diabetes metabolic research ace<NUMBER> coreceptor sarscov<NUMBER> dpp<NUMBER> coreceptor merscov medical economic consequences sarscov<NUMBER> epidemic require ongoing realtime adaptation protocols standard medical procedures deliver diabetes care bring sarscov<NUMBER> control lower morbidity mortality including people diabetes elderly human population waits breath bated vaccine coronaviruses enveloped positive singlestranded rna viruses widely distributed humans animals worldwide <NUMBER> although human coronavirus infections mild major outbreaks two betacoronaviruses severe acute respiratory syndrome coronavirus sarscov <NUMBER> middle east respiratory syndrome coronavirus merscov <NUMBER> caused deadly pneumonia mortality rates <NUMBER> sarscov <NUMBER> merscov <NUMBER> december <NUMBER> clusters pneumonia cases unknown etiology emerged wuhan hubei province china deep sequencing analysis lower respiratory tract samples indicated novel coronavirus causative agent named severe acute respiratory syndromecoronavirus<NUMBER> sarscov<NUMBER> disease causes called covid<NUMBER> <NUMBER> <NUMBER> although sarscov<NUMBER> shown phylogenetic clinical similarities sarscov novel coronavirus appears higher transmissibility lower case fatality rates <NUMBER> <NUMBER> january <NUMBER> world health organization declared covid<NUMBER> outbreak public health emergency international concern march <NUMBER> epidemic upgraded pandemic <NUMBER> today <NUMBER> <NUMBER> confirmed cases officially reported <NUMBER> countries territories <NUMBER> deaths <NUMBER> conducted scoping review provide brief summary general characteristics covid<NUMBER> well detailed description critical assessment association new infectious disease diabetes hope review provide meaningful information future research ultimately contribute better clinical management patients covid<NUMBER> diabetes literature review carried search articles pubmed google scholar databases till <NUMBER> april <NUMBER> following keywords used sarscov<NUMBER> covid<NUMBER> infection pathogenesis incubation period transmission clinical features diagnosis treatment diabetes interposition boolean operator also retrieved full text relevant cross references search results furthermore accessed currently available scientific literature recommendations united states centers disease control prevention cdc websites incubation period described time infection illness onset study <NUMBER> patients china laboratoryconfirmed symptomatic covid<NUMBER> median incubation period four days interquartile range <NUMBER> <NUMBER> <NUMBER> another study including <NUMBER> confirmed cases reported median incubation period approximately <NUMBER> days symptoms would develop <NUMBER> infected individuals within <NUMBER> days <NUMBER> based incubation period sarscov merscov well observational data united states cdc estimated symptoms covid<NUMBER> usually develop within <NUMBER> days exposure therefore fourteen days time applied internationally monitoring restricting movement healthy individuals quarantine period <NUMBER> initial covid<NUMBER> patients direct contact history local chinese seafood wildlife market suggesting commonsource zoonotic exposure main mode transmission <NUMBER> findings virus genome sequencing analysis pointed sarscov<NUMBER> bat coronavirus bat cov might share ancestor although bats sale seafood market <NUMBER> later cases reported among health care workers others without exposure history wildlife visiting wuhan indicated humantohuman transmission <NUMBER> currently considered virus mainly transmitted droplets direct contact aerosols droplets transmission may occur respiratory droplets produced infected person coughs sneezes ingested inhaled individuals nearby within <NUMBER> feet subject also get infected touching surface object contaminated virus subsequently touching hisher mouth nose eyes <NUMBER> additionally shown experimentally virus remain viable aerosols least <NUMBER> hours <NUMBER> transmitted closed environments inhaled lungs <NUMBER> therefore airborne transmission possibility aerosol generating procedures eg endotracheal intubation bronchoscopy noninvasive positivepressure ventilation tracheostomy cardiopulmonary resuscitation etc <NUMBER> although viable virus identified fecal swabs fecaloral route appear driver covid<NUMBER> transmission <NUMBER> uncertain long individual covid<NUMBER> remains infectious period infectivity often assessed indirectly detection viral rna respiratory specimens however viral rna necessarily confirm presence infectious virus higher viral loads detected soon symptom onset suggesting transmission may likely occur earlier stages infection <NUMBER> viral shedding duration seems vary according disease severity found around <NUMBER> patients milder symptoms negative viral rna test nasopharyngeal swabs day <NUMBER> postonset test remained positive longer time severe cases <NUMBER> hand reported viral load detected asymptomatic patients similar symptomatic subjects <NUMBER> indeed transmission asymptomatic carriers individuals within incubation period described <NUMBER> nevertheless extent occurs remains determined even though age groups affected covid<NUMBER> median age appears around <NUMBER> years usually higher among severe cases nonsurvivors specific gender bias seems exist contamination virus men tend higher propensity cases <NUMBER> <NUMBER> <NUMBER> fewer cases identified among children infants large chinese report including <NUMBER> patients <NUMBER> infected younger <NUMBER> years old <NUMBER> clinical spectrum covid<NUMBER> heterogeneous adults children present mild flulike symptoms may rapidly develop acute respiratory distress syndrome ards respiratory failure arrhythmias acute cardiac injury shock multiple organ failure death <NUMBER> <NUMBER> commonly reported symptoms fever cough fatigue sputum production shortness breath however headache upper respiratory symptoms eg sore throat rhinorrhea gastrointestinal symptoms eg nausea diarrhea occur less often <NUMBER> <NUMBER> <NUMBER> although described initial chinese studies smell taste disorders eg anosmia dysgeusia also found frequently patients covid<NUMBER> italy <NUMBER> laboratory examination results patients normal decreased white blood cell counts particularly lymphocytopenia <NUMBER> however severe patients neutrophil count inflammatory markers ddimer blood urea creatinine levels generally higher decreased lymphocyte counts <NUMBER> chest computed tomography ct commonly shows groundglass opacifications without consolidative abnormalities also likely bilateral peripheral distribution involve lower lobes <NUMBER> <NUMBER> confirmed cases may present normal ct images <NUMBER> abnormalities also identified prior development symptoms patients <NUMBER> diagnosis covid<NUMBER> cannot made without microbiologic analysis patients meet criteria discussed undergo testing sarscov<NUMBER> addition testing respiratory pathogens eg influenza respiratory syncytial virus etc since testing covid<NUMBER> suspected cases limited owing inadequate capacity local health authorities may introduce specific criteria priority cases <NUMBER> although many laboratory tests developed realtime fluorescence rtpcr current standard diagnostic method diagnosis covid<NUMBER> detecting positive nucleic acid sarscov<NUMBER> sputum throat swabs secretions lower respiratory tract samples <NUMBER> <NUMBER> community surveillance introduced countries order register new cases covid<NUMBER> map transmission route according literature following recommended <NUMBER> <NUMBER> individuals new onset fever andor respiratory tract symptoms eg cough dyspnea patients severe lower respiratory tract illness without clear cause without history close contact confirmed covid<NUMBER> patient travelled area community transmission subjects new onset fever andor respiratory tract symptoms eg cough dyspnea patients severe lower respiratory tract illness contact covid<NUMBER> patients travelled within <NUMBER> days location community transmission sarscov<NUMBER> present furthermore patients older <NUMBER> years age well underlying conditions like diabetes hypertension cardiovascular diseases cvds chronic renal disease cancer immunocompromising conditions develop symptoms fever cough andor dyspnea prioritized testing persons close contact within <NUMBER> meters sarscov<NUMBER> infected individual prolonged period direct contact infectious secretions wearing personal protective equipment although pathophysiological mechanisms still understood observed severe fatal cases covid<NUMBER> occurred elderly patients underlying comorbidities particularly cvds diabetes mellitus chronic lung renal disease hypertension cancer <NUMBER> <NUMBER> <NUMBER> <NUMBER> one chinese metaanalysis including <NUMBER> patients showed prevalent cardiovascular metabolic comorbidities covid<NUMBER> hypertension <NUMBER> <NUMBER> ci <NUMBER> <NUMBER> cardiocerebrovascular disease <NUMBER> <NUMBER> ci <NUMBER> <NUMBER> followed diabetes <NUMBER> <NUMBER> ci <NUMBER> <NUMBER> report patients diabetes hypertension <NUMBER>fold increase risk severe disease requiring intensive care unit icu admission cardiocerebrovascular disease <NUMBER>fold increase <NUMBER> subset <NUMBER> patients covid<NUMBER> italy died mean number preexisting underlying conditions <NUMBER> <NUMBER> subjects comorbidity <NUMBER> consistently reported addition pneumonia sarscov<NUMBER> may cause damage organs including heart liver kidneys <NUMBER> <NUMBER> therefore full attention paid treatment original comorbidities especially older patients already severe underlying conditions diabetes one leading causes morbidity mortality throughout world condition associated several macrovascular microvascular complications ultimately impact overall patients survival <NUMBER> relationship diabetes infection long clinically recognized <NUMBER> infections particularly influenza pneumonia often common serious older people type <NUMBER> diabetes mellitus t<NUMBER>dm <NUMBER> <NUMBER> nevertheless evidence remains controversial regarding whether diabetes indeed increases susceptibility impacts outcomes infections cardiovascular renal comorbidities frequently associated diabetes main factors involved <NUMBER> diabetes uncontrolled glycaemia reported significant predictors severity deaths patients infected different viruses including <NUMBER> pandemic influenza h<NUMBER>n<NUMBER> <NUMBER> sarscov <NUMBER> merscov <NUMBER> current sarscov<NUMBER> pandemic studies find clear association diabetes severe disease <NUMBER> <NUMBER> however reports china <NUMBER> <NUMBER> italy <NUMBER> showed older patients chronic diseases including diabetes higher risk severe covid<NUMBER> mortality scarce data exist regarding glucose metabolism development acute complications diabetes eg ketoacidosis patients covid<NUMBER> infection sarscov<NUMBER> diabetes possibly triggers higher stress conditions greater release hyperglycemic hormones eg glucocorticoids catecholamines leading increased blood glucose levels abnormal glucose variability <NUMBER> hand retrospective study wuhan reported around <NUMBER> patients t<NUMBER>dm covid<NUMBER> suffered least one episode hypoglycemia <NUMBER> mmoll <NUMBER> hypoglycemia shown mobilize proinflammatory monocytes increase platelet reactivity contributing higher cardiovascular mortality patients diabetes <NUMBER> yet remains largely unknown exactly inflammatory immune response occurs patients well whether hyperor hypoglycemia may alter sarscov<NUMBER> virulence virus interferes insulin secretion glycemic control furthermore impact usual diabetes drug treatment covid<NUMBER> outcomes well therapeutic approaches covid<NUMBER> glucose regulation remains unspecified diabetes chronic inflammatory condition characterized multiple metabolic vascular abnormalities affect response pathogens <NUMBER> hyperglycemia insulin resistance promote increased synthesis glycosylation end products ages proinflammatory cytokines oxidative stress addition stimulating production adhesion molecules mediate tissue inflammation <NUMBER> <NUMBER> inflammatory process may compose underlying mechanism leads higher propensity infections worse outcomes thereof patients diabetes <NUMBER> several defects immunity associated hyperglycemia even though clinical relevance vitro disturbances still fully understood <NUMBER> poorly controlled diabetes linked inhibited lymphocyte proliferative response different kinds stimuli <NUMBER> well impaired monocytemacrophage neutrophil functions <NUMBER> abnormal delayed type hypersensitivity reaction <NUMBER> complement activation dysfunction <NUMBER> also described patients diabetes vitro studies shown pulmonary epithelial cells exposure high glucose concentrations significantly increases influenza virus infection replication indicating hyperglycemia may enhance viral replication vivo <NUMBER> animal models structural lung changes related diabetes augmented vasculature permeability collapsed alveolar epithelium <NUMBER> hand patients diabetes generally present significant reduction forced vital capacity fvc forced expiratory volume one second fev<NUMBER> associated raised plasma glucose levels <NUMBER> patients covid<NUMBER> commonly show admission lymphocytopenia lesser extent thrombocytopenia leukopenia prominent among severe disease <NUMBER> elevated levels proinflammatory cytokines including interleukin<NUMBER> il<NUMBER> creactive protein well increased coagulation activity marked higher ddimer concentrations also associated severity <NUMBER> <NUMBER> t<NUMBER>dm besides marked inflammatory process previously discussed imbalance coagulation fibrinolysis takes place increased levels clotting factors relative inhibition fibrinolytic system insulin resistance t<NUMBER>dm associated endothelial dysfunction enhanced platelet aggregation activation abnormalities favor development hypercoagulable prothrombotic state <NUMBER> additionally atherosclerosis vascular inflammation endothelial dysfunction also part pathogenesis chronic conditions eg hypertension cvds <NUMBER> animal studies involving sarscov reported older age related defects tcell bcell function excess inflammation markers thus t<NUMBER>dm alone association older age hypertension andor cvds might contribute deficient control sarscov<NUMBER> replication prolonged proinflammatory response potentially leading poor outcomes <NUMBER> binding target cells hostcell protease cleaves spike allows virus enter replicate <NUMBER> angiotensinconverting enzyme <NUMBER> ace<NUMBER> identified one main receptors sarscov <NUMBER> sarscov<NUMBER> <NUMBER> ace<NUMBER> widely expressed respiratory tract heart kidneys intestines cerebral neurons endothelium arteries veins immune cells pancreas <NUMBER> chinese study compared <NUMBER> sarscov patients without previous diabetes receive steroid treatment <NUMBER> matched healthy siblings showed <NUMBER> <NUMBER> sarscov patients developed diabetes hospitalization since immunostaining ace<NUMBER> strong pancreatic islets suggested sarscov might damaged islets caused acute insulin dependent diabetes mellitus <NUMBER> therefore although evidence needed pancreatic damage may also present covid<NUMBER> patients possibly contributing worse outcomes subjects diabetes previous studies reported decreased mortality endotracheal intubation patients viral pneumonia continued use ace inhibitors aceis angiotensin receptor blockers arbs <NUMBER> <NUMBER> medications postulated significant immunomodulatory effects <NUMBER> reduce pulmonary systemic inflammatory response decreasing cytokines <NUMBER> <NUMBER> commonly used diabetes hypertension <NUMBER> therefore impact clinical course covid<NUMBER> widely debated considering ace<NUMBER> functional receptor sarscov<NUMBER> levels increased ace inhibitors arbs argued drugs might affect negatively outcome covid<NUMBER> patients <NUMBER> contrary advocated aceis arbs might rather beneficial <NUMBER> sarscov infection virus spike protein reduce ace<NUMBER> expression mice injected sarscov spike presented worsened acute lung failure could attenuated blocking reninangiotensin pathway <NUMBER> nevertheless retrospective analysis performed <NUMBER> patients covid<NUMBER> cvd show significant difference proportion aceiarb medication survivors nonsurvivors <NUMBER> similar aceis arbs ibuprofen <NUMBER> thiazolidinediones <NUMBER> also result increased levels ace<NUMBER> thus generating questions regarding safety drugs patients covid<NUMBER> although diabetes associated worse outcomes covid<NUMBER> patients susceptibility sarscov<NUMBER> infection may higher people diabetes according several studies prevalence diabetes people infected virus general population even slightly lower <NUMBER> <NUMBER> metaanalysis <NUMBER> studies describing data <NUMBER> chinese patients covid<NUMBER> reported diabetes prevalence <NUMBER> <NUMBER> similar national prevalence <NUMBER> reported <NUMBER> <NUMBER> italian study conducted among <NUMBER> patients confirmed sarscov<NUMBER> infection university hospital padova found equivalent pattern prevalence diabetes patients <NUMBER> mean age <NUMBER> years <NUMBER> among people aged <NUMBER> years mean age <NUMBER> years region <NUMBER> <NUMBER> although underreporting may issue consider potential biological mechanisms disregarded shown dipeptidyl peptidase<NUMBER> dpp<NUMBER> primary receptor merscov <NUMBER> since dpp<NUMBER> inhibitors commonly applied treatment diabetes worldwide future research explore whether dpp<NUMBER> may also act receptor sarscov<NUMBER> thus contributing potential protective effect drugs <NUMBER> far antisarscov<NUMBER> drug vaccine officially approved covid<NUMBER> treatment <NUMBER> several clinical trials progress assess safety efficacy potential treatment alternatives including remdesivir tocilizumab lopinavirritonavir ribavirin interferon chloroquine phosphate arbidol among others <NUMBER> one promising pharmacological option relevance patients diabetes chloroquine hydroxyanalogue hydroxychloroquine widely used malaria autoimmune diseases chloroquine also reported potential broadspectrum antiviral drug although efficacy safety chloroquine covid<NUMBER> treatment remain unclear recent study showed drug highly effective controlling sarscov<NUMBER> infection vitro addition immunomodulant antiinflammatory effect chloroquine increases endosomal ph interferes glycosylation cellular receptors sarscov thereby blocking viral infection <NUMBER> preliminary results <NUMBER> patients included chinese clinical trial showed chloroquine superior control group shortening disease course inhibiting pneumonia exacerbation promoting virus negative conversion radiological improvement without severe side effects <NUMBER> hand several studies reported hydroxychloroquine improves glycemic control decompensated treatmentrefractory patients diabetes <NUMBER> <NUMBER> even approved treat t<NUMBER>dm india addon therapy patients achieve glycemic targets two oral glucoselowering drugs <NUMBER> although inflammation associated impaired glucose control underlying mechanism hydroxychloroquines hypoglycemic effect remains unclear <NUMBER> described chloroquine increases c peptide response potentially reflecting improved pancreatic βcell function <NUMBER> reduced intracellular insulin degradation increased insulin accumulation also identified possible effects hydroxychloroquine animals models <NUMBER> given previously reported impact chloroquinehydroxychloroquine glucose metabolism caution taken drug administered patients diabetes covid<NUMBER> dose adjustment oral antidiabetic drugs andor insulin might necessary order prevent potential hypoglycemic events effect corticosteroids covid<NUMBER> also investigation <NUMBER> acute lung damage ards partly due host immune response corticosteroids suppress lung inflammation also inhibit immunity pathogen clearance <NUMBER> sarscov merscov infections pulmonary histology showed inflammation diffuse alveolar damage <NUMBER> therefore corticosteroids broadly applied <NUMBER> <NUMBER> however evidence show benefits rather reported delayed viral rna clearance increased mortality rate complications including diabetes psychosis avascular necrosis <NUMBER> interim guidance clinical management severe acute respiratory infection sarscov<NUMBER> infection suspected advises use corticosteroids outside clinical trials <NUMBER> considering hyperglycemic effect <NUMBER> impact drugs immune response <NUMBER> special caution taken patients diabetes included trials assessing safety efficacy corticosteroids covid<NUMBER> <NUMBER> data available regarding appropriate management patients diabetes infected sarscov<NUMBER> well patients covid<NUMBER> develop glycemic decompensation rigorous glucose monitoring careful consideration drug interactions might attenuate worsening symptoms adverse outcomes although hyperglycemia usually main concern context one disregard possibility hypoglycemic episodes result interplay drug treatment viral pathogenesis typical metabolic disturbances diabetes patient tailored therapeutic strategies optimal glucose control goals formulated based disease severity presence comorbidities diabetesrelated complications age factors multidisciplinary team approach including infectologists endocrinologists pulmonologists psychologists nutritionists exercise rehabilitation specialists may necessary prolonged hospitalization periods recovery special attention paid diabetic nephropathy diabetesrelated heart complications since also higher risk severe covid<NUMBER> death <NUMBER> <NUMBER> finally increased vigilance testing outpatient diabetes clinics covid<NUMBER> well lower thresholds hospitalization patients may positive impact outcomes covid<NUMBER> rapidly spread since initial identification wuhan shown broad spectrum severity early isolation early diagnosis early management might collectively contribute better control disease outcomes diabetes comorbidities significant predictors morbidity mortality patients covid<NUMBER> future research urgently needed provide better understanding regarding potential differences genetic predispositions across populations underlying pathophysiological mechanisms association covid<NUMBER> diabetes clinical management last months rapid publications reporting outbreak novel betacoronavirus sarscov<NUMBER> flooded scientific literature <NUMBER> soon number cases outside china increased <NUMBER>fold number countries cases increased threefold world health organization declared novel coronavirus covid<NUMBER> outbreak global pandemic <NUMBER> <NUMBER> covid<NUMBER> virus first named <NUMBER> novel corona virus <NUMBER>ncov<NUMBER> immediately identified isolated subsequently officially changed name severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> <NUMBER> novel coronavirus structurally related virus causes severe acute respiratory syndrome sars <NUMBER> previous current covid<NUMBER> pandemic reports hyperglycemia overt diabetes considered independent sars vs nonsars pneumonia <NUMBER> centers disease control prevention cdc also highlighted patients overt diabetes andor metabolic syndrome might tentimes greater risk death contract covid<NUMBER> <NUMBER> average infected person spreads infection additional persons virus stays oropharynx early course disease leading higher infectivity presymptomatic stages figure <NUMBER> sources mrc centre global infectious disease analysis imperial college london stated minor differences transmission rates r<NUMBER> infection basic reproduction number viruses lead drastic differences final number overall infections mathematically estimated covid<NUMBER> virus r<NUMBER> <NUMBER> meaning four individuals infected virus r<NUMBER> <NUMBER> would infect <NUMBER> would infect <NUMBER> figure <NUMBER> mean interval <NUMBER> days onset illness hospitalization documented <NUMBER> early reports city wuhan hubei province china indicated patient mean age <NUMBER> years old <NUMBER> affected males previously observed influenza higher mortality found among patients preexisting comorbidities elderly <NUMBER> diabetes stood among coexisting conditions <NUMBER> <NUMBER> lack routine clinical criteria diagnosis individuals insulin resistance adipose tissue dysfunction entities accompanied chronic lowgrade subclinical inflammation perhaps acting underlying mechanism enhancing cytokine storm hyperinflammatory state triggers multiorgan failure covid<NUMBER> infected individuals although diabetes classified noncommunicable disease <NUMBER> evidence indicates major role infectious agents possible interactive factors associated diabetic status <NUMBER> common infections occur frequently diabetic individuals moreover infectious agents possible immunologic impact different classes diabetes type <NUMBER> <NUMBER> accompanied diabetic genetic component combined immune dysfunction <NUMBER> review centers presence diabetes potential risk factor severity death subgroup patients severe covid<NUMBER> disease dysglycemia requiring hospitalization oxygen support admission intensive care unit also includes prediabetic states insulin resistance metabolic syndrome adipose tissue dysfunction probable impact covid<NUMBER> like diseases associated coronavirus family sars covid<NUMBER> mainly disease respiratory system could interact metabolic endocrine system <NUMBER> lack routine clinical criteria diagnosis individuals insulin resistance adipose tissue dysfunction entities accompanied chronic lowgrade subclinical inflammation perhaps acting underlying mechanism enhancing cytokine storm hyperinflammatory state triggers multiorgan failure covid<NUMBER> infected individuals although diabetes classified noncommunicable disease <NUMBER> evidence indicates major role infectious agents possible interactive factors associated diabetic status <NUMBER> common infections occur frequently diabetic individuals moreover infectious agents possible immunologic impact different classes diabetes type <NUMBER> <NUMBER> accompanied diabetic genetic component combined immune dysfunction <NUMBER> review centers presence diabetes potential risk factor severity death subgroup patients severe covid<NUMBER> disease dysglycemia requiring hospitalization oxygen support admission intensive care unit also includes prediabetic states insulin resistance metabolic syndrome adipose tissue dysfunction probable impact covid<NUMBER> like diseases associated coronavirus family sars covid<NUMBER> mainly disease respiratory system could interact metabolic endocrine system <NUMBER> enteroviruses <NUMBER> hepatitis c virus <NUMBER> prionlike protein aggregates <NUMBER> suspected play role pathobiology diabetes diabetics also present defects adaptive immunity delayed th<NUMBER> type hypersensitive reactions reduced lymphocyte proliferation <NUMBER> <NUMBER> defects innate response diabetes come dysfunction granulocytes monocytemacrophages dendritic cells natural killer nk cells b cells cells cytokine signaling <NUMBER> <NUMBER> parent diabetes increases risk developing diabetes mellitus <NUMBER> <NUMBER> diabetespredisposing genes also play important roles immunity individuals carrying genes prone defective immune defenses <NUMBER> studies rodents shown merscov infection t<NUMBER>d mice presented immunoinflammatory abnormalities developed altered profile cytokines increased expression il<NUMBER>α following infection observing presence t<NUMBER>d viral infection resulted deleterious lung damage dysregulated immune response <NUMBER> allard et al reported presence diabetes <NUMBER> patients <NUMBER> confirmed influenza h<NUMBER>n<NUMBER> odds ratio icu admission <NUMBER> among hospitalized patients diabetes compared without concluded diabetes triples risk hospitalization h<NUMBER>n<NUMBER> infection quadruples risk icu admission hospitalized <NUMBER> recent study found among <NUMBER> patients <NUMBER> us hospitals <NUMBER> patients died discharged mortality rate <NUMBER> <NUMBER> diabetes andor uncontrolled hyperglycemia patients compared <NUMBER> <NUMBER> patients without diabetes hyperglycemia among <NUMBER> patients diabetes andor hyperglycemia died discharged <NUMBER> <NUMBER> uncontrolled hyperglycemia patients <NUMBER> died compared <NUMBER> <NUMBER> diabetes patients <NUMBER> uncontrolled hyperglycemia defined ≥<NUMBER> blood glucoses bgs <NUMBER> mgdl within <NUMBER>hour period <NUMBER> direct damage βcell islets reported sars coronavirus binds pancreatic ace<NUMBER> receptors reducing insulin secretion causing βcell dysfunction hyperglycemia given t<NUMBER>d increases expression angiotensinconverting enzyme lung liver heart direct damage key organs could explain certain extent findings multiorgan failure sarscov severe infections <NUMBER> report higher mortality uncontrolled hyperglycemia patients reported bode et al <NUMBER> fact sars coronavirus binds pancreatic ace<NUMBER> receptors decreases insulin secretion causes bcell dysfunction <NUMBER> lead valid speculation uncontrolled hyperglycemia <NUMBER> mgdl covid<NUMBER> patients could marker severe state genetic basis type <NUMBER> diabetes t<NUMBER>d well established <NUMBER> identified genes explaining <NUMBER> heritability predisposing gene variants t<NUMBER>d ins ptpn<NUMBER> il<NUMBER> ifih<NUMBER> involved immune function regulation tcell activation innate virus immunity already characterized <NUMBER> <NUMBER> additionally hyperglycemia linked chronic inflammatory processes diabetes related vulnerability infection affects innate immunity impeding production type interferon multiple effects including antiviral activity peripheral blood mononuclear cells show impaired production il<NUMBER>β key mediator inflammation diabetics indicating reduced innate cell activation <NUMBER> scd<NUMBER>l shed activated lymphocytes platelets plasma levels scd<NUMBER>l elevated hyperglycemic t<NUMBER>d patients immune activation achieved binding cd<NUMBER>l cells macrophages b cells hyperactivation cd<NUMBER> bolsters production proinflammatory cytokines inflammatory milieu downregulating antigenspecific responses <NUMBER> il<NUMBER> membraneassociated molecule promotes activation nk cd<NUMBER> teffector memory cells expression il<NUMBER>il<NUMBER>ra occurs viral infections pathogenic elevated serum levels il<NUMBER> reported t<NUMBER>d patients <NUMBER> <NUMBER> recent study demonstrated oglcnac transferase ogt key enzyme protein oglcnacylation mediated influenza virus iavinduced cytokine storm hexosamine biosynthesis pathway hbpassociated oglcnac enzyme ogt induced iav bind interferon regulatory factor<NUMBER> irf<NUMBER> oglcnacylation irf<NUMBER> required ubiquitination irf<NUMBER> pathogens <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> subsequent cytokine production identified molecular mechanism hbpmediated oglcnacylation regulates irf<NUMBER> function iav infection highlighting importance glucose metabolism iavinduced cytokine hyperinflammatory responses <NUMBER> evidence clearly demonstrates diabetics dysfunctional innate adaptive immune responses contributing increased susceptibility viral bacterial fungal infections abnormal diabetic pathophysiology alters leukocyte normal activities chemotaxis phagocytosis ability kill intracellular pathogens <NUMBER> several familybased studies disease heritability indicated type <NUMBER> diabetes t<NUMBER>d strongly heritable highly prevalent large extended families one two members diagnosed disease heritability average <NUMBER> <NUMBER> according international diabetes federation diabetes caused <NUMBER> million deaths <NUMBER> <NUMBER> million adults diabetes world <NUMBER> rise <NUMBER> million <NUMBER> million children adolescents type <NUMBER> diabetes reports may <NUMBER>th <NUMBER> indicated sarscov<NUMBER> virus resulted <NUMBER> confirmed infections <NUMBER> deaths worldwide us reports indicate <NUMBER> confirmed infections <NUMBER> deaths cdc suggested <NUMBER> million <NUMBER> million americans could contract disease <NUMBER>month period based mortality data current hospital capacity number deaths cdcs scenarios could range <NUMBER> <NUMBER> million <NUMBER> early reports january <NUMBER> regarding covid<NUMBER>diabetes connection alarmed field <NUMBER> confirmed covid<NUMBER> patients admitted hospital china eight diabetic <NUMBER> <NUMBER> <NUMBER> patients admitted icu six <NUMBER> died <NUMBER> yang colleagues reported diabetes found <NUMBER> <NUMBER> nonsurvivors group <NUMBER> intensive care unit patients novel covid<NUMBER> <NUMBER> zhang colleagues showed <NUMBER> patients admitted hospital covid<NUMBER> <NUMBER> diabetes <NUMBER> another study reported <NUMBER> diabetes among <NUMBER> patients severe disease <NUMBER> patients confirmed covid<NUMBER> <NUMBER> guo et al reported mortality rate covid<NUMBER> infected patients among people diabetes without comorbidities <NUMBER> paper also highlighted could initial milder evolution symptoms sarscov<NUMBER> infection diabetic individuals consequent delay appropriate aggressive intervention may lead catastrophic lifethreatening late outcomes interleukin<NUMBER> il<NUMBER> fibrinogen creactive protein reported significantly elevated patients diabetes covid<NUMBER> infection <NUMBER> recent metaanalysis including <NUMBER> infected patients seven studies reported prevalence diabetes <NUMBER> <NUMBER> ci <NUMBER> <NUMBER> global prevalence diabetes among adults <NUMBER> years age rose <NUMBER> <NUMBER> <NUMBER> <NUMBER> according data <NUMBER> reports chinese centre disease control prevention <NUMBER> cases covid<NUMBER> showed patients diabetes threefold higher mortality rate without diabetes <NUMBER> vs <NUMBER> respectively perhaps largest published study relevant covid<NUMBER> patients diabetes <NUMBER> although understand new lethal disease information urgently needed caution advisable interpreting findings studies data presented mainly crosssectional longitudinal comparing followup data time number subjects time small without control group although diabetes found highly prevalent among severely covid<NUMBER> affected patients studies interesting note europe example nearly coronavirus deaths people aged <NUMBER> older many patients diabetic obese people <NUMBER> times likely develop t<NUMBER>d <NUMBER> researchers france recently reported obesity bmi <NUMBER> kgm <NUMBER> severe obesity bmi <NUMBER> kgm <NUMBER> present <NUMBER> <NUMBER> <NUMBER> consecutive patients admitted intensive care single center sarscov<NUMBER> concluded covid<NUMBER> disease severity increases higher bmi <NUMBER> researchers nyu langone health reported <NUMBER> individuals tested positive covid<NUMBER> <NUMBER> <NUMBER> body mass index bmi <NUMBER> <NUMBER> <NUMBER> total cohort bmi <NUMBER> <NUMBER> <NUMBER> patients discharged <NUMBER> <NUMBER> admitted hospital acute care <NUMBER> <NUMBER> either directly admitted transferred icu admission concluded although patients aged <NUMBER> years generally considered lower risk group covid<NUMBER> disease severity based data obesity age group appears previously unrecognized risk factor hospital admission need critical care <NUMBER> recent editorial also highlighted increased prevalence obesity older adults italy compared china may key factor regarding differences mortality two countries <NUMBER> authors mentioned millions people infected <NUMBER> h<NUMBER>n<NUMBER> influenza virus thousands hospitalized unfortunately died obesity severe obesity identified main risk factors hospitalization mechanical ventilation <NUMBER> particularly mentioned case california <NUMBER> h<NUMBER>n<NUMBER> influenza virus patients hospitalized critical condition <NUMBER> older <NUMBER> years old <NUMBER> cases <NUMBER> bmi ≥ <NUMBER> <NUMBER> <NUMBER> bmi ≥ <NUMBER> <NUMBER> also <NUMBER> h<NUMBER>n<NUMBER> story new mexico <NUMBER> obesity <NUMBER> requiring mechanical ventilation severe obesity <NUMBER> yang et al also reported metaanalysis compared nonintensive care unit icu vs icu covid<NUMBER> patients icu patients higher plasma levels proinflammatory cytokines il<NUMBER> il<NUMBER> il<NUMBER> gscf ip<NUMBER> mcp<NUMBER> mip<NUMBER>a tumor necrosis factor tnfα <NUMBER> covid<NUMBER> infections evidence supporting involvement inflammation pathogenesis type <NUMBER> t<NUMBER>d t<NUMBER>d mechanisms thought responsible inflammatory state t<NUMBER>d include activation nuclear factorκb nfκb jun nterminal kinase jnk pathways activation interleukin<NUMBER>β il<NUMBER>β il<NUMBER> tnfα recruitment activation immune cells <NUMBER> diabetes hypertension share common pathways among sympathetic nervous system sns reninangiotensinaldosterone system raas including angiotensinconverting enzyme ace oxidative stress adipokines insulin resistance ir currently considered prothrombotic state peroxisome proliferatoractivated receptors ppars <NUMBER> sarscov<NUMBER> envelope spike glycoprotein binds angiotensinconverting enzyme <NUMBER> ace<NUMBER> access human cells ace<NUMBER> degrades angiotensin ii angiotensin <NUMBER> ace<NUMBER> inhibition allows angiotensin ii bind angiotensin <NUMBER> receptor at<NUMBER>r at<NUMBER>r exert proinflammatory responses insulin resistant t<NUMBER>d patients severe covid<NUMBER> infection may increased activation at<NUMBER>rat<NUMBER>r <NUMBER> describing diabetic patients would higher risk fatality nondiabetic covid<NUMBER> infection present however also consider nondiabetic covidinfected individuals could higher risk well develop diabetes longterm consequence infection ace<NUMBER> access sarscov<NUMBER> enter human cells fully expressed hepatocytes βcells expected infection liver pancreas acute infection <NUMBER> therefore potential impairment liver glucose utilization uptake pancreatic insulin secretion could devastating acute andor long consequence covid<NUMBER> infection individuals sarscov<NUMBER> could also predispose immune system certain individuals overreact βcells develop autoimmune diabetic disease therefore must always keep mind could dark side covid<NUMBER> towards insulinglucose axis given role acutely infecting liver βcells molecular level diabetes hallmark immunometabolic diseases cluster chronic pathologies including insulin resistance hypertension dyslipidemias cardiovascular disease cvd leading cause death across world pathologies associated multiple immune risk factors metabolic origin may obvious symptomfree individuals <NUMBER> <NUMBER> recent research increased awareness key role adipose tissue dysfunction plays development ir underlying cause t<NUMBER>d immunometabolic diseases <NUMBER> core mechanisms dysfunction involves localized immunometabolic processes expansion involving immune response impaired angiogenesis hypoxia inflammation inappropriate extracellular matrix ecm remodeling fibrosis would inexorably become systemic later stages dysfunction characterized macrophage infiltration adipose tissue <NUMBER> interactions macrophages adipocytes represent early molecular events lead subclinical inflammation ultimately giving rise ir sequelae glucotoxicity lipotoxicity endothelial dysfunction systemic inflammation cvd <NUMBER> <NUMBER> current lack clinically oriented indicators assess complex phenomenon dysfunction early detection cardiovascular immunometabolic risk develops evident systemic muscle liver ir overt metabolic syndrome chronic subclinical lowgrade systemic inflammation <NUMBER> <NUMBER> figure <NUMBER> adiponectinleptin ratio alr recently developed functional marker adipose tissue dysfunction <NUMBER> individuals low alr characterized lower secretion antiinflammatory adiponectin relation proinflammatory leptin levels unhealthy adipose tissue hypoxia proinflammatory macrophage polarization altered adipokine profile ir individuals higher risk systemic subclinical inflammation cardiovascular immunometabolic pathologies <NUMBER> <NUMBER> consequence chronic positive energy balance leading dysfunction ectopic deposition nonesterified fatty acids nefa triacylglycerol liver skeletal muscle pancreas promoting lipotoxicity proinflammatory state ir <NUMBER> another new biomarker already validated adipose tissueinsulin resistance iri index adipoir plasmafree fatty acids × fasting plasma insulin fpi mmollpmoll calculated based linear relationship rise fpi level inhibition rate fasting plasma nefa <NUMBER> individuals elevated adipoir pronounced adipose tissue ir leading severe local systemic proinflammatory state <NUMBER> wen et al reported degree adipose tissue insulin resistance increases obesity t<NUMBER>d associated prediabetes <NUMBER> recent published research rodriguez et al reported data systemic measurements alr adipoiri index symptomfree adults characterize dysfunction <NUMBER> investigators used age gender weight waist body fat matched groups volunteer study subjects blood pressure biochemical phenotypic measurements fasting plasma glucose triglycerides within normal ranges pattern metabolically driven inflammation characterized increased circulating leptin concentrations along decreased levels adiponectin indicative impaired adipose tissue adipokinome found symptomfree subgroup low l alr proinflammatory fasting systemic biomarker levels high h low l alr adipoiri groups showed higher systemic levels tnfα il<NUMBER> hscreactive protein crp pai<NUMBER> symptomfree subjects l alr data also showed mean homeostasis model assessment homa frankly elevated insulin glucagonlike peptide <NUMBER> glp<NUMBER> postprandial curves area curve auc increased l alr group compared subjects h alr particularly insulin curve showed striking elevation individuals l alr concluded apparently symptomfree individuals cluster altered immunometabolic phenotypes related impaired angiogenesis hypoxia inflammation inappropriate extracellular matrix ecm remodeling macrophage polarization could place systemic molecular construct coined adipose tissue dysfunction would trigger early events leading development insulin resistance systemic inflammation <NUMBER> deleterious scenario could also somehow served underlying mechanism enhancing covid<NUMBER>driven cytokine stormlike hyperinflammatory state subjects without overt diabetes undetected immunometabolic abnormalities chronic lowgrade systemic pathogens <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> inflammation severely infected covid<NUMBER> trigger multiorgan failure death <NUMBER> therefore great deal individuals exposed covid<NUMBER> subclinical inflammation adipose tissue dysfunction prediabetes might also higher risk developing severe lifethreatening respiratory illness covid<NUMBER> infection figures <NUMBER> <NUMBER> accumulating evidence suggesting subgroup patients severe covid<NUMBER> might profound myocarditis fatal arrhythmias <NUMBER> brainstem infection leading respiratory failure encephalopathy cytokinelike storm syndrome hyperinflammation liver heart kidney cytopenias hyperferritinemia severe hypercytokinemia multiorgan failure figure <NUMBER> <NUMBER> recent preprint petrilli et al reported crosssectional analysis patients laboratoryconfirmed covid<NUMBER> infection treated academic health system new york city <NUMBER> march <NUMBER> <NUMBER> april <NUMBER> among <NUMBER> covid<NUMBER> patients <NUMBER> hospitalized <NUMBER> <NUMBER> died <NUMBER> patients required mechanical ventilation <NUMBER> <NUMBER> died relevant hospitalization risk criteria age <NUMBER> years bmi <NUMBER> heart failure key question would many obese individuals metabolically unhealthy <NUMBER> critical illness important parameters abnormal oxygen saturation ddimer ferritin procalcitonin proinflammatory creactive protein crp <NUMBER> two important features decision tree admission age <NUMBER> obesity <NUMBER> note new research document yet certified peer review therefore used guide clinical practice brought attention two manifestations highly complex multifactorial developmental environmentally dependent pathology critical importance human survival <NUMBER> although different presentation transmission acute communicable covid<NUMBER> pandemic mirrors chronic noncommunicable diabetes pandemic many pathobiological aspects interest emphasize ties intimate molecular immunoinflammatory mechanisms relate enhance morbidity lethality covid<NUMBER> meets diabetes figure <NUMBER> focus use information scientific data address pathologies study common underlying pathways example recent publications highlighted significance two coronavirus receptor proteins angiotensin converting enzyme <NUMBER> ace<NUMBER> dipeptidyl peptidase<NUMBER> dpp<NUMBER> also highlighting dual physiologic effects transducers metabolic signals pathways regulating inflammation renal cardiovascular physiology glucose homeostasis <NUMBER> opens door consider glucoselowering agents dpp<NUMBER> inhibitors tools intervene interaction covd<NUMBER> dysglycemic states <NUMBER> still much learn important considerations include natural history covid<NUMBER> infection different t<NUMBER>d t<NUMBER>d individuals age relates disease outcomes severity among patients without diabetes whether antidiabetic medications affect disease progression infected diabetic individuals given compelling data related two disorders surprised serious consequences frank diabetes dysglycemic state <NUMBER> <NUMBER> infected covid<NUMBER> although surprising relationship however frightening given fast transmission rate sarscov<NUMBER> global prevalence diabetes unfortunate scenario motivate research community use current situation though dire make meaningful progress preventing treating epidemics valid question covid<NUMBER> positivetest cases present mild symptoms compared others severe symptomatology ending fatal outcomes far data indicates people older immunocompromised significant underlying conditions heart failure coronary heart disease arrhythmia diabetic nephropathy mainly kind limited lung function asthma acute chronic pulmonary disease among others likely develop poorer outcomes multiorgan failure <NUMBER> however unclear covid<NUMBER> caused death perhaps thousands young young people without apparent underlying health conditions scientists desperately trying unravel covid<NUMBER> lethal young apparently healthy individuals speculate genetics play key role young people might structural variations gene encodes ace<NUMBER> receptor influencing binding sarscov<NUMBER> spike protein making susceptible covid<NUMBER> infection <NUMBER> sarscov<NUMBER> supposedly affects women less men due presence two x chromosomes women immune regulatory genes encoded x chromosome female gender causing lower viral load levels <NUMBER> indeed current data shows overall covid<NUMBER> fatality rates much higher men factors indicate perhaps men develop higher susceptibility women due unhealthy lifestyle habits cigarette smoking alcohol consumption examples contributing lung liver disease risk factors severe covid<NUMBER> according cdc <NUMBER> <NUMBER> severity cases young may also related viral load time exposure virus <NUMBER> according <NUMBER> men age <NUMBER> cigarette smokers compared <NUMBER> women <NUMBER> us population age <NUMBER> obese us department health human services reported african americans also dying virus alarmingly disproportionate rates risk severe coronavirus outcome increased high blood pressure diabetes conditions prevalent among black americans nearly third african american adults high blood pressure compared <NUMBER> white adults unhealthy life styles cigarette smoking alcohol consumption obesity diabetes high blood pressure male gender clusters cardiometabolic risk factors always accompanying presence metabolic syndrome <NUMBER> well aware major inflammatory mechanisms contribute pathogenesis progression syndrome <NUMBER> adipose tissue dysfunction monocytes macrophages phagocyte activity contribute proinflammatory milieu release leptin low adiponectin chemokines cytokines circulating inflammatory crp fibrinogen promoting systemic inflammation insulin resistance therefore far metabolic syndrome inflammatory disorder <NUMBER> combined data reports rodriguez et al <NUMBER> petrilli et al <NUMBER> seem indicate perhaps symptomfree obese individuals severe fatal covid<NUMBER> could metabolically unhealthy <NUMBER> concerning nonobese symptomfree individuals underlying undetected adipose tissue dysfunction low alr high adipoiri index exposed covid<NUMBER> infection also high risk severe fatal covid<NUMBER> outcomes <NUMBER> metabolically unhealthy obese individuals adipose tissue dysfunction present key proinflammatory conditions highly underestimated rarely diagnosed among symptomfree individuals figure <NUMBER> systemic proinflammatory setting symptomfree individuals without overt diabetes hypertension metabolically unhealthy obesity nonobese adipose tissue dysfunction could require hospitalization progress severe critical reaction requiring icu intervention turn could perhaps contribute enhance hyperinflammatory state symptomfree individuals infected severe covid<NUMBER> triggering multiorgan failure shown figure <NUMBER> brought attention two manifestations highly complex multifactorial developmental environmentally dependent pathology critical importance human survival <NUMBER> although different presentation transmission acute communicable covid<NUMBER> pandemic mirrors pathogens <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> chronic noncommunicable diabetes pandemic many pathobiological aspects interest emphasize ties intimate molecular immunoinflammatory mechanisms relate enhance morbidity lethality covid<NUMBER> meets diabetes figure <NUMBER> focus use information scientific data address pathologies study common underlying pathways example recent publications highlighted significance two coronavirus receptor proteins angiotensin converting enzyme <NUMBER> ace<NUMBER> dipeptidyl peptidase<NUMBER> dpp<NUMBER> also highlighting dual physiologic effects transducers metabolic signals pathways regulating inflammation renal cardiovascular physiology glucose homeostasis <NUMBER> opens door consider glucoselowering agents dpp<NUMBER> inhibitors tools intervene interaction covd<NUMBER> dysglycemic states <NUMBER> still much learn important considerations include natural history covid<NUMBER> infection different t<NUMBER>d t<NUMBER>d individuals age relates disease outcomes severity among patients without diabetes whether antidiabetic medications affect disease progression infected diabetic individuals given compelling data related two disorders surprised serious consequences frank diabetes dysglycemic state <NUMBER> infected covid<NUMBER> although surprising relationship however frightening given fast transmission rate sarscov<NUMBER> global prevalence diabetes unfortunate scenario motivate research community use current situation though dire make meaningful progress preventing treating epidemics diabetes mellitus dm complex chronic disease characterized high blood glucose absolute relative insulin deficiency includes type<NUMBER> diabetes type <NUMBER> diabetes special type diabetes among morbidity type <NUMBER> diabetes highest global prevalence t<NUMBER> dm <NUMBER> estimated <NUMBER> billion <NUMBER> <NUMBER> total number deaths caused high fasting plasma ages <NUMBER> million type <NUMBER> diabetes accounted <NUMBER> million deaths <NUMBER> novel coronavirus pneumonia covid<NUMBER> caused severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> seriously endangering human life health property safety march <NUMBER> <NUMBER> world health organization announced global pandemic <NUMBER> many early studies found patients chronic diseases diabetes severe worse prognosis <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> number retrospective analysis patients covid<NUMBER> showed prevalence diabetes patients increased varying degrees condition usually serious general patients <NUMBER> <NUMBER> <NUMBER> analysis china chinese center disease control prevention cdc shows mortality combined diabetic patients <NUMBER> overall mortality <NUMBER> <NUMBER> national institutes health italy reported prevalence diabetes patients died sarscov<NUMBER>infection <NUMBER> <NUMBER> according preliminary data american centers disease control prevention march <NUMBER> <NUMBER> diabetes common basic health condition among people infected sarscov<NUMBER> <NUMBER> furthermore estimated yy wz contributed equally work cofirst authors project funded treatment novel coronavirus pneumonia covid <NUMBER> integrated traditional chinese medicine western medicine <NUMBER>yfs<NUMBER> sponsors involved design execution writing study authors report conflicts interest data sharing applicable article datasets generated analyzed current study <NUMBER> patients need admitted icu <NUMBER> diabetic patients likely suffer serious infection due hyperglycemia chronic inflammatory state microcirculation damage factors <NUMBER> found type <NUMBER> diabetes may increase expression angiotensin converting enzyme <NUMBER> ace<NUMBER> lung <NUMBER> novel coronavirus pneumonia promoted ace<NUMBER> binding site sarscov<NUMBER> decrease ace<NUMBER> expression may result severe lung injury infection <NUMBER> serious infections serious diseases glucocorticoids damage insulin sensitivity infectious diseases lead high mortality diabetic patients <NUMBER> however covid<NUMBER> mortality combined diabetes still clear duration age gender race blood glucose control diabetes may effect mortality covid<NUMBER> study solve metaanalysis necessary report system review plan accordance preferred report item system review metaanalysis plan prismap guidelines <NUMBER> <NUMBER> study conducted accordance prisma extension statement nma <NUMBER> population adult dead covid<NUMBER> included study restrictions region gender age patients intervention study investigate comparisons diabetes nondiabetes covid<NUMBER> patients according whether diabetes mellitus combined divided diabetes group trail diabetes group comparison patients die excluded outcomes primary outcome mortality ofcovid<NUMBER> patients secondary outcomes include blood glucose control level inflammatory markers study design studies mortality covid<NUMBER> included study mortality covid<NUMBER> fbg fasting blood glucose pbg postprandial blood glucose hba<NUMBER>c glycated hemoglobin crp creactive protein computer retrieval three english database including pubmed embase cochrane library <NUMBER> chinese databases including china national knowledge infrastructure cnki database wanfang data knowledge service platform vip information resource integration service platform cqvip china biology medicine disc sino med searched inception april <NUMBER> <NUMBER> language limitation english chinese addition google scholar baidu scholar used find potential missing papers time limitation literatures novel coronavirus pneumonia covid<NUMBER> mortality prognosis blood glucose control diabetes type <NUMBER> diabetes type <NUMBER> diabetes new coronavirus pneumonia crp key words search identify eligible studies reference lists relevant publications reviewed manual search example search process presented table <NUMBER> based predetermined inclusion criteria two independent reviewers evaluate titles abstracts exclude papers considered relevant remaining provisions included assessment reviewers carefully examine full text potentially relevant article process study identification exclusion described prisma flow chart differences research options resolved consultation record excel file fig <NUMBER> two researchers independently screened literature extracted data cross checked case difference shall settled discussion consultation third party process literature selection first step read title excluding obviously irrelevant literature second step read abstract full text determine whether include necessary contact author original study email phone obtain uncertain important information study content data extraction includes <NUMBER> basic information first author publication time research location sample size sex ratio age research type <NUMBER> outcome indicators concern <NUMBER> relevant elements bias risk assessment bias risk assessment included study <NUMBER> researchers independently assessed bias risk included study nos scale cross checked results data analysis conducted review manager version <NUMBER> stata <NUMBER> software mac risk ratio rr used analysis statistic <NUMBER> ci provided heterogeneity results analyzed x <NUMBER> test test level <NUMBER> degree heterogeneity determined byi <NUMBER> statistical heterogeneity results study fixed effect model used metaanalysis statistical heterogeneity results study source heterogeneity analyzed excluding influence obvious clinical heterogeneity random effect model used metaanalysis level metaanalysis set <NUMBER> significant clinical heterogeneity treated subgroup analysis sensitivity analysis descriptive analysis substantial heterogeneity studies conduct subgroup analysis explore heterogeneity avoid post hoc analysis subgroup analysis conducted according <NUMBER> hypotheses race course diabetes glucose level improve reliability subgroup analysis evaluate credibility subgroup analysis according guidance credible subgroup analysis enough studies included metaregression conducted explore heterogeneity subgroup effects occur simultaneously subgroup analysis regression analysis considered credible draw funnel chart allcause mortality outcome indicators diabetes diabetes covid<NUMBER> patients ensure stability results conduct sensitivity analysis results excluding studies included analysis one one reanalyzing results comparing differences reobtained results original results way able assess impact individual studies overall outcomes robustness integrity studies important factor affecting accuracy results conclusions metaanalysis integrity included studies mainly measured reporting bias publication bias common therefore study identify report bias publication bias assessment funnel plot drawn investigate publication bias funnel plot asymmetric publication bias exists research small sample statistically significant results published obvious asymmetry funnel plot likely publication bias <NUMBER> egger test conducted statistical assessment publication bias publication bias considered exist p <NUMBER> <NUMBER> <NUMBER> patient public involvement patients public participate study since confidential patient data involved study formal ethics approval required framework prisma statements nma applied guide review authors perform study results disseminated peerreviewed publication covid<NUMBER> widespread world causing great casualties property losses battle related mankind study comprehensive systematic review aim compare mortality covid<NUMBER> diabetes nondiabetes analyze sex age course disease race blood glucose control level covid<NUMBER> dead patients prognosis patients new diabetes mellitus predicted blood glucose control strengthened clinical treatment epidemiology covid<NUMBER> incidence severity illness mortality seem shifted towards older people particularly diabetes hypertension cardiovascular disease <NUMBER> considering research costs data arrange study analyze diabetes related complications next study consider providing systematic review role diabetes complications development covid<NUMBER> meanwhile great practical significance clarify harm diabetes public health also provide reference clinicians modification required update protocol include changes entire research process conceptualization yan yang wen zhong chunguang xie data curation xiaoxu fu formal analysis yan yang wen zhong funding acquisition chunguang xie world health organization declared coronavirus sarscov<NUMBER> pandemic march <NUMBER> <NUMBER> virus termed severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> responsible outbreak intense respiratory illness named coronavirus disease yuen et al <NUMBER> infection first appeared wuhan china spread world reached continents almost countries muniyappa gubbi <NUMBER> sarscov<NUMBER> singlestranded rna confirmed cause respiratory infections lung injury humans betacoronavirus family includes sarscovs merscovs sarscov<NUMBER> members family share high genetic similarity induce comparable pathological parameters particularly oxidative stress inflammatory effect chen <NUMBER> respiratory system primary target coronavirus members induce lung injury dysfunction leading fatal pneumonia channappanavar perlman <NUMBER> respiratory dysfunction caused continuing outbreak novel coronavirus sarscov<NUMBER> major concern diabetic obese individuals worldwide despite low fatality rate caused covid<NUMBER> compared earlier coronavirus epidemics produced sarscov middle east respiratory syndrome coronavirus merscov diabetic obese people high risk recently reported diabetes important risk factor progression adverse outcome attention must paid diabetic obese hypertensive patients particularly considering rapid deterioration bloomgarden <NUMBER> guo et al <NUMBER> therefore adequate information relationship covid<NUMBER> metabolic syndrome required better management patients melatonin <NUMBER>methoxynacetyltryptamine neuroendocrine small molecule variety important physiological functions normal pathophysiological circumstances effective antioxidant powerful free radical scavenging activity zare javid et al <NUMBER> also stimulates messenger rna mrna levels various antioxidant enzymes melatonin possesses antiinflammatory capacity immunomodulatory activity effectively boosts immune system body properties suggest potential therapeutic use melatonin improve clinical outcomes patients accordingly intervention antioxidants potential approach overcome oxidative stress attenuate proinflammatory mediators diabetic obese patients anticipated upregulation immune system potential intervention block virus progression consequences context melatonin worthy candidate used strengthen immune system covid<NUMBER> infection related complications obese diabetic patients metabolic diseases cell death oxidative stress strongly related inflammation changes proinflammatory cytokines strategic position crossroad oxidative stress inflammation muriach et al <NUMBER> cytokine dysregulation may responsible clinical manifestation high levels proinflammatory biomarkers feature diabetic obese patients moreover several factors suggested explain increased susceptibility sarscov<NUMBER> infection diabetic obese persons factors include weakness immune system increased susceptibility hyperinflammation cytokine storm syndrome muniyappa gubbi <NUMBER> term inflammatory cytokine storm introduced underscore overreaction bodys immune system massive production inflammatory cytokines jose manuel <NUMBER> prevalence virus infection clinical consequences featured older age individuals obesity diabetes category population exhibits weak immune activity increased oxidative stress due decline endogenous antioxidants levels inflammatory mediators typically increase age metabolic syndrome even absence acute infection physiological stress cardinali hardeland <NUMBER> individuals remarkably high risk hospitalization death among sarscov<NUMBER>infected patients muniyappa gubbi <NUMBER> obesity risk factor pathogenesis diabetes insulin resistance known cytokines inflammatory parameters substances involved insulin resistance increased obese individuals algoblan et al <NUMBER> addition patients metabolic disorders susceptible oxidative endoplasmic reticulum stress inflammation alicka marycz <NUMBER> oxidative stress caused due increased generation reactive oxygen nitrogen species ability antioxidant system body oxidative stress major depressant immune system body reported patients t<NUMBER> diabetes mellitus vulnerable infections due hyperglycemiainduced virulence various microorganisms dworzański et al <NUMBER> accompanied increased reactive oxygen species generation activation signaling pathways associated reactive oxygen species gargouri et al <NUMBER> hu et al <NUMBER> ebv sarscov<NUMBER> induce oxidative stress infection might contribute pathology recent research reported sarscov<NUMBER>infected patients diabetes higher risk developing severe pneumonia uncontrolled inflammatory responses hypercoagulable state associated dysregulation glucose metabolism compared covid<NUMBER> individuals without dm guo et al <NUMBER> furthermore serum levels inflammatory mediators including il<NUMBER> creactive protein remarkably increased compared nondiabetic patients suggesting diabetic patients vulnerable high inflammatory wave leading rapid deterioration guo et al <NUMBER> individuals diabetes mellitus severe obesity bmi ≥<NUMBER> kgm <NUMBER> likely infected higher risk complications death covid<NUMBER> muniyappa gubbi <NUMBER> another recent study reported increased morbidity mortality diabetic patients sarscov<NUMBER> infection indicating glycemic control essential individuals coexistence covid<NUMBER> diabetes hill et al <NUMBER> similarly yet another recent report unveiled interaction covid<NUMBER> infection diabetes two global pandemics maddaloni buzzetti <NUMBER> authors emphasized il<NUMBER> major inflammatory cytokine whose levels increased diabetes contributed susceptibility diabetic patients covid<NUMBER> infection initiation serious pathological illness hence deactivation il<NUMBER> receptors practical approach treatment covid<NUMBER>induced lung dysfunction diabetes novel study reported stressed conditions necessary improve optimize blood glucose management strategy diabetic patients covid<NUMBER> infection zhou tan <NUMBER> authors study inferred potential important reasons sensitivity diabetic patients covid<NUMBER> demonstrated diabetic diet personalized diet unavailable accompanied inability quarantined inpatients perform exercise due limited indoor space poor pulmonary function addition anxiety caused covid<NUMBER> induces hyperglycemia miazgowski et al <NUMBER> finally pancreatic tissue potential target viral infection leading glucose metabolism disorders yang et al <NUMBER> zhou tan <NUMBER> furthermore recent report reviewed possible mechanisms play significant roles diabetes mellitus including hostviral interactions host immune responses muniyappa gubbi <NUMBER> coronaviruses penetrate cells leading apoptosis enhance inflammatory responses signified activation proinflammatory cytokines help attract inflammatory cells including cd helper th<NUMBER> cells sarscov<NUMBER> infects immune cells increases apoptosis lymphocytes cd<NUMBER> cd<NUMBER> cd<NUMBER> cells leading lymphocytopenia results excessive secretion proinflammatory cytokines process termed cytokine storm leading hyperinflammation consequent failure body organs deng et al <NUMBER> gao et al <NUMBER> severe inflammation increased reactive oxygen species production leading oxidative stress gravierhernandez et al <NUMBER> similarly oxidative stressrelated gene polymorphisms likely associated hepatitis b virusinduced liver disease suggesting information variations useful risk assessment hbvinduced liver disease et al <NUMBER> experimental animal study demonstrated important role reactive oxygen species pathology immune response respiratory syncytial virus rsv transcriptional profile reactive oxygen speciesrelated genes respiratory system rsv infection natural host discussed recently hofstetter sacco <NUMBER> zika virus zikv associated congenital malformations recent research reported astrocytes targets zikv infection zikv induces mitochondrial dysfunction oxidative stress dna breakage human astrocytes ledur et al <NUMBER> regarding patients positive epsteinbarr virus analysis antioxidant enzyme activity demonstrated lower activities superoxide dismutase sod glutathione peroxidase gpx patients diabetes mellitus obesity healthy individuals dworzański et al <NUMBER> also reported chronic infections caused various viruses influence entire immunity diabetic patients previous study reported oxidative stress induced infection epsteinbarr virus early stages infection b lymphocytes epithelial lymphoblastoid cell lines oxidative stress manifested increased lipid peroxidation decreased activities cat sod suggesting alteration molecular mechanisms promoting cellular resistance reactive oxygen species lassoued et al <NUMBER> studies demonstrated oxidative stress factors leading dna damage induce expression ebv lytic genes arvey et al <NUMBER> dworzański et al <NUMBER> gargouri et al <NUMBER> mitochondrial reactive oxygen species key player induction pathological inflammation influenza virus infection mice recent research reported infection influenza virus enhanced production mitochondrial reactive oxygen species induces innate immune inflammation leading intensification viral pathogenesis mechanism demonstrated therapeutic potential antioxidants treat influenza virus pathology macrophages essential innate immune responses play remarkable role protecting animals viral infections infections macrophages infectious bronchitis coronavirus ibv connecticut a<NUMBER> conna<NUMBER> strains produced intracellular coronaviruslike particles within cells ibv causes respiratory defects increased macrophage count respiratory system animals macrophages infected ibv conna<NUMBER> strains production antimicrobial molecule nitric oxide inhibited amarasinghe et al <NUMBER> also demonstrated coronaviruses sarscov<NUMBER> replicate within human macrophages cheung et al <NUMBER> reported viroporin induce production il<NUMBER>β fluxes potassium hydrogen calcium ions addition reactive oxygen species autophagy endoplasmic reticulum stress involved activation farag et al <NUMBER> melatonin neuroendocrine hormone synthesized released primarily pineal gland melatonin multifunctional molecule based antioxidant activity direct indirect free radical scavenging ability boost immune system mortezaee et al <NUMBER> antiinflammatory actions hardeland <NUMBER> melatonin associated variety signaling mechanisms including erk mapk pathways cui et al <NUMBER> sung et al <NUMBER> addition several cell signaling pathways including erk<NUMBER>cebpα involved regulatory roles melatonin tcell biology ren et al <NUMBER> melatonin also stimulated sirt<NUMBER>nrf<NUMBER> signaling pathway reduce lipopolysaccharideinduced reactive oxygen species generation shah et al <NUMBER> moreover melatonin ameliorates h <NUMBER> <NUMBER> induced oxidative stress modulation erkaktnfkb pathway moniruzzaman et al <NUMBER> melatonin exerts action directly indirectly using specific melatonin receptors mt<NUMBER> mt<NUMBER> cellular membranes melatonin achieves many physiological effects interacting membrane mt<NUMBER> mt<NUMBER> receptors intracellular proteins quinone reductase <NUMBER> calmodulin calreticulin tubulin pandiperumal et al <NUMBER> melatonin mt<NUMBER> mt<NUMBER> receptors g protein coupled receptors expressed various cells body organs pandiperumal et al <NUMBER> study using melatonin receptor knockout mice indicated active role receptors regulation blood glucose muhlbauer et al <NUMBER> also mentioned melatonin administration normalized metabolic syndrome elderly hypertensive patients via receptors shatilo et al <NUMBER> blood melatonin levels continuously decreased age exhibiting highest level childhood youth periods lowest level older individuals furthermore nighttime melatonin levels plasma higher daytime life span secretion melatonin exhibits circadian rhythm regulates sleepawake cycle reutrakul et al <NUMBER> explains deterioration sleep quality older people moreover matches might explain higher number infections susceptibility infection severity covid<NUMBER> symptoms older persons young individuals increased oxidative stress inflammation common feature patients diabetes periodontal diseases doubleblind placebocontrolled trial supplementation melatonin found significantly increase serum activities sod cat gpx decrease lipid peroxidation diabetic patients periodontal disease effect accompanied lower il<NUMBER>b levels melatonintreated patients control individuals zare javid et al <NUMBER> treated patients administered <NUMBER> mg melatonin confirming previous study using <NUMBER> mg immediateor sustainedreleased dose patients t<NUMBER> diabetes rybka et al <NUMBER> studies indicate melatonin significantly regulated antioxidant enzymes increased total antioxidant capacity body earlier study reported melatonin ubiquitous shows unequal intracellular distribution including high concentrations mitochondria likely aid capacity resist oxidative stress cellular apoptosis another study reported melatonin improved glycemic state exerted antioxidant activity upregulating gsh content activities sod cat glutathionestransferase brain animal experimental studies shown melatonin efficiently decreased production blood inflammatory cytokines leptin resistin reduced adipocyte hypertrophy improved blood lipid profile therefore melatonin termed modulator glucose metabolism pharmacological dose melatonin enhanced effects metformin insulin sensitivity body weight gain given combination metformin exhibited dual therapy treatment diabetes associated obesity dantasferreira et al <NUMBER> recently latter research group demonstrated melatonin remarkable therapeutic action decreasing obesityinduced inflammatory storm authors anticipated melatonin used lowcost therapeutic agent improve disorders associated obesity confirm previous study melatonin antidiabetic hypolipidemic impact human animal model metabolic syndrome cardinali hardeland <NUMBER> reported melatonin immunomodulatory roles dual proinflammatory antiinflammatory actions proinflammatory effect exhibited fight pathogens whereas antiinflammatory action manifested highgrade inflammation case sepsis oxidative stress organ injury also lowgrade inflammation associated aging neurodegenerative diseases hardeland <NUMBER> doubleedge blade melatonin attributed several mechanisms besides ability downregulate proinflammatory cytokine production upregulate antiinflammatory cytokine production melatonin exhibits high antioxidant capacity downregulate inducible nitric oxide synthases inhibit neuronal nitric oxide synthases downregulate cyclooxygenase<NUMBER> inhibit highmobility group box<NUMBER> signaling tolllike receptor<NUMBER> activation prevent inflammasome nlrp<NUMBER> activation inhibit nfκb activation hardeland <NUMBER> novel potential therapy using melatonin prevent treat obesity caused systemic inflammatory disease reported melatonin alleviates adipose tissue inflammation elevating αketoglutarate diverting adiposederived exosomes macrophages mice liu et al <NUMBER> based information sustaining normal levels melatonin elderly individuals diabetic obese people important strategy strengthen bodys defense system consequently immune system melatonin found exhibit effective inhibition pathological manifestations cases viral infections humans reiter et al <NUMBER> plants sarscov<NUMBER> newly discovered virus shortage research literature delays development effective treatment strategies particular potential effects melatonin human experimental animals deadly pathogen however melatonin exerts remarkable antiviral effects several viruses humans animals early work reported encephalomyocarditis virus semliki forest virus causes severe inflammation nervous tissue result high mortality rate melatonin administered pharmacological dose successfully attenuated inflammation parameters reduced number deaths bennathan et al <NUMBER> maestroni et al <NUMBER> recent report ebola infection demonstrated virus hampers immune system initiates blood coagulation significant inflammation reaction induces overwhelmed generation toxic free radicals development oxidative stress severe damage cells tissue eventually causes organ system dysfunction failure reiter et al <NUMBER> regard authors reported melatonin prevent hemorrhagic shock syndrome major pathological parameter associated ebola virus infection action mediated primarily reduction circulating proinflammatory cytokines melatonin also upregulates heme oxygenase<NUMBER> ho<NUMBER> obstructs replication ebola virus anderson et al <NUMBER> recently research group confirmed melatonin effective safe lowcost therapeutic option ebola virus junaid et al <NUMBER> also strongly suggested melatonin protect acute lung injury aliacute respiratory distress syndrome caused virus pathogens attributed wellknown antiinflammatory antioxidant effects zhang et al <NUMBER>b human papillomavirus associated oral genital cancers dsouza addepalli <NUMBER> shafabakhsh et al <NUMBER> melatonin exerted defensive impact oral cancer oral ulcer preventive controlling role melatonin oral cancer caused due hpv attributed primarily immunoenhancement increasing b lymphocyte activity increasing monocyte activity increasing natural killer cell activity increasing secretion cytokines il<NUMBER> il<NUMBER> ultimately lead oncostatic activity dsouza addepalli <NUMBER> addition melatonin combination indoleamine <NUMBER>dioxygenase<NUMBER> inhibitor administered immunometabolic adjuvant improved efficacy immunotherapeutic treatment hpvassociated tumors moreno et al <NUMBER> possible melatonin directly interacts sarscov<NUMBER> membrane genetic material speculated melatonin affect biological activity viruses supported fact melatonin small molecule amphiphilic nature readily cross biological membranes freely enter cells reach subcellular organelles structures amin et al <NUMBER> addition evidence indicating melatonin pleiotropy encompasses regulation gene expression primary epigenetic mechanisms including dna methylation chromatin modification noncoding rna capote moreno et al <NUMBER> based recent findings comprehensive molecular studies required elucidate ability melatonin reverse inhibit biological activity sarscov<NUMBER> diabetic obese patients date direct experimental evidence viricidal effect melatonin indirect antiviral actions due antiinflammatory antioxidant immunomodulatory immune enhancing characteristics reiter et al <NUMBER> zhang et al <NUMBER>b contrast aforementioned melatonins immunemodulatory characteristics agents showed limited effectiveness modulating immunoreactivity toward viruses instance statins cannot prevent patients infected <NUMBER> h<NUMBER>n<NUMBER> pandemic influenza developing severe disease addition direct evidence shown angiotensin receptor blockers arbs angiotensinconverting enzyme inhibitors aceis might effective therapy severe influenzainduced cytokine storm liu et al <NUMBER> sequence similarity spike proteins sarscov sarscov<NUMBER> recently validated sarscov<NUMBER> also uses ace<NUMBER> receptor polyphenols proved immunomodulatory antioxidant effect vivo vitro however major obstacle bioavailability impact biofunctionality yahfoufi et al <NUMBER> melatonin several properties suggesting utility variety circumstances high biological safety exogenous melatonin used variety doses even including extreme doses andersen et al <NUMBER> zhang et al <NUMBER>a worth mentioning melatonin dose <NUMBER> mgday demonstrated acceptable safety level clinical trials chen et al <NUMBER> othman et al <NUMBER> seabra et al <NUMBER> zhang et al <NUMBER>b adverse events generally minor shortlived easily managed foley steel <NUMBER> addition highsafety profile administered several routes melatonin constitutes natural easytosynthesize product found shelves long halftime review presents short brief account recently published papers role melatonin potential benefits based included therapeutic adjuvant treatment course covid<NUMBER> patients chronic diseases common trend exists increased number sarscov<NUMBER>infected cases low levels blood melatonin people chronic metabolic diseases elderly people individuals show decreased levels endogenous antioxidants including antioxidant enzymes melatonin accompanied weak immune system increased susceptibility inflammation ability melatonin decrease viral infections obese diabetic patients attributed characteristics potent antioxidant effects improving endogenous antioxidant system immunomodulatory strong antiinflammatory capability altogether features strongly recommend melatonin useful therapeutic option sarscov<NUMBER>infected patients without chronic metabolic diseases improve health although direct evidence support utility melatonin treatment protocols covid<NUMBER> patients extensive data published past <NUMBER> years recommend utility appreciate thank white army including doctors nurses frontlines fighting adverse devastating virus shall remember forever also thank mansoura university gives great support fighting new deadly infection none capotemoreno ramos e egea j lopezmunoz f gilmartin e romero <NUMBER> potential melatonin adjuvant therapy oral cancer era epigenomics cancers basel <NUMBER> <NUMBER> dantasferreira rf raingard h dumont schusterklein c guardiolalemaitre b pevet p challet e <NUMBER> melatonin potentiates effects metformin glucose metabolism food intake highfatfed rats endocrinol diabetes metab <NUMBER>e<NUMBER> doi<NUMBER>edm<NUMBER> world health organization declared coronavirus sarscov<NUMBER> pandemic march <NUMBER> <NUMBER> virus termed severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> responsible outbreak intense respiratory illness named coronavirus disease covid<NUMBER> yuen et al <NUMBER> infection first appeared wuhan china spread world reached continents almost countries muniyappa gubbi <NUMBER> sarscov<NUMBER> singlestranded rna confirmed cause respiratory infections lung injury humans betacoronavirus family includes sarscovs merscovs sarscov<NUMBER> members family share high genetic similarity induce comparable pathological parameters particularly oxidative stress inflammatory effect chen <NUMBER> respiratory system primary target coronavirus members induce lung injury dysfunction leading fatal pneumonia channappanavar perlman <NUMBER> respiratory dysfunction caused continuing outbreak novel coronavirus sarscov<NUMBER> major concern diabetic obese individuals worldwide despite low fatality rate caused covid<NUMBER> compared earlier coronavirus epidemics produced sarscov middle east respiratory syndrome coronavirus merscov diabetic obese people high risk recently reported diabetes important risk factor progression adverse outcome covid<NUMBER> attention must paid diabetic obese hypertensive patients particularly considering rapid deterioration bloomgarden <NUMBER> guo et al <NUMBER> therefore adequate information relationship covid<NUMBER> metabolic syndrome required better management patients melatonin <NUMBER>methoxynacetyltryptamine neuroendocrine small molecule variety important physiological functions normal pathophysiological circumstances effective antioxidant powerful free radical scavenging activity zare javid et al <NUMBER> also stimulates messenger rna mrna levels various antioxidant enzymes melatonin possesses antiinflammatory capacity immunomodulatory activity effectively boosts immune system body properties suggest potential therapeutic use melatonin improve clinical outcomes patients accordingly intervention antioxidants potential approach overcome oxidative stress attenuate proinflammatory mediators diabetic obese patients anticipated upregulation immune system potential intervention block virus progression consequences context melatonin worthy candidate used strengthen immune system covid<NUMBER> infection related complications obese diabetic patients metabolic diseases cell death oxidative stress strongly related inflammation changes proinflammatory cytokines strategic position crossroad oxidative stress inflammation muriach et al <NUMBER> cytokine dysregulation may responsible clinical manifestation high levels proinflammatory biomarkers feature diabetic obese patients moreover several factors suggested explain increased susceptibility sarscov<NUMBER> infection diabetic obese persons factors include weakness immune system increased susceptibility hyperinflammation cytokine storm syndrome muniyappa gubbi <NUMBER> term inflammatory cytokine storm introduced underscore overreaction bodys immune system massive production inflammatory cytokines jose manuel <NUMBER> prevalence virus infection clinical consequences featured older age individuals obesity diabetes category population exhibits weak immune activity increased oxidative stress due decline endogenous antioxidants levels inflammatory mediators typically increase age metabolic syndrome even absence acute infection physiological stress cardinali hardeland <NUMBER> individuals remarkably high risk hospitalization death among sarscov<NUMBER>infected patients muniyappa gubbi <NUMBER> obesity risk factor pathogenesis diabetes insulin resistance known cytokines inflammatory parameters substances involved insulin resistance increased obese individuals algoblan et al <NUMBER> addition patients metabolic disorders susceptible oxidative endoplasmic reticulum stress inflammation alicka marycz <NUMBER> oxidative stress caused due increased generation reactive oxygen nitrogen species ability antioxidant system body oxidative stress major depressant immune system body reported patients t<NUMBER> diabetes mellitus vulnerable infections due hyperglycemiainduced virulence various microorganisms dworza� nski et al <NUMBER> earlier studies shown infection epsteinbarr virus ebv accompanied increased reactive oxygen species generation activation signaling pathways associated reactive oxygen species gargouri et al <NUMBER> hu et al <NUMBER> ebv sarscov<NUMBER> induce oxidative stress infection might contribute pathology recent research reported sarscov<NUMBER>infected patients diabetes higher risk developing severe pneumonia uncontrolled inflammatory responses hypercoagulable state associated dysregulation glucose metabolism compared covid<NUMBER> individuals without dm guo et al <NUMBER> furthermore serum levels inflammatory mediators including il<NUMBER> creactive protein remarkably increased compared nondiabetic patients suggesting diabetic patients vulnerable high inflammatory wave leading rapid deterioration guo et al <NUMBER> individuals diabetes mellitus severe obesity bmi �<NUMBER> kgm <NUMBER> likely infected higher risk complications death covid<NUMBER> muniyappa gubbi <NUMBER> another recent study reported increased morbidity mortality diabetic patients sarscov<NUMBER> infection indicating glycemic control essential individuals coexistence covid<NUMBER> diabetes hill et al <NUMBER> similarly yet another recent report unveiled interaction covid<NUMBER> infection diabetes two global pandemics maddaloni buzzetti <NUMBER> authors emphasized il<NUMBER> major inflammatory cytokine whose levels increased diabetes contributed susceptibility diabetic patients covid<NUMBER> infection initiation serious pathological illness hence deactivation il<NUMBER> receptors practical approach treatment covid<NUMBER>induced lung dysfunction diabetes novel study reported stressed conditions necessary improve optimize blood glucose management strategy diabetic patients covid<NUMBER> infection zhou tan <NUMBER> authors study inferred potential important reasons sensitivity diabetic patients covid<NUMBER> demonstrated diabetic diet personalized diet unavailable accompanied inability quarantined inpatients perform exercise due limited indoor space poor pulmonary function addition anxiety caused covid<NUMBER> induces hyperglycemia miazgowski et al <NUMBER> finally pancreatic tissue potential target viral infection leading glucose metabolism disorders yang et al <NUMBER> zhou tan <NUMBER> furthermore recent report reviewed possible mechanisms play significant roles diabetes mellitus including hostviral interactions host immune responses muniyappa gubbi <NUMBER> coronaviruses penetrate cells leading apoptosis enhance inflammatory responses signified activation proinflammatory cytokines help attract inflammatory cells including cdþ helper th<NUMBER> cells sarscov<NUMBER> infects immune cells increases apoptosis lymphocytes cd<NUMBER> cd<NUMBER> cd<NUMBER> cells leading lymphocytopenia results excessive secretion proinflammatory cytokines process termed cytokine storm leading hyperinflammation consequent failure body organs deng et al <NUMBER> gao et al <NUMBER> infection human immunodeficiency virus hepatitis c virus results severe inflammation increased reactive oxygen species production leading oxidative stress gravierhernandez et al <NUMBER> similarly oxidative stressrelated gene polymorphisms likely associated hepatitis b virusinduced liver disease suggesting information variations useful risk assessment hbvinduced liver disease et al <NUMBER> experimental animal study demonstrated important role reactive oxygen species pathology immune response respiratory syncytial virus rsv transcriptional profile reactive oxygen species related genes respiratory system rsv infection natural host discussed recently hofstetter sacco <NUMBER> zika virus zikv associated congenital malformations recent research reported astrocytes targets zikv infection zikv induces mitochondrial dysfunction oxidative stress dna breakage human astrocytes ledur et al <NUMBER> regarding patients positive epsteinbarr virus analysis antioxidant enzyme activity demonstrated lower activities superoxide dismutase sod glutathione peroxidase gpx patients diabetes mellitus obesity healthy individuals dworza� nski et al <NUMBER> also reported chronic infections caused various viruses influence entire immunity diabetic patients previous study reported oxidative stress induced infection epsteinbarr virus early stages infection b lymphocytes epithelial lymphoblastoid cell lines oxidative stress manifested increased lipid peroxidation decreased activities cat sod suggesting alteration molecular mechanisms promoting cellular resistance reactive oxygen species lassoued et al <NUMBER> studies demonstrated oxidative stress factors leading dna damage induce expression ebv lytic genes arvey et al <NUMBER> dworza� nski et al <NUMBER> gargouri et al <NUMBER> mitochondrial reactive oxygen species key player induction pathological inflammation influenza virus infection mice recent research reported infection influenza virus enhanced production mitochondrial reactive oxygen species induces innate immune inflammation leading intensification viral pathogenesis mechanism demonstrated therapeutic potential antioxidants treat influenza virus pathology macrophages essential innate immune responses play remarkable role protecting animals viral infections infections macrophages infectious bronchitis coronavirus ibv connecticut a<NUMBER> conna<NUMBER> strains produced intracellular coronaviruslike particles within cells ibv causes respiratory defects increased macrophage count respiratory system animals macrophages infected ibv conna<NUMBER> strains production antimicrobial molecule nitric oxide inhibited amarasinghe et al <NUMBER> also demonstrated coronaviruses sarscov<NUMBER> replicate within human macrophages cheung et al <NUMBER> viroporins virusencoded proteins alter membrane permeability trigger subsequent cellular signals many viruses including corona viruses encode viroporins required maximal viral replication virulence case sarscov castañorodriguez et al <NUMBER> corona viruses encode two viroporins e protein <NUMBER>a protein act ionconductive pores experiments planar lipid bilayers sarscov encodes additional viroporin <NUMBER>a reported less impact replication virulence sarscov two viroporins castanorodriguez et al <NUMBER> could possibly responsible inflammasome activation inflammasomes large multimolecular complexes activate caspase<NUMBER> turn enhances production interleukin<NUMBER>beta il<NUMBER>β interleukin<NUMBER> il<NUMBER> recent research reported viroporin induce production il<NUMBER>β fluxes potassium hydrogen calcium ions addition reactive oxygen species autophagy endoplasmic reticulum stress involved activation farag et al <NUMBER> melatonin neuroendocrine hormone synthesized released primarily pineal gland melatonin multifunctional molecule based antioxidant activity direct indirect free radical scavenging ability boost immune system mortezaee et al <NUMBER> antiinflammatory actions hardeland <NUMBER> melatonin associated variety signaling mechanisms including erk mapk pathways cui et al <NUMBER> sung et al <NUMBER> addition several cell signaling pathways including erk<NUMBER>cebpα involved regulatory roles melatonin tcell biology ren et al <NUMBER> melatonin also stimulated sirt<NUMBER>nrf<NUMBER> signaling pathway reduce lipopolysaccharideinduced reactive oxygen species generation shah et al <NUMBER> moreover melatonin ameliorates h <NUMBER> <NUMBER> induced oxidative stress modulation erkaktnfkb pathway moniruzzaman et al <NUMBER> melatonin exerts action directly indirectly using specific melatonin receptors mt<NUMBER> mt<NUMBER> cellular membranes melatonin achieves many physiological effects interacting membrane mt<NUMBER> mt<NUMBER> receptors intracellular proteins quinone reductase <NUMBER> calmodulin calreticulin tubulin pandiperumal et al <NUMBER> melatonin mt<NUMBER> mt<NUMBER> receptors g protein coupled receptors expressed various cells body organs pandiperumal et al <NUMBER> study using melatonin receptor knockout mice indicated active role receptors regulation blood glucose muhlbauer et al <NUMBER> also mentioned melatonin administration normalized metabolic syndrome elderly hypertensive patients via receptors shatilo et al <NUMBER> blood melatonin levels continuously decreased age exhibiting highest level childhood youth periods lowest level older individuals furthermore nighttime melatonin levels plasma higher daytime life span secretion melatonin exhibits circadian rhythm regulates sleepawake cycle reutrakul et al <NUMBER> explains deterioration sleep quality older people moreover matches might explain higher number infections susceptibility infection severity covid<NUMBER> symptoms older persons young individuals increased oxidative stress inflammation common feature patients diabetes periodontal diseases doubleblind placebocontrolled trial supplementation melatonin found significantly increase serum activities sod cat gpx decrease lipid peroxidation diabetic patients periodontal disease effect accompanied lower il<NUMBER>b levels melatonintreated patients control individuals zare javid et al <NUMBER> treated patients administered <NUMBER> mg melatonin confirming previous study using <NUMBER> mg immediateor sustainedreleased dose patients t<NUMBER> diabetes rybka et al <NUMBER> studies indicate melatonin significantly regulated antioxidant enzymes increased total antioxidant capacity body earlier study reported melatonin ubiquitous shows unequal intracellular distribution including high concentrations mitochondria likely aid capacity resist oxidative stress cellular apoptosis another study reported melatonin improved glycemic state exerted antioxidant activity upregulating gsh content activities sod cat glutathionestransferase brain gurelgokmen et al <NUMBER> several studies agree effectiveness melatonin block oxidative stress inflammation cell death improve organ function several human trials highsafety profile melatonin also strengthens conclusion diabetes characterized hyperglycemia insulin resistance dyslipidemia augmented inflammatory state karamitri jockers <NUMBER> diabetic patients lower melatonin levels blood healthy people reutrakul et al <NUMBER> evidence indicating ability melatonin reduce development diabetes derived observation altered glucose metabolism insulin resistance shiftworkers high illumination level night associated low blood melatonin levels cipollaneto et al <NUMBER> research group explained receptors melatonin regulate glut<NUMBER> expression initiate phosphorylation insulin receptor intracellular substrates mobilizing insulinsignaling pathway cipollaneto et al <NUMBER> key role melatonin receptors regulation glucose metabolism confirmed using melatonin receptor knockout mice muhlbauer et al <NUMBER> reduction melatonin production elderly people chronic metabolic diseases induces insulin resistance glucose intolerance sleep disturbance metabolic circadian disorganization characterizing state chronodisruption leading obesity cipollaneto et al <NUMBER> findings indicate melatonin complementary therapy play vital role reestablishing healthy condition individuals chronic metabolic diseases increased accumulations fat body organs tissues develop inflammation cause several metabolic disorders including diabetes hypertension dyslipidemia due antioxidant properties melatonin treatment improve inflammatory mechanisms energy metabolism animal experimental studies shown melatonin efficiently decreased production blood inflammatory cytokines leptin resistin reduced adipocyte hypertrophy improved blood lipid profile farias et al <NUMBER> therefore melatonin termed modulator glucose metabolism pharmacological dose melatonin enhanced effects metformin insulin sensitivity body weight gain given combination metformin exhibited dual therapy treatment diabetes associated obesity dantasferreira et al <NUMBER> recently latter research group demonstrated melatonin remarkable therapeutic action decreasing obesityinduced inflammatory storm authors anticipated melatonin used lowcost therapeutic agent improve disorders associated obesity confirm previous study melatonin antidiabetic hypolipidemic impact human animal model metabolic syndrome cardinali hardeland <NUMBER> reported melatonin immunomodulatory roles dual proinflammatory antiinflammatory actions proinflammatory effect exhibited fight pathogens whereas antiinflammatory action manifested highgrade inflammation case sepsis oxidative stress organ injury also lowgrade inflammation associated aging neurodegenerative diseases hardeland <NUMBER> doubleedge blade melatonin attributed several mechanisms besides ability downregulate proinflammatory cytokine production upregulate antiinflammatory cytokine production melatonin exhibits high antioxidant capacity downregulate inducible nitric oxide synthases inhibit neuronal nitric oxide synthases downregulate cyclooxygenase<NUMBER> inhibit highmobility group box<NUMBER> signaling tolllike receptor<NUMBER> activation prevent inflammasome nlrp<NUMBER> activation inhibit nfκb activation hardeland <NUMBER> novel potential therapy using melatonin prevent treat obesity caused systemic inflammatory disease reported melatonin alleviates adipose tissue inflammation elevating αketoglutarate diverting adiposederived exosomes macrophages mice liu et al <NUMBER> based information sustaining normal levels melatonin elderly individuals diabetic obese people important strategy strengthen bodys defense system consequently immune system melatonin found exhibit effective inhibition pathological manifestations cases viral infections humans reiter et al <NUMBER> plants sarscov<NUMBER> newly discovered virus shortage research literature delays development effective treatment strategies particular potential effects melatonin human experimental animals deadly pathogen however melatonin exerts remarkable antiviral effects several viruses humans animals early work reported encephalomyocarditis virus semliki forest virus causes severe inflammation nervous tissue result high mortality rate melatonin administered pharmacological dose successfully attenuated inflammation parameters reduced number deaths bennathan et al <NUMBER> maestroni et al <NUMBER> recent report ebola infection demonstrated virus hampers immune system initiates blood coagulation significant inflammation reaction induces overwhelmed generation toxic free radicals development oxidative stress severe damage cells tissue eventually causes organ system dysfunction failure reiter et al <NUMBER> regard authors reported melatonin prevent hemorrhagic shock syndrome major pathological parameter associated ebola virus infection action mediated primarily reduction circulating proinflammatory cytokines melatonin also upregulates heme oxygenase<NUMBER> ho<NUMBER> obstructs replication ebola virus anderson et al <NUMBER> recently research group confirmed melatonin effective safe lowcost therapeutic option ebola virus junaid et al <NUMBER> also strongly suggested melatonin protect acute lung injury aliacute respiratory distress syndrome caused virus pathogens attributed wellknown antiinflammatory antioxidant effects zhang et al <NUMBER>b human papillomavirus associated oral genital cancers dsouza addepalli <NUMBER> shafabakhsh et al <NUMBER> melatonin exerted defensive impact oral cancer oral ulcer preventive controlling role melatonin oral cancer caused due hpv attributed primarily immunoenhancement increasing b lymphocyte activity increasing monocyte activity increasing natural killer cell activity increasing secretion cytokines il<NUMBER> il<NUMBER> ultimately lead oncostatic activity dsouza addepalli <NUMBER> addition melatonin combination indoleamine <NUMBER> <NUMBER>dioxygenase<NUMBER> inhibitor administered immunometabolic adjuvant improved efficacy immunotherapeutic treatment hpvassociated tumors moreno et al <NUMBER> possible melatonin directly interacts sarscov<NUMBER> membrane genetic material speculated melatonin affect biological activity viruses supported fact melatonin small molecule amphiphilic nature readily cross biological membranes freely enter cells reach subcellular organelles structures amin et al <NUMBER> addition evidence indicating melatonin pleiotropy encompasses regulation gene expression primary epigenetic mechanisms including dna methylation chromatin modification noncoding rna capote moreno et al <NUMBER> based recent findings comprehensive molecular studies required elucidate ability melatonin reverse inhibit biological activity sarscov<NUMBER> diabetic obese patients date direct experimental evidence viricidal effect melatonin indirect antiviral actions due antiinflammatory antioxidant immunomodulatory immune enhancing characteristics reiter et al <NUMBER> zhang et al <NUMBER>b contrast aforementioned melatonins immunemodulatory characteristics agents showed limited effectiveness modulating immunoreactivity toward viruses instance statins cannot prevent patients infected <NUMBER> h<NUMBER>n<NUMBER> pandemic influenza developing severe disease addition direct evidence shown angiotensin receptor blockers arbs angiotensinconverting enzyme inhibitors aceis might effective therapy severe influenzainduced cytokine storm liu et al <NUMBER> sequence similarity spike proteins sarscov sarscov<NUMBER> recently validated sarscov<NUMBER> also uses ace<NUMBER> receptor polyphenols proved immunomodulatory antioxidant effect vivo vitro however major obstacle bioavailability impact biofunctionality yahfoufi et al <NUMBER> melatonin several properties suggesting utility variety circumstances high biological safety exogenous melatonin used variety doses even including extreme doses andersen et al <NUMBER> zhang et al <NUMBER>a worth mentioning melatonin dose <NUMBER> mgday demonstrated acceptable safety level clinical trials othman et al <NUMBER> seabra et al <NUMBER> zhang et al <NUMBER>b adverse events generally minor shortlived easily managed foley steel <NUMBER> addition highsafety profile administered several routes melatonin constitutes natural easytosynthesize product found shelves long halftime review presents short brief account recently published papers role melatonin potential benefits based included therapeutic adjuvant treatment course covid<NUMBER> patients chronic diseases common trend exists increased number sarscov<NUMBER>infected cases low levels blood melatonin people chronic metabolic diseases elderly people individuals show decreased levels endogenous antioxidants including antioxidant enzymes melatonin accompanied weak immune system increased susceptibility inflammation ability melatonin decrease viral infections obese diabetic patients attributed characteristics potent antioxidant effects improving endogenous antioxidant system immunomodulatory strong antiinflammatory capability altogether features strongly recommend melatonin useful therapeutic option sarscov<NUMBER>infected patients without chronic metabolic diseases improve health although direct evidence support utility melatonin treatment protocols covid<NUMBER> patients extensive data published past <NUMBER> years recommend utility none none december <NUMBER> acute infectious pneumonia unknown cause broke wuhan quickly spread throughout world <NUMBER> <NUMBER> pathogen identified unique clade βcoronaviruses related severe acute respiratory syndrome sars middle east syndrome mers officially named severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> <NUMBER> subsequently coronaviruscaused pneumonia defined coronavirus disease <NUMBER> covid <NUMBER> world health organization february <NUMBER> <NUMBER> april <NUMBER> <NUMBER> sarscov<NUMBER> caused <NUMBER> confirmed cases <NUMBER> death china globally virus spread <NUMBER> countries including united states britain italy south korea japan covid<NUMBER> higher transmission rate greater risk mortality comparison influenza although majority patients believed favorable outcome older people underlying diseases may poor prognosis <NUMBER> diabetes mellitus one common conditions among elderly contributes greatly morbidity worldwide moreover numerous studies shown diabetic patients susceptible various pathogens mycobacterium tuberculosis streptococcus pneumoniae staphylococcus aureus <NUMBER> several retrospective studies wuhan indicated diabetes one prevalent comorbidities covid<NUMBER> patients <NUMBER> <NUMBER> <NUMBER> suggested diabetics probably susceptible sarscov<NUMBER> patients might worse prognosis order understand whether covid<NUMBER> patients diabetes severe disease progression worse prognosis <NUMBER> covid<NUMBER> patients studied data demographic clinical laboratory radiologic treatments complications well clinical outcomes carefully collected analyzed results indicate diabetes mellitus significantly associated poor prognosis covid<NUMBER> retrospective singlecenter cohort study included <NUMBER> patients obtained data including demographic clinical laboratory radiological characteristics treatments complications clinical outcomes patients electronic medical records patients followed march <NUMBER> <NUMBER> data carefully reviewed three independent researchers jian shang qian wang haiping zhang discrepancies reviewers resolved discussion fourth researcher jun lin confirm sarscov<NUMBER>s infection throat swab samples collected upper respiratory tracts patients tested using rtpcr nextgeneration sequencing technology described previously pathogen detection performed following four institutions chinese center disease control prevention chinese academy medical science academy military medical sciences wuhan institute virology chinese academy sciences <NUMBER> diabetes mellitus diagnosed meeting one following <NUMBER> <NUMBER> fasting plasma glucose level ≥ <NUMBER> mmoll <NUMBER> plasma glucose level ≥ <NUMBER> mmoll two hours <NUMBER> gram oral glucose load glucose tolerance test ogtt <NUMBER> casual plasma glucose level ≥ <NUMBER> mmoll <NUMBER> glycated hemoglobin hba <NUMBER>c ≥ <NUMBER> mmolmol fever defined axillary temperature exceeding <NUMBER>℃ assessment disease severity critical illness identified satisfying least one following criteria <NUMBER> respiratory failure requiring mechanical ventilation <NUMBER> shock performance <NUMBER> multiple organ failure requiring icu monitoring respiratory failure defined arterial partial pressure oxygen pao <NUMBER> <NUMBER> mmhg acute liver injury defined alanine aminotransferase increase <NUMBER> times limit reference aspartate aminotransferase increase <NUMBER> times limit reference total bilirubin increase <NUMBER> times limit reference regardless liver comorbidities <NUMBER> acute myocardial injury defined serum level myocardial biomarkers highsensitivity troponin creatine kinasemb exceeding upper reference limit new abnormities electrocardiogram <NUMBER> acute kidney injury defined based kdigo clinical practice guidelines <NUMBER> categorical variables presented frequency rates percentages continuity variables described using median interquartile range iqr used chisquare test fishers exact test compare variables diabetes nondiabetes groups categorical data otherwise mannwhitney u test applied continuous variables kaplanmeier method logrank test used compare prognosis covid<NUMBER> patients different groups furthermore multivariate cox proportional hazards analysis used analyze independent prognosis factors survival covid<NUMBER> patients statistical analyses performed using spss software version <NUMBER> p value less <NUMBER> considered statistically significant total <NUMBER> patients covid<NUMBER> included retrospective study table <NUMBER> median age <NUMBER> years iqr <NUMBER> ranging <NUMBER> <NUMBER> years <NUMBER> patients female <NUMBER> common symptom beginning disease fever <NUMBER> followed cough <NUMBER> anorexia <NUMBER> fatigue <NUMBER> dyspnea <NUMBER> half patients one comorbidities including hypertension <NUMBER> diabetes <NUMBER> cardiovascular disease <NUMBER> chronic respiratory disease <NUMBER> chronic liver disease <NUMBER> malignancy <NUMBER> chronic kidney disease <NUMBER> according initial clinical data <NUMBER> <NUMBER> patients critical ill shown table <NUMBER> covid<NUMBER> patients divided diabetes group n<NUMBER> nondiabetes group n<NUMBER> elderly people diabetes group patients diabetes likely symptoms fatigue <NUMBER> p <NUMBER> dyspnea <NUMBER> p <NUMBER> proportions diabetes patients hypertension <NUMBER> p <NUMBER> cardiovascular disease <NUMBER> p <NUMBER> significantly higher nondiabetes furthermore critical ill patients diabetes group <NUMBER> p <NUMBER> laboratory radiologic findings patients described table <NUMBER> admission many patients tended lymphopenia elevated levels infectionrelated biomarkers creactive protein procalcitonin abnormal levels neutrophil alanine aminotransferase alt total bilirubin albumin blood urea nitrogen bun serum creatinine cardiac troponin ddimer according radiologic findings <NUMBER> patients <NUMBER> presented bilateral pneumonia unilateral pneumonia occurred <NUMBER> patients <NUMBER> compared nondiabetic patients diabetic patients higher levels neutrophils p <NUMBER> total bilirubin p <NUMBER> blood urea nitrogen p <NUMBER> cardiac troponin p <NUMBER> creactive protein p <NUMBER> procalcitonin p <NUMBER> ddimer p <NUMBER> lower levels lymphocytes p <NUMBER> albumin p <NUMBER> furthermore diabetic patients significant higher incidence bilateral pneumonia <NUMBER> p <NUMBER> figure <NUMBER> results indicated covid<NUMBER> patients diabetes severe inflammatory response lung infiltration might contribute poorer prognosis data treatments complications clinical outcomes summarized furthermore patients died diabetes groups <NUMBER> vs <NUMBER> p <NUMBER> data indicated clinical outcomes diabetic patients worse nondiabetic patients kaplanmeier method logrank test used study investigate relationship diabetes covid<NUMBER> prognosis results indicated diabetic patients significant lower overall survival rate nondiabetic patients hr <NUMBER> p <NUMBER> figure <NUMBER> furthermore multivariate cox analysis performed following adjustment potential prognostic factors included age sex hypertension cardiovascular diseases diabetes chronic respiratory diseases chronic kidney diseases chronic liver diseases acute kidney injury acute liver injury respiratory failure acute cardiac injury data showed diabetes hr <NUMBER> p <NUMBER> acute kidney injury hr <NUMBER> p <NUMBER> two independent prognosis factors mortality covid<NUMBER> patients table <NUMBER> results indicate diabetes potential risk factor prognosis covid<NUMBER> <NUMBER> diabetic patients <NUMBER> uncontrollable plasma glucose levels required insulin therapy subgroup analysis divided diabetic patients insulin required n <NUMBER> noninsulin required n <NUMBER> groups according whether needed insulin table <NUMBER> found elderly p <NUMBER> diabetes mellitus chronic inflammatory disease characterized multiple macrovascular microvascular abnormities affect bodys response pathogens <NUMBER> relationship diabetes infection always important concern clinicians infectious diseases especially influenza pneumonia common among elderly diabetic patients addition previous studies shown diabetes risk factor morbidity mortality multiple viral infections including <NUMBER> influenza h<NUMBER>n<NUMBER> merscov sarscov <NUMBER> <NUMBER> <NUMBER> however relationship diabetes covid<NUMBER> prognosis rarely reported retrospective cohort study analyzed data <NUMBER> patients covid<NUMBER> including <NUMBER> cases diabetes <NUMBER> cases nondiabetes first compared differences demographic clinical characteristics two groups results indicate proportion elderly patients diabetes group significantly higher nondiabetes group well known diabetes aging disease previous studies shown aging one important risk factors affecting prognosis covid<NUMBER> <NUMBER> therefore high proportion elderly patients diabetes group might suggest poor clinical outcome furthermore analyzed symptoms patients first visit found diabetic patients likely symptoms fatigue anorexia might eventually lead poor nutritional status patients according criteria methods evaluated disease severity patients found critical ill patients diabetes group suggest diabetic patients likely progress severe condition infection sarscov<NUMBER> lymphopenia common patients covid<NUMBER> thrombocytopenia leukopenia relatively rare <NUMBER> previous studies shown covid<NUMBER> patients especially severe conditions significantly increased levels serum inflammationrelated biomarkers including interleukin <NUMBER> creactive protein procalcitonin indicators closely related prognosis disease <NUMBER> <NUMBER> diabetes hyperglycemia insulin resistance promote synthesis numerous proinflammatory cytokines adhesion molecules exacerbate oxidative stress inflammation body <NUMBER> however clear whether diabetes aggravate inflammatory response covid<NUMBER> patients order clarify question laboratory data analyzed study results showed diabetic patients higher levels neutrophils creactive protein procalcitonin lower level lymphocytes comparison nondiabetic patients besides lab findings also analyzed radiologic data found diabetic patients significant higher incidence bilateral pneumonia nondiabetic patients results indicate covid<NUMBER> patients diabetes severe inflammatory responses lung infiltration might contribute worse prognosis sarscov<NUMBER>s infection ddimer fibrin degradation product one main markers coagulation activity <NUMBER> high concentration serum ddimer closely related variety thrombotic diseases including myocardial infarction cerebral infraction pulmonary embolism venous thrombosis <NUMBER> study found concentration serum ddimer diabetic patients significantly higher nondiabetic patients indicating covid<NUMBER> patients diabetes likely develop hypercoagulable prothrombotic state sarscov sarscov<NUMBER> share receptor angiotensinconverting enzyme <NUMBER> ace<NUMBER> <NUMBER> <NUMBER> reported ace<NUMBER> widely expressed multiple organs including heart respiratory tract liver kidney pancreas intestine <NUMBER> might provide explanation covid<NUMBER> patients multiple organ dysfunctions study observed incidence respiratory failure acute cardiac injury diabetes group significantly higher nondiabetes group results suggest attention paid respiratory support heart protection covid<NUMBER> patients diabetes far clear evidence indicate antiviral treatment significantly improve prognosis covid<NUMBER> patients majority patients received treatments oxygen therapy fluid management respiratory support received antibiotics corticosteroids intravenous immunoglobin critical ill patients required icu monitoring mechanical ventilation study diabetic patients likely receive corticosteroids intravenous immunoglobin mechanical ventilation nondiabetic patients indicated diabetic patients severe disease progression needed advanced therapy despite receiving advanced treatment mortality patients diabetes group still significantly higher nondiabetes group order determine role diabetes prognosis covid<NUMBER> patients kaplanmeier method survival curve applied study results indicate diabetic patients significant lower overall survival rate nondiabetic patients exclude influence factors multivariate cox analysis performed data showed diabetes independent prognosis factors mortality covid<NUMBER> patients thus intensive monitors conducted diabetic patients prevent disease getting worse aging one important factors affecting prognosis covid<NUMBER> patients study kaplanmeier survival curve showed patients older <NUMBER> years shorter overall survival time hr <NUMBER> p <NUMBER> supplementary figure <NUMBER> suggesting olderage associated poor prognosis covid<NUMBER> however results multivariate analysis show aging independent risk factor covid<NUMBER> prognosis probably due influence multiple confounding factors limited sample size study diabetes patients uncontrollable plasma glucose levels may complications worse prognosis usually requiring insulin therapy divided diabetic patients insulin required noninsulin required groups according whether needed insulin found incidence respiratory failure acute cardiac injury acute kidney injury death insulin required group significantly higher noninsulin required group kaplanmeier survival curve showed insulin required diabetic patients shorter overall survival time results indicate diabetic patients requiring insulin higher risk disease progression worse prognosis infection sarscov<NUMBER> study several limitations first selection bias exits retrospective cohort study prospective studies needed second research based single center study largescale multicenter researches need performed validate conclusions conclusion diabetes independent risk factor prognosis covid<NUMBER> diabetic patients intensely monitored treatment especially require insulin therapy diabetes mellitus dm prevalent metabolic disorder characterized hyperglycemia resulting absolute relative deficiencies insulin secretion andor insulin action <NUMBER> dm considered prothrombotic condition increased platelet reactivity <NUMBER> morphological changes platelets increased platelet activity reported dm mean platelet volume mpv found significantly higher diabetic patients <NUMBER> <NUMBER> mpv accurate measure platelet size considered markers determinants platelet function larger platelets higher mpv hemostatically reactive produce higher amounts prothrombotic factor thromboxane increase thromboxane generation causes thrombotic susceptibility therefore results thrombotic complications <NUMBER> <NUMBER> december <NUMBER> pneumonia cases unknown origins recognized reported china earlier patients pneumonia worked visited seafood market selling live animals wuhan newly identified illness termed covid<NUMBER> world health organization spread rapidly china rest world <NUMBER> march <NUMBER> declared outbreak global pandemic novel betacoronavirus identified covid<NUMBER> pathogen triggered severe pneumonia acute even lethal lung failure confirmed cases covid<NUMBER> worldwide nearly approaching <NUMBER> million mortality rate <NUMBER> according situation report world health organisation april <NUMBER> <NUMBER> <NUMBER> individuals diabetes higher overall risk infection results multiple disturbances inherent immunity patients diabetes severe disease infected respiratory viruses especially influenza pneumonia indeed diabetes seen important risk factor mortality patients infected pandemic influenza <NUMBER> h<NUMBER>n<NUMBER> severe acute respiratory syndrome sars coronavirus middle east respiratory syndromerelated coronavirus merscov <NUMBER> data covid<NUMBER> patients diabetes limited present diabetes present <NUMBER> <NUMBER> fatalities due covid<NUMBER> wuhan china <NUMBER> study <NUMBER> patients covid<NUMBER> inwuhan china diabetes risk factor severe disease course <NUMBER> however another study <NUMBER> patients <NUMBER> deaths <NUMBER> recovered patients wuhan showed number comorbidities significant predictor mortality <NUMBER> analysis <NUMBER> studies regarding laboratory abnormalities patients covid<NUMBER> mention raised blood glucose diabetes predictor severe disease <NUMBER> notwithstanding small series report <NUMBER> cases covid<NUMBER> published chinese centre disease control prevention showed increased mortality people diabetes <NUMBER> overall <NUMBER> patients diabetes <NUMBER> however mpv covid<NUMBER> patients diabetes fully reported may diagnostic prognostic value study aimed compare levels mpv diabetics covid infection whether could used diagnostic indicator diabetics study conducted bezmialem vakif university hospital largest city turkey namely istanbul february <NUMBER> april <NUMBER> population represented consecutive <NUMBER> patients laboratory confirmed covid cases type <NUMBER> dm t<NUMBER>dm admitting covid outpatient clinic ageand sexmatched <NUMBER> nondiabetic laboratory confirmed noncovid adults admitting family medicine outpatient clinic control group sex age matched individuals nonspecific upper respiratory infections patients urinary tract infection patients soft tissue infection enrolled study retrospectively analyzed mpv values ageand sexmatched <NUMBER> laboratory confirmed covid patients without diabetes admitted covid outpatient clinic previous results complete blood count enrolled nondiabetic individuals covid infection studied last visit outpatient clinic hospital onset covid infection yielded archive records via patient information management system hospital group ageand sexmatched <NUMBER> laboratory confirmed covid patients without diabetes admitted covid outpatient clinic also enrolled study diabetic nondiabetic subjects underwent complete clinical evaluation well drugs taken height centimeters rounded nearest <NUMBER> cm weight kilogrammes rounded nearest <NUMBER> kg subjects recorded body mass index bmi calculated weight kilograms divided height square meters diagnosis dm based previous history diabetes treated without drug therapies fasting glycaemia <NUMBER> mgdl random glycaemia <NUMBER> mgdl hba<NUMBER>c <NUMBER> according ada criteria two samplings adults whose fasting glucose values <NUMBER> mgdl accepted normal sujects included nondiabetic group excluded patients iron deficiency anemia hypohyperthyroidism congestive heart failure recent infection sake minimizing confounding factors include patients leukocytosis anemia thrombocytopenia may effect platelet erythrocyte size patients known inflammatory conditions rheumatoid arthritis systemic lupus erythematosus excluded nondiabetic subjects coronary artery disease diabetics antiplatelet drugs aspirin clopidogrel also excluded subjects diagnosed malignancy also excluded <NUMBER> written informed consent taken subject study inclusion blood withdrawal done following overnight fasted state ≥ <NUMBER> hours clinic nurse physician duty fasting blood samples collected transferred immediately appropriate tubes described centrifugation collected serum transferred prelabeled plain tubes delivered biochemistry laboratory bezmialem vakif university hospital identify sarscov<NUMBER> infection throat swab samples obtained participants admission tested using realtime reverse transcriptasepolymerase chain reaction assays past results complete blood count enrolled diabetic individuals covid infection studied last routine outpatient clinic visit newest visit month ago oldest visit three months ago start covid infection participant yielded archive records via patient information management system hospital measured mpv platelet using automated hematology analyzer sysmex <NUMBER> usa venous blood samples collected dipotassium edta tested within <NUMBER> hour collection minimize variations due sample aging samples maintained room temperature samples plasma glucose estimation hba<NUMBER>c collected sodium fluoride dipotassium edta respectively estimation fasting plasma glucose hba<NUMBER>c levels carried glucose oxidase method chemical autoanalyzer cobas <NUMBER> roche germany hba<NUMBER>c highperformance liquid chromatography method noted quality assurance qa standards maintained ts en iso <NUMBER> whereas qa department audits laboratory regular intervals data analyzed using statistical package social sciences version <NUMBER> spss chicago il usa normal continuous variables presented mean ± standard deviation test significance calculated unpaired students test cases controls correlation mpv parameters performed twotailed pearsons total <NUMBER> subjects <NUMBER> covid patients type <NUMBER> diabetes <NUMBER> healthy controls <NUMBER> patients nonspesific infections <NUMBER> covid patients without type <NUMBER> diabetes enrolled study general characteristics laboratory data groups enrolled study shown table <NUMBER> <NUMBER> <NUMBER> male diabetics <NUMBER> <NUMBER> female diabetics study <NUMBER> <NUMBER> nondiabetic males <NUMBER> <NUMBER> nondiabetic females study gender statistically significant different groups p <NUMBER> mean age diabetic population <NUMBER> ± <NUMBER> years whereas nondiabetic population <NUMBER> ± <NUMBER> years age groups statistically significant different p <NUMBER> mean duration diabetes <NUMBER> ± <NUMBER> years mean bmi diabetic group <NUMBER> ± <NUMBER> kgm <NUMBER> <NUMBER> ± <NUMBER> kgm <NUMBER> nondiabetic subjects p <NUMBER> mean fasting blood glucose level diabetic population <NUMBER> ± <NUMBER> mgdl nondiabetic group <NUMBER> ± <NUMBER> mggl p <NUMBER> mean hba<NUMBER>c level diabetic group <NUMBER> ± <NUMBER> compared <NUMBER> ± <NUMBER> nondiabetic group p <NUMBER> mean platelet count diabetic group <NUMBER> ± <NUMBER> × <NUMBER> <NUMBER> l <NUMBER> ± <NUMBER> × <NUMBER> <NUMBER> l nondiabetic group p <NUMBER> covid patients diabetes mpv significantly higher <NUMBER> ± <NUMBER> compared last routine visit results diabetic individuals <NUMBER> ± <NUMBER> fl p <NUMBER> mean ldl cholesterol level <NUMBER> ± <NUMBER> mgdl diabetic group <NUMBER> ± <NUMBER> mgdl normal subjects level ldl cholesterol statistically significant different groups p <NUMBER> mean mpv values enrolled covid patients laboratory confirmed recovery yielded data showed mean mpv decreased <NUMBER>±<NUMBER> patients recovered original level p<NUMBER> looked mpv values enrolled subjects classifying patients asymptomatic covid moderately severe covid severe covid detected statisticaly significant differences among groups <NUMBER> ± <NUMBER> <NUMBER> ± <NUMBER> <NUMBER> ± <NUMBER> respectively p<NUMBER> mean mpv values control group individuals nonspecific upper respiratory infections patients urinary tract infection patients soft tissue infection found <NUMBER> ± <NUMBER> p<NUMBER> made correlation analysis mpv covid<NUMBER> however statistically significant differences mpv values ageand sexmatched <NUMBER> laboratory confirmed covid patients without diabetes admitted covid outpatient clinic detected <NUMBER> ± <NUMBER> <NUMBER> ± <NUMBER> covid infection individuals respectively p<NUMBER> comparison mpv person diabetes covid infection healthy person <NUMBER> ± <NUMBER> <NUMBER> ± <NUMBER> respectively p<NUMBER> thought increase mpv caused infection diabetes analyzed statistically significant difference person infections analyzed mpv values participants detected mpv subjects diabetes covid infection <NUMBER> ± <NUMBER> however mpv subjects diabetes covid infection <NUMBER> ± <NUMBER> p <NUMBER> mean mpv subjects diabetes covid infection recovery found <NUMBER>±<NUMBER> compared levels onset covid infection p<NUMBER> comparison mpv person diabetes covid infection healthy person <NUMBER> ± <NUMBER> <NUMBER> ± <NUMBER> respectively p<NUMBER> analyzed statistically significant difference person infections best knowledge studies examined association mpv covid patients diabetes mellitus primary health care turkey dm complex syndrome characterized chronic hyperglycemia responsible wellknown sensitivity infections results multiple disturbances inherent immunity diabetes affects <NUMBER> million individuals world significant morbidity mortality worldwide <NUMBER> detected prevalence diabetes turkish population reached <NUMBER> according turdep ii study <NUMBER> reported mpv might used simple costeffective laboratory test followup dm shown diabetes mellitus platelets become reactive mpv increased therefore mpv would useful prognostic marker widespread complications diabetes <NUMBER> mpv might used simple costeffective laboratory test followup dm thereby help hold morbidity mortality covid<NUMBER> acute infectious disease caused new coronavirus sarscov<NUMBER> usual clinical characteristics involve fever dry cough fatigue sore throat rhinorrhea conjunctivitis headache myalgia dyspnea nausea vomiting diarrhea patients may gradually develop dyspnea severe cases disease progresses rapidly mods septic shock difficult correct metabolic acidosis coagulation dysfunction may ocur within days patients severe inflammatory storms leading death <NUMBER> therefore judging development trend diagnosis disease early stage taking active effective treatment patients may develop severe illness effectively reduce mortality rate platelets important immune cells human body play important role hemostasis coagulation vascular integrity maintenance angiogenesis innate immunity inflammatory response tumor biology recent research revealed platelets active components immune system besides previously considered passive immunemodulatory role crosstalk immune system platelets emerged critical modulators atherothrombosis vascular inflammation effector cells combat microbial infection <NUMBER> changes number activity closely related variety diseases <NUMBER> <NUMBER> addition wellestablished function thrombus formation platelets also rapidly emplaced sites inflammation recent studies reveal modulation inflammatory processes platelets occur via interaction neutrophils internalization pathogens secretion cytokines platelet microbicidal proteins pmps inflammatory regulators <NUMBER> platelets produced mature megakaryocytes bone marrow current studies shown variety cytokines including tpo il<NUMBER> il<NUMBER> il<NUMBER> il<NUMBER> stem cell factor scf promote production megakaryocytes <NUMBER> absolute value lymphocytes platelet levels used sensitive indicators reflect bodys infection inflammation control mpv indicator clinical value covid<NUMBER> patients diabetes therefore analyzed changes peripheral blood covid<NUMBER> patients diabetes association changes covid infection observation patients included found mean platelet volume level patients positively correlated covid infection reason may possible platelet changes covid<NUMBER> patients addition may also related limited number patients enrolled study thought statistically significant difference mpv diabetic patients onset covid infection healthy individuals caused hyperglycemia diabetes previous studies possible causes platelet changes covid<NUMBER> patients analyzed shown lung may one organs mature megakaryocytes release platelets thrombocytopenia patients sarscov infection may associated lung damage <NUMBER> injury lung tissue pulmonary endothelial cells lead activation aggregation retention platelets lung formation thrombus injured site may lead depletion platelets megakaryocytes resulting decreased platelet production increased consumption <NUMBER> new type inflammation index mpv mainly reflects level systemic inflammation previous studies confirmed mpv closely related tumors diabetes coronary heart disease connective tissue diseases increase mpv related tumor size lymph node infiltration distant metastasis prognosis used potential inflammatory indicator clinical diagnosis communityacquired pneumonia <NUMBER> <NUMBER> <NUMBER> indicator inflammation mpv mainly caused megakaryocytes bone marrow hematopoietic tissue major participant thrombosis plays crucial role inflammatory response recruit neutrophils inflammatory cells site injury plt exists inactive form activated quickly site vascular injury rapidly activated response proinflammatory cytokine infectious factors activation platelets mechanism even without vascular damage opens new functions platelets namely inflammation immune regulation proinflammatory cytokine activity plt mediated interaction leukocytes circulation followed release cytokines chemokine promote inflammation <NUMBER> study limitations study conducted singlecenter hospital limited sample size larger cohort studies diabetic patients covid<NUMBER> pneumonia would help define clinical characteristics exploration new indicators disease conclusion presence rapidly emerging novel infection faced recent months identification biomarkers could predict disease presence essential guiding clinical care biomarkers needed identify disease among patients data revealed <NUMBER> diabetic patients laboratory confirmed covid<NUMBER> presumed mpv getting increased covid infection may indicative useful diagnostic marker emerging covid infection diabetics consideration findings propose mpv used simple economic rapid commonly available costeffective tool monitor onset covid infection primary care prevalence diabetes patients covid<NUMBER> coronavirus disease <NUMBER> caused severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> infection varied across countries ranging <NUMBER> china <NUMBER> lombardy italy <NUMBER> us <NUMBER> <NUMBER> <NUMBER> <NUMBER> diabetes modulate hostviral interactions hostimmune responses via several mechanisms could also lead poorer outcomes see muniyappa gubbi review <NUMBER> major clinical importance studies far reported twoto threefold higher prevalence diabetes patients severe infections requiring admission intensive care units icu invasive ventilation compared less severe infection well increased mortality rate patients diabetes table <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> however diabetes patients constitute highly heterogeneous population terms type diabetes duration disease quality glucose control presence diabetic complications interference comorbidities obesity hypertension type glucoselowering therapy among others different factors could playing significant role final prognosis diabetes patients hospitalized covid<NUMBER> virtually unknown absence large prospective studies address crucial question fact available data literature rather scarce reports considered prognostic factors based theoretical grounds <NUMBER> one small retrospective singlecentre observational study china analyzed clinical characteristics outcomes <NUMBER> severe covid<NUMBER> patients diabetes <NUMBER> found survivors covid<NUMBER> diabetes differ significantly nonsurvivors diabetes prevalence associated comorbidities including hypertension cardiovascular disease cvd chronic pulmonary disease indeed survival independent overall glycaemic control assessed glycated haemoglobin hba<NUMBER>c hospitalization however given small number patients analysis interpreted caution largest series <NUMBER> patients hospitalized covid<NUMBER> new york city us mentioned passing patients died diabetes likely received invasive mechanical ventilation care icu compared without diabetes information provided regarding characteristics diabetes patients <NUMBER> one key question whether diabetes risk factor covid<NUMBER> infection poorer outcomes deleterious role hyperglycaemia immune responses defence infections <NUMBER> multiple complications associated diabetes especially cvd andor renal disorders comorbidities frequently encountered obesity hypertension obstructive sleep apnoea type <NUMBER> diabetes t<NUMBER>d patient population <NUMBER> furthermore potential interference certain medications frequently prescribed diabetes patients also worthy attention <NUMBER> <NUMBER> reninangiotensinaldosterone system raas blockers suspected facilitate intracellular penetration sarscov<NUMBER> <NUMBER> dipeptidyl peptidase dpp<NUMBER> inhibitors interfere immune response <NUMBER> thus identifying risk factors progression serious lifethreatening covid<NUMBER> infection key step would allow preventative strategies diabetes population limit incidence traumatic outcomes need tracheal intubation mechanical ventilation death coronado coronavirus sarscov<NUMBER> diabetes outcomes study largescale nationwide <NUMBER> french centres observational study patients diabetes hospitalized covid<NUMBER> carried march <NUMBER> <NUMBER> main objective identify clinical biological characteristics associated disease severity mortality patients diabetes hospital covid<NUMBER> primary outcome combined tracheal intubation mechanical ventilation andor death within <NUMBER> days hospital admission individual components primary outcome considered prespecified secondary outcome also hospital discharge day <NUMBER> <NUMBER> focused <NUMBER> participants admitted <NUMBER> march <NUMBER> <NUMBER> centres predominantly t<NUMBER>d patients <NUMBER> gender distribution <NUMBER> female vs <NUMBER> male mean age <NUMBER> years median body mass index bmi <NUMBER> kgm² microvascular including chronic kidney disease macrovascular complications found <NUMBER> <NUMBER> patients respectively medical history hypertension identified <NUMBER> <NUMBER> using raas inhibitors mean glycated haemoglobin hba<NUMBER>c level <NUMBER> ± <NUMBER> <NUMBER> ± <NUMBER> mmolmol routine glucoselowering medications mostly comprised metformin <NUMBER> insulin therapy <NUMBER> dpp<NUMBER> inhibitors <NUMBER> composite primary outcome noted <NUMBER> participants <NUMBER> died <NUMBER> discharged day <NUMBER> whereas univariate analyses several characteristics admission significantly associated primary outcome higher bmi male gender previous treatment raas blockers latter two borderline significance multivariable analyses bmi remained positively associated primary outcome odds ratio <NUMBER> <NUMBER> confidence interval ci <NUMBER> note however association largely driven tracheal intubation rather death moreover increased risk primary outcome appeared less patients grade<NUMBER> obesity bmi ≥ <NUMBER> kgm² overweight <NUMBER> kgm² grade <NUMBER> obesity bmi <NUMBER> kgm² also noteworthy age history microvascular macrovascular complications decreased estimated glomerular filtration rate egfr comorbidities treated obstructive sleep apnoea independently associated risk death day <NUMBER> <NUMBER> age also played major role <NUMBER> diabetes patients <NUMBER> years age compared diabetes patients <NUMBER> years age previous longterm glucose control assessed hba<NUMBER>c measurement significantly associated primary outcome unlike early clinical dyspnoea biological elevated creactive protein crp markers severe disease fact ageand genderadjusted nonlinear models plasma glucose concentrations admission significantly positively associated primary outcome death day <NUMBER> however negative impact admission ambient glucose concentrations longer significant multivariate analysis also worth noting diabetesrelated disorders severe hyperglycaemia including ketosis ketoacidosis also hypoglycaemic events reported time admission conclusion coronado study confirmed severity prognosis covid<NUMBER> infection people diabetes <NUMBER> study population required tracheal intubation mechanical ventilation mortality rate <NUMBER> early <NUMBER> days admission multivariate analysis increased bmi already starting overweight range independent prognostic factor covid<NUMBER> severity assessed composite primary outcome large cohort diabetes patients major importance however history vascular diabetes complications treated obstructive sleep apnoea significantly increased risk death contrast parameters previous admission glucose control routine pharmacological therapies including raas blockers dpp<NUMBER> inhibitors independently associated prognosis time coronado largest published observational study specifically focused characteristics diabetes patients hospitalized covid<NUMBER> infection designed address three main objectives characterize phenotype patients diabetes hospitalized covid<NUMBER> ii determine prevalence poor prognoses using primary outcome combining death tracheal intubation mechanical ventilation within first <NUMBER> days hospital admission iii identify prognostic factors associated early severity covid<NUMBER> specific inpatient diabetes population key step towards implementing preventative strategies reduce risk lifethreatening outcomes however numerous factors may interfere relationship covid<NUMBER> infection poor outcomes patients diabetes fig <NUMBER> present discussion focuses three merit particular interest mostly concern patients t<NUMBER>d represented <NUMBER> patients included coronado study <NUMBER> number patients type <NUMBER> diabetes t<NUMBER>d deemed small draw definite conclusions patient subgroup although vascular diabetic complications significantly influence composite primary outcome significantly associated death coronado cohort <NUMBER> surprising well established cvd renal impairment associated higher death rates diabetes population longterm acute conditions encountered severe covid<NUMBER> infection <NUMBER> addition besides causing severe pneumonia well known sarscov<NUMBER> coronavirus induce cardiovascular complications <NUMBER> <NUMBER> acute renal injury <NUMBER> <NUMBER> making highly plausible detrimental complications likely frequent severe predisposed patients one question interest potential role glucose control outcomes related covid<NUMBER> patients diabetes crucial point analyzed according three separate periods prior admission assessed hba<NUMBER>c measurement ii time hospital admission indicated concomitant plasma glucose concentrations iii hospital stay fig <NUMBER> important message present results coronado previous glucose control significant impact severity covid<NUMBER> people diabetes require hospitalization indeed hba<NUMBER>c levels associated neither composite primary outcome death rate <NUMBER> results may seem surprising chronic hyperglycaemia long known damp immunological defences diabetes patients <NUMBER> <NUMBER> however caution still required hba<NUMBER>c measurements missing onethird thestudied population thus would appear prudent wait final analysis coronado even larger cohort drawing definite conclusions role patients past glucose control final outcomes moreover coronado focused hospitalized patients diabetes still known whether poor glucose control might favour occurrence less severe covid<NUMBER> infection diabetes patients requiring hospitalization similarly plasma glucose concentration admission significantly correlated primary outcome multivariate analysis ageand genderadjusted nonlinear models admission plasma glucose concentrations significantly positively associated primary outcome death day <NUMBER> nevertheless observation relied upon one glucose measurement performed standardized conditions across study patients example venous vs capillary glucose fasting vs postprandial variable time delay last administration glucoselowering medication especially insulin … thus caution required interpretation data may speculated least patients acute hyperglycaemia admission could linked disease severity stressful conditions especially hypoxia respiratory distress dyspnoea hospital admission associated primary outcome already present thus plasma glucose admission could considered early marker disease severity also potential interest previously reported sars coronavirus may able enter pancreatic islets ace<NUMBER> receptor thereby causing damage beta cells leading acute diabetes <NUMBER> however whether reverse causality relationship covid<NUMBER> infection acute hyperglycaemia remains speculative question cannot answered observational study coronado one important aspect considered coronado study management diabetes quality glucose control hospitalization admission day <NUMBER> attention good glucose control recently recommended <NUMBER> demonstrated large study <NUMBER> cases covid<NUMBER> <NUMBER> preexisting t<NUMBER>d <NUMBER> retrospective observational study china patients wellcontrolled blood glucose optimal target levels glycaemia <NUMBER> <NUMBER> nevertheless consensus maintaining blood glucose concentrations <NUMBER> mmoll diabetes patients hospitalized icus well covid<NUMBER> <NUMBER> however even impact glucose control hospitalization diabetes patients covid<NUMBER> yet prospectively investigated need diabetes care customized icus strongly suggested help healthcare providers already overwhelmed dramatic pandemic situation need support vital functions thereby potentially exposing patients diabetes poorer management specific disease <NUMBER> likewise also suggested individualized care strategies novel therapeutic regimens use modern diabetes technology might help reduce clinical inertia hampering proper diabetes management icus situation could lead poor glucose control potentially worse outcomes patients diabetes covid<NUMBER> infection <NUMBER> fact diabetes patients covid<NUMBER> control glucose levels situation variable often decreased food intakes also confronted severe infection generally accompanied fever cytokinemediated insulinresistant state addition already mentioned also possible sars coronavirus penetrate pancreatic islets damage beta cells thereby aggravating course diabetes triggering acute hyperglycaemia <NUMBER> thus covid<NUMBER> represents double threat patients diabetes difficulty controlling diabetes setting confirmed one hand rather large number ketoacidosis episodes already reported <NUMBER> hand episodes hypoglycaemia probably due unanticipated lack food two metabolic adverse events reported hospital admission coronado cohort <NUMBER> many patients diabetes treated raas blockers either antihypertensive agents nephroprotection coronado study <NUMBER> diabetes cohort received pharmacotherapy yet controversy literature possible negative neutral even positive impact raas blockers risk associated medications administered covid<NUMBER> patients <NUMBER> <NUMBER> <NUMBER> however coronado provided reassuring results raas blockers associated primary outcome according multivariable analysis <NUMBER> observations agreement results studies <NUMBER> <NUMBER> <NUMBER> support recommendation stop raas blockers diabetes patients possibly exposed sarscov<NUMBER> infection <NUMBER> also discussed authors negative impact diuretics reported study could attributed severe baseline condition patients suffering heart failure severe hypertension final question whether glucoselowering medications could differentially affect risk covid<NUMBER> infection severe outcomes <NUMBER> <NUMBER> although still many uncertainties seeking answers <NUMBER> similar concern discussed raas blockers raised use dpp<NUMBER> inhibitors <NUMBER> <NUMBER> although worse signs reported among <NUMBER> patients treated agents coronado cohort increased risk associated insulin probably due fact use pharmacotherapy reflects advanced diabetes disease patients often older frail <NUMBER> possible protective role metformin proposed based theoretical grounds pleiotropic effects compound yet investigated clinical practice <NUMBER> note coronado however fewer people died using metformin also hypothesized dapagliflozin available france recently prevent severe course covid<NUMBER> infection preventing lowering cytosolic ph reducing viral load <NUMBER> large international randomized controlled trial currently underway investigate potential role dapagliflozin diabetes nondiabetes patients covid<NUMBER> dapagliflozin respiratory failure patients covid<NUMBER> clinicaltrialsgov identifier nct<NUMBER> icus proper use insulin therapy without question mainstay therapy <NUMBER> nevertheless view major interest raised covid<NUMBER> diabetes population anticipated dedicated observational studies possibly randomized controlled trials designed near future investigate various positive andor negative influences available glucoselowering agents patients t<NUMBER>d exposed sarscov<NUMBER> coronavirus <NUMBER> frequent concurrence diabetes obesity may confound least complicate identification independent role either condition negative effects obesity severity covid<NUMBER> <NUMBER> need invasive mechanical ventilation <NUMBER> <NUMBER> already reported independently presence diabetes addition coronado study confirmed deleterious role obesity even overweight lifethreatening outcomes large diabetic mainly t<NUMBER>d population covid<NUMBER> <NUMBER> multivariate analyses bmi remained prognostic factor composite primary outcome negative impact obesity outcome largely driven effect tracheal intubation mechanical ventilation whereas effect mortality considerably lower death unequivocal outcome mechanical ventilation depends physicians decision patients acceptance remains unclear obesity aggravates covid<NUMBER> severity markedly increases need tracheal intubation mechanical ventilation <NUMBER> although several underlying mechanisms may considered obese patients impaired respiratory mechanics resulting combination poor respiratory muscle strength reduced lung volume increased airway resistance impaired gas exchange addition subtle yet complex interactions may arise adipose tissue immune system <NUMBER> <NUMBER> instance overexpression inflammatory adipokines visceral fat depots affect immune response impair chemotaxis alter macrophage differentiation <NUMBER> addition inflammatory response visceral also thoracic epicardial mediastinal fat deposits lead upregulation greater release inflammatory cytokines interleukin il<NUMBER> <NUMBER> suggested adipose tissue people obesity may act reservoir extensive viral spread increased shedding immune activation cytokine amplification <NUMBER> indeed even hypothesized excess fat might lead possible presence ectopic fat deposits alveolar interstitial space thereby directly exposing lungs viral infection turn could aggravate inflammatory infiltrate phenomenon could contribute massive oedema observed covid<NUMBER> patients require mechanical ventilation <NUMBER> moreover obesity associated increased risk comorbidities hypertension renal impairment obstructive sleep apnoea <NUMBER> nonalcoholic fatty liver disease nafld <NUMBER> conditions aggravate prognosis <NUMBER> particular interest coronado cohort obstructive sleep apnoea found independent risk factor early death also elevated levels aspartate transaminase ast previous history nafld associated primary outcome elevated ast levels noted admission may reflection liver cytolysis directly due sarscov<NUMBER> infection <NUMBER> related multipleorgan damage secondary hypoxia systemic cytokine storm andor haemodynamic shock <NUMBER> <NUMBER> fact ast elevation frequently observed severe forms covid<NUMBER> infection especially hospitalization <NUMBER> longitudinal retrospective cohort study <NUMBER> patients covid<NUMBER> china abnormal ast levels associated highest mortality risk compared indicators liver damage hr <NUMBER> ast levels <NUMBER> ul hr <NUMBER> ast <NUMBER> ul <NUMBER> metaanalysis <NUMBER> studies involving total <NUMBER> patients sarscov<NUMBER> infection ast <NUMBER> ul associated <NUMBER> criticalfatal covid<NUMBER> <NUMBER> findings coronado line observations taking bmi account even population diabetes might improve risk stratification thereby allowing effective selection diabetes patients likely require early hospital admission stricter safety measures minimize increased risk developing severe complications however studies reported bmi cutoff association greater risk severe complications related covid <NUMBER> coronado higher risk already observed overweight patients diabetes however increased risk primary outcome appeared less pronounced diabetes patients grade<NUMBER> obesity bmi ≥ <NUMBER> kgm² authors considered observation agreement socalled obesity paradox previously reported icus patients exposed severe respiratory distress syndromes nevertheless researchers french study reported higher risks bmi ≥ <NUMBER> kgm² <NUMBER> whereas one us study <NUMBER> reported even higher risk bmi ≥ <NUMBER> kgm² another large us study <NUMBER> cohorts covid<NUMBER> patients specifically focused diabetes fact suggested covid<NUMBER> may challenge obesity paradox <NUMBER> although data patients morbid obesity bmi ≥ <NUMBER> kgm² yet required support conclusion <NUMBER> thus clearly need evidence raise awareness bmi score considered cutoff increased risk severe illness result covid<NUMBER> <NUMBER> addition whether cutoff might differ patients without diabetes also requires investigation case given potentially critical role body weight fat mass determining severity pneumonia requiring respiratory assistance important systematically collect anthropometric information patients hospitalized covid<NUMBER> <NUMBER> one noteworthy suggestion obesity could shift severe covid<NUMBER> infections towards younger age groups <NUMBER> <NUMBER> indeed may speculated similar shift occurred patients diabetes coronado cohort onethird aged <NUMBER> years although direct comparison nondiabetes population remains mandatory confirm hypothesis ultimately obesity plays crucial role therapeutic actions targeting adipose tissue could help reduce burden covid<NUMBER> disease including large cohort patients t<NUMBER>d <NUMBER> likewise adipose tissue related obesity plays deleterious role excessive immune reaction inflammation diabetes patients obesity might benefit greater extent pharmacological therapy modulates cytokine activity especially il<NUMBER> andor complement system <NUMBER> tocilizumab proposed therapeutic option compassionate use patients covid<NUMBER> <NUMBER> recent observation found hyperglycaemia admission hospital stay associated higher il<NUMBER> levels reduced efficacy tocilizumab leading poorer outcomes covid<NUMBER> patients regardless presence known diabetes <NUMBER> however studies necessary confirm finding diabetes one important comorbidities linked severity infection sarscov<NUMBER> coronado study designed characterize phenotype patients diabetes hospitalized covid<NUMBER> determine prevalence need mechanical ventilation death identify prognostic factors associated poorer outcomes first largescale observational study undoubtedly provided major piece complex puzzle linking diabetes covid<NUMBER> infection prognostic factors identified focusing bmi relation need respiratory assistance presence previous diabetes complications associated risk death however answers still require analyses even larger cohorts especially order reassess influence previous glucose control based larger numbers hba<NUMBER>c measurements means final results coronado study awaited great interest addition impact glucose control hospitalization outcomes related covid<NUMBER>which investigated coronadois certainly deserving specific investigation moreover results certain pharmacological therapies currently investigation improve prognosis highrisk populations diabetes patients also likely available near future coronavirus disease <NUMBER> caused novel coronavirus sarscov<NUMBER> severe acute respiratory syndrome coronavirus <NUMBER> abruptly reached pandemic proportions sarscov<NUMBER> member betacoronavirus family well sarscov severe acute respiratory syndrome coronavirus merscov middle east respiratory syndromerelated coronavirus since beginning <NUMBER> number confirmed cases covid<NUMBER> dramatically increased worldwide leaping million march <NUMBER> <NUMBER> although majority covid<NUMBER> patients develop mild moderate clinical features <NUMBER> severe pneumonia acute respiratory distress syndrome ards multiorgan failure leading high death rate may develop notably marked sex differences emerged covid<NUMBER> prevalence prognosis particular agespecific risk disease reported significantly higher males females except age <NUMBER> years moreover agespecific risks death hospitalization least two fold higher males females among age ranges <NUMBER> furthermore patients advanced age underlying pathologies mainly hypertension diabetes cardiovascular disease cvd prone experience severe form disease <NUMBER> even though overall mortality considerably varies among countries fatalityrate age groups displays similar patterns rising consistently <NUMBER>year age group <NUMBER> importantly presence comorbidities increases mortality sample <NUMBER> patients died covid<NUMBER> italy prevalence diabetes <NUMBER> <NUMBER> differently covid<NUMBER> spread diabetes known boundaries number affected people reached nearly half billion worldwide <NUMBER> number deaths attributed diabetes complications around <NUMBER> million <NUMBER> <NUMBER> notably <NUMBER> diabetic patients <NUMBER> years old <NUMBER> thus although extremely different connotations covid<NUMBER> diabetes two pandemics share burden wide diffusion elderly population dramatic impact global mortality economic health resources short review focused open questions emerging effort fully understand link covid<NUMBER> diabetes mainly context possible harmful beneficial effects commonly used drugs patients diabetes course covid<NUMBER> infection diabetes reportedly major cause mortality morbidity worldwide conceivable link diabetes infectious diseases postulated particular lower respiratory tract infections known rather common severe elderly type <NUMBER> diabetes t<NUMBER>d <NUMBER> although evidence suggests diabetes unlikely significantly increase susceptibility sarscov<NUMBER> infection higher risk worse covid<NUMBER> progression outcomes observed <NUMBER> mechanisms underlying association completely clear yet exacerbated proinflammatory cascade impaired immune response diabetic patients covid<NUMBER> suspected crucially involved particular increased levels proinflammatory markers leukocyte neutrophil count procalcitonin creactive protein ferritin circulating cytokines trigger cytokine storm namely il<NUMBER> il<NUMBER> il<NUMBER> receptor tnfα detected diabetic patients severe covid<NUMBER> compared patients without diabetes <NUMBER> furthermore altered immune response diabetic patients possibly due impaired lymphocyte neutrophil monocytemacrophage function long hypothesised especially presence poorly controlled glycaemia <NUMBER> <NUMBER> higher concentrations ddimer fibrinogen hallmarks severe forms covid<NUMBER> also reported patients diabetes compared patients without diabetes suggesting patients might prone develop coagulation abnormalities course infection known significantly associated worse prognosis <NUMBER> <NUMBER> recent retrospective study involving chinese patients n <NUMBER> moderate severe critical disease major risk factors mortality poor outcomes evaluated among enrolled patients <NUMBER> n <NUMBER> diabetes including t<NUMBER>d type <NUMBER> diabetes gestational diabetes overall diabetes increased odds inhospital death poor prognosis diabetic patients older significant alterations several laboratory parameters associated poor prognosis compared patients without diabetes particular higher levels ddimer female diabetic patients increased ldh neutrophil count compared nondiabetic patients cvd common men diabetes nondiabetic men notably multivariable regression analysis insulin therapy independently associated poor prognosis creactive protein independent risk factor either mortality poor prognosis patients covid<NUMBER> diabetes <NUMBER> besides research also needed clarify whether hypoglycaemia might also contribute adverse outcomes increased mortality covid<NUMBER> patients diabetes <NUMBER> patients diabetes high prevalence high blood pressure increased risk cvd <NUMBER> hence treatment hypertension largely includes drug classes demonstrated reduce cardiovascular events angiotensinconverting enzyme ace inhibitors angiotensin receptor blockers arbs <NUMBER> since ace converts angiotensin angiotensin ii potent vasoconstrictor sodiumretentive agent blockage reninangiotensinaldosterone system raas leads effective reduction blood pressure ace shows homology angiotensinconverting enzyme <NUMBER> ace<NUMBER> receptor transmembrane spike glycoprotein surface sarscov sarscov<NUMBER> binds allowing internalization virus alveolar cells cell types <NUMBER> ace<NUMBER> clearly direct target ace inhibitors ubiquitous monocarboxypeptidase converts angiotensin ii antiinflammatory antifibrotic angiotensin<NUMBER> contrasting potent vasoconstrictor sodiumretentive proinflammatory profibrotic effects indeed angiotensin<NUMBER> binding mas receptor induces nitric oxide release protecting tissue injury <NUMBER> another known substrate ace<NUMBER> angiotensin converted angiotensin<NUMBER> <NUMBER> <NUMBER> latter turn converted angiotensin<NUMBER> ace therefore competing angiotensin ii binding <NUMBER> limited animal vitro studies reported upregulation ace<NUMBER> induced arbs far lesser extent ace inhibitors predominantly heart kidney effect partly explained increase local levels angiotensin ii induced arbs ace inhibitors <NUMBER> indeed arbs block angiotensin ii type <NUMBER> at<NUMBER> receptors consequently increase availability substrate angiotensin ii upregulates ace<NUMBER> <NUMBER> based assumption speculated treatment arbs ace inhibitors might favour entry sarscov<NUMBER> lung cells therefore increasing risk adverse outcomes severe forms covid<NUMBER> infection conversely beneficial effect background therapy arb course disease supposed two complex mechanisms might support hypothesis firstly angiotensin ii binding receptor at<NUMBER> might enhance shedding transmembrane ace<NUMBER> promoted adam<NUMBER> disintegrin metalloprotease therefore releasing soluble ace<NUMBER> locally soluble form ace<NUMBER> unable mediate sarscov<NUMBER> internalization longer annexed cell membrane <NUMBER> secondly upregulation ace<NUMBER> probably induced arbs might necessarily negative effects sarscov<NUMBER> internalization lung cells inevitably induces downregulation ace<NUMBER> increase substrate angiotensin ii potent vasoconstrictor proinflammatory agent might contribute exacerbation lung injury indeed animal models lung injury clear association activation angiotensin iiat<NUMBER> signalling severity lung damage observed detrimental effects cascade counterbalanced activation ace<NUMBER>angiotensin<NUMBER>mas receptor axis <NUMBER> specifically models sepsis acid aspiration frequently cause acute lung injury ards ace<NUMBER> knockout mice experienced severe tissue damage characterized marked inflammatory cell infiltration increased vascular permeability lung oedema bleeding compared wildtype mice similarly angiotensin ii type <NUMBER> at<NUMBER> receptors knockout mice marked lung damage models injection recombinant human ace<NUMBER> protein ace<NUMBER> knockout mice considerably decreased severity lung injury <NUMBER> line findings pretreatment recombinant human ace<NUMBER> able reduce inflammatory cell infiltration tissue injury mouse model respiratory syncytial virus infection <NUMBER> evidence clinical studies still rather limited patients ards recombinant human ace<NUMBER> increased angiotensin<NUMBER> decreased angiotensinii concentrations even though study prematurely discontinued lack clinical improvement <NUMBER> overall evidence animal models suggests conceivable pneumoprotective role ace<NUMBER> at<NUMBER> receptor context lung injury loss pulmonary ace<NUMBER> might therefore harmful effects exacerbating inflammation promoting respiratory distress fibrosis way activation ace angiotensin ii at<NUMBER> receptor axis might exert detrimental effects worsening lung damage rationale raas inhibition therefore counterbalancing effects reducing angiotensin ii increasing ace<NUMBER> notably arb ace inhibitors attenuated lpsinduced lung injury several preclinical studies <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> recently milne et al analysed gene expression ace<NUMBER> ace agtr<NUMBER> encoding at<NUMBER> tmprss<NUMBER> transmembrane protease serine <NUMBER> requested cofactor internalization sarscov<NUMBER> adam<NUMBER> large number healthy lung tissue samples collected patients undergoing lung resection cancer significant association use ace inhibitors reduced ace<NUMBER> gene expression observed differently use arbs linked relevant changes ace<NUMBER> expression significantly correlated increased ace decreased agtr<NUMBER> expression <NUMBER> although findings quite contrast data animal studies highlighted gene expression rather protein concentration analysed collected tissue samples exhibit lung injury ards covid<NUMBER> results severe lung damage imbalance raas system context cannot excluded recently pilot study covid<NUMBER> patients found higher levels circulating angiotensin ii compared healthy subjects correlation angiotensin ii concentration severity disease observed well <NUMBER> thus effects ace inhibitors arbs might different extremely damaged context therefore explored animal models covid<NUMBER> mounting evidence recent clinical studies suggests raas inhibitor use related increased risk covid<NUMBER> infection poor outcomes retrospective cohort study <NUMBER> patients screened covid<NUMBER> test positivity significantly associated ace inhibitor arb therapy <NUMBER> similarly us study relationship emerged prior ace inhibitor arb use increased likelihood positive sarscov<NUMBER> test result adjusting relevant confounding factors <NUMBER> italian communitybased casecontrol study association found ace inhibitor arb treatment covid<NUMBER> infection although use drugs rather frequent due high prevalence cvd <NUMBER> overall findings excluded increased risk covid<NUMBER> infection patients already treated raas inhibitors studies evaluated link covid<NUMBER> progression raas inhibitor therapy recent korean populationbased cohort study involving <NUMBER> covid<NUMBER> patients use ace inhibitors arbs associated higher mortality risk adjustment confounders <NUMBER> recent systematic review including total n <NUMBER> covid<NUMBER> patients different countries ace inhibitor arb use associated increased severity covid<NUMBER> illness <NUMBER> interestingly metaanalysis <NUMBER> covid<NUMBER> patients seven cohort studies five casecontrol studies use raas inhibitors linked higher risk covid<NUMBER> infection severity mortality whereas mortality risk significantly lower patients treated ace inhibitors arbs compared treated antihypertensive drugs <NUMBER> taking together data observational studies indicates raas inhibitor therapy unlikely negative impact course infection however whether patients covid<NUMBER> might take advantage initiating drugs terms disease progression outcomes explored clinical trials still ongoing cvd wellknown major complications diabetes risk developing cvd <NUMBER>to fivefold higher patients t<NUMBER>d nondiabetic patients mainly due diabetesrelated coronary atherosclerosis <NUMBER> addition diabetic cardiomyopathy may occur independently coronary artery disease likely developing helper <NUMBER> driven responses within cardiomyocyte <NUMBER> <NUMBER> besides common clinical features covid<NUMBER> cardiovascular damage may occur nearly <NUMBER> patients <NUMBER> cause major concern due high related mortality mechanisms underlying complication largely unknown direct viral damage destabilization coronary plaques reportedly suspected play consistent role notably sample <NUMBER> patients covid<NUMBER> guo et al observed presence background coronary heart disease cardiomyopathy associated frequent occurrence myocardial damage highlighted marked increase serum troponin course disease <NUMBER> accordingly mortality considerably higher among patients myocardial injury concomitant cvd <NUMBER> patients without cvd <NUMBER> remarkably considerable percentage patients displaying myocardial injury diabetes <NUMBER> compared patients without myocardial injury <NUMBER> myocardial injury may therefore contribute poorer outcomes observed diabetic patients covid<NUMBER> <NUMBER> note patients myocardial injury prone develop malignant arrhythmias ards coagulopathy acute kidney injury explained high mortality <NUMBER> importantly ace inhibitors arbs broadly used patients myocardial injury mortality significantly differ treated nontreated patients although consistent evidence excluding harms suggesting benefits raas inhibitors covid<NUMBER> patients hearth injury lacking arbs able increase ace<NUMBER> expression hearts animal models arterial hypertension <NUMBER> even pathological context possible effects drugs elucidated downregulation ace<NUMBER> cardiomyocytes blood vessels induced sarscov<NUMBER> internalization might exacerbate myocardial injury endothelial dysfunction compromising heart function patients diabetes underlying cvd <NUMBER> <NUMBER> addition patients t<NUMBER>d high rate lipid alterations statins first line therapy dyslipidaemia remarkably evidence preclinical studies suggests statins might modulate ace<NUMBER> expression several tissues including heart observed atorvastatin increased ace<NUMBER> protein expression heart kidney rabbits atherosclerosis <NUMBER> another study diabetic rats displayed significantly lower expression ace<NUMBER> impaired systolic diastolic function compared control rats combined treatment insulin fluvastatin associated higher levels ace<NUMBER> compared nontreated diabetic rats <NUMBER> ace<NUMBER> multisubstrate enzyme targeted several molecules although extremely limited evidence animal studies peroxisome proliferatoractivated receptor gamma pparγ agonists insulinsensitizer drugs treatment type <NUMBER> diabetes t<NUMBER>d might increase expression ace<NUMBER> different tissues animal model hypertension insulinsensitizer rosiglitazone modulated ace<NUMBER>angiotensin<NUMBER>angiotensin ii axis aortic tissue lowered blood pressure increasing expression ace<NUMBER> <NUMBER> similarly high fat diet fed rats animal model obesity pioglitazone increased expression ace<NUMBER> insulinsensitive tissues liver adipose tissue skeletal muscle likely modulation reninangiotensin system <NUMBER> ace<NUMBER> widely distributed human tissues remarkably expression found even lower lung sites <NUMBER> hence mediators thought play role facilitating sarscov<NUMBER> infection priming serine protease tmprss<NUMBER> requested binding ace<NUMBER> internalization sarscov<NUMBER> tmprss<NUMBER> cleaves protein s<NUMBER> s<NUMBER> subunits necessary step membrane fusion viral internalization contextually drags ace<NUMBER> alveolar cells <NUMBER> light antibodies targeting sprotein tmprss<NUMBER> inhibitors might prevent sarscov<NUMBER> entry lung cell <NUMBER> individuating possible candidate coreceptors therefore great importance development new therapeutic strategies contrast infection dpp<NUMBER> ubiquitously expressed cell surface exopeptidase important metabolic functions mainly regulates bioactivity gutderived hormones glucagonlike peptide<NUMBER> glp<NUMBER> glucosedependent insulinotropic polypeptide gip stimulate insulin secretion response oral glucose administration known incretin effect <NUMBER> dpp<NUMBER> inhibitors dpp<NUMBER>i commonly used drugs treatment t<NUMBER>d prevent degradation incretins inhibiting catalytic activity dpp<NUMBER> result ßcell insulin secretion potentiated glycaemia significantly reduced independently catalytic function dpp<NUMBER> displays inflammatory immune functions <NUMBER> indeed expressed mainly tlymphocytes involved activation proliferation <NUMBER> interestingly proinflammatory factors significantly increase dpp<NUMBER> expression circulating immune cells <NUMBER> unlike sarscov sarscov<NUMBER> binds ace<NUMBER> entry lung cells dpp<NUMBER> functional receptor merscov <NUMBER> hence several mouse human monoclonal antibodies preventing protein binding dpp<NUMBER> given promising results treatment mers <NUMBER> note recently reported dpp<NUMBER> shares patterns expression ace<NUMBER> lung precisely alveolar type <NUMBER> cells main target sarscov<NUMBER> <NUMBER> vankadari et al recently set docking model dpp<NUMBER> sarscov<NUMBER> spike glycoprotein <NUMBER> predicted several dpp<NUMBER> residues might involved interaction sarscov<NUMBER> s<NUMBER> domain spike protein also targeted coronaviruses enter host cells functional receptor dpp<NUMBER> however validation needed draw conclusions establish whether possible adhesion dpp<NUMBER> spike protein may play role sarscov<NUMBER> infection consequently important issues addressed claiming possible beneficial effects dpp<NUMBER> modulation covid <NUMBER> <NUMBER> according data chen et al patients diabetes moderatesevere covid<NUMBER> use dpp<NUMBER>i significantly impact mortality clinical outcomes <NUMBER> presence diabetes considerably influences course covid<NUMBER> infection risk factor poor outcomes limited preclinical studies ace<NUMBER> expression found modulated several players different tissues largely employed treatment diabetes antihypertensive considerably lesser extent insulinsensitizers statins light potential harmful protective effects treatments covid<NUMBER> infection might interesting soil research date data supporting drugs clearly interfere sarscov<NUMBER> access lung cells tissues completely lacking stressed absence evidence consistent clinical studies discontinuation adoption therapies attempt influence course infection strongly discouraged coronavirus disease <NUMBER> covid<NUMBER> caused severe acute respiratory syndrome coronavirus <NUMBER> emerged rapidly spreading communicable disease affecting individuals worldwide march <NUMBER> <NUMBER> <NUMBER> confirmed cases <NUMBER> china <NUMBER> outside china covid<NUMBER> led <NUMBER> deaths globally <NUMBER> posed serious threat human safety population generally susceptible coronavirus especially diabetes vulnerable disease <NUMBER> several published studies reported <NUMBER> <NUMBER> covid<NUMBER> patients comorbid diabetes <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> report <NUMBER> patients covid<NUMBER> published chinese center disease control prevention found increased mortality people diabetes <NUMBER> overall <NUMBER> patients diabetes <NUMBER> addition zhous research results also revealed risk inhospital death <NUMBER> times higher patients diabetes without diabetes <NUMBER> obviously presence diabetes associated increased mortality therefore blood glucose management diabetic patients plays important role reducing mortality case presentation describes successful experience blood glucose management severe covid<NUMBER> patient diabetes <NUMBER>yearold woman covid<NUMBER> admitted hospital february <NUMBER> <NUMBER> due productive coughing <NUMBER> days without obvious cause severe acute respiratory syndrome coronavirus <NUMBER> rna test positive chest computerized tomography scan revealed lungs multilobe patchy density increased shadow infectious lesions suspicious viral pneumonia lung involvement pneumonectasis heart enlarged predominantly left ventricle aorta hardened mediastinal lymph nodes enlarged physical examination admission revealed body temperature <NUMBER>°c pulse <NUMBER> beats per minute respiratory rate <NUMBER> breaths per minute blood pressure <NUMBER> mm hg arterial oxygen saturation <NUMBER> oxygen <NUMBER> lmin breath sounds lungs thick wet rales initial laboratory tests showed white blood cell count <NUMBER> â <NUMBER> <NUMBER> l neutrophil ratio <NUMBER> lymphocyte ratio <NUMBER> urine sugar acetone bodies diagnosed covid<NUMBER> severe infection type <NUMBER> diabetes lopinavir ritonavir given orally antiviral therapy well interferon alpha inhalation second day admission biochemical test revealed multiple abnormal results blood glucose <NUMBER> mmoll interleukin<NUMBER> <NUMBER> pgml erythrocyte sedimentation rate <NUMBER> mmh etc results blood gas analysis indicated partial pressure oxygen <NUMBER> mm hg oxygen <NUMBER> lmin oxygenation index less <NUMBER> mm hg therefore transferred intensive care unit february <NUMBER> <NUMBER> diagnosis covid<NUMBER> critical infection type <NUMBER> diabetes highflow oxygen therapy given mechanical ventilation second day intensive care unit admission patients vital signs relatively stable except abnormal postprandial blood glucose <NUMBER> mmoll <NUMBER> peripheral blood glucose level <NUMBER> mmoll <NUMBER> insulin <NUMBER> ml saline insulin <NUMBER> iu used control blood glucose transfusion speed adjusted according level peripheral blood glucose based patients disease situation implemented comprehensive measures control blood glucose actively treating covid<NUMBER> infection first established multidisciplinary team including specialists critical care respiratory endocrinology nursing discussed treatment care plans daily basis given postprandial nocturnal blood glucose patient relatively high oral hypoglycemic agents could effective controlling patients blood glucose therefore insulin used patient based current blood glucose condition endocrine experts recommended predinner subcutaneous injection <NUMBER> <NUMBER> iu insulin hspart <NUMBER> <NUMBER> iu insulin glargine injection sleeping dose insulin adjusted daily according patients blood glucose maintain fasting glucose level <NUMBER> <NUMBER> mmoll postprandial blood glucose level <NUMBER> <NUMBER> mmoll second individualized diabetic diet plan formulated patient dietitians endocrinologists degrade blood glucose fluctuation caused food third medical staff tailored early activity plan patient mainly included following <NUMBER> aspects body position management nurses assisted patient changing body position sitting bed sitting beside bed standing ground postural training lasted <NUMBER> minutes per session <NUMBER> times day within patients tolerance b activity management hospitalization conducted early activities patient included passive movement active motion total training time less <NUMBER> minutes per session limited causing aggravating fatigue c respiratory management vibration sputum apparatus used promote sputum discharge addition abdominal breathing blowing balloons also performed exercise patients breathing function fourth patient assisted maintaining good mental health patients psychological status evaluated root psychological problems identified communication patient b patient assisted establishing social support system following methods strengthened contact patient family members wechat telephone etc encourage addition college students medical university encouraged write letters containing blessings encouragement patient could feel care society addition wechat group patients needed mutual assistance set managed specialized medical staff could solve problems patients faced timely manner patients could share successful experiences well c virtual reality technology applied made full use immersive interactive imaginative virtual reality technology put patient virtual environment eliminate negative emotions patients attention diverted ipad small stereo used play videos soothing music patient liked help recall good memories illness reduce time spent immersed thoughts ward illness relieve anxiety depression fifth monitored blood glucose changes closely according <NUMBER> time points <NUMBER> hours <NUMBER> meals sleep night designed blood glucose monitoring form record results measurement told patient specific blood glucose value every time aiming remind pay attention implementing comprehensive measures mentioned without adverse unanticipated events patients blood glucose gradually became stable fig <NUMBER> discharged hospital march <NUMBER> <NUMBER> <NUMBER> consecutive negative nucleic acid tests novel coronavirus normal blood glucose levels achieving satisfactory condition patient discharged hospital followed professional medical staff monitor blood glucose fluctuations covid<NUMBER> related condition telemedicine wechat used remote guidance ethics committee affiliated hospital zunyi medical university guizou china approved study protocol informed consent obtained patient publication case report knowledge first report share experience blood glucose management severe covid<NUMBER> patient diabetes patient recovered discharged <NUMBER> days hospitalization comprehensive treatment nursing measures data covid<NUMBER> patients diabetes limited present kulcsars research revealed diabetes associated greater weight loss greater pulmonary inflammation <NUMBER> another study published chinese center disease control prevention also showed overall mortality covid<NUMBER> patients <NUMBER> number <NUMBER> patients diabetes <NUMBER> obvious diabetics higher risk lung infection death counterparts meanwhile blood glucose control covid<NUMBER> patients diabetes difficult stress anxiety condition <NUMBER> <NUMBER> pancreatic tissue potential target virus <NUMBER> inability quarantined patients perform exercise due space constraints poor pulmonology condition <NUMBER> therefore great attention paid controlling patients blood glucose levels reduce complications mortality caused diabetes patient established multidisciplinary team closely monitored blood glucose level formulated series measures including individualized diabetes diet early activities psychological care etc obviously measures undertaken resulted desired effects process treating caring covid<NUMBER> patients diabetes necessary pay attention following issues first patients blood glucose fluctuates greatly recommended report endocrinologist injecting insulin determine whether insulin dose needs adjusted second diabetes diets different patients daily eating habits therefore extremely important perform good health education obtain patients support cooperation order enhance compliance third early activities carried step step according patients individual situations implemented ensuring patient safety fourth regard psychological care important understand patients family backgrounds educational levels hobbies information knowing patients basic information medical staff implement individualized targeted psychological care case showed comprehensive measures performed multidisciplinary team achieved good treatment effects covid<NUMBER> patient diabetes targeted treatment nursing methods performed based patients actual situations clinical practice weve affected covid<NUMBER> pandemic closely tragically readers lost family members friends colleagues give heartfelt condolences death statistic loss much loved valued person us experience emotional effects modern plague nations attempts fight spare thought people past epidemics plague epidemics england <NUMBER>th century local constable would padlock door house someone died plague living inhabitants inside red cross lord mercy upon us written door house guarded watchmen make sure noone left entered <NUMBER> united nations pointed although covid<NUMBER> crisis first instance physical health crisis seeds major mental health crisis well action taken <NUMBER> early uk covid<NUMBER> outbreak uk government warned people diabetes among others clinically vulnerable meaning higher risk severe illness coronavirus take particular care minimise contact others outside household classed extremely vulnerable <NUMBER> <NUMBER> march <NUMBER> may <NUMBER> onethird people covid<NUMBER> died hospital england diabetes adjusting confounders odds dying hospital covid<NUMBER> people diabetes compared people without diabetes <NUMBER> type <NUMBER> diabetes <NUMBER> type <NUMBER> diabetes <NUMBER> overall deaths people diabetes england doubled covid<NUMBER> epidemic hyperglycaemia obesity type <NUMBER> type <NUMBER> diabetes independently associated increased covid<NUMBER> mortality <NUMBER> news rightly received widespread publicity causing understandable fear anxiety among people diabetes especially time uk lockdown gradually easing gps diabetes teams much help reduce patients risk factors provide support important governments actors communicate covid<NUMBER> ways promote mental health psychosocial wellbeing… communication communicated empathy include advice emotional wellbeing undue anxiety caused inconsistent incomprehensible threatening communication needs avoided <NUMBER> vital public information accurate top <NUMBER> viewed youtube videos coronavirus covid<NUMBER> analysed <NUMBER> views nonfactual information found <NUMBER> videos totalling <NUMBER> views government professional videos highquality factual information accounted <NUMBER> videos <NUMBER> views extremely worrying far people viewed nonfactual fake information accessed correct information covid<NUMBER> <NUMBER> laura <NUMBER> type <NUMBER> diabetes works ambulance technician laura partner police officer developed covid<NUMBER> worst days found limiting news channel hour day focusing positive things helped lower stress levels painting reading gardening im mental health important even unprecedented time cant begin tell inspired motivated diabetic community especially seeing type <NUMBER> key workers frontliners showing strength unity right im feeling positive looking forward returning job frontline… dont know whether type <NUMBER> diabetes experienced worse symptoms partner did… needless say type <NUMBER> diabetic testing positive covid<NUMBER> scary emotional pill swallow took day day keep fit healthy believe helped recover well <NUMBER> studies psychological effects natural disasters epidemics people diabetes people diabetes already risk psychological problems people severe mental health disease likely diabetes general population us metaanalysis found diabetes doubled risk depression compared general population <NUMBER> anxiety also common among diabetes one systematic review <NUMBER> people diabetes generalised anxiety disorder <NUMBER> elevated symptoms anxiety <NUMBER> common factor disasters epidemics major disruption covid<NUMBER> pandemic people confined home unable visit relatives working differently supplies disrupted health care arrangements changed paused international travel virtually ceased people diabetes worrying getting right food insulin supplies accessing usual diabetes services cessation care home example foot care may sought medical help needed elderly acquaintance cancelled important hospital appointment convinced would catch coronavirus hospital staff others dont want trouble busy nhs noncovid<NUMBER> deaths pandemic appear increased <NUMBER> several studies shown glycaemic control worsens people diabetes affected natural disasters example flooding <NUMBER> hurricane katrina struck new orleans surrounding area <NUMBER> affecting million people subsequent weeks following hurricane financial loss loss personal belongings occasionally bereavement led severe depression impacting diabetes many patients <NUMBER> great east japan earthquake followed tsunami caused fukushima daiichi nuclear accident <NUMBER> people died hundreds thousands displaced homes <NUMBER> rikuzentakata hospital washed away later <NUMBER> people diabetes returned seen makeshift clinic glycaemic bp controls <NUMBER> tsunamiaffected patients worsened <NUMBER> affected earthquake alone <NUMBER> worsening glycaemic control survivors japanese earthquake significantly associated psychological stresses stressrelated somatic symptoms sleep disturbances anxiety social dysfunction adjustment confounding factors <NUMBER> general population pandemic united nations states good mental health critical countrys response recovery covid<NUMBER> risk psychological problems health care workers older people young people preexisting mental health conditions conflict situations <NUMBER> among young people adolescents stress social isolation may affect brain health development uk survey covid<NUMBER> pandemic found <NUMBER> <NUMBER> young people history mental health needs felt mental health worse quarter longer able access usual mental health support plans cancelled means nothing look ahead find trapped void thoughts eating disorder brought many urges relapse take control <NUMBER> diabetes common older people social isolation reduced intellectual stimulation reduced physical activity increase risk cognitive decline dementia older people one us analysis concluded found social disconnectedness predicted higher amounts perceived isolation turn predicted higher amounts depression anxiety symptoms reverse direction depression anxiety symptoms predicted higher amounts perceived isolation turn predicted higher amounts social disconnectedness <NUMBER> many supporting resources covid<NUMBER> pandemic online many older people proficient nursing journal commented is… need recognise older people previously reported socially isolated lonely may disproportionately affected requirements social isolation due covid<NUMBER> removal social contacts may occurred grocery shopping attending community groups places worship daytoday activities <NUMBER> around world millions experiencing various degrees lockdown quarantine recent rapid review psychological impact quarantine included <NUMBER>st century outbreaks coronavirus infections severe acute respiratory syndrome sars middle east respiratory syndrome mers influenza virus h<NUMBER>n<NUMBER> ebola combined reports described emotional disturbance low mood <NUMBER> depression irritability <NUMBER> stress insomnia emotional exhaustion isolation <NUMBER> frightened <NUMBER> nervous <NUMBER> sad <NUMBER> felt guilty surprisingly <NUMBER> happy <NUMBER> relieved reported confusion <NUMBER> among <NUMBER> people quarantined toronto sars outbreak <NUMBER> posttraumatic stress disorder ptsd <NUMBER> depressed longer quarantine likely people ptsd knowing exposed someone sars increased likelihood ptsd depression <NUMBER> korean mers epidemic <NUMBER> general public reported fear infected <NUMBER> reported emotional distress risk factors associated increased rates fear were… concern public transportation use difficulty going outside perception state protecting people helplessness situations cannot controlled fear infection among <NUMBER> people quarantined contact mers <NUMBER> mers refused participate <NUMBER> individuals <NUMBER> showed strong refusal participate study profanity ranting mers patients mostly isolated hospital third caught infection hospital less access food water bathing selfcare products isolated infected isolation among mers patients symptoms anxiety experienced <NUMBER> compared <NUMBER> noninfected people anger reported <NUMBER> <NUMBER> respectively four six months isolation ended anxiety occurred among mers patients <NUMBER> compared <NUMBER> among noninfected people anger <NUMBER> <NUMBER> respectively <NUMBER> chinese study <NUMBER> health care staff <NUMBER> hospitals covid<NUMBER> pandemic <NUMBER> depression <NUMBER> anxiety <NUMBER> insomnia <NUMBER> distress <NUMBER> staff working wuhan severe psychological symptoms staff directly engaged diagnosis treatment care patients covid<NUMBER> <NUMBER> fight <NUMBER> novel coronavirus <NUMBER>ncov medical workers wuhan facing enormous pressure including high risk infection inadequate protection contamination overwork frustration discrimination isolation patients negative emotions lack contact families exhaustion severe situation causing mental health problems stress anxiety depressive symptoms insomnia denial anger fear mental health problems affect medical workers attention understanding decision making ability might hinder fight <NUMBER>ncov could also lasting effect overall wellbeing chinese authorities set psychological support measures medical workers wuhan <NUMBER> among beijing hospital staff sars work exposure quarantining outbreak relative friend got sars strongly associated high pts symptom levels among group high pts symptoms nearly onehalf <NUMBER> worked locations staff high levels exposure sars patients less onequarter low pts symptoms <NUMBER> worked areas staff sense altruism towards health care work less likely pts pts symptoms persisted three years <NUMBER> affected staff <NUMBER> among hospital staff taiwan hospital <NUMBER> developed acute stress disorder likely quarantined potential sars contacts nonquarantined staff outbreak <NUMBER> staff felt stigmatised rejected neighbourhood <NUMBER> want work thought resigning <NUMBER> singapore among health care workers caring covid<NUMBER> patients <NUMBER> anxiety <NUMBER> depression <NUMBER> stress <NUMBER> ptsd surprisingly anxiety greater among nonmedical health care workers <NUMBER> medical staff <NUMBER> adjusting confounders <NUMBER> china health care staff sent help colleagues wuhan hubei study compared frontline nurses caring covid<NUMBER> patients nonfrontline nurses members general public vicarious traumatisation scores frontline nurses lower nonfrontline staff similar general public <NUMBER> despite tragedies challenges surround us british sense humour still alive john pritchard essex wrote becoming fed fed <NUMBER> uk lockdown started easing opinions lifestyle survey found worry covid<NUMBER> fallen <NUMBER> previous week <NUMBER> wellbeing issues <NUMBER> <NUMBER> included worry future stress anxiety half boredom inability make plans affected <NUMBER> nearly <NUMBER> <NUMBER> <NUMBER> adults believed britain somewhat kind coronavirus pandemic larger proportion <NUMBER> <NUMBER> <NUMBER> said britain would kind recovered coronavirus pandemic <NUMBER> affected way ongoing covid<NUMBER> pandemic pandemics natural disasters inevitably psychological effects may profound longlasting people risk psychological problems include health care staff older people adolescents young people preexisting mental health conditions conflict situations deaths people diabetes doubled covid<NUMBER> outbreak people diabetes twice risk death covid<NUMBER> compared general population people diabetes risk frightened need good access usual diabetes care services provide education help improve risk factors give psychological support depression anxiety common among people diabetes combined reports effects quarantine sars mers ebola epidemics describe emotional disturbance depression irritability stress insomnia emotional exhaustion patient diabetes coping emotionally pandemic colleagues coping <NUMBER> december <NUMBER> world health organisation informed cluster cases pneumonia unknown aetiology wuhan city hubei province china <NUMBER> january <NUMBER> announced novel coronavirus identified <NUMBER> coronaviruses large family viruses although responsible mild disease common cold also responsible severe disease outbreaks severe acute respiratory syndrome sarscov <NUMBER> middle east respiratory syndrome merscov <NUMBER> <NUMBER> declared outbreak public health emergency international concern named syndrome caused novel coronavirus covid<NUMBER> coronavirus disease <NUMBER> associated severe acute respiratory syndrome sarscov<NUMBER> <NUMBER> clinical spectrum covid<NUMBER> infection appears remarkably heterogeneous ranging mild symptoms multiorgan failure death perception people diabetes higher risk infection severe disease covid<NUMBER> <NUMBER> people type <NUMBER> diabetes glucose values close target may greater risk developing sarscov<NUMBER> <NUMBER> similarly evidence accumulates many people infected covid<NUMBER> remain asymptomatic <NUMBER> remains uncertain exactly additional risk preexisting diabetes poses although risk contracting covid<NUMBER> may greater viral infections cause severe symptoms complications people diabetes <NUMBER> also noted number people diabetes increased risk due concomitant immunosuppression following solid organ transplantation <NUMBER> early reports wuhan province revealed diabetes mellitus overrepresented among severely ill patients covid<NUMBER> <NUMBER> <NUMBER> finding keeping analysis people hospitalised sarscov even transient hyperglycaemia associated increased mortality <NUMBER> diabetes also identified one common comorbidities case series <NUMBER> patients new york city area requiring hospitalisation sarscov<NUMBER> <NUMBER> proposed mechanisms explain observed association diabetes sarscov<NUMBER> include chronic inflammation impaired immune response increased coagulation activity direct pancreatic islet cell injury <NUMBER> wellcontrolled diabetes associated better outcomes poorly controlled diabetes <NUMBER> even shortterm hyperglycaemia stun innate immune system <NUMBER> emerging evidence suggests context covid<NUMBER> acute hyperglycaemia may greater risk factor adverse outcomes diagnosis diabetes <NUMBER> sarscov<NUMBER> pandemic highlights importance understanding shared disease pathophysiology particularly might inform therapeutic choices people diabetes emerging data suggests sarscov<NUMBER> also common patients hypertension cardiovascular disease although prevalence rate varied different studies well globally <NUMBER> obesity also risk factor severe covid<NUMBER>related illness <NUMBER> metaanalysis eight studies n <NUMBER> odds ratio severe sarscov<NUMBER> significantly higher patients diabetes unlike hypertension cardiovascular disease <NUMBER> may therefore appropriate say complications comorbidities linked diabetes associated higher mortality rate presence diabetes per se <NUMBER> apparent association worse outcomes might also reflect higher prevalence type <NUMBER> diabetes older people <NUMBER> angiotensinconverting enzyme <NUMBER> ace<NUMBER> established sarscov receptor conflicting data translational relevance <NUMBER> role ace<NUMBER> explaining association cardiovascular disease diabetes sarscov<NUMBER> suggested ace<NUMBER> expression reduced people diabetes possibly result glycosylation expression increased patients taking ace inhibitors angiotensin receptor blockers <NUMBER> speculation around possible adverse protective effects proven helpful people prescribed ace inhibitor drugs angiotensin receptor blockers advised continue taking <NUMBER> membraneassociated dipeptidyl peptidase <NUMBER> dpp<NUMBER> also functions coronavirus receptor <NUMBER> currently evidence support clinically meaningful effects immune function dpp<NUMBER> inhibition <NUMBER> acute viral infection previously linked rapid development transient insulin resistance <NUMBER> infection covid<NUMBER> also generally associated increased insulin requirement <NUMBER> many unanswered questions regarding course clinical recovery following sarscov<NUMBER> interest diabetes appears associated increased time viral clearance <NUMBER> covid<NUMBER> also impact health people diabetes infected virus find clinical care compromised service disruption clinical teams challenged fulfil general responsibilities prioritise acute care relation covid<NUMBER> whilst ensuring essential diabetes care continues <NUMBER> people diabetes continue require emergency admissions medical management specialists important role play expediting treatment minimising length stay <NUMBER> many inpatient diabetes services looked increase capacity recognition reported association diabetes hospitalisation covid<NUMBER> infection mitigate impact potentially reduced workforce direction given minimise outpatient attendances movement towards virtual consultations including support recently discharged hospital reduce risk readmission community services underestimate importance contributions maintaining diabetes care triaging clinic lists supports identification patients might still require facetoface review specialist teams also acknowledge clinic postponement equate cancellation proportion cases traditional reliance biochemical parameters inform management decisions diabetes mean access phlebotomy services must also considered useful information cannot obtained shared data <NUMBER> secondary care services may need continue close full capacity include multidisciplinary diabetic foot services pregnancy diabetes services international working group diabetic foot looked remind clinicians patients diabetic foot disease need hospitalised <NUMBER> inpatient teams also ensure acute foot infection missed nonspecific symptoms attributed sarscov<NUMBER> precautionary identification pregnant women higher risk severe covid<NUMBER>related illness led rapid implementation remote antenatal care including diabetes management modifications also made screening pathway gestational diabetes <NUMBER> national locally driven crisis management plans must look manage anxiety health clinical staff people care also around redeployment service reconfiguration redeployment new ways working inevitably impact education training healthcare providers diabetes management alternative approaches need adopted longerterm healthcare impact social lockdown may apparent time short term interruption daily activities including diet exercise may significant impact glucose control may anxiety sleep disturbance structured diabetes education recommended national institute health care excellence nice since <NUMBER> <NUMBER> much delivered group education suspended may able restart time technology companies quick reassure users around supply chains <NUMBER> centres diabetes technology supplies traditionally delivered clinical site rather directly users recognise additional risk carries companies agreed extend warranties insulin pumps also offered remote pump upgrade services appropriate initial insights suggested covid<NUMBER> infection increased risk emergency states hyperglycaemia ketones diabetic ketoacidosis dka hyperosmolar hyperglycaemic state <NUMBER> atypical presentations challenged inpatient diabetes teams led anxiety around prescription sodiumglucose cotransporter <NUMBER> sglt<NUMBER> inhibitors remains important people type <NUMBER> type <NUMBER> diabetes follow sick day rules become unwell illness sglt<NUMBER> inhibitors significant cardiovascular renal benefits people type <NUMBER> diabetes associated small increased risk ketoacidosis date anecdotal reports ketoacidosis patients sarscov<NUMBER> taking sglt<NUMBER> inhibitors suspended acute medical admission vomiting dehydration <NUMBER> metformin also used caution unwell patients interestingly metformin proposed immunomodulatory actions <NUMBER> glucagonlike peptide <NUMBER> glp<NUMBER> receptor agonists also exert antiinflammatory actions may even attenuate pulmonary inflammation <NUMBER> although shortterm safety glp<NUMBER> agonists demonstrated critically unwell patients <NUMBER> still insufficient experience make recommendations around use patients sarscov<NUMBER> perhaps exception sglt<NUMBER> inhibitors patients mild covid<NUMBER> symptoms normal oral intake continue usual antihyperglycaemic medications review glucoselowering medications carefully considered given possible implications increased glycaemic variability <NUMBER> insulin used extensively management hyperglycaemia critically ill patients <NUMBER> insulin also exerts antiinflammatory actions <NUMBER> challenges fluid replacement dka due concerns acute respiratory distress syndrome availability infusion pumps intravenous insulin administration also reported <NUMBER> subcutaneous insulin regimes may prove helpful management hyperglycaemia tissue perfusion compromised analysis capillary blood glucose tests patients sarscov<NUMBER> admitted medical centre wuhan suggested suboptimal adherence current best practice management hyperglycaemia <NUMBER> perhaps surprising given pressure healthcare systems increased exposure healthcare staff associated frequent capillary blood glucose monitoring adjustment insulin infusions emerging evidence suggests good glycaemic control associated improved outcomes patients hospitalised sarscov<NUMBER> <NUMBER> automated closedloop insulindelivery systems proven safe effective noncritical care environments <NUMBER> feasibility fully automated closedloop glucose control also studied critical illness <NUMBER> may option finding patients admitted sarscov<NUMBER> often developed acute hyperglycaemia following hospitalisation suggests opportunity exists interventional glycaemic management <NUMBER> prevalence diabetes stress hyperglycaemia people hospitalised covid<NUMBER> infection recognition improved glycaemic control might improve outcomes reduce length stay patients sarscov<NUMBER> underlined importance specialist inpatient diabetes teams acute care current pandemic also highlighted opportunities continuing expanding innovations delivery diabetes care virtual consultations healthcare providers people diabetes use diabetes technology <NUMBER> crisis management created unprecedented interest remote care patients providers removed many longstanding regulatory barriers us food drug administration also allowed use personal blood glucose meters continuous glucose monitoring devices hospital duration pandemic <NUMBER> <NUMBER> virtual consultations might also support people diabetes seen right person right time instead waiting months routine clinic appointments might physician specialist nursediabetes educator dietician clinical psychologist <NUMBER> group facetoface structured diabetes education may possible time opportunities pilot alternative forms delivery patientled remote models structured diabetes education reported improve uptake clinical outcomes digital version desmond evidencebased type <NUMBER> diabetes structured education programme made free everyone type <NUMBER> diabetes uk april <NUMBER> <NUMBER> bertie online offers fully remote diabetes structured education people type <NUMBER> diabetes <NUMBER> enforced service redesign pandemic also enable innovations diabetes care might become apparent coming months article based previously conducted studies contain studies human participants animals performed authors funding funding sponsorship received publication article authorship named authors meet international committee medical journal editors icmje criteria authorship article take responsibility integrity work whole given approval version published disclosures jonathan schofield member journals editorial board lalantha leelarathna hood thabit nothing disclose compliance ethics guidelines article based previously conducted studies contain studies human participants animals performed authors open access article licensed creative commons attributionnoncommercial <NUMBER> international license permits noncommercial use sharing adaptation distribution reproduction medium format long give appropriate credit original authors source provide link creative commons licence indicate changes made images third party material article included articles creative commons licence unless indicated otherwise credit line material material included articles creative commons licence intended use permitted statutory regulation exceeds permitted use need obtain permission directly copyright holder view copy licence visit httpcreativecommonsorglicensesbync<NUMBER> <NUMBER> december <NUMBER> world health organisation informed cluster cases pneumonia unknown aetiology wuhan city hubei province china <NUMBER> january <NUMBER> announced novel coronavirus identified <NUMBER> coronaviruses large family viruses although responsible mild disease common cold also responsible severe disease outbreaks severe acute respiratory syndrome sarscov <NUMBER> middle east respiratory syndrome merscov <NUMBER> <NUMBER> declared outbreak public health emergency international concern named syndrome caused novel coronavirus covid<NUMBER> coronavirus disease <NUMBER> associated severe acute respiratory syndrome sarscov<NUMBER> <NUMBER> clinical spectrum covid<NUMBER> infection appears remarkably heterogeneous ranging mild symptoms multiorgan failure death perception people diabetes higher risk infection severe disease covid<NUMBER> <NUMBER> people type <NUMBER> diabetes glucose values close target may greater risk developing sarscov<NUMBER> <NUMBER> similarly evidence accumulates many people infected covid<NUMBER> remain asymptomatic <NUMBER> remains uncertain exactly additional risk preexisting diabetes poses although risk contracting covid<NUMBER> may greater viral infections cause severe symptoms complications people diabetes <NUMBER> also noted number people diabetes increased risk due concomitant immunosuppression following solid organ transplantation <NUMBER> early reports wuhan province revealed diabetes mellitus overrepresented among severely ill patients covid<NUMBER> <NUMBER> <NUMBER> finding keeping analysis people hospitalised sarscov even transient hyperglycaemia associated increased mortality <NUMBER> diabetes also identified one common comorbidities case series <NUMBER> patients new york city area requiring hospitalisation sarscov<NUMBER> <NUMBER> proposed mechanisms explain observed association diabetes sarscov<NUMBER> include chronic inflammation impaired immune response increased coagulation activity direct pancreatic islet cell injury <NUMBER> wellcontrolled diabetes associated better outcomes poorly controlled diabetes <NUMBER> even shortterm hyperglycaemia stun innate immune system <NUMBER> emerging evidence suggests context covid<NUMBER> acute hyperglycaemia may greater risk factor adverse outcomes diagnosis diabetes <NUMBER> sarscov<NUMBER> pandemic highlights importance understanding shared disease pathophysiology particularly might inform therapeutic choices people diabetes emerging data suggests sarscov<NUMBER> also common patients hypertension cardiovascular disease although prevalence rate varied different studies well globally <NUMBER> obesity also risk factor severe covid<NUMBER>related illness <NUMBER> metaanalysis eight studies n <NUMBER> odds ratio severe sarscov<NUMBER> significantly higher patients diabetes unlike hypertension cardiovascular disease <NUMBER> may therefore appropriate say complications comorbidities linked diabetes associated higher mortality rate presence diabetes per se <NUMBER> apparent association worse outcomes might also reflect higher prevalence type <NUMBER> diabetes older people <NUMBER> angiotensinconverting enzyme <NUMBER> ace<NUMBER> established sarscov receptor conflicting data translational relevance <NUMBER> role ace<NUMBER> explaining association cardiovascular disease diabetes sarscov<NUMBER> suggested ace<NUMBER> expression reduced people diabetes possibly result glycosylation expression increased patients taking ace inhibitors angiotensin receptor blockers <NUMBER> speculation around possible adverse protective effects proven helpful people prescribed ace inhibitor drugs angiotensin receptor blockers advised continue taking <NUMBER> membraneassociated dipeptidyl peptidase <NUMBER> dpp<NUMBER> also functions coronavirus receptor <NUMBER> currently evidence support clinically meaningful effects immune function dpp<NUMBER> inhibition <NUMBER> acute viral infection previously linked rapid development transient insulin resistance <NUMBER> infection covid<NUMBER> also generally associated increased insulin requirement <NUMBER> many unanswered questions regarding course clinical recovery following sarscov<NUMBER> interest diabetes appears associated increased time viral clearance <NUMBER> covid<NUMBER> also impact health people diabetes infected virus find clinical care compromised service disruption clinical teams challenged fulfil general responsibilities prioritise acute care relation covid<NUMBER> whilst ensuring essential diabetes care continues <NUMBER> people diabetes continue require emergency admissions medical management specialists important role play expediting treatment minimising length stay <NUMBER> many inpatient diabetes services looked increase capacity recognition reported association diabetes hospitalisation covid<NUMBER> infection mitigate impact potentially reduced workforce direction given minimise outpatient attendances movement towards virtual consultations including support recently discharged hospital reduce risk readmission community services underestimate importance contributions maintaining diabetes care triaging clinic lists supports identification patients might still require facetoface review specialist teams also acknowledge clinic postponement equate cancellation proportion cases traditional reliance biochemical parameters inform management decisions diabetes mean access phlebotomy services must also considered useful information cannot obtained shared data <NUMBER> secondary care services may need continue close full capacity include multidisciplinary diabetic foot services pregnancy diabetes services international working group diabetic foot looked remind clinicians patients diabetic foot disease need hospitalised <NUMBER> inpatient teams also ensure acute foot infection missed nonspecific symptoms attributed sarscov<NUMBER> precautionary identification pregnant women higher risk severe covid<NUMBER>related illness led rapid implementation remote antenatal care including diabetes management modifications also made screening pathway gestational diabetes <NUMBER> national locally driven crisis management plans must look manage anxiety health clinical staff people care also around redeployment service reconfiguration redeployment new ways working inevitably impact education training healthcare providers diabetes management alternative approaches need adopted longerterm healthcare impact social lockdown may apparent time short term interruption daily activities including diet exercise may significant impact glucose control may anxiety sleep disturbance structured diabetes education recommended national institute health care excellence nice since <NUMBER> <NUMBER> much delivered group education suspended may able restart time technology companies quick reassure users around supply chains <NUMBER> centres diabetes technology supplies traditionally delivered clinical site rather directly users recognise additional risk carries companies agreed extend warranties insulin pumps also offered remote pump upgrade services appropriate initial insights suggested covid<NUMBER> infection increased risk emergency states hyperglycaemia ketones diabetic ketoacidosis dka hyperosmolar hyperglycaemic state <NUMBER> atypical presentations challenged inpatient diabetes teams led anxiety around prescription sodiumglucose cotransporter <NUMBER> sglt<NUMBER> inhibitors remains important people type <NUMBER> type <NUMBER> diabetes follow sick day rules become unwell illness sglt<NUMBER> inhibitors significant cardiovascular renal benefits people type <NUMBER> diabetes associated small increased risk ketoacidosis date anecdotal reports ketoacidosis patients sarscov<NUMBER> taking sglt<NUMBER> inhibitors suspended acute medical admission vomiting dehydration <NUMBER> metformin also used caution unwell patients interestingly metformin proposed immunomodulatory actions <NUMBER> glucagonlike peptide <NUMBER> glp<NUMBER> receptor agonists also exert antiinflammatory actions may even attenuate pulmonary inflammation <NUMBER> although shortterm safety glp<NUMBER> agonists demonstrated critically unwell patients <NUMBER> still insufficient experience make recommendations around use patients sarscov<NUMBER> perhaps exception sglt<NUMBER> inhibitors patients mild covid<NUMBER> symptoms normal oral intake continue usual antihyperglycaemic medications review glucoselowering medications carefully considered given possible implications increased glycaemic variability <NUMBER> insulin used extensively management hyperglycaemia critically ill patients <NUMBER> insulin also exerts antiinflammatory actions <NUMBER> challenges fluid replacement dka due concerns acute respiratory distress syndrome availability infusion pumps intravenous insulin administration also reported <NUMBER> subcutaneous insulin regimes may prove helpful management hyperglycaemia tissue perfusion compromised analysis capillary blood glucose tests patients sarscov<NUMBER> admitted medical centre wuhan suggested suboptimal adherence current best practice management hyperglycaemia <NUMBER> perhaps surprising given pressure healthcare systems increased exposure healthcare staff associated frequent capillary blood glucose monitoring adjustment insulin infusions emerging evidence suggests good glycaemic control associated improved outcomes patients hospitalised sarscov<NUMBER> <NUMBER> automated closedloop insulindelivery systems proven safe effective noncritical care environments <NUMBER> feasibility fully automated closedloop glucose control also studied critical illness <NUMBER> may option finding patients admitted sarscov<NUMBER> often developed acute hyperglycaemia following hospitalisation suggests opportunity exists interventional glycaemic management <NUMBER> prevalence diabetes stress hyperglycaemia people hospitalised covid<NUMBER> infection recognition improved glycaemic control might improve outcomes reduce length stay patients sarscov<NUMBER> underlined importance specialist inpatient diabetes teams acute care current pandemic also highlighted opportunities continuing expanding innovations delivery diabetes care virtual consultations healthcare providers people diabetes use diabetes technology <NUMBER> crisis management created unprecedented interest remote care patients providers removed many longstanding regulatory barriers us food drug administration also allowed use personal blood glucose meters continuous glucose monitoring devices hospital duration pandemic <NUMBER> <NUMBER> virtual consultations might also support people diabetes seen right person right time instead waiting months routine clinic appointments might physician specialist nursediabetes educator dietician clinical psychologist <NUMBER> group facetoface structured diabetes education may possible time opportunities pilot alternative forms delivery patientled remote models structured diabetes education reported improve uptake clinical outcomes digital version desmond evidencebased type <NUMBER> diabetes structured education programme made free everyone type <NUMBER> diabetes uk april <NUMBER> <NUMBER> bertie online offers fully remote diabetes structured education people type <NUMBER> diabetes <NUMBER> enforced service redesign pandemic also enable innovations diabetes care might become apparent coming months article based previously conducted studies contain studies human participants animals performed authors funding funding sponsorship received publication article authorship named authors meet international committee medical journal editors icmje criteria authorship article take responsibility integrity work whole given approval version published disclosures jonathan schofield member journals editorial board lalantha leelarathna hood thabit nothing disclose compliance ethics guidelines article based previously conducted studies contain studies human participants animals performed authors open access article licensed creative commons attributionnoncommercial <NUMBER> international license permits noncommercial use sharing adaptation distribution reproduction medium format long give appropriate credit original authors source provide link creative commons licence indicate changes made images third party material article included articles creative commons licence unless indicated otherwise credit line material material included articles creative commons licence intended use permitted statutory regulation exceeds permitted use need obtain permission directly copyright holder view copy licence visit httpcreativecommonsorglicensesbync<NUMBER> disease burden coronavirus infectious disease <NUMBER> covid<NUMBER> caused severe acute respiratory syndrome coronavirus<NUMBER> sars cov<NUMBER> increasing continuously million confirmed patients <NUMBER> thousand deaths globally <NUMBER> high prevalence diabetes important understand special aspects covid<NUMBER> infection people diabetes becomes even important parts world seeing restrictions mobility patients order contain pandemic recently group published article highlighting special considerations management diabetes todays times covid<NUMBER> pandemic <NUMBER> much data various parts world accumulated since association diabetes covid<NUMBER> management diabetes covid<NUMBER> infection innovative strategies medical consultation view limited access healthcare facilities patients chronic diseases review aims collate currently available data diabetes covid<NUMBER> infection specifically looks relation diabetes covid<NUMBER> terms epidemiology pathophysiology therapeutics review updated till time writing however data evolving conclusions made might change later searched pubmed database google scholar using key terms covid<NUMBER> sarscov<NUMBER> diabetes antidiabetic therapy april <NUMBER> <NUMBER> full texts retrieved articles accessed diabetes associated complications increase risk morbidity mortality acute infections due suppressed innate humoral immune functions levels glycated hemoglobin hba<NUMBER>c <NUMBER> linked <NUMBER> increased risk hospitalization pneumoniarelated severity bacterial infection <NUMBER> past viral pandemics witnessed association diabetes increased morbidity mortality diabetes considered independent risk factor complications death <NUMBER>e<NUMBER> outbreak severe acute respiratory syndrome sarscov<NUMBER> <NUMBER> similarly presence diabetes tripled risk hospitalization quadrupled risk intensive care unit icu admission influenza h<NUMBER>n<NUMBER> infection outbreak <NUMBER> <NUMBER> <NUMBER> outbreak middle east respiratory syndrome coronavirus merscov diabetes prevalent nearly <NUMBER> population odds ratio severe critical merscov ranged <NUMBER> <NUMBER> diabetic cohort <NUMBER> compared overall population mortality rate patients mers diabetes <NUMBER> <NUMBER> <NUMBER> emerging data suggests covid<NUMBER> common patients diabetes hypertension cardiovascular disease cvd although prevalence rate varied different studies well countrywise data pooled data <NUMBER> chinese studies n ¼ <NUMBER> characteristics comorbidities patients covid<NUMBER> singh et al <NUMBER> reported prevalence hypertension diabetes cvd <NUMBER> <NUMBER> <NUMBER> patients respectively similarly metaanalysis <NUMBER> trials included <NUMBER> covid<NUMBER> patients yang et al <NUMBER> reported prevalence <NUMBER> <NUMBER> <NUMBER> hypertension diabetes cvd respectively patients covid<NUMBER> epidemiology working group chinese center disease control prevention investigated <NUMBER> <NUMBER> patients covid<NUMBER> shown hypertension diabetes cvd associated nearly <NUMBER> <NUMBER> <NUMBER> patients respectively <NUMBER> contrast italian study onder et al found diabetes nearly <NUMBER> cvd associated nearly <NUMBER> <NUMBER> patients admitted covid<NUMBER> <NUMBER> similarly small study <NUMBER> patients united states bhatraju et al <NUMBER> reported diabetes associated <NUMBER> patient covid<NUMBER> study covid<NUMBER> surveillance group italy n ¼ <NUMBER> shown <NUMBER> patients covid<NUMBER> diabetes died covid<NUMBER> response team centers disease control prevention cdc usa reported prevalence <NUMBER> data <NUMBER> covid<NUMBER> patients <NUMBER> <NUMBER> table <NUMBER> summarizes prevalence comorbidities available studies todate patients covid<NUMBER> <NUMBER>e<NUMBER> noted findings could mere reflection high prevalence diabetes across globe including china diabetes capital world thus causality cannot inferred observed elevated proportions evolving data also suggest patients covid<NUMBER> diabetes often associated severe critical disease varying <NUMBER> <NUMBER> different studies <NUMBER>e<NUMBER> <NUMBER> <NUMBER> <NUMBER> wang et al <NUMBER> study <NUMBER> patients reported <NUMBER> patients covid<NUMBER> comorbidities including diabetes required admission icu compared <NUMBER> patients without comorbidities analysis <NUMBER> patients covid<NUMBER> wu et al <NUMBER> table <NUMBER> summarizes prevalence nonsevere mild moderate severe critical disease patients diabetes covid<NUMBER> fig <NUMBER> illustrates graphical representation nonsevere severe covid<NUMBER> patients diabetes interestingly prevalence nonsurvivors also higher diabetic subjects covid<NUMBER> varied <NUMBER> <NUMBER> different studies <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> table <NUMBER> summarizes prevalence survivors nonsurvivors among patients diabetes covid<NUMBER> fig <NUMBER> depicts graphical representation data univariate analysis <NUMBER> patients covid<NUMBER> zhou et al <NUMBER> found diabetes <NUMBER> <NUMBER> ci <NUMBER> <NUMBER> p <NUMBER> inhospital mortality however association however cfr high <NUMBER> patients cvd <NUMBER> diabetes <NUMBER> hypertension <NUMBER> based findings acknowledging higher morbidities mortality associated comorbidities researchers recently proposed course treatment prognosis covid<NUMBER> stratified based absence presence comorbidities type b c type represents covid<NUMBER> patients pneumonia comorbidities type b denotes covid<NUMBER> pneumonia comorbidities type c denotes covid<NUMBER> pneumonia multiorgan dysfunction <NUMBER> <NUMBER> special aspects pathophysiology diabetes relationship antidiabetic drugs context covid<NUMBER> sars cov<NUMBER> like sars cov<NUMBER> utilises ace<NUMBER> receptor entry cell <NUMBER> ace<NUMBER> expressed type ii alveolar epithelial cells lungs upper respiratory tract also several locations like heart endothelium renal tubular epithelium intestinal epithelium pancreas sglycoprotein surface sars cov<NUMBER> binds ace<NUMBER> causes conformational change sglycoprotein allows proteolytic digestion host cell proteases tmprss<NUMBER> furin ultimately leading internalization virion <NUMBER> cellular entry virus triggers inflammatory response recruitment helper cells produce interferon g leads recruitment inflammatory cells leading cytokine storm could lead organ damage multiorgan failure seen severe disease discussed diabetes associated poorer outcomes covid<NUMBER> study <NUMBER> patients covid<NUMBER> wuhan found increased time viral clearance patients diabetes <NUMBER> apart usual mechanisms impaired neutrophil chemotaxis phagocytosis diabetes predisposes infections general several specific factors responsible increased risk severity infection sars cov<NUMBER> diabetes increased ace<NUMBER> expression diabetic mice found increased expression ace<NUMBER> renal cortex liver pancreas lungs <NUMBER> recently phenomewide mendelian randomization study found diabetes causally related ace<NUMBER> expression <NUMBER> though significance observations clear present increased ace<NUMBER> expression might predispose people diabetes infection sars cov<NUMBER> b increased furin diabetes associated increase furin type<NUMBER> membranebound protease belonging proprotein convertase subtilisinkexin family pcsk involved entry coronaviruses cell increased furin reported diabetes might facilitate viral replication <NUMBER> c impaired tcell function alterations cd<NUMBER> lymphocytes reported animal models mers <NUMBER> lymphocytopenia observed patients covid<NUMBER> correlated prognosis <NUMBER> increased interleukin<NUMBER> il<NUMBER> several cytokines increased covid<NUMBER> infection amongst il<NUMBER> increased diabetes may play deleterious role covid<NUMBER> infection <NUMBER> monoclonal antibody il<NUMBER> receptor tocilizumab tested trial covid<NUMBER> <NUMBER> ace<NUMBER> receptors expressed pancreatic islets infection sars cov<NUMBER> seen cause hyperglycaemia people without preexisting diabetes hyperglycaemia seen persist <NUMBER> years recovery sars indicating transient damage beta cells <NUMBER> though similar effect reported covid<NUMBER> may important monitor blood glucose levels acute stage follow data differential effects oral antidiabetic drugs disease course covid<NUMBER> metformin antiproliferative immunomodulatory effects virtue inhibition amp activated protein kinase shown protective role pneumonia mouse models <NUMBER> one study patients tuberculosis patients treated metformin better survival receive metformin <NUMBER> median <NUMBER> years follow <NUMBER> patients diabetes mendy et al <NUMBER> showed metformin significantly associated decreased risk mortality patients chronic lower respiratory diseases hr <NUMBER> <NUMBER> ci <NUMBER> <NUMBER> even adjustment multiple confounding factors study <NUMBER> patients follow <NUMBER>year period ho et al <NUMBER> showed metformin users significantly lower risk death hr <NUMBER> <NUMBER> ci <NUMBER> <NUMBER> compared nonmetformin users patients coexistent chronic obstructive pulmonary disease diabetes thiazolidinediones tzd seen increase risk pneumonia study compared sulfonylureas <NUMBER> experimental studies suggest pioglitazone reduces steatohepatitis increasing ace<NUMBER> expression liver tissues <NUMBER> purported increase ace<NUMBER> expression relation covid<NUMBER> led researchers propose avoiding tzd patients diabetes covid<NUMBER> experimental studies also suggest liraglutide glp<NUMBER> receptor agonist increases ace<NUMBER> expression lungs type <NUMBER> diabetic rat improves right ventricular hypertrophy <NUMBER> implications findings current context covid<NUMBER> relation antidiabetic drugs yet fully clear dipeptidyl peptidase<NUMBER> dpp<NUMBER> tissue oligopeptides involved multiple biological processes include control activity growth factors chemokines bioactive peptides tcell activation beside regulating glucose metabolism <NUMBER> relationship coronavirus cellular typeii transmembrane protein dpp<NUMBER> cd<NUMBER> generated great interest recently dpp<NUMBER> serves receptor merscov way ace<NUMBER> receptor sars cov sars cov<NUMBER> <NUMBER> <NUMBER> experimental studies suggested certain polymorphisms dpp<NUMBER> associated reduced chance merscov infection <NUMBER> finding might explain perplexing absence merscov cases africa despite presence virus camels presumably frequent presence protective polymorphisms dpp<NUMBER> africans <NUMBER> moreover generated immense interest whether use dpp<NUMBER> inhibitors dpp<NUMBER>i reduce viral entry merscov one vitro study sitagliptin vildagliptin saxagliptin could block coronavirus viral entry cells <NUMBER> though ace<NUMBER> recognized main receptor sars cov<NUMBER> recent modeling study rule interaction cd<NUMBER> dpp<NUMBER> <NUMBER> moreover possible interaction dpp<NUMBER> reninangiotensin system ras pathways seems plausible although completely studied interestingly dipeptidyl aminopeptidase iiii cleaves angiotensin ii <NUMBER>e<NUMBER> angiotensin iii <NUMBER>e<NUMBER> iv <NUMBER>e<NUMBER> cascading favorable effect angiotensin<NUMBER> at<NUMBER> receptors similarly various endoand oligopeptidase cleaves angiotensin <NUMBER> directly angiotensin <NUMBER>e<NUMBER> favorable cascading effect suggest plausible interaction nonspecific dpp<NUMBER>i ace<NUMBER> theoretically possible therefore area needs future research regard studies found coadministration angiotensinconverting enzyme inhibitors acei dpp<NUMBER> inhibitors led increased sympathetic tone consequent adverse hemodynamic effect <NUMBER>e<NUMBER> interaction observed acei vildagliptin <NUMBER>to <NUMBER>folds increased risk angioedema noted possibly due diminished degradation bradykinin substance p <NUMBER> contrast experimental study sitagliptin shown inhibit ace could partially explain purported beneficial cv effects <NUMBER> dpp<NUMBER> inhibitors associated increased risk upper respiratory infections however agents shown lead increased risk pneumonia <NUMBER> present insufficient evidence either use dpp<NUMBER>i patients diabetes covid<NUMBER> <NUMBER> glycemic control important patient covid<NUMBER> though limited data association blood glucose levels disease course covid<NUMBER> present data infections like sars influenza h<NUMBER>n<NUMBER> shown patients poor glycemic control increased risk complications death <NUMBER> <NUMBER> patients mild infection normal oral intake continue usual antihyperglycemic medications however advisable discontinue sglt<NUMBER> inhibitors risk dehydration euglycemic ketosis metformin may also need stopped vomiting poor oral intake doses antihyperglycemic drugs like sulfonylureas insulin may altered depending upon blood glucose levels hospitalised patient covid<NUMBER> especially respiratory distress would require insulin ideally patients poor oral intake mechanical ventilation would require intravenous insulin infusion frequent monitoring blood glucose every hour every <NUMBER> h see next section however adjustment infusion rates would necessitate visit patient increase exposure medical personnel need explore alternate insulin administration strategies one use subcutaneous short acting insulin analogues approach used successfully mild moderate diabetic ketoacidosis however safety critically ill patients less clear <NUMBER> <NUMBER> secondly single dose basal insulin attempted critically ill patients one study thailand could attractive option would reduce contact patient considerably <NUMBER> needs research especially critically sick patients finally insulin pump continuous subcutaneous insulin infusion csii could option models advantage altering insulin rates remotely via bluetooth <NUMBER> fully automated closedloop glucose control tried critical illness feasible could useful treating patients covid<NUMBER> <NUMBER> blood glucose monitoring poses special challenge necessitates frequent visits patients bedside especially patient critically ill receiving intravenous insulin however attempts could made minimize exposure patient critically ill heshe may given glucose testing device selfmonitoring may taught blood glucose readings communicated phone necessary action taken continuous glucose monitoring cgm could help especially systems data remotely accessed without visiting patient though evidence cgm interference commonly prescribed medications like acetaminophen atenolol lisinopril shown useful reliable critically ill patients <NUMBER> <NUMBER> treatment ace inhibitors arb potential cause regulation ace<NUMBER> <NUMBER> mice coronavirus induced lung injury showed improvement treated angiotensin receptor blocker losartan <NUMBER> retrospective analysis showed reduced rates death endotracheal intubation patients viral pneumonia continued ace inhibitors <NUMBER> however contrary view increased expression ace<NUMBER> could theoretically increase risk infection sars cov<NUMBER> could concern people diabetes already elevated risk infections many factors however evidence support hypothesis currently retrospective analysis <NUMBER> covid<NUMBER> hospitalised patients cardiovascular disease wuhan significant difference proportion aceiarb medication nonsurvivors survivors <NUMBER> view lack robust evidence either benefit harm reasonable patients continue using ace inhibitors arb recommended european society cardiology council hypertension european society hypertension american heart association <NUMBER>e<NUMBER> several studies protective effect statins pneumonia <NUMBER> statins known increase ace<NUMBER> levels may protect viral entry sars cov<NUMBER> <NUMBER> however increase ace<NUMBER> could counterintuitive current context nevertheless statins known inhibit nuclear factor kappa b nfkb activation might help blunting cytokine storm <NUMBER> calcium channel blockers ccb shown reduce severity disease mortality patients pneumonia presumably inhibiting calcium influx cell <NUMBER> precise role agents covid<NUMBER> studied however seems safe continue drugs control blood pressure hypertensive patients since ccb effect ace<NUMBER> expression researchers proposed preferable use patients covid<NUMBER> hypertension <NUMBER> though aspirin antiinflammatory properties may advisable continue patients sepsis disseminated intravascular coagulation however patients underlying coronary artery disease needs continued anticoagulant unless otherwise contraindicated treatment diabetes poses challenge current times world going unprecedented pandemic lockdowns places people confined home opportunities exercise limited regular walks visits gyms swimming pools possible also considerable mental stress unpredictability disease well social immobility alterations daily routine affect dietary intake well stress could lead inappropriate eating access fresh fruits vegetables could limited may tendency eat packaged foods high calories saturated fat transfat patients may find difficult procure medicines insulin needles glucose strips etc partial complete lockdowns problem becomes pronounced elderly living alone factors could cause glucose dysregulation could predispose patients complications like infections hyperosmolar coma ketoacidosis even acute cardiac events care taken vary calorie intake markedly healthy balanced diet good amount protein fiber limitation saturated fats important maintain good glycemic control <NUMBER> exercise continued home based exercise like cycling treadmill stationary jogging resistance exercise small weights beneficial <NUMBER> regular intake antidiabetic drugs insulin important emphasized <NUMBER> telemedicine helpful times patients consult physician via telemedicine appropriate advice treatment given <NUMBER> article dealing telemedicine publication special issue <NUMBER> care feet emphasized order avoid foot related complications telemedicine temperature mats screen inflammation without visit clinic patients show inflammation called clinic <NUMBER> <NUMBER> patients need educated need visit hospital urgently emergency situations like vomiting drowsiness shortness breath chest pain weakness limbs altered sensorium etc diabetes associated increased incidence severity covid<NUMBER> experimental evidence effect diabetes viral entry cell inflammatory response infection important control blood glucose patients infected covid<NUMBER> treating diabetes present restrictions movement challenging however innovations like telemedicine useful trying times hereby declare conflict interest related article pneumonia caused severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> first time reported december <NUMBER> <NUMBER> <NUMBER> since covid<NUMBER> pandemic disease caused virus spread around world april <NUMBER> <NUMBER> million confirmed cases total almost <NUMBER> <NUMBER> deaths identified worldwide everything started wuhan hubei province china <NUMBER> months ago therefore practically relevant clinical data coming china findings showing arterial hypertension diabetes cardiovascular diseases chronic obstructive pulmonary disease common comorbidities patients covid<NUMBER> tables <NUMBER> <NUMBER> even though number studies followup rather limited data suggesting hypertension diabetes cardiovascular disease underlying conditions associated adverse outcomeadmission intensive care unit mechanic ventilation death <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> table <NUMBER> however findings inconsistent data epidemiological analytical majority studies analyze effect many confounding factors age sex obesity could significantly change interaction comorbidities outcome clear sudden outbreak covid<NUMBER> raised great attention forced rapid publication order explain epidemiology therapeutic approach outcome many parameters available inclusion risk factors obesity would probably interfere final results possible far therefore one careful interpretation available data indicating hypertension diabetes one responsible risk factors least global population aim review summarize currently available data regarding prevalence diabetes patients covid<NUMBER> role outcome patients hence comprehensive systematic search performed pubmed scopus web science google scholar find articles published april <NUMBER> <NUMBER> still unknown whether patients diabetes higher susceptibility covid<NUMBER> observation risk higher infection disease severity however percentage patients diabetes varies <NUMBER> <NUMBER> <NUMBER> <NUMBER> two largest metaanalyses included <NUMBER> <NUMBER> <NUMBER> <NUMBER> covid<NUMBER> patients respectively diabetes detected <NUMBER> <NUMBER> <NUMBER> <NUMBER> however noted large level heterogeneity exists published studies differ sample size age patients severity covid<NUMBER> hospital facilities investigated comorbidities therapeutic approach finally outcome one largest study published n <NUMBER> far diabetes present <NUMBER> covid<NUMBER> patients significantly prevalent patients severe form disease experienced primary outcome end point admission intensive care unit use mechanical ventilation death <NUMBER> group authors larger group covid<NUMBER> patients n <NUMBER> reported diabetes <NUMBER> significantly prevalent among covid<NUMBER> patients severe form patients nonsevere form disease <NUMBER> vs <NUMBER> <NUMBER> recent study included <NUMBER> noncritically ill covid<NUMBER> patients reported diabetes <NUMBER> patients <NUMBER> even though prevalence diabetes low covid<NUMBER> patients aggravation illness followup frequently diabetic comparison complication covid<NUMBER> lian et al <NUMBER> included <NUMBER> patients covid<NUMBER> divided patients two groups younger <NUMBER> years older <NUMBER> years thereby contributing explain diabetes related susceptibility severity covid<NUMBER> authors showed many comorbidities hypertension cardiovascular disease chronic obstructive pulmonary disease including diabetes prevalent patients older <NUMBER> years patients younger <NUMBER> years <NUMBER> difference age probably one main reasons risk ascribed diabetes patients covid<NUMBER> studies investigated cardiac injury covid<NUMBER> patients defined increased cardiospecific enzymes showed diabetes significantly frequent among patients cardiac injury patients without <NUMBER> <NUMBER> nevertheless prevalence hypertension cardiovascular diseases chronic renal disease significantly higher patients experienced cardiac injury would difficult separate effect diabetes underlying diseases moreover large difference age covid<NUMBER> patients detected cardiac injury cardiac injury also could contribute worse outcome cardiac injury <NUMBER> <NUMBER> authors concluded cardiac injury common covid<NUMBER> patients <NUMBER> associated significantly higher mortality population <NUMBER> <NUMBER> guo et al <NUMBER> investigated effect diabetes progression prognosis patients covid<NUMBER> limited sample found serum levels inflammationrelated biomarkers il<NUMBER> creactive protein serum ferritin coagulation index ddimer significantly higher patients diabetes compared without <NUMBER> indicates diabetic patients predisposed hyperinflammatory state ultimately leads prompt deterioration covid<NUMBER> significant difference age diabetics nondiabetics diabetics frequently cardiovascular disease nondiabetic counterparts <NUMBER> however even diabetic patients without comorbidities analyzed results remained sameinflammatory procoagulant factors significantly higher diabetic patients among patients diabetes <NUMBER> insulin therapy increased dose insulin admission whereas <NUMBER> oral antidiabetic therapy admission started insulin therapy admission <NUMBER> means patients poor glycemic control hospitalization diabetes hyperinflammatory condition seems may increase susceptibility covid<NUMBER> independently underlying diseases several possible mechanisms inflammation b hypercoagulable state c activation reninangiotensinaldosterone system raas dysregulation sympathetic nervous system evidence sarscov novel coronavirus responsible covid<NUMBER> uses ace<NUMBER> surfaces epithelial cells bind enter infected cells <NUMBER> ace<NUMBER> located cardiac kidney lung intestinal tissues converts angiotensin ii angiotensin <NUMBER> promotes vasodilation function raas diabetic patients already significantly modified <NUMBER> acute change activity ace<NUMBER> may final trigger hyperinflammatory hypercoagulable storm covid<NUMBER> however hypotheses without reliable clinical evidence observations covid<NUMBER> pandemic indicated raas inhibitors frequently taken covid<NUMBER> patients unfavorable outcome <NUMBER> raised large concerns use raas inhibitors often prescribed diabetic patients without concomitant hypertension another frequent comorbidity covid<NUMBER> patients recent findings covid<NUMBER> patients showed raas inhibitors improve outcome patients <NUMBER> confirmed recent position statements several societies strongly recommended continuation regular treatment raas inhibitors data regarding influence diabetes outcome diabetic patients still limited table <NUMBER> predictors mortality whereas ddimer <NUMBER> μgml independent predictor coagulable parameters findings challenging hypothesis hyperinflammation state diabetic patients may responsible mortality patients covid<NUMBER> nevertheless number patients study limited n <NUMBER> drawing conclusion easy task wu et al <NUMBER> compared covid<NUMBER> patients without acute respiratory distress syndrome ards found diabetes significant predictor ards hr <NUMBER> <NUMBER> ci <NUMBER> mortality hr <NUMBER> <NUMBER> ci <NUMBER> underlined multivariate analysis adjustment age sex possible confounding factors performed due small sample size n <NUMBER> metaanalysis included <NUMBER> patients covid<NUMBER> found diabetes well hypertension chronic obstructive pulmonary disease associated exacerbation admission intensive care unit <NUMBER> study aimed investigate effect diabetes progression prognosis patients covid<NUMBER> reported significantly higher mortality among diabetic patients without comorbidities <NUMBER> vs <NUMBER> <NUMBER> however diabetic patients almost twice old nondiabetics <NUMBER> vs <NUMBER> years must taken consideration majority inflammatory parameters creactive protein serum ferritin erythrocyte sedimentation rate interleukin<NUMBER> procoagulant factors ddimer fibrinogen also significantly higher among diabetic patients without comorbidities <NUMBER> diabetic complications prevalent patients died borderline statistical significance interestingly ketoacidosis infectious shock conditions would assumed responsible findings prevalent among covid<NUMBER> patients lethal outcome <NUMBER> initiation insulin admission speaks favor poor glycemic regulation also related higher mortality however <NUMBER> diabetic patients included study <NUMBER> comorbidities study may provide directions future studies conclusions coronary artery disease particularly asymptomatic form frequently present diabetic patients could excluded potential confounding factor additional limitation still many uncertainties whether diabetes interferes sarscov<NUMBER> facilities entrance coronavirus epi number limitations available data selfreporting comorbidities hospital admission used investigation cause significant underreporting comorbidities due lack awareness andor lack diagnostic testing could interfere relationship comorbidities clinical outcome furthermore followup short patients remained hospital data analyzed meaning actual outcome unknown directly influenced influence diabetes severity outcome covid<NUMBER> patients clear large gap evidence known antidiabetic therapy used diabetic patients many patients untreated many uncontrolled diabetes obesity one important comorbidities diabetic patients investigated large studies comprehensive analysis risk factors longer followup necessary answer questions raised surprised upcoming results western countries currently affected covid<NUMBER> different currently available data nevertheless patients diabetes hypertension particularly advanced age priority vaccine becomes available conflict interest httpsorcidorg<NUMBER> coronavirus infection outbreaks occurred frequently last two decades led significant mortality despite focus reducing mortality preventing spread virus patients died due several complications illness understanding pathological mechanisms implications continuously evolving number symptoms occur patients due involvement various endocrine glands clinical presentations went largely unnoticed first outbreak severe acute respiratory syndrome sars <NUMBER> <NUMBER> derangements continued convalescence phase sometimes occurred recovery similar pathological biochemical changes reported novel coronavirus disease outbreak <NUMBER> review focus endocrine changes reported sars coronavirus sars coronavirus<NUMBER> battle pandemic becomes imperative address underlying endocrine disturbances contributing towards predicting mortality patients <NUMBER> december <NUMBER> office china informed cases pneumonia unknown cause originating city wuhan hubei china <NUMBER> next <NUMBER> months severe acute respiratory syndrome coronavirus<NUMBER> sarscov<NUMBER> illness commonly called covid<NUMBER> affected four million people globally <NUMBER> million cases usa making new epicentre illness followed much western europe mortality rates different parts world show vast differences studies consistently shown presence comorbidities specially type <NUMBER> diabetes mellitus significantly increases mortality patients sarscov<NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> study china also showed patients intensive care unit sarscov<NUMBER> infection likely underlying diabetes <NUMBER> vs <NUMBER> others <NUMBER> certain forms hypophysitis thyroiditis adrenalitis viral aetiologies changes endocrine functions observed previous coronavirus outbreak sarscov led considerable morbidity important predictors mortality therefore imperative know endocrinopathic impact sarscov<NUMBER> illness purpose review highlight available data endocrine changes patients recapitulate existing knowledge previous coronavirus outbreaks better risk stratification management patients sarscov<NUMBER> infection articles reporting endocrine changes sarscov<NUMBER> sarscov patients considered electronic database pubmed searched using medical subject headings mesh terms related sarscov<NUMBER> sarscov different hormones since sarscov outbreak occurred <NUMBER> search results limited january <NUMBER> onwards consider articles pertaining outbreaks viruses considerable number articles chinese language included translated english supplemented handsearching reference lists additional studies case reports similarly google scholar database handsearched studies listing type <NUMBER> diabetes mellitus risk factor sarscov<NUMBER> sarscov excluded since mention biochemical changes articles corticosteroid induced hyperglycaemia audio interviews articles detailing reninangiotensin aldosterone system raas inhibitors excluded initial search showed <NUMBER> articles finally <NUMBER> included figure <NUMBER> coronavirus infections cause systemic disease injures many organs patients manifest many hormonal metabolic disturbances changes thyroid pancreas adrenal glands reported detail sarscov current sarscov<NUMBER> infections pathology data clinical features management outcome endocrinopathies highlighted figure <NUMBER> detailed histopathological study effects sars infection thyroid gland done sarscov outbreak <NUMBER> extensive injury parafollicular cells follicular epithelium destruction exfoliation epithelial cells follicle leading disruption changes responsible lower levels thyroid hormones noted clinical studies parafollicular cells responsible calcitonin production could identified sections tissue sample patients sars damage interfollicular tissue including parafollicular cells may adversely affect calcitonin production interesting finding absence inflammatory infiltrate features cellular necrosis supporting hypothesis extensive apoptosis responsible thyroid injury pathology data thyroid gland patients sarscov<NUMBER> infection published yao et al conducted minimally invasive autopsies different organs patients died sarscov<NUMBER> investigated pathological changes <NUMBER> reported abnormalities thyroid follicular morphology note lymphocytic infiltration interstitium none tissue immunohistochemistry pcr analyses detected sarscov<NUMBER> thyroid gland findings variance reported sarscov though patient characteristics two studies nearly however irrespective pathological findings studies found similar pattern biochemical changes limited data suggest thyroid gland hypothalamopituitarythyroid hpt axis directly affected sarscov<NUMBER> illness study <NUMBER> patients sarscov<NUMBER> showed thyroid stimulating hormone tsh free triiodothyronine t<NUMBER> concentrations significantly lower deceased patients <NUMBER> miuml <NUMBER> pmoll recovered patients <NUMBER> miuml <NUMBER> pmoll difference thyroxine t<NUMBER> levels statistically significant <NUMBER> study wang et al reported serum levels t<NUMBER> t<NUMBER> patients sarscov significantly lower control group low t<NUMBER> levels correlated disease severity serum t<NUMBER> t<NUMBER> levels decreased respectively <NUMBER> <NUMBER> <NUMBER> patients sarscov acute phase <NUMBER> <NUMBER> convalescent phase disease <NUMBER> authors also noted lower levels tsh patients dysfunction hpt axis caused diminished level serum tsh patients sarscov despite low serum t<NUMBER> t<NUMBER> significant difference serum parathyroid hormone level observed patients sarscov control group acute convalescent phases illness changes thyroid hormone levels may persist clinical recovery leow et al studied sarscov survivors hormonal derangements <NUMBER> months recovery noted <NUMBER> patients developed biochemical hypothyroidism <NUMBER> majority patients <NUMBER> central aetiology <NUMBER> developed primary hypothyroidism positive antibodies continued receive thyroid hormone replacement end study followup changes thyroid profile patients central hypothyroidism normalised central hypocortisolism also present <NUMBER> patients central hypothyroidism authors suggested dysfunctional hpt axis evidenced results thyroid hormones coexistence central hypocortisolism studies suggest monitoring thyroid function tests acute illness well convalescence sarscov<NUMBER> possibility replacement therapy indicated reports recovery thyroid function <NUMBER> months sarscov patients implying reassessment survivors current pandemic <NUMBER> many viruses enteroviruses coxsackie b virus <NUMBER> retroviruses rubella mumps cytomegalovirus epsteinbarr varicella zoster virus implicated development diabetes mellitus humans <NUMBER> review coronavirus also reported cause diabetes animal human studies case report foal suggested pancreas could direct viral damage due coronavirus leading diarrhoea transient diabetes mellitus simultaneously <NUMBER> demonstrated coronaviruses enter human lungs pancreas tissues interacting ace<NUMBER> receptor expression ace<NUMBER> much stronger pancreatic endocrine tissue compared exocrine tissue <NUMBER> extent tissue damage sarscov direct function level expression tissue ace<NUMBER> thus sarscov viruses may damage pancreatic islets cause acute insulin dependent diabetes mellitus acute pancreatitis pancreatic biopsy findings sarscov<NUMBER> patients identical previous studies sarscov patients yao et al reported obvious abnormalities epithelial cells exocrine pancreas however degeneration islet cells noted <NUMBER> observed patients mild sarscov receive glucocorticoid medications disease course higher level fasting plasma glucose fpg first day hospitalisation nonsars pneumonia newonset diabetes developed <NUMBER> sarscov patients previous diabetes received steroid treatment illness <NUMBER> hyperglycaemia independent predictor mortality morbidity sarscov patients without history diabetes mellitus <NUMBER> yang et al demonstrated steroid treatment mean fpg level significantly higher sarscov patients deceased vs survivors vs nonsars pneumonia group <NUMBER>±<NUMBER> vs <NUMBER>±<NUMBER> vs <NUMBER>±<NUMBER> mmoll p<NUMBER> hyperglycaemia fpg≥<NUMBER> mmoll steroid treatment significantly associated death <NUMBER> adjustment age gender incremental rise mortality increasing fpg another interesting association noted hypoxaemia higher fpg levels <NUMBER> among patients known history diabetes commencement steroid therapy hypoxaemia arterial oxygen saturation <NUMBER> higher fpg levels hypoxia survivor <NUMBER>±<NUMBER> vs <NUMBER>±<NUMBER> mmoll deceased <NUMBER>±<NUMBER> vs <NUMBER>±<NUMBER> mmoll groups estimated every <NUMBER> mmoll increase fpg hr increased <NUMBER>fold death <NUMBER>fold hypoxia morbidity survivors deceased patients irrespective steroid dosage elevated fpg values started falling third week indicating gradual recovery islet cell function half billion people currently living diabetes worldwide patients diabetes poorer outcome previous epidemics sarscov h<NUMBER>n<NUMBER> epidemics <NUMBER> <NUMBER> clinical course sarscov<NUMBER> infection patients diabetes without comorbidities recently reported guo et al wuhan china <NUMBER> patients diabetes may present milder symptoms initially higher risk rapid progression severe pneumonia uncontrolled cytokine storm hypercoagulable state contributing poorer prognosis interleukin<NUMBER> il<NUMBER> level found higher sarscov<NUMBER> cases diabetes without diabetes wang et al hypothesised sarscov<NUMBER> infection patients diabetes might trigger stress condition increase secretion hyperglycaemic hormones glucocorticoid catecholamines resulting elevated blood glucose abnormal glucose variability diabetic complications turn leading higher mortality morbidity rates patients <NUMBER> study <NUMBER> sarscov<NUMBER> patients demonstrated <NUMBER> patients elevated blood glucose mean glucose value <NUMBER> mmoll <NUMBER> wu et al <NUMBER> showed sarscov<NUMBER> patients developing acute respiratory distress syndrome ards higher glucose levels <NUMBER> vs <NUMBER> mmoll compared patients develop ards hr <NUMBER> similarly sarscov<NUMBER> patients presenting gastrointestinal symptoms increased glucose level independent risk factor severecritical illness multivariate analysis <NUMBER> <NUMBER> sarscov<NUMBER> patients diabetes high risk progressing rapidly ards septic shock et al recommended fpg <NUMBER> mmoll <NUMBER>hour postprandial plasma glucose <NUMBER> h pg <NUMBER> mmoll mild cases fpg <NUMBER> mmoll <NUMBER> h pg <NUMBER> mmoll critically ill patients sarscov<NUMBER> <NUMBER> sum sarscov infections damage islet cells causing acute temporary diabetes high fpg associated metabolic changes lead increased morbidity mortality patients addition preexisting diabetes may considered risk factor poorer outcomes sarscov<NUMBER> pneumonia intensive blood glucose monitoring insulin therapy obtain optimal metabolic control may improve outcome patients tocilizumab monoclonal antibody il<NUMBER> may role patients diabetes control overexpressed il<NUMBER> used offlabel currently randomised controlled trial testing utility <NUMBER> european society endocrinology statement advises patients diabetes avoid physician office visits seek telephonicelectronic consultations optimal control blood sugar need get early referral emergency services case possible symptoms sarscov<NUMBER> <NUMBER> histological changes adrenal glands patients dying sarscov described ding et al postmortem biopsy samples <NUMBER> noted adrenal medulla infiltrated mainly monocytes lymphocytes another interesting finding focal necrosis gland addition vasculitis small veins adrenal medulla present similar studies conducted sarscov<NUMBER> patients date however reasons believe similar adrenal gland changes could occur given similarity viral structure mechanism entry human host cells sarscov genome sequences detected cytoplasm numerous neurons hypothalamus cortex <NUMBER> might induce either hypophysitis directly affect hypothalamus leading hypothalamicpituitary dysfunction leow et al <NUMBER> studied hypocortisolism patients recovered sarscov patients intact hypothalamicpituitaryadrenal hpa axis time acquiring sarscov included study patients also symptoms like lethargy malaise lassitude fatigue weakness orthostatic dizziness anorexia apathy anxiety depression recovery three months recovery <NUMBER>·<NUMBER> patients hypocortisolism <NUMBER>·<NUMBER> central hypocortisolism depicted low adrenocorticotropic hormone acth levels interesting note majority patients received systemic glucocorticoids part treatment sars ruling possibility hpa axis suppression exogenous corticosteroid use hypocortisolism however transient resolved <NUMBER>·<NUMBER> patients within year average duration <NUMBER>·<NUMBER>±<NUMBER>·<NUMBER> months patients also reported resolution symptoms including orthostatic hypotension comparison start study six patients <NUMBER> continued residual hypocortisolism <NUMBER>year followup one still required hydrocortisone replacement findings sarscov sarscov<NUMBER> patients suggest actively monitoring biochemical changes like serum cortisol acth shall biochemical changes go unnoticed may complicate postsars recovery symptomatic patients orthostatic hypotension may require physiological doses hydrocortisone replacement hpa axis recovery addition patients adrenal insufficiency cushings syndrome increased risk sarscov<NUMBER> infection adhere enhanced preventive steps changes cells anterior pituitary noted biopsy samples sarscov patients <NUMBER> immunohistochemical staining number somatotrophs thyrotrophs corticotrophs reduced number lactotrophs gonadotrophs significantly increased findings correlated biochemical abnormalities increased prolactin luteinising hormone follicle stimulating hormone sarscov reported earlier chinese literature seasonal h<NUMBER>n<NUMBER> influenza virus h<NUMBER>n<NUMBER> pandemic associated increased severity greater risk morbidity mortality obese persons compared normal weight persons overweight obesity negatively impact cellular immune response h<NUMBER>n<NUMBER> influenza <NUMBER> obesity associated several chronic diseases like diabetes mellitus obstructive sleep apnoea surfactant dysfunction lungs may increase risk complications sarscov<NUMBER> intensive care management patients severe obesity always challenging difficult <NUMBER> likely obesity independent risk factor severe sarscov<NUMBER> illness investigated early studies linked increased mortality rates sarscov<NUMBER> patients presence diabetes mellitus increased glucose levels associated development ards worsening sarscov<NUMBER> illness requiring intubation mechanical ventilation hyperglycaemia useful predictor assess patients triage effectively provide early management strategies strict glucose management required patients reduce mortality central hypothyroidism central hypocortisolism seem occur commonly patients infected coronavirus changes usually transient occur illness recovery crucial information calls reassessment survivors current pandemic identifying changes early prompt management prevent complications prospective randomised clinical trials cohort studies today coronavirus <NUMBER>ncov pandemic considered great threat global health numerous deaths attributed deadly virus across world last months morbidity mortality reported across world last two months <NUMBER> documented details elsewhere everybody susceptible newlyemerged coronavirus people underlying conditions hypertension diabetes apt develop serious lifethreatening complications <NUMBER> although people osteoporosis taking osteoporosis medications neither greater risk contracting disease susceptible develop serious complications prevention osteoporotic fractures present situation utmost importance <NUMBER> however seeking medical attentions including treatment monitoring services osteoporotic patients makes higher risk infection matter fact todays resourceconstrained health systems developing developed world placing extra burden health systems quite irresponsible moreover patients osteoporosis diabetes exponentially increase risk contracting disease exposing hospitals healthcare facilities potentially remedied promoting usage digital health technology patients osteoporosis diabetes encouraged use telehealth services far avoid exposing highrisk clinical environments <NUMBER> iran unfortunately among countries higher numbers contracted diseased corona virus cases globe middle east <NUMBER> endocrinology metabolism research institute emri tehran university medical sciences tums assigned world health organization collaborating centre research education management diabetes osteoporosis since <NUMBER> collaboration continued <NUMBER> <NUMBER> capacity emri regularly designs carries different national international events objective promoting knowledge skills iranian clinicians scientists latest advances field endocrinology metabolic diseases many educational events sessions designed implemented direct supervision globallyrenowned organizations world health organization iof international osteoporosis federation past months collaboration domestic international organizations concerned scientist emri meticulously following covid<NUMBER> pandemic developments unfold main objective delivering best possible prevention management service people diabetes osteoporosis activities include design publication treatment protocols well professional public educational materials books booklets videos persian language published materials freely accessible iranian persianspeaking patients clinicians across world early beginnings outbreak emri published booklet entitled diabetes management sick days aimed easing psychological burden imposed patients diabetes caregivers publication freely available official website institute moreover simultaneously educational video clip persian language entitled diabetes management coronavirus produced published emri website initially view development robust infrastructure iranian diabetes academy ida <NUMBER> formed platform production dissemination valid credible information diabetes complications healthcare providers patient elearning technology addressing current epidemics instruction pamphlet patients diabetes caregivers entitled covid<NUMBER> outbreak guidance people diabetes published moreover based information provided international diabetes federation idf booklet entitled professional guideline management patients diabetes coronavirus pandemic adapted use iranian health care providers made accessible interested individuals organizations noteworthy moreover several cme modules persian diabetes management ida website immense benefit health care providers interested individuals freely access online modules promote knowledge skills diabetes management current pandemic similarly international osteoporosis foundation iof published set general recommendations people osteoporosis entitled covid<NUMBER> osteoporosis encourage patients continue taking medications avoid fracture risks also iof produced informative material entitled delays medication aims inform patients continuation modification medicine currently use likewise material iof vitamin coronavirus translated provide applied information taking vitamin supplements sunlight stay home aforementioned materials translated persian uploaded official website emri invaluable information accessible free charge moreover emri working develop online course education health care professionals management osteoporosis pandemic period concerning global strategy digital health success digital transformation healthcare sector requires stakeholders think new ways contribute conquering national global health goals pandemic coronavirus infectious disease <NUMBER> covid<NUMBER> caused severe acute respiratory syndrome coronavirus<NUMBER> sarscov<NUMBER> involved <NUMBER> million people accounting nearly <NUMBER> thousand deaths worldwide may <NUMBER> <NUMBER> <NUMBER> rising prevalence cardiometabolic disorders globally people comorbidities also expected increasingly inflicted covid<NUMBER> uncontrolled diabetes glycated hemoglobin hba<NUMBER>c <NUMBER> linked nearly <NUMBER> increased risk pneumoniarelated hospitalization bacterial infection <NUMBER> likewise several past viral pandemics witnessed increased morbidity mortality patients diabetes <NUMBER> population found diabetes middle east respiratory syndrome coronavirus merscov outbreak <NUMBER> patients diabetes odds ratio <NUMBER> <NUMBER> severe critical type merscov infection relative high <NUMBER> rate mortality compared overall population <NUMBER> <NUMBER> <NUMBER> similarly diabetes associated <NUMBER>fold increased risk hospitalization <NUMBER>fold risk admission intensive care unit icu <NUMBER> influenza h<NUMBER>n<NUMBER> outbreak <NUMBER> diabetes also independent risk factor acute complications death severe acute respiratory syndrome sarscov<NUMBER> outbreak <NUMBER> <NUMBER> studies patients covid<NUMBER> pandemic also found people diabetes hypertension obesity cardiovascular disease cvd chronic obstructive pulmonary disease copd significant increased risk severity well mortality compounded higher mortality increasing age body mass index aim article report narrative review available literature find association diabetes covid<NUMBER> terms risk severity mortality additionally also reviewed relationship glycemic control severity mortality covid <NUMBER> put perspective impact antidiabetes drugs boolean search carried find literature pubmed medrxiv google scholar databases till may <NUMBER> <NUMBER> using specific keywords include sarscov<NUMBER> covid<NUMBER> risk severity mortality glycemic control diabetes antidiabetic drugs interposition full text related articles english language supplementary appendix retrieved addition full text relevant cross references also retrieved noticed several studies collected data hospital time period suggesting significant overlap therefore carefully chose describe results mainly largest study reported outcomes descripting analysis addition studies high importance first case series <NUMBER> patients hospitalized covid<NUMBER> china huang et al <NUMBER> reported nearly <NUMBER> diabetes retrospective chinese studies followed soon reported prevalence diabetes varied <NUMBER> <NUMBER> larger caseseries n<NUMBER> china guan et al <NUMBER> reported diabetes prevalence nearly <NUMBER> largest reported database n<NUMBER> chinese centre disease control prevention ccdc showed approximately <NUMBER> diabetes prevalence patients covid<NUMBER> <NUMBER> showed estimated diabetes prevalence nearly <NUMBER> <NUMBER> ci <NUMBER> hu et al <NUMBER> showed diabetes prevalence <NUMBER> <NUMBER> ci <NUMBER> pooled study <NUMBER> studies n<NUMBER> covid<NUMBER> however caution required interpreting results first almost metaanalyses pooled data majority studies reported either single two centers china time period therefore highly likely many studies overlapped data may cause inaccurate results second majority earlier metaanalysis conducted pooled studies reported china include data part world finally available data yet clear whether chance contracting covid<NUMBER> higher patients diabetes since reported prevalence proportions could merely reflect higher prevalence diabetes across globe interestingly wang et al <NUMBER> reported prevalences diabetes covid<NUMBER> closely similar nationwide diabetes prevalence around <NUMBER> type <NUMBER> diabetes china collectively yet clear whether presence diabetes increases risk contracting covid<NUMBER> date eight metaanalysis assessed severity covid<NUMBER> patients comorbidities including diabetes <NUMBER> metaanalysis calculated either relative risk rr odds ratio found significant <NUMBER>to <NUMBER>fold increase uniformity definition severity across studies included metaanalyses varied study study severe defined world health organization following present respiratory frequency ≥<NUMBER>minute blood oxygen saturation ≤<NUMBER> pao<NUMBER>fio<NUMBER> ratio <NUMBER> andor lung infiltrates <NUMBER> lung field within <NUMBER> hours ccdc <NUMBER> defined severe covid<NUMBER> following present hypoxia dyspnea <NUMBER> lung involvement within <NUMBER> hours second mentioned earlier many studies included metaanalyses overlapped data third metaanalyses calculated risk odds ratio severity comparing patients diabetes required mechanical ventilation intensive care unit icu admission versus patient diabetes require either thus neither metaanalyses calculated risk severity patients diabetes versus without diabetes cohorts therefore conclusion metaanalyses suggest patients severe covid<NUMBER> likely diabetes fourth comorbidities commonly associated diabetes also increase severity hypertension obesity cvd chronic kidney disease ckd adjusted conducting metaanalyses finally metaanalyses yet answered whether patients diabetes higher chance severe covid<NUMBER> compared nondiabetic populations end one retrospective study although smaller one looked severity patients diabetes covid<NUMBER> absence comorbidities compared groups without diabetes guo et al <NUMBER> compared hematological biochemical profile total <NUMBER> patients covid<NUMBER> <NUMBER> diabetes compared <NUMBER> without diabetes interestingly hematological biochemical parameters generally characterized marker severe covid<NUMBER> significantly higher patients diabetes compared cohorts without diabetes significant decrease lymphocyte red blood cells rbc level hemoglobin marked increase neutrophils erythrocyte sedimentation rate esr ddimer observed patients diabetes compared cohorts without diabetes moreover patients diabetes compared without diabetes without comorbidities n <NUMBER> vs <NUMBER> respectively even biochemical hematological markers severe covid<NUMBER> significantly higher cohorts diabetes significant increase neutrophil esr αhydroxybutyrate dehydrogenase lactic dehydrogenase alanine aminotransferase alt fibrinogen creactive protein ferritin crp interleukin<NUMBER> il<NUMBER> significant decrease lymphocyte hemoglobin rbc albumin observed patients diabetes compared cohorts without diabetes changes clearly point poor prognosis suggests excessive inflammatory response cytokine storm increase hypercoagulability patients diabetes compared groups without diabetes indeed computed tomography scan ctscan chest based scoring scale also fared poorly suggestive severe covid<NUMBER> patients diabetes compared cohorts without diabetes another large retrospective study conducted zhu et al <NUMBER> similarly chest ct scan significantly unilateral bilateral lesions cohorts diabetes compared patients without diabetes significant increase acute respiratory syndrome ards septic shock acute kidney injury acute heart injury requirement oxygen inhalation noninvasive invasive ventilation including extracorporeal membrane oxygenation ecmo observed patients diabetes compared groups without diabetes p<NUMBER> odds ratio inhospital mortality nearly <NUMBER>fold higher <NUMBER> <NUMBER> ci <NUMBER> patients diabetes covid<NUMBER> univariate analysis n<NUMBER> conducted zhou et al <NUMBER> although significant multivariate regression analysis similarly bivariate cox regression analysis conducted wu et al <NUMBER> nonsignificant increase trend hazard ratio hr death hr <NUMBER> <NUMBER> ci <NUMBER> observed patients diabetes covid<NUMBER> nevertheless ccdc reported case fatality rate cfr <NUMBER> patients diabetes compared cfr <NUMBER> overall population <NUMBER> patients covid<NUMBER> <NUMBER> indeed three metaanalysis studied mortality outcome shown huang colleagues <NUMBER> pooled data <NUMBER> studies also found significant increase mortality rr <NUMBER> <NUMBER> ci <NUMBER> mentioned earlier metaanalyses two important limitation include overlapping data included studies analyzing mortality patients diabetes cohorts without diabetes covid<NUMBER> therefore metaanalysis suggests patients died covid<NUMBER> likely diabetes rather suggesting patients diabetes likely succumb death compared cohorts without diabetes <NUMBER> large retrospective study n<NUMBER> zhu et al reported significant <NUMBER> relative increase allcause mortality hr <NUMBER> <NUMBER> ci <NUMBER> p<NUMBER> patients diabetes n<NUMBER> compared groups without diabetes n<NUMBER> covid<NUMBER> even adjustment multiple confounding factors <NUMBER> previous viral pandemics sarscov<NUMBER> merscov h<NUMBER>n<NUMBER> influenza suggested patients diabetes poor glycemic control significant increased risk complications death limited number studies date analyzed outcomes severity mortality stratified level glycemia patients diabetes covid<NUMBER> interestingly bode et al <NUMBER> reported significantly higher percentage death <NUMBER> vs <NUMBER> p<NUMBER> patients covid<NUMBER> n<NUMBER> uncontrolled hyperglycemia defined ≥<NUMBER> blood glucose value <NUMBER> mgdl within <NUMBER>hour period diagnosed diabetes hba<NUMBER>c <NUMBER> compared patients diabetes hba<NUMBER>c ≥<NUMBER> suggests stress hyperglycemia may worser outcome icu compared known patient diabetes however findings based small number cohorts relatively large retrospective study <NUMBER> patients diabetes zhu et al <NUMBER> reported significant increase septic shock <NUMBER> vs <NUMBER> p<NUMBER> ards <NUMBER> vs <NUMBER> p<NUMBER> acute kidney injury <NUMBER> vs <NUMBER> p<NUMBER> acute heart injury <NUMBER> vs <NUMBER> p<NUMBER> patients poorlycontrolled diabetes n<NUMBER> defined blood glucose <NUMBER> mgdl compared wellcontrolled diabetes n<NUMBER> groups defined blood glucose <NUMBER> mgdl adjusted hr allcause mortality <NUMBER> <NUMBER> ci <NUMBER> p<NUMBER> patients wellcontrolled vs poorlycontrolled diabetes interestingly increased signal ards acute kidney injury acute heart injury remained highly significant poorly controlled arm even compared propensity scorematched groups matched comorbidities include hypertension cardiovascular disease cerebrovascular disease chronic kidney disease moreover adjusted hr allcause mortality <NUMBER> <NUMBER> ci <NUMBER> p<NUMBER> wellcontrolled group compared poorly controlled diabetes even <NUMBER> propensitymatching collectively findings suggest poorglycemic control blood glucose <NUMBER> mgdl <NUMBER> mmoll associated significantly higher risk severity mortality people without diabetes compared people wellcontrolled blood glucose blood glucose <NUMBER> mgdl <NUMBER> mmoll data currently available differential effects antidiabetic drugs patients diabetes covid<NUMBER> several expert groups across world opined dos donts regards choosing interestingly expert groups including us proposed avoiding metformin sodium glucose cotransporter<NUMBER> inhibitors sglt<NUMBER>is particular sicker patients moderate severe covid<NUMBER> anticipation increased lactic acidosis euglycemic diabetic ketoacidosis eudka drugs respectively <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> others also proposed concerns light interaction angiotensin converting enzyme<NUMBER> ace<NUMBER> covid<NUMBER> since antidiabetic drugs associated overexpression ace<NUMBER> different human organs <NUMBER> however clear evidence drugs could detrimental patients diabetes covid<NUMBER> counterintuitively also possible anticipated cardiovascular benefit metformin cardiorenal benefit sglt<NUMBER>is would longer stopping drugs table <NUMBER> summarizes expected concerns possible benefit antidiabetic agents patients diabetes covid<NUMBER> metformin virtue inhibiting amp activated protein kinase anticipated antiproliferative immunomodulatory effects mouse model metformin shown protective role legionella pneumonia human studies past also examined role metformin sepsis lung diseases liang et al <NUMBER> metaanalysis <NUMBER> observational studies showed metformin use patients diabetes prior admission significantly lowered mortality rate <NUMBER> <NUMBER> ci <NUMBER> p <NUMBER> sepsis compared nonusers metaanalysis <NUMBER> observational studies zhang et al <NUMBER> found people diabetes metformin significantly lower incidence active tuberculosis rr <NUMBER> <NUMBER> zhu et al <NUMBER> reported significantly different proportion patients diabetes covid<NUMBER> receiving metformin <NUMBER> propensitymatched wellcontrolled group compared poorlycontrolled arm <NUMBER> vs <NUMBER> p<NUMBER> still showed significantly less severe covid<NUMBER> less mortality former group hints anticipated harm metformin perhaps possible benefit although needs confirmed studies animal studies suggested increased ace<NUMBER> expression liver tissues one mechanisms pioglitazone reduces steatohepatitis <NUMBER> pioglitazone also associated causing downregulation adam<NUMBER> disintegrin metalloproteinase<NUMBER> ace<NUMBER> cleaving enzymes human skeletal muscles lead increase ace<NUMBER> indeed purported increase ace<NUMBER> pioglitazone led researchers propose avoiding drug patients diabetes anticipation theoretical increased chance contracting covid<NUMBER> <NUMBER> interestingly human studies showed increased risk pneumonia thiazolidinediones tzd use compared sulfonylureas sus nested casecontrolled study spanish general practice research database studied <NUMBER> cases community acquired pneumonia cap total <NUMBER> cases gorricho et al <NUMBER> found <NUMBER>fold adjusted <NUMBER> <NUMBER> ci <NUMBER> increase cap tzd use compared sus singh et al <NUMBER> metanalysis <NUMBER> randomized controlled trial n<NUMBER> patients type <NUMBER> diabetes also showed significantly higher risk lower respiratory tract infection pneumonia tzd compared placebo active treatment rr <NUMBER> <NUMBER> ci <NUMBER> <NUMBER> contrast experimental studies found protective effect tzd lung inflammatory markers reduction several inflammatory markers tumor necrosis alpha tnfα il<NUMBER> il<NUMBER> ferritin reduction fibrotic lung reaction silicaexposed rats pioglitazone may suggest possible direct beneficial effect lung inflammation <NUMBER> several studies humans also shown significant reduction proinflammatory cytokines including il<NUMBER>b il<NUMBER> il<NUMBER> tnfα markers insulin resistance pioglitazone <NUMBER> findings led researchers propose pioglitazone patients diabetes covid<NUMBER> <NUMBER> concern overexpression ace<NUMBER> thus theoretically increased risk covid<NUMBER> historically older sus tolbutamide shown significant reduction pneumocystis carinii pneumonia experimental studies due structural similarities sulfonamide antibiotics trimethoprimsulfamethoxozole <NUMBER> increase cap observed modern sus compared tzd reported gorricho et al <NUMBER> mentioned earlier however hypoglycemic potential warrants lower dosage since lymphocyte protein cd<NUMBER> structurally similar dipeptidyl peptidase<NUMBER> dpp<NUMBER> expectedly apprehension whether inhibition dpp<NUMBER> dpp<NUMBER>inhibitors dpp<NUMBER>is associated increased risk infections although initial report increase nasopharyngitis dpp<NUMBER>is recent modeling study rule interaction sarscov<NUMBER> dpp<NUMBER> despite ace<NUMBER> functional receptor <NUMBER> one hypothesis suggested like rna viruses inherit high mutation rate sarscov<NUMBER> may continually mutate adapt changes environment including types invading cells possible sarscov<NUMBER> also mutate like another novel coronavirus invade cells via coupling dpp<NUMBER> principal receptor merscov infections provoking theory proposed easy mutational characteristics sarscov<NUMBER> dpp<NUMBER>is effective tool mutant coronavirus <NUMBER> similar optimism expressed previously suggesting dpp<NUMBER> may represent potential target preventing reducing risk progression acute respiratory complications type <NUMBER> diabetes may add covid<NUMBER> infection <NUMBER> optimism primarily based potential antiinflammatory effects dpp<NUMBER>is possibly reduce burden cytokine storm covid<NUMBER> however antiinflammatory effect dpp<NUMBER>is equivocal protect ensuing cytokine storm covid<NUMBER> <NUMBER> although adequate data dpp<NUMBER>is currently patients diabetes covid<NUMBER> study zhu et al <NUMBER> reported significantly different proportion patients diabetes covid<NUMBER> receiving dpp<NUMBER>is propensitymatched wellcontrolled arm vs poorlycontrolled arm <NUMBER> vs <NUMBER> p<NUMBER> significantly less severe covid<NUMBER> lesser mortality former group might hint possible benefit dpp<NUMBER>is although needs proven studies sglt<NUMBER>is associated increase ace<NUMBER> expression kidney therefore theoretically concern higher chance covid<NUMBER> <NUMBER> april <NUMBER> <NUMBER> <NUMBER> patients moderate severe manifestation duration without need mechanical ventilator dare<NUMBER> include patients history least one following hypertension type <NUMBER> diabetes atherosclerotic cardiovascular disease heart failure andor chronic kidney disease stage <NUMBER> <NUMBER> egfr ≥<NUMBER> mlmin<NUMBER>m <NUMBER> receive <NUMBER> mg dapagliflozin placebo <NUMBER>days primary objective dare<NUMBER> time first occurrence either death cause newworsened organ dysfunction <NUMBER> days follow defined least one following respiratory decompensation new worsening congestive heart failure requirement vasopressor therapy andor inotropic mechanical circulatory support ventricular tachycardia fibrillation lasting least <NUMBER> seconds andor associated hemodynamic instability pulseless electrical activity resuscitated cardiac arrest initiation renal replacement therapy expected completion december <NUMBER> <NUMBER> growing argument dapagliflozin particular shown decrease lactic acidosis thus potential reverse acidbase balance inside cells hypoxia prevent cell injury cytokine storm covid<NUMBER> illness patients diabetes <NUMBER> glp<NUMBER> receptor agonists glp<NUMBER>ras liraglutide shown increase ace<NUMBER> expression lungs heart improved right ventricular hypertrophy rats type <NUMBER> diabetes <NUMBER> experimental study also suggested antiinflammatory effects therapeutic benefit acute lung injury liraglutide <NUMBER> however purported increase ace<NUMBER> expression raise theoretical concern patients covid<NUMBER> <NUMBER> moreover since glp<NUMBER>ras associated increased gastrointestinal adverse events experts suggested avoiding class drugs sick days nevertheless since several glp<NUMBER>ras shown significant cardiovascular benefit cvots stopping drugs may disadvantageous insulin always preferred modality emergent situation irrespective degree renal hepatic dysfunction thus used stage covid<NUMBER> subcutaneous sc insulin patients diabetes mild moderate covid<NUMBER> taking food orally challenging issue however hospitalized covid<NUMBER> patient diabetes poor oral intake mechanical ventilator eventually need intravenous insulin infusion hourly <NUMBER>hourly monitoring frequent adjustment infusion rates would increase chance exposure health care providers hcp minimize frequent exposure use sc short acting insulin analogues one approach however role critically ill patients fully known alternatively minimize exposure even single per day sc dose longacting basal insulin could attractive option demonstrated one study thailand found similar outcome compared continuous insulin infusion critically ill patients <NUMBER> models insulin pump continuous subcutaneous insulin infusion csii insulin rates remotely adjusted via bluetooth useful minimize exposure hcp increased prevalence diabetes noted across studies metaanalysis data yet suggest increased risk contracting covid<NUMBER> people diabetes general prevalence appeared similar countrywise prevalence diabetes however available studies clearly suggest patients diabetes significantly higher severe variety covid<NUMBER> well increased mortality compared cohorts without diabetes data also suggest poorlycontrolled diabetes stress hyperglycemia blood glucose <NUMBER> mgdl <NUMBER> mmoll significantly higher risk severe covid<NUMBER> increased mortality compared patients wellcontrolled blood glucose blood glucose <NUMBER> mgdl <NUMBER> mmoll collectively findings suggest every clinician strive achieve bloodglucose targets <NUMBER> mgdl without provoking hypoglycemia patients diabetes stress hyperglycemia covid<NUMBER> although large data currently available regards role antidiabetic agents patients covid<NUMBER> available evidence yet fully clear specific drugs favorable unfavorable effect patients diabetes nonetheless findings call increased emphasis future preventative therapies vaccination programs patients diabetes addition traditional risk prevention social distancing selfisolation concern beneficial effect due antiinflammatory action antiinflammatory positive anabolic effects makes insulin choice infections continued stage whether people diabetes higher susceptibility covid<NUMBER> currently unknown perception risk higher infection severe disease example first three deaths related hong kong occurred people diabetes large series <NUMBER> cases <NUMBER> laboratoryconfirmed covid<NUMBER> cases <NUMBER> china classified severe <NUMBER> sixteen percent severe disease diabetes contrast <NUMBER> remaining <NUMBER> cases mild disease diabetes likewise <NUMBER> severe disease hypertension compared <NUMBER> among mild disease highlighting increased risk adverse outcomes among chronic diseases like diabetes currently unknown people diabetes hypertension chronic diseases severely affected covid<NUMBER> one possible explanation involves angiotensinconverting enzyme <NUMBER> ace<NUMBER> ace<NUMBER> present cardiac kidney lung intestinal tissue converting angiotensin ii angiotensin <NUMBER> counteracts effects angiotensin ii promotes vasodilation similar manner coronavirus caused severe acute respiratory syndrome sarscov novel coronavirus responsible covid<NUMBER> utilizes ace<NUMBER> surfaces epithelial cells bind gain entry infected cells <NUMBER> <NUMBER> diabetes conditions hypertension associated activation reninangiotensin system different tissues furthermore people diabetes hypertension often treated ace inhibitors angiotensin receptor blockers arbs lead increased expression ace<NUMBER> thereby facilitating viral uptake increasing risk severe infection people diabetes <NUMBER> whilst observations led suggestions switching people reninangiotensin system blockers agents may modify disease risk <NUMBER> would premature unwarranted absence experimental evidence support approach contrary treatment arbs proposed potential therapeutic strategy covid<NUMBER> <NUMBER> supported observations blocking reninangiotensin system animal models attenuated lung injury caused sarscov also utilizes ace<NUMBER> <NUMBER> recent position statement european society cardiology also strongly recommends physicians patients continue treatment usual antihypertensive treatment clinical scientific evidence suggest treatment ace inhibitors arbs discontinued covid<NUMBER> infection <NUMBER> ª <NUMBER> diabetes uk direct infection however issue people diabetes infection outbreak challenged delivery healthcare many ways healthcare professionals hospitals may redeployed caring increasing caseloads people admitted fever suspected disease workforce may diminished healthcare providers become affected disease clinic visits may postponed treatment diabetesrelated issues may delayed may unwillingness people diabetes expose potential infection may avoid attendance hospitals clinics retinal screening although may overcome certain extent utilising phone video consultations forms communication healthcare delivery becomes increasingly interrupted fragmented access basic medical supplies insulin may become increasingly difficult somewhat akin challenges faced natural disasters panic buying already made harder people diabetes obtain alcohol wipes gel perform hygiene injection glucose monitoring regions lack access medications supplies also experienced people need undergo quarantine colleagues hong kong example contacted people quarantined cruise ship run medications including insulin due unexpected delays travels difficulty gaining access medications another contagion occurred result covid<NUMBER> fear resulting anxiety sleep disturbances may adversely affect glucose control important lessons learned regard controlling epidemic shared highlighted back march <NUMBER> almost exactly <NUMBER> years ago several asian countries subsequently countries hit sars outbreak caused sars coronavirus <NUMBER> since many measures implemented region prevent similar outbreaks infectious diseases example hong kong measures include increasing distances inpatient beds provision negativepressure ventilation rooms isolation wards major public hospitals defined protocols protection aerosolgenerating procedures well public health response alert system perhaps important however response attitude general public experienced threat major infectious disease outbreak population whole developed high degree awareness tenacity preparedness part help avoid transmission hong kong people accepted need frequent handwashing environmental hygiene wearing surgical masks regardless whether one respiratory symptoms tolerance towards social isolation avoiding unnecessary gatherings outbreak socialdistancing measures coupled government policies towards restricting travel limiting transmission largescale institutions universities schools rigorous contact tracing early testing diagnosis isolation treatment appear effect controlling spread asian countries flattening epidemic curve <NUMBER> increasing number countries find battling rapid rise cases lessons learned serve inform guide public health response alarming pandemic lessons learned europe lastly another casualty covid<NUMBER> epidemic years diabetic medicine symposium <NUMBER> line many medical organizations diabetes uk took decision cancel years professional conference bid limit spread virus although people cannot hear lectures accompanying review articles still available journal <NUMBER> <NUMBER> <NUMBER> bariatric surgery used decades treat patients severe obesity <NUMBER> global guidelines established diabetes surgery summit dss international consensus conference series formally recognised gastrointestinal surgery standard therapy type <NUMBER> diabetes practice known metabolic surgery <NUMBER> coronavirus disease <NUMBER> covid <NUMBER> outbreak unprecedented pressure free inpatient capacity intraoperative risks viral contagion among patients staff hospitals worldwide obliged postpone elective operations including bariatric metabolic surgery increased hazards severe covid<NUMBER> complications patients obesity type <NUMBER> diabetes <NUMBER> support rationale pause elective surgery peak pandemic return normal services gradual surgeons competing reduced capacity address backlog elective procedures hence access bariatric metabolic surgery continue constrained given uncertainty regarding effects duration covid<NUMBER> outbreak combined progressive nature obesity diabetes related conditions delaying bariatric metabolic surgery could increase risks morbidity mortality surgical candidates risk harm however variable among individuals depending type severity disease indications bariatric metabolic surgery traditional weightcentric criteria patient selection bariatric surgery still commonly used today reflect severity disease <NUMBER> therefore cannot used prioritise treatment based actual clinical needs furthermore physical distancing policies continued lockdowns might limit adherence lifestyle interventions worsening metabolic deterioration among candidates bariatric metabolic surgery additionally reduced access nonurgent care covid<NUMBER> pandemic might impede postoperative monitoring potential surgical nutritional complications clear urgent need therefore exists strategies mitigate harm patients covid<NUMBER> pandemic approaches include nonsurgical interventions optimise metabolic weight control patients awaiting surgery telemedicine protocols postoperative surveillance use appropriate criteria triage surgical candidates foreseeable period reduced capacity elective surgery address issues dss <NUMBER> organisers directed group international experts assess effect covid<NUMBER> pandemic candidates surgical treatment obesity type <NUMBER> diabetes specific aim develop criteria help prioritise bariatric metabolic surgery elective surgery resumed beyond elective surgery refers operations planned scheduled advance procedures however optional important lifechanging implications access elective surgery reduced doctors prioritise patients greatest need greater risk harm delayed treatment healthcare systems elective surgery categorised urgent semiurgent nonurgent <NUMBER> <NUMBER> urgent elective surgery required within <NUMBER> days conditions might deteriorate quickly semiurgent conditions although likely deteriorate quickly could reasonably cause severe pain dysfunction harm delayed beyond <NUMBER> months nonurgent elective surgery planned conditions unlikely cause substantial discomfort dysfunction harm treated within <NUMBER> year although complications bariatric metabolic operations require emergency surgical treatment eg haemorrhage leak intestinal obstruction bariatric metabolic procedures represent genuine elective surgery date however consensus exists criteria identify urgent semiurgent nonurgent indications bariatric metabolic surgery basis type severity patients conditions many reasons bariatric metabolic operations suspended intense phase covid<NUMBER> pandemic including infection risks among patients staff factors inherent operations increased hazards severe covid<NUMBER> complications among patients obesity type <NUMBER> diabetes laparoscopic surgery involves aerosolgenerating techniques carbon dioxide pneumoperitoneum electro cautery ultrasonic shearing techniques could easily increase risk viral contagion staff <NUMBER> <NUMBER> including severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> upper gastrointestinal endoscopy another aerosolproducing procedure also commonly done bariatric metabolic surgery patients undergoing major surgery risk lifethreatening inflammatory complications infection including viruses systemic inflammatory response syndrome sepsis <NUMBER> although conclusive evidence laparoscopy upper endoscopy promote covid<NUMBER> transmission postponing elective metabolic bariatric interventions acute phase covid<NUMBER> outbreak seems sensible except urgent revisional surgery emergency endoscopic interventions complications eg haemorrhage stoma stenosis leaks despite potential higher risk contagion laparoscopic approach bariatric metabolic surgery associated substantial benefits compared traditional open surgery especially patients severe obesity benefits include lower rates mortality complications including pulmonary procedural shorter hospital stays <NUMBER> <NUMBER> reasons laparoscopic access remain preferred approach open techniques elective bariatric metabolic surgery resumes appropriate personal protective equipment used however given increased risk sarscov<NUMBER> infection staff obesity increases risk complications viral respiratory infections <NUMBER> influenza h<NUMBER>n<NUMBER> pandemic california <NUMBER> people died obesity higher bmi associated mortality <NUMBER> patients admitted intensive care sarscov<NUMBER> class <NUMBER> obesity bmi <NUMBER> kgm² independent risk factor disease severity <NUMBER> similarly patients diabetes augmented risk severe covid<NUMBER> mortality <NUMBER> <NUMBER> <NUMBER> <NUMBER> several mechanisms suggested increase risk complications viral infections obesity type <NUMBER> diabetes including lowgrade chronic inflammation overproduction proinflammatory cytokines reduced natural killer cell number activity impaired antigenstimulation responses <NUMBER> <NUMBER> <NUMBER> another factor might role relationship obesity diabetes increased risk complications sarscov<NUMBER> enters host cells binding angiotensinconvertingenzyme <NUMBER> ace<NUMBER> receptor ace<NUMBER> transforms angiotensin <NUMBER> angiotensin <NUMBER> thereby reducing vaso constriction sodium retention inflammation metabolic degeneration <NUMBER> chronic hyperglycaemia regulates ace<NUMBER> expression <NUMBER> reduction ace<NUMBER> covid<NUMBER> infection could contribute hyperinflammation respiratory failure patients type <NUMBER> diabetes <NUMBER> people obesity also prone hypoventilation syndrome cardiovascular disease <NUMBER> heart failure <NUMBER> conditions could increase risk covid<NUMBER> mortality elective bariatric metabolic surgery resumes pandemic contained sarscov<NUMBER> probably still circulate population given risks severe complications covid<NUMBER> patients obesity type <NUMBER> diabetes recommend covid<NUMBER> screening mandatory preoperatively patients considering bariatric metabolic surgery class <NUMBER> obesity type <NUMBER> diabetes common indications bariatric metabolic surgery associated reduced quality life increased morbidity mortality ability cause lifethreatening complications however varies depending severity stage disease burden comorbidities degree harm delaying metabolic bariatric surgery depends patients condition surgical efficacy different stages disease availability effectiveness nonsurgical therapies control disease progression awaiting surgery understanding prognostic factors morbidity mortality obesity type <NUMBER> diabetes help define criteria surgical prioritisation diabetes major cause morbidity death including cardiovascular renal neurological retinal complications approximately twothirds people diabetes die cardiovascular disease relative risk <NUMBER>·<NUMBER>·<NUMBER> times greater people without diabetes <NUMBER> biological progression type <NUMBER> diabetes characterised declining βcell function continuing insulin resistance manifested clinically deteriorations multiple parameters including hba <NUMBER>c fasting postprandial glucose levels uk prospective diabetes study <NUMBER> reported significant associations hyperglycaemia development diabetes complications death <NUMBER> risk reduction diabetesrelated endpoint <NUMBER> absolute hba <NUMBER>c reduction factors beyond hyperglycaemia also influence type <NUMBER> diabetes prognosis triad study <NUMBER> <NUMBER> predictors allcause mortality <NUMBER> years <NUMBER> years study followup included older age male sex nonhispanic white race lower education income longer duration diabetes lower bmi hypertension macrovascular disease retinopathy nephropathy neuropathy among specific predictors cardiovascular mortality also treatment insulin without oral medication higher ldl cholesterol history nephropathy transient ischaemic attack stroke angina myocardial infarction coronary artery peripheral vascular disease use antihypertensive cholesterollowering medications obesity increases risks many illnesses including diabetes hypertension dyslipidaemia liver disease coronary artery cerebrovascular disease many cancers cholelithiasis infertility psychosocial dys function osteoarthritis chronic kidney disease also covid<NUMBER> together complications power fully reduce quality life exacerbate obesityassociated mortality even covid<NUMBER> obesity reduced life expectancy <NUMBER> years <NUMBER> notably higher allcause mortality associated obesity class <NUMBER> bmi <NUMBER>·<NUMBER> kgm² <NUMBER> bmi ≥<NUMBER> kgm² corresponding candidates bariatric surgery class <NUMBER> obesity bmi <NUMBER>·<NUMBER> kgm² <NUMBER> obesity hypoventilation syndrome obesityassociated heart failure substantially increase mortality obesity hypoventilation syndrome represents combination obesity chronic daytime hypercapnia <NUMBER> <NUMBER> prevalence obesity hypoventilation syndrome highest among patients bmi <NUMBER> kgm² <NUMBER> mortality untreated obesity hypoventilation syndrome high <NUMBER> <NUMBER>·<NUMBER> years diagnosis <NUMBER> obesity heart failure associated increased mortality <NUMBER>unit increase bmi heart failurerelated mortality increases <NUMBER>·<NUMBER> times <NUMBER> since bmi alone reflect obesityrelated mortality morbidity staging systems kings obesity criteria <NUMBER> edmonton obesity staging system eoss <NUMBER> developed assess individual patients risk basis evidence subclinical established endstage comorbidities <NUMBER> retrospective application eoss data national health nutrition examination survey showed patients stages <NUMBER> eoss increased allcause mortality compared stages <NUMBER> <NUMBER> finding supports idea presence type severity obesityrelated complications addition bmi <NUMBER> inform decision making prioritisation treatment especially surgery nonalcoholic fatty liver disease characterised excess hepatic fat aggressive form nonalcoholic steatohepatitis includes hepatocyte injury inflammation fibrosis <NUMBER> <NUMBER> <NUMBER> two conditions affect <NUMBER> western population rates rising worldwide <NUMBER> <NUMBER> patients obesity diabetes nonalcoholic fatty liver disease nonalcoholic steatohepatitis <NUMBER> <NUMBER> nonalcoholic steatohepatitis lead cirrhosis <NUMBER> cases liver failure hepatocellular carcinoma <NUMBER> beyond liverrelated mortality nonalcoholic steatohepatitis substantially increase microvascular macrovascular complications cardiovascular mortality patients obesity type <NUMBER> diabetes <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> nonrandomised trials suggest rouxeny gastric bypass resolves histological features nonalcoholic steatohepatitis <NUMBER> patients <NUMBER> <NUMBER> randomised clinical trials observational studies show patients classes obesity bariatric metabolic surgery promotes greater longterm weight loss best available nonsurgical interventions regardless operation chosen <NUMBER> <NUMBER> <NUMBER> <NUMBER> multiple obser vational studies also indicate bariatric metabolic surgery lowers longterm risk allcause mortality compared matched nonsurgical patients <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> data eight observational studies involving total <NUMBER> <NUMBER> patients suggest bariatric metabolic surgery associated reduced risk types cancer odds ratio or<NUMBER>·<NUMBER> <NUMBER> ci <NUMBER>·<NUMBER>·<NUMBER> obesityassociated cancer or<NUMBER>·<NUMBER> <NUMBER> ci <NUMBER>·<NUMBER>·<NUMBER> <NUMBER> <NUMBER> <NUMBER> without exception <NUMBER> allcause mortality studies published date shows patients bariatric metabolic surgery live longer matched nonsurgical controls <NUMBER> concerning type <NUMBER> diabetes least <NUMBER> randomised controlled trials comparing bariatric metabolic surgery conventional diabetes therapies ie lifestyle plus medication patients type <NUMBER> diabetes show surgery superior control hyperglycaemia reduction cardiovascular overall mortality risk improvement quality life reduction risk renal complications <NUMBER> <NUMBER> <NUMBER> safety bariatric metabolic surgery compares favourably elective operations including hysterectomy chole cystectomy knee replacement surgical treatments diabetes highly costeffective cost per qualityadjusted lifeyear ranging us<NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> based evidence dss guidelines formally endorsed <NUMBER> worldwide medical scientific organisations recognised payers worldwide recommend consideration bariatric metabolic surgery appropriate candidates including class <NUMBER> obesity achieve adequate glycaemic control medical therapy <NUMBER> delay bariatric metabolic surgery occurring due covid<NUMBER> augment burden disease among surgical candidates increase particularly affect patients type <NUMBER> diabetes given metabolic surgery causes remission hyperglycaemia cases <NUMBER> likelihood hyperglycaemia remission however depends upon soon operation done natural history diabetes algorithms designed predict surgical remission eg diarem<NUMBER> addiarem diabetter abcd <NUMBER> <NUMBER> <NUMBER> <NUMBER> consistently show longstanding disease one powerful indicators failure achieve benefit <NUMBER> remission rates drop notably <NUMBER> years diabetes moreover sos study <NUMBER> reported substantially lower type <NUMBER> diabetes remission among patients <NUMBER> years known disease <NUMBER> years known disease thus delaying metabolic surgery reduces chances diabetes remission delayed metabolic surgery might cause even greater harm patients type <NUMBER> diabetes higher risk microvascular macrovascular complications mortality especially medications lifestyle interventions achieving adequate metabolic control patients without diabetes severe respiratory obesity hypoventilation syndrome cardiac renal complications obesity individuals weight reduction crucial advancing timesensitive lifesaving treatments eg organ transplants also greater risks harm delaying bariatric metabolic surgery patients surgically remediable metabolic diseases especially diabetes incur healthcare costs per day without conditions studies compared costs <NUMBER> years surgical nonsurgical patients found pharmacy expenses decrease substantially bariatric metabolic surgery compared matched nonsurgical patients <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> primarily due lower diabetes medication costs <NUMBER> hence metabolic surgery decreases daily healthcare costs especially patients requiring multidrug therapy longer surgery delayed patients less costsaving becomes various nonsurgical options used mitigate harm delaying bariatric metabolic surgery manage patients surgery panel <NUMBER> regarding need optimise glycaemic control patients type <NUMBER> diabetes especially advanced microvascular macrovascular complications <NUMBER> considered available evidence pharmacological strategies promote weight loss glucagonlike peptide<NUMBER> receptor agonists glp<NUMBER>ra sodiumglucose cotransporter <NUMBER> sglt<NUMBER> inhibitors <NUMBER> glp<NUMBER>ras reduce hba <NUMBER>c <NUMBER> <NUMBER> promoting clinically relevant weight loss <NUMBER> sglt<NUMBER> inhibitors however might contraindicated covid<NUMBER> concerns potential subclinical vascular congestion risk acute metabolic decompensation associated drugs <NUMBER> also considered available data regarding efficacy dietary pharmacological interventions weight loss <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> strategy achieve weight loss weight maintenance patients multiple weightresponsive comorbidities face prolonged waiting times bariatric metabolic surgery regarding strategies maximise surgical outcomes patients already surgery recommendations based results studies investigating efficacy pharmacological approaches people persistent recurrent type <NUMBER> diabetes surgery among individuals recent study <NUMBER> showed glp<NUMBER>ra liraglutide reduce hba <NUMBER>c <NUMBER>·<NUMBER> <NUMBER> additional weight loss reviewed existing evidencebased recommendations postoperative nutritional care <NUMBER> define safe pragmatic methods virtual consultation telemedicine panel <NUMBER> even covid<NUMBER> pandemic metabolic bariatric surgery underused many reasons including misconceptions stigma obesity bariatric surgery <NUMBER> barriers might penalise candidates surgery times limited resources given seriousness diseases require metabolic bariatric surgery clinicians hospital managers policy makers ensure operations delayed widespread misconception last resort <NUMBER> eventually covid<NUMBER> crisis abate elective operations resume leaving enormous backlog patients would benefit bariatric metabolic surgery prioritise serve first limited resources broad level answer simple patients well enough safe surgical candidates preference afforded greatest risk morbidity mortality disease probable risk reduced surgery logic would apply instance many surgical candidates poorly controlled type <NUMBER> diabetes substantial metabolic respiratory cardiovascular disease traditional bmicentric criteria patient selection however tend skew access bariatric metabolic surgery opposite direction despite strong evidence surgery achieves greatest health benefits among patients type <NUMBER> diabetes minority operations preoperative type <NUMBER> diabetes cardiometabolic disease <NUMBER> furthermore many publicly funded healthcare systems eg uk national health service candidates bariatric metabolic surgery currently placed single elective surgery waiting list regardless indication priority established largely firstcome firstserved basis rather nonsurgical options mitigate harm delaying surgery • glycaemic control optimised patients awaiting metabolic surgery type <NUMBER> diabetes especially advanced microvascular macrovascular complications desirable prepare surgery also case severe acute respiratory syndrome coronavirus <NUMBER> infection • patients achieve glycaemic targets lifestyle modifications metformin addition glucagonlike peptide<NUMBER> receptor agonist glp<NUMBER>ra sodiumglucose cotransporter <NUMBER> sglt<NUMBER> inhibitor advance combined goals improving metabolic control causing weight loss limiting weight gain use sglt<NUMBER> inhibitors however recommended case acute coronavirus disease <NUMBER> covid<NUMBER> infection concerns potential subclinical vascular congestion risk acute metabolic decompensation associated drugs • patients multiple weightresponsive comorbidities face prolonged waiting times surgery dietary pharmacological interventions weight control might become necessary • diets higher protein content lower glycaemic index effective considered • among patients already taking weightloss medications efforts made continue drugs surgery scheduled since rapid weight regain predictable discontinued • countries weightloss medications eg phentermine orlistat glp<NUMBER>ras naltrexonebupropion phenterminetopiramate accessible clinicians could consider use weight loss weight maintenance important patients multiple weightresponsive comorbidities • telemedicine strategies supervised specialist bariatric metabolic surgery providers used • people persistent recurrent type <NUMBER> diabetes surgery weightreducing diabetes medications eg glp<NUMBER>ras considered weight maintenance also encouraged patients type <NUMBER> diabetes remission mitigate risk disease recurrence • insufficient evidence justify deviations current evidencebased recommendations postoperative nutritional care patients bariatric metabolic surgery • minimise risk nutritionrelated complications providers engage patients intervals current guidelines • clinical signs eg weight visual changes rash weakness oedema anasarca neuropsychiatric signs symptoms eg nausea tingling bowelhabit changes fatigue nutritional deficiency must assessed virtual clinic sessions • routine laboratory tests eg albumin thiamine b<NUMBER> vitamin vitamin iron calcium deferred obtained standard intervals particularly patients operations greater risk nutrient malabsorption longlimb diversionary procedures • urgent facetoface meetings laboratory tests mandated symptoms suggest severe biochemical deficiencies surgical complications eg intestinal obstruction acute cholecystitis • misconceptions stigma obesity bariatric metabolic surgery might penalise candidates surgical treatment obesity diabetes times limited resources clinicians policy makers hospital managers recognise seriousness diseases require metabolic bariatric surgery ensure operations delayed • given risks severe complications covid<NUMBER> patients obesity type <NUMBER> diabetes covid<NUMBER> screening mandatory preoperatively patients considering bariatric metabolic surgery • despite potential higher risk contagion staff risk benefit laparoscopic approach remain favourable patients preferred use open techniques • appropriate personal protective equipment used recommended professional bodies public health agencies minimise risk staff operators clinical need approach comparable putting colorectal surgery candidates waiting list similar priority regardless whether diagnosis cancer benign neoplasia strong need therefore exists clinically sound criteria help prioritise access surgery times pandemics limited resources criteria also inform future waiting list management decision making structure surgical services prioritisation elective operation seek facilitate access according clinical need maximise equity access minimise harm delayed access adapted previous categorisations elective surgery <NUMBER> define objective prioritisation system reflecting principles bariatric meta bolic operations panel <NUMBER> figure given factors contributing morbidity mortality obesity type <NUMBER> diabetes surgical prioritisation based diseasespecific consider ations patients type <NUMBER> diabetes suggest surgery prioritised patients increased risk morbidity mortality risk would indicated poor glycaemic control despite maximal medical therapy use insulin previous cardiovascular disease albuminuria chronic kidney disease nonalcoholic steatohepatitis multiple cardio metabolic comorbidities <NUMBER> insulin use meaningful prioritisation criterion correlates increased cardiovascular mortality <NUMBER> reduced quality life <NUMBER> moreover metabolic surgery reduces abolishes figure examples conditions warrant expedited access bariatric metabolic surgery ahaamerican heart association severity obesityassociated symptoms eg mobility issues joint pain consequence extremely high bmi regardless comorbidities must also considered establishing priorities equally important effect obesityrelated conditions increase morbidity mortality eg obesity hypo ventilation syndrome chronic kidney disease severe obstructive sleep apnoea <NUMBER> availability nonsurgical options slow disease progression ie pharmacological diabetes treatments achieving adequate glycaemic control reduces need prior itisation expedited access surgery also considered bariatric metabolic operations used adjuvant therapy enable timesensitive treatments made unfeasible unsafe excess weight poor metabolic control figure many candidates bariatric metabolic surgery high risk morbidity mortality comorbid conditions patients access surgical treatment prioritised basis diseasefocused clinical needs rather primarily bmi mitigate harm delaying surgery approach especially needed periods access surgery reduced current covid<NUMBER> pandemic societal crises often spur developments provide benefits long storm passes diseaseoriented medically meaningful strategies triage patients seeking metabolic surgery covid<NUMBER> crisis help prioritise patients urgent need long future fr conceived idea initiative fr rvc gm cwr jim dea jv dec reviewed relevant medical literature prepared first draft report ga saa rlb sb gc sdp jbd rhe dh bmm apan apat fp prs pzz provided additional input appraisal evidence manuscript preparation coauthors participated development recommendations reviewed approved report rapid narrative literature review personal view references effect viral infections including coronavirus disease <NUMBER> covid<NUMBER> diabetes obesity laparoscopic surgery searched pubmed articles english published jan <NUMBER> <NUMBER> april <NUMBER> <NUMBER> used combinations terms sars h<NUMBER>n<NUMBER> coronavirus covid<NUMBER> sarscov<NUMBER> diabetes obesity bmi laparoscopy endoscopy severe acute respiratory syndrome acute respiratory distress syndrome comorbidities also reviewed recent guidelines professional organisations public health agencies elective surgery covid<NUMBER> pandemic evidence benefits bariatric metabolic surgery predicting factors morbidity mortality type <NUMBER> diabetes obesity nonalcoholic fatty liver disease nonalcoholic steatohepatitis classification elective surgery reviewed recently published systematic reviews consensus statements major scientific societies relevant individual articles cited documents members expert panel selected basis previous participation diabetes surgery summit series relevant expertise additional experts also invited join group provide complementary expertise ensure global representation subgroup expert panel first appraisal evidence draft recommendations generated first draft report synthetising literature review response specific query entire expert group engaged online discussion appraise evidence refine final consensus recommendations december <NUMBER> <NUMBER> cluster cases pneumonia unknown origin people associated huanan seafood wholesale market reported wuhan china days later chinese health authorities confirmed cluster associated novel coronavirus <NUMBER> comorbidities importantly patients admitted intensive care unit icu higher number comorbidities<NUMBER> admitted icu<NUMBER> suggests complications may risk factor adverse outcomes <NUMBER> assessing prevalence chronic diseases basis mitigating complications patients covid<NUMBER> infections however effort hampered limited number cases get convincing result provide systematic evaluation detail estimate prevalence comorbidities patients also assess risk underlying diseases severe patients compared nonsevere patients result may aid management developing policies prevention response covid<NUMBER> critical outcomes two investigators j yang yp wang performed literature search also independently extracted data included studies disagreements resolved third investigator yn zhou consensus extracted following variables author date age gender number participates severe nonsevere prevalence clinical symptoms fever cough fatigue dyspnea together comorbidities including hypertension diabetes respiratory system disease cardiovascular diseases calculations performed stata mp version <NUMBER> odds ratio <NUMBER> confidence intervals ci used describe ratio probability coronavirus occurring severe patients vs nonsevere owing heterogeneity within studies random effect model used estimating average effect precision would give conservative estimate <NUMBER> ci using <NUMBER> statistic cochrans q test assess statistical heterogeneity terms initially searched total <NUMBER> articles removed duplicates checked title abstract reviewed fulltext eight studies <NUMBER> eventually met predetermined inclusion exclusion criteria february <NUMBER> <NUMBER> total j u r n l p r e p r f <NUMBER> participants included metaanalysis presented table <NUMBER> median age <NUMBER> years <NUMBER> <NUMBER> men result metaanalysis showed prevalent clinical symptom fever <NUMBER>±<NUMBER> <NUMBER> ci <NUMBER> followed cough <NUMBER>±<NUMBER> <NUMBER> ci <NUMBER> fatigue <NUMBER>±<NUMBER> <NUMBER> ci <NUMBER> dyspnea <NUMBER>±<NUMBER> <NUMBER> ci <NUMBER> however <NUMBER> varying <NUMBER> <NUMBER> evaluates clinical features showed significant statistic heterogeneity p<NUMBER> prevalence comorbidities including hypertension diabetes respiratory system disease cardiovascular diseases shown figure <NUMBER> inserts b c prevalent comorbidity hypertension <NUMBER>±<NUMBER> <NUMBER> ci <NUMBER> diabetes <NUMBER>±<NUMBER> <NUMBER> ci <NUMBER> followed cardiovascular diseases <NUMBER>±<NUMBER> <NUMBER> ci <NUMBER> respiratory system disease <NUMBER>±<NUMBER> <NUMBER> ci <NUMBER> analysis proportion comorbidities significant heterogeneity observed estimates hypertension diabetes cardiovascular diseases p<NUMBER> respiratory system disease p<NUMBER> <NUMBER> index ranging <NUMBER> <NUMBER> figure <NUMBER> analyzed relationship complications severe group nonsevere group higher risk hypertension respiratory system disease cardiovascular diseases severe group compared nonsevere result <NUMBER> <NUMBER> ci <NUMBER> <NUMBER> <NUMBER> ci <NUMBER> <NUMBER> <NUMBER> ci <NUMBER>respectively showed low heterogeneity <NUMBER> <NUMBER> <NUMBER> however statistically significant difference diabetes <NUMBER> <NUMBER> ci <NUMBER> metaanalysis based data <NUMBER> studies laboratoryconfirmed covid <NUMBER> cases hospitals china result observed men women statistics <NUMBER> covid<NUMBER> infection merscov sarscov also found infect males females <NUMBER> <NUMBER> customary think women less likely affect many bacteria viruses men partly robust innate adaptive immune responses <NUMBER> however may related occupational risk factors men huanan wet market exposure history huangs report <NUMBER> aged people severe patients susceptible covid<NUMBER> may associated higher frequency comorbidities <NUMBER> metaanalysis comorbidities suggests hypertension prevalent approximately <NUMBER> patients diabetes cardiovascular diseases respiratory system disease present <NUMBER> <NUMBER> <NUMBER> cases respectively hypertension diabetes mellitus consistent prevalence hypertension diabetes china <NUMBER> <NUMBER> <NUMBER> comorbidities effect also noted similar effects respiratory illnesses merscov <NUMBER> study association also showed hypertension cardiovascular diseases respiratory system disease group overall severe patients older <NUMBER> significant number comorbid conditions nonsevere results suggest age comorbidities may risk factors critical patients diseases hypertension diabetes respiratory system disease study require ethical approval metaanalysis based published research original data anonymous authors declared conflicts interest work since first case china december <NUMBER> epidemic coronavirus disease<NUMBER> covid <NUMBER> disease caused severe acute respiratory syndromecoronavirus<NUMBER> sarscov<NUMBER> virus rapidly spread worldwide declared pandemic world health organization <NUMBER> march <NUMBER> <NUMBER> <NUMBER> well known people diabetes increased infection risk especially influenza pneumonia <NUMBER> <NUMBER> moreover diabetes previously reported major risk factor mortality people infected <NUMBER> h<NUMBER>n<NUMBER> pandemic influenza recently middle east respiratory syndromerelated coronavirus merscov <NUMBER> <NUMBER> epidemiological studies quickly consistently pointed diabetes one major comorbidities associated covid<NUMBER> affecting severity prevalence diabetes patients covid<NUMBER> first reported range <NUMBER> <NUMBER> chinese studies increasing severity disease <NUMBER> recently grasselli et al reported diabetes prevalence <NUMBER> patients admitted intensive care units icus severe covid<NUMBER> infection lombardy italy <NUMBER> furthermore covid<NUMBER>associated hospitalisation surveillance network covidnet reported diabetes prevalence <NUMBER> hospitalised patients usa <NUMBER> importantly studies published far reported twoto threefold higher prevalence diabetes patients icus compared less severe disease increased mortality people diabetes <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> instance retrospective study wuhan diabetes present <NUMBER> <NUMBER> covid<NUMBER> inpatients prevalence raised <NUMBER> deceased people compared <NUMBER> survived <NUMBER> recent metaanalysis demonstrated diabetes associated doubled risk icu admission tripled risk death <NUMBER> context patients diabetes listed people higher risk severe illness covid<NUMBER> several health authorities learned medical societies <NUMBER> however precise data regarding diabetes characteristics hospitalised people covid<NUMBER> still lacking moreover relationship diabetesrelated phenotypes severity covid<NUMBER> remains unknown coronado coronavirus sarscov<NUMBER> diabetes outcomes nationwide multicentre observational study aims identify clinical biological features associated disease severity mortality risk people diabetes hospitalised covid<NUMBER> study oversight coronado study launched french hospitals volunteering share data hospitalised covid<NUMBER> patients diabetes study sponsored chu centre hospitalier universitaire nantes designed accordance declaration helsinki conducted accordance french legislation approval obtained local ethics committee institutional review boardinstitutional ethics committee gneds groupe nantais déthique dans le domaine de la santé ref coronadov<NUMBER> cerees comité dexpertise pour les recherches les études et les évaluations dans le domaine de la santé n°i n n u n n l e n n é e e santé<NUMBER> cnil commission nationale de linformatique et des libertés dr<NUMBER> light purely noninterventional design observational study emergency situation related covid<NUMBER> pandemic cnil gneds repealed systematic collection written informed consent recommended collect oral nonopposition participate far possible particular publishing study information via posters hospitals living patients unable give consent admission received information inclusion coronado study discharge therefore clear free choice object use clinical data patient declining participate study expressing opposition data collection hospital information systems even hospital discharge excluded study aim coronado study describe phenotypic characteristics prognosis individuals admitted hospital covid<NUMBER> <NUMBER> march <NUMBER> april <NUMBER> inclusion criteria <NUMBER> hospitalisation dedicated covid<NUMBER> unit covid<NUMBER> diagnosis confirmed biologically sarscov<NUMBER> pcr test andor clinicallyradiologically ie groundglass opacity andor crazy paving chest computed tomography ct scan <NUMBER> personal history diabetes newly diagnosed diabetes admission ie hba <NUMBER>c ≥<NUMBER> mmol mol <NUMBER> hospitalisation owing rapid recruitment rate order make clinically relevant findings available quickly possible scientific committee <NUMBER> april <NUMBER> suggested premature database lock <NUMBER> april <NUMBER> participants admitted period <NUMBER> march <NUMBER> continuation recruitment modification first set analyses performed <NUMBER> participants selected according following criteria <NUMBER> meeting eligibility criteria <NUMBER> available information main outcome recorded day <NUMBER> following admission <NUMBER> available data age sex see flowchart fig <NUMBER> patient followup clinical outcomes composite primary endpoint combined tracheal intubation mechanical ventilation death within <NUMBER> days admission secondary outcomes included death day <NUMBER> tracheal intubation day <NUMBER> admission icus discharge day <NUMBER> participants discharged day <NUMBER> systematically contacted check nonoccurrence events day <NUMBER> data collection data collection performed clinical research associates physicians participating centres instructed systematically review medical files covid<NUMBER> inpatients select diabetes extract data medical files needed contact patients general andor specialist practitioners regular pharmacist biomedical laboratory collected data included clinical data age sex ethnicity bmi classification diabetes noted medical file physician charge patient duration diabetes recent glycaemic control ie two recent hba <NUMBER>c levels determined admission microvascular macrovascular complications comorbidities hba <NUMBER>c considered analysis determined locally <NUMBER> days following admission available result routine determination previous <NUMBER> months microvascular complications defined severe diabetic retinopathy proliferative retinopathy andor laser photocoagulation andor clinically significant macular oedema requiring laser andor intravitreal injections andor diabetic kidney disease proteinuria aer ≥<NUMBER> mg<NUMBER> h urinary albumincreatinine ratio ≥<NUMBER> mgg urinary albumincreatinine ratio ≥<NUMBER> mgmmol creatinine proteinuria ≥<NUMBER> mg<NUMBER> h andor egfr equal lower <NUMBER> ml min −<NUMBER> <NUMBER> −<NUMBER> using chronic kidney disease epidemiology collaboration ckdepi formula andor history diabetic foot ulcer macrovascular complications defined ischaemic heart disease acute coronary syndrome andor coronary artery revascularisation andor cerebrovascular disease stroke andor transient ischaemic attack andor peripheral artery disease amputation owing ischaemic disease andor lower limb artery revascularisation addition covid<NUMBER>related clinical radiological biological characteristics collected admission well clinical evolution hospital stay given number percentage participants prespecified protocol main objective study descriptive calculated population size <NUMBER> participants attrition <NUMBER> missing data percentage <NUMBER> main outcome would give us <NUMBER> ci equal <NUMBER> using clopperpearson estimate univariate logistic regression models used calculate associated primary outcome death day <NUMBER> natural log transformation consistently considered cases skewed distribution applied bmi biological features ageand sexadjusted ors primary outcome plotted bmi hba <NUMBER>c admission plasma glucose using degree <NUMBER> fractional polynomial approaches <NUMBER> multivariable logistic regression models used separately assess association primary outcome death day <NUMBER> clinical biological features standardisation process also applied using z scores purpose direct comparison initial statistical analysis plan four covariates systematically forced models age sex bmi hba <NUMBER>c however since hba <NUMBER>c contribute risk either primary outcome death day <NUMBER> owing significant number missing data hba <NUMBER>c bmi multivariable models ultimately took age sex account variables considered associated main outcome univariate analysis threshold twosided p value ≤<NUMBER> selected final model stepwise backwardforward built two distinct multivariable models separately main outcome risk death <NUMBER> first included covariates related patient history prior admission chronic diabetes complications comorbidities routine medications <NUMBER> second included covariates related medical presentation admission covid<NUMBER> symptoms biological determinations corresponds situation physician emergency room department assessing prognosis hisher patient statistical tests twosided type <NUMBER> error set <NUMBER> analyses performed available data without imputation using statistical software r version <NUMBER> httpscranrprojectorgbinwindowsbaseold<NUMBER> fig <NUMBER> demographic diabetesrelated characteristics clinical characteristics whole population shown table <NUMBER> mean ± sd age <NUMBER> ± <NUMBER> years <NUMBER> men classification diabetes cases mainly included type <NUMBER> diabetes <NUMBER> less frequently type <NUMBER> diabetes <NUMBER> aetiologies <NUMBER> addition <NUMBER> participants newly diagnosed diabetes admission hba <NUMBER>c ≥<NUMBER> mmolmol <NUMBER> median bmi <NUMBER> <NUMBER>th<NUMBER>th percentile <NUMBER> kgm <NUMBER> mean hba <NUMBER>c value <NUMBER> ± <NUMBER> mmolmol <NUMBER> ± <NUMBER> medical history hypertension dyslipidaemia found <NUMBER> <NUMBER> participants respectively microvascular macrovascular complications reported <NUMBER> <NUMBER> individuals respectively regarding routine glucoselowering medications <NUMBER> participants insulin therapy <NUMBER> received metformin <NUMBER> dipeptidyl peptidase <NUMBER> dpp<NUMBER> inhibitors moreover treatment reninangiotensinaldosterone system raas blockers ace inhibitors andor angiotensin ii receptor blockers arbs andor mineralocorticoidreceptor antagonists mras statins used <NUMBER> <NUMBER> participants respectively table <NUMBER> median duration symptoms admission <NUMBER> days <NUMBER>th<NUMBER>th percentile <NUMBER> days expected common signs fever <NUMBER> cough <NUMBER> fatigue <NUMBER> dyspnoea <NUMBER> digestive disorders <NUMBER> sarscov<NUMBER> pcr testing performed <NUMBER> participants positive result <NUMBER> thoracic ct imaging demonstrated typical groundglass opacity andor crazy paving <NUMBER> individuals <NUMBER> biological findings consistent obvious infection illustrated median creactive protein crp <NUMBER> <NUMBER> mgl median plasma glucose admission <NUMBER> <NUMBER> mmoll interest diabetesrelated disorders reported <NUMBER> participants admission <NUMBER> episodes severe hyperglycaemia including <NUMBER> ketosis <NUMBER> ketoacidosis well <NUMBER> hypoglycaemic events severe anorexia reported <NUMBER> participants <NUMBER> factors prior admission associated study outcomes univariate analysis considering primary outcome male sex frequent <NUMBER> vs <NUMBER> p <NUMBER> bmi significantly higher median <NUMBER> <NUMBER> vs <NUMBER> <NUMBER> <NUMBER> kgm <NUMBER> p <NUMBER> patients met primary outcome compared others use raas blockers <NUMBER> vs <NUMBER> p <NUMBER> table <NUMBER> electronic supplementary material esm table <NUMBER> furthermore several characteristics prior admission associated risk death day <NUMBER> including age hypertension microand macrovascular diabetic complications comorbidities heart failure treated obstructive sleep apnoea osa among prior medications metformin use lower people died contrast insulin therapy raas blockers βblockers loop diuretics mras found associated death day <NUMBER> table <NUMBER> esm table <NUMBER> using ageand sexadjusted nonlinear models bmi significantly positively associated primary outcome p <NUMBER> death day <NUMBER> p <NUMBER> fig <NUMBER> contrast hba <NUMBER>c level neither associated primary outcome death day <NUMBER> multivariable analyses conducted characteristics prior admission bmi remained associated primary outcome model sex age forced models comorbidities routine treatment entered adjusted model stepwise selection bmi independent factor associated primary outcome adjusted <NUMBER> <NUMBER> ci <NUMBER> <NUMBER> table <NUMBER> finally age history microvascular macrovascular complications treated osa found independently associated risk death day <NUMBER> table <NUMBER> sensitivity analysis conducted patients positive sarscov<NUMBER> pcr test found similar results primary outcome death data shown regarding covid<NUMBER> symptoms admission dyspnoea positively associated primary outcome death day <NUMBER> whereas cephalalgia upper respiratory tract symptoms rhinitis andor pharyngeal symptoms ageusiaanosmia well time symptom onset admission negatively associated death day <NUMBER> table <NUMBER> esm table <NUMBER> several biological parameters reflecting severity infection also associated primary outcome death day <NUMBER> crp creatine phosphokinase cpk lymphopaenia reduced kidney function assessed admission egfr increased plasma ast level associated outcomes table <NUMBER> esm table <NUMBER> ageand sexadjusted nonlinear models admission plasma glucose significantly positively associated primary outcome p <NUMBER> death day <NUMBER> p <NUMBER> fig <NUMBER> prognostic value characteristics admission finally investigated multivariable models table <NUMBER> among clinical symptoms dyspnoea predictor primary outcome regarding biological parameters lymphopaenia admission independently associated primary outcome increased ast crp concentrations dyspnoea plasma levels ast crp also independently associated risk death day <NUMBER> well decrease platelet count egfr table <NUMBER> similar results obtained primary outcome death day <NUMBER> considering patients positive pcr test data shown age corresponds increase <NUMBER> sd standardisation mras include spironolactone eplerenone models applied <NUMBER> participants yielding <NUMBER> primary outcomes <NUMBER> quantitative variables corresponds increase <NUMBER> sd natural log transformation standardisation except age natural log transformed egfr calculated according ckdepi formula coronado first study specifically dedicated people diabetes infected sarscov<NUMBER> admitted hospital coronado designed address three main goals <NUMBER> assess phenotypic characteristics patients diabetes hospitalised covid<NUMBER> <NUMBER> estimate prevalence primary outcome combines death tracheal intubation mechanical ventilation within first <NUMBER> days following admission <NUMBER> identify specific population certain prognostic factors associated early severity covid<NUMBER> considering variables prior admission results support independent association severe course covid<NUMBER> age sex longterm glucose control chronic complications hypertension usual medications including raas blockers dpp<NUMBER> inhibitors bmi turned independently associated primary outcome considering variables admission dyspnoea lymphopaenia increased ast crp levels independent prognostic factors severe course covid<NUMBER> knowledge coronado first study provides precise information regarding characteristics diabetes severe forms covid<NUMBER> study population roughly resembles french population people living diabetes except hba <NUMBER>c clearly higher study <NUMBER> mmolmol <NUMBER> <NUMBER> compared nationwide entred<NUMBER> survey participants older <NUMBER> years <NUMBER> mmolmol <NUMBER> <NUMBER> note overrepresentation declared type <NUMBER> diabetes <NUMBER> participants people diabetes hospitalised covid<NUMBER> primary outcome occurred <NUMBER> coronado participants design present study enable comparison severity covid<NUMBER> people without diabetes <NUMBER> study population required tracheal intubation mechanical ventilation mortality rate <NUMBER> early <NUMBER> days admission severity prognosis covid<NUMBER> observed people diabetes present study accordance previous epidemiological studies <NUMBER> <NUMBER> <NUMBER> metaanalyses <NUMBER> <NUMBER> important issue choice primary endpoint combines death unequivocal outcome tracheal intubation mechanical ventilation emphasised latter outcome result different factors impossible standardise centres <NUMBER> clinical deterioration <NUMBER> refusal intubated <NUMBER> futility ie medical decision intubate leading potentially fewer patients actually intubated compared meeting intubation criteria regarding clinical characteristics covid<NUMBER> coronado participants high prevalence fever respiratory symptoms cough dyspnoea lesser extent digestive disorders addition symptoms directly related covid<NUMBER> people diabetes also require management acute metabolic disorders quantitative variables corresponds increase <NUMBER> sd natural log transformation standardisation except age also standardised natural log transformed egfr calculated according ckdepi formula particular physicians warned risk ketoacidosis also hypoglycaemia probably favoured covid<NUMBER>induced anorexia without concomitant adaptation glucoselowering drugs aim providing clinicians criteria evaluate risk severe covid<NUMBER> individual level people diabetes performed multivariable analyses identify preadmission onadmission prognostic factors since preclinical studies previously highlighted potential mechanistic links glucose control immune response merscov infection <NUMBER> particularly interested studying relationship longterm glucose control covid<NUMBER> prognosis fact failed find association hba <NUMBER>c even highest values <NUMBER> mmolmol <NUMBER> either primary outcome death day <NUMBER> basis result order increase sample size analyses decided force hba <NUMBER>c multivariate models interesting finding association bmi study outcomes indeed study bmi positively independently associated primary outcome largely driven tracheal intubation interestingly recent report covid<NUMBER> patients icu showed association bmi requirement mechanical ventilation irrespective diabetic status <NUMBER> however association bmi longer statistically significant considering death day <NUMBER> also noted increased risk primary outcome appears less pronounced patients morbid obesity grade <NUMBER> bmi ≥<NUMBER> kgm <NUMBER> compared overweight grade <NUMBER> obesity situation previously described obesity paradox icus <NUMBER> additional studies clearly warranted decipher link obesity metabolic complications covid<NUMBER> severity specific attention fat mass distribution insulin resistance inflammatoryimmune profiles hypertension previously reported prevalent comorbidity general population severe covid<NUMBER> <NUMBER> <NUMBER> <NUMBER> independently associated severity disease study addition raas blockers ace inhibitors arbs mras independently associated main outcome supporting recent recommendation discontinue raas blockade <NUMBER> moreover found association glucoselowering drugs including dpp<NUMBER> inhibitors suggested potentially interfere coronavirus infection covid<NUMBER> prognosis <NUMBER> <NUMBER> complementary multivariable approach suitable identification characteristics admission associated covid<NUMBER> prognosis particular relevance management people diabetes setting emergency room notably found ageand sexindependent association increased admission plasma glucose levels severity covid<NUMBER> previously reported critically ill patients <NUMBER> however speculate observation rather consequence severity infection causal primary factor another important result concerns identification prognostic factors early death people diabetes covid<NUMBER> compared primary outcome reflects aggressive management icus tracheal intubation death day <NUMBER> prevalent elderly participants <NUMBER> people older <NUMBER> years compared younger individuals addition individuals also frequently exhibited complications diabetes microvascular macrovascular complications mainly coronary heart disease well pulmonary diseases osa expected also frequently insulin therapy taking multiple drugs diuretics conversely metformin use associated reduced risk early death probably reflecting less advanced stage diabetes fewer comorbidities severe chronic kidney disease contraindicate use multivariable analyses age diabetic complications treated osa remained significantly independently associated death day <NUMBER> addition dyspnoea reduced egfr platelet count increased ast crp admission independent markers early death discrepancy primary combined outcome mainly driven tracheal intubation death day <NUMBER> could explained fact medical decisions pursue aggressive therapy frail population contrast data considered reassuring majority people living type <NUMBER> diabetes indeed death participants type <NUMBER> diabetes younger <NUMBER> years additional data collection currently ongoing provide precise picture rare individuals type <NUMBER> diabetes hospitalised covid<NUMBER> limitations must acknowledged current analysis focused hospitalised covid<NUMBER> cases results cannot generalised people covid<NUMBER> diabetes especially less severe form disease secondary limitation size study population large proportion ie <NUMBER> patients without available hba <NUMBER>c accordance observation <NUMBER> people diabetes three hba <NUMBER>c determinations previous year according french national registry data <NUMBER> finally present report focuses shortterm prognosis ie <NUMBER> days admission one cannot exclude possibility diabetes characteristics prior admission could associated severe covid<NUMBER> outcomes longer term however strengths must acknowledged originality medical question leading coronado initiative inclusion participants national basis addition large majority <NUMBER> covid<NUMBER> cases confirmed positive pcr test cases diagnosed medical andor radiological observations also structured data collection order obtain precise standardised recording phenotypic characteristics diabetic study population conclusion coronado study refined phenotypes covid<NUMBER> individuals diabetes admitted hospital showed chronic glycaemic control impact immediate severity covid<NUMBER> elderly populations longterm diabetes advanced diabetic complications andor treated osa particularly risk early death might require specific management avoid contamination sarscov<NUMBER> bmi also appears independent prognostic factor covid<NUMBER> severity population living diabetes requiring hospital admission articles creative commons licence intended use permitted statutory regulation exceeds permitted use need obtain permission directly copyright holder view copy licence visit httpcreativecommonsorglicensesby<NUMBER> since first case china december <NUMBER> epidemic coronavirus disease<NUMBER> covid <NUMBER> disease caused severe acute respiratory syndromecoronavirus<NUMBER> sarscov<NUMBER> virus rapidly spread worldwide declared pandemic world health organization <NUMBER> march <NUMBER> <NUMBER> <NUMBER> well known people diabetes increased infection risk especially influenza pneumonia <NUMBER> <NUMBER> moreover diabetes previously reported major risk factor mortality people infected <NUMBER> h<NUMBER>n<NUMBER> pandemic influenza recently middle east respiratory syndromerelated coronavirus merscov <NUMBER> <NUMBER> epidemiological studies quickly consistently pointed diabetes one major comorbidities associated covid<NUMBER> affecting severity prevalence diabetes patients covid<NUMBER> first reported range <NUMBER> <NUMBER> chinese studies increasing severity disease <NUMBER> recently grasselli et al reported diabetes prevalence <NUMBER> patients admitted intensive care units icus severe covid<NUMBER> infection lombardy italy <NUMBER> furthermore covid<NUMBER>associated hospitalisation surveillance network covidnet reported diabetes prevalence <NUMBER> hospitalised patients usa <NUMBER> importantly studies published far reported twoto threefold higher prevalence diabetes patients icus compared less severe disease increased mortality people diabetes <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> instance retrospective study wuhan diabetes present <NUMBER> <NUMBER> covid<NUMBER> inpatients prevalence raised <NUMBER> deceased people compared <NUMBER> survived <NUMBER> recent metaanalysis demonstrated diabetes associated doubled risk icu admission tripled risk death <NUMBER> context patients diabetes listed people higher risk severe illness covid<NUMBER> several health authorities learned medical societies <NUMBER> however precise data regarding diabetes characteristics hospitalised people covid<NUMBER> still lacking moreover relationship diabetesrelated phenotypes severity covid<NUMBER> remains unknown coronado coronavirus sarscov<NUMBER> diabetes outcomes nationwide multicentre observational study aims identify clinical biological features associated disease severity mortality risk people diabetes hospitalised covid<NUMBER> study oversight coronado study launched french hospitals volunteering share data hospitalised covid<NUMBER> patients diabetes study sponsored chu centre hospitalier universitaire nantes designed accordance declaration helsinki conducted accordance french legislation approval obtained local ethics committee institutional review boardinstitutional ethics committee gneds groupe nantais déthique dans le domaine de la santé ref coronadov<NUMBER> cerees comité dexpertise pour les recherches les études et les évaluations dans le domaine de la santé n°i n n u n n l e n n é e e santé<NUMBER> cnil commission nationale de linformatique et des libertés dr<NUMBER> light purely noninterventional design observational study emergency situation related covid<NUMBER> pandemic cnil gneds repealed systematic collection written informed consent recommended collect oral nonopposition participate far possible particular publishing study information via posters hospitals living patients unable give consent admission received information inclusion coronado study discharge therefore clear free choice object use clinical data patient declining participate study expressing opposition data collection hospital information systems even hospital discharge excluded study aim coronado study describe phenotypic characteristics prognosis individuals admitted hospital covid<NUMBER> <NUMBER> march <NUMBER> april <NUMBER> inclusion criteria <NUMBER> hospitalisation dedicated covid<NUMBER> unit covid<NUMBER> diagnosis confirmed biologically sarscov<NUMBER> pcr test andor clinicallyradiologically ie groundglass opacity andor crazy paving chest computed tomography ct scan <NUMBER> personal history diabetes newly diagnosed diabetes admission ie hba <NUMBER>c ≥<NUMBER> mmol mol <NUMBER> hospitalisation owing rapid recruitment rate order make clinically relevant findings available quickly possible scientific committee <NUMBER> april <NUMBER> suggested premature database lock <NUMBER> april <NUMBER> participants admitted period <NUMBER> march <NUMBER> continuation recruitment modification first set analyses performed <NUMBER> participants selected according following criteria <NUMBER> meeting eligibility criteria <NUMBER> available information main outcome recorded day <NUMBER> following admission <NUMBER> available data age sex see flowchart fig <NUMBER> patient followup clinical outcomes composite primary endpoint combined tracheal intubation mechanical ventilation death within <NUMBER> days admission secondary outcomes included death day <NUMBER> tracheal intubation day <NUMBER> admission icus discharge day <NUMBER> participants discharged day <NUMBER> systematically contacted check nonoccurrence events day <NUMBER> data collection data collection performed clinical research associates physicians participating centres instructed systematically review medical files covid<NUMBER> inpatients select diabetes extract data medical files needed contact patients general andor specialist practitioners regular pharmacist biomedical laboratory collected data included clinical data age sex ethnicity bmi classification diabetes noted medical file physician charge patient duration diabetes recent glycaemic control ie two recent hba <NUMBER>c levels determined admission microvascular macrovascular complications comorbidities hba <NUMBER>c considered analysis determined locally <NUMBER> days following admission available result routine determination previous <NUMBER> months microvascular complications defined severe diabetic retinopathy proliferative retinopathy andor laser photocoagulation andor clinically significant macular oedema requiring laser andor intravitreal injections andor diabetic kidney disease proteinuria aer ≥<NUMBER> mg<NUMBER> h urinary albumincreatinine ratio ≥<NUMBER> mgg urinary albumincreatinine ratio ≥<NUMBER> mgmmol creatinine proteinuria ≥<NUMBER> mg<NUMBER> h andor egfr equal lower <NUMBER> ml min −<NUMBER> <NUMBER> −<NUMBER> using chronic kidney disease epidemiology collaboration ckdepi formula andor history diabetic foot ulcer macrovascular complications defined ischaemic heart disease acute coronary syndrome andor coronary artery revascularisation andor cerebrovascular disease stroke andor transient ischaemic attack andor peripheral artery disease amputation owing ischaemic disease andor lower limb artery revascularisation addition covid<NUMBER>related clinical radiological biological characteristics collected admission well clinical evolution hospital stay given number percentage participants prespecified protocol main objective study descriptive calculated population size <NUMBER> participants attrition <NUMBER> missing data percentage <NUMBER> main outcome would give us <NUMBER> ci equal <NUMBER> using clopperpearson estimate univariate logistic regression models used calculate associated primary outcome death day <NUMBER> natural log transformation consistently considered cases skewed distribution applied bmi biological features ageand sexadjusted ors primary outcome plotted bmi hba <NUMBER>c admission plasma glucose using degree <NUMBER> fractional polynomial approaches <NUMBER> multivariable logistic regression models used separately assess association primary outcome death day <NUMBER> clinical biological features standardisation process also applied using z scores purpose direct comparison initial statistical analysis plan four covariates systematically forced models age sex bmi hba <NUMBER>c however since hba <NUMBER>c contribute risk either primary outcome death day <NUMBER> owing significant number missing data hba <NUMBER>c bmi multivariable models ultimately took age sex account variables considered associated main outcome univariate analysis threshold twosided p value ≤<NUMBER> selected final model stepwise backwardforward built two distinct multivariable models separately main outcome risk death <NUMBER> first included covariates related patient history prior admission chronic diabetes complications comorbidities routine medications <NUMBER> second included covariates related medical presentation admission covid<NUMBER> symptoms biological determinations corresponds situation physician emergency room department assessing prognosis hisher patient statistical tests twosided type <NUMBER> error set <NUMBER> analyses performed available data without imputation using statistical software r version <NUMBER> httpscranrprojectorgbinwindowsbaseold<NUMBER> fig <NUMBER> demographic diabetesrelated characteristics clinical characteristics whole population shown table <NUMBER> mean ± sd age <NUMBER> ± <NUMBER> years <NUMBER> men classification diabetes cases mainly included type <NUMBER> diabetes <NUMBER> less frequently type <NUMBER> diabetes <NUMBER> aetiologies <NUMBER> addition <NUMBER> participants newly diagnosed diabetes admission hba <NUMBER>c ≥<NUMBER> mmolmol <NUMBER> median bmi <NUMBER> <NUMBER>th<NUMBER>th percentile <NUMBER> kgm <NUMBER> mean hba <NUMBER>c value <NUMBER> ± <NUMBER> mmolmol <NUMBER> ± <NUMBER> medical history hypertension dyslipidaemia found <NUMBER> <NUMBER> participants respectively microvascular macrovascular complications reported <NUMBER> <NUMBER> individuals respectively regarding routine glucoselowering medications <NUMBER> participants insulin therapy <NUMBER> received metformin <NUMBER> dipeptidyl peptidase <NUMBER> dpp<NUMBER> inhibitors moreover treatment reninangiotensinaldosterone system raas blockers ace inhibitors andor angiotensin ii receptor blockers arbs andor mineralocorticoidreceptor antagonists mras statins used <NUMBER> <NUMBER> participants respectively characteristics covid<NUMBER> admission characteristics covid<NUMBER> admission provided table <NUMBER> median duration symptoms admission <NUMBER> days <NUMBER>th<NUMBER>th percentile <NUMBER> days expected common signs fever <NUMBER> cough <NUMBER> fatigue <NUMBER> dyspnoea <NUMBER> digestive disorders <NUMBER> sarscov<NUMBER> pcr testing performed <NUMBER> participants positive result <NUMBER> thoracic ct imaging demonstrated typical groundglass opacity andor crazy paving <NUMBER> individuals <NUMBER> biological findings consistent obvious infection illustrated median creactive protein crp <NUMBER> <NUMBER> mgl median plasma glucose admission <NUMBER> <NUMBER> mmoll interest diabetesrelated disorders reported <NUMBER> participants admission <NUMBER> episodes severe hyperglycaemia including <NUMBER> ketosis <NUMBER> ketoacidosis well <NUMBER> hypoglycaemic events severe anorexia reported <NUMBER> participants <NUMBER> factors prior admission associated study outcomes univariate analysis considering primary outcome male sex frequent <NUMBER> vs <NUMBER> p <NUMBER> bmi significantly higher median <NUMBER> <NUMBER> vs <NUMBER> <NUMBER> <NUMBER> kgm <NUMBER> p <NUMBER> patients met primary outcome compared others use raas blockers <NUMBER> vs <NUMBER> p <NUMBER> table <NUMBER> electronic supplementary material esm table <NUMBER> furthermore several characteristics prior admission associated risk death day <NUMBER> including age hypertension microand macrovascular diabetic complications comorbidities heart failure treated obstructive sleep apnoea osa among prior medications metformin use lower people died contrast insulin therapy raas blockers βblockers loop diuretics mras found associated death day <NUMBER> table <NUMBER> esm table <NUMBER> using ageand sexadjusted nonlinear models bmi significantly positively associated primary outcome p <NUMBER> death day <NUMBER> p <NUMBER> fig <NUMBER> contrast hba <NUMBER>c level neither associated primary outcome death day <NUMBER> multivariable analyses conducted characteristics prior admission bmi remained associated primary outcome model sex age forced models comorbidities routine treatment entered adjusted model stepwise selection bmi independent factor associated primary outcome adjusted <NUMBER> <NUMBER> ci <NUMBER> <NUMBER> table <NUMBER> finally age history microvascular macrovascular complications treated osa found independently associated risk death day <NUMBER> table <NUMBER> sensitivity analysis conducted patients positive sarscov<NUMBER> pcr test found similar results primary outcome death data shown regarding covid<NUMBER> symptoms admission dyspnoea positively associated primary outcome death day <NUMBER> whereas cephalalgia upper respiratory tract symptoms rhinitis andor pharyngeal symptoms ageusiaanosmia well time symptom onset admission negatively associated death day <NUMBER> table <NUMBER> esm table <NUMBER> several biological parameters reflecting severity infection also associated primary outcome death day <NUMBER> crp creatine phosphokinase cpk lymphopaenia reduced kidney function assessed admission egfr increased plasma ast level associated outcomes table <NUMBER> esm table <NUMBER> ageand sexadjusted nonlinear models admission plasma glucose significantly positively associated primary outcome p <NUMBER> death day <NUMBER> p <NUMBER> fig <NUMBER> prognostic value characteristics admission finally investigated multivariable models table <NUMBER> among clinical symptoms dyspnoea predictor primary outcome regarding biological parameters lymphopaenia admission independently associated primary outcome increased ast crp concentrations dyspnoea plasma levels ast crp also independently associated risk death day <NUMBER> well decrease platelet count egfr table <NUMBER> similar results obtained primary outcome death day <NUMBER> considering patients positive pcr test data shown age corresponds increase <NUMBER> sd standardisation mras include spironolactone eplerenone coronado first study specifically dedicated people diabetes infected sarscov<NUMBER> admitted hospital coronado designed address three main goals <NUMBER> assess phenotypic characteristics patients diabetes hospitalised covid<NUMBER> <NUMBER> estimate prevalence primary outcome combines death tracheal intubation mechanical ventilation within first <NUMBER> days following admission <NUMBER> identify specific population certain prognostic factors associated early severity covid<NUMBER> considering variables prior admission results support independent association severe course covid<NUMBER> age sex longterm glucose control chronic complications hypertension usual medications including raas blockers dpp<NUMBER> inhibitors bmi turned independently associated primary outcome considering variables admission dyspnoea lymphopaenia increased ast crp levels independent prognostic factors severe course covid<NUMBER> knowledge coronado first study provides precise information regarding characteristics diabetes severe forms covid<NUMBER> study population roughly resembles french population people living diabetes except hba <NUMBER>c clearly higher study <NUMBER> mmolmol <NUMBER> compared nationwide entred<NUMBER> survey participants older <NUMBER> years <NUMBER> mmolmol <NUMBER> <NUMBER> note overrepresentation declared type <NUMBER> diabetes <NUMBER> participants people diabetes hospitalised covid<NUMBER> primary outcome occurred <NUMBER> coronado participants design present study enable comparison severity covid<NUMBER> people without diabetes <NUMBER> study population required tracheal intubation mechanical ventilation mortality rate <NUMBER> early <NUMBER> days admission severity prognosis covid<NUMBER> observed people diabetes present study accordance previous epidemiological studies <NUMBER> <NUMBER> <NUMBER> metaanalyses <NUMBER> <NUMBER> important issue choice primary endpoint combines death unequivocal outcome tracheal intubation mechanical ventilation emphasised latter outcome result different factors impossible standardise centres <NUMBER> clinical deterioration <NUMBER> refusal intubated <NUMBER> futility ie medical decision intubate leading potentially fewer patients actually intubated compared meeting intubation criteria regarding clinical characteristics covid<NUMBER> coronado participants high prevalence fever respiratory symptoms cough dyspnoea lesser extent digestive disorders addition symptoms directly related covid<NUMBER> people diabetes also require management acute metabolic disorders models applied <NUMBER> participants yielding <NUMBER> primary outcomes <NUMBER> quantitative variables corresponds increase <NUMBER> sd natural log transformation standardisation except age also standardised natural log transformed egfr calculated according ckdepi formula particular physicians warned risk ketoacidosis also hypoglycaemia probably favoured covid<NUMBER>induced anorexia without concomitant adaptation glucoselowering drugs aim providing clinicians criteria evaluate risk severe covid<NUMBER> individual level people diabetes performed multivariable analyses identify preadmission onadmission prognostic factors since preclinical studies previously highlighted potential mechanistic links glucose control immune response merscov infection <NUMBER> particularly interested studying relationship longterm glucose control covid<NUMBER> prognosis fact failed find association hba <NUMBER>c even highest values <NUMBER> mmolmol <NUMBER> either primary outcome death day <NUMBER> basis result order increase sample size analyses decided force hba <NUMBER>c multivariate models interesting finding association bmi study outcomes indeed study bmi positively independently associated primary outcome largely driven tracheal intubation interestingly recent report covid<NUMBER> patients icu showed association bmi requirement mechanical ventilation irrespective diabetic status <NUMBER> however association bmi longer statistically significant considering death day <NUMBER> also noted increased risk primary outcome appears less pronounced patients morbid obesity grade <NUMBER> bmi ≥<NUMBER> kgm <NUMBER> compared overweight grade <NUMBER> obesity situation previously described obesity paradox icus <NUMBER> additional studies clearly warranted decipher link obesity metabolic complications covid<NUMBER> severity specific attention fat mass distribution insulin resistance inflammatoryimmune profiles hypertension previously reported prevalent comorbidity general population severe covid<NUMBER> <NUMBER> <NUMBER> <NUMBER> independently associated severity disease study addition raas blockers ace inhibitors arbs mras independently associated main outcome supporting recent recommendation discontinue raas blockade <NUMBER> moreover found association glucoselowering drugs including dpp<NUMBER> inhibitors suggested potentially interfere coronavirus infection covid<NUMBER> prognosis <NUMBER> <NUMBER> complementary multivariable approach suitable identification characteristics admission associated covid<NUMBER> prognosis particular relevance management people diabetes setting emergency room notably found ageand sexindependent association increased admission plasma glucose levels severity covid<NUMBER> previously reported critically ill patients <NUMBER> however speculate observation rather consequence severity infection causal primary factor another important result concerns identification prognostic factors early death people diabetes covid<NUMBER> compared primary outcome reflects aggressive management icus tracheal intubation death day <NUMBER> prevalent elderly participants <NUMBER> people older <NUMBER> years compared younger individuals addition individuals also frequently exhibited complications diabetes microvascular macrovascular complications mainly coronary heart disease well pulmonary diseases osa expected also frequently insulin therapy taking multiple drugs diuretics conversely metformin use associated reduced risk early death probably reflecting less advanced stage diabetes fewer comorbidities severe chronic kidney disease contraindicate use multivariable analyses age diabetic complications treated osa remained significantly independently associated death day <NUMBER> addition dyspnoea reduced egfr platelet count increased ast crp admission independent markers early death discrepancy primary combined outcome mainly driven tracheal intubation death day <NUMBER> could explained fact medical decisions pursue aggressive therapy frail population contrast data considered reassuring majority people living type <NUMBER> diabetes indeed death participants type <NUMBER> diabetes younger <NUMBER> years additional data collection currently ongoing provide precise picture rare individuals type <NUMBER> diabetes hospitalised covid<NUMBER> limitations must acknowledged current analysis focused hospitalised covid<NUMBER> cases results cannot generalised people covid<NUMBER> diabetes especially less severe form disease secondary limitation size study population large proportion ie <NUMBER> patients without available hba <NUMBER>c accordance observation <NUMBER> people diabetes three hba <NUMBER>c determinations previous year according french national registry data <NUMBER> finally present report focuses shortterm prognosis ie <NUMBER> days admission one cannot exclude possibility diabetes characteristics prior admission could associated severe covid<NUMBER> outcomes longer term however strengths must acknowledged originality medical question leading coronado initiative inclusion participants national basis addition large majority <NUMBER> covid<NUMBER> cases confirmed positive pcr test cases diagnosed medical andor radiological observations also structured data collection order obtain precise standardised recording phenotypic characteristics diabetic study population conclusion coronado study refined phenotypes covid<NUMBER> individuals diabetes admitted hospital showed chronic glycaemic control impact immediate severity covid<NUMBER> elderly populations longterm diabetes advanced diabetic complications andor treated osa particularly risk early death might require specific management avoid contamination sarscov<NUMBER> bmi also appears independent prognostic factor covid<NUMBER> severity population living diabetes requiring hospital admission articles creative commons licence intended use permitted statutory regulation exceeds permitted use need obtain permission directly copyright holder view copy licence visit httpcreativecommonsorglicensesby<NUMBER> named international committee taxonomy viruses ictv severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> novel coronavirus origin associated city wuhan hubei province china spread rapidly worldwide causing thousands deaths characterizing infection public health problem global interest <NUMBER> <NUMBER> high infectivity rate coronavirus disease <NUMBER> caused sarscov<NUMBER> reached pandemic proportions <NUMBER> according report published world health organization june <NUMBER>st number confirmed cases reaches <NUMBER> distributed <NUMBER> countries emphasis european american continents two million cases together adding around <NUMBER> infected global number covid<NUMBER> already killed <NUMBER> people worldwide especially among elderly patients individuals comorbidities currently united states us already <NUMBER> confirmed cases despite large number infected people countries like spain <NUMBER> deaths italy <NUMBER> deaths united kingdom <NUMBER> deaths presented highest mortality rate exceeding <NUMBER> <NUMBER> disease evolution symptoms vary asymptomatic patients severe cases respiratory failure lead death <NUMBER> risk factors may associated evolution disease severity study conducted us march <NUMBER> <NUMBER> patients hospitalized covid<NUMBER> fourteen states <NUMBER> total history comorbidities total <NUMBER> hypertensive <NUMBER> obese patients chronic liver diseases totaled <NUMBER> diabetics represented <NUMBER> people cardiovascular diseases <NUMBER> <NUMBER> another study conducted wuhan city china <NUMBER> patients covid<NUMBER> followed <NUMBER> comorbidities hypertension <NUMBER> diabetes <NUMBER> coronary disease <NUMBER> <NUMBER> june <NUMBER>st <NUMBER> brazil <NUMBER> confirmed cases covid<NUMBER> <NUMBER> deaths associated comorbidities heart disease common comorbidity total <NUMBER> deaths followed diabetes kidney disease neurological disease pneumopathy obesity immunosuppression asthma total <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> deaths respectively <NUMBER> context metabolic syndrome ms inserted common denominator comorbidities since defined set metabolic disorders include insulin resistance dyslipidemia central obesity hypertension risk factors development type <NUMBER> diabetes cardiovascular diseases <NUMBER> <NUMBER> <NUMBER> estimated ms affected <NUMBER> north american population <NUMBER> european population approximately <NUMBER> chinese population <NUMBER> <NUMBER> scenario relationship ms comorbidities aggravate covid<NUMBER> prognosis cannot ignored also presence different ethnicities continents places sm important risk factor covid<NUMBER> thus review aimed providing overview metabolic changes associated ms relationship development worsening sarscov<NUMBER> infection well review proposed drugs treatment patients collated discussed available evidences emerged far presence obesity diabetes cardiovascular liver disease patients covid<NUMBER> proposed therapies systematically searched pubmed google scholar databases june <NUMBER>st <NUMBER> using keywords covid<NUMBER> metabolic syndrome following terms obesity diabetes liver nafld hypertension cardiovascular disease chloroquine hydroxychloroquine antiretroviral drugs treatment coronavirus also accessed full text relevant cross references search results points obesity global epidemic estimating <NUMBER> <NUMBER> million people aged <NUMBER> years obese worldwide <NUMBER> since obesity risk factor several diseases including infectious ones data become even alarming <NUMBER> bodies obese patients constant chronic inflammation due high concentrations chemokines adipokines proinflammatory cytokines chronic inflammation causes delayed inferior immune response decreased activation macrophages infection course addition immune memory obese individuals also impaired humoral cellular weakening adaptive response immune system disease immunization patients <NUMBER> <NUMBER> <NUMBER> obesity previously identified risk factor viral infections due influence immune response <NUMBER> <NUMBER> h<NUMBER>n<NUMBER> outbreak obese patients stringent complications care needs <NUMBER> relation covid<NUMBER> research points high rate obese patients complications need hospitalization <NUMBER> study carried new york city nyc us showed among <NUMBER> patients tested positive covid<NUMBER> <NUMBER> obesity <NUMBER> total body mass index bmi <NUMBER> kgm <NUMBER> severe obesity much likely develop severe forms disease patients greater need hospitalization care intensive care unit icu <NUMBER> another study also nyc followed <NUMBER> patients covid<NUMBER> <NUMBER> <NUMBER> hospitalized observed individuals bmi <NUMBER> kgm <NUMBER> six times likely hospitalized <NUMBER> retrospective study <NUMBER> patients covid<NUMBER> conducted hospital wuhan city bmi patients critical group bmi <NUMBER> kgm <NUMBER> significantly higher noncritical group <NUMBER> patients died <NUMBER> <NUMBER> bmi <NUMBER> kgm <NUMBER> <NUMBER> view alarming number cases countries like us estimated around <NUMBER> population obese <NUMBER> europe according recent estimates obesity affects <NUMBER> <NUMBER> population <NUMBER> obesity represents serious problem related covid<NUMBER> data reflect current alarming situation faced european countries already mentioned united kingdom italy spain also us brazil whose number serious cases deaths tops global statistics pointing obesity risk factor covid<NUMBER> mortality <NUMBER> <NUMBER> diabetes seventh deadly disease worldwide approximately <NUMBER> million deaths directly <NUMBER> represents risk factor development pathologies standing disease great medical interest <NUMBER> relationship infectious diseases yet fully understood however addition suppressing patients immunity cause metabolic dysfunction directly affects homeostasis entire organism <NUMBER> study relationship diabetes morbidity mortality rate among patients sarscov observed patients known history diabetes died <NUMBER> versus <NUMBER> diabetic survivors <NUMBER> diabetes patients reported four times chance hospitalization h<NUMBER>n<NUMBER> pandemic <NUMBER> like sarscov h<NUMBER>n<NUMBER> diabetes appears comorbidity potential aggravate lead death sarscov<NUMBER> infection metaanalysis included <NUMBER> infected people wuhan hubei province china <NUMBER> diabetic patients <NUMBER> another study conducted wuhan <NUMBER> patients followed <NUMBER> died among nonsurvivors <NUMBER> diabetic <NUMBER> death rate reported chinese center disease control <NUMBER> cases <NUMBER> increased <NUMBER> analyzed diabetics patients group <NUMBER> diabetes identified second common comorbidity among cases covid<NUMBER> hypotheses raised high incidence rate diabetic patients directly linked high gene expression angiotensinconverting enzyme <NUMBER> ace<NUMBER> cells used sarscov<NUMBER> enter human cells due treatment ace inhibitors angiotensin ii typei receptor blockers arbs <NUMBER> would increase risk patients infection would also make difficult control comorbidity treatment covid<NUMBER> relationship yet fully understood studies needed confirm since drug treatment protocols diabetic patients remain metabolic dysfunction <NUMBER> hypertension appeared research various countries continents common comorbidity among infected sarscov<NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> well cardiovascular diseases cvd appear risk factors severe complications covid<NUMBER> arterial hypertension heart failure arrhythmia diseases cardiovascular system generate several complications sarscov<NUMBER> infection course <NUMBER> analysis <NUMBER> patients covid<NUMBER> observed <NUMBER> patients problems hypertension coronary heart disease <NUMBER> patients developed severe forms pneumonia caused sarscov<NUMBER> <NUMBER> individuals heart disease <NUMBER> metaanalysis involving <NUMBER> patients covid<NUMBER> found patients cvd five times likely develop disease critical stage <NUMBER> data chinese center disease control prevention pointed <NUMBER> mortality rate group <NUMBER> infected covid<NUMBER> however number much higher among patients hypertension cvd reaching <NUMBER> <NUMBER> respectively <NUMBER> addition history cvd aggravating factor covid<NUMBER> development cardiovascular complications also result infection acute myocardial injury observed <NUMBER> confirmed cases disease elevation highsensitivity cardiac troponin found <NUMBER> cases troponin among patients mild symptoms infection found low concentration <NUMBER> <NUMBER> investigation <NUMBER> patients covid<NUMBER> evaluated <NUMBER> patients history cvd died <NUMBER> high troponin levels <NUMBER> high concentration ace<NUMBER> cardiac tissue pointed possible mechanism lesions since enzyme used sarscov<NUMBER> invade cell making heart favorable site viral colonization diabetes many drugs used treat hypertension act ace inhibitors arbs increasing ace<NUMBER> expression individual <NUMBER> <NUMBER> <NUMBER> highly active tissue high demand energy produced mitochondria hypoxia promoted covid<NUMBER> cause damage myocardium severe consequences infected patient <NUMBER> <NUMBER> currently cvd main cause death responsible <NUMBER> deaths <NUMBER> much reflection eating habits sedentary lifestyle modern life provided population ms contributing factor development cvd current pandemic scenario sedentary lifestyle takes toll <NUMBER> liver important organ diverse body metabolic functions damage caused hepatic tissue covid<NUMBER> observed addition pathologies affect inserted risk factors complications severe manifestations pneumonia caused novel coronavirus <NUMBER> like organs liver cells especially bile duct cells ace<NUMBER> enzyme surface placing liver tissue possible infection site virus <NUMBER> previously <NUMBER> severe acute respiratory syndrome coronaviruses sarscov outbreak studies shown direct action virus hepatocytes causing apoptosis cells inducing injury elevated serum levels proinflammatory cytokines also found patients liver damage like <NUMBER> epidemic middle east respiratory syndrome mers coronavirus merscov liver damage caused infection observed infected patients however unlike sarscov sarscov<NUMBER> merscov uses another receptor invade cell dipeptidylpeptidase iv dpp<NUMBER> widely expressed hepatocytes sarscov infection high serum levels inflammatory cytokines described patients <NUMBER> <NUMBER> current pandemic caused novel coronavirus studies already observed abnormal concentrations liver function markers study <NUMBER> patients observed patients nafld higher risk covid<NUMBER> progression <NUMBER> patients progressive condition <NUMBER> <NUMBER> nafld inflammation liver tissue resulting proinflammatory cytokines released adipose tissue becomes even aggravated pathogen presence sarscov<NUMBER> complications fully clarified potentially severe infected patient <NUMBER> observed approximately <NUMBER> <NUMBER> patients covid<NUMBER> elevated transaminases especially metabolic disorders associated obesity nonalcoholic fatty liver disease nafld <NUMBER> <NUMBER> yet clear whether liver damage primary caused directly virus inflammatory reaction secondary caused drugs used treatment hypoxia caused pneumonia however even modest changes exist certainly history preexisting liver disease tends worsen infection prognosis <NUMBER> <NUMBER> context nafld considered hepatic manifestation ms characterized deposit fat liver tissue inserted comorbidity subject detailed observation <NUMBER> prevalence estimated <NUMBER> <NUMBER> population western countries <NUMBER> <NUMBER> among asian countries significantly increased obese diabetic patients <NUMBER> researches relationship nafld covid<NUMBER> still scarce absence known effective therapy due pandemic situation recently many drugs treatment covid<NUMBER> tested drugs previously proposed treatment viral diseases including previous outbreaks coronavirus sarscov merscov began tested emphasis chloroquine hydroxychloroquine analog associated azithromycin corticosteroids antiviral medications patients <NUMBER> proposed pharmacological treatments summarized table <NUMBER> shows mechanism action adverse effects drugs experimental studies suggested chloroquine cq proven antimalarial drug inhibit replication various intracellular microorganisms including coronavirus vitro <NUMBER> <NUMBER> suggested possible inhibition sarscov<NUMBER> replication terminal glycosylation ace<NUMBER> produced pulmonary vessels inhibiting link virus receptor inhibition viral infection raising endosomal ph also reported thus interfering viruscell fusion addition observed medicine contributed prevention viral spread cell cultures <NUMBER> hydroxychloroquine hcq also increase intracellular ph inhibit lysosomal activity antigenpresenting cells process reduces cell activation differentiation expression costimulatory proteins production cytokines cytoplasm interferes synthesis viral nucleic acids attenuating proinflammatory response mechanisms strengthen hypothesis hcq suppress sarscov<NUMBER> inhibiting hyperactivation immune system triggered virus thus reducing disease progression mild severe however still without clinical evidence <NUMBER> <NUMBER> although hcq cq shown antiviral activity sarscov<NUMBER> vitro hcq appears potent action furthermore hcq clinical safety superior cq longterm use allows use higher doses interactions drugs <NUMBER> nonrandomized controlled trial showed azithromycin associated hcq significantly efficient eliminate virus <NUMBER> patients detectable viral load <NUMBER> days treatment however drugs must used carefully azithromycin indiscriminate use antimicrobial cause bacterial resistance use cq may cause increase qt interval retinopathy cardiovascular disorders certainly concern hypertensive patients <NUMBER> research warns adverse effects real effectiveness medications according studies widespread use hcq expose patients fatal consequences including skin reactions liver failure ventricular arrhythmia especially prescribed association azithromycin furthermore risk cq phosphate cause acute poisoning even death <NUMBER> <NUMBER> <NUMBER> <NUMBER> researchers analyzed <NUMBER> patients covid<NUMBER> new york city <NUMBER> <NUMBER> treated hcq treated total <NUMBER> developed respiratory failure <NUMBER> intubated <NUMBER> died without intubation according analysis patients took hcq likely develop respiratory failure use <NUMBER> makes randomized controlled trials hcq extremely necessary patients covid<NUMBER> mainly associated metabolic disorders patients type <NUMBER> type <NUMBER> diabetes andor hypertension treated ace inhibitors andor arbs considerable increase eca<NUMBER> receptors expression may facilitate virus entry authors report patients using drugs develop severe fatal covid<NUMBER> <NUMBER> appropriate alternative treatment use calcium channel blockers antihypertensive agents suggested patientcentered approach used guide choice pharmacological agents considering age severity covid<NUMBER> cardiovascular comorbidities risk hypoglycemia <NUMBER> <NUMBER> another possibly promising drug favipiravir drug proven action ebola virus drugs efficiency reducing sarscov<NUMBER> infection due inhibition rna polymerase activity <NUMBER> <NUMBER> randomized clinical trial <NUMBER> patients china showed favipiravir <NUMBER> effective arbidol <NUMBER> treatment covid<NUMBER> patients hypertension andor diabetes used favipiravir experienced reduction fever cough relief faster patients used arbidol however difference auxiliary oxygen therapy noninvasive mechanical ventilation patients <NUMBER> antiretroviral drugs lopinavirritonavir oral combination agent approved us food drug administration fda treatment hiv demonstrated vitro activity coronaviruses inhibiting <NUMBER>chymotrypsinlike protease <NUMBER> adverse effects lopinavirritonavir include gastrointestinal discomfort nausea diarrhea <NUMBER> hepatotoxicity <NUMBER> <NUMBER> <NUMBER> patients covid<NUMBER> adverse effects may exacerbated combination therapy due viral infection <NUMBER> remdesivir gs<NUMBER> adenosine nucleoside analogue prodrug broadantiviral spectrum phyloviruses paramyxoviruses pneumoviruses coronaviruses <NUMBER> vitro studies shown ability remdesivir inhibit coronaviruses replication primary human lung cells <NUMBER> <NUMBER> patients hospitalized severe covid<NUMBER> treated compassionateuse remdesivir showed clinical improvement <NUMBER> <NUMBER> patients <NUMBER> <NUMBER> well showed shortened time recovery evidence lower respiratory tract infection remdesivir group <NUMBER> however another study remdesivir adults severe covid<NUMBER> associated significant clinical benefits patients received remdesivir numerically faster time clinical improvement receiving placebo symptom duration <NUMBER> days less <NUMBER> studies adverse events reported followup patients <NUMBER> <NUMBER> anemia decreased hemoglobin thrombocytopenia acute kidney injury decreased estimated glomerular filtration rate increased blood creatinine increased total bilirubin hyperglycemia increased aminotransferase levels suggests clinical investigation patients complications associated metabolic syndrome <NUMBER> <NUMBER> <NUMBER> another potential adjuvant therapy covid<NUMBER> use convalescent plasma hyperimmune immunoglobulins <NUMBER> justification treatment antibodies recovered patients help immune response virus individuals covid<NUMBER> preventive measure infection cases vulnerable individuals diverse metabolic disorders nitazoxanide traditionally anthelmintic agent broad antiviral activity relatively favorable safety profile demonstrated vitro antiviral activity mers sarscov<NUMBER> <NUMBER> <NUMBER> lack robust evidence antiviral activity immunomodulatory effects safety profile nitazoxanide justify study therapeutic option covid<NUMBER> current evidence demonstrates use corticosteroids decrease inflammatory responses lungs however benefit overcome adverse effects including delayed viral clearance respiratory tract blood high rates complications including hyperglycemia psychosis avascular necrosis well increased risk secondary infection although direct evidence use corticosteroids covid<NUMBER> limited result revisions viral pneumonias instructive observational studies patients sars mers reported association corticosteroids improved survival <NUMBER> <NUMBER> <NUMBER> risk hyperglycemia diabetic patients reduced although eliminated good glycemic control although several therapeutic agents evaluated treatment covid<NUMBER> therapy yet shown efficacious patients proposed treatments covid<NUMBER> drugs mechanisms action adverse effects chloroquine metabolic syndrome risk factor influences covid<NUMBER> progression prognosis prevalence obese diabetic hypertensive liver damage patients severe cases covid<NUMBER> multiple countries demonstrates importance care risk group prophylaxis monitoring treatment similarly drugs currently evaluated infection treatment promising need studies prove efficacy safety due adverse effects may exacerbated combination therapy due viral infection development vaccine immunization still best longterm solution prevention future outbreaks sarscov<NUMBER> addition people age preexisting diseases heart disease diabetes obesity among others also need redouble care measures prevent coronavirus n u c r p <NUMBER> dear editor read interest article kaiser ub colleagues j clin endocrinol metab entitled response covid<NUMBER> endocrinologists diabetologists <NUMBER> published recently appreciate authors valuable insights fighting coronavirus disease <NUMBER> covid<NUMBER> although primary clinical presentations covid<NUMBER> respiratory symptoms patients may pancreas damage knowledge damage caused severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> endocrine system underlying mechanism paramount importance timely effective treatments patients multiple organ damages might correlated expressions sarscov<NUMBER> coronavirus receptor angiotensin converting enzyme <NUMBER> ace<NUMBER> different organs abundant ace<NUMBER> immunostaining observed lung kidney heart especially critical illnesses sars coronavirus enters islets pancreas ace<NUMBER> receptor damages islets <NUMBER> similarly high expression ace<NUMBER> islets pancreas may cause pancreas damage sarscov<NUMBER> infection however pancreas injury noticed clinical settings might symptoms pancreatic injury less specific compared systemic lesions stress hyperglycemia insulin resistance common critically ill patients although use corticosteroids patients covid<NUMBER> remains controversial physicians tend use glucocorticoids critically ill patients infection control however use corticosteroids may lead glucocorticoidinduced hyperglycemia stress hyperglycemia reported <NUMBER> sars patients retrospective analysis <NUMBER> nondiabetic sars patients showed nonsurvivors consistently higher fasting bloodglucose caused anaerobic metabolism survivors dosages methylprednisolone <NUMBER> patients diabetes increased risk bacterial mycotic parasitic viral infections death intensive care unit icu admission mechanical ventilation diabetic patients sars <NUMBER> times nondiabetic patients <NUMBER> preexisting diabetes independent predictor death morbidity sars patients <NUMBER> proportion diabetic patients h<NUMBER>n<NUMBER> cases <NUMBER> <NUMBER> number diabetic patients admitted icu due h<NUMBER>n<NUMBER> influenza <NUMBER> times nondiabetic patients <NUMBER> systematic analysis <NUMBER> middle east respiratory syndrome coronavirus merscov cases suggested diabetes prevalent <NUMBER> patients <NUMBER> diabetes also high risk factor causing infected patients progress severe cases merscov outbreak c c e p e n u c r p <NUMBER> recent study showed <NUMBER> sarscov<NUMBER> coexisted diabetes <NUMBER> patients diabetes likely develop acute respiratory distress syndrome require icu mechanical ventilation compared nondiabetic patients indicating patients diabetes higher risk progressing critically ill cases particular attention paid stress hyperglycemia diabetes covid<NUMBER> blood glucose clinical presentations could determine occurrence stress hyperglycemia using corticosteroids patients known diabetes glucocorticoids used caution intensive monitoring insulin therapy may obtain optimal metabolic control improve outcome patients n u c r p prevent spread coronavirus disease covid<NUMBER> total lockdown place india <NUMBER> th march <NUMBER> <NUMBER> days study aim assess impact duration lockdown glycaemic control diabetesrelated complications systematic search conducted using cochrane library simulation model created using glycemic data previous disasters taken similar impact current lockdown taking baseline hba<NUMBER>c diabetesrelated complications data indiaspecific database multivariate regression analysis conducted analyse relationship duration lockdown glycaemic targets diabetesrelated complications predictive model extremely robust r<NUMBER> predicted outcomes period lockdown upto <NUMBER> days predicted increment hba<NUMBER>c baseline end <NUMBER> days <NUMBER> days lockdown projected <NUMBER> <NUMBER> respectively similarly annual predicted percentage increase complication rates end <NUMBER>day lockdown <NUMBER> nonproliferative diabetic retinopathy <NUMBER> proliferative diabetic retinopathy <NUMBER> retinal photocoagulation <NUMBER> microalbuminuria <NUMBER> proteinuria <NUMBER> peripheral neuropathy <NUMBER> lower extremity amputation <NUMBER> myocardial infarction <NUMBER> stroke <NUMBER> infections duration lockdown directly proportional worsening glycaemic control diabetesrelated complications increase diabetesrelated complications put additional load overburdened healthcare system also increase covid<NUMBER> infections patients uncontrolled glycemia keywords diabetes lockdown disaster multivariate regression analysis complications highlights • lockdown india attempt preventing spread virus may adversely impact diabetes control well associated complications putting restriction available resources changes lifestyle • probably first study highlight increment hba<NUMBER>c well diabetesrelated complications increasing duration lockdown world experiencing viral onslaught herculean proportion form covid<NUMBER> coronavirus disease <NUMBER> caused sarscov<NUMBER> severe acute <NUMBER> respiratory syndrome coronavirus <NUMBER> <NUMBER> infection rate well death covid <NUMBER> exhibited exponential growth <NUMBER> whole attention prevention management strategies related however disease evolved learned patient population equal risk morbidity mortality elderly additional comorbidities form diabetes hypertension background cardiovascular compromise higher risk without comorbid diseases <NUMBER> india houses second largest population patient diabetes mellitus china <NUMBER> although pandemic covid <NUMBER> originated china unlike diabetes prevalence india yet experienced lesser impact covid<NUMBER> <NUMBER> attempt stem spread virus individuals travelling india endemic areas internal community spread feature stage <NUMBER> disease process temporary <NUMBER> days lockdowncomplete restriction international domestic travel social isolation suspension nonessential services announced prime minister india <NUMBER> th march <NUMBER> one hand could vital step stemming spread virus however likely issues related impact lockdown patients diabetes worsening hyperglycaemia increase diabetesrelated complications could due limitation free space exercise limited resources implement healthy lifestyle restrictions availability antihyperglycaemic agents difficulty obtainingof physicians guidance limitations transport goods movement patients likely shortage drugs insulin glucose testing strps glucose meters factors potential increase stress level associated impact preexisting disease impact lockdown glycaemic target diabetesrelated complications difficult collect real data one could use simulation model created aid multivariate regression analysis could predict answer questions hypothesised lockdown india period <NUMBER> days beyond lead worsening glycemia later increase diabetesrelated complications analysis planned answer stated hypothesis absence previous data searched scenarios similar lockdown situation zeroed several disasters earthquakes tsunamis hurricanes wars closely simulatea lockdown far resource limitations challenges concerned <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> baseline glycosylated haemoglobin hba<NUMBER>ca<NUMBER>c associated diabetesrelated complications indian population data diabcare study taken <NUMBER> using parameters baseline analysis planned aiming predicting endoflockdown hba<NUMBER>c well diabetesrelated complication rates thereof webbased search conducted addressing diabetes control times disaster resources become scarce lifestyle modification opportunities become constricted background selected simulate proposed <NUMBER> days lockdown india facing menace coronavirus outbreak disaster period included closely simulate resource challenged atmosphere search pubmed google scholar cochrane library conducted using following search terms disaster diabetes mellitus blood glucose targets diabetic complications keywords subsequently clubbing disaster diabetes mellitus yielded <NUMBER> citations combined blood glucose targets diabetes complications yielded <NUMBER> citations per preplanned inclusion criteria filters imposed include trials resulting <NUMBER> studies available analysis six citations related disaster diabetes mellitus included analyse predicted hba<NUMBER>c end lockdown disasters included analysis hurricane katrina usa<NUMBER> days considered lockdown period <NUMBER> kobe earthquake japan<NUMBER> days considered lockdown period <NUMBER> hanshinawashi earthquake japan <NUMBER> days considered lockdown period <NUMBER> gulf war iraq <NUMBER> days considered lockdown period <NUMBER> murmura earthquake turkey <NUMBER> days considered lockdown period <NUMBER> great eastern japan earthquake tsunami japan <NUMBER> days considered lockdown period <NUMBER> data collected comma separatedvalues csv file uploaded jupyter notebook analysed python <NUMBER> software windows <NUMBER> <NUMBER> bit usa revalidation process simplicity understanding data also analysed using excel xlstat statistical software windows <NUMBER> <NUMBER> bit usa postlockdown hba<NUMBER>c available plan include seventh citation related indian data mean hba<NUMBER>c value representative indian population <NUMBER> prevalent diabetesrelated micro macrovascular complications baseline data diabcare study collected one year <NUMBER> centres across country resulting surveying <NUMBER> diabetic patients <NUMBER> mean hba<NUMBER>c well annual rates complications collected crosssectional study final step planned predict post lockdown complication rates depending predicted hba<NUMBER>c duration lockdown days data calculated premise current state conditions patients constrained resources continue major intervention control glycemia introduction new drugs insulin etc carried results analysis presented five steps step <NUMBER> first step estimate hba<NUMBER>c increment observed time period respective disasters table <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> table <NUMBER> analysis hba<NUMBER>c increment preand postdisaster hba<NUMBER>c levels number days additional determinant number days indicate period population mostly resource challenged facing challenges enumerated current lockdown india step <NUMBER> linear regression analysis performed number days hba<NUMBER>c increment fig <NUMBER> fig <NUMBER> linear regression analysis number days hba<NUMBER>c increment without significant outlier gulf war correlation analysis revealed moderately good correlation postdisaster hba<NUMBER>c duration disaster r<NUMBER> strong correlation baseline hba<NUMBER>c r<NUMBER> step <NUMBER> multivariate regression analysis done revealing strong association inputs days count baseline hba<NUMBER>c output postdisaster hba<NUMBER>c relationship days count postdisaster hba<NUMBER>c statistically significant p<NUMBER> relationship baseline hba<NUMBER>c postdisaster hba<NUMBER>c p<NUMBER> multivariate linear model robust r <NUMBER> <NUMBER> adjusted r <NUMBER> <NUMBER> table <NUMBER> formula generated multivariate regression analysis postdisaster a<NUMBER>c b<NUMBER> b<NUMBER> number days lockdown b<NUMBER>baseline a<NUMBER>c inserting intercepts equation turns postdisaster a<NUMBER>c <NUMBER> <NUMBER> number days lockdown <NUMBER>baseline a<NUMBER>c table <NUMBER> summary output multivariate regression analysis done inputs days count baseline hba<NUMBER>c output postdisaster hba<NUMBER>c step <NUMBER> diabcare india study <NUMBER> taken reference baseline characteristics baseline mean hba<NUMBER>c india well diabetesrelated complication rates prevalent hba<NUMBER>c hence inserting mean baseline hba<NUMBER>c diabcare study ie <NUMBER> calculated postdisaster predicted hba<NUMBER>c table <NUMBER> predicted data accepted major intervention major changes treatment physician initiation insulin therapy etc done step <NUMBER> established relationship days lockdown predicted endoflockdown hba<NUMBER>c posterior diabetesrelated complication rates calculated taking baseline data diabcare study <NUMBER> baseline hba<NUMBER>c <NUMBER> table <NUMBER> table <NUMBER> predicted diabetesrelated complication rates proportion increasing duration lockdown <NUMBER> days associated increase hba<NUMBER>c increasing duration lockdown increment hba<NUMBER>c baseline continues increase carries along increasing annual complication rates annual predicted percentage increment complication rates baseline end <NUMBER>day lockdown due covid<NUMBER> pandemic <NUMBER> nonproliferative diabetic retinopathy <NUMBER> proliferative diabetic retinopathy <NUMBER> retinal photocoagulation <NUMBER> microalbuminuria <NUMBER> overt proteinuria <NUMBER> peripheral neuropathy <NUMBER> amputation <NUMBER> myocardial infarction <NUMBER> stroke <NUMBER> infections annual predicted percentage increment complication rates baseline end <NUMBER>day lockdown due covid<NUMBER> pandemic <NUMBER> nonproliferative diabetic retinopathy <NUMBER> proliferative diabetic retinopathy <NUMBER> retinal photocoagulation <NUMBER> microalbuminuria <NUMBER> overt proteinuria <NUMBER> peripheral neuropathy <NUMBER> amputation <NUMBER> myocardial infarction <NUMBER> stroke <NUMBER> infections first kind analysis show substantial increase hba<NUMBER>c diabetesrelated complications people diabetes data estimates based assumptions numbers generated good enough alert us strengthen already challenged healthcare resources toward highrisk population achieving maintaining good glycemic control defined hba<NUMBER>c <NUMBER> one primary requirements reduce diabetes related complications <NUMBER> <NUMBER> also important take consideration whole world struggling contain deadly viral illness focus comorbidities facilitating viralrelated morbidities mortality cannot compromised sufficient evidence indicate poor glycemic control presence organ dysfunction predisposes individual infected covid<NUMBER> far greater risk mortality without hence paramount importance achieve well maintain good glycemic control short well long term benefits pandemic one worrisome factors restriction routine physician consultations result patients suffering chronic diseases although stable offered usual standards care physicians also paramedical staff numbers reduced channelized toward dedicated covid<NUMBER>related care result noncovid related complications rate expected rise independently predispose patients acquire covid<NUMBER> infection analysis therefore designed deduce adverse impact total lockdown glycemic targets associated complications likely first study make deduction absence prior data simulation model created natural unnatural disasters faced past based simulation model created predict adverse impact covid<NUMBER> related lockdown diabetes related complications moderate correlation postdisaster hba<NUMBER>c duration disaster r<NUMBER> strong correlation baseline hba<NUMBER>c r<NUMBER> based result multivariate regression analysis done revealing strong model predict postlockdown hba<NUMBER>c depending duration days lockdown assuming uniform baseline hba<NUMBER>c derived diabcare study latest epidemiological database diabetes complications india postlockdown hba<NUMBER>c increases baseline duration lockdown got extended examplehba<NUMBER>c <NUMBER> <NUMBER> days lockdown <NUMBER> <NUMBER> days lockdown addition increment hba<NUMBER>c permitted us calculate annual proportional increase diabetesrelated complications rate increased duration lockdown increased prevent increase hba<NUMBER>c associateddiabetesrelated complications system must put place facilitate patent doctor interface telecommunication online consultations use social media platforms bring whole medical care home virtual sense dedicated campaigns launched utilizing audiovisual media encouraging lifestyle modifications home government must put required mechanism prevent shortages medicines insulins one main limitations study nonavailability diabetesrelated outcomes lockdown replicated bringing scenario natural nonnatural disasters similar may occur lockdown clearly lot differences lockdown hurricane earthquake tsunami disasters taken analysis occurred several years gulf war <NUMBER> years ago since information flow modes virtual consultations increased may help patients control diabetes better information flow availability physicians drugs resources varied different countries may general better previously factors may lead overestimation risk model however limited availability resources needed manage diabetes bridging factor made us choose disasters prior analysis finally modelbased prediction problem related overestimating risk profile principle strength analysis robustness multivariate regression model robust statistically significant secondly absence previous data reported covid<NUMBER> fatalities history diabetes mellitus <NUMBER> literature search performed using pubmed review interrelationships hyperglycemia reninangiotensin system ras covid<NUMBER> effects antihyperglycemic medications herein discuss roles classic nonclassic reninangiotensin system ras lung injury glucose homeostasis among patients covid<NUMBER> also discuss putative roles glucoselowering medications type <NUMBER> diabetic patients covid<NUMBER> introduce current evidence use hospitalized patients severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> uses angiotensinconverting enzyme ii ace<NUMBER> receptor enter host cell serine protease tmprss<NUMBER> virus spike protein priming <NUMBER> binding sarscov<NUMBER> spike protein ace<NUMBER> activates disintegrin metalloprotease<NUMBER> adam<NUMBER> induces ace<NUMBER> shedding via process tightly coupled tnfα production <NUMBER> downregulation ace<NUMBER> cell surface expression lung tissue associated severe clinical outcome cases sarscov<NUMBER> infection <NUMBER> considering sarscov<NUMBER> sarscov<NUMBER> share <NUMBER> sequence spike protein <NUMBER> sarscov<NUMBER> likely downregulate ace<NUMBER> expression recently monteil v et al showed human recombinant soluble ace<NUMBER> significantly blocks sarscov<NUMBER> infections providing rationale soluble ace<NUMBER> might protect lung injury also block sarscov<NUMBER> entering target cells <NUMBER> ace<NUMBER> expressed lung kidney pancreas tissues degrades angiotensin ii angiotensin<NUMBER> <NUMBER> ace<NUMBER> receptor protects lung injury modulating ras decreasing angiotensin ii levels <NUMBER> moreover activation angiotensin <NUMBER>ace<NUMBER> axis inhibits reactive oxygen species production downregulates proinflammatory cytokine secretion immunomodulatory tissueprotective features <NUMBER> physiologic standpoint increased baseline ace<NUMBER> expression could potentially increase sarscov<NUMBER> infectivity upregulation ace<NUMBER> expression ace<NUMBER> replacement acute respiratory distress syndrome phase ards phase may turn beneficial accumulating evidence supports protective roles ace<NUMBER> diabetes ace<NUMBER> might play several roles glucose homeostasis <NUMBER> ace<NUMBER> deficiency leads altered glucose metabolism ace<NUMBER>knockout mice showed βcell defect associated decrease insulin secretion manner dependent angiotensin ii may reflect collectrinlike action ace<NUMBER> <NUMBER> mice ace<NUMBER> overexpression pancreas significantly improved glucose tolerance enhanced islet function increased βcell proliferation insulin content <NUMBER> <NUMBER> loss ace<NUMBER> increases insulin resistance highcalorie diet fed mice reduction glut<NUMBER> administration angiotensin<NUMBER> improved insulin tolerance suggesting significant role angiotensin<NUMBER> glucose homeostasis <NUMBER> <NUMBER> hyperglycemia stimulates tissue ras vice versa increased activity angiotensin ii signaling pathways contribute development diabetes complications <NUMBER> <NUMBER> ace<NUMBER> thought act compensatory mechanism hyperglycemiainduced ras activation loss ace<NUMBER> mice disrupts balance ras diabetic state leads angiotensin iiat<NUMBER> receptordependent systolic dysfunction impaired vascular function <NUMBER> adam<NUMBER> involved shedding transmembrane ace<NUMBER> release catalytically active ectodomain circulation <NUMBER> adam<NUMBER>mediated ectodomain shedding might compromise ras compensatory axis impairing ace<NUMBER> enzymatic activity ability process angiotensin ii cell surface <NUMBER> mice hyperglycemia increases adam<NUMBER> activity renal ace<NUMBER> shedding urine <NUMBER> urinary ace<NUMBER> excretion correlated positively progression diabetic renal injury probably resembling unopposed angiotensin ii effect humans urinary ace<NUMBER> levels significantly higher insulinresistant subjects type <NUMBER> diabetes mellitus controls normal glucose tolerance <NUMBER> addition urinary ace<NUMBER> appears positively associated inflammatory cytokines resembling increased ace<NUMBER> shedding <NUMBER> <NUMBER> localization ace<NUMBER> expression endocrine part pancreas suggests sars coronavirus enters islets using ace<NUMBER> receptor damages islets causing acute diabetes fact yang j et al reported <NUMBER> sars patients previous history diabetes steroid treatment diagnosed diabetes hospitalization <NUMBER> diabetes <NUMBER> years followup <NUMBER> hypothesized sarscov<NUMBER>mediated downregulation ace<NUMBER> expression pancreas peripheral tissues may decrease insulin secretion increase insulin resistance induce hyperglycemiainduced ras activation hand ace<NUMBER> expression pancreas might facilitate sarscov<NUMBER> invasion direct βcell damage adam<NUMBER> activation sarscov<NUMBER> might also increase risk hyperglycemia mice accumulating evidence suggests increased adam<NUMBER> activity results increased insulin resistance hyperglycemia <NUMBER> adam<NUMBER> plays potential role inflammation cleave thereby activate variety cytokines cytokine receptors including tumor necrosis factor α tnfα interleukin<NUMBER> receptor il<NUMBER>r <NUMBER> increased inflammation might also contribute development islet βcell failure <NUMBER> accumulating evidence suggests patients severe covid<NUMBER> ards might cytokine storm syndrome including high levels il<NUMBER> tnfα <NUMBER> meanwhile ras activation propagate acute lung injury <NUMBER> hyperglycemia commonly observed acute critical illness early administration insulin acute illness associated better outcomes lower mortality rates <NUMBER> insulin therapy diabetic patients covid<NUMBER> disease warrant hospital care might associated better outcomes explanations <NUMBER> insulin exerts immunomodulatory effects independent glycemic control several studies suggest potential benefit insulin therapy different animal models acute lung injury ards insulin inhibits synthesis proinflammatory factors including tnfα il<NUMBER> attenuates oxidative stress seen acute lung injury <NUMBER> <NUMBER> <NUMBER> treating hyperglycemia insulin might restore ace<NUMBER> adam<NUMBER> expression ras balance shown mice akita mouse model type <NUMBER> diabetes insulin treatment normalized hyperglycemia decreased urinary ace<NUMBER> excretion restored renal ace<NUMBER> adam<NUMBER> expression physiological levels normalized rate shedding <NUMBER> recent study demonstrated marked serum pulmonary alterations ace activity nonobese diabetic nod mice lung nod mice ace activity increased ace<NUMBER>ace activity ratio decreased compared control mice interestingly insulin significantly increased ace<NUMBER>ace activity ratio mice lung restored ace ace<NUMBER> ace<NUMBER>ace ratio activities serum samples <NUMBER> therefore hypothesized restoring ace<NUMBER> expression physiological levels cell surface decreasing angiotensin ii levels insulin therapy might prevent rapid propagation toward cytokine storm lung injury covid<NUMBER> <NUMBER> early insulin therapy reduces risk developing diabetic ketoacidosis hyperglycemic hyperosmolar states taking account diabetic patients covid<NUMBER> may deteriorate rapidly acute lung injury ards antihyperglycemic medications table <NUMBER> <NUMBER> peroxisome proliferatoractivated receptorγ pparγ agonists attenuated lipopolysaccharide lpsinduced lung injury murine models <NUMBER> note type <NUMBER> diabetic mice insulin sensitizer rosiglitazone normalized hyperglycemia attenuated renal injury decreased urinary ace<NUMBER> excretion renal adam<NUMBER> protein expression unlike insulin affect renal ace<NUMBER> expression <NUMBER> hand pioglitazone upregulated ace<NUMBER> protein expression liver adipose tissue skeletal muscle rats highfat dietinduced nonalcoholic steatohepatitis <NUMBER> elevated ace<NUMBER> expression insulinsensitive tissues attenuate angiotensin iiinduced insulin resistance pioglitazone effect ace<NUMBER> expression lung unknown however taking consideration risk fluid retention advisable withhold pparγ agonists acutely ill patients <NUMBER> interestingly glp<NUMBER> agonist liraglutide provoked increase ace<NUMBER> expression lungs diabetic control rats circulating angiotensin <NUMBER> diabetic animals <NUMBER> based findings might proposed glp<NUMBER> agonist therapy might exert protective effects sarscov<NUMBER> induced lung injury <NUMBER> emerging evidence suggesting antiinflammatory effect sodium glucose cotransporter <NUMBER> inhibitors sglt<NUMBER> inhibitors <NUMBER> however recently published treatment recommendations advise withhold agents covid<NUMBER> illness due increased risk dehydration development diabetic ketoacidosis dka <NUMBER> anyhow prospective phase iii clinical study ongoing assess potential effect dapagliflozin reducing risk serious complications organ failure hospitalized patients covid<NUMBER> illness clinicaltrialsgov nct<NUMBER> <NUMBER> <NUMBER> sulfonylurea glibenclamide alleviate acute lung injury inhibiting nucleotidebinding oligomerization domain nodlike receptor family pyrin domain containing <NUMBER> nlrp<NUMBER> inflammasome signaling pathway <NUMBER> glibenclamide downregulates proinflammatory cytokines reactive oxygen species suppresses migration inflammatory cells <NUMBER> however use sulfonylureas inpatient setting discouraged potential risk hypoglycemia <NUMBER> summary current evidence reveals considerable interrelationships hyperglycemia coronavirusinduced lung injury insulin therapy seems promising alleviating lung injury given wide clinical spectrum covid<NUMBER> fact patients needing hospital care may deteriorate rapidly reasonable consider early introduction insulin upon admission hospital suggested target glucose range <NUMBER> mgdl <NUMBER> mmoll cases <NUMBER> although considerable evidence supports use incretinbased therapies critically ill patients hyperglycemia prospective studies comparing agents insulin required establish efficacy safety <NUMBER> <NUMBER> antihyperglycemic agents lack safety data concerning use hospitalized patients moderate severe covid<NUMBER> pneumonia future studies carried elucidate interface diabetes covid<NUMBER> unveil glycemic extraglycemic effects glucoselowering medications disease since late december <NUMBER> many patients pneumonia unclear etiology reported infected novel coronavirus formerly named <NUMBER> novel coronavirus <NUMBER>ncov recently named covid<NUMBER> coronavirus disease <NUMBER> world health organization wuhan hubei province china <NUMBER> <NUMBER> epidemiological investigation showed patients linked huanan seafood wholesale market previous studies showed evidence person person transmission <NUMBER>ncov family hospital settings <NUMBER> <NUMBER> <NUMBER> clinical features <NUMBER>ncov appeared similar sarscov leading high possibility icu admission high mortality fever fatigue dry cough shortness breath acute respiratory distress syndrome ards <NUMBER> march <NUMBER> <NUMBER> <NUMBER> cases identified <NUMBER> death cases recorded china number identified cases countries <NUMBER> <NUMBER> death cases recorded number newly confirmed cases overseas still growing especially south korea italy iran france germany <NUMBER>ncov outbreak becomes greater global threat terrorism although fatal rate <NUMBER>ncov less sarscov <NUMBER> mortality merscov <NUMBER> mortality confirmed cases <NUMBER>ncov higher sarscov merscov <NUMBER> diabetes mellitus important global health issue leading severe morbidity mortality <NUMBER> international diabetes federation anticipated number diabetic patients increase <NUMBER> million <NUMBER> finally increase <NUMBER> million <NUMBER> <NUMBER> previous report showed diabetes mellitus linked increased risk infectious disease hospitalisation <NUMBER> former study demonstrated incidence postoperative pneumonia higher t<NUMBER>dm patients without disease <NUMBER> another study indicated longterm mortality communityacquired pneumonia among patients undiagnosed diabetes mellitus higher patients without diabetes mellitus <NUMBER> therefore aims metaanalysis determine prevalence diabetes mellitus among <NUMBER>ncov <NUMBER> literature search performed using pubmed embase web science medline inclusion criteria follows <NUMBER> two independent investigators independently examined extracted data literature search debate determined mutual discussion following information extracted selected studies corresponding authors name publication year country origin study design diagnostic criteria <NUMBER>ncov prevalence diabetes mellitus metaanalysis performed using stata package version <NUMBER> stata corporation college station tx usa merge prevalence studies determine pooled prevalence <NUMBER> confidence interval ci using generic inverse variance method χ<NUMBER>testbased q statistic test p<NUMBER> i<NUMBER> <NUMBER> conducted assess betweenstudy heterogeneity fixedeffects model applied p≥<NUMBER> i<NUMBER>≤<NUMBER> otherwise random effect model applied p<NUMBER> i<NUMBER> <NUMBER> analysis sensitivity conducted evaluate stability metaanalysis metaninf algorithm stata publication bias investigated visual inspection funnel plots beggs rank correlation test eggers regression test meta bias algorithm stata asymmetric inverted funnel shape p<NUMBER> shows possible existence publication bias <NUMBER> performed literature search process pubmed embase web science medline <NUMBER> records identified database searching <NUMBER> additional records identified sources <NUMBER> records removed duplication <NUMBER> records screened eligibility <NUMBER> records excluded screening titles abstracts reviewing remaining <NUMBER> records removed <NUMBER> records according reasons explained figure <NUMBER> altogether <NUMBER> studies published feb <NUMBER> <NUMBER> met inclusion criteria assessed metaanalysis figure <NUMBER> <NUMBER> characteristics <NUMBER> studies exhibited table <NUMBER> included studies retrospective design diagnosis <NUMBER>ncov based world health organization interim guidance <NUMBER> studies included studies came asia china total sample <NUMBER> patients <NUMBER>ncov included analysis among <NUMBER> studies maximum number cases <NUMBER> whereas minimum <NUMBER> <NUMBER> studies involving <NUMBER> cases <NUMBER> studies involving less <NUMBER> cases among <NUMBER> studies pooled prevalence dm <NUMBER> <NUMBER> ci <NUMBER> obvious heterogeneity <NUMBER> <NUMBER> p<NUMBER> prevalence dm studies figure <NUMBER> sensitivity analysis omission study significant influence combined estimates exhibited relatively low sensitivity figure <NUMBER> symmetry funnel plot showed absence publication bias within studies figure <NUMBER> p values beggs test eggers test <NUMBER> <NUMBER> respectively prevalence dm severe patients <NUMBER>ncov <NUMBER> <NUMBER> ci <NUMBER> obvious heterogeneity <NUMBER> <NUMBER> p<NUMBER> prevalence dm studies figure <NUMBER> prevalence dm severe patients <NUMBER>ncov significantly higher moderate patients <NUMBER>ncov <NUMBER> <NUMBER> ci <NUMBER> <NUMBER> obvious heterogeneity <NUMBER> <NUMBER> p<NUMBER> studies figure <NUMBER> <NUMBER> prevalence dm moderate patients <NUMBER>ncov <NUMBER> <NUMBER> ci <NUMBER> obvious heterogeneity <NUMBER> <NUMBER> p<NUMBER> prevalence dm studies figure <NUMBER> mean age severe covid<NUMBER> group <NUMBER> years mean age moderate covid<NUMBER> group <NUMBER> years mean age moderate covid<NUMBER> group significantly younger mean age severe covid<NUMBER> group <NUMBER> <NUMBER> ci <NUMBER> figure <NUMBER> <NUMBER> metaanalysis collected data observational studies <NUMBER>ncov patients diabetes mellitus world diagnosis <NUMBER>ncov based world health organization interim guidance rtpcr pooled prevalence dm <NUMBER>ncov patients <NUMBER> <NUMBER> ci <NUMBER> <NUMBER> eligible studies comprising total <NUMBER> cases obvious heterogeneity <NUMBER> <NUMBER> p<NUMBER> prevalence dm studies partly due sample size design ， screening methods diagnostic method solved sensitivity analyses prevalence dm rising due increased obesity population ageing close relationship diabetes infection previous study showed patients dm susceptible developing infections lower upper respiratory tract infections urinary tract infections <NUMBER> another study demonstrated patients diabetes likely admitted hospital infection compared patients without diabetes <NUMBER> former study showed infections serious older people type <NUMBER> diabetes <NUMBER> metaanalysis <NUMBER> prospective cohort studies showed patients diabetes higher risk death causes compared patients without diabetes <NUMBER> previous study demonstrated prevalence rates type <NUMBER> diabetes mellitus <NUMBER> <NUMBER> ci <NUMBER> <NUMBER> years age group <NUMBER> <NUMBER> ci <NUMBER> <NUMBER> years age group china <NUMBER> another study showed agestandardized prevalence total diabetes <NUMBER> <NUMBER> among men <NUMBER> among women similar prevalence dm <NUMBER>ncov patients <NUMBER> <NUMBER> ci <NUMBER> overall prevalence type <NUMBER> diabetes mellitus <NUMBER> <NUMBER> <NUMBER> prevalence diabetes <NUMBER> <NUMBER> years age group slightly higher prevalence dm severe patients <NUMBER>ncov whose median age <NUMBER> years <NUMBER> <NUMBER> ci <NUMBER> <NUMBER> however research limitations first perform subgroup analysis due many included studies divide participants different groups outcome analysis second studies metaanalysis retrospective obvious heterogeneity adopted randomeffects metaanalysis solve problem third study singlearm metaanalysis without control group causality hard determine fourth included studies retrospective studies age groups also <NUMBER> cannot obtain data age <NUMBER>ncov patients diabetes mellitus included studies perform age adjustment analysis study summary metaanalysis demonstrated diabetes prevalent patients <NUMBER>ncov especially severe patients <NUMBER>ncov far research first report showing prevalence diabetes mellitus patients <NUMBER>ncov beneficial inhibit spread <NUMBER>ncov future patients diabetes get coronavirus disease <NUMBER> covid<NUMBER> risk severe disease course mortality several factors especially impaired immune response heightened inflammatory response hypercoagulable state contribute increased disease severity however many contentious issues evidence rather limited theoretical concerns effects different antihyperglycaemic drugs similarly despite recognition angiotensin converting enzyme <NUMBER> ace<NUMBER> receptor severe acute respiratory syndrome coronavirus <NUMBER> sars cov<NUMBER> role ace<NUMBER> lung injury conflicting results use angiotensin converting enzyme ace inhibitors angiotensin receptor blockers arb patients management patients diabetes times restrictions mobility poses challenges novel approaches like telemedicine useful need study natural course covid<NUMBER> patients diabetes understand individual regional ethnic variations disease prevalence course diabetes covid<NUMBER> evidence current status unanswered research questions high prevalence diabetes globally makes frequent comorbidity patients coronavirusassociated disease <NUMBER> though diabetes increases risk infection general studies reported prevalence diabetes almost similar general population patients covid<NUMBER> metaanalysis eight trials china showed diabetes present <NUMBER> <NUMBER> patients covid<NUMBER> <NUMBER> understandably prevalence diabetes patients covid<NUMBER> varies region age ethnicity known whether patients diabetes wellcontrolled blood glucose levels increased risk infection severe acute respiratory syndrome coronavirus <NUMBER> sars cov<NUMBER> patients diabetes develop covid<NUMBER> seen worse prognosis increased mortality studies <NUMBER> chinese patients diabetes hazard ratio <NUMBER> <NUMBER> ci <NUMBER> p <NUMBER> acute respiratory distress syndrome ards <NUMBER> reported metaanalysis nine studies china n <NUMBER> showed significant correlation severity covid<NUMBER> diabetes <NUMBER> <NUMBER> ci <NUMBER> p <NUMBER> <NUMBER> similarly case fatality rate <NUMBER> patients diabetes opposed <NUMBER> without diabetes report <NUMBER> patients covid<NUMBER> chinese centre disease control <NUMBER> recent study <NUMBER> patients covid<NUMBER> <NUMBER> centres across usa found diabetes associated fourfold increase mortality <NUMBER> diabetes increases severity covid<NUMBER> unclear though several factors may responsible table <NUMBER> poor glycaemic control impairs several aspects innate adaptive immune response viral infections potential secondary bacterial infection lungs <NUMBER> <NUMBER> defects immunity namely inappropriate tcell action impaired natural killer cell activity defects complement action could reduce viral clearance <NUMBER> interestingly ards patients covid<NUMBER> driven severe hypoxaemia despite relatively wellpreserved lung mechanics preexisting proinflammatory state could accentuate cytokine storm believed responsible ards well multiorgan dysfunction covid<NUMBER> <NUMBER> context important note strong association type <NUMBER> diabetes obesity abnormal secretion adipokines cytokines like tnfalfa interferon may impair immunity predispose severe infection <NUMBER> diabetes associated increased plasminogen levels postulated increase virulence sars cov<NUMBER> <NUMBER> presence inflammation prothrombotic factors shown study <NUMBER> patients hospitalised covid<NUMBER> wuhan china significantly higher serum levels interleukein <NUMBER> erythrocyte sedimentation rate creactive protein ferritin fibrinogen ddimer reported patients diabetes compared without diabetes <NUMBER> increased viral replication diabetes may also due increase furin type<NUMBER> membranebound protease involved entry coronaviruses cell <NUMBER> addition preexisting comorbidities associated diabetes like hypertension coronary artery disease chronic kidney disease worsen prognosis lastly hypoglycaemia could occur treatment diabetes may additionally worsen clinical outcomes respect role angiotensin converting enzyme <NUMBER> ace<NUMBER> receptor pathogenesis covid<NUMBER> patients diabetes intriguing sars cov<NUMBER> enters cell binding ace<NUMBER> process involves many steps several enzymes proteins <NUMBER> experimental evidence downregulation ace<NUMBER> diabetes <NUMBER> may predispose severe lung injury hand ace<NUMBER> receptor sars cov<NUMBER> downregulation might reduce entry virus cells issues discussed context use antihyperglycemic antihypertensive drugs precise effect treatment various oral antihyperglycaemic agents severity covid<NUMBER> known though theoretical considerations metformin shown modest benefits lower respiratory tract infections pulmonary tuberculosis <NUMBER> though gastrointestinal tolerability sick patients concern thiazolidinediones shown increase ace<NUMBER> levels <NUMBER> however propensity thiazolidinediones cause fluid retention risk congestive heart failure covid<NUMBER> would make agents unfavourable treatment glucagonlike peptide<NUMBER> agonists shown increase ace<NUMBER> increase surfactant experimental animals <NUMBER> practical significance changes ace<NUMBER> levels use thiazolidinediones glucagonlike peptide<NUMBER> agonists known sulfonylureas effective risk hypoglycaemia especially setting irregular meals might preclude use nevertheless sulfonylureas considered whenever blood glucose monitoring possible data regarding use dipeptidyl peptidase <NUMBER> dpp<NUMBER> inhibitors previous viral epidemics dpp<NUMBER> prime receptor middle east respiratory syndrome coronavirus responsible entry cell <NUMBER> hence possibility dpp<NUMBER> facilitating entry sars cov<NUMBER> cell cannot ruled context interesting postulation widespread use dpp<NUMBER> inhibitors india many countries might protecting individuals diabetes infection hand dpp<NUMBER> inhibitors potentially interfere immune response may harmful clinical data dpp<NUMBER> inhibitors shown generally case <NUMBER> increasing use sodium glucose cotransporter <NUMBER> sglt<NUMBER> inhibitors worldwide india interestingly sglt<NUMBER> inhibitors could also activate ace<NUMBER> indirectly especially used along ace inhibitors <NUMBER> hypothetical possibility sglt<NUMBER> inhibitors reducing lactate production reduction oxygen demand tissues could reduce viral entry raising cytosolic ph <NUMBER> caution dehydration possibility euglycaemic ketoacidosis need observed using sglt<NUMBER> inhibitors sick patients covid<NUMBER> insulin also shown increase ace<NUMBER> expression attenuating effect disintegrin metalloprotease adam<NUMBER> <NUMBER> practical relevance findings known present case insulin thus appears safe continue usual antihyperglycemic medications patients mild infection good general condition normal oral intake however sglt<NUMBER> inhibitors might need discontinuation due risk dehydration euglycaemic ketoacidosis metformin may also need stopped vomiting poor oral intake doses antihyperglyacemic drugs like sulfonylureas insulin may altered depending upon blood glucose levels hospitalised patients especially requiring intensive care would need insulin glycaemic control angiotensin converting enzyme ace inhibitors angiotensin receptor blockers arb commonly used drugs patients diabetes especially hypertension kidney dysfunction lot literature debate whether drugs could benefit harm patients covid<NUMBER> infection issue discussed scientific experimental data support potential harm duet ace inhibitorsarb covid<NUMBER> lot interest ace inhibitors arbs following identification ace<NUMBER> receptor sars cov<NUMBER> ace inhibitors arbs increase levels ace<NUMBER> inhibiting conversion angiotensin <NUMBER> angiotensin <NUMBER> increased ace<NUMBER> expression could theoretically increase viral binding entry cell though clinical evidence support otherwise attractive hypothesis reduced angiotensin <NUMBER> result ace inhibition increased angiotensin <NUMBER> result increased activity ace<NUMBER> could reduce cytosolic ph could result favourable environment viral endocytosis <NUMBER> also angiotensin <NUMBER> shown increase sympathetic activity acting mas receptors brainstem could contribute cardiovascular morbidity observed patients <NUMBER> however concerns hypothetical minimal evidence scientific experimental data support benefit due ace inhibitorsarb covid<NUMBER> increased ace<NUMBER> might result increased viral entry limited availability serine protease tmprss<NUMBER> required viral binding <NUMBER> increased ace<NUMBER> consequently angiotensin <NUMBER> vasodilatory antifibrotic effects shown protective lung injury animals <NUMBER> treatment arbs reported reduce mortality ebola virus infection <NUMBER> previously small study ten patients ards showed recombinant ace<NUMBER> well tolerated led increase angiotensin <NUMBER> levels <NUMBER> <NUMBER> controlled studies use ace inhibitors arbs patients covid<NUMBER> <NUMBER> clinical evidence inconclusive one study china find association ace inhibitor use severity disease increased mortality patients covid<NUMBER> receiving ace inhibitors arbs another study <NUMBER> <NUMBER> one study usa find significant difference mortality patients received ace inhibitors arbs <NUMBER> subject situation far clear many unknown factors might operative interaction ace<NUMBER> diabetes ace inhibitorsarbs lung injury lack evidence either benefit harm prompted european society cardiology council hypertension european society hypertension american heart association advise continuing ace inhibitors arbs case patient develops covid<NUMBER> <NUMBER> clinical trial underway study arb losartan recombinant human ace<NUMBER> patients covid<NUMBER> several commentaries relationship diabetes covid<NUMBER> <NUMBER> however several unanswered questions remain knowledge information limited clearly research could lead important insights table <NUMBER> discussed <NUMBER> natural history covid<NUMBER> patients diabetes natural course disease infection patients diabetes sars cov<NUMBER> documented well example dont know incubation period different people diabetes also possible patients diabetes young short duration diabetes well controlled may less severe covid<NUMBER> infection possibility reduced viral clearance diabetes reported patients corticosteroids <NUMBER> could public health implications patients diabetes could remain infectious longer period without diabetes chloroquine also licensed use india patients type <NUMBER> diabetes although efficacy chloroquine proven used patients covid<NUMBER> <NUMBER> chloroquine weak antihyperglycaemic effect theoretical risk hypoglycaemia used combination antihyperglycaemic drugs b corticosteroids though neither effective recommended frequently used ards sepsis would worsen glycemic levels <NUMBER> covid<NUMBER> pancreatic beta cells significant expression ace<NUMBER> receptors pancreatic islets hyperglycaemia lasting <NUMBER> years reported patients sars <NUMBER> direct injury beta cells possibility patients recovering covid<NUMBER> might need major changes antihyperglycaemic regimen recently newonset diabetes reported patients covid<NUMBER> <NUMBER> <NUMBER> suboptimal lifestyle measures issues lockdown restrictions movement people lockdowns several parts world order contain pandemic poses challenges evaluation treatment patients diabetes limited opportunities exercise regular walks visits gyms swimming pools possible dietary irregularity could occur staying home b considerable mental stress unpredictability disease well social immobility brought excellent study healthy people china time huge burden covid<NUMBER> <NUMBER> c patients may find difficult procure healthy foods medicines insulin needles glucose strips etc partial complete lockdowns problem becomes pronounced elderly poor disadvantaged sections society could underreporting symptoms perceived need avoid visiting hospitals factors could cause glucose dysregulation could predispose patients complications like infections hyperosmolar coma ketoacidosis even acute cardiac events prediction model effect lockdown india blood glucose showed <NUMBER> increase hba<NUMBER>c end <NUMBER> days lockdown future increase diabetesrelated complications <NUMBER> <NUMBER> people wellcontrolled diabetes higher risk getting covid<NUMBER> infection nondiabetic individuals <NUMBER> effect obesity severity covid<NUMBER> people diabetes <NUMBER> specific diet supplement could help patients diabetes covid<NUMBER> <NUMBER> role renin angiotensin aldosterone system raas inhibitors raas determining predisposition covid<NUMBER> severity <NUMBER> use remote education advice telemedicine also emails texts helpful times impart education shown improve glycaemia telemedicine guidelines physicians india published <NUMBER> patients need educated need visit hospital urgently emergency situations like vomiting drowsiness shortness breath chest pain weakness limbs altered sensorium etc <NUMBER> <NUMBER> covid<NUMBER> testing patients diabetes given increased severity covid<NUMBER> patients diabetes case could made testing people diabetes presence disease would humongous task considering high prevalence diabetes highrisk groups like high hba<NUMBER>c comorbidities long duration diabetes elderly could chosen testing however utility approach remains proven frequent false negative tests repeated testing may required asymptomatic individuals since treatment currently recommended asymptomatic people therefore apart isolating detecting patients might prove meaningful clinically <NUMBER> ethnic variations severity covi<NUMBER> patients diabetes united states disease caused disproportionately fatalities blacks asians compared whites <NUMBER> south asia africa korea seen much lower mortality rest world whether different approaches topublic health measures innate immunity due ethnicityspecific variability response viral infection availability good medical resources remains studied interactions ethnicity diabetes severity covid<NUMBER> interest considering racial disparities prevalence diabetes according recent report prevalence covid<NUMBER> mortality due disease correlated significantly frequency allele ace gene <NUMBER> polymorphisms ace gene well several genes involved pathophysiology covid<NUMBER> might responsible individual ethnic variations disease course <NUMBER> benefits lockdown could positive effects social restrictions patients time selfcare could pay attention diet exercise motivated b people stopped reduced alcohol smoking nonavailability c significant fall air pollution result reduced industrial vehicular emissions <NUMBER> increase blood glucose reported shortterm rise pm <NUMBER> particulate matter <NUMBER> microns diameter glycaemic improvement could occur fall pollution <NUMBER> view issues highlighted important recognise importance diabetes vital comorbidity patients covid<NUMBER> several contentious issues ongoing research hopefully shed light behaviour covid<NUMBER> patients diabetes author contributions rg planned outline manuscript rg reviewed literature wrote manuscript rg ah edited manuscript conflict interest authors declare conflict interest publishers note springer nature remains neutral regard jurisdictional claims published maps institutional affiliations december <NUMBER> coronavirus disease <NUMBER> covid<NUMBER> caused novel coronavirus severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> started wuhan china <NUMBER> world health organization declared covid<NUMBER> pandemic march <NUMBER> <NUMBER> <NUMBER> may <NUMBER> total <NUMBER> million confirmed cases <NUMBER> deaths reported worldwide number new confirmed cases yet reduced <NUMBER> february <NUMBER> covid<NUMBER> outbreak began daegu korea <NUMBER> confirmed cases <NUMBER> deaths reported fortunately spread covid<NUMBER> well controlled korea <NUMBER> article entitled acute hyperglycemic crises coronavirus disease<NUMBER> case reports kim et al <NUMBER> reported two cases serious acute diabetes complications precipitated covid<NUMBER> daegu diabetes especially poorly controlled associated increased risk infection adverse outcomes <NUMBER> based recent reports china italy prevalence diabetes among covid<NUMBER> confirmed cases similar country <NUMBER> however recent studies reported patients severe covid<NUMBER> disease older comorbidities ie diabetes cancer cardiovascular disease <NUMBER> <NUMBER> diabetes indeed associated increased serious covid<NUMBER> presentation mortality adjusting potential risk factors <NUMBER> means diabetes seems effect severe coronavirus disease treatment process poor outcomes rather patient susceptibility covid<NUMBER> infection regard covid<NUMBER> poorly controlled diabetes patients thought cause acute serious diabetic complications however best knowledge reports regarding occurrence diabetic ketoacidosis hyperglycemic hyperosmolar state patients covid<NUMBER> therefore study valuable describes cases detail including diagnosis treatment process outcomes opinion would better describe outcome followup treatment second patient case addition medication history patient including glucoselowering drugs antihypertensive drugs cholesterollowering drugs admission covid<NUMBER> treatment needs added study angiotensinconverting enzyme <NUMBER> ace<NUMBER> known cellular receptor sarscov<NUMBER> <NUMBER> several medications used mainly patients diabetes insulin glucagonlike peptide<NUMBER> thiazolidinediones ace inhibitors angiotensin ii receptor blockers statins reported affect ace<NUMBER> expression level angiotensin ii <NUMBER> although data drugs influence covid<NUMBER> lacking recommended share authors opinion effects drugs used diabetes patients severe presentation prognosis lastly would like express gratitude tribute medical staff daegu worked hard dedicated public health covid<NUMBER> outbreak covid<NUMBER> coronavirus disease<NUMBER> disease caused coronavirus sarscov<NUMBER> severe acute respiratory syndromecoronavirus<NUMBER> emerged rapidly spreading communicable disease affecting <NUMBER> countries across globe present disease primarily spread large respiratory droplets though possibility routes transmission cannot ruled virus found stool urine affected individuals <NUMBER> disease severity varied mild selflimiting flulike illness fulminant pneumonia respiratory failure death regional variations mortality rates estimates rapidly changing data becoming available <NUMBER> confirmed cases covid<NUMBER> worldwide mortality rate <NUMBER> according situation report world health organisation march <NUMBER> <NUMBER> <NUMBER> however much lower mortality <NUMBER> reported analysis data <NUMBER> patients laboratoryconfirmed covid<NUMBER> <NUMBER> hospitals mainland china <NUMBER> considering number unreported unconfirmed cases likely much higher reported cases actual mortality may less <NUMBER> similar severe seasonal influenza <NUMBER> india <NUMBER>confirmed cases till <NUMBER>th march <NUMBER> contact surveillance cases going understanding epidemiological characteristics infection evolving daily basis disease spreading different parts globe individuals diabetes risk infections especially influenza pneumonia risk reduced though completely eliminated good glycaemic control people diabetes <NUMBER> years age recommended pneumococcal annual influenza vaccinations patients diabetes severe disease infected respiratory viruses indeed diabetes seen important risk factor data covid<NUMBER> patients diabetes limited present diabetes present <NUMBER> <NUMBER> fatalities due covid<NUMBER> wuhan china <NUMBER> study <NUMBER> patients covid<NUMBER> wuhan china diabetes risk factor severe disease course <NUMBER> however another study <NUMBER> patients <NUMBER> deaths <NUMBER> recovered patients wuhan showed number comorbidities significant predictor mortality <NUMBER> analysis <NUMBER> studies regarding laboratory abnormalities patients covid<NUMBER> mention raised blood glucose diabetes predictor severe disease <NUMBER> notwithstanding small series report <NUMBER> cases covid<NUMBER> published chinese centre disease control prevention showed increased mortality people diabetes <NUMBER> overall <NUMBER> patients diabetes <NUMBER> knowledge prevalence covid<NUMBER> disease course people diabetes evolve detailed analyses carried reasonable assume people diabetes increased risk developing infection sarscov<NUMBER> coexisting heart disease kidney disease advanced age frailty likely increase severity disease following measures suggested prevention disease patients diabetes specific measures patients diabetes important people diabetes maintain good glycaemic control might help reducing risk infection also severity frequent monitoring blood glucose levels use selfmonitoring blood glucose required good glycemic control may lessen chances superadded bacterial pneumonia well b patients diabetes coexisting heart disease kidney disease need special care attempts made stabilise cardiacrenal status c attention nutrition adequate protein intake important deficiencies minerals vitamins need taken care exercise shown improve immunity though might prudent careful avoid crowded places like gymnasia swimming pools e important take influenza pneumonia vaccinations latter may decrease chances secondary bacterial pneumonia respiratory viral infection however data present viral epidemic available b general preventive measures thorough handwashing soap water encouraged since kills virus use alcoholbased hand rubs also useful b need practise proper respiratory hygiene covering mouth nose bent elbow tissue coughing sneezing touching mouth nose eyes avoided c contact affected person needs minimised use recommended face masks advised contact someone respiratory symptoms nonessential travel major affected areas avoided order restrict spread infection case person diabetes develops fever cough running nose dyspnoea appropriate health authority needs notified testing disease available selected places b affected person needs isolated <NUMBER> days till symptoms resolve whichever longercountryspecific guidelines need followed c majority patients mild disease managed home hydration maintained symptomatic treatment acetaminophen steam inhalation etc given patients type <NUMBER> diabetes measure blood glucose urinary ketones frequently fever hyperglycemia occurs frequent changes dosage correctional bolus may required maintain normoglycemia e antihyperglycemic agents cause volume depletion hypoglycemia avoided dosage oral antidiabetic drugs may need reduced patients follow sick day guidelines may need frequent monitoring blood glucose drug adjustment f hospitalised patients severe disease need frequent blood glucose monitoring oral agents especially metformin sodium glucose cotransporter<NUMBER> inhibitors need stopped g insulin preferred agent control hyperglycemia hospitalised sick patients absence specific antiviral drug anecdotal use drugs like lopinavir ritonavir interferon<NUMBER>b rna polymerase inhibitor remdesivir chloroquine reported <NUMBER>ncov receptor binding site strong affinity angiotensin converting enzyme <NUMBER> ace<NUMBER> inhibitors rennin angiotensin system may role treating severe respiratory disease <NUMBER> <NUMBER> zinc nanoparticles shown inhibitory effects h<NUMBER>n<NUMBER> viral load though effect covid<NUMBER> unknown untested <NUMBER> vitamin c supplementation role prevention pneumonia effect covid<NUMBER> needs evaluation <NUMBER> efforts develop vaccine underway major tool contain epidemic <NUMBER> coronavirus disease<NUMBER> covid <NUMBER> designated highly contagious infectious disease caused severe acute respiratory syndrome coronavirus<NUMBER> sarscov<NUMBER> since december <NUMBER> outbreak pneumonia cases emerged wuhan hubei china <NUMBER> due rapid sustained humantohuman transmission covid<NUMBER> pandemic led global health crisis devastating social economic political aspects life many clinicians health professionals scientists organizations governments actively defeated covid<NUMBER> shared experiences knowledge sarscov<NUMBER> diabetes one major risk factors fatal outcomes covid<NUMBER> <NUMBER> patients diabetes vulnerable infection hyperglycemia impaired immune function comorbidities hypertension dyslipidemia cardiovascular disease addition angiotensinconverting enzyme <NUMBER> ace<NUMBER> receptor sarscov<NUMBER> human body <NUMBER> hence use angiotensinconverting enzyme inhibitor acei angiotensin ii receptor blockers arb high level angiotensin ii patients diabetes requires attention fact reported overall proportion diabetics covid<NUMBER> <NUMBER> <NUMBER> china <NUMBER> italy <NUMBER> usa <NUMBER> severity mortality covid<NUMBER> significantly higher patients diabetes without <NUMBER> thus patients diabetes take precautions covid<NUMBER> pandemic addition knowledge molecular mechanism viral entry replication direct treatment strategies future research targeted antiviral drugs vaccines therefore review current knowledge covid<NUMBER> including global westernpacific regional epidemiology virology impact diabetes covid<NUMBER> treatment covid<NUMBER> standard care management diabetes critical period searched articles pubmed google scholar databases december <NUMBER> early may <NUMBER> using keywords covid<NUMBER> sarscov<NUMBER> diabetes epidemiology pathophysiology ace<NUMBER> manifestation treatment due sustained humantohuman transmission rapid spread sarscov<NUMBER> resulted formidable outbreak many cities china expanding internationally south korea<NUMBER> europe <NUMBER> united states <NUMBER> declared covid<NUMBER> outbreak pandemic march <NUMBER> <NUMBER> <NUMBER> case fatality rate cfr covid<NUMBER> lower sarscov<NUMBER> merscov <NUMBER> <NUMBER> respectively <NUMBER> however due high transmission rate absolute number fatality strikingly high may <NUMBER> <NUMBER> reported <NUMBER> confirmed cases including <NUMBER> deaths cfr <NUMBER> western pacific region <NUMBER> confirmed cases including <NUMBER> deaths cfr <NUMBER> reported httpswwwwhointdocsdefaultsourcecoronavirusesituationreports <NUMBER> recently countries moving less restrictive social distancing measures successful initial defense number covid<NUMBER> patients increasing japan hong kong singapore thus careful prevention treatment covid<NUMBER> still needed western pacific region fig <NUMBER> first confirmed case covid<NUMBER> republic korea south korea traveler wuhan china january <NUMBER> <NUMBER> <NUMBER> <NUMBER> therefore patients diabetes seem susceptible covid<NUMBER> severity mortality patients diabetes higher patients without diabetes infected covid<NUMBER> table <NUMBER> previous early large observational study found incidence diabetes higher patients severe illness <NUMBER> patients nonsevere illness <NUMBER> <NUMBER> singlecenter observational studies showed similar results ie higher <NUMBER> singlecenter study conducted korea reported <NUMBER>day mortality significantly higher patients diabetes without diabetes <NUMBER> vs <NUMBER> patients diabetes showed higher severity score inflammation marker levels <NUMBER> usa march <NUMBER> <NUMBER> among total <NUMBER> laboratoryconfirmed covid<NUMBER> cases diabetes mellitus <NUMBER> <NUMBER> frequently reported condition among <NUMBER> cases whose data underlying health conditions available percentage diabetics among cases resulted icu admission higher <NUMBER> among nonhospitalized cases <NUMBER> among cases nonicu admissions<NUMBER> <NUMBER> several metaanalyses also found incidence diabetes twofold higher developed severe disease patients experienced nonsevere disease <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> supplementary table <NUMBER> results suggest association diabetes poor prognosis increased mortality therefore intensive attention paid patients diabetes reason high morbidity mortality patients diabetes investigated hyperglycemia low immune function vascular complications comorbidities contributing factors fatal outcomes patients diabetes however studies analyzed effect hyperglycemia prognosis retrospective singlecenter study conducted korea reported age independent risk factor severe outcomes among patients diabetes baseline hba<NUMBER>c antidiabetic medication affect covid<NUMBER> outcomes <NUMBER> baseline hba<NUMBER>c take account fluctuations blood glucose levels glycemic variability important evaluating overall glycemic control <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> latest isolated sarscov<NUMBER> seventh corona virus causes severe fatal disease humans table <NUMBER> sarscov<NUMBER> novel βcoronavirus enveloped nonsegmented positivesense singlestrand rna virus identified complete genome sequences samples bronchoalveolar lavage fluid patients <NUMBER> sarscov<NUMBER> shares <NUMBER> sequence identity sarscov <NUMBER> <NUMBER> similarity merscov <NUMBER> spherical particle <NUMBER> nm diameter contains <NUMBER>kb ssrna genome <NUMBER> twothirds genome encodes polyprotein pp<NUMBER>ab cleaved <NUMBER> nonstructural proteins involved genome transcription replication <NUMBER> terminus encodes structural proteins including envelope glycoproteins spike envelope e membrane nucleocapsid n <NUMBER> genome packaged inside capsid formed nucleocapsid protein n membrane protein envelope protein e involved virion assembly spike protein mediates entry host cells <NUMBER> protein characterized receptorbinding domain rbd s<NUMBER> subunit facilitates binding host angiotensinconverting enzyme <NUMBER> ace<NUMBER> receptor sarscov sarscov<NUMBER> s<NUMBER> subunit responsible membrane fusion <NUMBER> rbd merscov attaches host cells via dipeptidyl peptidase <NUMBER> dpp<NUMBER> rather ace<NUMBER> <NUMBER> recent study demonstrated rbd unique sarscov<NUMBER> enhanced ace<NUMBER> receptorbinding affinity compared sarscov <NUMBER> binding ace<NUMBER> host cell factors mediate viral entry two serine proteases transmembrane protease serine <NUMBER> tmprss<NUMBER> furin cleave protein membrane fusion assist viral processing respectively <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> upon membrane fusion viral rna translated replicated amplified upon amplification viral rna viral structural nonstructural proteins generated interact viral rna membrane er golgi apparatus finally result viral budding exocytosis <NUMBER> angiotensinconverting enzyme <NUMBER> ace<NUMBER> protein reason ace<NUMBER> molecule subject much attention receptor sarscov<NUMBER> viral entry well important element cardiovascular system use acei arb medication cardiovascular disease severe clinical course patients cardiovascular comorbidity sarscov<NUMBER> infection ace<NUMBER> singlepass transmembrane protein protease activity found type ii pneumocytes lower respiratory tract myocardium endothelium gastrointestinal tract pancreatic islets bone marrow kidney spleen <NUMBER> broad expression ace<NUMBER> may explain multiorgan injury observed covid<NUMBER> role ace<NUMBER> cardiovascular system ace<NUMBER> converts angiotensin ang angiotensin <NUMBER> ang <NUMBER> also converts angiotensin ii ang ii angiotensin ang <NUMBER> acts mas receptor modestly lower blood pressure vasodilation promoting sodium water excretion kidney attenuate inflammation production nitric oxide<NUMBER> ace<NUMBER> counterregulatory enzyme ace<NUMBER> ace<NUMBER> converts ang ang ii acts angiotensin ii type<NUMBER> receptor at<NUMBER>r increase blood pressure inducing vasoconstriction increasing reabsorption sodium water kidney increasing oxidative stress promote inflammation fibrosis <NUMBER> fig <NUMBER> thus balance aceang ii ace<NUMBER>ang<NUMBER> determines whether acute lung injury aggravated alleviated controversies regarding whether reninangiotensin system ras inhibition harmful protective covid <NUMBER> even though ace inhibitors angiotensinreceptor blockers arb directly inhibit ace<NUMBER> <NUMBER> ace inhibitors affect expression ace<NUMBER> heart kidney arb could increase ace<NUMBER> abundance enhance viral entry however data support notion ace inhibitors at<NUMBER>r blockers facilitate coronavirus entry increasing ace<NUMBER> expression regarding protective view diminishing production ang ii ace inhibitor blocking ang iiat<NUMBER>r actions arb enhances generation ang<NUMBER> ace<NUMBER> activation mas receptor masr attenuates inflammation fibrosis lung injury interestingly administration losartan at<NUMBER>r blocker alleviated exacerbating effects sarscov spike protein animal model acute respiratory distress syndrome ards <NUMBER> losartan also ameliorated influenza virusinduced acute lung injury mice <NUMBER> fortunately retrospective singlecenter study conducted korea showed arb acei medication associated protective effect cardiac injury independent factor favorable outcomes patients covid<NUMBER> <NUMBER> angiotensin inhibitors improve blood pressure might help restore pulmonary function mas receptor pathway soluble ace<NUMBER> released blood cleavage membranebound protease disintegrin metalloprotease <NUMBER> adam<NUMBER> <NUMBER> result direct viral cytotoxicity pulmonary system due inflammatory activation host cannot remove virus via protective immune response covid<NUMBER> progresses stage iii severe status multiorgan dysfunction cytokine storm immune dysregulation fig <NUMBER> accumulating evidence suggests subgroup patients severe covid<NUMBER> might cytokine storm syndrome strong inflammatory response could linked uncontrolled pulmonary inflammation consequent covid<NUMBER> lethality <NUMBER> icu patients severe stage covid<NUMBER> high plasma levels interleukin il<NUMBER> il<NUMBER> granulocyte colonystimulating factor interferonγ inducible protein <NUMBER> monocyte chemoattractant protein <NUMBER> macrophage inflammatory protein <NUMBER>α tumor necrosis factorα nonicu patients suggesting presence hyperinflammatory condition also known cytokine storm <NUMBER> particular diabetes identified risk days vacated disinfection procedure <NUMBER> live virus also isolated cultured fecal specimens raising possibility orofecal transmission corroborating clinical evidence transmission lacking <NUMBER> therefore recommended precautions reduce airborne transmission use n<NUMBER> masks implemented aerosolproducing settings <NUMBER> humantohuman transmission well established covid<NUMBER> r <NUMBER> expected number secondary cases produced single typical infection completely susceptible population <NUMBER> estimated <NUMBER> comparison seasonal flu median r <NUMBER> <NUMBER> iqr <NUMBER> <NUMBER> measles r <NUMBER> <NUMBER> <NUMBER> however covid<NUMBER> r <NUMBER> calculated incomplete data may change information becomes available clinical spectrum sarscov<NUMBER> infection appears wide encompassing asymptomatic infection mild upper respiratory tract illness severe viral pneumonia respiratory failure even death prevalence asymptomatic patients exposure admission much onefifth among participants community facility designated isolation patients without moderatetosevere symptoms south korea <NUMBER> cases reported experience mild course <NUMBER> common symptoms mild covid<NUMBER> patients cough hyposmia sputum fever however common symptoms hospitalized patients fever cough fatigue dyspnea chest tightness sore throat headache <NUMBER> <NUMBER> addition patients manifested gastrointestinal symptoms diarrhea vomiting average length hospital stay <NUMBER> days range <NUMBER> days <NUMBER> based current information elderly chronic underlying diseases critical condition hospital stay long chest computed tomography showed groundglass opacities patchy bilateral shadowing <NUMBER> <NUMBER> however clinicians aware patients covid<NUMBER> also normal computed tomography findings complications covid<NUMBER> ards arrhythmia shock acute kidney injury acute cardiac injury liver dysfunction secondary infection multiple organ dysfunction disease quickly progress severe condition elderly people comorbidities diabetes hypertension cardiovascular disease cerebrovascular disease chronic obstructive pulmonary disease asthma immunocompromised state chronic kidney disease chronic liver disease severe obesity fig <NUMBER> samples nasal throat swab respiratory tract used test virus clinical diagnostic method covid<NUMBER> around world <NUMBER> test result positive diagnosis sarscov<NUMBER> confirmed currently recommends negative results presence clinical symptoms exposure infected patients must treated suspicion test repeated using additional samples lower respiratory tract <NUMBER> also would interesting examine cases positive converters initial metformin <NUMBER> pioglitazone <NUMBER> liraglutide <NUMBER> sodiumglucose cotransporter<NUMBER> inhibitor sglt<NUMBER> inhibitor <NUMBER> insulin <NUMBER> increased ace<NUMBER> expression animal study however metformin showed immunemodulating activity <NUMBER> pioglitazone reduced lung fibrotic reaction silica rats normally characterized overproduction tnfa <NUMBER> cardiology <NUMBER> calciumchannel blockers ccbs effect ace<NUMBER> expression since ccb shown reduce severity mortality patients pneumonia use proposed patients covid<NUMBER> hypertension<NUMBER> sarscov<NUMBER> rapidly spread globally approved evidencebased <NUMBER> hydroxychloroquine potentially combination azithromycin accelerated viral clearance small french pilot study <NUMBER> <NUMBER> nucleoside analogues remdesivir favipiravir geldesivir ribavirin etc limit virus replication remdesivir originally developed treatment ebola virus remdesivir successfully treated first us case covid<NUMBER> january <NUMBER> <NUMBER> <NUMBER> protease inhibitors lopinavir ritonavir etc used treat infection human immunodeficiency virus hiv <NUMBER> could improve outcomes merscov <NUMBER> sarscov <NUMBER> patients sarscov<NUMBER> viral loads patients south korea significantly decreased lopinavirritonavir treatment <NUMBER> <NUMBER> type <NUMBER> interferons induce antiviral cellular programs immune modulation <NUMBER> <NUMBER> recombinant il<NUMBER> receptor antagonist tocilizumab used successfully patients covid<NUMBER> <NUMBER> recombinant il<NUMBER> receptor antagonist anakinra trialed children adults covid<NUMBER> associated cytokine storm syndrome china nct<NUMBER> <NUMBER> <NUMBER> inhibitors janus kinases jak modulate cytokine receptor signaling including il<NUMBER> receptor well type <NUMBER> type <NUMBER> ifn receptors <NUMBER> clinical trials severe covid<NUMBER> ongoing chictr<NUMBER> chictr<NUMBER> <NUMBER> <NUMBER> corticosteroids control inflammation ards however preliminary data covid<NUMBER> showed highdose steroids beneficial effects lung injury associated complications thus highdose corticosteroids cannot generally recommended treatment covid<NUMBER> <NUMBER> management glycemic control pandemic period telemedicine helpful useful covid<NUMBER> pandemic <NUMBER> wearable health systems monitor blood glucose blood pressure physical activity caloric intake eating behavior sleep pattern adherence medication helpful comprehensive management patients diabetes ace<NUMBER> converts ang ang<NUMBER> ang ii angiotensin ii ang<NUMBER> acts mas receptor masr lower blood pressure vasodilation also attenuate inflammation fibrosis ace<NUMBER> converts ang ang ii acts angiotensin ii type <NUMBER> receptor at<NUMBER>r increase blood pressure inducing vasoconstriction increasing kidney reabsorption sodium water increasing oxidative stress promote inflammation fibrosis ace<NUMBER> also binds internalizes sarscov<NUMBER> priming serine protease tmprss<NUMBER> transmembrane proteaseserine<NUMBER>  even though angiotensinconverting enzyme ace <NUMBER> molecule receptor sarscov<NUMBER> viral entry evidence deleterious influence ace inhibitor angiotensin receptor blocker arb medication covid<NUMBER> outcomes strongly recommended ace inhibitor arbs withdrawn without consultation physician healthcare provider  optimal glucose control necessary critically ill patients diabetes also antidiabetic medications individualized according degree hyperglycemia contraindications adverse reactions severity covid<NUMBER>  various online services glucose management remote consultation wearable monitoring system educational tools helpful comprehensive management patients diabetes pandemic period  south koreas strategies favorable outcomes early recognition transparent prompt sharing information rapid establishment extensive diagnostic testing facilities implementing innovative aggressive measures control preventing community transmission redesigning triage treatment system mobilizing necessary resources clinical care article provides recent global westernpacific regional epidemiology lessons korean covid<NUMBER> experiences impact diabetes covid<NUMBER> outcomes virology pathophysiology clinical manifestations antiviral medications treatment covid<NUMBER> patients diabetes including individualization antidiabetic medications comprehensive managements patients diabetes pandemic period recent outbreak novel covid<NUMBER> disease rapid worldwide spread poses global health emergency novel virus thought belong family middle east respiratory syndrome mers coronavirus severe acute respiratory syndrome sars coronavirus unique right <NUMBER> researchers around globe investigating several risk factors may contribute severity covid<NUMBER> world health organization indicated elderly individuals well underlying medical conditions higher risk developing severe covid<NUMBER> disease <NUMBER> today june <NUMBER> th <NUMBER> <NUMBER> million people infected virus <NUMBER> lost lives deaths believed associated existence comorbidities generally patients compromised immune systems considered particularly vulnerable <NUMBER> several research works targeted epidemiological clinical characteristics patients infected covid<NUMBER> however risk factors severity mortality sufficiently investigated <NUMBER> identifying major risk factors taking corresponding clinical measures could contribute massively saving lives previous studies identified comorbidities hypertension diabetes mellitus stroke cancer kidney issues high cholesterol among highrisk factors thus paper represents systematic review literature shed light effects preexisting conditions covid<NUMBER> disease severity additionally method currently exists determine level risk comorbidities pose paper serves purpose achieving reasonable option draw lessons earlier experiences practices search conducted freely available covid<NUMBER> open research dataset cord<NUMBER> <NUMBER> cord<NUMBER> resource consisting <NUMBER> scholarly articles including <NUMBER> articles full text related covid<NUMBER> sarscov<NUMBER> coronaviruses dataset frequently updated new research appears peerreviewed publications archive services became available screen every article dataset developed search engine addition bm<NUMBER> search index <NUMBER> bm<NUMBER> retrieval function ranks set documents based query terms appearing document regardless proximity within document papers indexed simply applying preprocessing function clean tokenize abstracts documents indexed created document vectors loading optimized cached json tokens followed applying document similarity index using annoy <NUMBER> annoy c library python bindings search documents space close given query details implantation please visit httpsgithubcomdgunningcord<NUMBER> filtering articles undertaken using keywords questions eg effects diabetes covidnormal coronavirussarscov<NUMBER>ncovcovid<NUMBER> disease severity mortality search terms repeated comorbidities considered paper illustrated fig <NUMBER> systematic approach used screen full covid<NUMBER> open research dataset <NUMBER> systematic method <NUMBER> articles found scored highly confidence rating additional search run employing google scholar pubmed ensure every relevant article included <NUMBER> papers read thoroughly causing <NUMBER> articles excluded list additional <NUMBER> articles manually added list ultimate list <NUMBER> articles split six categories <NUMBER> articles focusing cancer <NUMBER> diabetes mellitus <NUMBER> kidney issues <NUMBER> stroke <NUMBER> hypertension <NUMBER> high cholesterol diabetes one serious comorbidities linked severity three wellknown human pathogenic coronavirus infections including sarscov <NUMBER> patients diabetes increased risk severe complications including adult respiratory distress syndrome ards multiorgan failure depending global region <NUMBER> covid<NUMBER> pandemic patients diabetes emphasizes importance link covid<NUMBER> diabetes <NUMBER> according gupta r et al <NUMBER> individuals diabetes risk infections especially influenza pneumonia patients diabetes severely affected contract respiratory viruses therefore diabetes seen important risk factor mortality patients infected pandemic influenza <NUMBER> h<NUMBER>n<NUMBER> sars coronavirus middle east respiratory syndromerelated coronavirus merscov <NUMBER> <NUMBER> <NUMBER> several studies show among covid<NUMBER> patients also noticeable percentage patients suffering diabetes mellitus dm yang x et al <NUMBER> found among <NUMBER> nonsurvivors group <NUMBER> covid<NUMBER> patients median age <NUMBER> <NUMBER> male <NUMBER> diabetes patients additionally <NUMBER> patients confirmed covid<NUMBER> median age <NUMBER> <NUMBER> male autonomous regions china <NUMBER> severe disease comorbidities <NUMBER> diabetes mellitus <NUMBER> zhang jj et al <NUMBER> analyzed data <NUMBER> patients median age <NUMBER> <NUMBER> male admitted hospitals wuhan china confirmed covid<NUMBER> cases <NUMBER> patients diabetes <NUMBER> reviewed <NUMBER> confirmed covid<NUMBER> patients <NUMBER> diabetes hospitalized west court union hospital wuhan china patient median age <NUMBER> significant difference observed males females however indicated authors patients diabetes significantly higher leukocyte neutrophil counts well higher levels fasting blood glucose serum creatinine urea nitrogen creatine kinase isoenzyme mb admission compared without diabetes cox proportional hazard model showed diabetes adjusted hazard ratio ahr<NUMBER> <NUMBER> ci <NUMBER> fasting blood glucose ahr<NUMBER> <NUMBER> ci <NUMBER> associated fatality covid<NUMBER> adjusting potential confounders authors concluded diabetes mellitus associated greater disease severity well higher risk mortality patients covid<NUMBER> recommended primary secondary prevention strategies needed covid<NUMBER> patients diabetes bloomgarden zt et al <NUMBER> stated mortality rates pneumonia among patients diabetes hong kong age <NUMBER> exceed mortality rates age group cardiovascular disease cancer <NUMBER> similar evidence risk amid persons diabetes reported two earlier cov infections sars <NUMBER> affecting <NUMBER> individuals mainly asia <NUMBER> <NUMBER> mers <NUMBER> affecting <NUMBER> individuals mainly saudi arabia <NUMBER> furthermore diabetes present <NUMBER> <NUMBER> fatalities due covid<NUMBER> study wuhan china <NUMBER> huang c et al <NUMBER> investigated <NUMBER> hospitaladmitted patients identified laboratoryconfirmed <NUMBER>ncov infection infected patients men <NUMBER> median age <NUMBER> years <NUMBER> diabetes however cases small proportion patients affected report <NUMBER> cases <NUMBER> confirmed covid<NUMBER> cases published chinese centre disease control prevention showed increased mortality rate people diabetes <NUMBER> overall <NUMBER> patients diabetes <NUMBER> bellochavolla oy <NUMBER> predicted mortality due sarscov<NUMBER> developed mechanistic score <NUMBER> relating obesity diabetes covid<NUMBER> outcomes data mexico among <NUMBER> subjects predominantly male median age <NUMBER> authors observed <NUMBER> subjects sarscov<NUMBER> <NUMBER> deaths sarscov<NUMBER> causes risk factors lethality covid<NUMBER> included earlyonset diabetes obesity advanced age immunosuppression ckd additionally observed obesity mediates <NUMBER> effect diabetes covid<NUMBER> lethality authors used stratified points according categories low risk ≤<NUMBER> mild risk <NUMBER> <NUMBER> moderate risks <NUMBER> high risk <NUMBER> <NUMBER> <NUMBER> high risk ≥<NUMBER> score diabetes <NUMBER> <NUMBER> deaths sarscov<NUMBER> <NUMBER> diabetes total <NUMBER> patients median age <NUMBER> <NUMBER> male confirmed covid<NUMBER> studied guo w et al <NUMBER> demographic data medical history symptoms signs laboratory findings chest computed tomographies ct well treatment measures collected analyzed authors found <NUMBER> covid<NUMBER> patients comorbidities except diabetes higher risk severe pneumonia release tissue injuryrelated enzymes excessive uncontrolled inflammation responses hypercoagulable state associated dysregulation glucose metabolism authors recommended diabetes considered risk factor rapid progression poor prognosis covid<NUMBER> extensive care administered patients diabetes case rapid deterioration authors described mortality rate covid<NUMBER> amongst diabetic patients without comorbidities <NUMBER> abovementioned studies summarized table <NUMBER> according recently published results mainly chinese cohort patients cancer vulnerable covid<NUMBER> complications however susceptible cancer patients infection covid<NUMBER> yet established liang w et al <NUMBER> collected analyzed <NUMBER> cases <NUMBER> hospitals <NUMBER> provincial administrative regions china cases diagnosed laboratoryconfirmed covid<NUMBER> total <NUMBER> cases excluded insufficient records previous disease history number covid<NUMBER> cases history cancer <NUMBER> <NUMBER> <NUMBER> ci <NUMBER> <NUMBER> covid<NUMBER> cases according <NUMBER> cancer epidemiology statistics seems higher incidence cancer overall chinese population <NUMBER> <NUMBER>·<NUMBER> per <NUMBER> people lung cancer frequent type five <NUMBER> <NUMBER> patients compared patients without cancer patients cancer older mean age <NUMBER> years significant differences sex baseline symptoms comorbidities baseline severity xray importantly patients cancer observed higher risk severe events compared patients without cancer seven <NUMBER> <NUMBER> patients vs <NUMBER> <NUMBER> <NUMBER> patients fishers exact p<NUMBER> authors concluded patients cancer might higher risk covid<NUMBER> individuals without cancer additionally showed patients cancer poorer outcomes covid<NUMBER> providing timely reminder physicians cancer patients require intensive care infected diabetes considered risk factor rapid progression poor prognosis covid<NUMBER> na available ccbync <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted june <NUMBER> <NUMBER> zhang l et al <NUMBER> regarded cancer patients highly vulnerable group current covid<NUMBER> pandemic authors included <NUMBER> cancer patients laboratoryconfirmed covid<NUMBER> <NUMBER> designated hospitals wuhan china jan <NUMBER> <NUMBER> feb <NUMBER> median age patients <NUMBER> <NUMBER> males <NUMBER> lung cancer authors mentioned cancer patients show deteriorating conditions poor outcomes covid<NUMBER> infection addition yu j et al <NUMBER> reviewed medical records including demographic clinical treatment data <NUMBER> patients cancer admitted zhongnan hospital wuhan university china dec <NUMBER> <NUMBER> feb <NUMBER> <NUMBER> outcomes covid<NUMBER> among patients cancer reported authors estimated infection rate sarscov<NUMBER> patients cancer single institution <NUMBER> <NUMBER> <NUMBER> patients <NUMBER> ci <NUMBER> higher cumulative incidence diagnosed covid<NUMBER> cases reported city wuhan time <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> cases data cutoff february <NUMBER> <NUMBER> median age infected patients <NUMBER> years seven <NUMBER> <NUMBER> patients nonsmall cell lung carcinoma nsclc five <NUMBER> treated either chemotherapy without immunotherapy n <NUMBER> radiotherapy n <NUMBER> three patients <NUMBER> developed sars one patient required intensivelevel care march <NUMBER> <NUMBER> <NUMBER> patients <NUMBER> discharged whereas <NUMBER> deaths <NUMBER> recorded <NUMBER> patients cancer screened <NUMBER> nsclc authors stated patients nsclc older <NUMBER> years higher incidence covid<NUMBER> aged <NUMBER> years younger <NUMBER> vs <NUMBER> table <NUMBER> summarize details three mentioned case studies high blood pressure hypertension one common conditions severe covid<NUMBER> patients <NUMBER> section review several studies looked relationship hypertension severity covid<NUMBER> relationship high blood pressure increased risk pneumonia subject study analyzed uk biobank data <NUMBER> hypertension patients <NUMBER> patients developing pneumonia afterward <NUMBER> data analysis shows risk respiratory disease significantly higher patients hypertension patients hypertension also found higher risk acute respiratory disease chronic lower respiratory disease independent age sex smoking status bmi generalizing results covid<NUMBER> plausible led many studies focus hypertension strong indication covid<NUMBER> severity several recent studies investigated variability covid<NUMBER> disease severity patients hypertension medicinal therapy <NUMBER> authors reported among <NUMBER> hospitalized covid<NUMBER> patients <NUMBER> diagnosed hypertension furthermore mortality rates among patients angiotensinconverting enzyme inhibitors acei hypertension treatment <NUMBER> p<NUMBER> well patients angiotensin ii receptor blockers arbs <NUMBER> p<NUMBER> lower compared antihypertensive agents <NUMBER> therefore results support continuation acei arb therapy covid<NUMBER> hypertensive patients results supported another study <NUMBER> <NUMBER> covid<NUMBER> patients hypertension retrospectively grouped arbsaceis n<NUMBER> nonarbsaceis n<NUMBER> according antihypertensive medications group covid<NUMBER> patients without hypertension randomly selected match previous group based age sex results study show arbsaceis group lower proportion critical patients <NUMBER> vs <NUMBER> p<NUMBER> lower death rate <NUMBER> vs <NUMBER> p<NUMBER> however differences statistically significant similarly liu et al <NUMBER> investigated disease severity patients hypertension used acei arb ccb betablockers bb compared patients take hypertension medication considering <NUMBER> elderly patients age <NUMBER> results show patients took arb significantly lower risk developing severe disease compared patients took drugs however although patients took acei ccb bb also lower risk developing severe disease statistical significance compared patients took drugs could due limited number patients drugs compared arb another study <NUMBER> authors argued based retrospective investigation different hypertension drugs calcium channel blockers ccbs show significant efficacy covid<NUMBER> patients also conducted vitro experiments examine efficacy ccbs hypertension drugs blocking sarscov<NUMBER> replication cells results show ccbs block virus replication however blocking mechanism apparent therefore investigations ccbs efficacy postentry virus replication vitro clinically needed although studies cited show hypertension medications beneficial covid<NUMBER> patients recent retrospective observational study <NUMBER> found patients hypertension took aceiarb drugs higher risk developing severe case covid<NUMBER> p <NUMBER> however statistically significant difference may due limited number patients hypertension <NUMBER> <NUMBER> covid<NUMBER> patients also group patients hypertension older comorbidities chronic renal insufficiency cardiovascular disease diabetes mellitus cerebrovascular disease patients without hypertension interestingly another study <NUMBER> hypothesizes hypertension treatment acei arbs results upregulation ace<NUMBER> may increase risk developing severe covid<NUMBER> based structural study suggesting sarscov<NUMBER> uses ace<NUMBER> receptor <NUMBER> also noted ccb treatment hypertension lead upregulation ace<NUMBER> turn makes safe treatment hypertension covid<NUMBER> patients however theory supported previously cited retrospective studies covid<NUMBER> patients ccbync <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted june <NUMBER> <NUMBER> took acei arbs <NUMBER> besides sanchisgomar et al <NUMBER> noted several health organizations recommended continued use aceis arbs treating hypertension covid<NUMBER> patients also found based review study significant differences aceis arbs managing hypertension arbs favorable option severe cases covid<NUMBER> also reviewed several articles employed systematic reviews metaanalysis published studies effects hypertension covid<NUMBER> disease severity <NUMBER> systematic reviews show hypertension one major comorbidities fatality covid<NUMBER> cases similarly zuin et al <NUMBER> carried systematic review metaanalysis show covid<NUMBER> patients hypertension significantly higher mortality risk however noted studies comorbidities either linked linked hypertension needed also roncon et al <NUMBER> looked rate icu admission covid<NUMBER> patients hypertension found among <NUMBER> patients mean age <NUMBER> years <NUMBER> males patients hypertension significantly increased risk icu admission or<NUMBER> <NUMBER> ci <NUMBER> <NUMBER> p<NUMBER> abovementioned cases summarized table <NUMBER> cholesterol level alteration found occur viral infection hiv hepatitis c virus hcv <NUMBER> mechanism alteration involves virus binding scavenger receptor b type <NUMBER> srb<NUMBER> facilitates selective uptake highdensity lipoprotein hdl cholesterol lipid components receptorbound hdl particles including free cholesterol fc triglycerides tg <NUMBER> also found membrane cholesterol important component facilitate viral entry host cells <NUMBER> role cholesterol viral infection investigated even current pandemic sarscov<NUMBER> ren et al <NUMBER> found cholesterol depletion cellular membrane significantly impaired efficiency viral infection wei et al <NUMBER> studied cholesterol metabolism covid<NUMBER> patients compared normal reference population general found fc hdl ldl cholesterol level significantly low covid<NUMBER> patients compare reference population tg levels also lower significant level moreover cholesterol metabolism mild moderate severe critical covid<NUMBER> patients also presented discussed levels hdlc significantly lower patients severe critical disease patients moderate mild disease another study <NUMBER> hdl cholesterol levels along serum albumin levels used predictors severity covid<NUMBER> disease study investigated differences clinical features mild severe covid<NUMBER> patients features studied included hypoproteinemia hypoalbuminemia decreased apoa<NUMBER> ccbync <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted june <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint patients grouped two types mild severe critical condition included also noted patients severe disease significantly older median age <NUMBER> compared patients mild disease median age <NUMBER> results show patients severe disease significantly lower hdl cholesterol also observed increased levels albumin hdl cholesterol patients late stage recovering covid<NUMBER> another recent study <NUMBER> looked serum cholesterol level patients covid<NUMBER> wenzhou china laboratory test results show patients significantly low fc hdlcholesterol ldlcholesterol levels compared healthy control moreover investigated cholesterol levels two categories patients primary infection cases wuhan secondary infection cases never wuhan infected persontoperson transmission reported hdlcholesterol primary infection group significantly lower secondary infection group similar results <NUMBER> cholesterol levels fc hdl ldl improving patients recovered inverse correlation hdl cholesterol level severity covid<NUMBER> also highlighted <NUMBER> author argued taking statin drug therapy cholesterol may increase covid<NUMBER> infections statins drugs used lower cholesterol protect heart attack stroke taking statins results low production endogenous cholesterol leads upregulation ldl cell membrane stated earlier found important component facilitate viral entry host cells overview articles investigating cholesterol levels covid<NUMBER> patients summarized table <NUMBER> apart fever respiratory complications acute kidney injury observed patients covid<NUMBER> investigate possible cause kidney damage covid<NUMBER> patients lin w al <NUMBER> used published kidney bladder cell atlas data well independent unpublished kidney singlecell rnaseq data generated inhouse evaluate ace<NUMBER> gene expressions cell types healthy kidneys bladders results showed enriched expression subtypes proximal tubule cells kidney low detectable levels expression bladder epithelial cells results indicated urinary system potential route covid<NUMBER> infection along respiratory system digestion system findings suggested ccbync <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted june <NUMBER> <NUMBER> kidney abnormalities sars covid<NUMBER> patients may due proximal tubule cell damage subsequent systematic inflammatory response induced kidney injury beyond laboratory tests viruses related indicators urine may needed special patients covid<NUMBER> novel coronavirus recent study reported human kidney specific target sarscov<NUMBER> infection <NUMBER> authors examined viral nucleocapsid protein situ kidney postmortem found sarscov<NUMBER> antigens accumulated kidney tubules suggesting sarscov<NUMBER> infects human kidney directly inducing aki contributing viral spreading body <NUMBER> alberici f et al <NUMBER> describe <NUMBER> kidney transplant recipients median age <NUMBER> years <NUMBER> male sarscov<NUMBER> induced pneumonia patients presented fever one complained difficulty breathing overall <NUMBER> kidney transplant recipients died median period <NUMBER> days symptom onset preliminary findings describe rapid clinical deterioration associated chest radiographic deterioration escalating oxygen requirement renal transplant recipients sarscov<NUMBER> pneumonia thus limited cohort longterm kidney transplant patients sarscov<NUMBER> induced pneumonia characterized high risk progression significant mortality wang j et al <NUMBER> conducted study one male patient age <NUMBER> history close contact confirmed covid<NUMBER> case type <NUMBER> diabetes <NUMBER> years hypertension <NUMBER> years patient underwent comprehensive treatment covid<NUMBER> organ transplant patients covid<NUMBER> infection might poorer prognosis systemic immunosuppressive state however severe case cured even without discontinuing reducing immunosuppressant therapy immunosuppressed case might help physicians establish optimal treatment strategies similar severe cases whether covid<NUMBER> causes significant acute kidney injury aki remains controversial zhou h et al <NUMBER> retrospectively analyzed clinical characteristics urine blood routine tests well laboratory parameters <NUMBER> hospitalized covid<NUMBER> patients wuhan china patient presented increased serum creatinine scr <NUMBER> <NUMBER> patients showed increased blood urea nitrogen bun indicating cases kidney dysfunction however among <NUMBER> <NUMBER> patients history kidney disease received routine urine test upon hospitalization <NUMBER> <NUMBER> patients displayed abnormality urinalyses proteinuria hematuria leukocyturia none patients recorded acute kidney injury aki throughout study meanwhile patients abnormal urinalysis typically displayed worse disease progression reflected laboratory parameter presentations including markers liver injury inflammation coagulation authors concluded urinalysis better unveiling potential kidney impairment covid<NUMBER> patients blood chemistry tests additionally urinalysis could used reflect predict disease severity cheng et al <NUMBER> determined prevalence acute kidney injury aki patients covid<NUMBER> evaluated association markers abnormal kidney function death patients covid<NUMBER> authors studied cohort <NUMBER> patients median age <NUMBER> <NUMBER> male covid<NUMBER> wuhan <NUMBER> <NUMBER> <NUMBER> died hospitals study period aki occurred <NUMBER> patients kaplanmeier analysis demonstrated patients kidney disease significantly higher risk inhospital death thus authors believed prevalence kidney disease admission development aki hospitalization patients covid<NUMBER> high associated inhospital mortality hence clinicians increase awareness kidney disease patients severe covid<NUMBER> acute stroke remains medical emergency even covid<NUMBER> pandemic avula et al <NUMBER> investigated <NUMBER> patients covid<NUMBER> also presented acute stroke <NUMBER> patients table <NUMBER> radiographic evidence stroke pcrconfirmed covid<NUMBER> infection authors elucidated clinical characteristics imaging findings clinical course warned covid<NUMBER> patients present cerebrovascular accidents ccbync <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted june <NUMBER> <NUMBER> use appropriate personal protective equipment every suspected patient studies urgently needed improve current understandings neurological pathology setting covid<NUMBER> infection ischemic stroke also experimental evidence il<NUMBER> protective effect helps ccbync <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted june <NUMBER> <NUMBER> improvement poststroke angiogenesis <NUMBER> could also due presence thrombocytopenia covid<NUMBER> patients indeed may true influenza pneumonia ie increased stroke risk may true sarscov<NUMBER> main limitation remark however certainly short observation period <NUMBER> month oxley tj et al <NUMBER> reported <NUMBER> <NUMBER> male <NUMBER> female largevessel stroke patients confirmed sarscov<NUMBER> mean age <NUMBER> patients younger <NUMBER> years presented health system new york city severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> infection diagnosed five patients although patients covid<NUMBER> related symptoms fever cough lethargy reduced nih stroke scalescore nihss studies reviewed paper assessed effects diabetes cancer hypertension high cholesterol kidney issues stroke covid<NUMBER> severity thorough examination evidence provided reports inferences relationship preexisting conditions covid<NUMBER> madeit apparent individuals diabetes increased risk covid<NUMBER> infection medical complications including death suggestions made possible pathophysiological mechanisms relationship diabetes covid<NUMBER> management definite conclusions made based current limited evidence data <NUMBER> research regarding relationship clinical management warranted <NUMBER> furthermore article guo et al <NUMBER> left several relevant questions addressed association covid<NUMBER> diabetes differ different types diabetes antidiabetic drugs impact disease progression impact aging diabetics without diabetes results study read light limitations small sample size large age difference study groups patients comorbidities excluded still provides relevant insights could inform covid<NUMBER> interacts preexisting conditions <NUMBER> recently published reports provided results suggesting cancer patients susceptible covid<NUMBER> complications studies lung cancer frequently observed covid<NUMBER> cases analyzed hospitals china however according moujaess e et al <NUMBER> reports could lead many oncologists change daily practice cancer care without solid evidence recommendations data presented carefully interpreted small sample also cancer patients cohort mentioned <NUMBER> instance significantly older median age control <NUMBER>·<NUMBER> vs <NUMBER>·<NUMBER> years well significant history smoking suggesting two factors might associated poor covid<NUMBER> outcomes cancer history moreover results interpreted caution absence adjustment prevalence different comorbidities chinese population <NUMBER> also xia et al <NUMBER> commented mentioned studies highlighted reasons cautious suggesting current evidence remains insufficient explain conclusive association cancer covid<NUMBER> though one effect risen concern due number covid<NUMBER> patients surpassing hospital healthcare capacity cancer patients may overlooked resulting negative consequences treatments hypertension like diabetes proven linked significantly higher risk respiratory infection making solid indicator covid<NUMBER> severity additionally systematic reviews indicate hypertension common comorbidity covid<NUMBER> death cases well linked significantly higher mortality risk increased incidence icu admission although noted studies comorbidities connected hypertension necessary nonetheless evident many patients virus also suffer hypertension result comorbidity well medicinal therapies covid<NUMBER> observed also found hypertension treatment continued lower severity risk researchers recommended ccbs treatment others found significant differences using aceis arbs ccbs however seems general agreement health organizations recommended hypertension treatment continued covid<NUMBER> patients <NUMBER> cholesterol previously investigated concerning many viral infections typically selective uptake cholesterol viruses bind cellular membrane ultimately enables severe infection therefore analyses conducted connection covid<NUMBER> cholesterol publications indicated fc hdl ldl cholesterol levels significantly low patients viral infection compared control studies explained ability sarscov<NUMBER> virus use serum cholesterol entry host cells therefore low serum cholesterol level used early predictor covid<NUMBER> severity patients also observing improvement serum cholesterol levels may indicate improvement conditions patients also worth noting statin drugs cholesterol may contribute severity covid<NUMBER> disease inhibiting endogenous cholesterol leading upregulation ldl leads higher membrane cholesterol levels enhance ability sarscov<NUMBER> enter host cells addition multiple complications observed acute kidney injury also detected covid<NUMBER> patients results indicated urinary system respiratory system digestion system potential routes covid<NUMBER> infection one study indicating human kidney specific target virus findings propose kidney abnormalities covid<NUMBER> patients may due proximal tubule cell damage subsequent systematic inflammatory response induced kidney injury additionally one study sarscov<NUMBER> antigens seen accumulate kidney tubules implying direct impact kidney leading aki induction viral spread within body also studies describing rapid clinical deterioration escalating oxygen requirement high risk progression significant mortality kidney transplant patients similarly incidence kidney disease admission well development aki correlated fatality covid<NUMBER> patients however covid<NUMBER> causes acute kidney injury remains uncertain many authors concluded clinicians must still try increase awareness kidney issues patients severe infection urinalysis may used predict extent disease severity one study identified <NUMBER> covid patients neurological symptoms mainly patients severe disease several mechanisms covid<NUMBER> increase stroke risk recognized neither proven significant studies required investigate neurological pathology covid<NUMBER> infection additionally may need improve specific vte diagnostic strategies safety thromboprophylaxis identify role il<NUMBER> plays ischemic stroke however risks associated ischemic stroke covid<NUMBER> patients still uncertain cancer patients medical resources must allocated target strain covid<NUMBER> placed ischemic stroke care meanwhile relationship covid<NUMBER> stroke must examined first case pneumonia caused severe acute respiratory syndrome coronavirus <NUMBER> sars‐cov‐<NUMBER> reported wuhan hubei province china december <NUMBER> <NUMBER> march coronavirus disease <NUMBER> covid‐<NUMBER> caused virus spread around world sars‐cov‐<NUMBER> human coronavirus belong group benign coronaviruses cause common cold smaller group coronaviruses cause acute respiratory distress syndrome severe acute respiratory syndrome coronavirus—sars middle east respiratory syndrome coronavirus—mers <NUMBER> <NUMBER> recently published studies showed arterial hypertension diabetes cardiovascular diseases chronic obstructive pulmonary disease prevalent among patients covid‐<NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> investigations outcome patients scarce data limited nevertheless hypertension considered one important risk factors covid‐<NUMBER> relationship hypertension adverse outcome still questionable aim review paper summarize current knowledge relationship hypertension covid‐<NUMBER> role hypertension outcome patients comprehensive search performed pubmed scopus web science google scholar find review papers topic published may <NUMBER> <NUMBER> sars‐cov‐<NUMBER> infection triggered s‐protein virus binds angiotensin‐converting enzyme <NUMBER> ace<NUMBER> highly expressed heart lungs kidney gastrointestinal tract plays important role several cardiovascular immune pathways <NUMBER> sars‐cov‐<NUMBER> binds ace<NUMBER> much higher affinity compared sars‐cov <NUMBER> additionally sars‐cov‐<NUMBER> shows pathogenic activity attacking type ii alveolar epithelial cells expressing ace<NUMBER> previous studies coronavirus causes sars demonstrated virus binds ace<NUMBER> pulmonary alveoli superficial spike proteins causes lung damage even lung function failure <NUMBER> loss ace<NUMBER> caused binding sars‐cov‐<NUMBER> may shift system overall higher angiotensin ii lower angiotensin‐<NUMBER>‐<NUMBER> tone role angiotensin ii covid‐<NUMBER> hypertensive patients seems crucial due role functioning renin‐angiotensin‐aldosterone system raas promotes vasoconstriction sodium retention oxidative stress inflammation fibrosis increases bioactive peptide angiotensin‐<NUMBER>‐<NUMBER> <NUMBER> epidemiological data coming china indicate arterial hypertension cardiovascular diseases diabetes chronic obstructive pulmonary disease prevalent concomitant diseases patients covid‐<NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> table <NUMBER> number investigations provided least short follow‐up intrahospital outcome limited even though data demonstrated prevalence hypertension covid‐<NUMBER> patients lethal outcome high <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> still debated whether hypertension predictor mortality independently cardiovascular risk factors age obesity diabetes comorbidities coronary artery disease heart failure atrial fibrillation cerebrovascular disease renal impairment prevalence hypertension among patients covid‐<NUMBER> different studies ranged <NUMBER>‐<NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER>‐<NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> several reasons variations average age significantly higher patients elevated prevalence hypertension <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> might important reason different prevalence hypertensive patients among studies advanced age associated higher prevalence comorbidities diabetes renal impairment arterial hypertension obesity altogether increased proportion hypertensive patients <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> prevalence overweight obesity reported available studies covid‐<NUMBER> “circulus vitiosus” hypertension obesity diabetes difficult break therefore conclusion cannot made without detailed data links chain impact smoking forgotten relation copd hypertension higher propensity covid‐<NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> however results conflicting majority authors find higher prevalence smoking patients adverse outcome <NUMBER> <NUMBER> <NUMBER> level renal damage cannot excluded one contribute factor higher percentage hypertension advance stage covid‐<NUMBER> hypertensive patients studies reported large prevalence cardiovascular diseases covid‐<NUMBER> patients also classified therefore difficult estimate individual effect coronary artery disease heart failure atrial fibrillation occurrence severity covid‐<NUMBER> li et al summarized findings <NUMBER> studies showed prevalence hypertension cardio‐ cerebrovascular disease diabetes patients covid‐<NUMBER> <NUMBER> <NUMBER> <NUMBER> respectively <NUMBER> incidences hypertension cardio‐cerebrovascular diseases diabetes two‐ threefolds higher patients severe type covid‐<NUMBER> non‐severe counterparts yang et al included <NUMBER> covid‐<NUMBER> patients <NUMBER> studies reported prevalent comorbidities hypertension diabetes cardiovascular diseases respiratory system disease <NUMBER> frequent comorbidities severe patients hypertension respiratory system disease cardiovascular disease large meta‐analysis included <NUMBER> patients covid‐<NUMBER> found pooled prevalence hypertension cardiovascular disease smoking history diabetes <NUMBER> <NUMBER> <NUMBER> <NUMBER> respectively <NUMBER> table <NUMBER> authors meta‐analyses agreed large heterogeneity studies obviously limited quality study partly explained different designs large variation sample size among studies <NUMBER> <NUMBER> essential data still missing would dangerous ascribe large portion risk sars‐cov‐<NUMBER> infection severity covid‐<NUMBER> risk factor including hypertension would reasonable hypothesize uncontrolled comorbidities well combination concomitant diseases may increase risk infection severity covid‐<NUMBER> examined many controversies effect angiotensin‐converting enzyme inhibitors acei angiotensin ii receptor blockers arb covid‐<NUMBER> patients <NUMBER> authors expressed concern use renin‐angiotensin‐aldosterone system raas inhibitors variation ace<NUMBER> expression may partly responsible sars‐cov‐<NUMBER> virulence <NUMBER> <NUMBER> population‐based studies estimated small proportion hypertensive patients china <NUMBER> <NUMBER> treated antihypertensive therapy raas inhibitors used <NUMBER> <NUMBER> treated patients <NUMBER> <NUMBER> therefore anticipated small percentage covid‐<NUMBER> patients china actually treated acei arb hand prevalence cardiac damage covid‐<NUMBER> patients negligible associated adverse outcome subjects <NUMBER> <NUMBER> data regarding frequency heart failure covid‐<NUMBER> patients scarce valid chronic kidney disease therapeutic point view acei arb important roles treatment conditions—cardiac injury heart failure renal impairment particularly albuminuria therefore withdrawing raas inhibitors switching medications would uncertain benefits certain disadvantages would expected problem raas inhibitors would escalate western countries europe usa patients taking antihypertensive medications particularly raas inhibitors significantly higher percentage china however studies italy usa show association raas inhibitors susceptibility coronavirus complications mortality covid‐<NUMBER> <NUMBER> <NUMBER> <NUMBER> even new investigation china confirmed findings <NUMBER> switching raas inhibitors another antihypertensive therapy would lead insufficient blood pressure control could induce complications covid‐<NUMBER> patients infection sars‐cov‐<NUMBER> novel data showed raas inhibitors could even improve outcome hypertensive patients covid‐<NUMBER> <NUMBER> authors hypothesized raas inhibitors indirect antiviral role regulating immune function inhibiting inflammatory responses <NUMBER> based available data despite theoretical possibilities multiple specialty societies recommended covid‐<NUMBER> patients continue therapy raas inhibitors <NUMBER> <NUMBER> <NUMBER> limited number studies provided outcome data short follow‐up therefore one careful interpretation findings guan et al demonstrated patients severe covid‐<NUMBER> primary end point admission intensive care unit use mechanical ventilation death significantly higher percentage hypertension diabetes coronary artery disease cerebrovascular disease copd chronic renal disease cancer <NUMBER> authors investigate relationship different demographic clinical parameters severity disease outcome shi et al reported hypertension diabetes coronary artery disease cerebrovascular disease copd cancer prevalent patients myocardial injury diagnosed elevation high‐sensitivity troponin creatinine kinase‐myocardial band ck‐mb <NUMBER> cardiac injury associated significantly higher mortality <NUMBER> vs <NUMBER> authors investigate comorbidities associated cardiac injury mortality must noted patients cardiac injury significantly older guo et al demonstrated similar results compared covid‐<NUMBER> patients without elevation troponin found <NUMBER> patients covid‐<NUMBER> cardiac injury <NUMBER> study chronic renal dysfunction usage raas also prevalent patients cardiac injury however patients cardiac injury almost <NUMBER> years older frequently men without injury also taken account also reported underlying cardiovascular disease worsening outcome patients myocardial injury <NUMBER> defining myocardial injury elevation troponin circumstances could questionable biomarker may increased many conditions inflammation andor sepsissystemic inflammatory response syndrome kidney injury authors clearly stated disorders included term “cardiovascular disease” clear whether hypertension included term furthermore difficult understand cardiomyopathies included whether patients heart failure included chen et al reported hypertension cardiovascular disease diabetes prevalent among covid‐<NUMBER> patients died comparison survivors <NUMBER> however large difference age sex distribution groups authors investigate effect comorbidities outcome population <NUMBER> table <NUMBER> zhou et al reported hypertension diabetes coronary heart disease chronic renal disease copd frequent among non‐survivors survivors <NUMBER> authors found hypertension diabetes coronary heart disease predictors mortality covid‐<NUMBER> patients nevertheless none comorbidities remained significant predictor mortality adjustment age sex smoking status findings confirmed importance comprehensive risk assessment including relevant risk factors comorbidities large original study included <NUMBER> patients guan et al showed adjusting age smoking status patients copd diabetes hypertension malignancy likely reach composite end points admission intensive care unit invasive ventilation death without <NUMBER> malignancy copd hypertension diabetes increased risk adverse outcome <NUMBER>‐ <NUMBER>‐ <NUMBER>‐ <NUMBER>‐fold respectively <NUMBER> patients two comorbidities significantly higher risk composite end point patients single comorbidity stratification patients according age <NUMBER> years vs ≥<NUMBER> years show significant difference strength associations number comorbidities mortality covid‐<NUMBER> <NUMBER> however cannot excluded confounding factors besides aging smoking might also responsible association comorbidities outcome would also helpful divide primary outcome two separate outcomes admission intensive care unit andor invasive ventilation b death would provide separated information independent predictors severity mortality covid‐<NUMBER> performed small study authors found hypertension diabetes predictors acute respiratory distress syndrome mortality covid‐<NUMBER> patients <NUMBER> unfortunately multivariable analysis adjustment relevant confounding factors performed investigation number limitations mentioned investigations self‐reporting comorbidities hospital admission represents one under‐reporting comorbidities due lack awareness andor lack diagnostic testing could interfere associations comorbidities clinical outcome importantly duration follow‐up short patients remained hospital time publishing studies means real outcome unknown obesity reported available studies influence could investigated furthermore one study reported basal values systolic diastolic blood pressure would help estimate percentage uncontrolled hypertension refers prevalence patients uncontrolled diabetes studies included small number patients additional obstacle one forget fact majority studies come china cautious extrapolating findings countries outbreak covid‐<NUMBER> studies consider potential sources bias confounding additional investigations improved design warranted recent findings reported arterial hypertension represented one common comorbidities patients covid‐<NUMBER> prevalence ranged <NUMBER> <NUMBER> impact hypertension outcome particularly mortality covid‐<NUMBER> patients clear due lack data studies provide evidence raas inhibitors avoided switched patients large studies consider potential sources bias confounding factors well longer follow‐up necessary public pressure find answers high physicians duty stay rational scientific approach available upcoming data response covid<NUMBER> pandemic need substantial changes procedures accessing healthcare services subspecialties care expecting mothers special pregnancy requires control visits specific times assess unborn child develops normally essential happen mother good health prime ministry decree dated march <NUMBER> <NUMBER> details measures containment coronavirus infection including travel limitations individuals throughout country closure nonessential businesses public places etc listed among exceptions possibility patients travel outpatient visits pregnancy decree confirms current organization network maternalneonatal care outpatient setting outpatient family services consultori well hospital setting diagnostic imaging laboratory testing procedures specific certain gestational age also guaranteed recommended safety measures place gestational diabetes gdm condition promptly recognized treated translates increased risk maternal fetal complications short long term currently evidence relationship covid<NUMBER> gdm known hyperglycaemia worsens immune response infections associated inflammatory state turn worsens insulin resistance therefore even current pandemic reduce attention towards diagnosis treatment gdm italy screening diagnosis gdm follows guidelines published <NUMBER> istituto superiore di sanità iss according risk gdm oral glucose tolerance test oggt <NUMBER> gestational weeks prescribed high risk cases <NUMBER> gestational weeks medium risk cases screening recommended women low risk gdm high risk women normal ogtt <NUMBER> gestational weeks repeat ogtt <NUMBER> gestational weeks purpose document provide temporary guide gdm screening replacing current guidelines possible implement standard gdm screening unfavorable riskbenefit ratio pregnant women usual laboratory facilities available <NUMBER> changes screening procedure gdm reported specifically produced response health emergency covid<NUMBER> pandemic <NUMBER> therefore recommended changes cease effect replaced current guidelines lg iss physiological pregnancy sid amd <NUMBER> standard care <NUMBER> <NUMBER> subsequent updates healthcare authorities declare end national health emergency <NUMBER> drafting recommendations took account following considerations currently available scientific evidence recognize alternative <NUMBER> gram oral glucose tolerance test sampling blood glucose measurements <NUMBER> <NUMBER> <NUMBER> postload therefore ogtt remains gold standard diagnosis gdm b health emergency facing unprecedented coronavirus transmission specific although completely known characteristics c risk benefit ratio contingent situation taken account basis recommend implement following changes algorithm screening gdm usual schedule outpatient visits unfavorable risk benefit ratio identified team making exposure pregnant woman risk coronavirus transmission worth healthcare system provide limited services <NUMBER> first visit pregnancy women must exclude presence overt diabetes although undiagnosed criteria diagnosis overt diabetes either one fasting plasma glucose ≥ <NUMBER> mgdl one random plasma glucose ≥ <NUMBER> mgdl one glycated hemoglobin ≥ <NUMBER> fig <NUMBER> many studies shown preexisting diabetes recognized promptly treated associated adverse maternal fetal outcomes particular recent canadian study <NUMBER> analyzed maternal fetal outcomes <NUMBER> women documenting <NUMBER> preexisting diabetes pregnancy among women risk preterm birth perinatal mortality congenital malformations neonatal hypoglycaemia significantly higher among women gdm <NUMBER> screening procedure ogtt cannot safely performed diagnosis gdm acceptable even without performing entire curve fasting plasma glucose ≥ <NUMBER> mgdl order consider impaired fasting glucose acceptable surrogate diagnosis gdm fasting glucose measurement performed within recommended time windows risk level high medium risk defined aforementioned lg iss physiological pregnancy <NUMBER> fig <NUMBER> b event screening gdm possible procedure carried compliance provisions social distancing place medical facilities expectant mother healthcare personnel wear recommended personal protective equipment surgical mask gloves rationale one single point ogtt recommended threshold sufficient diagnose gdm data literature suggest fasting plasma glucose alone used diagnose gestational diabetes since sensitivity specificity fasting plasma glucose sample <NUMBER> pregnant women <NUMBER> <NUMBER> respectively <NUMBER> nonetheless important underline procedure limited measurement basal glucose alone underestimates cases gdm indeed certain percentage gdm patients basal glucose values <NUMBER> mg postload values <NUMBER> <NUMBER> hours abnormal addition note completing sampling ogtt even fasting diagnostic value detected allows detect metabolic disorders different clinical impact therefore define appropriate therapeutic strategy stratifying patients according metabolic cardiovascular risk short long term therefore ogtt screening method gdm significant benefits woman fetus covid<NUMBER> pandemic likely risk associated performing full ogtt may outweigh benefit mother fetus fasting blood glucose value ≥ <NUMBER> mgdl threshold state fasting glucose value considered diagnostic gdm obtained gestational age ogtt carried ie <NUMBER> weeks highrisk pregnant women <NUMBER> <NUMBER> weeks medium risk women <NUMBER> diagnosis gdm first visit diabetes center periodic patients contact maintained telemedicine consultations reduce access healthcare facilities need define implement shared standard management processes include communication recording monitoring tools italy diabetes clinics mostly share management software activating option downloading remote capillary glucose data continuous glucose monitoring devices app sugr sharing tools useful define specific pdtas provide management support clinicians aim harmonize behavior clinicians innovative tools telemedicine <NUMBER> limit need patients leave homes access healthcare facility important coordinate prescription performance laboratory tests diagnostic imagingprocedures recommended various specialists involved management pregnancy rationale pregnancy complicated gdm carries increased risk mediumand longterm complications mother fetus sense management hyperglycemia pregnancy particularly rigorous may require frequent laboratory testing diagnostic imagingprocedures support treatment decisions eg monitoring fetal growth parameters andor early detection complications clinicians need assess riskbenefit ratio individual patient considering one hand increased risk coronavirus transmission access healthcare facility end reduced risk maternal andor fetal complications early detection risk assessment need also shared specialists involved care women <NUMBER> defer postpartum ogtt end coronavirus health emergency except cases persistence hyperglycemia delivery eg high capillary blood glucose values immediate postpartum high insulin requirement pregnancy cases clinicians need inform woman importance postpartum screening glucose tolerance attending followup visits time carried telemedicine consultations including monitoring nutrition breastfeeding rationale pregnancy complicated gdm increases risk type <NUMBER> diabetes cardiovascular diseases short longterm delivery italy scientific societies sid amd recommend testing glucose tolerance <NUMBER> gram ogtt performed <NUMBER> weeks <NUMBER> months delivery identify early impairment glucose tolerance furthermore recommended assessing metabolic parameters necessary according patients history primary concern current coronavirus pandemic limit unnecessary exposure individuals coronavirus transmission therefore although recognize importance postpartum assessment glucose tolerance women gdm assessment postponed end current pandemic emergency exception policy cases persistent hyperglycemia documented cases telemedicine consultation specialist may suggest opportunity assessments <NUMBER> pregnant women gdm documented coronavirus infection recommended intensify glucose control management rationale literature currently reports pregnancies complicated gdm covid<NUMBER> general diabetes increasing risk coronavirus infection worsen prognosis covid<NUMBER> <NUMBER> pregnant women gdm coronavirus infection insulin recommended treatment hyperglycaemia since condition responding nutritional management <NUMBER> given importance fasting plasma glucose measurement recommendation mandatory respect standardized conditions preanalytical phase especially regard choice appropriate anticoagulant order avoid occurrence false negatives due reduction blood glucose vitro avoid excessive latency samples collection analysis <NUMBER> sarscov<NUMBER> shares <NUMBER> homology bat sarslikecovzxc<NUMBER> <NUMBER> human sarscov around <NUMBER> middle east respiratory syndrome coronavirus merscov <NUMBER> coronaviruses sarscov<NUMBER> comprises four structural proteins e envelope protein membrane protein n nucleocapsid protein spike protein well eight accessory proteins <NUMBER> spike surface glycoprotein plays essential role promoting attachment virus receptor host cells may determine host tropism transmission ability receptorbinding domain rbd sprotein sarscov<NUMBER> shares identical <NUMBER>d structure rbd sprotein sarscov well <NUMBER> amino acid sequence homology <NUMBER> vitro vivo studies showed angiotensinconverting enzyme <NUMBER> ace<NUMBER> cellular receptor sarscov virus <NUMBER> <NUMBER> novel sarscov<NUMBER> also binds ace<NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> times higher affinity sarscov <NUMBER> addition sarscov<NUMBER> employs cellular transmembrane serine protease <NUMBER> tmprss<NUMBER> protein priming allowing internalization replication host cells <NUMBER> ace<NUMBER> naturally occurring enzyme abundantly present humans mainly cell membrane lung alveolar epithelial cells <NUMBER> <NUMBER> <NUMBER> <NUMBER> enterocytes small intestine <NUMBER> provide entry routes sarscov infection probably sarscov<NUMBER> additionally ace<NUMBER> also expressed arterial venous endothelial cells arterial smooth muscle cells <NUMBER> cholangiocytes <NUMBER> testis <NUMBER> <NUMBER> pancreas <NUMBER> <NUMBER> cardiovascular <NUMBER> <NUMBER> <NUMBER> renal <NUMBER> <NUMBER> <NUMBER> urothelial <NUMBER> mucosal <NUMBER> gastrointestinal tissues <NUMBER> <NUMBER> minor extent ace<NUMBER> homologous firstly discovered ace<NUMBER> enzymes part reninangiotensin system ras crucial role regulating blood pressure maintaining electrolyte fluid homeostasis potent vasoconstrictorvasodepressor actions <NUMBER> ras enzymatic cascade starting cleavage angiotensinogen renin form angiotensin ang peptide metabolized ace<NUMBER> removes two amino acids cterminal end form potent vasopressor peptide ang ii <NUMBER> ang ii levels endogenously regulated ace<NUMBER> membranebound monocarboxypeptidase cleaves terminal leucine phenylalanine residues ang ang ii originating ang <NUMBER> ang <NUMBER> respectively hexapeptide ang <NUMBER> exerts potent vasodilator antifibrotic antiproliferation antiinflammatory effect via activation mas receptor effects counterbalance ace<NUMBER>ang iiatr<NUMBER> system <NUMBER> similar manner ace<NUMBER> inhibitor drugs aceis antihypertensive effect substantially lower risk death heart failure stroke <NUMBER> patients hypertension diabetes benefit use drugs since ace<NUMBER> insensitive blockade ace<NUMBER> inhibitors also use inhibitor drugs increases ace<NUMBER> gene expression activity probably due accumulation ang <NUMBER> ace<NUMBER> found protective effects lung injury different lung injury animal models <NUMBER> <NUMBER> <NUMBER> specifically diabetes ace<NUMBER> seems protective role progression cardiovascular renal complications suggested potential therapeutic target management diabetes complications <NUMBER> <NUMBER> studies mice showed role ace<NUMBER> improvement glycemia levels mice diabetes direct effects pancreas <NUMBER> improving insulin sensitivity glucosemediated insulin release <NUMBER> reduction risk type <NUMBER> diabetes development <NUMBER> effect diabetes expression ace<NUMBER> well established studies animal models diabetes evidenced either increased reduced expression ace<NUMBER> renal tissues pancreatic tissues depending disease stage contrary levels ace<NUMBER> lung tissue mice diabetes seem lower compared renal pancreatic tissues <NUMBER> <NUMBER> similarly study nonobese diabetic nod mouse model showed increase ace<NUMBER> serum liver pancreas lung <NUMBER> study performed <NUMBER> soropaavonen et al showed increased serum ace<NUMBER> activity type <NUMBER> diabetes mellitus dm patients vascular complications without complications <NUMBER> found aceis angiotensin ii receptor blockers arbs cause overexpression ace<NUMBER> patients treated drugs <NUMBER> study soropaavonen patients treated aceis increased ace<NUMBER> activity independently presence vascular complications <NUMBER> however expression ace<NUMBER> mrna measured expression levels ace<NUMBER> associated susceptibility sarscov sarscov<NUMBER> infection different cell lines <NUMBER> <NUMBER> <NUMBER> therefore raising concern patients treated aceis arbs could higher risk infection associated morbidity mortality sarscov<NUMBER> infection due higher expression virus entry gate target tissues <NUMBER> nevertheless conflicting information found topic data suggest aceis arbs protective effects lung injury <NUMBER> relatively clinical studies matter compared preclinical studies animal models may erroneous admit effects ras inhibitors ace<NUMBER> expression translatable human physiology additionally measurements ace<NUMBER> plasma levels performed studies may reliable indicator ace<NUMBER> activity since full length protein predominantly membrane bound <NUMBER> taking advantage ace<NUMBER> sarscov<NUMBER> gains access cells however shown soon infection ace<NUMBER> expression rapidly downregulated <NUMBER> whether effect caused virus prevent ace<NUMBER> protective effects <NUMBER> results indirect mechanism yet clear confirmed clinical studies longterm use aceis arbs patients associated increased risk sarscov<NUMBER> infection neither developing severe covid<NUMBER> even higher risk inhospital death <NUMBER> <NUMBER> <NUMBER> studies highlight withdrawal medications recommended prevent serious covid<NUMBER> since wellknown benefits protecting kidney myocardium <NUMBER> clinical decompensation caused removal potentially causing serious condition viral infection multiorgan damage characteristic sars nevertheless major affected organs include lungs heart kidney severity disease progression death predictor factors include old age thrombocytopenia severe hypoxia hyperglycemia <NUMBER> hyperglycemia also consequence sarscov infection due ace<NUMBER>dependent damage pancreatic islets exocrine tissue islet damage elevation fasting plasma glucose levels diabetes development hospitalization reported <NUMBER> although pancreas damage transient patients cases diabetes remained <NUMBER>years followup <NUMBER> case sarscov<NUMBER> transient damage pancreas already documented <NUMBER> given higher infectivity affinity ace<NUMBER> receptor increased concern relative complications caused hyperglycemia well longterm effects infection recovered patients hyperglycemia characteristic diabetes chronic metabolic disorder left untreated leads serious complications ranging limb amputations kidney failure blindness cardiovascular disease <NUMBER> <NUMBER> disorder may caused insufficient insulin production pancreas resistance insulin action mixture <NUMBER> therefore hyperglycemia underlies many complications developed disease course tight control glucose blood levels patients diabetes essential since beginning covid<NUMBER> outbreak diabetes reported one highrisk factors rapid disease progression bad prognosis covid<NUMBER> <NUMBER> instance retrospective cohort study <NUMBER> chinese patients infected sarscov<NUMBER> showed <NUMBER> patients comorbidity diabetes representing <NUMBER> patients <NUMBER> another study showed among <NUMBER> deaths due sarscov<NUMBER> wuhan <NUMBER> diabetes <NUMBER> also different cohort study analyzing <NUMBER> patients wuhan confirmed covid<NUMBER> pneumonia revealed <NUMBER> patients diabetes also observed among patients developed acute respiratory distress syndrome ards <NUMBER> total cohort patients comorbidities develop ards diabetes second frequent comorbidity <NUMBER> ardspatients versus <NUMBER> nonards patients <NUMBER> furthermore largest case series covid<NUMBER> china reported chinese center disease control prevention showed dm patients higher mortality rates <NUMBER> compared overall population <NUMBER> total <NUMBER> analyzed cases <NUMBER> comes surprise reported people diabetes demonstrate higher susceptibility several infectious diseases tuberculosis pneumonia influenza <NUMBER> underlying mechanisms completely understood depend type infection hypotheses raised possible explanations dm highrisk factor covid<NUMBER> may due hyperglycemic environment known increase virulence pathogens besides also reported phagocytosis chemotaxis impaired production interleukins response infection reduced well response cells neutrophils <NUMBER> <NUMBER> overall immune response vital fight covid<NUMBER> infection impaired especially diabetic patients poor blood glucose control furthermore several studies shown dm patients significant decrease forced vital capacity fvc forced expiratory volume one second fev<NUMBER> important indicators lung function impaired pulmonary function significantly associated poorly controlled diabetes consequently hyperglycemic levels <NUMBER> <NUMBER> <NUMBER> therefore reduced pulmonary capacity may also increase susceptibility respiratory infections possibly representing another factor myriad events might increase vulnerability dm patients towards covid<NUMBER> absence specific antiviral drug physicians considering trying lopinavir ritonavir interferon<NUMBER>b rna polymerase inhibitor remdesivir tamiflu already reported diseases <NUMBER> inclusively zinc oxide nanoparticles also considered since shown inhibitory effects h<NUMBER>n<NUMBER> viral load <NUMBER> plus vitamin c also good supplement immune system preventive effects pneumonia <NUMBER> however none shown yet evidences beneficial covid<NUMBER> mentioned suggested therapeutics diabetes hypertension namely aceis arbs responsible upregulating ace<NUMBER> hand functional receptor sarscov<NUMBER> uses cellular entry <NUMBER> sense authors hypothesize therapeutics may contribute increased infection advice discontinue aceis arbs used patients diabetes hypertension however clear evidence animals humans confirming theory besides ace<NUMBER> also increased thiazolidinediones ibuprofen well exercise dehydration plus recently published chinese study showing transplantation ace<NUMBER>mesenchymal stem cells improves outcome patients covid<NUMBER> pneumonia <NUMBER> studies actually already shown overexpressed ace<NUMBER> plays protective role lungs sarscov<NUMBER> infection suggesting arbs aceis therapy <NUMBER> <NUMBER> proof preclinical study authors injected animals spike glycoprotein sarscov cause severe lung injury verified ace<NUMBER> significantly downregulated treating arb losartan severe acute lung injury attenuated <NUMBER> evidence supported findings china showed ace<NUMBER> blockade resulted exacerbated lung damage reduced animal survival respiratory syncytial virus infection <NUMBER> actually comment israel author published early march proposing arbs aceis treatment patients covid<NUMBER> infection reduce risk severity viral pneumonia <NUMBER> however coronavirus spike protein binds ace<NUMBER> downregulation ace<NUMBER> leads excessive accumulation angiotensin ii vasoconstrictor pulmonary inflammation fibrosis edema less ace<NUMBER> convert angiotensin <NUMBER> vasodilator antiproliferative cytoprotective big question know wins battle virus binds ace<NUMBER> upregulated lungs protective effects caused ace<NUMBER> upregulation clarified yet sense european medicines agency ema recommend treatment arbs aceis maintained patients diabetes hypertension <NUMBER> patients stop taking may face complications regarding kidney failure increased mortality either way alternative treatment calcium channel blockers ccbs used since seem increase ace<NUMBER> expression activity <NUMBER> commonly according standard procedure sick patients stop taking metformin sodiumglucose transporter <NUMBER> inhibitors due adverse side effects acidosis fat metabolism <NUMBER> addition glucagonlike peptide receptor<NUMBER> analogues also stopped since may cause nausea vomiting pioglitazone among side effects described elsewhere <NUMBER> plus aromatase inhibitors also stopped since reduce insulin sensitivity insulin one used acutely sick patients severe breathing disorders <NUMBER> recovered stabilized noninsulin therapy introduced knowing virus infection multistep process possible targets treat covid<NUMBER> strong candidate could exert potent antiviral effect antimalaria chloroquine described virus processing internalization facilitated low ph phdependent endosomal cysteine protease cathepsins <NUMBER> chloroquine becomes entrapped membraneenclosed low ph organelles rapidly protonated concentrated endosomes interfering acidification hydroxychloroquine considered shortterm treatment trials <NUMBER> antiviral activity chloroquine combined azithromycin covid<NUMBER> vitro recently reported however authors found evidence strong antiviral activity clinical benefit combination treatment hospitalized patients severe covid<NUMBER> either way ongoing randomized clinical trials hydroxychloroquine provide definitive answer regarding alleged efficacy combination assess safety <NUMBER> also amiodarone ability interfere endocytic pathway suggested possible inhibitor sars coronavirus <NUMBER> binding ace<NUMBER> virus requires essential serine protease tmprss<NUMBER> protein priming using tmprss<NUMBER> inhibitors eg camostat mesylate already used treat cancer hepatitis possible adjuvant therapy <NUMBER> according ema potential treatments clinical trials remdesivir investigational lopinavirritonavir antihiv chloroquine hydroxychloroquine antimalaria rheumatoid arthritis systemic interferons interferon beta multiple sclerosis monoclonal antibodies activity components immune system <NUMBER> plus diagnostics treatments vaccines considered covid<NUMBER> summed artis ventures platform <NUMBER> overall chance developing serious complications due sarscov<NUMBER> infection higher people health conditions associated discussed diabetes complications associated disease weakened immune response hyperglycemia present higher risk infected patients figure <NUMBER> covid<NUMBER> progression also higher risk develop secondary infections therefore worsening health state reasons effective tight management diabetes specifically glucose plasma levels extremely important infected patients diabetes additionally use aceis arbs sarscov<NUMBER> infected patients raised questions regarding beneficial harmful effects disease progression enough evidence yet allows drawing conclusions issue therefore care must taken use drugs abrupt withdrawal recommended could lead even serious complications several strategies tested control covid<NUMBER> pandemic better understanding sarscov<NUMBER> effects highrisk patients fundamental decrease morbidities mortality coronaviruses singlestranded enveloped rna virus belonging coronaviridae family beta genus type diameter <NUMBER> nm known cause respiratory infections human <NUMBER> <NUMBER> end <NUMBER> china experienced outbreak novel coronavirus killed thousand infected <NUMBER> individuals within first <NUMBER> days later spread rapidly world <NUMBER> time initially named novel coronavirus <NUMBER> <NUMBER>ncov chinese center disease control prevention renamed severe acute respiratory syndrome coronavirus<NUMBER> sarscov<NUMBER> world health organization disease caused sarscov<NUMBER> named coronavirus disease <NUMBER> covid <NUMBER> <NUMBER> around <NUMBER> similar genetic sequence <NUMBER> pandemic severe acute respiratory syndrome coronavirus sarscov <NUMBER> fever dry cough fatigue identified common symptoms infections well prolonged prothrombin time lymphopenia identified common characteristics infections <NUMBER> transmission route covid<NUMBER> humans bat intermediate host transmission still research <NUMBER> virus used intermediate host acquire series genetic mutations infect humans effectively <NUMBER> local transmission covid<NUMBER> occurred respiratory droplets saliva feces urine infected individuals <NUMBER> march <NUMBER> officially declared global pandemic <NUMBER> <NUMBER>st april <NUMBER> <NUMBER> million deaths covid<NUMBER> reported among <NUMBER> million confirmed cases globally <NUMBER> several clinical studies reported cardiovascular diseases cvd common cause comorbidity patients covid<NUMBER> also proportion patients became critically ill dead <NUMBER> besides disease associated cvd complications <NUMBER> cvd complications significant contributor mortality among patient disease awareness emergency clinicians becoming vital <NUMBER> studies also reported higher risk diabetic individual get infected sarscov<NUMBER> article part topical collection covid<NUMBER> virus complications may die disease <NUMBER> study tried cover association covid<NUMBER> infection individuals cvd dm related complications associated covid<NUMBER> infection covid<NUMBER> preexisting cvd severe symptoms covid<NUMBER> common patients preexisting cvd became infected therefore large proportion deaths covid<NUMBER> resulted among patients <NUMBER> metaanalysis <NUMBER> patients covid<NUMBER> showed patients cardiac disease <NUMBER> hypertension <NUMBER> likely require intensive care <NUMBER> another study conducted <NUMBER> patients covid<NUMBER> showed fatality rate nearly fivefold higher patients preexisting cvd compared patients without cvd <NUMBER> vs <NUMBER> <NUMBER> study <NUMBER> patients wuhan china <NUMBER> patients comorbidity <NUMBER> died <NUMBER> hypertension <NUMBER> died <NUMBER> cvd <NUMBER> died <NUMBER> similar findings suggested studies high risk mortality patients preexisting cvd <NUMBER> <NUMBER> <NUMBER> <NUMBER> studies reported patients hypertension cvd higher expression angiotensinconverting enzyme<NUMBER> ace<NUMBER> could potential reason enhancing susceptibility patients sarscov<NUMBER> possible mechanistic pathway severity covid<NUMBER> cvd fig <NUMBER> <NUMBER> alongside patients cvd likely hypercoagulability due increase level ddimer increases risk pulmonary embolism therefore hypoxia heart failure <NUMBER> also patients acute coronary syndrome acs reduced cardiac function observed leading myocardial ischemia might act factor worsen condition patients covid<NUMBER> may lead death <NUMBER> angiotensinconverting enzyme <NUMBER> ace<NUMBER> membranebound aminopeptidase identified functional receptor sarscov<NUMBER> <NUMBER> spike protein sarscov<NUMBER> binds ace<NUMBER> trigger infection highly expressed lungs heart <NUMBER> angiotensin ii converted angiotensin ace responsible vasoconstriction increased blood pressure vascular remodeling clinical observation revealed significant elevation plasma angiotensin ii patient covid<NUMBER> suggests binding covid<NUMBER> ace<NUMBER> causes release excessive angiotensin ii reninangiotensin system ras increasing heart loading cardiomyocyte hypertrophy high blood pressure <NUMBER> invasion virus lung surface cells cardiomyocytes causes inflammation release proinflammatory cytokines interleukin il <NUMBER> tumor necrosis factor interferon endothelial adhesive factor granulocytes colonystimulating factor chemoattractant protein <NUMBER> overactivating immune response body increased apoptosis myocardial cells enhance risk cardiovascular events <NUMBER> besides activity proinflammatory cytokines myocardial dysfunction could caused severe lung failure infection reduced amount oxygen supply hypoxemia <NUMBER> study performed <NUMBER>yearold white women without previous history cvd admitted hospital covid<NUMBER> infection found severe left ventricular dysfunction <NUMBER> increased levels cardiac troponin observed patient identified sensitive marker myocardial injury cardiac magnetic resonance imaging mri analysis showed diffuse edema acute myocarditis moreover study suggests onset symptoms couple days influenzalike syndrome indicates potential myocyte dissemination virus therefore onset heart failure <NUMBER> association covid<NUMBER> infection myocardial injury first reported wuhan china study <NUMBER> patients disease among <NUMBER> patients high sensitivity troponin threshold <NUMBER> pgml <NUMBER> according report national health commission china patients died covid<NUMBER> <NUMBER> without prior cvd furthermore patients substantial heart damage elevated level troponin virus infections influenza parvovirus b<NUMBER> described one common causes myocarditis <NUMBER> though exact mechanism behind myocardial injury induced sarscov<NUMBER> fully understood previous report revealed presence sarscov genome heart <NUMBER> patients infection raises possibility direct damage cardiomyocytes virus <NUMBER> sarscov sarscov<NUMBER> highly homologous genome may pathophysiology mechanism suggests direct myocardial involvement via ace<NUMBER> <NUMBER> studies also report cytokine storm patients covid<NUMBER> due imbalance subtypes helper cells may contribute myocardial injury <NUMBER> study reported heart failure initial presentation covid<NUMBER> <NUMBER> patients cardiomyopathy <NUMBER> patients <NUMBER> according another study <NUMBER> patients heart failure nearly half patients known history cvd hypertension heart failure could occur due exacerbation prior left ventricular dysfunction occurrence new cardiomyopathy patients remains unclear <NUMBER> due excessive inflammation immobilization diffuse intravascular coagulation dic covid<NUMBER> may lead venous thromboembolism <NUMBER> studies revealed significant abnormalities coagulation pathway patients covid<NUMBER> along elevated ddimer <NUMBER> study performed <NUMBER> intensive care unit icu patients covid<NUMBER> pneumonia patients received standard dose thromboprophylaxis despite regular systemic thrombosis prophylaxis <NUMBER> patients thrombotic complications remarkably high <NUMBER> confirmed venous thromboembolic event vte <NUMBER> study suggests anticoagulation therapy low molecular weight heparin may reduce mortality patients severe covid<NUMBER> infection <NUMBER> cardiac arrhythmia another cardiovascular complication patients covid<NUMBER> infection <NUMBER> study revealed presence cardiac arrhythmias <NUMBER> hospitalized <NUMBER> icu patients infected covid<NUMBER> <NUMBER> however high prevalence cardiac arrhythmias may arise hypoxia abnormal metabolism neurohormonal inflammatory stress induced covid<NUMBER> infection studies suggest covid<NUMBER>infected individuals dm higher risk developing complications including death <NUMBER> though association diabetes covid<NUMBER>induced severe disease clear yet <NUMBER> however covid<NUMBER>infected individuals diabetes shown three times fatality rate <NUMBER> compared without diabetes <NUMBER> reported chinese centre disease studying <NUMBER> covid<NUMBER> cases <NUMBER> individuals dm susceptible infections especially influenza pneumonia therefore pneumococcal annual influenza vaccination recommended individuals diabetes <NUMBER> years age <NUMBER> compromised immune system particularly innate immunity <NUMBER> also innate immunity may affected temporarily transient hyperglycemia response infection numerous factors hyperglycemia altered production cytokine impaired cellmediated immune response inhibition neutrophil chemotaxis ineffective microbial clearance phagocytic cell dysfunction may contribute immune dysfunction diabetic individuals possible mechanistic pathway severity covid<NUMBER> dm fig <NUMBER> <NUMBER> hypothesis suggests ace<NUMBER> may play vital role severity covid<NUMBER> infection diabetic individuals virus utilize ace<NUMBER> invading host pneumocytes <NUMBER> ace<NUMBER> also expressed pancreatic tissue <NUMBER> alongside individuals diabetes shown elevated levels proinflammatory cytokine especially il<NUMBER> il<NUMBER> tumor necrosis factorα tnfα different markers creactive protein ddimer fibrinogen may prolong cytokine storms lead severe illness diabetic individuals covid<NUMBER> infection role markers covid<NUMBER> induce dm fig <NUMBER> <NUMBER> significant increase infection replication influenza virus pulmonary endothelial cells exposed elevated concentration glucose vitro indicating increased viral replication hyperglycemic condition therefore hyperglycemia may also play role pathogenesis prognosis respiratory viral diseases though study needed conclude matter <NUMBER> elevated levels glucose may also suppress immune response virus according experimental data glycemic control beneficial clinically patients diabetes respiratory viral infection like covid<NUMBER> <NUMBER> sarscov<NUMBER> virus attaches ace<NUMBER> enzyme low cytosolic ph invades cell leading infection <NUMBER> angiotensin ii strong role ph alkalizing angiotensinconverting enzyme inhibitor acei angiotensin receptor blockers arbs reduce levels angiotensin ii cause low cytosolic ph <NUMBER> therefore diabetes patients treated acei arbs shown elevated expression ace<NUMBER> people higher chance develop severe fetal covid<NUMBER> infection <NUMBER> study reported hypoglycemia <NUMBER>yearold patient type <NUMBER> diabetes treated chloroquine phosphate <NUMBER> mg <NUMBER> consecutive weeks <NUMBER> use chloroquine frequent covid<NUMBER>infected patients therefore infected patients type <NUMBER> diabetes monitored closely hypoglycemia could associated increased risk mortality patients previous study sarscov patients without previous diabetes demonstrated pancreatic damage <NUMBER> patients leading acute type <NUMBER> diabetes mellitus hospitalization <NUMBER> may also possible patients covid<NUMBER> infection though evidence required conclude alongside dipeptidyl peptidase<NUMBER> dpp<NUMBER> shown primary receptor merscov chance dpp<NUMBER> receptor may act receptor covid<NUMBER> infection important explore dpp<NUMBER> inhibitors widely used treatment diabetes mellitus <NUMBER> individuals prior cvd diabetes higher risk develop severe covid<NUMBER> infection alongside development cvd complications mostly myocardial injury cardiomyopathy venous thromboembolism cardiac arrhythmias among individuals without prior cvd also emerging concern diabetic individuals medications acei arbs chloroquine dpp<NUMBER> inhibitors using issues also arise study predicts use could worsen conditions patients covid<NUMBER> call careful use medications diabetic individuals infection lastly number infections increasing day day quite predictable increase number complicated cases well therefore medical professional needs aware prepare managing emergencies effectively funding information receive financial support organizations conflict interest authors declare conflict interest ethical approval required informed consent informed consent necessary clinical spectrum coronavirus disease <NUMBER> caused novel coronavirus named severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> ranges asymptomatic presentation mild upper respiratory symptoms severe pneumonia respiratory failure acute respiratory distress syndrome ards death due sepsis septic shock <NUMBER> although commonly reported flulike symptoms fever fatigue headache sore throat coughing dyspnea gastrointestinal symptomatology frequently encountered clinical practice representing covid<NUMBER> patients chief complaint cases <NUMBER> addition progressive diffuse vascular derangement represents major threat severe covid<NUMBER> presentation histological evidence endothelial inflammation congestion thrombosis several internal organs including heart kidneys lungs liver intestines <NUMBER> postmortem studies underlined luminal mural fibrin deposition pulmonary septal capillaries disseminated microvascular injury reminiscent thrombotic microangiopathies distinct features <NUMBER> <NUMBER> addition consistent inflammationinduced procoagulant shift endothelial cells clinical course covid<NUMBER> occasionally worsened deep vein thrombosis pulmonary embolism <NUMBER> based current available evidence patients diabetes expected enhanced disease severity increased risk admitted intensive care unit icu respiratory failure multiorgan dysfunction following sarscov<NUMBER> infection <NUMBER> <NUMBER> compared patients receive icu care larger fraction icu patients covid<NUMBER> found underlying diabetes <NUMBER> vs <NUMBER> <NUMBER> presumably type <NUMBER> t<NUMBER>d <NUMBER> preliminary observations hubei chinese province outbreak began also recently corroborated lombardy intensive care unit icu network found t<NUMBER>d fourth common comorbidity among <NUMBER> critically ill patients admitted icu covid<NUMBER> <NUMBER> patients <NUMBER> spread epidemic northern italy across europe <NUMBER> even relevant onethird covid<NUMBER> patients dying italy t<NUMBER>d <NUMBER> congruous independent association condition fatal complications two coronavirusrelated respiratory infection epidemics severe acute respiratory syndrome sars <NUMBER> middle east respiratory syndrome mers <NUMBER> <NUMBER> given extremely high global prevalence diabetes affecting <NUMBER> million adults worldwide still rise accordance last international diabetes federation idf atlas <NUMBER> covid<NUMBER> pandemic represents serious threat large vulnerable population intensive supportive care plus optimum pharmacological management critical address clinical course covid<NUMBER> prevent fatal outcomes herein provide brief narrative overview mechanisms potential benefits safety issues novel classes antidiabetic drugs covid<NUMBER> crisis focus infectious outcomes dipeptidylpeptidase <NUMBER> dpp<NUMBER> inhibitors also known gliptins represent relatively new class oral antidiabetic agents block inactivation distal gutderived insulinotropic hormone glucagonlike peptide <NUMBER> glp<NUMBER> positively affecting glucose control minimal risk hypoglycemia drugs gained popularity secondline option managing t<NUMBER>d due favorable side effect profile competitive costs <NUMBER> date five dpp<NUMBER> inhibitors available european market including sitagliptin saxagliptin linagliptin alogliptin vildagliptin specific pharmacodynamic pharmacokinetic properties potentially relevant implications patients affected liver kidney disease notwithstanding comparable glycemic efficacy inhibition dpp<NUMBER> activity <NUMBER> according mechanistic studies dpp<NUMBER> formerly known tcell antigen cd<NUMBER> multifunctional soluble cellbound serine protease abundantly expressed lymphocytes adipocytes well many cell types including endothelial epithelial cells plays critical roles modulation glucose homeostasis inflammatory responses <NUMBER> interestingly dpp<NUMBER> identified functional receptor human coronaviruserasmus medical center hcovemc <NUMBER> virus responsible mers genetically close sarscov<NUMBER> addition antibodies directed dpp<NUMBER> could impair hcovemc infection primary human bronchial epithelial cells <NUMBER> observation s<NUMBER> domain sarscov<NUMBER> spike glycoprotein interacts host receptor protein dpp<NUMBER> <NUMBER> <NUMBER> raised hypothesis sarscov<NUMBER> may use dpp<NUMBER> functional receptor gain entry host addition welldocumented angiotensinconverting enzyme <NUMBER> ace<NUMBER> <NUMBER> although direct involvement dpp<NUMBER> modulation sarscov<NUMBER> entry denied stably transfected human embryonic <NUMBER>t cell line <NUMBER> computational evidence <NUMBER> raised speculation questions whether targeting one potential host determinants virulence dpp<NUMBER> inhibitors would useful attenuating covid<NUMBER> infection viral exposure <NUMBER> <NUMBER> especially patients t<NUMBER>d typically depicted pathogenic dysregulation dpp<NUMBER> expression <NUMBER> apart antihyperglycemic effect related proteasedependent modulation enteroinsular axis dpp<NUMBER> inhibitors possess unique immunomodulatory therapeutic potential autoimmune rheumatological disorders <NUMBER> <NUMBER> cancer <NUMBER> remarkably mers <NUMBER> targeting dpp<NUMBER> inflect natural viral dynamics thus suggested pharmacologically reasonable strategy case covid<NUMBER> well severe respiratory diseases related coronaviruses <NUMBER> <NUMBER> interestingly rheumatological disorders severe covid<NUMBER> share overproduction nfkbdependent proinflammatory cytokines mediators il<NUMBER> il<NUMBER> tnfα common key pathogenetic mechanism <NUMBER> <NUMBER> blockade il<NUMBER> receptors tocilizumab humanized igg<NUMBER> monoclonal antibody commonly used patients rheumatoid arthritis currently investigation patients severe covid<NUMBER> pneumonia whereas inhibition il<NUMBER> release hydroxychloroquine firstline diseasemodifying antirheumatic drug dmard therapy investigation patients mild moderate covid<NUMBER> prevent disease progression wwwaifagovit addition immunomodulant antiinflammatory effects hydroxychloroquine interfere glycosylation sarscov<NUMBER> spike proteins ace<NUMBER> receptors blocking vitro experimental models viral entry <NUMBER> empiric prophylactic use among patients healthcare workers high risk infection recently advocated indian council medical research httpsicmrnicincontentcovid <NUMBER> also noteworthy infection progression sarscov<NUMBER> decreases activity expression ace<NUMBER> <NUMBER> primary component alternate reninangiotensin system ras counteracts angiotensin ii angii unbalanced angii activity indicated critical driver severe covid<NUMBER> manifestations lungs organs <NUMBER> regard dpp<NUMBER> inhibitors could interfere ras system reduce angii levels thereby ameliorating hypertension comorbid cardiac remodeling experimental animal models <NUMBER> however despite plausible pharmacological rationale validation drugs originally different therapeutic indications preventing treating covid<NUMBER> challenging even case dpp<NUMBER> inhibitors current computational preclinical evidence suffice date may <NUMBER> neither data available regarding clinical demographic characteristics people diabetes developing severe covid<NUMBER> complications know whether background glycemic levels antidiabetic therapies might role epidemiological experimental clinical research programs comprehensibly difficult pandemic many possible barriers including risk infection healthcare workers research staff deployment provide clinical care <NUMBER> metanalysis evidenced treatment dpp<NUMBER> inhibitors increase overall risk respiratory infections respect placebo conventional oral antidiabetic comparators metformin sulfonylureas thiazolidinediones <NUMBER> <NUMBER> ci <NUMBER> <NUMBER> although subgroup analysis performed concerning relationships specific viral pathogens <NUMBER> recently large prospective cohort study france evidenced inverse association diabetes noninfluenza respiratory virus illnesses course three flu seasons <NUMBER> study ended covid<NUMBER> pandemic however hospitalized patients flulike symptoms tested positive noninfluenza respiratory viruses including coronavirus <NUMBER>e less likely diabetes patients infected seasonal influenza viruses <NUMBER> vs <NUMBER> unfortunately background information medication use assessed study except immunosuppressive drugs <NUMBER> therefore whether specific antidiabetic medications would prevented noninfluenza respiratory virusrelated hospitalization patients diabetes remains uncertain interestingly regardless viral strain coronavirus infections counteracted submucosal mast cells respiratory tract forefront part innate immunity response <NUMBER> endothelial transmigration mast cells control stromal derived factor <NUMBER> sdf<NUMBER> cleaved inactivated dpp<NUMBER> <NUMBER> <NUMBER> dosedependent ability selectively induce production il<NUMBER> proinflammatory mediators mast cells sdf<NUMBER> orchestrates leukocyte recruitment vascular remodeling context arteriogenesis could boosted dpp<NUMBER> blockage experimental animal models <NUMBER> <NUMBER> addition increased plasmatic levels sdf<NUMBER> associated maturation migration leukocytes mucosal compartments immune responsedependent abortion human immunodeficiency virus <NUMBER> hiv<NUMBER> infection <NUMBER> intriguing question could raised whether dpp<NUMBER> inhibitorrelated augmentation sdf<NUMBER> levels mast cells mucosal entry sites would confer resistance sarscov<NUMBER> coronaviruses regard evidence suggests neutralizing pathogens mast cells release antiviral cytotoxic mediators circumstances aggravate clinical course disease <NUMBER> dual effects mast cells viral infections could introduce arguments controversies debate use dpp<NUMBER> inhibitors potential protective strategy severe covid<NUMBER> manifestations <NUMBER> downregulation inhibition dpp<NUMBER> activity mers hiv<NUMBER> demonstrated <NUMBER> date indication binding sarscov<NUMBER> would lead similar effects addition concerning covid<NUMBER> related vascular damage noted contrast preclinical evidence human studies shown either neutral <NUMBER> detrimental <NUMBER> effect dpp<NUMBER> blockage endothelial function setting diabetes figure <NUMBER> summarizes potential benefits harms dpp<NUMBER> inhibitors covid<NUMBER> outcomes mast cells viral infections could introduce arguments controversies debate use dpp<NUMBER> inhibitors potential protective strategy severe covid<NUMBER> manifestations <NUMBER> downregulation inhibition dpp<NUMBER> activity mers hiv<NUMBER> demonstrated <NUMBER> date indication binding sarscov<NUMBER> would lead similar effects addition concerning covid<NUMBER> related vascular damage noted contrast preclinical evidence human studies shown either neutral <NUMBER> detrimental <NUMBER> effect dpp<NUMBER> blockage endothelial function setting diabetes figure <NUMBER> summarizes potential benefits harms dpp<NUMBER> inhibitors covid<NUMBER> outcomes sodiumglucose cotransporter <NUMBER> sglt<NUMBER> inhibitors also known gliflozins last class antidiabetic drugs approved us food drugs european regulatory agencies fda ema respectively treatment t<NUMBER>d <NUMBER> four sglt<NUMBER> inhibitors currently available european market namely canagliflozin dapagliflozin empagliflozin ertugliflozin comparable glycemic efficacy despite differences terms selectivity toward sglt<NUMBER> <NUMBER> concerning pharmacological mechanism action sglt<NUMBER> inhibitors suppress renal glucose reabsorption enhance urinary glucose excretion insulinindependent manner therefore suitable patients marked decline βcell function autoimmune inflammatory processes including pancreatitis cystic fibrosis hemochromatosis thereby allowing offlabel prescriptions common practice <NUMBER> <NUMBER> clinical trials postmarketing surveillance drawn attention increased risk genitourinary infections volume depletion accompanying use sglt<NUMBER> inhibitors presence diabetes <NUMBER> yet utmost significance time covid<NUMBER> pandemic exceptional risk diabetic ketoacidosis dka associated sglt<NUMBER> inhibitors among vulnerable patient categories longstanding t<NUMBER>d patients marked βcell insufficiency patients autoimmune diabetes intercurrent illness <NUMBER> dka potentially lifethreatening metabolic complication diabetes may occur consequence absolute relative insulin deficiency typically characterized hyperglycemia <NUMBER> mgdl generally <NUMBER> mgdl ketosis plasma βhydroxybutyrate <NUMBER> mmoll acidosis ph <NUMBER> <NUMBER> related sglt<NUMBER> inhibition dka may even deceitful euglycemic presentation <NUMBER> mgdl sodiumglucose cotransporter <NUMBER> sglt<NUMBER> inhibitors also known gliflozins last class antidiabetic drugs approved us food drugs european regulatory agencies fda ema respectively treatment t<NUMBER>d <NUMBER> four sglt<NUMBER> inhibitors currently available european market namely canagliflozin dapagliflozin empagliflozin ertugliflozin comparable glycemic efficacy despite differences terms selectivity toward sglt<NUMBER> <NUMBER> concerning pharmacological mechanism action sglt<NUMBER> inhibitors suppress renal glucose reabsorption enhance urinary glucose excretion insulinindependent manner therefore suitable patients marked decline βcell function autoimmune inflammatory processes including pancreatitis cystic fibrosis hemochromatosis thereby allowing offlabel prescriptions common practice <NUMBER> <NUMBER> clinical trials postmarketing surveillance drawn attention increased risk genitourinary infections volume depletion accompanying use sglt<NUMBER> inhibitors presence diabetes <NUMBER> yet utmost significance time covid<NUMBER> pandemic exceptional risk diabetic ketoacidosis dka associated sglt<NUMBER> inhibitors among vulnerable patient categories longstanding t<NUMBER>d patients marked βcell insufficiency patients autoimmune diabetes intercurrent illness <NUMBER> dka potentially lifethreatening metabolic complication diabetes may occur consequence absolute relative insulin deficiency typically characterized hyperglycemia <NUMBER> mgdl generally <NUMBER> mgdl ketosis plasma βhydroxybutyrate <NUMBER> mmoll acidosis ph <NUMBER> <NUMBER> related sglt<NUMBER> inhibition dka may even deceitful euglycemic presentation <NUMBER> mgdl increased urinary loss glucose mitigates hyperglycemia <NUMBER> recently fda raised warning realworld offlabel use sglt<NUMBER> inhibitors among patients autoimmune diabetes given association dka incidence rate <NUMBER> personyears <NUMBER>fold higher would expected based clinical trial data peak <NUMBER> personyears young adult women <NUMBER> years age <NUMBER> extremely high dka incidence young women autoimmune diabetes may related distorted eating attitudes behaviors anxiety body weight size lower adherence toward insulin replacement therapy frequently observed particular population <NUMBER> however noted sexual dimorphism also exists genitourinary side effects sglt<NUMBER> inhibitors <NUMBER> represent potential precipitating factors dka along respiratory gastrointestinal infections covid<NUMBER> <NUMBER> severe covid<NUMBER> outcomes including lethality appear less frequent women <NUMBER> <NUMBER> probably due sexbased immunological responses <NUMBER> although discrepancies smoking habits <NUMBER> prevalence hypertension specific multimorbidity combinations <NUMBER> contrast intrinsic vulnerability pregnancy status <NUMBER> might less important light whether female gender would still favorable impact severe covid<NUMBER> outcomes presence diabetes remains defined gender bias could avoided providing medical care covid<NUMBER> may increase insulin demand induce fever nausea anorexia consequent hyperketonemia accentuates gastrointestinal symptoms infection vicious cycle metabolic decompensation toward dka either hyperglycemic euglycemic susceptible diabetic patients sglt<NUMBER> inhibitors exacerbated volume depletion persistent glycosuria initial symptoms covid<NUMBER> illness patients offlabel prescription longlasting t<NUMBER>d severe βcell insufficiency requiring insulin therapy temporarily stop sglt<NUMBER> inhibitor contact medical provider monitor capillary blood ketones take supplemental boluses rapid insulin along liquids carbohydrates full episode covid<NUMBER>related dka successfully prevented measures nevertheless recognized pharmacological effects sglt<NUMBER> inhibitor treatment may persist beyond several halflives elimination patients still require hospitalization dka even stopping sglt<NUMBER> inhibitor glycosuria ketonemia persisting <NUMBER> days <NUMBER> glp<NUMBER> receptor agonists glp<NUMBER> ras also known incretinmimetics provide pharmacologic levels exogenous glp<NUMBER> analogously endogenous gutderived incretin hormones improve glucose homeostasis enhanced glucosedependent insulin secretion delayed gastric emptying increased postmeal satiety <NUMBER> <NUMBER> providing additional benefit weight loss glp<NUMBER> ras represent preferable secondline option patients obesity inadequately controlled t<NUMBER>d adjunct lifestyle interventions metformin <NUMBER> addition due claimed protective effects cardiovascular outcome clinical trials glp<NUMBER> ras sglt<NUMBER> inhibitors recently endorsed american diabetes association appropriate secondline treatment t<NUMBER>d patients established atherosclerotic cardiovascular disease ascvd high related risk ≥<NUMBER> years age coronary carotid lowerextremity artery stenosis <NUMBER> left ventricular hypertrophy irrespective glycemic levels <NUMBER> date several glp<NUMBER> ras different halflives pharmacokinetics properties licensed europe subcutaneous administration twicedaily exenatide oncedaily liraglutide lixisenatide onceweekly dulaglutide albiglutide semaglutide <NUMBER> whereas daily preparation semaglutide oral administration forthcoming wwwemaeuropaeu similar dpp<NUMBER> inhibitors systemic antiinflammatory effects associated use glp<NUMBER> ras patients t<NUMBER>d consequence inhibitory activity cytokine release due interference nfkb signaling pathways <NUMBER> animal models sepsis administration liraglutide proved improve survival vascular dysfunction along inflammatory hemostatic parameters <NUMBER> addition given contribution glp<NUMBER> receptors airway remodeling <NUMBER> several clinical trials underway address theoretical potential glp<NUMBER> ras amelioration chronic obstructive respiratory diseases even relevant animal studies glp<NUMBER> ra liraglutide associated upregulation ace<NUMBER> cellbound protease abundantly expressed alveolar epithelial cells enterocytes vessels upstream counterregulatory ras pathway exerts negative effect inflammatory fibrotic processes <NUMBER> although still unsupported clear translational evidence glp<NUMBER> rasinduced upregulation ace<NUMBER> could ameliorate lung injury covid<NUMBER> antagonizing reduction ace<NUMBER> expression levels hallmarks infection progression <NUMBER> <NUMBER> preventing overactivated immune response critical ards <NUMBER> hand ace<NUMBER> enables virus entry host target cells <NUMBER> <NUMBER> <NUMBER> raising speculation increased susceptibility covid<NUMBER> infection case ace<NUMBER> overregulation consequence longterm treatment ace inhibitors andor angii receptor blockers glp<NUMBER> ras combination hypertensive patients diabetes <NUMBER> ex vivo vitro demonstrations viral particle aggregates within human kidney endothelial cells <NUMBER> engineered blood vessel organoids <NUMBER> suggest sarscov<NUMBER> virus could target endothelium via locally expressed surface receptor ace<NUMBER> triggering systemic vascular dysfunction shifts vascular balance towards inflammation hypercoagulability leading multiorgan failure critical cases <NUMBER> <NUMBER> however date robust clinicalepidemiological studies put forward concerning correlation medications use covid<NUMBER> severity adjusting potential confounding variables sex age comorbidities possibly affecting ace<NUMBER> expression patterns issue whether treatmentinduced overregulation ace<NUMBER> target tissues would lead increased risk sarscov<NUMBER> infection pulmonaryprotective activity would prevail yet solved hence current position statements council hypertension european society cardiology wwwescardioorg clarify ace inhibitors angiotensin ii receptor blockers continued prescribed according previously established guidelines time despite experts suggestions reconsider diabetes management casebycase basis view patient setting clinical judgment <NUMBER> <NUMBER> specific recommendations initiation use glp<NUMBER> ras covid<NUMBER> pandemic provided diabetes specialists par abovementioned antihypertensive drugs believe reason supported evidence contraindicate vice versa overpromote glp<NUMBER> ras managing people t<NUMBER>d however urgent need determine whether use influence clinical course covid<NUMBER> regard remarked <NUMBER> current evidence glp<NUMBER> ras dpp<NUMBER> inhibitors critically ill diabetic patients covid<NUMBER> complications inadequate make therapeutic recommendations insulin therapy safely sustained preferred option managing diabetes different note retain special consideration also paid eventuality gastrointestinal symptoms related glp<NUMBER> ras patients recover covid<NUMBER> nausea vomiting diarrhea reported <NUMBER> <NUMBER> <NUMBER> respectively diabetic patients glp<NUMBER> ras <NUMBER> usually gastrointestinal disorders arise first weeks treatment pronounced background metformin insulin therapy <NUMBER> however metformin directly elicit mild gastrointestinal intolerance correlation insulin therapy may underline longstanding t<NUMBER>d poor glycemic control condition commonly associated impaired gastric motility may accentuate deceleration gastric emptying induced exogenous glp<NUMBER> ras <NUMBER> recently metaanalysis <NUMBER> studies including <NUMBER> patients covid<NUMBER> evidenced anorexia nausea vomiting diarrhea abdominal pain discomfort common manifestations covid<NUMBER> especially severe forms infection requiring hospitalization icu care <NUMBER> <NUMBER> notwithstanding postulated prognostic relevance gastrointestinal symptoms may also accompany course milder forms covid<NUMBER> <NUMBER> <NUMBER> appear associated prolonged illness <NUMBER> given sustained attenuation appetite sensations dietary energy intake coupled gastrointestinal intolerance use glp<NUMBER> ras may delay patient recovery temporary suspension cautiously considered fragile cases figure <NUMBER> summarizes potential benefits harms glp<NUMBER> ras covid<NUMBER> outcomes according recent international panel experts <NUMBER> people diabetes yet infected covid<NUMBER> intensify glycemic control means primary prevention severe illness wellknown fact poorly controlled hyperglycemia impairs immune functions worsens clinical course infections forms diabetes <NUMBER> <NUMBER> addition reference particular case covid<NUMBER> evidenced glycosylation ace<NUMBER> receptors posttranslational reaction boosted hyperglycemia necessary cell entry ace<NUMBER> alone suffice <NUMBER> lowering amount glycosylated ace<NUMBER> antihyperglycemic measures diabetic patients may thus reduce burden sarscov<NUMBER> infection case viral exposure optimize diabetes management previously established international guidelines <NUMBER> <NUMBER> relevance specific national adaptations reimbursement criteria glucoselowering drugs must considered however patients diabetes develop covid<NUMBER> treatment sglt<NUMBER> inhibitors glp<NUMBER> ras deserve careful attention casebycase basis dependent clinical presentation concurrent comorbidities types treatments need discontinued due covid<NUMBER> alternative choice insulin irrespective patient setting <NUMBER> <NUMBER> table <NUMBER> reassumes efficacy safety concerns around novel antidiabetic drugs special reference covid<NUMBER> outcomes according recent international panel experts <NUMBER> people diabetes yet infected covid<NUMBER> intensify glycemic control means primary prevention severe illness wellknown fact poorly controlled hyperglycemia impairs immune functions worsens clinical course infections forms diabetes <NUMBER> <NUMBER> addition reference particular case covid<NUMBER> evidenced glycosylation ace<NUMBER> receptors posttranslational reaction boosted hyperglycemia necessary cell entry ace<NUMBER> alone suffice <NUMBER> lowering amount glycosylated ace<NUMBER> antihyperglycemic measures diabetic patients may thus reduce burden sarscov<NUMBER> infection case viral exposure optimize diabetes management previously established international guidelines <NUMBER> <NUMBER> relevance specific national adaptations reimbursement criteria glucoselowering drugs must considered however patients diabetes develop covid<NUMBER> treatment sglt<NUMBER> inhibitors glp<NUMBER> ras deserve careful attention casebycase basis dependent clinical presentation concurrent comorbidities types treatments need discontinued due covid<NUMBER> alternative choice insulin irrespective patient setting <NUMBER> <NUMBER> table <NUMBER> reassumes efficacy safety concerns around novel antidiabetic drugs special reference covid<NUMBER> outcomes even current practices treating diabetic patients infected sarscov<NUMBER> different general population special care required patients diabetes given greater risk complications inhospital death furthermore novel antidiabetic drugs sglt<NUMBER> inhibitors glp<NUMBER> ras routinely employed t<NUMBER>d management may exacerbate clinical expression covid<NUMBER> thus stopped fragile patients conversely although univocal evidence suggests dpp<NUMBER> inhibitors may retain potential preventing andor mitigating clinical course covid<NUMBER> considering minimal risk upon use relatively long experience easy availability worldwide dpp<NUMBER> inhibitors might taken account clinical use experimental drugs however order justify either overpromotion offlabel use drug class reliable unbiased observational research addressing clinical outcomes predictors case sarscov<NUMBER> exposure fundamental prerequisite patient generalization applied setting diabetes funding publication cofinanced support european commission fesr fse <NUMBER> regione calabria european commission regione calabrias support production publication constitute endorsement contents reflect views authors cannot held responsible use may made information contained therein authors declare conflict interest new coronavirus severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> infection began spread wuhan china early december <NUMBER> rapidly spread around globe disease condition associated novel coronavirus referred coronavirus disease <NUMBER> covid <NUMBER> outbreak declared pandemic march <NUMBER> <NUMBER> world health organization <NUMBER> may <NUMBER> <NUMBER> outbreak reached globally <NUMBER> confirmed cases <NUMBER> deaths <NUMBER> patients recovered <NUMBER> numbers much greater <NUMBER> despite fact covid<NUMBER> mortality rate date lower <NUMBER> <NUMBER> sarscov<NUMBER> binds mainly angiotensin converting enzyme <NUMBER> ace<NUMBER> receptors host cells abundant lungs heart blood vessels intestine decade research still specific treatments effective vaccines coronavirus <NUMBER> <NUMBER> <NUMBER> <NUMBER> covid<NUMBER> presents respiratory symptoms mild severe significant percentage patients develop acute respiratory disease syndrome ards severe symptoms associated true cytokine storm particular il<NUMBER> death one outcomes <NUMBER> old age underlying morbidities cardiovascular diseases particular hypertension metabolic disorders obesity diabetes identified significant risk factors covid<NUMBER> morbidity mortality <NUMBER> <NUMBER> <NUMBER> however asthma copd may common comorbidities <NUMBER> moreover real impact sarscov<NUMBER> asthma control unclear systematic search carried following <NUMBER> electronic databases embase medline medrxiv scopus assess relationship asthma covid<NUMBER> using studies english language may <NUMBER> <NUMBER> search terms included covid<NUMBER> sarscov<NUMBER> coronavirus asthma allergy case series comorbidities epidemiology hospitalization risk factors additionally references initial included studies hand searched identify possibly eligible studies results first epidemiologic studies covid<NUMBER> pandemic china apparently identify asthma risk factor severe covid<NUMBER> <NUMBER> <NUMBER> <NUMBER> children treated wuhan childrens hospital wuhan china <NUMBER> <NUMBER> required intensive care mechanical ventilation underlying diseases asthma reference <NUMBER> data found crosssectional multicenter study carried <NUMBER> hospitals across hubei province china including hospitalized children covid<NUMBER> <NUMBER> table <NUMBER> dong et al <NUMBER> china nationwide case series <NUMBER> pediatric patients mean age <NUMBER> years covid<NUMBER> observed cases chinese center disease control prevention january <NUMBER> <NUMBER> february <NUMBER> <NUMBER> hubei province report asthma case survey <NUMBER> adult patients admitted covid<NUMBER> china clinical characteristics allergy status patients investigated patients communityacquired cases hypertension <NUMBER> diabetes mellitus <NUMBER> common comorbidities drug hypersensitivity <NUMBER> urticaria <NUMBER> selfreported several patients asthma allergic diseases reported patients authors concluded allergic diseases asthma risk factors sarscov<NUMBER> infection older age high number comorbidities ie cardiovascular metabolic diseases associated covid<NUMBER> severity <NUMBER> authors studied larger sample <NUMBER> confirmed covid<NUMBER> adult patients hospitalized found <NUMBER> patient asthma <NUMBER> hypertension diabetes mellitus frequently found comorbidities <NUMBER> another retrospective multicenter cohort study included <NUMBER> adult inpatients confirmed covid<NUMBER> wuhan china <NUMBER> least <NUMBER> comorbid disease hypertension common followed diabetes coronary heart dis ease asthma reference <NUMBER> survey <NUMBER> adult patients admitted covid<NUMBER> tongji hospital wuhan china asthma prevalence rate <NUMBER> found markedly lower adult population region <NUMBER> <NUMBER> study asthma identified risk factor disease severity contrast hypertension <NUMBER> nationwide analysis china <NUMBER> including <NUMBER> covid<NUMBER> cases <NUMBER> hospitals <NUMBER> provincial administrative regions reported overall rate severe cases mortality <NUMBER> <NUMBER> respectively prevalent comorbidity hypertension <NUMBER> followed diabetes <NUMBER> one hundred thirty <NUMBER> patients reported <NUMBER> comorbidities none cases physiciandiagnosed asthma adjusting age smoking status copd hr <NUMBER> <NUMBER> ci <NUMBER> diabetes hr <NUMBER> <NUMBER> ci <NUMBER> hypertension hr <NUMBER> <NUMBER> ci <NUMBER> malignancy hr <NUMBER> <NUMBER> ci <NUMBER> identified significant severity risk factors including intensive care unit icu admission mechanical ventilation death <NUMBER> europe sample <NUMBER> patients covid<NUMBER> died italy mean age <NUMBER> years reported comorbidities associated increased mortality risk thirty percent patients ischemic heart disease <NUMBER> diabetes <NUMBER> active cancer <NUMBER> atrial fibrillation <NUMBER> dementia <NUMBER> history stroke reference chronic respiratory diseases made ie asthma chronic obstructive pulmonary disease copd <NUMBER> also retrospective case series <NUMBER> consecutive patients laboratoryconfirmed covid<NUMBER> admitted icu <NUMBER> hospitals lombardy region italy february <NUMBER> march <NUMBER> <NUMBER> <NUMBER> patients least <NUMBER> comorbidity hypertension common comorbidity affecting <NUMBER> <NUMBER> patients available data second common comorbidities cardiovascular disease <NUMBER> hypercholesterolemia <NUMBER> <NUMBER> history copd reference patients asthma <NUMBER> confidence study <NUMBER> included <NUMBER> pediatric covid<NUMBER> cases also italy median age <NUMBER> years <NUMBER> mild disease <NUMBER> severe disease reference chronic respiratory diseases found previous pediatric chinese surveys lu et al <NUMBER> dong et al <NUMBER> borobia et al <NUMBER> la paz university hospital madrid spain sample <NUMBER> adult patients median age <NUMBER> years admitted hospital either died <NUMBER> discharged <NUMBER> identified common comorbidity hypertension <NUMBER> followed chronic cardiovascular diseases <NUMBER> diabetes <NUMBER> asthma identified <NUMBER> covid<NUMBER> patients lower prevalence rate <NUMBER> fatal cases copd affected <NUMBER> population prevalence <NUMBER> fatal cases also spain catalonia prietoalhambra et al <NUMBER> analyzed primary care database covering <NUMBER> million people including <NUMBER> covid<NUMBER> patients hospitalized outpatients common comorbidities hypertension <NUMBER> obesity <NUMBER> asthma present <NUMBER> patients copd found <NUMBER> <NUMBER> patients treated inhalers <NUMBER> covid<NUMBER> patients hospitalized lausanne university hospital switzerland <NUMBER> asthma prevalence rate <NUMBER> found asthma prevalence rate <NUMBER> patients required mechanical ventilation usa bhatraju et al <NUMBER> seattle wa usa reported <NUMBER> patients covid<NUMBER> admitted icu mortality rate <NUMBER> coexisting disorders <NUMBER> diabetes <NUMBER> current former tobacco smokers <NUMBER> chronic kidney disease <NUMBER> asthma corresponding <NUMBER> cases mild asthma treated systemic corticosteroids week icu admission outpatients presumed asthma exacerbation patients subsequently admitted icu severe respiratory failure requiring invasive mechanical ventilation <NUMBER> arentz et al <NUMBER> wausa described case series characteristics outcomes <NUMBER> patients covid<NUMBER> admitted icu evergreen hospital mean age <NUMBER> years range <NUMBER> years common comorbidities identified chronic kidney disease <NUMBER> congestive heart failure <NUMBER> diabetes <NUMBER> copd <NUMBER> two patients asthma <NUMBER> data usa regarding <NUMBER> cases children <NUMBER> years showed <NUMBER> least <NUMBER> comorbidity <NUMBER> chronic respiratory diseases ie asthma common associated diseases although authors quantify prevalence comorbidities frequently present pediatric patients required hospitalization compared admitted hospital <NUMBER> vs <NUMBER> reference asthma significant risk factor <NUMBER> sample <NUMBER> adult covid<NUMBER> patients admitted california usa hospitals <NUMBER> nondiscriminated asthma copd <NUMBER> data analysis patients hospitalized <NUMBER> states usa covid<NUMBER> march <NUMBER> n <NUMBER> <NUMBER> confirmed hospitalization much frequent adults <NUMBER> aged ≥<NUMBER> years among patients information underlying conditions n <NUMBER> <NUMBER> <NUMBER> comorbidities common hypertension cardiovascular diseases <NUMBER> followed obesity <NUMBER> diabetes mellitus <NUMBER> seventeen percent covid<NUMBER>positive patients asthma <NUMBER> copd according centers disease control prevention cdc report admitted patients aged <NUMBER> years obesity prevalent underlying condition <NUMBER> followed asthma <NUMBER> <NUMBER> report <NUMBER> hospitals georgia usa also summarized medical data <NUMBER> adult patients confirmed covid<NUMBER> admitted march <NUMBER> overall <NUMBER> <NUMBER> patients underlying conditions hypertension <NUMBER> diabetes <NUMBER> cardiovascular diseases <NUMBER> found severe obesity bmi ≥<NUMBER> present <NUMBER> patients asthma identified <NUMBER> patients <NUMBER> patients aged <NUMBER> years <NUMBER> aged <NUMBER> years <NUMBER> aged ≥<NUMBER> years statistically significant differences copd <NUMBER> <NUMBER> large sample hospitalized covid patients <NUMBER> adults included <NUMBER> patients hospitalized covid<NUMBER> new york city area ny usa <NUMBER> treated icu <NUMBER> received invasive mechanical ventilation <NUMBER> died <NUMBER> asthma prevalence found <NUMBER> reference asthma severitycontrol copd found <NUMBER> common comorbidities hypertension <NUMBER> obesity <NUMBER> diabetes <NUMBER> <NUMBER> ny mount sinai hospitals <NUMBER> prevalence asthma found <NUMBER> hospitalized patients significantly different died <NUMBER> <NUMBER> also ny usa first <NUMBER> consecutive adult patients positive sarscov<NUMBER> pcr test presented emergency department hosasthma covid<NUMBER> pandemic <NUMBER> int arch allergy immunol doi <NUMBER> pitalized new yorkpresbyteriancolumbia university irving medical center march <NUMBER> april <NUMBER> <NUMBER> asthma prevalence <NUMBER> found also significantly different admitted icu <NUMBER> <NUMBER> isaric prospective observational cohort study <NUMBER> near realtime analysis participation <NUMBER> uk hospitals <NUMBER> covid<NUMBER> hospitalized patients included february <NUMBER> april <NUMBER> <NUMBER> mostly adults commonest comorbidities chronic cardiac disease <NUMBER> uncomplicated diabetes <NUMBER> nonasthmatic chronic pulmonary disease <NUMBER> asthma <NUMBER> <NUMBER> documented reported comorbidity increased age comorbidities including obesity associated higher probability mortality <NUMBER> recent data opensafely collaborative study <NUMBER> identified asthma significant risk factor death covid<NUMBER> england uk authors conducted cohort study included <NUMBER> adults using national primary care electronic health record data linked inhospital covid<NUMBER> death data february <NUMBER> <NUMBER> april <NUMBER> <NUMBER> older age age strongly associated risk age group ≥<NUMBER> years <NUMBER>fold increased risk compared aged <NUMBER> years comorbidities associated higher risk covid<NUMBER> hospital death including asthma fully adjusted hr <NUMBER> <NUMBER> <NUMBER> greater hr recent use oral corticosteroid ocs hr <NUMBER> <NUMBER> ci <NUMBER> <NUMBER> data uk biobank <NUMBER> prospective casecontrol study showed asthma prevalence <NUMBER> <NUMBER> covid<NUMBER> hospitalized patients adults asthma prevalence <NUMBER> control population disease identified independent risk factor covid<NUMBER> hospitalizationseverity contrast hypertension copd oldest population age ≥<NUMBER> years included uk biobank <NUMBER> tendency asthma prevalence found hospitalized covid<NUMBER> patients versus controls <NUMBER> vs <NUMBER> asthma identified independent risk factor severity report middle east saudi arabia <NUMBER> included <NUMBER> hospitalized adult patients mean age <NUMBER> years found <NUMBER> <NUMBER> covid<NUMBER> population hypertension diabetes respectively asthma prevalence <NUMBER> <NUMBER> patient asthma admitted icu study aiming estimate risk factors hospitalization death mexican population <NUMBER> infected sarscov<NUMBER> n <NUMBER> mean age <NUMBER> years <NUMBER> hospitalized <NUMBER> fatal cases hypertension prevalent comorbidity found <NUMBER> followed obesity <NUMBER> diabetes <NUMBER> asthma prevalence <NUMBER> population <NUMBER> hospitalized patients <NUMBER> fatal cases patients hypertension obesity diabetes likely hospitalized die people without comorbidities asthma identified independent risk factor hospitalization andor mortality <NUMBER> based available literature clear evidence patients asthma higher risk infected becoming severely ill sarscov<NUMBER> although recent reports usa uk suggest asthma much common children adults covid<NUMBER> previously reported asia first surveys continental europe nevertheless prevalence several underlying conditions identified us hospitalized patients covid<NUMBER> similar hospitalized influenza patients influenza seasons <NUMBER> <NUMBER> ie regarding chronic respiratory diseases <NUMBER> <NUMBER> particular note uk association asthma higher risk covid<NUMBER> hospital death hr increasing received ocs probably indicating greater severity disease contrasts previous findings several countries asthma chronic respiratory diseases underrepresented hospitalized patients <NUMBER> also uk asthma reported <NUMBER> <NUMBER> hospitalized patients increased risk death <NUMBER> <NUMBER> among school age children viral infection reportedly accounts <NUMBER> asthma exacerbations viruses frequently isolated symptomatic patients asymptomatic patients <NUMBER> <NUMBER> even though respiratory viruses one common triggers asthma exacerbations age groups viruses affect patients equally particular human rhinovirus identified main individual contributor asthma exacerbations coronavirus one less identified triggers asthma exacerbations children well adults <NUMBER> recent literature review concerning virus detection asthma exacerbations confirmed exacerbations mainly associated rhinovirus infection continents <NUMBER> previous sars outbreaks patients asthma particular children appeared less susceptible coronavirus reported low rate asthma exacerbations good prognosis followup <NUMBER> <NUMBER> contrast influenza epidemics asthma associated severe disease including need mechanical ventilation adults also children <NUMBER> exact reasons remain unknown confirmed current coronavirus pandemic <NUMBER> recent covid<NUMBER> literature definite conclusions drawn regarding asthma control severity similarly information extrapolated asthma phenotypes ie regarding whether asthma allergic covid<NUMBER> outcomes vary asymptomatic infection death possible clinical range reflects different airway levels sarscov<NUMBER> receptor ace<NUMBER> spike protein activator transmembrane protease serine <NUMBER> tmprss<NUMBER> considering virus cell entry also depends sprotein priming host cell proteases blood eosinophil levels wellknown predictor airway t<NUMBER> inflammation <NUMBER> measurement blood eosinophil levels used accessible strong proxy investigation association airway t<NUMBER> inflammation covid<NUMBER> outcomes early reports china detailed clinical investigation hospitalized covid<NUMBER> cases suggested severe eosinopenia together lymphopenia potential indicator diagnosis worse prognosis including death <NUMBER> believed low eosinophil counts peripheral blood would related sarscov<NUMBER> infection however recent studies china italy reported eosinopenia patients severe covid<NUMBER> <NUMBER> <NUMBER> <NUMBER> although relationship eosinophil counts covid<NUMBER> uncertain attention warranted monitor eosinophil counts among patients asthma using biological therapies lead decreased eosinophil counts clinical course covid<NUMBER> cases infected sarscov<NUMBER> <NUMBER> sajuthi et al <NUMBER> studied children role t<NUMBER> inflammation viral infection regulating gene expression ace<NUMBER> tmprss<NUMBER> found strong influence t<NUMBER> cytokinedriven inflammation ace<NUMBER> downregulation tmprss<NUMBER> upregulation expression levels clinical implications covid<NUMBER> outcomes contrast authors found equally strong positive influence respiratory virus infections ace<NUMBER> expression <NUMBER> least theoretically patients asthma high t<NUMBER> inflammation consequence interferondependent inflammation requires close monitoring given enhanced risk complications due sarscov<NUMBER> infection recent study included asthma patients <NUMBER> different cohorts children adults found ace<NUMBER> receptor expression lower patients high allergic sensitization nonatopic asthma associated reduced expression <NUMBER> data suggest reduced ace<NUMBER> expression may potential contributor among several factors reduced covid<NUMBER> severity patients respiratory allergies ie allergic asthma <NUMBER> additionally early evidence coming severe asthma research program<NUMBER> sarp inhaled corticosteroid therapy also associated reduction ace<NUMBER> tmprss<NUMBER> gene expression sputum <NUMBER> data stress importance maintain asthma controlled using treatment according best practices including inhaled steroids also evidence support taking ics may beneficial dealing coronavirus infections vitro studies shown inhibitory actions budesonide coronavirus hcov<NUMBER>e replication cytokine production <NUMBER> preliminary yet peerreviewed data suggest ciclesonide blocks sarscov<NUMBER> ribonucleic acid replication <NUMBER> inhibits cytopathic activity <NUMBER> may clinical implications although gene expression ace<NUMBER> tmprss<NUMBER> differ healthy asthmatic patients also found males african americans patients diabetes increased expression ace<NUMBER> tmprss<NUMBER> sputum cells may associated poor prognosis patients infected sarscov<NUMBER> <NUMBER> dong et al <NUMBER> elegantly described selected cases patients covid<NUMBER> children adults demonstrating profile complexity different clinical presentations mild severe cases patients common allergic diseases rhinitis atopic dermatitis develop distinct symptoms severe courses may suggest positive balance type <NUMBER> immune regulation covid<NUMBER> pathogenesis new data emerging daily rapidly updating understanding novel coronavirus crucial patients asthma allergic diseases allergic rhinitis maintain controller medication inhaled corticosteroids biologics <NUMBER> <NUMBER> <NUMBER> including allergen immunotherapy <NUMBER> without making dose adjustments stopping medication may lead higher risk asthma exacerbations increased ocs use higher probability need emergency room access hospitalization risk factors coronavirus exposure spread likewise important maintain wellcontrolled rhinitis rhinosinusitis together known risk factors asthma exacerbations <NUMBER> available data ocs use asthma exacerbations though limited <NUMBER> reported cases mild asthmatics <NUMBER> accordance data previous coronavirus outbreaks showing systemic corticosteroids associated higher viral load <NUMBER> <NUMBER> uk data suggesting increased death risk patients int arch allergy immunol doi <NUMBER> asthma especially recently received systemic steroids <NUMBER> stress clinicians must cautious recognize differences hypoxic respiratory failure bronchospasm carefully balance need ocs prescription <NUMBER> bronchodilators must delivered metered dose inhalers spacers order prevent viral spread related nebulizer use <NUMBER> shown kaye et al <NUMBER> evidence increased adherence asthma copd pharmacologic treatment first months covid<NUMBER> encouraging hopefully positive effect improvement control asthma minimize need acute care inflammatory chronic respiratory disease conclusion unclear whether patients asthma higher risk developing covid<NUMBER> andor becoming severely ill future studies age groups needed provide greater understanding impact underlying asthma allergic diseases t<NUMBER> inflammation covid<NUMBER> susceptibility disease outcomes better understand interactions better able protect vulnerable people including highrisk groups recent outbreak novel covid<NUMBER> disease rapid worldwide spread poses global health emergency novel virus thought belong family middle east respiratory syndrome mers coronavirus severe acute respiratory syndrome sars coronavirus unique right <NUMBER> researchers around globe investigating several risk factors may contribute severity covid<NUMBER> world health organization indicated elderly individuals well underlying medical conditions higher risk developing severe covid<NUMBER> disease <NUMBER> today june <NUMBER> th <NUMBER> <NUMBER> million people infected virus <NUMBER> lost lives deaths believed associated existence comorbidities generally patients compromised immune systems considered particularly vulnerable <NUMBER> several research works targeted epidemiological clinical characteristics patients infected covid<NUMBER> however risk factors severity mortality sufficiently investigated <NUMBER> identifying major risk factors taking corresponding clinical measures could contribute massively saving lives previous studies identified comorbidities hypertension diabetes mellitus stroke cancer kidney issues high cholesterol among highrisk factors thus paper represents systematic review literature shed light effects preexisting conditions covid<NUMBER> disease severity additionally method currently exists determine level risk comorbidities pose paper serves purpose achieving reasonable option draw lessons earlier experiences practices search conducted freely available covid<NUMBER> open research dataset cord<NUMBER> <NUMBER> cord<NUMBER> resource consisting <NUMBER> scholarly articles including <NUMBER> articles full text related covid<NUMBER> sarscov<NUMBER> coronaviruses dataset frequently updated new research appears peerreviewed publications archive services became available screen every article dataset developed search engine addition bm<NUMBER> search index <NUMBER> bm<NUMBER> retrieval function ranks set documents based query terms appearing document regardless proximity within document papers indexed simply applying preprocessing function clean tokenize abstracts documents indexed created document vectors loading optimized cached json tokens followed applying document similarity index using annoy <NUMBER> details implantation please visit httpsgithubcomdgunningcord<NUMBER> filtering articles undertaken using keywords questions eg effects hypertension covidnormal coronavirussarscov<NUMBER>ncovcovid<NUMBER> disease severity mortality icu search terms repeated comorbidities considered paper illustrated fig <NUMBER> systematic approach used screen full covid<NUMBER> open research dataset <NUMBER> systematic method <NUMBER> articles found scored highly confidence rating additional search run employing google scholar pubmed ensure every relevant article included <NUMBER> papers read thoroughly causing <NUMBER> articles excluded list additional <NUMBER> articles manually added list ultimate list <NUMBER> articles split six categories <NUMBER> articles focusing cancer <NUMBER> diabetes mellitus <NUMBER> kidney issues <NUMBER> stroke <NUMBER> hypertension <NUMBER> high cholesterol diabetes one serious comorbidities linked severity three wellknown human pathogenic coronavirus infections including sarscov <NUMBER> patients diabetes increased risk severe complications including adult respiratory distress syndrome ards multiorgan failure depending global region <NUMBER> covid<NUMBER> pandemic patients diabetes emphasizes importance link covid<NUMBER> diabetes <NUMBER> according gupta et al <NUMBER> individuals diabetes risk infections especially influenza pneumonia patients diabetes severely affected contract respiratory viruses therefore diabetes seen important risk factor mortality patients infected pandemic influenza <NUMBER> h<NUMBER>n<NUMBER> sars coronavirus middle east respiratory syndromerelated coronavirus merscov <NUMBER> <NUMBER> <NUMBER> several studies show among covid<NUMBER> patients also noticeable percentage patients suffering diabetes mellitus dm yang et al <NUMBER> found among <NUMBER> nonsurvivors group <NUMBER> covid<NUMBER> patients <NUMBER> diabetes patients additionally <NUMBER> patients confirmed covid<NUMBER> autonomous regions china <NUMBER> severe disease comorbidities <NUMBER> dm <NUMBER> zhang et al <NUMBER> analyzed data <NUMBER> patients admitted hospitals wuhan china confirmed covid<NUMBER> cases <NUMBER> patients diabetes moreover zhang et al <NUMBER> reviewed <NUMBER> confirmed covid<NUMBER> patients hospitalized wuhan china authors indicated patients diabetes significantly higher leukocyte neutrophil counts well higher levels fasting blood glucose serum creatinine urea nitrogen creatine kinase isoenzyme mb admission compared without diabetes cox proportional hazard model showed diabetes adjusted hazard ratio ahr<NUMBER> <NUMBER> ci <NUMBER> fasting blood glucose ahr<NUMBER> <NUMBER> ci <NUMBER> associated fatality covid<NUMBER> adjusting potential confounders authors concluded dm associated greater disease severity therefore recommended primary secondary prevention strategies needed covid<NUMBER> patients diabetes bloomgarden et al <NUMBER> stated mortality rates pneumonia among patients diabetes hong kong age ≥ <NUMBER> exceed mortality rates age group cardiovascular disease cancer <NUMBER> similar evidence risk amid persons diabetes reported two earlier cov infections sars <NUMBER> <NUMBER> <NUMBER> mers <NUMBER> <NUMBER> furthermore diabetes present <NUMBER> <NUMBER> fatalities due covid<NUMBER> study wuhan china <NUMBER> huang et al <NUMBER> investigated <NUMBER> hospitaladmitted patients identified laboratoryconfirmed <NUMBER>ncov infection however cases small proportion patients affected report <NUMBER> cases <NUMBER> confirmed covid<NUMBER> cases published chinese centre disease control prevention showed increased mortality rate people diabetes <NUMBER> overall <NUMBER> patients diabetes <NUMBER> bellochavolla oy <NUMBER> predicted mortality due sarscov<NUMBER> developed mechanistic score relating obesity diabetes covid<NUMBER> outcomes data mexico among <NUMBER> subjects authors observed <NUMBER> subjects sarscov<NUMBER> <NUMBER> deaths sarscov<NUMBER> causes risk factors lethality covid<NUMBER> included earlyonset diabetes obesity advanced age immunosuppression ckd authors used stratified points score diabetes <NUMBER> indicated mild risk <NUMBER> deaths sarscov<NUMBER> <NUMBER> diabetes total <NUMBER> patients confirmed covid<NUMBER> studied guo et al <NUMBER> authors found <NUMBER> patients comorbidities except diabetes higher risk severe pneumonia release tissue injuryrelated enzymes excessive uncontrolled inflammation responses hypercoagulable state associated dysregulation glucose metabolism authors recommended diabetes considered risk factor rapid progression poor prognosis covid<NUMBER> authors described mortality rate covid<NUMBER> amongst diabetic patients without comorbidities <NUMBER> abovementioned studies summarized table <NUMBER> na available apparent individuals diabetes increased risk covid<NUMBER> infection medical complications including death suggestions made possible pathophysiological mechanisms relationship diabetes covid<NUMBER> management definite conclusions made based current limited evidence data <NUMBER> research regarding relationship clinical management warranted <NUMBER> furthermore article guo et al <NUMBER> left several relevant questions addressed association covid<NUMBER> diabetes differ different types diabetes antidiabetic drugs impact disease progression impact aging diabetics without diabetes results study read light limitations small sample size large age difference study groups patients comorbidities excluded still provides relevant insights could inform covid<NUMBER> interacts preexisting conditions <NUMBER> according recently published results mainly chinese cohort patients cancer vulnerable covid<NUMBER> complications however susceptible cancer patients infection covid<NUMBER> yet established liang et al <NUMBER> collected analyzed <NUMBER> cases <NUMBER> hospitals <NUMBER> provincial administrative regions china cases diagnosed laboratoryconfirmed covid<NUMBER> number covid<NUMBER> cases history cancer <NUMBER> <NUMBER> <NUMBER> ci <NUMBER> <NUMBER> covid<NUMBER> cases according <NUMBER> cancer epidemiology statistics seems higher incidence cancer overall chinese population <NUMBER>·<NUMBER> per <NUMBER> people lung cancer frequent type <NUMBER> compared patients without cancer patients cancer relatively older significant differences sex baseline symptoms comorbidities baseline severity xray importantly patients cancer observed higher risk severe events compared patients without cancer <NUMBER> vs <NUMBER> <NUMBER> patients fishers exact p<NUMBER> authors concluded patients cancer might higher risk covid<NUMBER> individuals without cancer additionally showed patients cancer poorer outcomes covid<NUMBER> providing timely reminder physicians cancer patients require intensive care infected zhang et al <NUMBER> nonsmallcell lung carcinoma nsclc authors stated patients nsclc older <NUMBER> years higher incidence covid<NUMBER> aged <NUMBER> years younger <NUMBER> vs <NUMBER> table <NUMBER> summarize details three mentioned case studies mentioned studies lung cancer frequently observed covid<NUMBER> cases analyzed hospitals china however according moujaess et al <NUMBER> reports could lead many oncologists change daily practice cancer care without solid evidence recommendations data presented carefully interpreted small sample also cancer patients cohort mentioned <NUMBER> instance significantly older median age control <NUMBER>·<NUMBER> vs <NUMBER>·<NUMBER> years well significant history smoking suggesting two factors might associated poor covid<NUMBER> outcomes cancer history moreover results interpreted caution absence adjustment prevalence different comorbidities chinese population <NUMBER> also xia et al <NUMBER> commented mentioned studies highlighted reasons cautious suggesting current evidence remains insufficient explain conclusive association cancer covid<NUMBER> though one effect risen concern due number covid<NUMBER> patients surpassing hospital healthcare capacity cancer patients may overlooked resulting negative consequences treatments high blood pressure hypertension one common conditions severe covid<NUMBER> patients <NUMBER> section review several studies looked relationship hypertension severity covid<NUMBER> relationship high blood pressure increased risk pneumonia subject study analyzed uk biobank data <NUMBER> hypertension patients <NUMBER> patients developing pneumonia afterward <NUMBER> data analysis shows risk respiratory disease significantly higher patients hypertension patients hypertension also found higher risk acute respiratory disease chronic lower respiratory disease independent age sex smoking status bmi generalizing results covid<NUMBER> plausible led many studies focus hypertension strong indication covid<NUMBER> severity several recent studies investigated variability covid<NUMBER> disease severity patients hypertension medicinal therapy <NUMBER> authors reported among <NUMBER> hospitalized covid<NUMBER> patients <NUMBER> diagnosed hypertension furthermore mortality rates among patients angiotensinconverting enzyme inhibitors acei hypertension treatment <NUMBER> p<NUMBER> well patients angiotensin ii receptor blockers arbs <NUMBER> p<NUMBER> lower compared antihypertensive agents <NUMBER> therefore results support continuation acei arb therapy covid<NUMBER> hypertensive patients results supported another study <NUMBER> <NUMBER> covid<NUMBER> patients hypertension retrospectively grouped arbsaceis n<NUMBER> nonarbsaceis n<NUMBER> according antihypertensive medications group covid<NUMBER> patients without hypertension randomly selected match previous group based age sex results study show arbsaceis group lower proportion critical patients <NUMBER> vs <NUMBER> p<NUMBER> lower death rate <NUMBER> vs <NUMBER> p<NUMBER> however differences statistically significant similarly liu et al <NUMBER> investigated disease severity patients hypertension used acei arb ccb betablockers bb compared patients take hypertension medication considering <NUMBER> elderly patients age <NUMBER> results show patients took arb significantly lower risk developing severe disease compared patients took drugs however although patients took acei ccb bb also lower risk developing severe disease statistical significance compared patients took drugs could due limited number patients drugs compared arb another study <NUMBER> authors argued based retrospective investigation different hypertension drugs calcium channel blockers ccbs show significant efficacy covid<NUMBER> patients also conducted vitro experiments examine efficacy ccbs hypertension drugs blocking sarscov<NUMBER> replication cells results show ccbs block virus replication however blocking mechanism apparent therefore investigations ccbs efficacy postentry virus replication vitro clinically needed although studies cited show hypertension medications beneficial covid<NUMBER> patients recent retrospective observational study <NUMBER> found patients hypertension took aceiarb drugs higher risk developing severe case covid<NUMBER> p <NUMBER> however statistically significant difference may due limited number patients hypertension <NUMBER> <NUMBER> covid<NUMBER> patients also group patients hypertension older comorbidities chronic renal insufficiency cardiovascular disease diabetes mellitus cerebrovascular disease patients without hypertension interestingly another study <NUMBER> hypothesizes hypertension treatment acei arbs results upregulation ace<NUMBER> may increase risk developing severe covid<NUMBER> based structural study suggesting sarscov<NUMBER> uses ace<NUMBER> receptor <NUMBER> also noted ccb treatment hypertension lead upregulation ace<NUMBER> turn makes safe treatment hypertension covid<NUMBER> patients however theory supported previously cited retrospective studies covid<NUMBER> patients took acei arbs <NUMBER> besides sanchisgomar et al <NUMBER> noted several health organizations recommended continued use aceis arbs treating hypertension covid<NUMBER> patients also found based review study significant differences aceis arbs managing hypertension arbs favorable option severe cases covid<NUMBER> also reviewed several articles employed systematic reviews metaanalysis published studies effects hypertension covid<NUMBER> disease severity <NUMBER> systematic reviews show hypertension one major comorbidities fatality table <NUMBER> hypertension like diabetes proven linked significantly higher risk respiratory infection making solid indicator covid<NUMBER> severity additionally systematic reviews indicate hypertension common comorbidity covid<NUMBER> death cases well linked significantly higher mortality risk increased incidence icu admission although noted studies comorbidities connected hypertension necessary nonetheless evident many patients virus also suffer hypertension result comorbidity well medicinal therapies covid<NUMBER> observed also found hypertension treatment continued lower severity risk researchers recommended ccbs treatment others found significant differences using aceis arbs ccbs however seems general agreement health organizations recommended hypertension treatment continued covid<NUMBER> patients <NUMBER> cholesterol level alteration found occur viral infection hiv hepatitis c virus hcv <NUMBER> mechanism alteration involves virus binding scavenger receptor b type <NUMBER> srb<NUMBER> facilitates selective uptake highdensity lipoprotein hdl cholesterol lipid components receptorbound hdl particles including free cholesterol fc triglycerides tg <NUMBER> also found membrane cholesterol important component facilitate viral entry host cells <NUMBER> role cholesterol viral infection investigated even current pandemic sarscov<NUMBER> ren et al <NUMBER> found cholesterol depletion cellular membrane significantly impaired efficiency viral infection wei et al <NUMBER> studied cholesterol metabolism covid<NUMBER> patients compared normal reference population general found fc hdl ldl cholesterol level significantly low covid<NUMBER> patients compare reference population tg levels also lower significant level moreover cholesterol metabolism mild moderate severe critical covid<NUMBER> patients also presented discussed levels hdlc significantly lower patients severe critical disease patients moderate mild disease another study <NUMBER> hdl cholesterol levels along serum albumin levels used predictors severity covid<NUMBER> disease study investigated differences clinical features mild severe covid<NUMBER> patients features studied included hypoproteinemia hypoalbuminemia decreased apoa<NUMBER> patients grouped two types mild severe critical condition included also noted patients severe disease significantly older median age <NUMBER> compared patients mild disease median age <NUMBER> results show patients severe disease significantly lower hdl cholesterol also observed increased levels albumin hdl cholesterol patients late stage recovering covid<NUMBER> another recent study <NUMBER> looked serum cholesterol level patients covid<NUMBER> wenzhou china laboratory test results show patients significantly low fc hdlcholesterol ldlcholesterol levels compared healthy control moreover investigated cholesterol levels two categories patients primary infection cases wuhan secondary infection cases never wuhan infected persontoperson transmission reported hdlcholesterol primary infection group significantly lower secondary infection group similar results <NUMBER> cholesterol levels fc hdl ldl improving patients recovered inverse correlation hdl cholesterol level severity covid<NUMBER> also highlighted <NUMBER> author argued taking statin drug therapy cholesterol may increase covid<NUMBER> infections statins drugs used lower cholesterol protect heart attack stroke taking statins results low production endogenous cholesterol leads upregulation ldl cell membrane stated earlier found important component facilitate viral entry host cells overview articles investigating cholesterol levels covid<NUMBER> patients summarized table <NUMBER> cholesterol previously investigated concerning many viral infections typically selective uptake cholesterol viruses bind cellular membrane ultimately enables severe infection therefore analyses conducted connection covid<NUMBER> cholesterol publications indicated fc hdl ldl cholesterol levels significantly low patients viral infection compared control studies explained ability sarscov<NUMBER> virus use serum cholesterol entry host cells therefore low serum cholesterol level used early predictor covid<NUMBER> severity patients also observing improvement serum cholesterol levels may indicate improvement conditions patients also worth noting statin drugs cholesterol may contribute severity covid<NUMBER> disease inhibiting endogenous cholesterol leading upregulation ldl leads higher membrane cholesterol levels enhance ability sarscov<NUMBER> enter host cells apart fever respiratory complications acute kidney injury observed patients covid<NUMBER> investigate possible cause kidney damage covid<NUMBER> patients lin et al <NUMBER> used published kidney bladder cell atlas data well independent unpublished kidney singlecell rnaseq data generated inhouse evaluate ace<NUMBER> gene expressions cell types healthy kidneys bladders results showed enriched expression subtypes proximal tubule cells kidney low detectable levels expression bladder epithelial cells results indicated urinary system potential route covid<NUMBER> infection along respiratory system digestion system findings suggested kidney abnormalities sars covid<NUMBER> patients may due proximal tubule cell damage subsequent systematic inflammatory response induced kidney injury beyond laboratory tests viruses related indicators urine may needed special patients covid<NUMBER> novel coronavirus recent study reported human kidney specific target sarscov<NUMBER> infection <NUMBER> authors examined viral nucleocapsid protein situ kidney postmortem found sarscov<NUMBER> antigens accumulated kidney tubules suggesting sarscov<NUMBER> infects human kidney directly inducing aki contributing viral spreading body <NUMBER> alberici et al <NUMBER> describe <NUMBER> kidney transplant recipients median age <NUMBER> years <NUMBER> male sarscov<NUMBER> induced pneumonia patients presented fever one complained difficulty breathing overall <NUMBER> kidney transplant recipients died median period <NUMBER> days symptom onset preliminary findings describe rapid clinical deterioration associated chest radiographic deterioration escalating oxygen requirement renal transplant recipients sarscov<NUMBER> pneumonia thus limited cohort longterm kidney transplant patients sarscov<NUMBER> induced pneumonia characterized high risk progression significant mortality wang et al <NUMBER> conducted study one male patient age <NUMBER> history close contact confirmed covid<NUMBER> case type <NUMBER> diabetes <NUMBER> years hypertension <NUMBER> years patient underwent comprehensive treatment covid<NUMBER> organ transplant patients covid<NUMBER> infection might poorer prognosis systemic immunosuppressive state however severe case cured even without discontinuing reducing immunosuppressant therapy immunosuppressed case might help physicians establish optimal treatment strategies similar severe cases whether covid<NUMBER> causes significant acute kidney injury aki remains controversial zhou et al <NUMBER> retrospectively analyzed clinical characteristics urine blood routine tests well laboratory parameters <NUMBER> hospitalized covid<NUMBER> patients wuhan china total <NUMBER> <NUMBER> patients showed increased blood urea nitrogen bun indicating cases kidney dysfunction however among <NUMBER> <NUMBER> patients history kidney disease received routine urine test upon hospitalization <NUMBER> <NUMBER> patients displayed abnormality urinalyses proteinuria hematuria leukocyturia none patients recorded acute kidney injury aki throughout study meanwhile patients abnormal urinalysis typically displayed worse disease progression reflected laboratory parameter presentations including markers liver injury inflammation coagulation authors concluded urinalysis better unveiling potential kidney impairment covid<NUMBER> patients blood chemistry tests additionally urinalysis could used reflect predict disease severity cheng et al <NUMBER> determined prevalence acute kidney injury aki patients covid<NUMBER> evaluated association markers abnormal kidney function death patients covid<NUMBER> authors studied cohort <NUMBER> patients covid<NUMBER> wuhan <NUMBER> <NUMBER> <NUMBER> died hospitals study period aki occurred <NUMBER> patients kaplanmeier analysis demonstrated patients kidney disease significantly higher risk inhospital death thus authors believed prevalence kidney disease admission development aki hospitalization patients covid<NUMBER> high associated inhospital mortality hence clinicians increase awareness kidney disease patients severe covid<NUMBER> overview articles investigating kidney disease among covid<NUMBER> patients summarized table <NUMBER> addition multiple complications observed acute kidney injury also detected covid<NUMBER> patients results indicated urinary system respiratory system digestion system potential routes covid<NUMBER> infection one study indicating human kidney specific target virus findings propose kidney abnormalities covid<NUMBER> patients may due proximal tubule cell damage subsequent systematic inflammatory response induced kidney injury additionally one study sarscov<NUMBER> antigens seen accumulate kidney tubules implying direct impact kidney leading aki induction viral spread within body also studies describing rapid clinical deterioration escalating oxygen requirement high risk progression significant mortality kidney transplant patients similarly incidence kidney disease admission well development aki correlated fatality covid<NUMBER> patients however covid<NUMBER> causes acute kidney injury remains uncertain many authors concluded clinicians must still try increase awareness kidney issues patients severe infection urinalysis may used predict extent disease severity note eur neurol journal editor morelli et al <NUMBER> mentioned february <NUMBER> <NUMBER> first covid<NUMBER> patient recorded italy march <NUMBER> <NUMBER> <NUMBER> admissions casualty department ischemic stroke authors suggested reason could controversial role il<NUMBER> plays stroke although high il<NUMBER> levels reported harm brain infarct volume longterm outcome <NUMBER> ischemic stroke also experimental evidence il<NUMBER> protective effect helps improvement poststroke angiogenesis <NUMBER> could also due presence thrombocytopenia covid<NUMBER> patients indeed may true influenza pneumonia ie increased stroke risk may true sarscov<NUMBER> main limitation remark however certainly short observation period <NUMBER> month oxley et al <NUMBER> reported <NUMBER> <NUMBER> male <NUMBER> female largevessel stroke patients confirmed sarscov<NUMBER> presented health system new york city severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> infection diagnosed five patients although patients covid<NUMBER> related symptoms fever cough lethargy reduced nih stroke scalescore nihss overview articles investigating stroke among covid<NUMBER> patients summarized table <NUMBER> one study identified <NUMBER> covid patients neurological symptoms mainly patients severe disease several mechanisms covid<NUMBER> increase stroke risk recognized neither proven significant studies required investigate neurological pathology covid<NUMBER> infection additionally may need improve specific vte diagnostic strategies safety thromboprophylaxis identify role il<NUMBER> plays ischemic stroke however risks associated ischemic stroke covid<NUMBER> patients still uncertain cancer patients medical resources must allocated target strain covid<NUMBER> placed ischemic stroke care meanwhile relationship covid<NUMBER> stroke must examined studies reviewed paper assessed effects diabetes cancer hypertension high cholesterol kidney issues stroke covid<NUMBER> severity thorough examination evidence provided reports inferences relationship preexisting conditions covid<NUMBER> made conclusion observed diabetes hypertension cholesterol levels possess apparent relation covid<NUMBER> severity comorbidities cancer kidney issues stroke must evaluated detect strong relationship virus additionally treatment options must examined provide optimal treatment ensure better outcomes patients suffering comorbidities however noted whether definitive measurements exist care patients well research involved largely prioritized tackle deadly pandemic since december <NUMBER> china experiencing outbreak pneumonia novel coronavirus <NUMBER> officially named severe acute respiratory characterized covid<NUMBER> pandemic spread rapidly throughout china <NUMBER> countries following months outbreak causing <NUMBER> confirmed cases thousands deaths march <NUMBER> <NUMBER> sarscov<NUMBER> belongs subgenus sarbecovirus βcov lineage b shares <NUMBER> sequence severe acute respiratory syndrome coronavirus sarscov <NUMBER> homology middle east respiratory syndrome coronavirus merscov <NUMBER> <NUMBER> china climbing prevalence rate diabetes recent decades according latest nationally representative crosssectional survey among <NUMBER> participants <NUMBER> mainland china overall prevalence diabetes <NUMBER> adults <NUMBER> elderly <NUMBER> patients diabetes susceptible infected bacteria viruses fungus individuals without diabetes owing relatively lower immune function <NUMBER> <NUMBER> result patients might increased risk sarscov<NUMBER> infection consequently poor prognosis although many studies described clinical characteristics covid<NUMBER> far <NUMBER> <NUMBER> <NUMBER> <NUMBER> information respect diabetes among patients well characterized yet current study retrospectively reviewed clinical data <NUMBER> patients laboratoryconfirmed covid<NUMBER> compared differences clinical characteristics laboratory markers treatment strategies shortterm prognosis including death patients without diabetes hope findings provide new insights risk stratification disease management therapeutic strategies covid<NUMBER> patients diabetes retrospective cohort study among patients covid <NUMBER> demographic clinical features laboratory radiological findings treatment strategy shortterm prognosis data patients obtained medical records clinical outcomes followed march <NUMBER> <NUMBER> data checked two senior physicians pp jz patients enrolled study laboratoryconfirmed covid<NUMBER> patients diagnostic criteria covid<NUMBER> based positive detection viral nucleic acids severity covid<NUMBER> defined based diagnostic treatment guidelines version <NUMBER> national health committee china severe subtype defined patient met one following criteria <NUMBER> respiratory distress respiratory frequency ≥ <NUMBER>min <NUMBER> pulse oximeter oxygen saturation ≤ <NUMBER> rest <NUMBER> oxygenation index artery partial pressure oxygeninspired oxygen fraction pao<NUMBER>fio<NUMBER> ≤ <NUMBER> mmhg critically ill subtype followed criteria mentioned met one following criteria <NUMBER> needs mechanical ventilation due respiratory failure <NUMBER> shock <NUMBER> combined multiple organ failure requiring transfer intensive care unit icu pharyngeal swab specimens collected patient viral nucleic acid detection sarscov<NUMBER> using realtime reversetranscriptase polymerasechainreaction rtpcr assay previously described <NUMBER> viral nucleic acid testing data reviewed transferred standardized forms electronic medical records hospital including case report forms nursing records laboratory radiological findings two senior physicians pp jz independently reviewed data information demographic data symptoms preexisting chronic comorbidities computed tomographic images chest laboratory results collected treatment strategies recorded hospitalization antiviral therapy antibiotic therapy use corticosteroid respiratory support time onset illness hospital admission also recorded patients diabetes identified based patients documented medical history guidelines prevention control t<NUMBER>d china <NUMBER> cardiovascular disease including coronary artery disease congestive heart failure history myocardial infarction included reports isolated hypertension included chronic pulmonary disease chronic obstructive pulmonary disease copd allergic airway disease use supplemental oxygen home included presence ards designated berlin definition <NUMBER> cardiac injury identified serum level hypersensitive cardiac troponin hstni upper limit normal range new abnormalities shown electrocardiography echocardiography <NUMBER> acute kidney injury aki classified basis highest serum creatinine level urine output criteria based kdigo clinical practice guideline aki <NUMBER> prognosis defined based patient discharged hospital discharged yet death hospitalization followup observation conducted march <NUMBER> <NUMBER> continuous variables shown median interquartile range iqr compared mannwhitney test since laboratory data skewed distribution categorical variables presented counts proportions compared chisquare test fishers exact test cox proportional hazard model used determine associations diabetes fbg fatality covid<NUMBER> adjusted potential confounders adjusted hazard ratio ahr <NUMBER> confidence interval ci presented effect size statistical analyses graphs generated plotted using graphpad prism version <NUMBER> software graphpad software inc spss version <NUMBER> ibm united states p value <NUMBER> considered statistically significant total <NUMBER> consecutive laboratoryconfirmed patients sarscov<NUMBER> infection included analyzed study <NUMBER> diabetes demographic clinical characteristics patients admission summarized diabetes laboratory radiological findings admission covid<NUMBER> patients without diabetes presented interestingly decreased eosinophil count also common patients <NUMBER> significant difference eosinophil count ratio patients decreased eosinophil count found patients without dm besides positive correlation eosinophil lymphocytes numbers admission observed data shown consistent previous study <NUMBER> laboratory findings showed significant differences two groups patients respect serum levels crp pct ldh covid<NUMBER> patients next compared severity treatment shortterm prognosis covid<NUMBER> patients without diabetes table <NUMBER> compared nondiabetes subjects patients diabetes likely develop severely critically ill subtypes p<NUMBER> complications including acute respiratory distress <NUMBER> vs <NUMBER> p<NUMBER> acute cardiac injury <NUMBER> vs <NUMBER> p<NUMBER> antibiotic therapy <NUMBER> vs <NUMBER> p<NUMBER> noninvasive invasive mechanical ventilation p<NUMBER> march <NUMBER> <NUMBER> <NUMBER> patients discharged hospital patients diabetes higher fatality rate without diabetes <NUMBER> vs <NUMBER> p<NUMBER> table <NUMBER> analysis severity treatment prognosis covid<NUMBER> patients assess association diabetes fbg fatality covid<NUMBER> cox proportional hazard model carried results retrospective cohort study characterized <NUMBER> covid<NUMBER> patients respect demographics clinical features preexisting chronic comorbidities treatment shortterm prognosis found covid<NUMBER> patients relatively high proportion <NUMBER> diabetes demonstrated diabetes associated alterations laboratory markers severe clinical subtypes time presentation worse prognosis compared without diabetes best knowledge study first investigate clinical characteristics prognosis covid<NUMBER> patients diabetes prevalence diabetes mellitus sharply climbing china last decades according latest nationally representative crosssectional survey mainland china <NUMBER> estimated prevalence diabetes elderly participants ≥<NUMBER> years old <NUMBER> <NUMBER> previous studies reported <NUMBER> <NUMBER> prevalence diabetes covid<NUMBER> patients <NUMBER> <NUMBER> <NUMBER> <NUMBER> reported higher prevalence rate diabetes patients might due larger proportion geriatric patients infected sarscov<NUMBER> study median age participants <NUMBER> years old older data previously reported <NUMBER> <NUMBER> <NUMBER> current study <NUMBER> patients male percentage similar reported wang et al <NUMBER> zhang et al <NUMBER> besides diabetes mellitus hypertension <NUMBER> cardiovascular diseases <NUMBER> also common underlying chronic illness covid<NUMBER> patients diabetes seemed comorbidities cardiovascular diseases chronic kidney diseases current study laboratory findings admission showed leucocytes neutrophils count proportion increased leucocytes higher covid<NUMBER> patients diabetes without might explained fact patients diabetes susceptible pathogens viral infection due lower immune function hospitalization patients diabetes likely receive antibiotic therapy well decreased lymphocytes count eosinophil count also common patients consistent results previous studies <NUMBER> however significant differences found cell counts percentage lymphocytes eosinophil count covid<NUMBER> patients without diabetes data revealed covid<NUMBER> patients diabetes higher nlr recently reported predictor severity covid<NUMBER> early stage <NUMBER> found covid<NUMBER> patients diabetes likely develop severely critically ill subtypes including complications ards acute cardiac injury resulting receiving antibiotic therapy mechanical ventilation cox regression model indicated diabetes fbg level admission independent predictors fatality covid adjusting potential confounders based findings diligently concluded diabetes associated deteriorating disease severity worsening prognosis patients covid<NUMBER> first report demonstrate diabetes associated aggravating disease severity poorer prognosis covid<NUMBER> patients increasing number studies shown patients diabetes higher mortality morbidity severe medical illness myocardial infarction high fbg plays independent predictive role hospitalized critically ill patients without diabetes well <NUMBER> <NUMBER> <NUMBER> diabetes also identified significant risk factor severe disease following respiratory tract infections <NUMBER> several studies demonstrated diabetes associated increased risks severity mortality sarscov merscov infection <NUMBER> <NUMBER> <NUMBER> <NUMBER> fbg level independent predictor fatality patients sars <NUMBER> recent study indicated wellcontrolled glycemia associated markedly improved outcomes covid<NUMBER> patients combined preexisting t<NUMBER>d <NUMBER> additionally found covid<NUMBER> patients diabetes also preexisting cardiovascular disease susceptible acute cardiac injury hospitalization might increase possibility shortterm poor prognosis patients diabetes sarscov<NUMBER> infection previous studies reported patients diabetes received intensive glycemic control lower risk cardiovascular events <NUMBER> nevertheless could conclude diabetes fbg independent predictive risks poor outcomes covid<NUMBER> patients adjusting confounders mediators diabetes results proinflammatory homeostatic immune response skewed toward helper cell <NUMBER> th<NUMBER> t<NUMBER> cells decrease regulatory cells treg <NUMBER> immune dysfunction diabetes alone following infection reported wide variety immune cells macrophages monocytes cd<NUMBER> cells <NUMBER> recent study reported number total cells cd<NUMBER> cd<NUMBER> cell subsets substantially reduced functionally exhausted covid<NUMBER> patients especially among geriatric critically ill patients required icu admission <NUMBER> kulcsar ka et al showed diabetic mice presented prolonged phase severe disease delayed recovery merscov infection attributed dysregulated immune response lower inflammatory monocytesmacrophages cd<NUMBER> cells <NUMBER> thus optimal management diabetes intensive glycemic control may help prevent occurrence lifethreatening infections complications associated diabetes mellitus well combat increased susceptibility infections due impaired cellular humoral immunity study subject limitations go unnoticed firstly study retrospective study included small proportion patients laboratoryconfirmed sarscov<NUMBER> infection wuhan berkson bias might introduced since asymptomatic patients mild symptoms less likely enrolled secondly due massive number patients lack medical resources interval onset illness hospital admission <NUMBER> days patients could complicate deteriorate condition nevertheless patients diabetes similar interval onset illness hospital admission compared without diabetes thirdly time study submission patients discharged yet final survival outcome could determined longterm prognosis observed fourthly diabetesassociated parameters including glycated hemoglobin peak levels postprandial levels plasma glucose could better reflect association plasma glucose control mortality patients covid<NUMBER> data available current study demonstrated diabetes mellitus associated greater disease severity poorer shortterm outcomes including death stronger personal prophylactic strategies advised patients diabetes intensive surveillance treatment considered infected sarscov<NUMBER> especially geriatric patients preexisting comorbidities authors declare conflict interests <NUMBER> <NUMBER> ahr adjusted hazard ratio ci confidence interval dm diabetes mellitus fbg fasting blood glucose adjusted age b additionally adjusted preexisting cardiovascular disease chronic kidney disease c additionally adjusted inflammatory biomarkers leucocytes neutrophils lymphocyte eosinophil nlr neutrophiltolymphocyte ratio creactive protein procalcitonin march <NUMBER> world health organization issued global alert case atypical pneumonia unknown cause subsequently defined severe acute respiratory syndrome sars reported journal diabetic medicine <NUMBER> reported ambient hyperglycemia independent predictor mortality morbidity sars patients although hyperglycemia predictor mortality diabetic nondiabetic patients acute illnesses association sars looked quite different even patients mild sars use glucocorticoid medications disease course higher level fpg first day hospitalization initially suspected sars later diagnosed nonsars pneumonia <NUMBER> acute damage pancreatic bcells coronavirus may occur systemic illness however experimental studies needed test hypothesis angiotensinconverting enzyme <NUMBER> ace<NUMBER> recognized human homologue ace key regulator blood pressure approximately <NUMBER> identical protein sequences since discovery <NUMBER> <NUMBER> <NUMBER> ace<NUMBER> implicated heart function hypertension diabetes effects mediated part ability convert angiotensin ii angiotensin <NUMBER> unexpectedly ace<NUMBER> also serves cellular entry point sars coronavirus sarscov <NUMBER> <NUMBER> study investigated pathogenesis pancreatic lesions glucose intolerance sars patients determining whether biochemical parameters measuring involvements liver kidney heart lung endocrine part pancreas hospitalization predictors death whether involvements especially endocrine part pancreas associated tissuespecific ace<NUMBER> expression study included <NUMBER> patients died sars <NUMBER> hospitalized sars patients survived <NUMBER> patients initially suspected sars later diagnosed nonsars pneumonia diagnostic criteria sars defined chinese ministry health similar centers disease control prevention cdc <NUMBER> final diagnosis patients equivocal clinical presentations made team experts based findings computed tomographic ct imaging lung study protocol approved ethics committee beijing municipal bureau health demographic data first blood cell count performed within <NUMBER> days hospitalization biochemical blood gas analysis data collected survival analysis definition old age c<NUMBER> years anemia hemoglobin hb <NUMBER> gl men <NUMBER> gl women thrombocytopenia platelet count <NUMBER> <NUMBER> <NUMBER> <NUMBER> per l normal level cd<NUMBER> cd<NUMBER> lymphocytes <NUMBER> <NUMBER> per cubic mm respectively clinically significant elevations alanine transaminase alt aspartate transaminase ast lactate dehydrogenase ldh c<NUMBER> c<NUMBER> c<NUMBER> respectively clinically significant elevation serum creatinine scr c<NUMBER> lmoll men c<NUMBER> lmoll women severe hypoxia oxygen saturation sao <NUMBER> <NUMBER> inhaling oxygen flow rate <NUMBER> lmin hyperglycemia fasting plasma glucose fpg c<NUMBER> mmoll sars patients database <NUMBER> received steroid treatment disease course concomitant diseases diabetes chronic hepatic kidney lung cardiovascular disorders cerebrovascular disorders blood dyscrasias sars diagnosed three years later individuals evaluated inclusion followup study <NUMBER> patients <NUMBER> <NUMBER> matched healthy nonsars siblings included signed informed consents baselines comparable participants nonparticipants followup study participants took medications serious chronic disease known affect glucose metabolism health status glucose tolerance assessed medical records particular screening medical histories physical examinations body mass index bmi calculated weight divided height squared kgm <NUMBER> <NUMBER> g oral glucose tolerance test ogtt carried blood samples glucose determinations collected intravenous cannula <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> min additional blood samples obtained determination serum insulin alt ast cr total cholesterol tc triglyceride tg low density lipoproteincholesterol ldlc high density lipoproteincholesterol hdlc homeostasis model assessment homa calculated estimate insulin sensitivity using formula homa ir fasting insulin luml <NUMBER> fasting glucose mmoll<NUMBER> <NUMBER> basic study receptor tissues including lung heart liver kidney pancreas obtained <NUMBER>yearold male braindead organ donor liver transplantation informed consent wife tissue procurement experimental protocols approved human ethics committee capital medical university beijing tongren hospital biopsy specimens embedded frozen immediately isopentane dry ice <NUMBER>°c stored <NUMBER>°c analysis immunohistochemical staining patterns sarscov receptor proteins different organs studied serial frozen sections made tissues immunohistochemically stained ace<NUMBER> compared negative controls sections treated follows two rinses <NUMBER> min <NUMBER> fetal bovine serum albumin diluted pbs shaker incubation <NUMBER> h <NUMBER> <NUMBER> solution pbs ph <NUMBER> <NUMBER> min quench endogenous peroxidase one rinse distilled water <NUMBER> min soaking <NUMBER> fetal bovine serum albumin <NUMBER> min incubation <NUMBER> <NUMBER> egg albumen solution normal rabbit serum <NUMBER> fetal bovine serum albumin diluted pbs <NUMBER> min room temperature incubation diluted antibody <NUMBER> negative control sections performed determine specificity antibody incubated pbs rather primary antibodies slices put refrigerator <NUMBER>°c overnight next day sections rinsed <NUMBER> times <NUMBER> fetal bovine serum albumin diluted pbs <NUMBER> min shaker incubated secondary antibody biotinlabelled rabbit antigoat <NUMBER>°c <NUMBER> min rinsed incubated streptavidinhorseradish peroxidase <NUMBER> min <NUMBER>°c rinsed incubated diaminobenzidine reagent <NUMBER> min desired color intensity obtained stained counterstain qualified pathologist identified structures stained positive ace<NUMBER> kaplanmeier survival curves plotted patients higher cutoff level compared plotted patients lower cutoff level logrank test used testing homogeneity survival functions across strata computed pooling defined strata thus adjusting stratum variables multivariable analyses cox proportional hazards model used estimate effects clinical characteristics survival statistical analyses performed using sas <NUMBER> linux sas cary nc usa figure <NUMBER> shows survival rates sars patients grouped defined old age anemia thrombocytopenia clinically significant elevation biochemical parameters except alt severe hypoxia hyperglycemia predictors death using cox proportional hazards model elevated fpg remained independently associated increased hazard ratio hr <NUMBER> <NUMBER> ci <NUMBER> <NUMBER> p <NUMBER> death old age also independent predictor mortality hr <NUMBER> <NUMBER> ci <NUMBER> <NUMBER> p <NUMBER> ldh sao <NUMBER> alt remained predictors mortality could distinguish exocrine endocrine pancreas clearly staining serial sections fig <NUMBER>a compared negative control sections fig <NUMBER>b sections incubated antibody showed strong staining ace<NUMBER> pancreatic islets weak staining ace<NUMBER> exocrine tissues pancreas fig <NUMBER>c lung ace<NUMBER> immunostaining abundant alveolar epithelial cells fig <NUMBER>d kidney weak glomerular visceral epithelial cells strong parietal epithelial cells fig <NUMBER>e heart ace<NUMBER> protein found myocardium fig <NUMBER>f interestingly hepatocytes negative ace<NUMBER> moreover unlike endothelial lining many small vessels endothelial lining sinusoids liver also negative ace<NUMBER> fig <NUMBER>g change fpg level clinical course sars <NUMBER> patients treated corticosteroids shown fig <NUMBER> fpg level patients initially suspected sars later diagnosed nonsars pneumonia <NUMBER> ± <NUMBER> mmoll suggesting acute pulmonary illness markedly influence glucose homeostasis level significantly different sars patients sarsp healthy siblings controls <NUMBER> ± <NUMBER> <NUMBER> ± <NUMBER> mmoll respectively compared nonsars pneumonia group control group healthy siblings sars patients significantly increased fpg level within <NUMBER> days hospitalization sars<NUMBER> <NUMBER> ± <NUMBER> mmoll <NUMBER> weeks hospitalization sars<NUMBER> <NUMBER> ± <NUMBER> mmoll p <NUMBER> glucose intolerance longer clinically evident discharge sarsd <NUMBER> ± <NUMBER> mmoll fig <NUMBER> using fpg c<NUMBER> mmoll diagnostic criterion diabetes <NUMBER> <NUMBER> <NUMBER> patients diabetes within <NUMBER> days <NUMBER> weeks hospitalization respectively six patients diabetes discharge two patients still diabetes <NUMBER> years followup demographic current biochemical values presented sars control groups table <NUMBER> significant betweengroup differences found age bmi blood pressure lipid profiles alt ast scr levels also significant difference fpg ppg homair key enzyme renin angiotensin system ras ace converts angiotensin ang vasoconstrictor ang ii thought responsible physiological pathophysiological effects ras classical view ras challenged discovery enzyme ace<NUMBER> degrades ang ii also leads formation vasodilatory antiproliferative peptide ang <NUMBER> <NUMBER> sarscov infection mediated binding spike protein cellular receptor target cells recent study proved ace<NUMBER> functional receptor sarscov protein <NUMBER> <NUMBER> investigation ace<NUMBER> protein localization <NUMBER> human organs found ace<NUMBER> abundant epithelia lung small intestine sarscov might enter <NUMBER> another investigation <NUMBER> human tissues harmer colleagues <NUMBER> confirmed ace<NUMBER> mrna expression bronchus lung parenchyma ileum testis cardiovascular renal gastrointestinal tissues pancreas fig <NUMBER> probability event free death survival among sars patients divided two groups yes red line green line old age c<NUMBER> years male gender anemia hb <NUMBER> men <NUMBER> women thrombocytopenia <NUMBER> <NUMBER> <NUMBER> <NUMBER> per l low level cd<NUMBER> <NUMBER> cd<NUMBER> <NUMBER> lymphocytes clinically significant elevation alt c<NUMBER> iul ast c<NUMBER> iul ldh c<NUMBER> iul scr c<NUMBER> lmoll men c<NUMBER> lmoll women hypoxia sao <NUMBER> <NUMBER> hyperglycemia fpg c<NUMBER> mmoll b multivariate baseline predictors death including old age c<NUMBER> years elevated alt c<NUMBER> iul elevated ldh c<NUMBER> iul hyperglycemia fpg c<NUMBER> mmoll among sars patients presented hazard ratio <NUMBER> ci multisystem nature sars infection demonstrated several autopsy studies <NUMBER> <NUMBER> <NUMBER> studies demonstrated atypical pathological changes hydropic degeneration fatty degeneration interstitial cell proliferation involving liver heart kidney pancreas patients suspected died sars one study alimentary tract digestive glands seven sars autopsies routine pathology electron microscopy em situ hybridization ish immunohistochemistry realtime polymerase chain reaction pcr found evidence direct viral infection liver pancreas <NUMBER> another study patients died sars immunohistochemistry situ hybridization using murine monoclonal antibody specific sarscov nucleoprotein probes specific sarscov rna polymerase gene fragment respectively found sarscov mainly lung distal convoluted renal tubule much lesser extent pancreas liver <NUMBER> interestingly ace<NUMBER> mrna detectable low levels rat liver increased following bile duct ligation <NUMBER>fold healthy livers ace<NUMBER> protein confined endothelial cells occasional bile ducts perivenular hepatocytes human cirrhosis widespread parenchymal expression <NUMBER>fold ace<NUMBER> protein <NUMBER> study immunostaining ace<NUMBER> protein strong pancreatic islets weak exocrine tissues abundant ace<NUMBER> immunostaining found alveolar epithelial cells lung parietal epithelial cells kidney myocardium heart hepatocytes differences ace<NUMBER> expression different organs consistent findings showing b negative immunostaining control shows nonspecific staining especially caused endogenous biotin c expression ace<NUMBER> pancreas assessed immunohistochemistry shows endocrine tissue strongly positive compared exocrine tissue lung marked ace<NUMBER> immunostaining found type type ii alveolar epithelial cells capillary endothelium e kidney ace<NUMBER> weakly present glomerular visceral parietal epithelium strongly present brush border cytoplasm proximal tubular cells cytoplasm distal tubules collecting ducts f heart ace<NUMBER> present myocytes myocardium border zone endothelium smalltolarge arteries well sporadically within smooth muscle vessels g liver küpffer cells hepatocytes endothelium sinusoids negative differences survival associated elevations various parameters significant elevation levels ast ldh scr severe hypoxia associated higher death rate suggested sars damaged several organs including heart kidney lung however significant elevation alt indicator liver damage associated higher mortality results implied higher level expression greater level damage sarscov interestingly hyperglycemia another possible reason higher death rate supported idea coronavirus acutely damaged pancreatic islets leading hyperglycemia consistent finding pancreatic islets strongly immunopositive ace<NUMBER> exocrine tissues weakly positive almost reports pancreatitis patients sars many viruses enteroviruses coxsackie b virus retroviruses rubella mumps cytomegalovirus epsteinbarr varicella zoster virus implicated basis temporal geographical associations development type <NUMBER> diabetes humans indeed serological evidence infection isolation viruses pancreas reported cases recently diagnosed diabetes <NUMBER> <NUMBER> previous report hyperglycemia independent predictor death patients even mild sars receiving glucocorticoid medications course higher level fpg <NUMBER> followup study diabetes occurred hospitalization <NUMBER> <NUMBER> patients received corticosteroids course sars <NUMBER> years followup two patients diabetes also <NUMBER> years followup fpg ppg insulin levels similar sars group matched healthy nonsars siblings suggested damage islets sarscov transient causal relation varicella zoster virus onset diabetes suggested two individuals presenting acute insulin dependent diabetes mellitus brief period <NUMBER> infected chicken pox recent past good diabetic control established insulin withdrawn weeks followup next two years reveal recurrence diabetes brief found sarscov damaged kidney heart lung endocrine part pancreas indicated results initial assays scr ldh ckmb sao <NUMBER> fpg measures predictors death correlated ace<NUMBER> expression multiple organs expression exocrine endocrine tissues pancreas suggests sarscov may damage islets cause acute insulin dependent diabetes mellitus <NUMBER> december <NUMBER> several clusters unusual pneumonia reported wuhan china <NUMBER> analysis five patient samples identified causative agent novel severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> enveloped positivesense rna virus <NUMBER> identical whole genome level bat coronavirus <NUMBER> later named <NUMBER> novel coronavirus <NUMBER> <NUMBER> clinical manifestations pneumonia ranged mild lower respiratory tract symptoms severe manifestations acute respiratory distress syndrome ards associated high mortality <NUMBER> new disease named <NUMBER> coronavirus disease covid<NUMBER> <NUMBER> usa reported first case <NUMBER> january <NUMBER> washington <NUMBER> <NUMBER> march <NUMBER> declared covid<NUMBER> pandemic <NUMBER> <NUMBER> cases <NUMBER> countries <NUMBER> deaths <NUMBER> <NUMBER> april <NUMBER> <NUMBER> <NUMBER> <NUMBER> cases worldwide <NUMBER> <NUMBER> deaths usa made <NUMBER> <NUMBER> confirmed cases <NUMBER> deaths <NUMBER> diabetes mellitus consistently one common comorbidities found patients covid<NUMBER> guan et al <NUMBER> showed approximately <NUMBER> patients covid<NUMBER> diabetes comorbidity however prevalence diabetes almost threefold higher covid<NUMBER> patients severe disease <NUMBER> compared nonsevere disease <NUMBER> zhou et al <NUMBER> showed diabetes associated comorbidity <NUMBER> patients covid<NUMBER> survived increased <NUMBER> nonsurvivors li et al <NUMBER> recently published metaanalysis six published studies showed incidence diabetes intensive care unit icu patients covid<NUMBER> twofold higher nonicu patients cdc recently reported <NUMBER> incidence diabetes <NUMBER> among <NUMBER> patients usa completed information underlying health conditions potential risk factors available <NUMBER> march <NUMBER> incidence diabetes <NUMBER> hospitalized increased <NUMBER> hospitalized nonicu <NUMBER> admitted icu thus almost onethird patients covid<NUMBER> admitted icu severe disease usa diabetes underlying health condition taken together diabetes may associated higher risk severe covid<NUMBER> disease necessity mechanical ventilation well risk death patients covid<NUMBER> develop severe lung disease requiring mechanical ventilation icu associated significant mortality chen et al <NUMBER> recently shown compared moderate cases severe cases covid<NUMBER> frequently lymphopenia hypoalbuminemia higher levels alanine aminotransferase lactate dehydrogenase ldh c reactive protein crp ferritin ddimer well markedly higher levels interleukin il <NUMBER> receptor il<NUMBER>r il<NUMBER> il<NUMBER> tumor necrosis factor alpha tnfα authors showed absolute number lymphocytes cd<NUMBER> cells cd<NUMBER> cells decreased nearly patients markedly lower severe cases moderate cases expressions interferongamma ifnγ cd<NUMBER> cells tended lower severe cases moderate cases authors concluded sarscov<NUMBER> infection induced cytokine storm lymphopenia particularly decrease cd<NUMBER> cell cd<NUMBER> cell counts well suppressed ifnγ production cd<NUMBER> cells might correlated disease severity similarly huang et al <NUMBER> shown compared nonicu patients icu patients severe covid<NUMBER> higher plasma levels il<NUMBER> il<NUMBER> il<NUMBER> tnfalpha diabetes associated severe covid<NUMBER> lung disease requiring admission icu report journal yan et al <NUMBER> studied clinical characteristics outcomes <NUMBER> severe covid<NUMBER> patients diabetes compare <NUMBER> patients editorial severe covid<NUMBER> without diabetes hospitalized china retrospective single center observational study authors demonstrate compared nondiabetics patients diabetes severe covid<NUMBER> exhibited severe inflammatory response likely receive mechanical ventilation higher mortality reduced survival duration indeed mortality rate <NUMBER> patients diabetes severe covid<NUMBER> disease <NUMBER> without diabetes alarming although authors caution patient population hospitalized sicker overall higher mortality <NUMBER> compared published analysis furthermore patients diabetes higher white cell count neutrophil count crp il<NUMBER>r il<NUMBER> il<NUMBER> ddimer ldh well nterminal probtype natriuretic peptide ntprobnp lower lymphocyte count results suggest greater proinflammatory cytokine response compared nondiabetics may also cautioned severe covid<NUMBER> patients diabetes older age associated comorbidities including hypertension cardiovascular disease cerebrovascular disease nondiabetic patients although even adjustment comorbidities patients diabetes lower survival rate nondiabetics unfortunately patients type <NUMBER> diabetes included analysis information group would helped assess outcomes younger covid<NUMBER> patients diabetes also less likely associated comorbidities authors show survivors covid<NUMBER> diabetes differ significantly nonsurvivors diabetes prevalence associated comorbidities including hypertension cardiovascular disease cerebrovascular disease chronic pulmonary disease men diabetes severe covid<NUMBER> likely die addition nonsurvivors diabetes higher white cell neutrophil count crp il<NUMBER>r il<NUMBER> tnfalpha lower lymphocyte count also nonsurvivors diabetes greater impairment cardiac higher troponin hepatic renal coagulation parameters survival patients diabetes independent overall glycemic control glycated hemoglobin hospitalization however may pointed given small number patients diabetes survived nine patients compared nonsurvivors <NUMBER> patients analysis interpreted caution conclusion yan et al shown patients diabetes severe covid<NUMBER> higher proinflammatory cytokines worse survival rate nondiabetics diabetes prevalence high usa china countries india covid<NUMBER> cases continuing increase thus diabetes covid<NUMBER> pose significant challenge healthcare providers globally given significant mortality severe disease contributors mi mb wrote first draft manuscript authors contributed critically reviewing paper approved final version funding authors declared specific grant research funding agency public commercial notforprofit sectors competing interests none declared patient consent publication required provenance peer review commissioned internally peer reviewed open access open access article distributed accordance creative commons attribution non commercial cc bync <NUMBER> license permits others distribute remix adapt build upon work noncommercially license derivative works different terms provided original work properly cited appropriate credit given changes made indicated use noncommercial see http creativecommons org licenses bync <NUMBER> <NUMBER> mandeep bajaj http orcid org <NUMBER> past two decades outbreak prevalence severe acute respiratory infections seen one serious hazards global health two prominent coronaviruses <NUMBER> sarscov <NUMBER> merscov markedly affected humans causing <NUMBER> <NUMBER> infections well <NUMBER> <NUMBER> deaths respectively <NUMBER> <NUMBER> early december <NUMBER> series pneumonia cases unknown reason emerged wuhan hubei china highthroughput sequencing lower respiratory tract samples revealed novel coronavirus named <NUMBER> novel coronavirus <NUMBER>ncov also named sarscov<NUMBER> <NUMBER> february <NUMBER>th <NUMBER> <NUMBER> confirmed cases <NUMBER> death cases documented china <NUMBER>ncov also targets respiratory tract shares many similar clinical symptoms sarscov merscov <NUMBER> common symptoms include fever fatigue dry cough followed always anorexia myalgia dyspnea bo li jing yang contributed equally article bo li libosubmit<NUMBER>com yunhe zhao zhaoyunhemedmailcomcn <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> lymphopenia prolonged prothrombin time also common characteristics <NUMBER> <NUMBER> <NUMBER> addition cardiologists also concerned whether patients cardiovascular disease greater risk <NUMBER>ncov whether new coronavirus infections impact cardiovascular system previous studies shown relationship cardiovascular metabolic diseases sars mers <NUMBER> <NUMBER> <NUMBER> systematic analysis <NUMBER> merscov cases showed diabetes hypertension prevalent <NUMBER> patients cardiac diseases present <NUMBER> cases <NUMBER> diabetes seen independent predictor mortality morbidity patients sars <NUMBER> spread <NUMBER>ncov increase cases <NUMBER>ncov infected individuals exhibit comorbidities hypertension diabetes cardiacerebrovascular disease chens study <NUMBER> cases <NUMBER> patients cardiacerebrovascular disease <NUMBER> huangs study <NUMBER> cases <NUMBER> patients diabetes <NUMBER> cardiovascular metabolic comorbidities might render susceptible poor prognosis given rapid spread <NUMBER>ncov updated metaanalysis significantly larger sample sizes integrating published studies urgently warranted accordingly present analysis identify cardiovascular epidemiological clinical characteristics <NUMBER>ncov infection greater precision also unravel impact infection cardiac injury preferred reporting items systematic reviews metaanalyses individual participant data prismaipd statement followed conduct reporting metaanalysis <NUMBER> identify studies illustrating prevalence impact cardiovascular metabolic diseases <NUMBER> novel coronavirus infection china embase pubmed carefully searched december <NUMBER> february <NUMBER> following search terms keywords used alone combination novel coronavirus influenza pneumonia cardiovascular disease hypertension diabetes cardiac injury inclusion criteria follows <NUMBER> comparative studies randomised controlled trials rcts nonrcts published english <NUMBER> study population ten participants included study <NUMBER> study intervention patients studies confirmed infected <NUMBER> novel coronavirus <NUMBER> parameters comorbidities cardiovascular metabolic diseases outcome cardiac injury given case reports nonhuman studies studies without adequate information studies written chinese fear data duplication excluded present metaanalysis prevalence comorbidities including hypertension cardiovascular cerebrovascular diseases diabetes table <NUMBER> fig <NUMBER> together clinical outcome cardiac injury confirmed elevation troponin creatine kinase seen second choice troponin provided extracted identified studies table <NUMBER> fig <NUMBER> primary outcome measure compare prevalence comorbidities impact cardiac injury icu nonicu cases severe nonsevere data second choice icu data provided cochrane collaborations tool followed assess risk bias analyses performed using openmeta analyst version <NUMBER> https wwwcebmbrown eduopenmeta revman software version <NUMBER> forest plots used illustrate prevalence cardiovascular metabolic diseases <NUMBER>ncov infection severity selected studies well impact <NUMBER>ncov infection cardiac injury results included studies performed fixedeffect models mantelhaenszel method <NUMBER> randomeffect models cases significant heterogeneity estimates <NUMBER> used <NUMBER> statistics assess magnitude heterogeneity <NUMBER> <NUMBER> <NUMBER> represented low moderate high degrees heterogeneity respectively chosen proper effect model based analysis results fixed effect model used <NUMBER> <NUMBER> random effect model used <NUMBER> ≥ <NUMBER> <NUMBER> initially identifying <NUMBER> articles <NUMBER> duplicate documents identified leaving trials review titles abstracts <NUMBER> documents nonhuman researches reviews studies clinical trials excluded leaving <NUMBER> studies carefully detailed evaluated last six studies excluded participants trials meet criteria set one study published medrxiv added finally total six studies <NUMBER> patients included <NUMBER> <NUMBER> <NUMBER> <NUMBER> fig <NUMBER> selected studies published <NUMBER> different sample patient sizes ranged <NUMBER> <NUMBER> patients table <NUMBER> summarizes study characteristics systematic analysis studies described epidemiological clinical features covid<NUMBER> cases reported prevalence cardiovascular metabolic diseases well impact cardiac injury infectious disease identified six reports <NUMBER> patients table <NUMBER> majority cases localized wuhan recent travel wuhan contact people wuhan median ages respectively <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> years old according six studies infection diagnosed throughout whole spectrum age covering new born <NUMBER> years old studies men likely infected women overall proportion male <NUMBER> metaanalysis identified studies showed prevalent cardiovascular metabolic comorbidities hypertension <NUMBER> <NUMBER> ci <NUMBER> cardiacerebrovascular disease <NUMBER> <NUMBER> ci <NUMBER> followed diabetes <NUMBER> <NUMBER> ci <NUMBER> fig <NUMBER> significant heterogeneity cochrans q estimates comorbidities among identified studies <NUMBER> index varied <NUMBER> <NUMBER> fig <NUMBER> compared difference prevalence three diseases severe patients nonsevere patients icu patients vs nonicu patients according data studies hypertension cardiacerebrovascular disease heterogeneity test results calculated <NUMBER> <NUMBER> <NUMBER> thus fixedeffect model used analyses results three included studies total amount <NUMBER> patients showed hypertension accounted <NUMBER> icu severe cases <NUMBER> nonicusevere cases similar pattern found cardiacerebrovascular disease statistics accounted <NUMBER> icusevere cases <NUMBER> nonicusevere cases proportion hypertension cardiacerebrovascular disease statistically significant higher icusevere patients compared nonicusevere patients hypertension rr <NUMBER> <NUMBER> ci <NUMBER> <NUMBER> z <NUMBER> p <NUMBER> cardiacerebrovascular disease rr <NUMBER> <NUMBER> ci <NUMBER> <NUMBER> z <NUMBER> p <NUMBER> fig <NUMBER> diabetes heterogeneity test showed <NUMBER> <NUMBER> random effect model used diabetes accounted <NUMBER> icusevere cases <NUMBER> nonicusevere cases result indicated higher proportion diabetes icusevere patients without statistical significance rr <NUMBER> <NUMBER> ci <NUMBER> <NUMBER> z <NUMBER> p <NUMBER> fig <NUMBER> last focused impact covid<NUMBER> cardiac injury two studies gave clear data statistically analyzed data showed <NUMBER> <NUMBER> ci <NUMBER> patients might suffered acute cardiac injury another two studies gave data creatine kinase seen biomarker cardiac injury proportion might <NUMBER> <NUMBER> ci <NUMBER> attempted compare differences cardiac injury incidences icusevere patients nonicusevere patients included two studies specifically identified myocardial injury data showed significant higher incidence acute cardiac injury icusevere patients compared nonicusevere patients rr <NUMBER> <NUMBER> ci <NUMBER> <NUMBER> z <NUMBER> p <NUMBER> fig <NUMBER> funnel plots demonstrated symmetrical distributions effect size hypertension cardiacerebrovascular diseases cardiac injury either side pooled estimate nonsymmetrical distribution effect size diabetes fig <NUMBER> coronaviruses enveloped rna viruses include six species cause diseases humans knowledge <NUMBER> four viruses among <NUMBER>e oc<NUMBER> nl<NUMBER> hku<NUMBER> reported cause common cold symptoms immunocompetent individuals <NUMBER> however two strains infamous sarscov merscov linked fatal illness caused plagues large numbers deaths <NUMBER> complete genome sequences <NUMBER>ncov showed identified novel betacoronavirus belonging sarbecovirus subgenus coronaviridae family subgenus sarscov <NUMBER> according previous research sarscov presence comorbidities increased mortality risk cardiac disease diabetes important components predict adverse outcomes <NUMBER> cardiac disease diabetes increase risk death twice much risk factors <NUMBER> thus necessary us evaluate prevalence cardiac metabolic diseases covid<NUMBER> present systematic analysis summarized data five studies covid<NUMBER> results demonstrated overall proportion hypertension cardiacerebrovascular disease diabetes respectively <NUMBER> <NUMBER> <NUMBER> according summary <NUMBER> report cardiovascular diseases china morbidities hypertension diabetes respectively <NUMBER> <NUMBER> <NUMBER> million cerebrovascular disease patients <NUMBER> million cardiovascular patients <NUMBER> therefore comparing data report find people hypertension diabetes susceptible <NUMBER>ncov infection prevalence hypertension diabetes people infected virus general population even slightly lower however comparing general population incidence cardiacerebrovascular disease patients covid<NUMBER> obviously much higher due sample size limited time far data collection still incomplete studies analyzed comorbidities death cases relationship cardiovascular metabolic diseases covid<NUMBER>induced death cannot determined assuredly patients hypertension cardiacerebrovascular diseases diabetes likely develop severeicu cases <NUMBER>ncov infection overall proportion hypertension cardiacerebrovascular diseases diabetes twofolds threefolds twofolds respectively higher icusevere cases nonicusevere counterparts although difference diseases metaanalysis statistical fig <NUMBER> metaanalysis proportion hypertension cardiacerebrovascular disease diabetes covid<NUMBER> cases weights calculated binary randomeffects model analysis values represent proportions <NUMBER> diseases covid<NUMBER> patients <NUMBER> ci heterogeneity analysis carried using q test among studies variation <NUMBER> index forest plots depict comparison incidences <NUMBER> diseases icusevere nonicusevere patients ◂ fig <NUMBER> metaanalysis incidence cardiac injury covid<NUMBER> cases weights calculated binary randomeffects model analysis values represent proportions cardiac injury covid<NUMBER> patients <NUMBER> ci heterogeneity analysis carried using q test among studies variation <NUMBER> index forest plots depict comparison incidences cardiac injury icu severe nonicusevere patients fig <NUMBER> funnel plots comparisons hypertension cardiacerebrovascular disease diabetes acute cardiac injury icusevere nonicusevere patients rr value <NUMBER> consider might sample size included studies algorithm adopts random effect model conservative approach speculate result might reach statistical significance researches publish data another important finding damage virus heart according present summary least <NUMBER> patients covid<NUMBER> suffered acute cardiac injury chens report first death <NUMBER>year old man previous chronic underlying disease admitted icu developed severe respiratory failure heart failure sepsis experienced sudden cardiac arrest <NUMBER>th day admission declared dead <NUMBER> case reminded us patients novel coronavirus might develop acute cardiac injury analysis indicates us incidence myocardial injury much higher icusevere patients <NUMBER> folds nonicucardiac patients furthermore observation also reminded us patients covid<NUMBER> associated unstable angina stemi poor cardiac reserve lower tolerance severe pneumonia likely develop cardiac insufficiency leading deterioration according information released shanghai health commission first covid<NUMBER> death shanghai patient <NUMBER> years old serious history hypertension cardiac dysfunction analysis death causes suggested patient died heart failure systemic multiple organ dysfunction course onset <NUMBER> ncov infection inducement pathogenesis <NUMBER> ncov infectionrelated acute myocardial injury still unknown according clinical presentation lab data disease well pathogenesis sarscov speculated <NUMBER>ncov infection may affect cardiovascular system multiple mechanisms first viral infection directly causes damage cardiomyocyte according oudits study sarscov viral rna detected <NUMBER> autopsied human heart samples sarscov infected patients toronto sars outbreak <NUMBER> also confirmed pulmonary infection human sarscov mice led ace<NUMBER>dependent myocardial infection <NUMBER> ace<NUMBER> important target sarscov <NUMBER> molecular modelling shown high structural similarity receptorbinding domains sarscov <NUMBER>ncov <NUMBER> ace<NUMBER> expression highly tissuespecific mainly expressed cardiovascular renal gastrointestinal systems small amount expressed lung cells therefore addition coronaviruses causing pneumonia ace<NUMBER> receptors lung epithelial cells also need pay attention possible viral effects myocardial tissue second hypoxaemia may also important reason cardiac injury huangs study <NUMBER> covid<NUMBER> patients various degree hypoxaemia need required highflow nasal cannula higherlevel oxygen support chens study <NUMBER> patients require oxygen therapy due severe <NUMBER>ncov infection pneumonia may cause significant gas exchange obstruction leading hypoxaemia significantly reduces energy supply cell metabolism increases anaerobic fermentation causing intracellular acidosis oxygen free radicals destroy phospholipid layer cell membrane meanwhile hypoxiainduced influx calcium ions also leads injury apoptosis cardiomyocytes third huangs study noted high concentration il<NUMBER>β ifnγ ip<NUMBER> mcp<NUMBER> could detected patients infected <NUMBER>ncov might lead activated thelper<NUMBER> th<NUMBER> cell responses <NUMBER> furthermore also found icu patients much higher concentrations inflammatory factors nonicu patients suggesting cytokine storm associated disease severity <NUMBER> addition repeated floods catecholamines due anxiety side effects medication also lead myocardial damage conclusion patients previous cardiovascular metabolic diseases may face greater risk infection <NUMBER>ncov also greatly affect development prognosis pneumonia simultaneously pay close attention viral infectionrelated heart damage course disease treatment coronavirus disease covid<NUMBER> caused severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> virus mainly causes lung immune system damage covid<NUMBER> currently global pandemic caused large number deaths many countries several studies shown severity mortality covid<NUMBER> related age comorbidities including diabetes hypertension cardiovascular cerebrovascular diseases <NUMBER> <NUMBER> hba<NUMBER>c considered gold standard evaluating blood glucose level provides average value past httpsdoiorg<NUMBER>jdiabres<NUMBER> <NUMBER>ó <NUMBER> elsevier bv rights reserved <NUMBER> months high hba<NUMBER>c level related risk complications diabetic patients <NUMBER> however whether increase hba<NUMBER>c level related high inflammation hypercoagulability mortality covid<NUMBER> patients reported performed retrospective study evaluate effect high hba<NUMBER>c level mortality inflammation covid<NUMBER> patients abnormal glucose metabolism materials methods admission period february <NUMBER> <NUMBER> hba<NUMBER>c levels <NUMBER> patients tested positive covid<NUMBER> <NUMBER> wards wuhan tongji hospital determined four patients excluded study following factors affected hba<NUMBER>c level <NUMBER> patients receiving glucocorticoids kidney transplantation chronic systemic lupus erythematosus <NUMBER> hemolytic anemia patient <NUMBER> patient myelosuppression leukemia chemotherapy excluding patients <NUMBER> patients finally included patients baseline demographic characteristics given table <NUMBER> covid<NUMBER> diagnosed based chinese novel coronavirus pneumonia diagnosis treatment plan trial version seven issued national health commission peoples republic china <NUMBER> diabetes diagnosed based <NUMBER> diagnostic criteria diabetes <NUMBER> covid<NUMBER> patients divided three groups b c patients group diabetes hba<NUMBER>c level <NUMBER> patients group b diabetes hba<NUMBER>c level <NUMBER> patients group c diabetic <NUMBER> patients group <NUMBER> patients group b <NUMBER> patients group c thirtyone patients <NUMBER> group c history type <NUMBER> diabetes <NUMBER> patients <NUMBER> newly diagnosed diabetes patients history diabetes received one oral hypoglycemic drug hospital admission common drug received metformin followed acarbose <NUMBER> patients <NUMBER> receiving insulin therapy admission since retrospective cohort study data pertaining patient characteristics medical history symptoms signs laboratory examination results blood oxygen saturation sao <NUMBER> admission final clinical outcomes collected electronic medical record system analysis laboratory examination results minimum blood leukocyte lymphocyte count values maximum values ferritin crp interleukin tumor necrosis factora tnfa lactate dehydrogenase ldh levels fibrinogen fbg erythrocyte sedimentation rate esr considered study date onset covid<NUMBER> considered based date onset symptoms patients treated accordance chinese novel coronavirus pneumonia diagnosis treatment plan trial version seven followed april <NUMBER> <NUMBER> study approved ethics committee peking university peoples hospital categorical variables expressed terms frequency percentage compared using chisquare test continuous variables expressed mean ± standard deviation normal distribution compared performing analysis variance median interquartile range iqr used skewed distribution pvalue <NUMBER> considered statistically significant statistical analyses performed using spss statistics windows version <NUMBER> ibm usa total <NUMBER> patients tested positive covid<NUMBER> undergoing sarscov<NUMBER> rna test included study median age patients <NUMBER> years iqr <NUMBER> years ranging <NUMBER> <NUMBER> years number men <NUMBER> number women <NUMBER> total <NUMBER> <NUMBER> patients comorbidities hypertension common <NUMBER> followed diabetes <NUMBER> cardiovascular cerebrovascular disease <NUMBER> chronic kidney disease <NUMBER> seven patients chronic renal failure undergoing longterm maintenance hemodialysis received intermittent renal replacement therapy irrt bedside hospitalization median time onset admission <NUMBER> iqr <NUMBER> days sao <NUMBER> <NUMBER> iqr <NUMBER> without oxygen inhalation time admission ranging <NUMBER> <NUMBER> table <NUMBER> median hba<NUMBER>c level <NUMBER> iqr <NUMBER> significant differences among groups regard various parameters including sao <NUMBER> serum ferritin crp esr fibrinogen fbg il<NUMBER> levels p <NUMBER> table <NUMBER> pairwise comparison within groups showed differences groups c groups b statistically significant terms esr crp serum ferritin fbg il<NUMBER> levels fig <NUMBER> correlation analysis revealed linear negative correlation sao <NUMBER> hba<NUMBER>c linear positive correlation serum ferritin crp fbg esr levels hba<NUMBER>c fig <NUMBER> total <NUMBER> patients died <NUMBER> hospitalization including <NUMBER> deaths group <NUMBER> <NUMBER> deaths group b <NUMBER> <NUMBER> deaths group c <NUMBER> patients underwent terminal withdrawal mechanical ventilation statistically significant difference groups c terms mortality rate p <NUMBER> table <NUMBER> study owing presence acute viral infections consider hba<NUMBER>c diagnostic standard diabetes according guidelines <NUMBER> first study report diabetic patients contracting covid<NUMBER> severe inflammation higher mortality <NUMBER> inflammations markers serum ferritin level crp level esr covid<NUMBER> cases coagulation factor fbg positively correlated hba<NUMBER>c level sao <NUMBER> negatively correlated hba<NUMBER>c level even patients elevated hba<NUMBER>c level diabetes levels inflammation markers fbg also significantly increased fig <NUMBER> p <NUMBER> however little known mechanism concerning increase levels inflammation markers hba<NUMBER>c level case covid<NUMBER> patients previous studies shown diabetes causes epithelial dysfunction pulmonary cilia increased vascular system permeability alveolar epithelial damage alveolar collapse also contributes abnormal immune system function <NUMBER> <NUMBER> similarly severely ill covid<NUMBER> patients lungs spleen lymph node structures damaged lymphocyte counts reduced <NUMBER> diabetes covid<NUMBER> may synergistically damage table <NUMBER> immune respiratory systems diabetic patients comorbidities due target organ damage together covid<NUMBER> leads severe inflammation hypercoagulability even low oxygenation eventually higher mortality covid<NUMBER> patients higher hba<NUMBER>c level may exhibit relatively higher level severity infection may also lead increase hba<NUMBER>c level previous studies also found severe acute respiratory syndrome sars patients even mild symptoms receive glucocorticoid therapy course disease higher fasting blood glucose levels <NUMBER> study excluding treatment exogenous corticosteroids hemolysis hba<NUMBER>c level <NUMBER> <NUMBER> patients still higher normal <NUMBER> <NUMBER> <NUMBER> patients newly diagnosed diabetes newonset diabetes patients previously reported studies along study suggest covid<NUMBER> may cause aggravate abnormal glucose metabolism possible mechanisms covid<NUMBER> causing abnormal glucose metabolism include islet b cell damage insulin resistance previous studies reported viruses directly cause pancreatic bcell damage <NUMBER> <NUMBER> angiotensin converting enzyme <NUMBER> ace<NUMBER> sarscov<NUMBER> receptor higher expression pancreatic endocrine tissues exocrine tissues <NUMBER> autopsy showed although small number islet cells degenerated pancreatic tissue immunohistochemical analysis polymerase chain reaction tests detect presence sarscov<NUMBER> pancreatic islet cells <NUMBER> thus indicating insufficient evidence regarding sarscov<NUMBER>induced damage islet cells levels plasminogen activator inhibitor <NUMBER> crp serum amyloid tnfa il<NUMBER>b il<NUMBER> shown increased obese type <NUMBER> diabetic patients il<NUMBER>b cause islet b cell dysfunction apoptosis levels factors reduced lifestylerelated changes weight loss suggests inflammatory markers may involved islet b cell damage insulin resistance <NUMBER> inflammatory factors released response sarscov<NUMBER> may also involved islet bcell damage insulin resistance resulting abnormal glucose metabolism study patients <NUMBER> iqr <NUMBER> days onset symptoms admission abnormal glucose metabolism long period time may cause increase hbv<NUMBER>c level limitations study first retrospective study bias caused excluding <NUMBER> patients may affected results second due limitation caused number deaths multivariate regression analysis could performed determine whether increase hba<NUMBER>c level independent risk factor death covid<NUMBER> patients third <NUMBER> years followup sars patients yang et al found fasting blood glucose postprandial blood glucose insulin levels sars group paired healthy nonsars siblings similar suggesting sarscovrelated islet damage insulin resistance short duration similarly whether increase hba<NUMBER>c level covid<NUMBER> patients transient also uncertain due short observation time hence investigations required conclusion hba<NUMBER>c associated inflammation hypercoagulability low sao <NUMBER> covid<NUMBER> patients mortality rate higher diabetic patients performing hba<NUMBER>c test admission helpful assessing inflammation hypercoagulability prognosis type <NUMBER> diabetes t<NUMBER>d correlates worse outcome covid<NUMBER> zhu et al show among <NUMBER> cases covid<NUMBER> t<NUMBER>d associated higher death rate diabetics better controlled blood glucose die lower rate diabetics poorly controlled blood glucose wellcontrolled blood glucose upper limit ≤ <NUMBER>mm poorlycontrolled blood glucose upper limit <NUMBER> mm death <NUMBER> diabetes c v <NUMBER> <NUMBER> novel coronavirus disease <NUMBER> caused infection newly emerged highly contagious coronavirus sarscov<NUMBER> wu mcgoogan <NUMBER> sarscov<NUMBER> mainly invades respiratory tract lungs leading new type coronavirus pneumonia severe cases covid<NUMBER> rapidly progress acute respiratory distress syndrome ards septic shock multiple organ dysfunction syndrome mods guan et al <NUMBER> elderly individuals along preexisting conditions hypertension cancer cardiovascular diseases diabetes mellitus acute kidney injury demonstrated higher risk developing severe cases covid<NUMBER> well suffering higher risk mortality zhang et al <NUMBER>b zhou et al <NUMBER> collision two global pandemics covid<NUMBER> type <NUMBER> diabetes t<NUMBER>d led grim reality t<NUMBER>d already second common comorbidity covid<NUMBER> however current evidence implicating t<NUMBER>d worse covid<NUMBER> prognosis mostly come relatively limitedsized cohorts deng peng <NUMBER> zhang et al <NUMBER>a zhou et al <NUMBER> thus clinical features patients t<NUMBER>d infected sarscov<NUMBER> remain comprehensively clarified largescale analysis needed efficiently precisely manage treatment patients well established patients diabetes susceptible infections general exhibit worse prognosis infected compared nondiabetic population kumar nathella babu <NUMBER> xu et al <NUMBER> higher susceptibility also previously observed coronaviral epidemics example patients severe acute respiratory syndrome sars preexisting t<NUMBER>d independently associated poor outcomes percentage known t<NUMBER>d history significantly higher among patients succumbed sars survived booth et al <NUMBER> yang et al <NUMBER> epidemiological studies also indicate t<NUMBER>d primary comorbidity associated severe lethal merscov infections alqahtani et al <NUMBER> regard current covid<NUMBER> pandemic several recent studies though limited participants already suggested t<NUMBER>d common comorbidity constitutes higher proportion patients severe icuadmitted cases covid<NUMBER> patients mild symptoms deng peng <NUMBER> wang et al <NUMBER> zhang et al <NUMBER>a zhou et al <NUMBER> associations diabetes worse outcome viral infections unexpected hyperglycemia detrimental control viremia inflammation aggravating morbidity mortality variety patients forbes et al <NUMBER> however overly rigid glucose control may increase risk severe hypoglycemia also lead increased mortality rodriguezgutierrez et al <NUMBER> consequently previous clinical trials examining effects glucose control mortality yielded conflicting results forbes et al <NUMBER> van den berghe et al <NUMBER> individuals covid<NUMBER> preexisting t<NUMBER>d key challenge clinicians improve outcomes face uncertainty regarding degree glycemic management maintained effects might benefits risks overall treatment thus detailed analyses data patients needed links plasma glucose levels clinic outcomes including mortality report performed retrospective longitudinal multicentered study cohort <NUMBER> confirmed covid<NUMBER> cases enrolled among <NUMBER> hospitals hubei province china focusing association plasma glucose levels clinic outcomes covid<NUMBER> patients t<NUMBER>d addition significant association diabetic status higher mortality rate patients covid<NUMBER> preexisting t<NUMBER>d versus nondiabetic subjects covid<NUMBER> study indicated wellcontrolled glycemia associated markedly improved outcome patients covid<NUMBER> preexisting t<NUMBER>d clinical characteristics patients covid<NUMBER> preexisting t<NUMBER>d upon admission clinic characteristics collected total <NUMBER> participants <NUMBER> confirmed cases covid<NUMBER> including <NUMBER> subjects preexisting t<NUMBER>d n <NUMBER> male <NUMBER> <NUMBER> nondiabetic cases n <NUMBER> male <NUMBER> figure <NUMBER> initial <NUMBER> cases enrolled <NUMBER> patients covid<NUMBER> excluded study including <NUMBER> clinical translational report patients younger <NUMBER> older <NUMBER> years old <NUMBER> patients without complete medical records <NUMBER> patients acute myocardial infarction <NUMBER> patients acute coronary syndrome <NUMBER> patients acute pulmonary embolism <NUMBER> patients acute stroke <NUMBER> patients acute severe pancreatitis <NUMBER> patients cirrhosis <NUMBER> patients stage <NUMBER> chronic renal insufficiency <NUMBER> patients severe congestive heart failure <NUMBER> patients pregnancy <NUMBER> patients malignancy <NUMBER> patients type <NUMBER> diabetes <NUMBER> patients history gestational diabetes <NUMBER> patient druginduced diabetes final cohort <NUMBER> covid<NUMBER> patients analyzed prevalence t<NUMBER>d <NUMBER> similar nationwide prevalence t<NUMBER>d china <NUMBER> wang et al <NUMBER> median ages <NUMBER> <NUMBER> <NUMBER> <NUMBER> diabetic nondiabetic groups respectively schematic overview illustrating participant enrollment cohort study various exclusion inclusion criteria among initial case group briefly total <NUMBER> patients covid<NUMBER> included various exclusion criteria <NUMBER> patients removed study remaining <NUMBER> patients data <NUMBER> patients without diabetes nont<NUMBER>d placed one group <NUMBER> individuals type <NUMBER> diabetes t<NUMBER>d placed second group <NUMBER> cases t<NUMBER>d <NUMBER> cases excluded due hypoglycemia lack bg readings remaining <NUMBER> cases t<NUMBER>d <NUMBER> considered wellcontrolled bg <NUMBER> poorly controlled bg two t<NUMBER>d groups <NUMBER> used propensity scorematched analysis bmi patients without t<NUMBER>d <NUMBER> <NUMBER> <NUMBER> <NUMBER> respectively median duration first symptom admission <NUMBER> days <NUMBER> groups major symptoms groups fever <NUMBER> cough <NUMBER> fatigue <NUMBER> dyspnea <NUMBER> similar general population patients chen et al <NUMBER> guan et al <NUMBER> huang et al <NUMBER> wang et al <NUMBER> patients t<NUMBER>d reported significantly higher incidences fatigue <NUMBER> versus <NUMBER> dyspnea <NUMBER> versus <NUMBER> compared nondiabetic group preexisting hypertension <NUMBER> versus <NUMBER> coronary heart disease chd <NUMBER> versus <NUMBER> cerebrovascular disease <NUMBER> versus <NUMBER> chronic kidney disease <NUMBER> versus <NUMBER> higher frequencies t<NUMBER>d group compared nondiabetic group chest ct scans indicated incidence bilateral lung lesion higher <NUMBER> versus <NUMBER> diabetic group compared nondiabetic patients heart rate respiratory rates show differences diabetic nondiabetic groups systolic blood pressure modestly higher diabetic group <NUMBER> mmhg versus <NUMBER> mmhg <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> lab findings showed blood glucose bg level much higher diabetic group compared nondiabetic group expected <NUMBER> mmoll <NUMBER> versus <NUMBER> mmoll <NUMBER> higher levels hba<NUMBER>c <NUMBER> <NUMBER> versus <NUMBER> <NUMBER> patients t<NUMBER>d significantly higher incidence lymphopenia <NUMBER> versus <NUMBER> higher ratio elevation leukocyte <NUMBER> versus <NUMBER> neutrophil <NUMBER> versus <NUMBER> counts peripheral blood relative nondiabetic individuals time elevated serum markers indicating inflammation creactive protein crp <NUMBER> versus <NUMBER> procalcitonin <NUMBER> versus <NUMBER> decreased kidney function creatinine <NUMBER> versus <NUMBER> increased coagulation status ddimer <NUMBER> versus <NUMBER> found frequently t<NUMBER>d group nondiabetic group furthermore spo<NUMBER> lower <NUMBER> occurred frequently diabetic group versus nondiabetic group <NUMBER> versus <NUMBER> admission patients covid<NUMBER> preexisting t<NUMBER>d require intensive inhospital treatment patients preexisting t<NUMBER>d received significantly intensive integrated treatments manage symptoms covid<NUMBER> nondiabetic subjects former group registered higher need antibiotics <NUMBER> versus <NUMBER> antifungal drugs <NUMBER> versus <NUMBER> systemic corticosteroids <NUMBER> versus <NUMBER> immunoglobin <NUMBER> versus <NUMBER> antihypertensive drug <NUMBER> versus <NUMBER> even vasoactive drugs <NUMBER> versus <NUMBER> oxygen inhalation <NUMBER> versus <NUMBER> noninvasive ventilation <NUMBER> versus <NUMBER> invasive ventilation <NUMBER> versus <NUMBER> also applied significantly frequently individuals t<NUMBER>d compared patients without t<NUMBER>d table s<NUMBER> <NUMBER>day followup period performed retrospective longitudinal analysis various parameters starting time admission hospital patient study noticed despite received aggressive treatment covid<NUMBER> comorbidities diabetic group greater incidences decreased lymphocyte counts increased neutrophil counts well higher levels serum interleukin<NUMBER> il<NUMBER> crp lactic dehydrogenase ldh accompanied higher bg levels compared nondiabetic group bg level also significantly associated comorbid hypertension chd incidences decreased lymphocyte count elevated neutrophil count levels serum crp creatinine entire cohort figure s<NUMBER> <NUMBER>day followup period starting admission inhospital death rate significantly higher patients preexisting t<NUMBER>d relative nondiabetic individuals <NUMBER> versus <NUMBER> p <NUMBER> table s<NUMBER> crude hr <NUMBER>day allcause mortality diabetic group versus nondiabetic individuals <NUMBER> <NUMBER> ci <NUMBER> p <NUMBER> table s<NUMBER> adjusting age gender hospital site admission hr allcause mortality two groups <NUMBER> <NUMBER> ci <NUMBER> p <NUMBER> table s<NUMBER> adjusted severity covid<NUMBER> found hr allcause mortality two groups <NUMBER> <NUMBER> ci <NUMBER> p <NUMBER> figure s<NUMBER> table s<NUMBER> adjust comorbidities closely related t<NUMBER>d including hypertension chd cerebrovascular disease chronic kidney disease diseases often coexist t<NUMBER>d furthermore individuals t<NUMBER>d greater occurrence ards <NUMBER> versus <NUMBER> acute heart injury <NUMBER> versus <NUMBER> acute kidney injury <NUMBER> versus <NUMBER> septic shock <NUMBER> versus <NUMBER> disseminated intravascular coagulation dic <NUMBER> versus <NUMBER> nondiabetic group table s<NUMBER> mixedeffect cox analysis indicated t<NUMBER>d significantly correlated occurrence ards acute kidney injury septic shock respective adjusted hrs <NUMBER> <NUMBER> ci <NUMBER> <NUMBER> <NUMBER> ci <NUMBER> <NUMBER> <NUMBER> ci <NUMBER> adjusting age gender severity covid<NUMBER> among patients table s<NUMBER> current study based largest diabetic covid<NUMBER> cohort far analyzed results unequivocal implicate diabetes mellitus higher risk death detrimental outcomes covid<NUMBER> notably care must taken interpreting significant difference outcomes diabetic nondiabetic patients covid<NUMBER> since notable differences covariate distributions two groups pathophysiological mechanisms underlying impact t<NUMBER>d covid<NUMBER> progression remain fully investigated patients diabetes pulmonary dysfunction involving lung volume pulmonary diffusing capacity control ventilation bronchomotor tone neuroadrenergic bronchial innervation reported fuso et al <NUMBER> may account propensity poor outcomes patients covid<NUMBER> t<NUMBER>d time dysregulated immune response caused t<NUMBER>d likely also responsible increased disease severity covid<NUMBER> patients t<NUMBER>d higher ratio lymphopenia increased levels neutrophils serum crp il<NUMBER> observed patients covid<NUMBER> preexisting t<NUMBER>d study findings dovetail immune dysregulation observed coronavirus infectiontriggered pneumonia kulcsar et al <NUMBER> experimental model mers diabetic mice lower numbers inflammatory monocytes macrophages cd<NUMBER> cells accompanied lower levels ccl<NUMBER> cxcl<NUMBER> expression kulcsar et al <NUMBER> furthermore t<NUMBER>d associated activation reninangiotensin system different tissues candido et al <NUMBER> considering sarscov<NUMBER> utilizes angiotensinconverting enzyme <NUMBER> ace<NUMBER> bind gain entry infected cells hoffmann et al <NUMBER> lu et al <NUMBER> reduces expression ace<NUMBER> kuba et al <NUMBER> overactivation reninangiotensin system may also contribute increased adverse risk patients covid<NUMBER> diabetes respect application reninangiotensin system inhibitors may therapeutic effect patients covid<NUMBER> preexisting t<NUMBER>d among cohort covid<NUMBER> t<NUMBER>d <NUMBER> individuals wellcontrolled bg <NUMBER> males <NUMBER> <NUMBER> individuals poorly controlled bg <NUMBER> males <NUMBER> median bg level much lower wellcontrolled bg group poorly controlled bg group <NUMBER> mmoll <NUMBER> versus <NUMBER> mmoll <NUMBER> figure s<NUMBER> levels hba<NUMBER>c two groups <NUMBER> <NUMBER> <NUMBER> <NUMBER> respectively patients wellcontrolled bg group also significantly lower incidences lymphopenia <NUMBER> versus <NUMBER> lower rates increased counts leukocyte <NUMBER> versus <NUMBER> neutrophil <NUMBER> versus <NUMBER> elevated serum crp <NUMBER> versus <NUMBER> clinical translational report clinical manifestations including chest ct imaging incidences major comorbidities similar two groups admission even patients covid<NUMBER> t<NUMBER>d wellcontrolled bg acquired significantly less integrated treatments poorly controlled bg significantly lower frequency pharmacological therapy wellcontrolled bg group versus poorly controlled group including usage antivirals <NUMBER> versus <NUMBER> antibiotics <NUMBER> versus <NUMBER> antifungal drugs <NUMBER> versus <NUMBER> systemic corticosteroids <NUMBER> versus <NUMBER> immunoglobin <NUMBER> versus <NUMBER> vasoactive drugs <NUMBER> versus <NUMBER> incidences oxygen inhalation <NUMBER> versus <NUMBER> noninvasive ventilation <NUMBER> versus <NUMBER> invasive ventilation <NUMBER> versus <NUMBER> extracorporeal membrane oxygenation <NUMBER> versus <NUMBER> lower wellcontrolled group poorly controlled group table <NUMBER> reduced risk allcause mortality detrimental complications patients covid<NUMBER> preexisting t<NUMBER>d correlated persistent lower bg levels wellcontrolled group higher lymphocyte counts lower neutrophil counts lower serum levels il<NUMBER> crp ldh throughout <NUMBER>day observation period starting time hospital admission figure <NUMBER> noticed inhospital death rate significantly lower <NUMBER> versus <NUMBER> wellcontrolled group relative poorly controlled group table s<NUMBER> crude hr <NUMBER>day allcause mortality two groups <NUMBER> <NUMBER> ci <NUMBER> p <NUMBER> table s<NUMBER> adjusting age gender severity covid<NUMBER> comorbidities site effect hr allcause mortality wellcontrolled bg group versus poorly controlled bg group <NUMBER> <NUMBER> ci <NUMBER> p <NUMBER> table s<NUMBER> evalue point estimate <NUMBER> upper limit ci <NUMBER> relative poorly controlled bg control patients wellcontrolled bg group developed less frequent occurrences ards <NUMBER> versus <NUMBER> acute heart injury <NUMBER> versus <NUMBER> acute kidney injury <NUMBER> versus <NUMBER> septic shock <NUMBER> versus <NUMBER> dic <NUMBER> versus <NUMBER> table s<NUMBER> adjusting age gender severity covid<NUMBER> site effect comorbidities respective hrs ards acute heart injury <NUMBER> <NUMBER> ci <NUMBER> p <NUMBER> <NUMBER> <NUMBER> ci <NUMBER> table <NUMBER> table s<NUMBER> propensity scorematched psm analysis performed avoid confounding variables could interfered association bg levels allcause mortality due lack reliable indicators severity t<NUMBER>d specifically included t<NUMBER>drelated comorbidities matching since comorbidities closely related severity t<NUMBER>d dynamic trajectories blood glucose lymphocytes c neutrophils e relative levels il<NUMBER> b crp ldh f <NUMBER>day followup duration <NUMBER> confidence interval represented shaded regions patients poorly controlled bg orange patients wellcontrolled bg blue bg represents averaged median bg patients day tested comorbidities included hypertension cardiovascular disease cerebrovascular disease chronic liver disease chronic kidney injury able match <NUMBER> patients wellcontrolled bg group <NUMBER> patients poorly controlled bg group ratio <NUMBER> <NUMBER> individuals included psm analysis figure <NUMBER> applying mixedeffect cox model using hospital site random effect adjusting imbalanced durations symptom onset admission results consistently significantly demonstrated lower risk allcause mortality patients wellcontrolled bg group adjusted hr <NUMBER> <NUMBER> ci <NUMBER> p <NUMBER> compared poorly controlled bg group figure <NUMBER> tables <NUMBER> s<NUMBER> although stronger integrated treatment applied poorly controlled bg group table s<NUMBER> robustness association glycemic variability mortality assessed additional sensitivity analyses using different matching variables results sensitivity analyses similar analysis hrs <NUMBER> <NUMBER> ci <NUMBER> p <NUMBER> first sensitivity analysis <NUMBER> <NUMBER> ci <NUMBER> p <NUMBER> second analysis table s<NUMBER> psm analysis respective adjusted hrs ards acute heart injury acute kidney injury <NUMBER> <NUMBER> ci <NUMBER> p <NUMBER> <NUMBER> <NUMBER> ci <NUMBER> p <NUMBER> <NUMBER> <NUMBER> ci <NUMBER> p <NUMBER> wellcontrolled bg group poorly controlled bg group table <NUMBER> glycemic variability shown important indicator possible risk predictor death complications individuals t<NUMBER>d forbes et al <NUMBER> impact hyperglycemia pathogenesis viralinduced respiratory diseases remains unclear elevated bg level reported increase glucose concentration airway epithelial secretion philips et al <NUMBER> may disrupt defensive capacity airway epithelia hand rigid glucose control increases risk severe hypoglycemia also result increased mortality rodriguezgutierrez et al <NUMBER> study found compared individuals wellcontrolled bg poor glycemic control patients covid<NUMBER> preexisting t<NUMBER>d associated worse outcome involving increased need medical interventions multiorgan injuries higher mortalities contrast patients glycemic variability <NUMBER> <NUMBER> mmoll significant association reduced medical interventions major organ injuries allcause mortality findings provide direct evidence supporting recent suggestions clinical management t<NUMBER>d covid<NUMBER> bornstein et al <NUMBER> conclusion t<NUMBER>d important risk factor covid<NUMBER> progression adverse endpoints wellcontrolled bg maintaining glycemic variability within <NUMBER> <NUMBER> mmoll associated significant reduction composite adverse outcomes death findings provide critical insights clinical characteristics patients covid<NUMBER> preexisting t<NUMBER>d possible avenues improving disease outcomes due retrospective nature study unprecedented scale covid<NUMBER> pandemic study several limitations first data obtained patient cohorts admitted <NUMBER> hospitals hubei province china therefore effect bg control may different among patients covid<NUMBER> preexisting t<NUMBER>d outpatient setting ethnically geographically diverse populations second able retrieve prehospital status t<NUMBER>d current cohort due urgent circumstance covid<NUMBER> pandemic status prehospital t<NUMBER>d could significantly associated numerous clinical parameters known independent risk factors poor outcomes covid<NUMBER> including cardiovascular abnormalities immunological dysfunction performed psm analysis support independent association t<NUMBER>d covid<NUMBER> pathology influence cofounders cannot fully excluded also given lack prehospital data possible us access bg levels changed result covid<NUMBER> progression andor severity third number patients t<NUMBER>d wellcontrolled bg study modest might powered sufficiently reflect overall complexity general population therefore largescale prospective cohort studies required ethnically geographically diverse cohorts better understand association importance bg control disease progression covid<NUMBER> fourth given retrospective nature study possible us determine active management bg levels normal range could ameliorate covid<NUMBER> severity adverse outcomes finally individuals type <NUMBER> diabetes excluded analysis initial cohort possible blood glucose control may also affect outcomes covid<NUMBER> detailed methods provided online version paper include following propensity scorematched model age gender hospital sites indicators severity covid<NUMBER> comorbidities hypertension coronary heart disease cerebral vascular disease chronic liver disease chronic renal diseases incidence increased creatinine matched c mixedeffect cox model using hospital site random effect adjusting imbalanced durations symptom onset admission medical records patients analyzed integrated research team including physicians data scientists statisticians deidentification process removing personal information eg name id participants designating using coding system basic information epidemiological records clinical manifestations laboratory findings radiographic characteristics ct treatments outcomes hospitalization recorded major clinical symptoms ie fever cough fatigue dyspnea comorbidities collected laboratory findings included routine blood test fasting blood glucose bg <NUMBER> h postprandial bg <NUMBER> hpg creactive protein crp procalcitonin ddimer serum indicators liver injury kidney injury heart dysfunction experienced physician team reviewed interpreted doublechecked data guarantee accuracy date disease onset defined day first symptom covid<NUMBER> noticed severe cases defined according whether patients indication respiratory rate <NUMBER> breathsmin spo<NUMBER> <NUMBER> room air pao<NUMBER>fio<NUMBER> <NUMBER> mmhg t<NUMBER>d status designated based patients medical history guideline prevention control t<NUMBER>d china <NUMBER> chinese diabetes society <NUMBER> timing frequency obtaining fasting <NUMBER>h postprandial bg <NUMBER> hpg varied individuals depending necessity related severity comorbid t<NUMBER>d severe t<NUMBER>d status accordingly obtained frequent bg surveillances glycemic variability defined range lowest fasting bg fbg <NUMBER> hpg level observation period wellcontrolled bg defined glycemic variability ranged <NUMBER> <NUMBER> mmoll since normal range fasting bg <NUMBER> <NUMBER> mmoll lower <NUMBER> mmoll targeting level <NUMBER> hpg dm management according guideline prevention control t<NUMBER>d china <NUMBER> chinese diabetes society <NUMBER> poorlycontrolled bg defined lowest fasting bg equal <NUMBER> mmoll highest <NUMBER> hpg level exceeded <NUMBER> mmoll observation window hypertension diagnosed systolic blood pressure equal <NUMBER> mm hg andor diastolic blood pressure equal <NUMBER> mm hg ards septic shock defined following interim guideline clinical management severe acute respiratory infection novel coronavirus <NUMBER>ncov infection suspected cardiac injury defined serum level cardiac injury biomarkers cardiac troponin ctni cardiac troponin ctnt high sensitivity cardiac troponin hsctni higher upper limit normal uln acute liver injury defined acutely increased level serum alanine aminotransferase alt serum alkaline phosphatase alp upper limit normal uln observed marrone et al <NUMBER> acute kidney injury indicated value serum creatinine level reached exceeded <NUMBER> mmmoll within <NUMBER> h kellum et al <NUMBER> disseminated intravascular coagulation dic diagnosed according criteria published international society thrombosis hemostasis isth gando et al <NUMBER> primary endpoint study <NUMBER>day allcause death covid<NUMBER> patients secondary endpoints occurrence ards septic shock acute cardiac injury acute kidney injury dic variables potentially confounding association bg outcomes covid<NUMBER> addressed using propensity scorematching psm method waljee et al <NUMBER> psm requires complete set variables every patient randomly missing values <NUMBER> selected parameters noninvasive tests therefore imputed nonparameter imputation method missforest applied estimation imputation error <NUMBER> bootstrapped cross validation applied repeated <NUMBER> times evaluating imputation performance training data <NUMBER> parameters randomly introduced missforest method yielded <NUMBER> iqr <NUMBER> differences datasets parameters introduced algorithm psm follows logisticp lnp<NUMBER>p b<NUMBER> b<NUMBER>x<NUMBER> b<NUMBER>x<NUMBER> bkxk p eb<NUMBER> b<NUMBER>x<NUMBER> b<NUMBER>x<NUMBER> bkxk<NUMBER>eb<NUMBER> b<NUMBER>x<NUMBER> b<NUMBER>x<NUMBER> bkxk p formula predicted probability glucose control procedure beta value variable regression coefficient variable variables potentially confounding association bg outcomes covid<NUMBER> addressed using psm method evaluating association glucose control level outcomes psm cohorts identified balancing age gender fever cough dyspnea ctdiagnosed lung lesions spo<NUMBER> breath frequency incidence increased leukocyte count alt ast ddimer creatinine crp procalcitonin decreased lymphocyte count well comorbidities hypertension coronary artery disease cerebrovascular disease chronic liver diseases chronic renal disease propensity score predicted probability glucose change contributed variables estimated based multivariable logistic regression model matching ratio <NUMBER> wellcontrolled bg versus poorlycontrolled bg entire hospitalization exact matching caliper size <NUMBER> applied matching pairs according propensity scores evaluation balance covariates conducted estimating standardized differences matching small absolute value less <NUMBER> considered qualified balancing robustness association bg level allcause mortality assessed analyzing evalue mixedeffect cox proportional hazards model address unmeasured confounders using methodology vanderweele ding haneuse et al <NUMBER> mathur et al <NUMBER> vanderweele ding <NUMBER> two sensitivity analyses performed evaluate robustness propensity scorematched cohort analyses among pairs statistical analysis performed using r<NUMBER> r foundation statistical computing vienna austria spss statistics version <NUMBER> ibm armonk ny usa data continuous variables presented median interquartile range iqr data categorical variables presented frequency rates percentage comparison <NUMBER> groups analyzed using students tests normally distributed mannwhitney u test nonnormally distributed continuous variables comparison categorical variables analyzed fishers exact test c<NUMBER> test generalized linear model glm performed evaluate correlation median blood glucose factors related viral infection glycemic control patients diabetes risk composite endpoints corresponding hazard ratio hr analyzed using cox proportional hazard model mixedeffect cox model cumulative rates death plotted applying kaplanmeier method difference twoside less <NUMBER> considered statistically significant cell metabolism <NUMBER> <NUMBER>e<NUMBER>e<NUMBER> june <NUMBER> <NUMBER> e<NUMBER> type <NUMBER> diabetes t<NUMBER>d correlates worse outcome covid<NUMBER> zhu et al show among <NUMBER> cases covid<NUMBER> t<NUMBER>d associated higher death rate diabetics better controlled blood glucose die lower rate diabetics poorly controlled blood glucose wellcontrolled blood glucose upper limit ≤ <NUMBER>mm poorlycontrolled blood glucose upper limit <NUMBER> mm death <NUMBER> diabetes c v <NUMBER> <NUMBER> novel coronavirus disease <NUMBER> caused infection newly emerged highly contagious coronavirus sarscov<NUMBER> wu mcgoogan <NUMBER> sarscov<NUMBER> mainly invades respiratory tract lungs leading new type coronavirus pneumonia severe cases covid<NUMBER> rapidly progress acute respiratory distress syndrome ards septic shock multiple organ dysfunction syndrome mods guan et al <NUMBER> elderly individuals along preexisting conditions hypertension cancer cardiovascular diseases diabetes mellitus acute kidney injury demonstrated higher risk developing severe cases covid<NUMBER> well suffering higher risk mortality zhang et al <NUMBER>b zhou et al <NUMBER> collision two global pandemics covid<NUMBER> type <NUMBER> diabetes t<NUMBER>d led grim reality t<NUMBER>d already second common comorbidity covid<NUMBER> however current evidence implicating t<NUMBER>d worse covid<NUMBER> prognosis mostly come relatively limitedsized cohorts deng peng <NUMBER> zhang et al <NUMBER>a zhou et al <NUMBER> thus clinical features patients t<NUMBER>d infected sarscov<NUMBER> remain comprehensively clarified largescale analysis needed efficiently precisely manage treatment patients well established patients diabetes susceptible infections general exhibit worse prognosis infected compared nondiabetic population kumar nathella babu <NUMBER> xu et al <NUMBER> higher susceptibility also previously observed coronaviral epidemics example patients severe acute respiratory syndrome sars preexisting t<NUMBER>d independently associated poor outcomes percentage known t<NUMBER>d history significantly higher among patients succumbed sars survived booth et al <NUMBER> yang et al <NUMBER> epidemiological studies also indicate t<NUMBER>d primary comorbidity associated severe lethal merscov infections alqahtani et al <NUMBER> regard current covid<NUMBER> pandemic several recent studies though limited participants already suggested t<NUMBER>d common comorbidity constitutes higher proportion patients severe icuadmitted cases covid<NUMBER> patients mild symptoms deng peng <NUMBER> wang et al <NUMBER> zhang et al <NUMBER>a zhou et al <NUMBER> associations diabetes worse outcome viral infections unexpected hyperglycemia detrimental control viremia inflammation aggravating morbidity mortality variety patients forbes et al <NUMBER> however overly rigid glucose control may increase risk severe hypoglycemia also lead increased mortality rodriguezgutierrez et al <NUMBER> consequently previous clinical trials examining effects glucose control mortality yielded conflicting results forbes et al <NUMBER> van den berghe et al <NUMBER> individuals covid<NUMBER> preexisting t<NUMBER>d key challenge clinicians improve outcomes face uncertainty regarding degree glycemic management maintained effects might benefits risks overall treatment thus detailed analyses data patients needed links plasma glucose levels clinic outcomes including mortality report performed retrospective longitudinal multicentered study cohort <NUMBER> confirmed covid<NUMBER> cases enrolled among <NUMBER> hospitals hubei province china focusing association plasma glucose levels clinic outcomes covid<NUMBER> patients t<NUMBER>d addition significant association diabetic status higher mortality rate patients covid<NUMBER> preexisting t<NUMBER>d versus nondiabetic subjects covid<NUMBER> study indicated wellcontrolled glycemia associated markedly improved outcome patients covid<NUMBER> preexisting t<NUMBER>d patients younger <NUMBER> older <NUMBER> years old <NUMBER> patients without complete medical records <NUMBER> patients acute myocardial infarction <NUMBER> patients acute coronary syndrome <NUMBER> patients acute pulmonary embolism <NUMBER> patients acute stroke <NUMBER> patients acute severe pancreatitis <NUMBER> patients cirrhosis <NUMBER> patients stage <NUMBER> chronic renal insufficiency <NUMBER> patients severe congestive heart failure <NUMBER> patients pregnancy <NUMBER> patients malignancy <NUMBER> patients type <NUMBER> diabetes <NUMBER> patients history gestational diabetes <NUMBER> patient druginduced diabetes final cohort <NUMBER> covid<NUMBER> patients analyzed prevalence t<NUMBER>d <NUMBER> similar nationwide prevalence t<NUMBER>d china <NUMBER> wang et al <NUMBER> median ages <NUMBER> <NUMBER> <NUMBER> <NUMBER> diabetic nondiabetic groups respectively chen et al <NUMBER> guan et al <NUMBER> huang et al <NUMBER> wang et al <NUMBER> patients t<NUMBER>d reported significantly higher incidences fatigue <NUMBER> versus <NUMBER> dyspnea <NUMBER> versus <NUMBER> compared nondiabetic group preexisting hypertension <NUMBER> versus <NUMBER> coronary heart disease chd <NUMBER> versus <NUMBER> cerebrovascular disease <NUMBER> versus <NUMBER> chronic kidney disease <NUMBER> versus <NUMBER> higher frequencies t<NUMBER>d group compared nondiabetic group chest ct scans indicated incidence bilateral lung lesion higher <NUMBER> versus <NUMBER> diabetic group compared nondiabetic patients heart rate respiratory rates show differences diabetic nondiabetic groups systolic blood pressure modestly higher diabetic group <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> versus <NUMBER> mmhg <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> lab findings showed blood glucose bg level much higher diabetic group compared nondiabetic group expected <NUMBER> mmoll <NUMBER> versus <NUMBER> mmoll <NUMBER> higher levels hba<NUMBER>c <NUMBER> <NUMBER> versus <NUMBER> <NUMBER> patients t<NUMBER>d significantly higher incidence lymphopenia <NUMBER> versus <NUMBER> higher ratio elevation leukocyte <NUMBER> versus <NUMBER> neutrophil <NUMBER> versus <NUMBER> counts peripheral blood relative nondiabetic individuals time elevated serum markers indicating inflammation creactive protein crp <NUMBER> versus <NUMBER> procalcitonin <NUMBER> versus <NUMBER> decreased kidney function creatinine <NUMBER> versus <NUMBER> increased coagulation status ddimer <NUMBER> versus <NUMBER> found frequently t<NUMBER>d group nondiabetic group furthermore spo<NUMBER> lower <NUMBER> occurred frequently diabetic group versus nondiabetic group <NUMBER> versus <NUMBER> admission patients covid<NUMBER> preexisting t<NUMBER>d require intensive inhospital treatment patients preexisting t<NUMBER>d received significantly intensive integrated treatments manage symptoms covid<NUMBER> nondiabetic subjects former group registered higher need antibiotics <NUMBER> versus <NUMBER> antifungal drugs <NUMBER> versus <NUMBER> systemic corticosteroids <NUMBER> versus <NUMBER> immunoglobin <NUMBER> versus <NUMBER> antihypertensive drug <NUMBER> versus <NUMBER> even vasoactive drugs <NUMBER> versus <NUMBER> oxygen inhalation <NUMBER> versus <NUMBER> noninvasive ventilation <NUMBER> versus <NUMBER> invasive ventilation <NUMBER> versus <NUMBER> also applied significantly frequently individuals t<NUMBER>d compared patients without t<NUMBER>d table s<NUMBER> <NUMBER>day followup period performed retrospective longitudinal analysis various parameters starting time admission hospital patient study noticed despite received aggressive treatment covid<NUMBER> comorbidities diabetic group greater incidences decreased lymphocyte counts increased neutrophil counts well higher levels serum interleukin<NUMBER> il<NUMBER> crp lactic dehydrogenase ldh accompanied higher bg levels compared nondiabetic group bg level also significantly associated comorbid hypertension chd incidences decreased lymphocyte count elevated neutrophil count levels serum crp creatinine entire cohort figure s<NUMBER> <NUMBER>day followup period starting admission inhospital death rate significantly higher patients preexisting t<NUMBER>d relative nondiabetic individuals <NUMBER> versus <NUMBER> p <NUMBER> table s<NUMBER> crude hr <NUMBER>day allcause mortality diabetic group versus nondiabetic individuals <NUMBER> <NUMBER> ci <NUMBER> p <NUMBER> table s<NUMBER> adjusting age gender hospital site admission hr allcause mortality two groups <NUMBER> <NUMBER> ci <NUMBER> p <NUMBER> table s<NUMBER> adjusted severity covid<NUMBER> found hr allcause mortality two groups <NUMBER> <NUMBER> ci <NUMBER> p <NUMBER> figure s<NUMBER> table s<NUMBER> adjust comorbidities closely related t<NUMBER>d including hypertension chd cerebrovascular disease chronic kidney disease diseases often coexist t<NUMBER>d furthermore individuals t<NUMBER>d greater occurrence ards <NUMBER> versus <NUMBER> acute heart injury <NUMBER> versus <NUMBER> acute kidney injury <NUMBER> versus <NUMBER> septic shock <NUMBER> versus <NUMBER> disseminated intravascular coagulation dic <NUMBER> versus <NUMBER> nondiabetic group table s<NUMBER> mixedeffect cox analysis indicated t<NUMBER>d significantly correlated occurrence ards acute kidney injury septic shock respective adjusted hrs <NUMBER> <NUMBER> ci <NUMBER> <NUMBER> <NUMBER> ci <NUMBER> <NUMBER> <NUMBER> ci <NUMBER> adjusting age gender severity covid<NUMBER> among patients table s<NUMBER> current study based largest diabetic covid<NUMBER> cohort far analyzed results unequivocal implicate diabetes mellitus higher risk death detrimental outcomes covid<NUMBER> notably care must taken interpreting significant difference outcomes diabetic nondiabetic patients covid<NUMBER> since notable differences covariate distributions two groups pathophysiological mechanisms underlying impact t<NUMBER>d covid<NUMBER> progression remain fully investigated patients diabetes pulmonary dysfunction involving lung volume pulmonary diffusing capacity control ventilation bronchomotor tone neuroadrenergic bronchial innervation reported fuso et al <NUMBER> may account propensity poor outcomes patients covid<NUMBER> t<NUMBER>d time dysregulated immune response caused t<NUMBER>d likely also responsible increased disease severity covid<NUMBER> patients t<NUMBER>d higher ratio lymphopenia increased levels neutrophils serum crp il<NUMBER> observed patients covid<NUMBER> preexisting t<NUMBER>d study findings dovetail immune dysregulation observed coronavirus infectiontriggered pneumonia kulcsar et al <NUMBER> experimental model mers diabetic mice lower numbers inflammatory monocytes macrophages cd<NUMBER> cells accompanied lower levels ccl<NUMBER> cxcl<NUMBER> expression kulcsar et al <NUMBER> furthermore t<NUMBER>d associated activation reninangiotensin system different tissues candido et al <NUMBER> considering sarscov<NUMBER> utilizes angiotensinconverting enzyme <NUMBER> ace<NUMBER> bind gain entry infected cells hoffmann et al <NUMBER> lu et al <NUMBER> reduces expression ace<NUMBER> kuba et al <NUMBER> overactivation reninangiotensin system may also contribute increased adverse risk patients covid<NUMBER> diabetes respect application reninangiotensin system inhibitors may therapeutic effect patients covid<NUMBER> preexisting t<NUMBER>d among cohort covid<NUMBER> t<NUMBER>d <NUMBER> individuals wellcontrolled bg <NUMBER> males <NUMBER> <NUMBER> individuals poorly controlled bg <NUMBER> males <NUMBER> median bg level much lower wellcontrolled bg group poorly controlled bg group <NUMBER> mmoll <NUMBER> versus <NUMBER> mmoll <NUMBER> figure s<NUMBER> levels hba<NUMBER>c two groups <NUMBER> <NUMBER> <NUMBER> <NUMBER> respectively patients wellcontrolled bg group also significantly lower incidences lymphopenia <NUMBER> versus <NUMBER> lower rates increased counts leukocyte <NUMBER> versus <NUMBER> neutrophil <NUMBER> versus <NUMBER> elevated serum crp <NUMBER> versus <NUMBER> clinical translational report clinical manifestations including chest ct imaging incidences major comorbidities similar two groups admission even patients covid<NUMBER> t<NUMBER>d wellcontrolled bg acquired significantly less integrated treatments poorly controlled bg significantly lower frequency pharmacological therapy wellcontrolled bg group versus poorly controlled group including usage antivirals <NUMBER> versus <NUMBER> antibiotics <NUMBER> versus <NUMBER> antifungal drugs <NUMBER> versus <NUMBER> systemic corticosteroids <NUMBER> versus <NUMBER> immunoglobin <NUMBER> versus <NUMBER> vasoactive drugs <NUMBER> versus <NUMBER> incidences oxygen inhalation <NUMBER> versus <NUMBER> noninvasive ventilation <NUMBER> versus <NUMBER> invasive ventilation <NUMBER> versus <NUMBER> extracorporeal membrane oxygenation <NUMBER> versus <NUMBER> lower wellcontrolled group poorly controlled group table <NUMBER> wellcontrolled blood glucose correlated reduced risk allcause mortality detrimental complications patients covid<NUMBER> preexisting t<NUMBER>d correlated persistent lower bg levels wellcontrolled group higher lymphocyte counts lower neutrophil counts lower serum levels il<NUMBER> crp ldh throughout <NUMBER>day observation period starting time hospital admission figure <NUMBER> noticed inhospital death rate significantly lower <NUMBER> versus <NUMBER> wellcontrolled group relative poorly controlled group table s<NUMBER> crude hr <NUMBER>day allcause mortality two groups <NUMBER> <NUMBER> ci <NUMBER> p <NUMBER> table s<NUMBER> adjusting age gender severity covid<NUMBER> comorbidities site effect hr allcause mortality wellcontrolled bg group versus poorly controlled bg group <NUMBER> <NUMBER> ci <NUMBER> p <NUMBER> table s<NUMBER> evalue point estimate <NUMBER> upper limit ci <NUMBER> relative poorly controlled bg control patients wellcontrolled bg group developed less frequent occurrences ards <NUMBER> versus <NUMBER> acute heart injury <NUMBER> versus <NUMBER> acute kidney injury <NUMBER> versus <NUMBER> septic shock <NUMBER> versus <NUMBER> dic <NUMBER> versus <NUMBER> table s<NUMBER> adjusting age gender severity covid<NUMBER> site effect comorbidities respective hrs ards acute heart injury <NUMBER> <NUMBER> ci <NUMBER> p <NUMBER> <NUMBER> <NUMBER> ci <NUMBER> table <NUMBER> table s<NUMBER> propensity scorematched psm analysis performed avoid confounding variables could interfered association bg levels allcause mortality due lack reliable indicators severity t<NUMBER>d specifically included t<NUMBER>drelated comorbidities matching since comorbidities closely related severity t<NUMBER>d dynamic trajectories blood glucose lymphocytes c neutrophils e relative levels il<NUMBER> b crp ldh f <NUMBER>day followup duration <NUMBER> confidence interval represented shaded regions patients poorly controlled bg orange patients wellcontrolled bg blue bg represents averaged median bg patients day tested comorbidities included hypertension cardiovascular disease cerebrovascular disease chronic liver disease chronic kidney injury able match <NUMBER> patients wellcontrolled bg group <NUMBER> patients poorly controlled bg group ratio <NUMBER> <NUMBER> individuals included psm analysis figure <NUMBER> applying mixedeffect cox model using hospital site random effect adjusting imbalanced durations symptom onset admission results consistently significantly demonstrated lower risk allcause mortality patients wellcontrolled bg group adjusted hr <NUMBER> <NUMBER> ci <NUMBER> p <NUMBER> compared poorly controlled bg group figure <NUMBER> tables <NUMBER> s<NUMBER> although stronger integrated treatment applied poorly controlled bg group table s<NUMBER> robustness association glycemic variability mortality assessed additional sensitivity analyses using different matching variables results sensitivity analyses similar analysis hrs <NUMBER> <NUMBER> ci <NUMBER> p <NUMBER> first sensitivity analysis <NUMBER> <NUMBER> ci <NUMBER> p <NUMBER> second analysis table s<NUMBER> psm analysis respective adjusted hrs ards acute heart injury acute kidney injury <NUMBER> <NUMBER> ci <NUMBER> p <NUMBER> <NUMBER> <NUMBER> ci <NUMBER> p <NUMBER> <NUMBER> <NUMBER> ci <NUMBER> p <NUMBER> wellcontrolled bg group poorly controlled bg group table <NUMBER> glycemic variability shown important indicator possible risk predictor death complications individuals t<NUMBER>d forbes et al <NUMBER> impact hyperglycemia pathogenesis viralinduced respiratory diseases remains unclear elevated bg level reported increase glucose concentration airway epithelial secretion philips et al <NUMBER> may disrupt defensive capacity airway epithelia hand rigid glucose control increases risk severe hypoglycemia also result increased mortality rodriguezgutierrez et al <NUMBER> study found compared individuals wellcontrolled bg poor glycemic control patients covid<NUMBER> preexisting t<NUMBER>d associated worse outcome involving increased need medical interventions multiorgan injuries higher mortalities contrast patients glycemic variability <NUMBER> <NUMBER> mmoll significant association reduced medical interventions major organ injuries allcause mortality findings provide direct evidence supporting recent suggestions clinical management t<NUMBER>d covid<NUMBER> bornstein et al <NUMBER> conclusion t<NUMBER>d important risk factor covid<NUMBER> progression adverse endpoints wellcontrolled bg maintaining glycemic variability within <NUMBER> <NUMBER> mmoll associated significant reduction composite adverse outcomes death findings provide critical insights clinical characteristics patients covid<NUMBER> preexisting t<NUMBER>d possible avenues improving disease outcomes due retrospective nature study unprecedented scale covid<NUMBER> pandemic study several limitations first data obtained patient cohorts admitted <NUMBER> hospitals hubei province china therefore effect bg control may different among patients covid<NUMBER> preexisting t<NUMBER>d outpatient setting ethnically geographically diverse populations second able retrieve prehospital status t<NUMBER>d current cohort due urgent circumstance covid<NUMBER> pandemic status prehospital t<NUMBER>d could significantly associated numerous clinical parameters known independent risk factors poor outcomes covid<NUMBER> including cardiovascular abnormalities immunological dysfunction performed psm analysis support independent association t<NUMBER>d covid<NUMBER> pathology influence cofounders cannot fully excluded also given lack prehospital data possible us access bg levels changed result covid<NUMBER> progression andor severity third number patients t<NUMBER>d wellcontrolled bg study modest might powered sufficiently reflect overall complexity general population therefore largescale prospective cohort studies required ethnically geographically diverse cohorts better understand association importance bg control disease progression covid<NUMBER> fourth given retrospective nature study possible us determine active management bg levels normal range could ameliorate covid<NUMBER> severity adverse outcomes finally individuals type <NUMBER> diabetes excluded analysis initial cohort possible blood glucose control may also affect outcomes covid<NUMBER> detailed methods provided online version paper include following study generate new reagents materials data related findings study available corresponding author upon reasonable request research team provide email address communication data approved shared others proposal detailed aims statistical plan informationmaterials may required guarantee rationality requirement security data patientlevel data without names identifiers shared review approval submitted proposal related requested materials multicentered retrospective cohort study study protocol approved institution ethic committee renmin hospital wuhan university zhongnan hospital wuhan university study design also individually approved collaborating hospital institutional ethics boards given urgency covid<NUMBER> pandemic informed consent forms waived ethics boards hospitals study subjects included patients covid<NUMBER> diagnosed december <NUMBER> th <NUMBER> march <NUMBER> th <NUMBER> covid<NUMBER> diagnosed based chest computed tomography ct manifestations andor reverse transcriptionpolymerase chain reaction rtpcr following criteria new coronavirus pneumonia prevention control program <NUMBER>th edition published national health commission china interim guidance national health commission china <NUMBER> world health organization <NUMBER> zhang et al <NUMBER>b total <NUMBER> patients covid<NUMBER> initially screened study data individuals however excluded subjects younger <NUMBER> older <NUMBER> incomplete medical records eg transfer hospital acute lethal organ injury eg acute myocardial infarction acute coronary syndrome acute pulmonary embolism acute stroke decompensated end stage chronic organ dysfunction eg decompensated cirrhosis decompensated chronic renal insufficiency severe congestive heart failure pregnancy type <NUMBER> diabetes getational diabetes malignancy study remaining cohort n <NUMBER> categorized diabetic n <NUMBER> nondiabetic n <NUMBER> groups according clinical diagnosis andor medical history admission figure <NUMBER> medical records patients analyzed integrated research team including physicians data scientists statisticians deidentification process removing personal information eg name id participants designating using coding system basic information epidemiological records clinical manifestations laboratory findings radiographic characteristics ct treatments outcomes hospitalization recorded major clinical symptoms ie fever cough fatigue dyspnea comorbidities collected laboratory findings included routine blood test fasting blood glucose bg <NUMBER> h postprandial bg <NUMBER> hpg creactive protein crp procalcitonin ddimer serum indicators liver injury kidney injury heart dysfunction experienced physician team reviewed interpreted doublechecked data guarantee accuracy date disease onset defined day first symptom covid<NUMBER> noticed severe cases defined according whether patients indication respiratory rate <NUMBER> breathsmin spo<NUMBER> <NUMBER> room air pao<NUMBER>fio<NUMBER> <NUMBER> mmhg t<NUMBER>d status designated based patients medical history guideline prevention control t<NUMBER>d china <NUMBER> chinese diabetes society <NUMBER> timing frequency obtaining fasting <NUMBER>h postprandial bg <NUMBER> hpg varied individuals depending necessity related severity comorbid t<NUMBER>d severe t<NUMBER>d status accordingly obtained frequent bg surveillances glycemic variability defined range lowest fasting bg fbg <NUMBER> hpg level observation period wellcontrolled bg defined glycemic variability ranged <NUMBER> <NUMBER> mmoll since normal range fasting bg <NUMBER> <NUMBER> mmoll lower <NUMBER> mmoll targeting level <NUMBER> hpg dm management according guideline prevention control t<NUMBER>d china <NUMBER> chinese diabetes society <NUMBER> poorlycontrolled bg defined lowest fasting bg equal <NUMBER> mmoll highest <NUMBER> hpg level exceeded <NUMBER> mmoll observation window hypertension diagnosed systolic blood pressure equal <NUMBER> mm hg andor diastolic blood pressure equal <NUMBER> mm hg ards septic shock defined following interim guideline clinical management severe acute respiratory infection novel coronavirus <NUMBER>ncov infection suspected cardiac injury defined serum level cardiac injury biomarkers cardiac troponin ctni cardiac troponin ctnt high sensitivity cardiac troponin hsctni higher upper limit normal uln acute liver injury defined acutely increased level serum alanine aminotransferase alt serum alkaline phosphatase alp upper limit normal uln observed marrone et al <NUMBER> acute kidney injury indicated value serum creatinine level reached exceeded <NUMBER> mmmoll within <NUMBER> h kellum et al <NUMBER> disseminated intravascular coagulation dic diagnosed according criteria published international society thrombosis hemostasis isth gando et al <NUMBER> primary endpoint study <NUMBER>day allcause death covid<NUMBER> patients secondary endpoints occurrence ards septic shock acute cardiac injury acute kidney injury dic variables potentially confounding association bg outcomes covid<NUMBER> addressed using propensity scorematching psm method waljee et al <NUMBER> psm requires complete set variables every patient randomly missing values <NUMBER> selected parameters noninvasive tests therefore imputed nonparameter imputation method missforest applied estimation imputation error <NUMBER> bootstrapped cross validation applied repeated <NUMBER> times evaluating imputation performance training data <NUMBER> parameters randomly introduced missforest method yielded <NUMBER> iqr <NUMBER> differences datasets parameters introduced algorithm psm follows logisticp lnp<NUMBER>p b<NUMBER> b<NUMBER>x<NUMBER> b<NUMBER>x<NUMBER> bkxk p eb<NUMBER> b<NUMBER>x<NUMBER> b<NUMBER>x<NUMBER> bkxk<NUMBER>eb<NUMBER> b<NUMBER>x<NUMBER> b<NUMBER>x<NUMBER> bkxk p formula predicted probability glucose control procedure beta value variable regression coefficient variable variables potentially confounding association bg outcomes covid<NUMBER> addressed using psm method evaluating association glucose control level outcomes psm cohorts identified balancing age gender fever cough dyspnea ctdiagnosed lung lesions spo<NUMBER> breath frequency incidence increased leukocyte count alt ast ddimer creatinine crp procalcitonin decreased lymphocyte count well comorbidities hypertension coronary artery disease cerebrovascular disease chronic liver diseases chronic renal disease propensity score predicted probability glucose change contributed variables estimated based multivariable logistic regression model matching ratio <NUMBER> wellcontrolled bg versus poorlycontrolled bg entire hospitalization exact matching caliper size <NUMBER> applied matching pairs according propensity scores evaluation balance covariates conducted estimating standardized differences matching small absolute value less <NUMBER> considered qualified balancing robustness association bg level allcause mortality assessed analyzing evalue mixedeffect cox proportional hazards model address unmeasured confounders using methodology vanderweele ding haneuse et al <NUMBER> mathur et al <NUMBER> vanderweele ding <NUMBER> two sensitivity analyses performed evaluate robustness propensity scorematched cohort analyses among pairs statistical analysis performed using r<NUMBER> r foundation statistical computing vienna austria spss statistics version <NUMBER> ibm armonk ny usa data continuous variables presented median interquartile range iqr data categorical variables presented frequency rates percentage comparison <NUMBER> groups analyzed using students tests normally distributed mannwhitney u test nonnormally distributed continuous variables comparison categorical variables analyzed fishers exact test c<NUMBER> test generalized linear model glm performed evaluate correlation median blood glucose factors related viral infection glycemic control patients diabetes risk composite endpoints corresponding hazard ratio hr analyzed using cox proportional hazard model mixedeffect cox model cumulative rates death plotted applying kaplanmeier method difference twoside less <NUMBER> considered statistically significant abbreviations ards acute respiratory distress syndrome dic disseminated intravascular coagulation hr hazard ratio ci confidence interval adjusted variables included age gender hospital sites random effect b adjusted variables included age gender indicators severity covid<NUMBER> comorbidities hypertension coronary heart disease cerebrovascular diseases chronic liver diseases chronic renal diseases hospital sites random effect c p values calculated based cox proportional hazard model <NUMBER> sensitivity analyses propensity score matched model age gender hospital sites indicators severity covid<NUMBER> comorbidities hypertension coronary heart disease cerebrovascular disease chronic renal diseases incidence increased creatinine matched b sensitivity analyses propensity score matched model age gender hospital sites indicators severity covid<NUMBER> comorbidities hypertension coronary heart disease cerebrovascular disease copd chronic liver diseases chronic renal diseases incidence increased creatinine matched c p values calculated based cox proportional hazard model covid<NUMBER> pandemic significant impact economy health system countries world also true australia australia seen huge surge covid<NUMBER> positive cases subsequent hospitalisations deaths experienced parts world however important social health strategies flatten curve reduce infections manage infected included closure international interstate borders local lockdown measures physical distancing shift work home closure nonessential businesses full partial closure schools tertiary education facilities diabetes care perspective significant concerted diversion hospital resources staff covid<NUMBER> specific activities reduced access primary care diagnostic hospital services diabetes combined fear exposure virus settings led significant drop access usual diabetes care provision outpatient private sector diabetes services via telehealth encouraged supported expanded new government subsidies importantly first time government funded subsidy care delivered via telephone inclusion credentialled diabetes educators funded telephonetelehealth support australian health professional consumer organisations worked cooperatively producing guidelines position statements educational resources specific covid<NUMBER> setting covid<NUMBER> pandemic review changes important determining permanently implemented learnings covid<NUMBER> help prepare australia future pandemics major health crises covid<NUMBER> pandemic caused sarscov<NUMBER> virus enormous impact around world whilst every country negatively impacted regarding socioeconomic health outcomes countries impacted based infection death rates include <NUMBER> may <NUMBER> united states <NUMBER> million confirmed cases <NUMBER> deaths spain <NUMBER> cases <NUMBER> deaths italy <NUMBER> <NUMBER> deaths united kingdom <NUMBER> cases <NUMBER> deaths httpscovid<NUMBER>whoint clear health systems even relatively affluent countries stretched beyond capacity example study italy showed large proportion criticallyill patients admitted intensive care unit icu required mechanical ventilation higher levels positive end expiratory pressure mortality rate <NUMBER> <NUMBER> australia <NUMBER> may <NUMBER> <NUMBER> positive cases <NUMBER> deaths httpswwwhealthgovaunewshealthalertsnovelcoronavirus<NUMBER>ncovhealthalertcoronaviruscovid<NUMBER>currentsituationandcasenumbers put comparative manner australia <NUMBER> deaths per million compared <NUMBER> deaths per million italy <NUMBER> deaths per million united states httpscovid<NUMBER>whoint early information china indicated people affected covid<NUMBER> requiring hospitalisation frequently comorbidities including diabetes hypertension coronary heart disease cerebrovascular disease obesity chronic kidney disease <NUMBER> <NUMBER> moreover progression acute respiratory distress syndrome death likely occur people type <NUMBER> diabetes <NUMBER> <NUMBER> appears associated obesity <NUMBER> adverse health outcomes respiratory cardiac failure death thought mediated cytokine storm <NUMBER> similar data emerging countries significantly impacted covid<NUMBER> including italy <NUMBER> note recent article reported association lower mortality better clinical outcomes people type <NUMBER> diabetes covid<NUMBER> wellcontrolled blood glucose levels <NUMBER> thus glycaemic control appears important factor people diabetes covid<NUMBER> likely outcomes first covid<NUMBER> positive case australia confirmed january <NUMBER> th <NUMBER> person returning wuhan china <NUMBER> followed lag phase doubling positive cases approximately every <NUMBER> days however march <NUMBER> st <NUMBER> covid<NUMBER> positive cases australia exceeded <NUMBER> <NUMBER> deaths australia clearly exponential part curve httpswwwhealthgovaunewshealthalertsnovelcoronavirus<NUMBER>ncovhealthalert australias success flattening curve illustrated figure <NUMBER> crude case fatality rate proportion cases requiring hospitalisation australia remain substantially lower corresponding values reported many comparable highincome countries total cases covid<NUMBER> notified australia <NUMBER> admitted hospital compared <NUMBER> cases reported requiring hospitalisation eueea noted higher proportion reported eueea affected countrys testing strategies european countries testing hospitalised individuals covid<NUMBER> highest rate hospitalised cases australia among <NUMBER> age group <NUMBER> per <NUMBER> populations followed <NUMBER> years age group <NUMBER> per <NUMBER> commonly reported comorbid conditions among hospitalised cases cardiac disease <NUMBER> diabetes <NUMBER> chronic respiratory conditions <NUMBER> hospitalised covid<NUMBER> cases <NUMBER> admitted intensive care unit icu <NUMBER> cases receiving ventilation commonlyreported comorbid conditions among cases admitted icu diabetes <NUMBER> cardiac disease <NUMBER> may <NUMBER> <NUMBER> median age cases died <NUMBER> years iqr <NUMBER> years <NUMBER> cases male <NUMBER> female commonly reported comorbid conditions among covid<NUMBER> deaths cardiac disease <NUMBER> diabetes <NUMBER> chronic respiratory disease <NUMBER> australian federal government took unprecedented step forming national cabinet including leaders state territory governments coordinate response covid<NUMBER> included physical distancing lockdown restrictions reduce spread covid<NUMBER> infections australian lockdown restrictions listed <NUMBER> reasons people leave house shopping essential items receiving medical care provision health care support exercising one person undertaking work study possible home measures included closing borders curbing incoming international flights addition closure nonessential services including cafes restaurants except takeaway services travel states territories halted severely restricted people tested <NUMBER> positive returned overseas trips contact known positive case encouraged voluntarily selfquarantine <NUMBER> days though subsequently progressed mandatory supervised quarantine hotels travellers returning overseas irrespective covid<NUMBER> status implementation lockdown rules australia caused panic buying exemplified shortage toilet paper pantry staples flour pasta rice resulting strict limits individual purchases products stockpiling localised shortterm shortages medicines occurred including insulin diabetesrelated products blood glucose ketone test strips insulin pump consumables cgm consumables resolved restrictions dispensing limits certain medications diabetesrelated products positive communication people diabetes maintain normal purchases stockpile schools closed students students essential workers schools australia jurisdiction state territory governments varied response across country measures considerable confusion concern recently australian government released covidsafe tracing mobile phone app encouraged australians download app linked relaxation social distancing shutdown measures interestingly reports app may interfered diabetes apps devices strong wellcoordinated response covid<NUMBER> australian health system prepare expected covid<NUMBER> patient influx hospitals  reconfiguring wards expanding establishing new icus separate facilities without covid<NUMBER>  setting separate inpatient covid<NUMBER> screening hot wards separate cold wards  setting special fever clinics initially attached hospital separate services particularly separated emergency departments <NUMBER>  innovative ways screening people implementation online selfregistration selfscreening tool <NUMBER> drive screening rapid throughput screening allow hospital workers mild symptoms screened get back work <NUMBER> hours  securing adequate personal protective equipment ppe including preexisting national medical resources stockpiles providing training specialised techniques urgentsafe gowning  suspension nonurgent surgery procedures public private hospitals  arrangements state governments private hospitals latter take covid noncovid patients required  upskilling education appropriate staff best practice procedures intubation minimise risk health professionals  callup shortterm registration recently retired healthcare professionals senior medical students  limitation suspension nonurgent medical ambulatory outpatient services including outpatient endocrinologydiabetes services focus provision services would prevent emergency department presentationsadmissions  contact tracing exposed person diagnosed covid<NUMBER> planning currently implementing covidsafe contact tracing app changes hospital services included redeployment staff covid<NUMBER> screening service areas depending local needs staff skillsets eg relative recency icu respiratory skills screening staff patients visitors entering minimised access points temperature measurements questions regarding overseas travel fever symptoms unwell contact known covid<NUMBER> patients many hospitals ward rounds limited two health professionals limitations numbers visitor one occasionally two including outpatient areas wards delivery suites importantly people residential agedcare facilities among highest risk groups covid<NUMBER> visitors facilities permitted changes required management education patients newly diagnosed diabetes families particularly children affected included insulin stabilisation avoid diabetic ketoacidosis dka hyperosmolar hyperglycaemia state hhs active highrisk diabetes foot disease diabetes pregnancy well inpatient diabetes care children newly diagnosed type <NUMBER> diabetes particularly dka fever often treated covid<NUMBER> swabs proved negative indicated rapid adoption telephonetelehealth diabetes services ensure continued diabetes outpatient care provided public hospital system important note major disruption changes business processes many allied health services including primary care optometry dentistry podiatry dietetic services australian government provided covid<NUMBER> specific support primary specialist care services establishing national call centre supporting general practiceled respiratory clinics providing online infection prevention control training <NUMBER> respect telehealth consultations ensure continuity care australian government broadened access universal access scheme medicare benefits scheme mbs creating telephonetelehealth item numbers health professionals including general practitioners consultant endocrinologists also removal previous requirement patient lived least <NUMBER> km distance health professionals practice access telehealth reimbursement importantly first time mbs item numbers telephone addition video conferencing consultations made available allied health professionals including credentialled diabetes educators order limit need patients isolation contact doctor pharmacy doctor able issue medication prescription without physically seeing patient send patients pharmacy could courier medication patients home home delivery medications pharmacies also made available vulnerable people example elderly disabilities national diabetes services scheme ndss initiative australian government commenced <NUMBER> administered diabetes australia ndss provides universal access australian residents diabetes subsidised products including blood glucose test strips urine test strips insulin pump consumables eligible subset continuousflash glucose monitoring systems ndss also provides useful statistical data numbers people diabetestype diabetes areas reside ndss provides information education support services diabetes selfmanagement dedicated national helpline online information well facetoface group education activities across nation ndss wide reach supports <NUMBER> australians diagnosed diabetes includes types diabetes given events unfolding overseas anticipated many australia verge huge increase covid<NUMBER> cases would stretch hospital health care system response pandemic australia swift positive proactive ensure people diabetes access medications products services required aware greater risk serious illness death covid<NUMBER> health professionals concerned becoming infected infecting immediate families able perform regular roles patient care delivery seconded covid<NUMBER> specific activities access use ppe <NUMBER> concerns exacerbated reports covid<NUMBER> infections deaths overseas health care professionals considerable advocacy support resources dedicated health professionals address mental health issues inevitably arise clear people diabetes greater risk serious health impacts pandemics covid<NUMBER> people without diabetes <NUMBER> <NUMBER> highlighted effective management blood glucose people diabetes covid<NUMBER> lead better outcomes lower mortality rates <NUMBER> <NUMBER> whether resources developed measures implemented positive effect health outcomes people diabetes yet known feedback people diabetes health professionals positive supportive proactive approach unprecedented pandemic australian healthcare professionals researchers also proactive proposing participating national international covid<NUMBER> related research australia diabetes health professionals supported telephone telehealth consultation incentives guidance respect blood glucose management medication use including specific information around use metformin sodiumglucose cotransporter <NUMBER> inhibitors sglt<NUMBER>i well related cardiometabolic medication angiotensin converting enzyme inhibitors aceiangiotensin ii receptor blockers arbs blood pressure management people diabetes discouraged stockpiling diabetes productsmedications continue diabetes care monitoring diabetes health professionals prepared intercurrent illness optimally manage glycaemia health general many changes necessary maintain access ongoing diabetes care provide effective communication australian diabetes community health professionals learnings australia covid<NUMBER> pandemic suggest swift proactive action required support people diabetes health professionals safely appropriately modify health service delivery interventions required manage diabetes medicine product supply chains covid<NUMBER> crisis continues provide unique opportunity leaders management diabetes share ideas collaborate learn important assess changes made relation diabetes care resulted response covid<NUMBER> determine permanently implemented changes include service delivery models reimbursement telephonetelehealth credentialled diabetes educators medical specialist services primary care providers ultimately learnings covid<NUMBER> help prepare australia future pandemics major health crises graph shows total number new confirmed covid<NUMBER> cases reported day including may <NUMBER> <NUMBER> australian states territories first cases covid<NUMBER> identified late january australia number new cases rapidly increased march since april reduction daily reported cases according previous reports diabetes seems risk factor worsens serious clinical events caused covid<NUMBER> diabetes per se risk factor increases probability getting virus paper discuss point many research data antidiabetic drugs context potential influence glucoselowering agents severity covid<NUMBER> described yet dipeptidylpeptidase<NUMBER> dpp<NUMBER> cell surface protein ubiquitously expressed many tissues also soluble molecule found serumplasma fluids dpp<NUMBER> involved infection cells viruses paper reviews data use dpp<NUMBER> inhibitors others diabetes drugs covid<NUMBER> patients available evidence yet suggested glucoselowering drugs including targeting dpp<NUMBER>related pathways produce significant harm benefit context human infections however insulin must remain firstchoice agent management critically illhospitalized patients recommended suspend agents unstable patients paper provides related french international recommendations people diabetes got infected covid<NUMBER> upholds infections may alter glucose control may require additional vigilance diabetes covid<NUMBER> global covid<NUMBER> pandemic resulted large body literature risk factors worsen clinical events associated virus indeed patients face disease severity patients symptomatic diabetes rapidly become one potential risk factors diabetes susceptibility factor andor severity factor could antidiabetic drugs particular dipeptidylpeptidase<NUMBER> dpp<NUMBER> inhibitors play role occurrence infections paper aims discussing issues beginning covid<NUMBER> pandemic suggested diabetes one susceptibility factors infection along advanced age high blood pressure smoking overweight obesity thus one first short series wuhan city heavily affected virus <NUMBER> patients <NUMBER> diabetes <NUMBER> hypertension <NUMBER> another series <NUMBER> infected hospitalized patients <NUMBER> diabetic <NUMBER> however lack control group makes possible increase prevalence infected hospitalized diabetic patients uncertain addition lower prevalence <NUMBER> diabetic patients presenting symptoms <NUMBER> days also reported small number patients concerned obstacle correctly estimating prevalence <NUMBER> thus metaanalysis <NUMBER> studies china <NUMBER> confirmed infected patients prevalence diabetes <NUMBER> similar prevalence diabetic patients china <NUMBER> meaning <NUMBER> <NUMBER> ages combined <NUMBER> <NUMBER> however since average age infected diabetic patients <NUMBER> years prevalence must compared one corresponding age group estimated <NUMBER> thus prevalence diabetics among patients covid<NUMBER> even lower general population <NUMBER> consistent observations trend described italy country heavily affected covid<NUMBER> epicenter epidemic padua <NUMBER> infected patients aged <NUMBER> years old average diabetics prevalence diabetic patients region age group higher described <NUMBER> <NUMBER> therefore based chinese italian data may diabetic patients affected covid<NUMBER> diabetic patient would put greater risk contracting disease one compares nondiabetic patient nonetheless among <NUMBER> patients hospitalized covid<NUMBER> new york city area april median age <NUMBER> years <NUMBER> female proportion diabetic patients higher <NUMBER> patients included suffered diabetes <NUMBER> hypertension <NUMBER> obese <NUMBER> large worldwide observational study <NUMBER> patients covid<NUMBER> <NUMBER> diabetes mellitus <NUMBER> date study able distinguish type <NUMBER> type <NUMBER> diabetic patients advanced age patients diabetes suggests high rate type <NUMBER> diabetic patients selection bias excluded since patients covid<NUMBER> tested virus proportion patients diabetes may overestimated rate diabetic patients varies depending patients location age method testing similarly depends hospitalization criteria changed time meaning patients one moderate forms disease decreasingly hospitalized compared practice followed beginning pandemic nevertheless pursuant various studies individuals diabetes seem similar risk getting covid<NUMBER> patients without diabetes diabetes would systematically increase likelihood infected covid<NUMBER> infected patients diabetes likely develop severe form disease metaanalysis <NUMBER> studies china reported relative risk severe form <NUMBER> <NUMBER> ci <NUMBER> ranged <NUMBER> lesser risk one study <NUMBER> higher risk five studies <NUMBER> example chinese observational study <NUMBER> patients confirmed infection prevalence diabetes severe form <NUMBER> <NUMBER> lower severity illness <NUMBER> another study <NUMBER> italian patients infected hospitalized lombardy intensive care units two third comorbidity factor <NUMBER> hypertension <NUMBER> diabetes <NUMBER> italy systematic review <NUMBER> patients diabetic patients resulted significant increased risk intensive care unit admission <NUMBER> <NUMBER> ci <NUMBER> p <NUMBER> higher mortality risk <NUMBER> <NUMBER> ci <NUMBER> p <NUMBER> <NUMBER> likely unfavorable outcomes <NUMBER> <NUMBER> ci <NUMBER> p <NUMBER> chinese retrospective study <NUMBER> patients <NUMBER> finally seattle <NUMBER> patients admitted intensive care units <NUMBER> diabetic <NUMBER> consistent reports metaanalysis <NUMBER> patients diabetes revealed diabetes associated composite poor outcome including mortality severe covid<NUMBER> acute respiratory distress syndrome need intensive care unit care disease progression rr <NUMBER> <NUMBER> ci <NUMBER> p <NUMBER> severe covid<NUMBER> rr <NUMBER> <NUMBER> ci <NUMBER> p <NUMBER> acute respiratory distress syndrome rr <NUMBER> <NUMBER> ci <NUMBER> p <NUMBER> disease progression rr <NUMBER> <NUMBER> ci <NUMBER> p <NUMBER> metaregression showed association composite poor outcome influenced age p <NUMBER> hypertension p <NUMBER> <NUMBER> worldwide observational study <NUMBER> patients covid<NUMBER> asia europe north america nonsurvivors greater prevalence diabetes mellitus however multivariate analysis diabetes mellitus independent predictor hospital death <NUMBER> diabetic patients covid<NUMBER> high risk severe pneumonia present marked proinflammatory prothrombotic state compared infected nondiabetic patients inflammation markers crp interleukin<NUMBER> ferritin ddimers increased compared nondiabetic patients marked inflammatory cytokine storm thought associated pejorative prognosis <NUMBER> review metaanalysis <NUMBER> studies including <NUMBER> patients covid<NUMBER> <NUMBER> severe cases high age independently associated severe form <NUMBER> review diabetes also associated occurrence severe form rr <NUMBER> <NUMBER> ci <NUMBER> association persisted study multivariate analysis taking account age rr <NUMBER> <NUMBER> ci <NUMBER> p <NUMBER> <NUMBER> risk severe form also increased presence unbalanced complicated diabetes studies patients h<NUMBER>n<NUMBER> viruses <NUMBER> middle east respiratory syndrome coronavirus merscov <NUMBER> <NUMBER> <NUMBER> <NUMBER> retrospective observational study march <NUMBER>st april <NUMBER>th <NUMBER> despite several limitations mortality rate <NUMBER> patients diabetes andor uncontrolled hyperglycemia compared <NUMBER> patients without diabetes hyperglycemia p <NUMBER> cohort <NUMBER> covid<NUMBER> patients without diabetes <NUMBER> hospitals hubei province china people admitted hospital covid<NUMBER> diabetes required medical interventions despite interventions also significantly higher mortality <NUMBER> versus <NUMBER> well greater incidence multiple organ injury patients wellcontrolled blood glucose glycemic variability within <NUMBER> <NUMBER> mmoll markedly lower mortality compared individuals poorly controlled blood glucose upper limit glycemic variability exceeding <NUMBER> mmoll adjusted hr <NUMBER> <NUMBER> ci <NUMBER> p <NUMBER> hospitalization <NUMBER> covid<NUMBER> patients uncontrolled hyperglycemia particularly high mortality rate variety immune system abnormalities postulated explain association hyperglycemia immune dysfunction including impairment polymorphonuclear monocytic white blood cell chemotaxis phagocytosis complement function cytokine dysregulation <NUMBER> fact acute hyperglycemia plays role improved effective glycemic management remained proved another study among <NUMBER> patients coronavirus hyperglycemia often transient generally resolved discharge hospital majority subjects <NUMBER> authors suggest clinicians treat hyperglycemia achieve bg targets <NUMBER> mgdl patients <NUMBER> klonoff et al proposed four risk factors increase risk poor outcomes susceptibility hyperglycemia corticosteroid therapy inadequate glucose monitoring lack contact healthcare professionals inappropriate discontinuation angiotensin receptor blockers <NUMBER> coronado ongoing french study aiming determine risk factors severe forms disease throughout country <NUMBER> china intensive care unit icu patients likely diabetes older <NUMBER> years vs <NUMBER> years twice many comorbidities <NUMBER> vs <NUMBER> compared need go icu <NUMBER> male sex frequent infected vs noninfected patients described proportion ranging <NUMBER> <NUMBER> men also appeared overrepresented icu patients <NUMBER> vs <NUMBER> difference statistically significant <NUMBER> <NUMBER> <NUMBER> among <NUMBER> infected patients mortality rate reported china <NUMBER> <NUMBER> presence diabetes <NUMBER> hypertensive patients <NUMBER> italy <NUMBER> fatal cases diabetes compared <NUMBER> general population age group diabetic patients therefore overrepresented among deceased patients <NUMBER> men average age <NUMBER> years <NUMBER> metaanalysis confirmed diabetes associated higher mortality rate rr <NUMBER> <NUMBER> paper discuss potential association covid<NUMBER> hypertension prescription angiotensinconverting enzyme inhibitors acei angiotensin ii receptor blockers arb already reported <NUMBER> remind except acute situations casebycase analysis recommended european society cardiology well french american associations published position papers advocate maintaining treatments acei arb patients infected virus similarly appears corticosteroid therapies aggravate patients condition although retrospective analysis difficult therapies generally used patient serious condition nonsteroidal antiinflammatory drugs nsaids ibuprofen increase risk developing serious form disease <NUMBER> therefore fever treated paracetamol regarding drugs specific type <NUMBER> diabetes increase risk infection issue arises dipeptidyl peptidase<NUMBER> dpp<NUMBER> inhibitors indeed addition role incretin metabolism glucose regulation dpp<NUMBER> also known cd<NUMBER> membrane glycoprotein found surface many cells nonspecific exopeptidase enzyme activity stimulates inflammatory immune responses modifying production several cytokines chemokines <NUMBER> <NUMBER> <NUMBER> <NUMBER> several studies therefore focused role dpp<NUMBER> inhibitors development infections data clinical trials suggested increase upper respiratory lower urinary tract infections ddp<NUMBER> inhibitors particularly sitagliptin <NUMBER> <NUMBER> <NUMBER> analysis international pharmacovigilance database vigibase indicated higher reporting infections associated dpp<NUMBER> inhibitors higher signal upper respiratory infections <NUMBER> casecontrol study nested cohort nearly <NUMBER> diabetic patients uk found association ddp<NUMBER> inhibitors use hospitalization communityacquired pneumonia <NUMBER> recent metaanalysis including <NUMBER> clinical trials <NUMBER> weeks duration also suggest increase overall risk infection iddp<NUMBER> inhibitors <NUMBER> patients diabetes sitagliptin believed reduce levels proinflammatory markers interleukin<NUMBER> il<NUMBER> tumor necrosis factorα tnfα <NUMBER> <NUMBER> thus dpp<NUMBER> inhibitors could via antiinflammatory effect play role course infection occurrence complications currently shown patients covid<NUMBER> significantly elevated il<NUMBER> levels associated increased risk respiratory failure <NUMBER> <NUMBER> addition human dpp<NUMBER> identified functional receptor spicule protein coronavirus caused middle east respiratory syndrome mers saudi arabia <NUMBER> <NUMBER> <NUMBER> antibodies directed dpp<NUMBER> inhibited merscov infection studies transgenic mice suggested complication rate people type <NUMBER> diabetes infected merscov may associated dpp<NUMBER> related disturbance immune response <NUMBER> although date direct consequences drawn current covid<NUMBER> epidemic whose gateway angiotensinconverting enzyme <NUMBER> ace<NUMBER> studies links dpp<NUMBER> coronavirus infection carried <NUMBER> similarly concerning antidiabetic medications established evidence supporting clinical benefit covid<NUMBER> patients potential risks must carefully kept mind indeed metformin glucagonlikepeptide<NUMBER> receptor glp<NUMBER>r agonists thiazolidinediones insulin associated antiinflammatory effects <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> could potentially beneficial context cytokine storm association observed insulin glucoselowering therapy among survivors nonsurvivors covid<NUMBER> <NUMBER> however suggested use metformin sodiumglucosetransporter<NUMBER> sglt<NUMBER> inhibitors glp<NUMBER>r agonists pioglitazone insulin may increase expression ace<NUMBER> therefore potentially associated severe condition <NUMBER> <NUMBER> <NUMBER> critically ill covid<NUMBER> patients risk metabolic acidosis associated metformin might exacerbated well consequences volume depletion sglt<NUMBER> inhibitors hence insulin remains drug choice situations pharmacovigilance data france provided national network pharmacovigilance centers <NUMBER> monitors daily basis adverse drug reactions associated drugs used covid<NUMBER> midapril <NUMBER> nearly <NUMBER> months first case territory <NUMBER> reported cases adverse drug reactions occurring context covid<NUMBER> patients diabetes median age patients <NUMBER> years minmax <NUMBER> years <NUMBER> male <NUMBER> n <NUMBER> cases serious <NUMBER> <NUMBER> died one third cases <NUMBER> patients presented heart rhythm disorders related mainly use hydroxychloroquine without azithromycin <NUMBER> high blood pressure <NUMBER> history heart disease eight cases <NUMBER> exposed lopinavirritonavir kaletra ® combination presented hepatic disorder n <NUMBER> exacerbation renal failure n <NUMBER> eleven cases <NUMBER> respiratory complications <NUMBER> hypertensive <NUMBER> pulmonary history cases <NUMBER> patients treated longterm sitagliptin required admission icu one case died <NUMBER> women <NUMBER> man <NUMBER> <NUMBER> years old <NUMBER> obese hypertensive none cases sitagliptin drug suspected worsening infection <NUMBER> cases also treated arb <NUMBER> received nsaid data show patients diabetes also subject serious adverse reactions drugs used covid<NUMBER> patients adverse reactions often comorbidities especially hypertension francophone society diabetology took early issue manage diabetes daily basis covid<NUMBER> situation without distinguishing management type <NUMBER> type <NUMBER> diabetes providing advice applies situations thus among <NUMBER> key messages overrisk serious forms diabetic patients comorbidities importance protectives behaviors value providing <NUMBER>week supply drugs sensors increased risk ketoacidosis type <NUMBER> diabetics highlighted <NUMBER> french high authority health haute autorité de santé provides recommendations manage diabetes points patients must take care manage glycemic control <NUMBER> period covid<NUMBER> infection patients diabetes avoid close contact others indicated wear masks apply protective behaviors glycaemia closely monitored case must attend practitioner visit icu practical sheets management diabetic patients drawn exclusively regarding covid<NUMBER> infection similar recommendations management perioperative period <NUMBER> also aim standardize management avoiding hyperglycemia could harmful infectious context also hypoglycemia whose negative impact regularly recalled particular case ischemic heart disease mentioned initial insulin resistance frequently observed use infusion pump insulin therapy recommended achieve glycemic targets noninsulin treatments type <NUMBER> diabetes stopped patients clinical condition renal cardiac respiratory function improved risk ketoacidosis context blood glucose monitoring carried classic blood glucose levels arterial venous capillary blood since glucose sensors may give erroneous measurements may validated resuscitation distorted high doses vitamin c paracetamol french society pharmacology therapeutics provided website answers medication management context covid<NUMBER> <NUMBER> american diabetes association pulling resources relevant diabetes covid<NUMBER> professionals treating patients diabetes also forum accessible free topic <NUMBER> paper highlights major safety concerns related covid<NUMBER> use glucoselowering drugs patients diabetes little information potential benefits risks agents context covid<NUMBER> infections paper upholds upon admission hospital unstable patients critically ill patients dpp<NUMBER> inhibitors glp<NUMBER>r agonists sglt<NUMBER> inhibitors metformin used caution discontinued general insulin extensively used critically ill hospitalized diabetic patients well patients concomitant sepsis therefore insulin relevant treatment situations particularly patients hospitalized intensive care units glucose lowering drugs discontinued careful attention must paid avoid hyperglycemia lack physical activity diet caused lockdown infection due covid<NUMBER> two situations may worsen glycemic control hospitalized ambulatory patients diabetes advised ensure careful monitoring blood glucose maintain regular communication health care provider authors competing interest declare none diabetic people passing covid<NUMBER> pandemic session optimum glycemic outcome keywords covid<NUMBER> diabetes diabetes management pandemic scoping review special consideration rapid spreading covid<NUMBER> globally extensively brought many consequences care particularly patients comorbid conditions <NUMBER> <NUMBER> diabetes ranked second prevalent comorbidities <NUMBER> <NUMBER> ci <NUMBER> among covid<NUMBER> patients cardiometabolic diseases <NUMBER> <NUMBER> <NUMBER> people living diabetes higher risk covid<NUMBER> infection potentially experiencing severe illness infected <NUMBER> <NUMBER> metaanalysis china reported covid<NUMBER> patients diabetes twice risk intensive care unit icu admission <NUMBER> makes diabetes independent predictor icu admission invasive mechanical ventilation covid<NUMBER> patients <NUMBER> <NUMBER> recent systematic review also identified covid<NUMBER> patients diabetes related increased risk icu admission <NUMBER> <NUMBER> ci <NUMBER> <NUMBER> <NUMBER> review nonscientific publication correspondences news commentary excluded outcome two independent searches compared difference finding communicated discussed numbers articles reported duplicated articles removed excel spreadsheet used shortlist articles selection procedure seven articles included review screening checking eligibility preferred reporting item systematic review metaanalysis prisma used guidance reporting searching process fig <NUMBER> <NUMBER> included articles compiled extracted excel worksheet extracted data included title authors date publication country region research objective study design target study sample size study setting data collection key findings research domains subdomains included articles categorized two domains ie diabetes management specific consideration diabetes management refers actions treat manage cope disease process diabetes specific consideration concerns particular situation requires thoughtfulness care diabetes management domain classified six subdomains ie glycemic control monitoring dietary intake physical activity medication education prevention specific consideration classified subdomains diabetes children adolescents pregnancy older people emergency critical care methodological characteristics articles also evaluated using excel spreadsheet article assessed study design target study sample size setting data classified presented percentage articles published journal diabetes metabolic diseases <NUMBER> n <NUMBER> followed medical virology journal <NUMBER> n <NUMBER> majority articles asian region <NUMBER> n <NUMBER> followed european american region <NUMBER> n <NUMBER> <NUMBER> n <NUMBER> respectively articles discussed diabetes management domain <NUMBER> provided information specific consideration domain fig <NUMBER> shows subdomains identified articles articles focused medication <NUMBER> <NUMBER> article <NUMBER> discussed covid<NUMBER> preventive action diabetes patients terms specific consideration domain articles focused emergency critical care <NUMBER> articles used review unclear study design <NUMBER> n <NUMBER> majority study targets patients <NUMBER> n <NUMBER> located hospital community setting <NUMBER> n <NUMBER> included studies reported sample size <NUMBER> n <NUMBER> table <NUMBER> information data extraction available table <NUMBER> included articles covered research domains subdomains presenting main findings although included running head diabetes coronavirus pandemic <NUMBER> articles provide detail information study design sample size data collection articles analyzed presented since covered research aims according american diabetes association standard diabetes care patients health care workers diabetes care includes comprehensive medical assessment comorbidities lifestyle management glycemic control medication obesity management risk reduction prevention diabetes complication <NUMBER> <NUMBER> <NUMBER> diabetes management discussed according standards care glycemic control monitoring dietary intake physical activity medication education prevention covid<NUMBER> infection context covid<NUMBER> pandemic diabetic patients must maintain glycemic control monitoring pandemic patients diabetes could potentially find difficulties glycemic control monitoring lockdown quarantine could problem getting access medicine glycemic monitoring materials including glucose strips glucometers needles thus recommended diabetic patients early purchase glycemic monitoring materials medicine online <NUMBER> <NUMBER> <NUMBER> tailored glycemic monitoring diabetic patients could adjusted considering age existing comorbidity clinical manifestation risk factors <NUMBER> glycemic monitoring using capillary blood test acceptable people living diabetes pandemic <NUMBER> <NUMBER> hospitalized covid<NUMBER> patients diabetes undergo closed glycemic control routine blood glucose monitoring previous research indicated covid<NUMBER> patients diabetes associated poor outcomes health <NUMBER> <NUMBER> discharged blood glucose monitoring highly recommended amid <NUMBER>week follow discharge avoid exposure infection <NUMBER> timing glycemic control monitoring adjusted particular occasion pandemic fasting postprandial blood glucose diabetes patients consume oral anti diabetic agents tolerable outcomes ie stable blood glucose record fasting blood glucose less <NUMBER> mgdl hba<NUMBER>c less equal <NUMBER> could performed twice week meanwhile diabetes patients administer insulin poor outcomes intermittent hypoglycemia blood glucose checked least four times day ie fasting pre lunch pre dinner bedtime sign symptom occurring hypoglycemia reason immediately check capillary blood glucose blood glucose checking recorded minimum consecutive three days communicated health care providers teleconsultation <NUMBER> <NUMBER> lockdown covid<NUMBER> pandemic could affect patients dietary habit patients diabetes may find limited access fresh fruits vegetables <NUMBER> <NUMBER> consume canned packaged foods high calories andor fats <NUMBER> healthy balanced diet emphasized encouraged dietician diabetic patients consultation <NUMBER> <NUMBER> recommended calorie intakes obese nonobese diabetes patients <NUMBER> kcalkg <NUMBER> kcalkg ideal body weights sedentary lifestyle respectively dietary advice include low carbohydrate intake low fats intake optimal protein intake meal skipping <NUMBER> daily diet divided three meals snack variation food composition recommended consisting <NUMBER> complex carbohydrates <NUMBER> fibers <NUMBER> fats <NUMBER> gkgday general patients <NUMBER> gkgday nephropathy macroalbuminuria proteins use oils <NUMBER> teaspoons day less <NUMBER> gday sodium intake patients could also use diabetes plate method ie half plate vegetables onefourth proteins onefourth complex carbohydrates alcohol smoking sugary sweetened foods avoided <NUMBER> social distancing lockdown home confinement require patients diabetes limit activities regular exercise however could still limited access indoor outdoor physical activities <NUMBER> home exercise treadmill stationary cycling jogging resistance training recommended <NUMBER> <NUMBER> <NUMBER> tailored physical activity quarantine practiced <NUMBER> minday intensity type activities could adjusted regarding individual patients condition recommended physical activity classified three exercises ie aerobics flexibility workout strength muscle exercises aerobic exercise moderate intensity ie brisk walking treadmill stationary jogging cycling dancing jumping sport aerobic gardening suggested minimum <NUMBER> minday <NUMBER> <NUMBER> unachievable patients could take two three times small portion aerobic exercise <NUMBER> min climbing stairs household routine activities <NUMBER> yoga practice stretching technique <NUMBER> <NUMBER> minday recommended flexibility training <NUMBER> <NUMBER> <NUMBER> steps yoga pranayama chronic condition could implemented enhance pulmonary function <NUMBER> <NUMBER> min squats pushups situps forward flexes small weight lift muscle training exercise every day recommended muscle training exercises <NUMBER> <NUMBER> physical activity diabetes patients heart diseases hypoglycemia history noticed particular circumstance <NUMBER> health care providers need assess patients adherence medication teleconsultation using valid brief tools also make sure diabetes patients sufficient medication stocks prescribe enough medication limited access clinic pandemic <NUMBER> date robust evidence anti diabetic agents context treatment covid<NUMBER> patients diabetes though anti diabetic agents indicate positive outcome glycemic control reduction application angiotensin converting enzyme ace inhibitors angiotensin receptor blockers arb hypothetically useful treat covid<NUMBER> patients however still data support currently association european american cardiology hypertension recommend ace inhibitors arb treat covid<NUMBER> although lacks evidence support <NUMBER> adjustment sulfonylurea insulin dose may necessary prevent hypoglycemia diabetes patients provided information adverse effects antidiabetic agents encourage report adverse effect <NUMBER> additionally reported <NUMBER> nonicu <NUMBER> icu patients covid<NUMBER> received glucocorticoid therapy daily treatment glucocorticoid associated hyperglycemia induced severe clinical manifestation recent review found use glucocorticoid recommended treat covid<NUMBER> pneumonia could cause harm previous reported covid<NUMBER> patients obtained hydroxychloroquine therapy smallrandomized trial covid<NUMBER> patients mild signsymptom pneumonia ct scan received oral hydroxychloroquine <NUMBER> mg twice day five days <NUMBER> patients indicated improvement covid<NUMBER> pneumonia none developed severe covid<NUMBER> pneumonia among covid<NUMBER> patients diabetes hydroxychloroquine works hypoglycemia agent decreasing hba<NUMBER>c hyperglycemia <NUMBER> covid<NUMBER> patients type <NUMBER> diabetes receive chloroquine therapy potentially experiencing hypoglycemia side effect chloroquine agent hypoglycemia immunomodulatory effects therefore patients closely monitored diabetic animals chloroquine causes increase level insulin serum providing signal cellular receptors postreceptor clearance <NUMBER> diabetic patients receive hydroxychloroquine obtain education contraindication diabetic neuropathy history seizure <NUMBER> covid<NUMBER> pandemic regular visit hospitalclinic diabetes impeded type <NUMBER>diabetes patients contact endocrinologists type <NUMBER> diabetes patients suggested consult internal medical specialists general practitioners <NUMBER> <NUMBER> recommended conduct online teleconsultation keep touch health care providers <NUMBER> <NUMBER> endocrinologist could provide consultation optimizing use smartphone application ie wechat whatsapps line share educational videos ebooks recommendations <NUMBER> previous metaanalysis showed telemedicine practice nonpandemic era emails phones videos <NUMBER> months china showed significant reduction hba<NUMBER>c <NUMBER> p <NUMBER> <NUMBER> another cochrane review telemedicine also indicated similar outcomes ie decline hba<NUMBER>c <NUMBER> p <NUMBER> <NUMBER> recent review <NUMBER> studies telemedicine among type <NUMBER> n <NUMBER> <NUMBER> diabetes n <NUMBER> patients showed significant reduction hba<NUMBER>c <NUMBER> <NUMBER> <NUMBER> video mode telemedicine also recommended first consultation patients privacy confidentiality consent surrogates caregivers patients maintained radiology laboratory findings prescription integrated medical records previous history complaint allergy hypoglycemia main concern identification noticeable neurological deficit applicable requesting patients perform simple neurological test video photograph could help suspecting lesion foot abscess visible wound patients recognize signsymptom hypoglycemia know treat health care providers always remind patients hand washing cough technique social distancing general precaution teleconsultation telemedicine teleconsultation compatible facetoface clinic visit acceptable considering time place preventing transmission cavid<NUMBER> telemedicine also doable clinical examination psychotropicnarcotic prescription <NUMBER> previously reported patients diabetes higher risk covid<NUMBER> infection general diabetes patients adhere social distancing home confinement policy primary preventive method avoid contacts exposure confirmed covid<NUMBER> patients much recommended patients diabetes arrange individual plan diabetes management staying home getting sick make list dietary intakes physical activities stress management confinement diabetes patients strongly recommended keep maintaining glycemic control part risk reduction infection andor prevent severe consequence infection confirmed covid<NUMBER> patients diabetes <NUMBER> <NUMBER> diabetes patients visit hospital consult physicians nurses suspected covid<NUMBER> infection fever cough dyspnea pneumonia visiting pandemic area recent contact confirmed covid<NUMBER> patients factors diabetes patients suspected covid<NUMBER> infection patients decide go hospital clinic patients diabetes use facemasks undergo diagnosis procedure taking samples noses throat <NUMBER> case home confinement patients families adhere rules affected suspected people could help prevent transmission patients andor families affected people live single room proper ventilation meanwhile family members stay different room applicable make sure always keep minimum onemeter distance affected person routine hand washing contact affected patient environment use disposable paper towel clean towel replace getting wet hand wash affected person use medical mask cover nose mouth caregivers also need wear fullcovered medical mask room affected person <NUMBER> diabetes management inevitably altered covid<NUMBER> pandemic therefore specific condition required specific circumstances following section discuss diabetes management certain population situation based current available evidences child adolescent newly diagnosed type <NUMBER> diabetes recommended take facetoface mode consultation type <NUMBER> diabetes patients families visit diabetes clinic initiate insulin administration health care providers make sure patients families receive diabetes education highlighted topic insulin administration hypoglycemia ketoacidosis signsymptom management follow type <NUMBER>diabetes patients ketoacidosis test advised experiencing hyperglycemia <NUMBER> patients gestational diabetes undergo facetoface consultation insulin initiation first visit patients obtain tailored education related diabetes current condition lifestyle management minor adjustment insulin dose may necessitated follow gestational diabetes patients using telemedicineteleconsultation <NUMBER> elderly patients diabetes likely deteriorated glycemic control result raised blood glucose amid covid<NUMBER> pandemic <NUMBER> hyperglycemia hypoglycemia could occur due limited access care lockdown quarantine stimulate unstable blood glucose lead serious complication elderly patients diabetes example ketoacidosis infection coma hyperosmolar cardiac event drawback distinct among elder diabetic patients live alone <NUMBER> recommended encourage always keep touch health care providers quickly seek help needed diabetic patients experiencing drowsiness vomiting chest pain short breath limb weakness altered sensory noticed emergency situation <NUMBER> addition diabetic patients foot lesion gangrene severe hypoglycemia gastroenteritis infection related covid<NUMBER> addressed special condition situations require hospitalclinic visit admission <NUMBER> health care providers make sure diabetic patients understand signssymptoms take initial action hospitalclinical appointment confirmed covid<NUMBER> patients diabetes receive critical care intensive blood glucose monitoring become priority care adverse effect drug reaction early identified <NUMBER> diabetes noticed independent factor icu admission raised risk mortality rate <NUMBER> <NUMBER> <NUMBER> reported covid<NUMBER> patients diabetes comorbidity twice risk admited icu receive critical care <NUMBER> study described covid<NUMBER> patients diabetes contributed <NUMBER> <NUMBER> icu admission due septic shock acute respiratory distress syndrome result blood glucose variability elevated blood pressure <NUMBER> <NUMBER> mortality risk covid<NUMBER> patients diabetes three times higher nondiabetic patients <NUMBER> current reports noted mortality rate covid<NUMBER> patients diabetes <NUMBER> <NUMBER> <NUMBER> <NUMBER> thus health care providers concern caring covid<NUMBER> patients diabetes hospitalization scoping review provide broader scope diabetes management action particular consideration thus included level evidence quality evaluation addition unclear methodological approach among included articles authors definitely express method section three included articles provide clear information study design data collection process five seven included articles specify sample size one article used onesample size case report limitation included studies causes limitation scoping review review produced summary diabetes management specific considerations amid covid<NUMBER> pandemic diabetes patients patients family members could use review deal diabetes management concern particular situations diabetes seek help needed health care providers policy makers could take concern review results facilitate people living diabetes passing covid<NUMBER> pandemic samples nose throat examined diagnosis procedure <NUMBER> since regular visit recommended suggested utilize teleconsultation smartphones keep touch healthcare providers <NUMBER> required calorie daily intake nonobese obese patients <NUMBER> kcalkg <NUMBER>kcalkg ideal body weights sedentary lifestyle respectively distributed three meals snack habits food composition maintained <NUMBER> complex carbohydrates <NUMBER> fibers <NUMBER> fats <NUMBER> gkgday general <NUMBER>kgday nephropathy macroalbuminuria protein three teaspoons oilday combined <NUMBER> vegetable oils <NUMBER> g sodium daily dario pitocco <NUMBER> linda tartaglione recent commentary diabetes research clinical practice described interplay middle east respiratory syndrome merscov another coronavirus responsible outbreak acute respiratory syndrome human dipeptidyl peptidase <NUMBER> dpp<NUMBER> identified functional receptor virus spike protein <NUMBER> interestingly hypothesized dpp<NUMBER> inhibition therapy currently available type <NUMBER> diabetes might represent target decreasing risk acute respiratory complications covid<NUMBER> unfortunately hypothesis basis another hypothesis best knowledge one yet shown dpp<NUMBER> possible receptor sarscov<NUMBER> contrary recent data exclude possibility confirming human angiotensinconverting enzyme <NUMBER> ace<NUMBER> receptor sarscov<NUMBER> analogy sarscov <NUMBER> dpp<NUMBER> like ancient roman god janus bifrons twofaced dual multifunctional molecule exists soluble form sdpp<NUMBER> circulation <NUMBER> also type ii transmembrane glycoprotein located endothelial epithelial cells immune cells cd<NUMBER> <NUMBER> dpp<NUMBER> bloodstream surface membrane rapidly inactivates biologically active molecules gastrointestinal hormones neuropeptides chemokines cases shifts receptor preference thus modifies functional activity addition enzymatic cleavage cd<NUMBER> executes multiple physiological mechanisms adhesion extracellular matrix proteins plays costimulatory role tcell maturation activation interaction antigenpresenting cells thus dpp<NUMBER> inhibition associated degree immune suppression may useful autoimmune diseases <NUMBER> however patients longterm immune suppression albeit mild could represent undesirable side effect <NUMBER> described case type <NUMBER> diabetes subject severe leucopenia consequence dpp<NUMBER> inhibitor sitagliptin therapy <NUMBER> diabetic subjects treated dpp<NUMBER> inhibitors increase respiratory tract infections <NUMBER> want highlight could produce respiratory side effects angioedema <NUMBER> rhinorrhea <NUMBER> cough dyspnea <NUMBER> consequences reduced degradation bradykinin substance p mers another example dpp<NUMBER> ambivalence expected human dpp<NUMBER> transgenic mice following merscov infection develop acute inflammatory response lung progressive pulmonary fibrosis <NUMBER> however hdpp<NUMBER> mice resistant hdpp<NUMBER>− mice merscov infection judged increased ld<NUMBER> reduced lung viral infection attenuated morbidity mortality reduced histopathology <NUMBER> possible explanation paradoxical protective effect dpp<NUMBER> merscov soluble dpp<NUMBER> act buffer competitively inhibiting virus entry host cells fact human patients affected mers reduction circulating levels sddp<NUMBER> inverse relationship il<NUMBER> level support antiviral effect sdpp<NUMBER> authors demonstrated viral infection inhibited <NUMBER> presence <NUMBER> ngml sdpp<NUMBER> <NUMBER> finally virus tropism complex phenomenon case coronavirus family understanding expression pattern receptor define cells infected mean cells express receptor even cells highest expression major targets case ace<NUMBER> human lung <NUMBER> th tissue amount receptors <NUMBER> probably spike protein impacts tissue tropism background genes including nucleocapsid replicase accessory genes also important determinants tropism conclusion <NUMBER> lack demonstration sarscov<NUMBER> binding dpp<NUMBER> <NUMBER> possible protective role funding authors receive specific grant funding agencies public commercial notforprofit sectors worsened short period time died multiple organ failure <NUMBER> angiotensinconverting enzyme <NUMBER> ace<NUMBER> surface receptor sars coronavirus sarscov directly interacting spike glycoprotein protein <NUMBER> recent study suggests affinity ace<NUMBER> receptorbinding domain rbd sarscov<NUMBER> <NUMBER> <NUMBER> times higher rbd sarscov indicating ace<NUMBER> might also receptor sarscov<NUMBER> <NUMBER> ace<NUMBER> reported widely expressed various organ systems including cardiovascular system kidneys lungs brain <NUMBER> might provide explanation covid<NUMBER> patients died multiple organ failure diabetes mellitus one leading causes morbidity worldwide anticipated rise substantially next decades <NUMBER> several investigations demonstrated higher susceptibility infectious diseases diabetic people like staphylococcus aureus mycobacterium tuberculosis <NUMBER> <NUMBER> <NUMBER> probably owing dysregulated immune system <NUMBER> reported plasma glucose levels diabetes independent predictors mortality morbidity patients sars <NUMBER> retrospective study wuhan china revealed <NUMBER> covid<NUMBER> patients <NUMBER> underlying diseases among <NUMBER> diabetes <NUMBER> therefore diabetic patients might increased risk covid<NUMBER> poorer prognosis figure whether diabetes risk factor influence progression prognosis covid<NUMBER> <NUMBER> covid<NUMBER> patients admitted wuhan union hospital <NUMBER> february <NUMBER> <NUMBER> february <NUMBER> included study according inclusion criteria basic information laboratory examinations chest computed tomography ct scans well treatment measures collected analysed found common underlying disease covid<NUMBER> patients diabetes associated worse prognosis extracted demographic data medical history exposure history symptoms signs laboratory findings chest ct scans treatment measures electronic medical records date disease onset defined day first symptom showed clinical outcomes followed <NUMBER> march <NUMBER> data analysed research team double checked two physicians ys lz laboratory validation sarscov<NUMBER> performed wuhan union hospital throatswab specimens obtained upper respiratory tract patients admission stored viraltransport medium total rna extracted within <NUMBER> hours using respiratory sample rna isolation kit zhongzhi wuhan china sarscov<NUMBER> examined rtpcr described previously <NUMBER> covid<NUMBER> patients met following criteria epidemiology history b fever respiratory symptoms c typical ct image abnormities viral pneumonia positive result rtpcr sarscov<NUMBER> rna patients divided diabetes nondiabetes group according medical history furthermore ct imaging scores used quantify pathological changes covid<NUMBER> patients values obtained two physicians blinded patients clinical data using introduced scoring system described performance score <NUMBER> unbilateral patchy shadows groundglass opacity <NUMBER> <NUMBER> bilateral patchy shadows groundglass opacity <NUMBER> <NUMBER> diffuse changes <NUMBER> <NUMBER> table <NUMBER> admission abnormalities chest ct images detected among patients prominent radiologic abnormalities bilateral groundglass opacity subsegmental areas consolidation consistent recent reports <NUMBER> representative chest ct imaging patients without diabetes compared latter showed severe pathological changes former figure <NUMBER>a furthermore severity pathological changes evaluated quantifiable score system described found diabetes group presented higher ct imaging score compared nondiabetes group figure <NUMBER>b table <NUMBER> figure <NUMBER> neutrophils analysed effect sarscov<NUMBER> pathology diabetes found patients diabetes control blood glucose levels insulin oral medicine admission among <NUMBER> patients took insulin increased dose insulin admission <NUMBER> patients took oral medicine admission started insulin therapy admission meant patients poor glycemic control hospitalization diabetic patients three diabetic complications patients diabetic complications likely die shown table <NUMBER> finally explored impact comorbidities prognosis patients diabetes analysis although indicators diabetic patients comorbidities slightly higher without comorbidities matter evaluated organ damage inflammatory factors hypercoagulability comorbidities little effect prognosis patients diabetes table s<NUMBER> common perceptions associate diabetes generally increased mortality morbidity infectious diseases although epidemiologic data would prove surprisingly scarce however seems confirmed diabetes predisposes certain types infection death <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> still unknown whether diabetes risk factor prognosis covid<NUMBER> type <NUMBER> diabetes widely viewed chronic lowgrade inflammatory disease caused longterm immune system imbalance metabolic syndrome nutrient excess associated obesity <NUMBER> <NUMBER> obesityassociated inflammation characterized increased abundance activation innate adaptive immunity cells adipose tissue along increased release inflammatory factors chemokines locally systemically <NUMBER> <NUMBER> according quantifiable score found diabetes group presented higher ct imaging score compared nondiabetes group means pneumonia diabetic patients severe nondiabetic patients addition imaging results laboratory results also give us hints biochemical results showed indicative enzymes abnormally elevated blood patients sarscov<NUMBER> pneumonia including ldh hbdh alt ggt indicated injury myocardium kidney liver result consistent extensive distribution sarscov<NUMBER> receptors ace<NUMBER> <NUMBER> also partially explain patients died multiple organ failure <NUMBER> important note levels enzymes even higher patients diabetes compared patients without diabetes give us clue injure organs much serious diabetes patients group without diabetes addition study found levels total protein albumin prealbumin haemoglobin significantly lower patients diabetes compared individuals without diabetes means diabetes patients likely undernourished according recent report analysing <NUMBER> hospitalized patients covid<NUMBER> found neutrophilia related cytokine storm induced virus invasion coagulation activation related sustained inflammatory response acute kidney injury related direct effects virus might associated death patients covid<NUMBER> <NUMBER> study also found patients sarscov<NUMBER> pneumonia especially severe pneumonia significantly reduced lymphocyte counts significantly increased inflammatory factors il<NUMBER> <NUMBER> fact advanced stage sars ebola virus infections cytokine storms also main cause eventual death many patients study found compared patients without diabetes absolute count lymphocytes peripheral blood patients diabetes significantly lower absolute count neutrophils remarkably higher furthermore serum levels inflammationrelated biomarker much higher compared without diabetes il<NUMBER> serum ferritin esr crp noteworthy diseases induce cytokine storm il<NUMBER> good predictor disease severity prognosis expression time longer cytokines tnf il<NUMBER> <NUMBER> addition significant rise serum f g u r e <NUMBER> biochemical examination results patients diabetes patients without diabetes p <NUMBER> considered statistically significant ferritin indicates activation monocytemacrophage system crucial part inflammatory storm results indicate patients diabetes susceptible form inflammatory storm eventually lead rapid deterioration covid<NUMBER> inflammatory storm ddimer increases significantly early stage result inflammation activating plasmin however inflammation progresses presence hypoxia hypoxiainduced molecules activate thrombin directly activation monocytemacrophages would also secrete mass tissue factors activate exogenous coagulation pathway lead overall hypercoagulable state even disseminated intravascular coagulation study found level ddimer fib significantly higher patients diabetes indicate prone hypercoagulable state patients without diabetes clinical medication showed insulin dose increased patient infected sarscov<NUMBER> shows virus impact patients glucose metabolism dysregulation glucose metabolism aggravate diabetes affect severity pneumonia works amplification loop meanwhile diabetic complications signify severity diabetes patients diabetic complications showed higher mortality rate proves diabetes risk factor prognosis covid<NUMBER> severity diabetes positively correlated poor prognosis whether interference comorbidities present found sarscov<NUMBER> pneumonia patients diabetes severe without diabetes evaluating organ damage inflammatory factors hypercoagulability likely progress worse prognosis therefore diabetes might could considered risk factor outcome sarscov<NUMBER> pneumonia intensive attention paid patients diabetes case rapid deterioration f g u r e <NUMBER> laboratory tests patients diabetes patients without diabetes blood test results patients diabetes patients without diabetes b inflammationrelated laboratory results patients diabetes patients without diabetes c coagulationrelated laboratory results patients diabetes patient without diabetes p <NUMBER> considered statistically significant dawn <NUMBER> central china faced outbreak highly transmittable novel strain coronavirus causing severe illness subsequently named sarscov<NUMBER> <NUMBER> coronavirus disease characterized severe acute respiratory syndrome high mortality rate especially among elderly people serious underlying medical conditions irrespectively age <NUMBER> <NUMBER> th march <NUMBER> countries reported numerous cases covid<NUMBER> declared outbreak pandemic <NUMBER> <NUMBER> th march europe active center pandemic shortly european countries began reporting confirmed cases deaths one european countries implemented various degrees lockdowns counter spread coronavirus outbreak <NUMBER> greece imposed closure educational institutions <NUMBER> th march <NUMBER> confirmed cases covid<NUMBER> full lockdown two weeks later much earlier many european neighbors far quick reflexes effective number covid<NUMBER> cases deaths one lowest europe nonetheless long way ahead lockdown subsequent social distancing practices cases meant complete isolation caused major change peoples daily living routines emerging evidence supports people become less physically active frequently consume nutritionally unbalanced diet <NUMBER> people chronic health conditions might limited access healthcare system even health supplies equipment children adolescents type <NUMBER> diabetes mellitus t<NUMBER>dm factors may lead impaired glycemic control physical activity healthy eating even steady daily routine contribute substantially effective diabetes management <NUMBER> <NUMBER> aim study monitor effect coronavirus lockdown glycemic variability insulin requirements eating portions habits children t<NUMBER>dm wearing insulin pump equipped continuous glucose monitoring system thus direct comparison parameters conducted threeweeks period lockdown equal time period prior lockdown invited children type <NUMBER> diabetes followed pediatric diabetes outpatient clinic wearing medtronic minimed <NUMBER>g insulin pump accompanied enlite tm sensor guardian tm <NUMBER> link transmitter upload data carelink system one month since initiation coronavirus lockdown study performed accordance helsinski declaration <NUMBER> approved scientific administrative council hippokration general hospital thessaloniki children caregivers informed nature purpose study verbal consent obtained every participant exclusion criteria included recent diagnosis t<NUMBER>dm less <NUMBER> months ii chronic acute medical condition medication would likely interfere glucose metabolism <NUMBER> weeks prior <NUMBER> weeks study period iii less <NUMBER> months experience pump sensor iv sensor duration study period less <NUMBER> v incomplete missing data inability upload data using carelink system v unwillingness participate study figure <NUMBER> shows flow chart study population selection carelink data uploaded patients caregivers analyzed categorized <NUMBER> periods lockdown period <NUMBER> weeks period starting <NUMBER> th march <NUMBER> ii period prior lockdown <NUMBER> weeks period ending <NUMBER> th march <NUMBER> demographic data regarding date birth date t<NUMBER>dm diagnosis date medtronic <NUMBER>g pump first use extracted patients medical files additionally anthropometric parameters including weight height pubertal status extracted records patients last visit clinic bmi calculated ratio weightheight <NUMBER> kgm <NUMBER> quetelet index every anthropometric parameter zscores calculated according cdc standards <NUMBER> recent hba<NUMBER>c values also recorded every patient shapirowilk test used assessing normality studied parameters wilcoxon signed ranks test parameters normal skewed distribution respectively parameters normal distribution linear correlations calculated pearsons correlation coefficient whereas spearmans correlation coefficient employed nonparametric variables p value <NUMBER> less considered statistically significant thirtyfour children <NUMBER> boys <NUMBER> t<NUMBER>dm finally enrolled statistical analysis decimal mean age time study <NUMBER> ± <NUMBER> years ranging <NUMBER> <NUMBER> years mean age time diagnosis t<NUMBER>dm <NUMBER> ± <NUMBER> years mean time using insulin pump <NUMBER> ± <NUMBER> years descriptive demographic anthropometric characteristics studied population presented table <NUMBER> following data stratification two studied periods significant differences arose table <NUMBER> whereas figure <NUMBER> illustrates significant changes meal timing data showed glycemic control coronavirus lockdown period adequately achieved comparable prelockdown period children type <NUMBER> diabetes mellitus wearing insulin pump equipped sensor results accordance reported <NUMBER> emerging studies showing difference glycemic control coronavirus lockdown period adults <NUMBER> adolescents <NUMBER> t<NUMBER>dm hybrid closed loop system interestingly bonora et al shown improved metabolic control adult patients t<NUMBER>dm stopped working contrast difference glycemic control reported continue work lockdown period <NUMBER> although reported amount carbohydrates consumed differ significantly two periods data meal timing drastically moved looser routine frequent latenight eating significantly increased percentage consuming first meal day later <NUMBER> large recent study adult population t<NUMBER>dm skipping breakfast associated lower odds reaching good glycemic control higher mean blood glucose values <NUMBER> however study could declare population breakfast skippers lateawakers information regarding actual wake time available report obtained carelink system previous study higher number reported meals day also associated higher variability blood glucose measurements nevertheless better overall glycemic control <NUMBER> better glycemic control also associated higher number eating occasions two studies performed adolescents t<NUMBER>dm <NUMBER> <NUMBER> whereas skipping meals associated higher odds suboptimal hba<NUMBER>c study <NUMBER> children t<NUMBER>dm <NUMBER> particular interest skipping breakfast associated increased postprandial glycemic response lunch recent experimental study healthy young individuals <NUMBER> regarding physical activity recent study assessing health wellbeing normal chinese adults living working one month restrictions contain covid<NUMBER> outbreak results showed exercise regularly <NUMBER> h per day life satisfaction negatively associated level restrictive measures <NUMBER> hand individuals exercise less half hour day life satisfaction significantly positively associated level restrictive measures severely affected locations reflecting better justification rationalization inactive lifestyles <NUMBER> patients t<NUMBER>dm regular physical activity associates several positive physical health effects including improvement cardiovascular function blood lipid profile well enhancement psychological wellbeing <NUMBER> however beneficial effects healthrelated outcomes perfectly coordinate improvements glycemic control something mainly attributed increased glucose variability exercise <NUMBER> accordance results showed statistically decreased coefficient variation cv mean blood glucose values indirect inverse indicator glucose variability lockdown period hand recent study tornese et al <NUMBER> adolescents t<NUMBER>dm continued physical activity lockdown period showed improved glycemic control compared <NUMBER> adolescents discontinued regular physical activity <NUMBER> additionally study percentage basal insulin requirements increased lockdown period indicating increased sedentary behavior however increase total daily insulin dose indicating compensatory bolus reduction result reduced carbohydrates consumption finally data showed significant reduction blood glucose readings lockdown period expected number blood glucose readings inversely correlated age r<NUMBER> p<NUMBER> data shown also difference blood glucose readings performed lockdown period lockdown inversely correlated frequency testing prior lockdown period correlation approaching significance r<NUMBER> p<NUMBER> data shown could reduction using glucose strips reflect endogenous stressor associated fear running medical supplies shortages basic medical supplies considered major stressor quarantine continues associated anxiety anger even <NUMBER> months release <NUMBER> order prepared provide effective pharmaceutical care general population patients chronic diseases coronavirus outbreak chinese pharmacists recently published recommendations guidelines <NUMBER> one studys main limitation derives subjective nature information provided carelink system especially reported carbohydrates consumed absence reporting physical activity sleep patterns additionally study population includes patients wearing insulin pump sensor representing group patients caregivers familiar technology usually aiming achieving best possible glycemic control thus generalization results patients t<NUMBER>dm avoided furthermore singlecenter study readers cautious expand conclusions different populations clinical scenarios also nature traditional control study allow adjustment potential confounders accompanying policies related outcomes hand studys statistical strength stems paired comparison patient serving control thus manage show coronavirus lockdown period children type <NUMBER> diabetes insulin pump continuous glucose monitoring automated insulin suspension system achieve adequate glycemic control regardless decreased physical activity possibly nutritionally imbalanced diet unpredictable meal schedules despite limitations patients caregivers proved welltrained experienced dealing possible unpredictabilities might come way maintain good glycemic control research receive specific grant funding agencies public commercial notforprofit sectors table <NUMBER> parameters glycemic control insulin requirements carbohydrates consumption three studied results expressed mean ± standard error  glycemic control coronavirus lockdown comparable prelockdown period children type <NUMBER> diabetes mellitus wearing insulin pump equipped sensor  mean time range tir significantly differ two periods however higher coefficient variation cv indicating increased glucose variability prelockdown period observed  meal schedule changed dramatically lockdown decrease percentages early breakfast early last meal day novel rna virus previously identified humans virus mainly affects respiratory tract causing characteristic symptoms fever dry cough dyspnoea significant risk severe complications including requiring intensive care unit support presenting acute respiratory syndrome death certain patients <NUMBER> testing times experienced recent generations number insecurities regarding management people covid<NUMBER> uncertainty appropriate treatments ensued adding anxiety amongst healthcare professionals hcps however need rely current systems hcps continue provide advice terms therapeutic uncertainty potential adverse harms associated therapy managing people particularly cardiometabolic diseases contracted increased risk contracting covid<NUMBER> help patient care build trust within setting objective present brief report summarize guide clinicians interaction management people covid <NUMBER> therapies used cardiometabolic diseases systematic review metaanalysis clinical imaging features outcomes confirmed covid<NUMBER> cases whole population analysed <NUMBER> studies mean age patients studies <NUMBER> years <NUMBER> male <NUMBER> comorbidities significant hypertension <NUMBER> cardiovascular disease cvd <NUMBER> diabetes <NUMBER> <NUMBER> diabetes associated multimorbidity <NUMBER> people type <NUMBER> diabetes least one chronic condition <NUMBER> four chronic conditions <NUMBER> hypertension common supplementary condition affecting twothirds people type <NUMBER> diabetes expected number chronic conditions increased significant increase polypharmacy half patients type <NUMBER> diabetes prescribed six medications regarding covid<NUMBER> concerns increased mortality patients cvd diabetes hypertension cerebrovascular disease study based <NUMBER> <NUMBER> confirmed cases china showed case fatality rate <NUMBER> <NUMBER> deaths general population compared <NUMBER> cvd <NUMBER> diabetes <NUMBER> study showed common comorbidities <NUMBER> hospitalized patients covid<NUMBER> hypertension <NUMBER> diabetes <NUMBER> <NUMBER> binding target cells ace<NUMBER> receptors <NUMBER> medications shown upregulate ace<NUMBER> animal studies therefore concerns patients taking medications increased risk developing severe coronavirus infections <NUMBER> perico et al <NUMBER> stated however evidence suggests ace<NUMBER> receptors lungs may play protective role covid<NUMBER> furthermore european society hypertension european society cardiology joint statement american college cardiology american heart association heart failure society america also advised treatment ace inhibitors arbs continue per usual guidelines patients risk covid<NUMBER> already diagnosed covid<NUMBER> <NUMBER> currently reliable experimental clinical data available suggest otherwise warn risk stopping medications suddenly causing acute heart failure worsening blood pressure <NUMBER> furthermore discontinuation drugs associated risk exacerbating heart failure thus causing symptoms breathlessness turn raise anxieties cause ambiguity whether symptoms infectionrelated attributable chronic health conditions <NUMBER> people diabetes advised hcps aware patients increased risk metabolic decompensation patients managed home hcps need ensure increased supply monitoring equipment glucose ketones adequate medication supplies information regarding following stringent social distancing measures <NUMBER> furthermore metabolic acidosis shown risk patients severe covid<NUMBER> infection <NUMBER> particular risk patients diabetes metformin metformin exacerbate lactic acidosis previously suggested patients increased risk lactic acidosis suspend metformin inhospital stay provided adequate insulin treatment <NUMBER> infections complications may put people diabetes increased risk covid<NUMBER> therefore good glycaemic control medication adherence vital <NUMBER> people diabetes hypertension multimorbidities associated poor medication adherence one metaanalysis eight studies regarding association poor medication adherence excess mortality chronic disease showed mean rate poor adherence <NUMBER> <NUMBER> study also showed good adherence associated reduction hospital admissions mortality patients type <NUMBER> diabetes <NUMBER> hcps therefore need address issue especially times patients anxious associated poor adherence metaanalysis <NUMBER> studies concerning depression medication adherence treatment chronic diseases showed <NUMBER> times increased risk depressed patient nonadhering treatment <NUMBER> patients diabetes mental illness may therefore experience decompensation mental illness due covid<NUMBER> may result decreased medication adherence patients need reassured encouraged hcps take medications even remote consultations using mobile phone technologies improve adherence advice needs given regarding stopping treatments lead morbidity mortality additionally also reports patients lifethreatening conditions myocardial infarction delaying medical attention due covid<NUMBER> outbreak <NUMBER> paramount address issues ensure appropriate management patients chronic conditions especially associated high mortality corticosteroid use previous outbreaks severe acute respiratory syndrome sarscov middle east respiratory syndrome merscov corticosteroids used extensively <NUMBER> nonetheless given guidance use corticosteroids covid<NUMBER> possibility harm unless medications needed health conditions <NUMBER> therefore adrenal insufficiency addisons disease secondary adrenal failure continue take medication follow sickday rules become unwell without delay <NUMBER> importantly also follow social distancing measures indefinitely still early phases clinical trials future research use medications along others hopefully undertaken quickly assist distressing times national institute health care excellence nice recently published first rapid covid<NUMBER> guidelines help maximize safety patients staff also positive evidence use certain medications treatment covid<NUMBER> including chloroquine hydroxychloroquine systematic review concluded chloroquine appears effective preventing sarscov<NUMBER> replication based known safety clinical research chloroquine patients covid<NUMBER> justified <NUMBER> one small study showed hydroxychloroquine treatment significantly associated viral load reductiondisappearance covid<NUMBER> patients effect reinforced azithromycin <NUMBER> must however proceed caution use hydroxychloroquine data become available patients sarscov<NUMBER> complications present hypotension tachycardia bradycardia arrhythmia even sudden cardiac death <NUMBER> may also associated hydroxychloroquine since prolong qtc interval particularly patients heart failure previous myocardial infarction would therefore advisable periodically monitor ecg treatment <NUMBER> copcov randomized controlled trial assessing chloroquinehydroxychloroquine prevention coronavirus disease healthcare setting clinicaltrialsgov nct<NUMBER> hopefully provide data reassure clinicians benefits safety agent patients diabetes also need carefully monitored recent evidence systematic review hydroxychloroquine potential antidiabetic properties potential risk hypoglycaemia turn associated increased risk cardiac arrhythmia associated increased cardiovascular events mortality <NUMBER> whilst treatments still exploration important time patients cardiometabolic endocrine medications supported encouraged adhere treatment regimes obtain support reduce mental health issues advised adhere lifestyle recommendations reduce risk detrimental health effects unnecessary admissions already overstretched healthcare system authors declare conflicts interest idea proposal kk sk nk composed initial draft ss reviewed corrected draft httpsorcidorg<NUMBER> kamlesh khunti httpsorcidorg<NUMBER> coronavirus disease caused severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> global pandemic initially started wuhan china spread extremely quickly making way <NUMBER> countries novel coronavirus continues evolve still many limitations knowledge exactly virus would impact critically older adults people age underlying medical conditions hypertension diabetes shown worse prognosis <NUMBER> diabetic patients increased morbidity mortality rates linked hospitalization intensive care unit icu admissions <NUMBER> people chronic obstructive pulmonary disease copd respiratory illnesses also higher risk severe illness covid<NUMBER> <NUMBER> risk contracting covid<NUMBER> patients copd found <NUMBER>fold higher patients without copd <NUMBER> article part topical collection covid<NUMBER> adekunle sanyaolu sanyakunlehotmailcom <NUMBER> federal ministry health abuja nigeria retrospective study middleaged elderly patients covid<NUMBER> found elderly population susceptible illness likely admitted icu higher mortality rate <NUMBER> agerelated changes geriatric population may due changes lung anatomy muscle atrophy results changes physiologic function reduction lung reserve reduction airway clearance reduction defense barrier function <NUMBER> clinical outcomes length stay directly correlate underlying conditions age covid<NUMBER> patient researchers china studied <NUMBER> patients icu covid<NUMBER> <NUMBER> subjects <NUMBER> patients died <NUMBER>th day median survival <NUMBER> days <NUMBER> patients many different comorbidities <NUMBER> patients hypertension <NUMBER> survivors median duration hospitalization negative test result <NUMBER> days <NUMBER> furthermore another study conducted china studied <NUMBER> covid<NUMBER> patients <NUMBER> patients least one comorbidity concluded older individuals greater <NUMBER> years likely exhibit severe form covid<NUMBER> disease <NUMBER> study <NUMBER> patients median age <NUMBER> years died giving effective mortality rate <NUMBER> <NUMBER> concluded older patients likely succumb covid<NUMBER> disease usa centers disease control prevention cdc uses covidnet <NUMBER> states monitor demographics covid<NUMBER> patients hospitalized <NUMBER> march <NUMBER> <NUMBER> <NUMBER> total <NUMBER> patients covidnet <NUMBER> patients underlying comorbidity <NUMBER> <NUMBER> patients <NUMBER> aged <NUMBER> years older least comorbidity <NUMBER> common comorbidities found obesity hypertension diabetes mellitus <NUMBER> purpose paper review comorbidities given patients severe covid<NUMBER> cases comorbidity furthermore would like examine specific comorbidities relation covid<NUMBER> disease progression outcomes based literature report since outbreak electronic literature search performed using pubmed google scholar ebscohost mendeley medline plus search limited peerreviewed articles published january april <NUMBER> <NUMBER> article selected included keywords coronavirus covid<NUMBER> sarscov<NUMBER> clinical features comorbidity diabetes hypertension articles reviewed included based applicability topic confirmed reported cases covid<NUMBER> wide range symptoms mild complaints fever cough critical cases associated difficulty breathing <NUMBER> common symptoms include cough fever chills shortness breath sob muscle aches sore throat unexplained loss taste smell diarrhea headache <NUMBER> symptoms start mild become intense <NUMBER> <NUMBER> days worsening pneumonia develops patients <NUMBER> approximately <NUMBER> <NUMBER> infected individuals become seriously ill develop difficulty breathing especially elderly underlying health conditions <NUMBER> metaanalysis study covid<NUMBER> patients depicted fig <NUMBER> showed fever <NUMBER> common symptom followed dry cough <NUMBER> fatigue <NUMBER> <NUMBER> symptoms noted productive cough <NUMBER> sob <NUMBER> muscle pain <NUMBER> sore throat <NUMBER> headache <NUMBER> <NUMBER> least common symptoms diarrhea <NUMBER> nausea vomiting <NUMBER> rhinorrhea <NUMBER> abdominal pain <NUMBER> chest pain <NUMBER> <NUMBER> symptoms covid<NUMBER> may appear anytime <NUMBER> <NUMBER> days exposure therefore <NUMBER>day quarantine recommended <NUMBER> average incubation period covid<NUMBER> approximately <NUMBER> days <NUMBER> wuhan china common symptoms observed onset outbreak include fever cough fatigue features prevalent sputum production headache hemoptysis gastrointestinal gi symptom diarrhea <NUMBER> <NUMBER> another study conducted beijing china showed average age patients covid<NUMBER> <NUMBER> years mean <NUMBER> days onset symptoms admission hospital <NUMBER> study also showed fever present <NUMBER> patients persisted <NUMBER> days symptoms resolved <NUMBER> days negative test result <NUMBER> individuals infected develop symptoms <NUMBER> positive cases recover disease without treatment <NUMBER> however also instances transmissions covid<NUMBER> one person another person became aware sick symptoms mild person know heshe illness <NUMBER> becomes essential seek medical attention immediately person suspects heshe may infected confirmed case covid<NUMBER> experiencing respiratory distress blue lips constant pain pressure chest <NUMBER> also important note covid<NUMBER> infectious sarscov merscov due numerous epidemiological biological characteristics <NUMBER> due covid<NUMBER> relatively new understudied disease data available limited however cases emerged observed comorbidities increase chances infection <NUMBER> based current information clinical expertise elderly especially longterm care facilities people age serious underlying medical conditions greater risk getting covid<NUMBER> <NUMBER> elderly vulnerable population chronic health conditions diabetes cardiovascular lung disease higher risk developing severe illness also increased risk death become ill <NUMBER> people underlying uncontrolled medical conditions diabetes hypertension lung liver kidney disease cancer patients chemotherapy smokers transplant recipients patients taking steroids chronically increased risk covid<NUMBER> infection <NUMBER> metaanalysis study covid<NUMBER> comorbidities depicted fig <NUMBER> total <NUMBER> patients <NUMBER> male <NUMBER> female mean age <NUMBER> years old <NUMBER> common comorbidities identified patients hypertension <NUMBER> cardiovascular cerebrovascular conditions <NUMBER> diabetes <NUMBER> <NUMBER> <NUMBER> less common comorbidities coexisting infection hiv hepatitis b <NUMBER> malignancy <NUMBER> respiratory illnesses <NUMBER> renal disorders <NUMBER> immunodeficiencies <NUMBER> <NUMBER> patients moderate severe asthma disadvantage virus affects respiratory tracts leading increased asthmatic attacks pneumonia acute respiratory distress <NUMBER> according cdcs morbidity mortality weekly report <NUMBER> patients aged <NUMBER> <NUMBER> years old underlying chronic lung disease asthma <NUMBER> iran case study reported genetic predisposition covid<NUMBER> increase probabilities getting infected sarscov<NUMBER> lead death virus <NUMBER> genetic predisposition seen <NUMBER> brothers iran <NUMBER> years apart age <NUMBER> <NUMBER> <NUMBER> years died due covid<NUMBER> despite identified comorbidities living separately one another <NUMBER> january <NUMBER> <NUMBER> wuhan china <NUMBER> patients admitted hospital tested positive covid<NUMBER> <NUMBER> <NUMBER> men median age <NUMBER> years old <NUMBER> <NUMBER> patients exposed huanan market <NUMBER> <NUMBER> underlying diseases diabetes <NUMBER> <NUMBER> hypertension <NUMBER> <NUMBER> cardiovascular <NUMBER> <NUMBER> <NUMBER> patients hiv positive along low cd<NUMBER> count antiretroviral therapy higher risk incidence medical issues including covid<NUMBER> <NUMBER> according international aids society ias people <NUMBER> human immunodeficiency virus hiv positive taking antiretroviral treatment low cd<NUMBER> count risk covid<NUMBER> one without hiv <NUMBER> <NUMBER> depicted fig <NUMBER> populationbased surveillance report via covid<NUMBER>associated hospitalization surveillance network covidnet reported clinical data <NUMBER> covid<NUMBER>positive patient hospitalizations march <NUMBER> march <NUMBER> <NUMBER> <NUMBER> among <NUMBER> patients studied <NUMBER> adults showed clinical data underlying medical conditions prevalent hypertension <NUMBER> obesity close second <NUMBER> <NUMBER> medical conditions included chronic lung disease <NUMBER> diabetes mellitus <NUMBER> cardiovascular diseases <NUMBER> <NUMBER> outcome covid<NUMBER> cause severe disease leading hospitalization icu potentially death especially elderly comorbidities <NUMBER> according cdc <NUMBER> <NUMBER> deaths reported usa occurred adults <NUMBER> years old <NUMBER> roughly <NUMBER> covid<NUMBER>positive cases result full recovery illness without hospitalizations interventions <NUMBER> still many facts know covid<NUMBER> due gaps knowledge therefore many studies underway better understand virus <NUMBER> wuhan china <NUMBER> patients admitted hospital tested positive covid<NUMBER> december <NUMBER> <NUMBER> january <NUMBER> <NUMBER> clinical outcomes shown <NUMBER> <NUMBER> fig <NUMBER> <NUMBER> <NUMBER> patients confirmed covid<NUMBER> hospital <NUMBER> pneumonia <NUMBER> developed acute respiratory distress syndrome ards <NUMBER> exhibited acute cardiac injury <NUMBER> acquired secondary infection <NUMBER> majority patients <NUMBER> discharged <NUMBER> remained hospitalized <NUMBER> ended icu <NUMBER> ended death <NUMBER> february <NUMBER> march <NUMBER> <NUMBER> study conducted evergreen washington characteristics outcomes <NUMBER> critically ill patients confirmed covid<NUMBER> diagnosis <NUMBER> study showed <NUMBER> patients required mechanical ventilation acute respiratory arrest seen <NUMBER> within <NUMBER> h developing ards <NUMBER> patients showed increasing severity respiratory problems leading poor shortterm outcomes higher risk death <NUMBER> march <NUMBER> <NUMBER> mortality rate <NUMBER> patients <NUMBER> critically ill <NUMBER> discharged hospital <NUMBER> shown cdcs mortality morbidity weekly report fig <NUMBER> case mortality increased patients age increased <NUMBER> <NUMBER> among age group ≤ <NUMBER> years icu admission mortality reported <NUMBER> covid<NUMBER> also noticed children disease took moderate course compared adults prognosis also seemingly better deaths infrequent <NUMBER> april <NUMBER> <NUMBER> reported <NUMBER> million confirmed covid<NUMBER> cases worldwide <NUMBER> cases resulting mortality <NUMBER> majority <NUMBER> deaths within usa <NUMBER> followed italy <NUMBER> spain <NUMBER> <NUMBER> new york hit hardest novel coronavirus spreading across usa cases deaths per capita state table <NUMBER> reports <NUMBER> covid<NUMBER> deaths involved least one comorbidity according new york state department health <NUMBER> multiple comorbidities associated severity covid<NUMBER> disease progression many poorer outcomes covid<NUMBER> related cardiovascular comorbid conditions <NUMBER> however may direct result cardiovascular condition attributed comorbidities along cardiovascular condition <NUMBER> patients type <NUMBER> diabetes also likely increased severity covid<NUMBER> <NUMBER> cohort study <NUMBER> patients covid<NUMBER> without type <NUMBER> diabetes shown type <NUMBER> diabetes required increased interventions hospital stay versus nondiabetic <NUMBER> shown poorer blood glucose control allaround increased mortality rate better glucose control <NUMBER> study concluded patients blood glucose specifically range <NUMBER> <NUMBER> mmoll overall decreased composite adverse events mortality <NUMBER> noted poor blood glucose control resulted substantially increased risk complications death <NUMBER> among comorbidities chronic obstructive pulmonary disease copd also associated poor disease progression metaanalysis multiple studies china found fourfold increase mortality patients preexisting copd diagnosed covid<NUMBER> <NUMBER> analysis smoking status patients severity covid<NUMBER> also studied one study found association smoking severe course covid<NUMBER> <NUMBER> study removed significant association smoking severe covid<NUMBER> disease <NUMBER> patients acute respiratory distress syndrome respiratory failure associated novel coronavirus may linked prothrombotic coagulopathy <NUMBER> autopsy covid<NUMBER>related deaths revealed dispersed microthrombi pulmonary vasculature demonstrating occlusive etiology respiratory failure <NUMBER> <NUMBER> <NUMBER> improvement noted three cases covid<NUMBER>related acute respiratory distress syndrome ards respiratory failure following treatment intravenous iv antithrombotic alteplase <NUMBER> results although reassuring transient two three cases recovery succumbing posttreatment <NUMBER> use antithrombolytic therapy needs studied ascertain results due treatment chance alone <NUMBER> retrospective metaanalysis including <NUMBER> covid<NUMBER> patients conducted march <NUMBER> <NUMBER> subjects underlying comorbidities risk acquiring covid<NUMBER> <NUMBER> common comorbidities hypertension copd diabetes cardiocerebrovascular disease observed significant risk factors subjects compared underlying disease states <NUMBER> intense supportive measures definitive treatment yet identified <NUMBER> authorities speculate subjects comorbidities linked severe disease outcome infected novel coronavirus compared patients underlying disease <NUMBER> study met barriers due diminutive sample size subjects one underlying comorbidity <NUMBER> literature earlier research underlying diseases increase mortality rate patients acquired covid<NUMBER> cardiac disease diabetes significant risk factors <NUMBER> insufficient sample size inadequate time led limitations data collected <NUMBER> <NUMBER> countries affected covid<NUMBER> resulting mass death worldwide cases evolve globally noted persons underlying chronic illnesses likely contract virus become severely ill due sars cov<NUMBER> relatively new virus data available limited however patients comorbidities deteriorating outcomes compared patients without covid<NUMBER> patients history hypertension obesity chronic lung disease diabetes cardiovascular <NUMBER> disease worst prognosis often end deteriorating outcomes ards pneumonia also elderly patients longterm care facilities chronic kidney disease patients cancer patients risk contracting virus significantly increased risk death among groups patients cases reported worldwide symptoms covid<NUMBER> ranged mild respiratory disease severe illness requires intubation mechanical ventilation since period patient asymptomatic incubation period <NUMBER> <NUMBER> days difficult establish early diagnosis much less curb transmission infection patient unknowingly exposed however within period respiratory symptoms develop important seek immediate care therefore patients comorbidities take necessary precautions avoid getting infected sars cov<NUMBER> usually worst prognosis precautions include regular handwashing soap water use alcoholbased hand sanitizer limiting persontoperson contact practicing social distancing wearing face mask public places overall limiting going public areas time unless necessary hence need global public health campaign raise awareness reducing burden comorbidity illnesses causing deaths covid<NUMBER>infected patients since severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> pandemic began china <NUMBER> confirmed cases <NUMBER> coronavirus disease<NUMBER> covid<NUMBER>related deaths reported korea april <NUMBER> <NUMBER> daegu city accounts <NUMBER> confirmed cases <NUMBER> deaths since outbreak began february <NUMBER> recent studies shown advanced age underlying medical comorbidities cardiovascular disease diabetes mellitus hypertension considered risk factors severe illness mortality among patients covid<NUMBER> <NUMBER> acute hyperglycemic crisesdiabetic ketoacidosis dka hyperosmolar hyperglycemic state hhsare serious acute metabolic complications diabetes commonly precipitated infection covid<NUMBER> also estimated trigger acute hyperglycemic crises patients inadequately controlled patients diabetes evidence association still limited described two covid<NUMBER> cases compromised acute hyperglycemic crisesdka hhsduring outbreak daegu south korea electric medical records index cases reviewed crosschecked two independent physicians informed consent waived retrospective nature study <NUMBER>yearold man admitted hospital suffering general weakness polydipsia polyuria mild dyspnea <NUMBER> days history type <NUMBER> diabetes mellitus t<NUMBER>dm hypertension recently discontinuing oral hypoglycemic agents oha managed blood glucose diet exercise glycosylated hemoglobin hba<NUMBER>c level patient <NUMBER> measured <NUMBER> months earlier initial vital signs blood pressure <NUMBER> mm hg heart rate <NUMBER> beatsmin respiratory rate <NUMBER> breathsmin body temperature <NUMBER>°c oxygen saturation <NUMBER> pulse oximetry room air upon admission plasma glucose <NUMBER> mgdl hba<NUMBER>c <NUMBER> blood chemistry revealed blood urea nitrogen <NUMBER> mgdl creatinine <NUMBER> mgdl sodium <NUMBER> meql potassium <NUMBER> meql plasma ketone body <NUMBER> mmoll arterial blood gas analysis abga room air demonstrated compensated metabolic acidosis patient reportedly contacted someone diagnosed covid<NUMBER> <NUMBER> days prior hospital admis sion chest radiograph showed peribronchial groundglass opacities lungs although obvious flulike symptom cough sputum sore throat fever fig <NUMBER> covid<NUMBER> confirmed march <NUMBER> <NUMBER> basis realtime reverse transcriptasepolymerase chain reaction rtpcr assay detected sarscov<NUMBER> therefore antiviral agents lopinavirritonavir empirical antibiotics symptomatic respiratory treatment covid<NUMBER> infection well treatment dka also performed dka improved proper insulin treatment dyspnea radiologic finding worsened mechanical ventilation initiated fourth day admission received intensive treatments continuous renal replacement therapy <NUMBER>th day admission extracorporeal membrane oxygenation <NUMBER>th day admission <NUMBER>th day hospitalization acute myocardial infarction diagnosed based elevation cardiac enzyme st segment electrocardiogram percutaneous coronary intervention performed however patient recover respiratory failure hemodynamic instability eventually died <NUMBER>th day hospitalization <NUMBER>yearold woman hospitalized shortness breath <NUMBER> days transferred patient confirmed covid<NUMBER> using rtpcr test high oxygen demand history t<NUMBER>dm hypertension dyslipidemia stopped taking oha several days due anorexia skin dry tough upon physical examination initial vital signs within normal ranges oxygen saturation <NUMBER> pulse oximetry <NUMBER> lmin oxygen mask upon hospital admission laboratory findings showed increases plasma levels glucose <NUMBER> mgdl effective osmolality <NUMBER> mosmkg hba<NUMBER>c <NUMBER> respectively urine serum ketone body detected abga <NUMBER> lmin oxygen mask showed ph <NUMBER> hco<NUMBER> − <NUMBER> mmoll serum sodium potassium within normal range chest radiograph showed multifocal patchy consolidation lung fields fig <NUMBER> based laboratory imaging results diagnosed hhs covid<NUMBER> treatment immediately provided intravenous fluid regular insulin antiviral agents empirical antibiotics hyperglycemia dehydration promptly improved proper management radiologic findings worsened increase oxygen demand second day invasive mechanical ventilation prone position initiated tracheostomy applied <NUMBER>th days hospitalization patients spontaneously breathing <NUMBER> days hospitalization subsequent covid<NUMBER> tests negative still needs support mechanical ventilator herein report two patients acute hyperglycemia precipitated covid<NUMBER> one case conjunction dka fatal hhs delayed recovery even rtpcr tests negative best knowledge first case report covid<NUMBER> combined dka hhs emerging information suggests individuals diabetes increased risk complications including death among covid<NUMBER> patients according clinical report china <NUMBER> involving <NUMBER> confirmed covid<NUMBER> patients diabetes second common comorbidity <NUMBER> among severe <NUMBER> cases enough evidences determine risk diabetes poor outcomes covid<NUMBER> patients yet small study showed covid<NUMBER> patients diabetes higher risk severe pneumonia also release excessive inflammatory biomarkers <NUMBER> results suggest people comorbidities especially dm susceptible covid<NUMBER> infection well known acute hyperglycemic crises significantly related morbidity death peoples diabetes <NUMBER> according recent study <NUMBER> hospitalization rate mortality rate per <NUMBER> diabetes cases due hyperglycemic crises past decade continued decline korea unfortunately experienced outbreak covid<NUMBER> limiting proper use medical resources community lessons learned cases chronic disease management could hampered unexpected outbreak appropriate aggressive management provided order improve prognosis covid<NUMBER> patients comorbidities diabetes hypertension cases imply acute hyperglycemic crises precipitated covid<NUMBER> results catastrophic outcomes patients diabetes poor glycemic control agile policies strategies effective distribution essential medical resources necessary prevent loss life due exacerbation chronic diseases potential conflict interest relevant article reported epidemic coronavirus disease<NUMBER> covid<NUMBER> caused severe acute respiratory syndromecoronavirus<NUMBER> sarscov<NUMBER> virus data describing characteristics prognosis patients covid<NUMBER> diabetes available example hospitalized patients coronado study <NUMBER> potential links diabetes covid<NUMBER> infection already described <NUMBER> indeed angiotensinconverting enzyme <NUMBER> ace<NUMBER> identified receptor coronavirus spike protein <NUMBER> ace expressed pancreatic beta cells <NUMBER> suggested sarscov<NUMBER> could induce beta cell damage new onset diabetes <NUMBER> phenotype new cases diabetes described report case <NUMBER>yearold woman medical history gastric bypass one year earlier family history diabetes aunts type <NUMBER> diabetes cousin type <NUMBER> diabetes diagnosed age <NUMBER> years presented two months earlier <NUMBER> march <NUMBER> severe asthenia fever stiffness dyspnea presented anosmia ageusia anorexia <NUMBER> march admitted emergency department symptomatic treatment delivered suspected covid<NUMBER> infection discharged glycemia normal time two weeks longer symptoms one month first symptoms covid<NUMBER> <NUMBER> april presented acute polyuriapolydipsia syndrome diabetes mellitus diagnosed <NUMBER> may glycemia <NUMBER> gl <NUMBER> mmoll nonsignificant ketosis <NUMBER> mmoll normal bicarbonate level <NUMBER> mmoll hba<NUMBER>c level <NUMBER> <NUMBER> mmolmol weight <NUMBER> kg gastric bypass <NUMBER> kg covid<NUMBER> <NUMBER> kg bmi <NUMBER> kgm <NUMBER> diabetes diagnosis diabetes immediately insulin requiring treated basal bolus regimen present metabolic comorbidities markers hypertension negative crp <NUMBER> mgl hdlc <NUMBER> gl ldlc <NUMBER> gl triglycerides <NUMBER> gl normal alt ast ggt ferritin levels liver steatosis ct scan lipase tsh levels normal pancreatic ct scan normal cpeptide low <NUMBER> pmolml normal values <NUMBER> <NUMBER> autoantibodies pancreatic beta cells tested finally glutamic acid decarboxylase<NUMBER> autoantibodies gad<NUMBER>a positive <NUMBER>uiml n <NUMBER> favor immunemediated type <NUMBER> diabetes whereas tyrosine phosphatase ia<NUMBER> antibodies ia<NUMBER>a zinc transporter <NUMBER> antibodies znt<NUMBER>a negative sarscov<NUMBER> serology positive elecsys® roche confirming previous covid<NUMBER> infection observation highlights fact covid<NUMBER> infection may also trigger type <NUMBER> diabetes onset viral infection particular enteroviruses also coronaviruses wellknown environmental trigger development type <NUMBER> diabetes <NUMBER> case presented herein short delay covid<NUMBER> infection diabetes onset remains determine hyperinflammation cytokine storm described infection could accelerate onset type <NUMBER> diabetes genetically susceptible individuals addition patient obese undergoing gastric bypass one year earlier obese patients higher risks develop viral infection like influenza complications <NUMBER> patient massive weight loss first year bariatric surgery conclusion relationship sarscov<NUMBER> exposition autoimmune diabetes development must studied incidence type <NUMBER> diabetes carefully observed next months managed antonio secchi funding research received specific grant funding agency public commercial notforprofit sectors conflict interest authors declare conflict interest associated manuscript statement human animal rights procedures followed accordance ethical standards responsible committee human experimentation institutional national helsinki declaration <NUMBER> revised <NUMBER> informed consent obtained patients included study introduction late february <NUMBER> due spread severe acute respiratory syndrome coronavirus<NUMBER> sarscov<NUMBER> italian government closed educational sport activities march introduced measures stop spread coronavirus disease covid<NUMBER> placing country state almost complete lockdown report impact restrictions glucose control among people type <NUMBER> diabetes t<NUMBER>d methods data collected <NUMBER> individuals t<NUMBER>d monitoring glucose levels using flash glucose monitoring device remotely connected diabetes clinic cloud platform retrieved information average glucose standard deviation percentage time hypoglycaemia <NUMBER> mgdl glucose range <NUMBER> mgdl hyperglycaemia <NUMBER> mgdl compared glycaemic measures collected lockdown collected sarscov<NUMBER> epidemic periods immediately lockdown results <NUMBER> patients stopped working home result lockdown overall glycaemic control improved first <NUMBER> days lockdown compared weeks spread sarscov<NUMBER> average glucose declined <NUMBER> ± <NUMBER> mgdl week lockdown <NUMBER> ± <NUMBER> mgdl lockdown p <NUMBER> standard deviation improved significantly time range increased <NUMBER> <NUMBER> p <NUMBER> time hyperglycaemia decreased <NUMBER> <NUMBER> p <NUMBER> number scans per day remained unchanged <NUMBER> patients continued working none measures glycaemic control changed lockdown conclusion despite limited possibility exercise incumbent psychologic stress glycaemic control improved patients t<NUMBER>d stopped working lockdown suggesting slowing routine daily activities beneficial effects t<NUMBER>d management least short term glycaemic control among people type <NUMBER> diabetes lockdown sarscov<NUMBER> outbreak italy carry study march <NUMBER> italy placed lockdown due outbreak new coronavirus disease diabetes management lockdown particularly challenging using data collected remote monitoring glucose sensors investigated whether glycaemic control people type <NUMBER> diabetes t<NUMBER>d lockdown improved worsened learned study individuals t<NUMBER>d stopped working lockdown significantly improved glucose control continued working essential services showed change glucose control results suggest slowing routine daily activities achieve beneficial effects shortterm management t<NUMBER>d longterm effects lockdown factors affect glucose control particular situation deserve future investigation achieving glycaemic control complex task people type <NUMBER> diabetes t<NUMBER>d involves multiple domains daily functioning <NUMBER> <NUMBER> maintain glucose levels much possible within range patients need pay attention meals insulin doses exercise regimens working activities social relations psychological stress well exercise selfcontrol <NUMBER> continuous challenge results people t<NUMBER>d occasionally deprioritizing glycaemic control favour activities <NUMBER> glucose control may improve holidays improvement highly variable <NUMBER> <NUMBER> <NUMBER> december <NUMBER> new coronavirus cov strain causes severe acute respiratory syndrome emerged wuhan china ultimately referred severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> rapidly spread throughout world <NUMBER> february march <NUMBER> italy second affected country worldwide <NUMBER> reduce spread infection late february <NUMBER> italian government issued series restrictions march <NUMBER> culminated almost complete lockdown country <NUMBER> lockdown intially involved sport educational activities extended commercial activities nonessential services lockdown citizens requested stay home <NUMBER> outpatient clinics closed hospitals coping thousands patients infected sarscov<NUMBER> sarscov<NUMBER> pandemic caused morbidity mortality among people cov disease also imposed heavy burden societal population health <NUMBER> expected individuals chronic disease diabetes suffer prolonged lockdown due limitations access outpatient clinics services remote glycaemic monitoring cloud platforms enabled diabetes specialists interact individuals t<NUMBER>d sarscov<NUMBER> pandemic lockdown widespread use flash glucose monitoring system fgm among patients t<NUMBER>d <NUMBER> allowed healthcare professionals hcps monitor patients webbased interface records realtime sensor readings note telemedicine shown improve psychosocial outcomes young adults diabetes <NUMBER> according recent metaanalysis fgm potential improve overall glucose control <NUMBER> reduce hypoglycaemia individuals t<NUMBER>d <NUMBER> <NUMBER> study examined glycaemic control first week lockdown spread sarscov<NUMBER> people t<NUMBER>d using fgm italy comparison prelockdown period study approved ethical committee university hospital padova procedures performed accordance helsinki declaration <NUMBER> later amendments agreement national regulations study conceived retrospective data collection patients provided written informed consent reuse clinical data research purposes patients t<NUMBER>d eligible inclusion study met following criteria attended diabetes outpatient clinic university hospital padova lived area using freestyle libre fgm system abbott diabetes care rome italy least <NUMBER> months sharing sensor data diabetes outpatient clinic webbased cloud system libreview abbott diabetes care <NUMBER> coverage sensor data libreview platform intended assist people diabetes hcps reviewing analysing evaluating sensor data support diabetes management order record spontaneous changes glycaemic control patients already sought therapeutic advice excluded enrolment patients provided online informed consent remotely connected diabetes clinic diagnosis t<NUMBER>d based american diabetes association ada criteria confirmed positive autoantibody testing <NUMBER> patients retrieved following data age sex diabetes duration body mass index history hypertension smoking habit recent glycated haemoglobin hba<NUMBER>c values lipid profile urinary albumin excretion rate uaer estimated glomerular filtration rate egfr ckdepi equation <NUMBER> presence chronic complications recorded follows nephropathy defined uaer <NUMBER> mgg egfr <NUMBER> mlmin<NUMBER> <NUMBER> somatic neuropathy defined based assessment using michigan neuropathy screening instrument eventually confirmed nerve conduction velocity testing autonomic neuropathy defined based results cardiac autonomic tests performed neurotester instrument meteda srl san benedetto del tronto italy including lyingtostanding response valsalva manoeuvre deep breathing orthostatic hypotension retinopathy stage defined based analysis digital retinography scored expert ophthalmologists coronary artery disease defined history myocardial infarction coronary revascularization evidence myocardial ischemia upon stress test available peripheral arterial disease defined history claudication rest pain peripheral artery revascularization anklebrachial index <NUMBER> cerebrovascular disease defined history stroke transient ischemic attack carotid atherosclerosis symptomatic asymptomatic also collected information concomitant medications insulin including metformin sodium glucose cotransporter<NUMBER> inhibitors drugs management concomitant risk factors raw data sensor glucose readings retrospectively retrieved patients <NUMBER>min intervals avoid impact scan frequency average glucose levels consider glucose readings sensor scans analysis raw data imported dedicated spreadsheet following metrics computed average glucose standard deviation sd coefficient variation cv expressed percentage average glucose time hypoglycaemia <NUMBER> mgdl time glucose range <NUMBER> mgdl time hyperglycaemia <NUMBER> mgdl number scans per day per convention set cutoff <NUMBER> mgdl define highlow average glucose sd cutoff <NUMBER> mgdl define stable unstable control primary endpoint average glucose variables calculated following periods fig <NUMBER>a <NUMBER> months sarscov<NUMBER> outbreak italy <NUMBER> week sarscov<NUMBER> outbreak italy closure sport educational activities lockdown padova area commercial activities nonessential services closed period <NUMBER> first week lockdown period <NUMBER> patients divided groups based whether stopped working activities lockdown whether continued working lockdown involved essential services eg workers healthcare system food supply chain patients continued working served negative controls stopped working lockdown period continuous variables presented mean ± sd normally distributed median total <NUMBER> patients t<NUMBER>d enrolled study categorized one two groups based whether stopped working n <NUMBER> continued working n <NUMBER> lockdown clinical characteristics two groups reported table <NUMBER> none patients known infected sarscov<NUMBER> quarantined close contact infected people <NUMBER> patients stopped working due lockdown average age <NUMBER> years <NUMBER> male average diabetes duration <NUMBER> years mean latest available hba<NUMBER>c value <NUMBER> prevalence complications low data collected week sarscov<NUMBER> outbreak italy compared first week lockdown period <NUMBER> average glucose decreased <NUMBER> ± <NUMBER> mgdl <NUMBER> ± <NUMBER> mmoll <NUMBER> ± <NUMBER> mgdl <NUMBER> ± <NUMBER> mmoll p <NUMBER> fig <NUMBER>b equal reduction <NUMBER> ± <NUMBER> mgdl <NUMBER> ± <NUMBER> mmoll standard deviation sensor readings decreased <NUMBER> ± <NUMBER> mg dl <NUMBER> ± <NUMBER> mmoll <NUMBER> ± <NUMBER> mgdl <NUMBER> ± <NUMBER> mmoll p <NUMBER> result simultaneous improvement average glucose standard deviation patients moved highunstable profile towards lowstable profile fig <NUMBER>c number patients lowstable profile area increased three eight p <NUMBER> however cv better measure glycaemic stability according international consensus recommendations <NUMBER> <NUMBER> change substantially across periods considered time hypoglycaemia significantly changed whereas time range increased <NUMBER> ± <NUMBER> <NUMBER> ± <NUMBER> p <NUMBER> time hyperglycaemia decreased <NUMBER> ± <NUMBER> <NUMBER> ± <NUMBER> p <NUMBER> fig <NUMBER>d number scans per day change significantly <NUMBER> ± <NUMBER> <NUMBER> ± <NUMBER> p <NUMBER> reduction average glucose directly correlated baseline average glucose r <NUMBER> p <NUMBER> number scans per day data collected period <NUMBER> compared collected <NUMBER> months sarscov<NUMBER> spread significant improvements noted table <NUMBER> data collected period <NUMBER> significantly different collected <NUMBER> week <NUMBER> months sarscov<NUMBER> outbreak data expressed mean ± standard deviation number patients percentage parenthesis urinary albumin creatinine ratio expressed median interquartile range square brackets significant different patient groups p <NUMBER> hdl highdensity lipoprotein ldl lowdensity lipoprotein mdi multidose insulin csii continuous subcutaneous insulin infusion sglt<NUMBER>i sodium glucose cotransporter<NUMBER> inhibitor acei angiotensin converting enzyme inhibitor arb angiotensin receptor blockers period <NUMBER> closure sport educational activities lockdown padova area commercial activities nonessential services closed period <NUMBER> first week lockdown patients continued working lockdown n <NUMBER> average age <NUMBER> years <NUMBER> male average diabetes duration <NUMBER> years thus longer group working eight patients insulin pump therapy none patients continued work showed improvement measures glucose control lockdown period period <NUMBER> compared <NUMBER> months week sarscov<NUMBER> outbreak average glucose standard deviation cv time hypoglycaemia time range time hyperglycaemia remained unchanged table <NUMBER> number scans per day difference observed regarding change glucose control metrics among insulin pump regimen multiple daily insulin injections data show first week lockdown due sarscov<NUMBER> outbreak northeast italy patients t<NUMBER>d stayed home achieved significant improvement glucose control among patients t<NUMBER>d followed clinic continued working period many insulin pump therapy deterioration glucose control observed sarscov<NUMBER> pandemic represents huge challenge public health worldwide <NUMBER> healthcare services faced severe challenges outbreaks coronavirus disease covid<NUMBER> resulting major cut backs care provided people chronic diseases including diabetes <NUMBER> <NUMBER> many outpatient clinics change routine interactions patient use telemedicine monitor patients home <NUMBER> italy widespread use fgm among people t<NUMBER>d allowed patients remotely connected clinic cloud diabetes professionals concerned glucose control could worsen lockdown limited possibility exercise severe psychologic stress imposed social distancing cultural environment heavily reliant direct interpersonal relationships outbreak nonessential activities shut citizens stopped usual working routine turned working home however people involved healthcare food supply chain continued work lockdown observation glucose control improved first week lockdown people t<NUMBER>d stayed home reassuring suggests slowing routine activities favourable effects glucose control short term remarkably reduction average glucose increase time range paralleled increased time hypoglycaemia remained stable speculate improvement occurred patients time concentrate diabetes control regular lifestyle including timing composition meals exposed workplace stress <NUMBER> addition knowledge diabetes worsens outcomes covid<NUMBER> <NUMBER> <NUMBER> may improved patients awareness compliance diabetes management evaluate whether glucose control changed patients t<NUMBER>d lockdown irrespectively whether stayed home included group patients continued working observation glucose control improve subgroup t<NUMBER>d patients supports interpretation however groups patients stopped working continued usual working activities comparable latter better baseline glucose control stayed home <NUMBER> insulin pump therapy users pump therapy represent approximately <NUMBER> patients t<NUMBER>d clinic <NUMBER> t<NUMBER>d patients nationwide <NUMBER> frequent use insulin pump therapy among group patients probably related fact healthcare workers andor shift workers often need pump therapy cope lifestyle working schedules patients continued working higher time range baseline improvements difficult obtain yet reasonable assume individuals subjected stronger challenges lockdown including exercise limitations social distancing workplace stress fear infection therefore patients maintained good glycaemic control reassuring terms effective selfmanagement diabetes speculate use fgm combined insulin pump therapy contributed effect <NUMBER> example limiting diabetesrelated distress <NUMBER> acknowledge detailed information interpret drivers glucose control lockdown changes insulin doses consumption snacks exercise available investigated future studies addition included patients t<NUMBER>d relatively good glycaemic control showing frequent sensor use therefore remains unclear whether results would apply patients worse glucose glycaemic control less frequent sensor scans finally analyse glycaemic control subsequent weeks lockdown patients remotely contacted physicians clinic advice manage diabetes thereby introducing bias hence mediumand longterm impact lockdown glucose control remains unknown summary report glucose control improved people t<NUMBER>d stayed home first week lockdown due covid<NUMBER> observation suggests slowing routine activities beneficial effects t<NUMBER>d control short term however longterm effects lockdown factors affect glucose control particular situation deserve future investigation boscari daniela bruttomesso gian paolo fadini received lecture fees support abbott manufacturer flash glucose monitoring system cloud platform described study benedetta maria bonora angelo avogaro declare conflict interest connection submitted material compliance ethics guidelines study approved ethical committee university hospital padova procedures performed accordance helsinki declaration <NUMBER> later amendments agreement national regulations study conceived retrospective data collection patients provided written informed consent reuse clinical data research purposes data availability datasets generated andor analysed current study available corresponding author reasonable request open access article licensed creative commons attributionnoncommercial <NUMBER> international license permits noncommercial use sharing adaptation distribution reproduction medium format long give appropriate credit original authors source provide link creative commons licence indicate changes made images third party material article included articles creative commons licence unless indicated otherwise credit line material material included articles creative commons licence intended use permitted statutory regulation exceeds permitted use need obtain permission directly copyright holder view copy licence visit httpcreativecommonsorglicensesbync<NUMBER> secondary hyperglycemia diabetes patients recommend clinicians pay attention blood glucose status covid<NUMBER> patients even diagnosed diabetes admission coronavirus disease <NUMBER> covid<NUMBER> sweeping across globe resulting <NUMBER> confirmed cases <NUMBER> deaths worldwide april <NUMBER> <NUMBER> mortality rates reported covid<NUMBER> patients considerable yet also appear wideranging <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> large differences patient mortality may attributed preexisting characteristics age comorbidities disease severity studies shown severe covid<NUMBER> patients higher incidence diabetes nonsevere covid<NUMBER> patients <NUMBER> <NUMBER> vs <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> moreover proportion diabetic patients higher among deceased survived <NUMBER> vs <NUMBER> <NUMBER> <NUMBER> similar phenomena observed two kinds coronavirus diseases severe acute respiratory syndrome sars middle east respiratory syndrome mers mortality severe disease manifestations sars mers related preexisting diabetes <NUMBER> <NUMBER> sars also found cause secondary hyperglycaemia patients history diabetes used glucocorticoids course disease <NUMBER> date knowledge studies comparing clinical features prognoses diabetic nondiabetic covid<NUMBER> patients weina guo et al found diabetes associated worse prognosis covid<NUMBER> patients <NUMBER> case covid<NUMBER> whether susceptibility disease severity particularly high reflects greater risk posed diabetes still uncertain <NUMBER> furthermore impact secondary hyperglycaemia outcomes patients covid<NUMBER> also unknown aim singlecenter retrospective study explore whether covid<NUMBER> patients diabetes secondary hyperglycaemia different clinical characteristics prognoses without significantly abnormal glucose metabolism covid<NUMBER> global pandemic believe information useful physicians treating growing number covid<NUMBER> patients diabetes underlying hyperglycaemia retrospective study exploratory comparison covid<NUMBER> patients diabetes secondary hyperglycaemia control patients patients hospitalized three wards zhongfa district tongji hospital wuhan covid<NUMBER> patients sent center enrolled study diagnosed according guidelines covid<NUMBER> issued chinese national health committee version <NUMBER> guidelines categorized adult patients mild moderate severe critical cases <NUMBER> patients moderate severe critical cases sent center laboratory tests based patients clinical needs fasting plasma glucose fpg tested morning admission commencement glucocorticoid therapy patients fbg levels ≥ <NUMBER> mmoll reexamined hemoglobin a<NUMBER>c hba<NUMBER>c levels determined next days patients divided three groups based diabetes history fpg hba<NUMBER>c levels group <NUMBER> n<NUMBER> composed patients without history diabetes whose fpg levels <NUMBER> mmoll group defined control group group <NUMBER> n<NUMBER> composed patients fpg levels ≥ <NUMBER> mmoll hba<NUMBER>c values <NUMBER> group defined secondary hyperglycaemia group group <NUMBER> n<NUMBER> composed patients history diabetes fbg levels ≥ <NUMBER> mmoll twice hba<NUMBER>c values ≥ <NUMBER> group defined diabetes group <NUMBER> considering compared fpg shortterm stress response accepted article caused viral infection admission fewer impact hba<NUMBER>c hba<NUMBER>c values prioritized fpg levels grouping criteria patients without diabetes history avoid overestimating incidence diabetes data obtained electronic medical records system information epidemiology demographics clinical symptoms signs medical history concomitant diseases laboratory inspections chest ct scans treatments hospitalization clinical outcomes collected patient compared among three groups medical laboratory results included complete blood count serum biochemical test alanine aminotransferase alt aspartate aminotransferase ast creatine estimated glomerular filtration rate egfr based ckdepi equation creatine kinase ck lactate dehydrogenase ldh plasma glucose coagulation profile myocardial enzyme test cardiac troponin ctni creatinine kinase mb ckmb myoglobin nterminal probrain natriuretic peptide ntprobnp inflammatory markers erythrocyte sedimentation rate esr hypersensitive creactive protein scrp ferritin procalcitonin pct cytokines interleukin<NUMBER>β interleukin<NUMBER> receptor interleukin<NUMBER> <NUMBER> <NUMBER> tumor necrosis factorα hba<NUMBER>c measured high performance liquid chromatography arkray ha<NUMBER> nasopharyngeal swabs tested rna sars coronavirus<NUMBER> sarscov<NUMBER> using realtime rtpcr assay hospital viral lab described epidemiology exposure confirmed patients demographics clinical symptoms signs admission reported medical history concomitant diseases laboratory tests ct scans first ct scan patients admission clinical classification treatments hospitalization including medication oxygen therapy clinical outcomes discharge hospitalization death composite outcomes defined admission intensive care unit icu use mechanical ventilation invasive noninvasive types death abovementioned data compared among three groups fitness accepted article discharge based improved respiratory symptoms fever least three consecutive days improved chest radiographic evidence negative results sarscov<NUMBER> rna sputum nasopharyngeal swabs respiratory specimens twice interval <NUMBER> hours <NUMBER> statistical analyses performed using spss version <NUMBER> spss inc chicago il continuous variables presented mean standard deviation skewed data presented median interquartile range basic characteristics <NUMBER> patients shown table <NUMBER> <NUMBER> percentage calcium antagonists βreceptor blockers αreceptor blockers <NUMBER> <NUMBER> <NUMBER> respectively significant difference kind antihypertensive drugs among three groups p<NUMBER> significant differences symptoms signs vital signs among three groups lower levels temperature admission found groups <NUMBER> <NUMBER> compared group <NUMBER> several laboratory test results differed among three groups shown table <NUMBER> regard complete blood count levels leukocytes neutrophils groups <NUMBER> <NUMBER> significantly higher group <NUMBER> p<NUMBER> ratios neutrophilia groups <NUMBER> <NUMBER> also higher group <NUMBER> seemed patients egfr levels within <NUMBER> mlmin<NUMBER>·<NUMBER>m <NUMBER> group <NUMBER> compared groups <NUMBER> <NUMBER> vs <NUMBER> p<NUMBER> <NUMBER> <NUMBER> vs <NUMBER> p<NUMBER> hypoproteinemia common groups <NUMBER> <NUMBER> compared group <NUMBER> p<NUMBER> finally also assessed inflammatory biomarkers found patients groups <NUMBER> <NUMBER> significantly higher scrp patients group <NUMBER> p<NUMBER> <NUMBER> respectively significant difference found groups <NUMBER> <NUMBER> esr group <NUMBER> much higher groups <NUMBER> <NUMBER> p<NUMBER> significant difference pct levels among three groups p<NUMBER> among cytokines found ratio il<NUMBER> increased group <NUMBER> significantly higher compared groups <NUMBER> <NUMBER> p<NUMBER> levels cytokines comparable among three groups <NUMBER> patients group <NUMBER> selfreported diabetes history prevalence selfreported diabetes study <NUMBER> <NUMBER> therapy information diabetes five patients unavailable details described medical records four patients one patient could offer therapy details three patients given antidiabetic therapy admission among <NUMBER> patients eight patients <NUMBER> received insulin therapy continued apply hospitalization <NUMBER> patients used simple oral antidiabetic drugs oads control blood glucose admission eight <NUMBER> moved insulin therapy hospitalization metformin <NUMBER> αglucosidase inhibitors <NUMBER> sulfonylureas <NUMBER> commonly taken oads types among patients used simple oad oad combined insulin therapy one accepted article case treated dipeptidyl peptidase<NUMBER> dpp<NUMBER> inhibitor admission sglt<NUMBER> inhibitor used admission admission <NUMBER> <NUMBER> patients group <NUMBER> treated insulin meal andor basal insulin <NUMBER> <NUMBER> patients started insulin therapy four diagnosed diabetes admission started using insulin two cases treated glucocorticoids hospitalization might indicate deterioration blood glucose status mainly caused covid<NUMBER> main interventions outcomes shown table <NUMBER> proportions critical patients groups <NUMBER> <NUMBER> significantly higher group <NUMBER> <NUMBER> <NUMBER> vs <NUMBER> p<NUMBER> april <NUMBER> <NUMBER> <NUMBER> <NUMBER> still hospitalized <NUMBER> <NUMBER> patients discharged <NUMBER> <NUMBER> patients died patients group <NUMBER> relatively long hospital stays compared patients group <NUMBER> <NUMBER>±<NUMBER> vs <NUMBER>±<NUMBER> days p<NUMBER> rate discharge significantly lower group <NUMBER> group <NUMBER> <NUMBER> vs <NUMBER>·<NUMBER> p<NUMBER> however significant differences length hospital stay discharge rate groups <NUMBER> <NUMBER> mortality rates patients groups <NUMBER> <NUMBER> seemed greater group <NUMBER> <NUMBER> <NUMBER> <NUMBER> p<NUMBER> respiratory support provided <NUMBER> patients started noninvasive accepted article ventilation niv owing difficulty correcting oxygenation <NUMBER> patients switched invasive ventilation iv eventually died significantly patients need mechanical ventilation support niv iv groups <NUMBER> <NUMBER> compared patients group <NUMBER> <NUMBER> vs <NUMBER> p<NUMBER> <NUMBER> vs <NUMBER> p<NUMBER> utilization rate niv group <NUMBER> significantly higher group <NUMBER> <NUMBER> vs <NUMBER> p<NUMBER> six patients one group <NUMBER> <NUMBER> three group <NUMBER> <NUMBER> two <NUMBER> group <NUMBER> successfully weaned niv switched oxygen masks n<NUMBER> nasal cannula n<NUMBER> achieving improved oxygenation contrast <NUMBER> patients <NUMBER> <NUMBER> using niv group <NUMBER> died including nine switched iv approximately <NUMBER> patients groups <NUMBER> <NUMBER> composite outcomes significantly higher patients group <NUMBER> p<NUMBER> logistic regression analysis adjusted confounders group <NUMBER> higher odds ratio composite outcomes group <NUMBER> <NUMBER> <NUMBER> confidence interval ci <NUMBER> p<NUMBER> composite outcomes risk <NUMBER> <NUMBER> ci <NUMBER> p<NUMBER> groups <NUMBER> compared group <NUMBER> close statistically significant difference significant difference composite outcomes risk group <NUMBER> compared group <NUMBER> <NUMBER> <NUMBER> ci <NUMBER> p<NUMBER> found covid<NUMBER> patients diabetes secondary hyperglycaemia critical classification approximately <NUMBER> times composite outcomes risk compared control importantly differences distinct covid<NUMBER> patient subsets considered treatment addition proportion diabetic patients among nonsurviving patients approximately two times among surviving patients guan w <NUMBER> investigated composite endpoints admission icu use mechanical ventilation death covid<NUMBER> patients patients subset diabetes likely experience endpoints subset without diabetes <NUMBER> vs <NUMBER> yangs study prevalence diabetes <NUMBER> nonsurviving covid<NUMBER> patients <NUMBER> surviving patients <NUMBER> found mortality rate due covid<NUMBER> diabetic patients <NUMBER> seemed higher <NUMBER> mortality rate control group found association diabetes composite outcomes covid<NUMBER> patients result barely missed statistical significance <NUMBER> <NUMBER> ci <NUMBER> might due limited sample size obtain robust positive results thus study suggests preexisting diabetes might increase risk composites outcomes patients covid<NUMBER> therefore attention paid diabetic patients covid<NUMBER> including patients undiagnosed diabetes multiple causes high rates severe critical cases high mortality covid<NUMBER> patients diabetes diabetic covid<NUMBER> patients highest proportions comorbidities hypertension cardiovascular disease among three groups prevalence cardiovascular disease almost statistically significant possibly due small sample size study study ratio egfr<NUMBER> mlmin<NUMBER>m <NUMBER> higher levels serum creatine ntprobnp group <NUMBER> indicated poor basic kidney heart function diabetic patients supports notion chronic comorbidities patients covid<NUMBER> risk factors severe cases compared nonsevere cases <NUMBER> addition type subclinical chronic inflammation diabetes shares common characteristics infectious disease proinflammatory status attenuation innate immune response furthermore function cells neutrophils macrophages lymphocytes reduced diabetic patients resulting damaged humoral immune systems rendering individuals susceptible accepted article range infectious diseases <NUMBER> covid<NUMBER> virus activates immunocyte induces secretion inflammatory cytokines chemokines cytokine storm pulmonary vascular endothelial cells organs <NUMBER> <NUMBER> study cytokine storm common reaction covid<NUMBER> patients evident diabetic covid<NUMBER> patients control group moreover study diabetic patients lymphocytopenia leukocytosis neutrophilia elevated scrp levels higher proportion antibiotic therapy hospitalization speculated covid<NUMBER> patients conditions would worsen concomitant bacterial infections therefore suggest severity disease high risk composite outcomes covid<NUMBER> patients diabetes associated chronic comorbidities weak immune responses potential concurrent bacterial infection since sample n<NUMBER> antidiabetic treatment cases admission small study especially dpp<NUMBER> inhibitors one case rarely administered relationship oral antidiabetic drugs susceptibility severity diabetic covid<NUMBER> currently uncertain study suggests covid<NUMBER> patients secondary hyperglycaemia constitute another population poor prognoses requires additional attention interestingly commonalities differences covid<NUMBER> patients secondary hyperglycaemia diabetes peculiarities group <NUMBER> higher levels leukocytes neutrophils scrp ntprobnp lower levels eosinophils coagulopathy higher proportion critical classification different group <NUMBER> similar diabetic patients indicating severity poor prognoses disease longer hospital stays higher percentage patients needing assisted ventilation composite outcomes nevertheless covid<NUMBER> patients secondary hyperglycaemia seem liver damage higher levels ldh increased il<NUMBER> ratio diabetes significantly higher inhospital mortality rate reported patients new hyperglycaemia eg stress hyperglycaemia undiagnosed diabetes also worse outcomes patients previous history diabetes subjects normoglycemia <NUMBER> increased gluconeogenesis decreased glycogenolysis due accepted article increased secretion counterregulatory hormones proposed potential mechanisms underlying stress hyperglycaemia hand autopsies covid<NUMBER> patients revealed islet cell degeneration <NUMBER> might indicate sarscov<NUMBER> could cause islet cell damage possibilities sarscov<NUMBER> sarscovs genomewide similarity approximately <NUMBER> <NUMBER> viruses enter cells angiotensin converting enzyme <NUMBER> ace<NUMBER> <NUMBER> found variety human tissues lung pancreas <NUMBER> acute damage pancreatic beta cells due sarscov<NUMBER> followed hyperglycaemia might occur systemic illness similar process patients sars <NUMBER> study proportion patients increased il<NUMBER> even much higher group <NUMBER> diabetes hyperglycaemia high levels cytokines reflect severity viral infection involvement multiple systems moreover severity covid<NUMBER> secondary hyperglycaemia patients even given highest proportion niv group still high probability close <NUMBER> withdrawal compared control diabetes groups matching characteristics acute viral injury since specific antiviral drugs confirmed effective clinical management hospitalized patients covid<NUMBER> focused supportive treatment complications reduce inflammationinduced lung injury due abundance cytokines covid<NUMBER> patients glucocorticoids frequently used treat severe critically ill patients glucocorticoid usage part covid<NUMBER> treatment regimens fluctuates <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> however riskbenefit ratio treatment glucocorticoids unclear especially hyperglycaemia patients recent study reported researchers wuhan showed systemic corticosteroid therapy shown significant benefits <NUMBER> believe corticosteroids routinely recommended diabetic covid<NUMBER> patients patients might experience obvious cytokine storm weak immune responses susceptible secondary bacterial infections especially considering aggravating effects glucocorticoids hyperglycaemia therefore glucocorticoids administered unless indicated reasons accepted article eg refractory septic shock rapid progression imaging overactivation human inflammatory response <NUMBER> treatment hyperglycaemia might important supportive treatment patients however given similarities differences clinical profiles covid<NUMBER> patients secondary hyperglycaemia diabetes strategies using glucocorticoids might differ require extra caution diagnosis diabetes study limited selfreported history diabetes also included levels fpg andor hba<NUMBER>c minimize possibility underestimating prevalence diabetes covid<NUMBER> patients noted compared high fpg level hba<NUMBER>c cutoff <NUMBER> identifies patients undiagnosed diabetes <NUMBER> patients secondary hyperglycaemia also included analysed new group study taking account high prevalence chronic comorbidities hypoxemia higher incidence heart kidney damage diabetes patients even considering liver dysfunction patients secondary hyperglycemia covid<NUMBER> recommended use insulin regimen patients poorly controlled hyperglycemia <NUMBER> research several limitations first <NUMBER> inpatients included inpatients study large sample study addition mild covid<NUMBER> patients admitted center could led biased understanding disease third retrospective study data study provide preliminary assessment clinical profiles prognosis diabetes secondary hyperglycaemia patients covid<NUMBER> finally due small number diabetic patients relationship special antidiabetic drugs severe critical covid<NUMBER> cases observed larger studies needed validate findings conclusion higher severity disease mortality rate covid<NUMBER> patients diabetes may due chronic comorbidities weak immune response higher risk secondary bacterial infections instead severe cytokine storm caused covid<NUMBER> might indicate need different therapeutic accepted article strategies however differences secondary hyperglycaemia diabetes secondary hyperglycaemia seems clue severe inflammation reaction multiple organs damage induced virus might require additional attention different treatments clinicians pay attention blood glucose status patients even patients without history diabetes covid<NUMBER> may indicative poor prognosis believe study provides evidence blood glucose status viewed key metric development effective public health strategy mitigate covid<NUMBER> associated poor prognoses article protected copyright rights reserved coronavirus disease <NUMBER> covid<NUMBER> pandemic emerged one greatest challenges faced humankind recent past people diabetes related comorbidities increased risk complications covid<NUMBER>related death older age multimorbidity hyperglycaemia cardiac injury severe inflammatory response predictors poor outcome complex interplay covid<NUMBER> diabetes effects related therapies explored patients experience mild illness covid<NUMBER> people diabetes increased risk severe disease optimising glycaemic control adopting measures prevent disease spread critical aspects management mild disease supportive many immunomodulatory antiviral therapies investigated treatment severe disease several agents specific considerations use people diabetes since mass population lockdowns considered key step controlling disease spread follows addition direct vulnerability severe covid<NUMBER> people diabetes affected limited access healthcare insulin medications blood glucose monitoring equipment measures prevent disease spread individual community level key mitigating rapidly escalating pandemic agents chemoprophylaxis vaccines explored people diabetes recognised vulnerable group complicated disease risk times disturbed social systems strategies needed safeguard health patients diabetes pandemic review summarises current knowledge perceived challenges prevention management covid<NUMBER> people diabetes prevention management covid<NUMBER> among patients diabetes appraisal literature coronavirus disease <NUMBER> caused severe acute respiratory syndromecoronavirus<NUMBER> sarscov<NUMBER> virus become pandemic within months first described hubei province china time writing affected <NUMBER> individuals <NUMBER> countries territories worldwide causing <NUMBER> deaths <NUMBER> usa certain regions europe currently experiencing highest disease burden apparently coming control china <NUMBER> covid<NUMBER> highly transmissible person person respiratory secretions virus enters mucous membranes upper respiratory tract later affecting lungs <NUMBER> majority cases covid<NUMBER> mild illness people develop severe disease characterised respiratory compromise dyspnoea respiratory rate ≥ <NUMBER> breaths per minute blood oxygen saturation ≤ <NUMBER> pao <NUMBER> fio <NUMBER> <NUMBER> andor pulmonary infiltrates <NUMBER> lung fields radiological imaging <NUMBER> minority patients develop critical disease septic shock respiratory andor multiorgan failure fewer <NUMBER> affected develop serious critical illness <NUMBER> likely overestimate since subclinical infection rates community unknown secondary pneumonic bacterial infection additional problem type <NUMBER> type <NUMBER> diabetes increase susceptibility infections complications <NUMBER> neutrophil dysfunction reduced cell response disordered humoral immunity contributory <NUMBER> bacterial viral respiratory people diabetes developing covid<NUMBER> increased risk complications mortality adherence healthy diet lifestyle access healthcare limited infection control measures community lockdown selfisolation quarantine general precautions prevent covid<NUMBER> infection critical people diabetes families patients multiple comorbidities need extra caution continuation good dietary practices safe physical activities regular glucose monitoring encouraged measures telemedicine services drug dispensing extended durations home delivery adopted reduce exposure diabetes patients ensuring uninterrupted continuity care people diabetes develop covid<NUMBER> continue routine medications unless illness severe severe covid<NUMBER> diabetes patients glycaemic control best achieved insulin sglt<NUMBER> inhibitors best discontinued unless illness mild ace inhibitorsarbs continued unless contraindications develop evidence emerges use individualised decisions taken continuing aspirin statins research pharmacological therapies treatment prevention covid<NUMBER> people diabetes urgently needed key points tract infections particularly common <NUMBER> diabetes associated increased morbidity mortality risk pneumonia <NUMBER> hyperglycaemia admission pneumonia <NUMBER> mmoll predicts poor outcome <NUMBER> sars epidemic <NUMBER> diabetes independent predictor mortality risk <NUMBER> <NUMBER> ci <NUMBER> <NUMBER> p <NUMBER> <NUMBER> presence comorbidities including diabetes also increased mortality risk independent age middle east respiratory syndromecoronavirus merscov epidemic <NUMBER> adjusted hr <NUMBER> <NUMBER> ci <NUMBER> <NUMBER> <NUMBER> another study diabetes strongest impact mortality risk among merscov patients <NUMBER> similarly among young patients novel influenza h<NUMBER>n<NUMBER> <NUMBER> diabetes increased risk intensive care unit icu admissions adjusted <NUMBER> <NUMBER> ci <NUMBER> <NUMBER> <NUMBER> increased risk severe disease according available evidence people diabetes higher susceptibility sarscov<NUMBER> infection <NUMBER> however observations recent covid<NUMBER> pandemic comparable epidemics higher rates complications mortality among patients diabetes hypertension diabetes coronary artery disease cerebrovascular disease main associations severe disease present <NUMBER> <NUMBER> <NUMBER> <NUMBER> respectively people severely affected covid<NUMBER> <NUMBER> mortality rate <NUMBER> <NUMBER> <NUMBER> <NUMBER> respectively people died infection <NUMBER> immunocompromised state obesity tobacco smoking risk factors severe disease death <NUMBER> <NUMBER> <NUMBER> larger study <NUMBER> patients covid<NUMBER> china indicated patients diabetes threefold higher mortality rate compared mortality rate covid<NUMBER> patients overall <NUMBER> vs <NUMBER> <NUMBER> italy overall case fatality rate higher <NUMBER> compared <NUMBER> china among group <NUMBER> covid<NUMBER> fatalities <NUMBER> diabetes <NUMBER> ischaemic heart disease <NUMBER> older age presence two comorbidities obesity also predict poor prognosis among covid<NUMBER> patients <NUMBER> <NUMBER> common associations diabetes may contribute least part observed increased risk nevertheless nationwide study <NUMBER> covid<NUMBER> patients china adjusting age smoking comorbidities diabetes independent risk factor composite outcome increased icu admission need ventilation death hr <NUMBER> <NUMBER> ci <NUMBER> <NUMBER> p <NUMBER> <NUMBER> far published data available disease severity among younger patients type <NUMBER> diabetes although experts field observed similar without <NUMBER> similar previous studies among patients influenza bacterial pneumonia elevated serum ferritin lactate dehydrogenase creactive protein crp procalcitonin erythrocyte sedimentation rate esr predicted severe disease among patients covid<NUMBER> <NUMBER> <NUMBER> may indicate secondary bacterial infection exacerbating covid<NUMBER> increased serum ferritin particular might suggest severe secondary bacterial infection among patients thereby making useful costeffective prognostic marker <NUMBER> <NUMBER> lymphopaenia also associated severe disease <NUMBER> <NUMBER> raised ddimer levels observed severe illness suggesting possible consumptive coagulopathy <NUMBER> anticoagulation linked decreased mortality rate covid<NUMBER> patients <NUMBER> among <NUMBER> covid<NUMBER> patients wuhan china people diabetes greater inflammatory response higher crp esr il<NUMBER> relative neutrophilia lymphopaenia higher incidence coagulopathy higher ddimer levels metabolic derangements hyperglycaemia transaminitis severe pneumonia higher radiological scores higher mortality rate compared without <NUMBER> however people diabetes study older higher prevalence cardiovascular disease noteworthy diabetes proinflammatory prothrombotic state <NUMBER> data indicate covid<NUMBER> least severe forms state severe inflammation thrombotic tendency diabetes may predisposed intense immune dysfunction resulting severe late disease supported observation renal cardiovascular comorbidities add proinflammatory state worsen outcome <NUMBER> elevated nterminal probraintype natriuretic peptide ntprobnp cardiac troponin ctni significantly correlated severe disease suggesting covid<NUMBER> may lead myocardial injury impair cardiac function <NUMBER> people diabetes preexisting ischaemic heart disease limited cardiac reserve may increase morbidity mortality risk receptor binding domain sarscov<NUMBER> uses host ace<NUMBER> fusion viral host cell membranes <NUMBER> ace<NUMBER> type <NUMBER> integral glycoprotein highly expressed kidney endothelium lungs heart <NUMBER> ace<NUMBER> converts angiotensin ii angiotensin<NUMBER> angiotensin<NUMBER> respectively fig <NUMBER> latter acts vasodilator antiinflammatory cardioprotective effects according animal studies expression ace<NUMBER> lung tissues low normal conditions <NUMBER> upregulated lung injury <NUMBER> fact animal studies <NUMBER> pilot studies humans <NUMBER> suggested potential therapeutic role ace<NUMBER> inflammatory acute lung injury furthermore sarscov virus responsible <NUMBER> sars epidemic appears downregulate ace<NUMBER> expression infected cells thought perpetuate inflammatory injury <NUMBER> <NUMBER> patients sars higher rates hyperglycaemia admission nonsars pneumonia patients irrespective premorbid glycaemic status disease severity glucocorticoid use <NUMBER> subsequently sarscov shown bind ace<NUMBER> pancreatic islet cells damage cause acute hyperglycaemia possibly contributing excessive mortality rate even among people without diabetes <NUMBER> similar mechanism may operate sarscov<NUMBER> infection contributing hyperglycaemia excess complications mortality rate although ace<NUMBER> shares characteristics ace<NUMBER> inhibited ace inhibitors acei fact acei angiotensin receptor blockers arbs upregulate ace<NUMBER> expression <NUMBER> therefore postulated aceiarb use might facilitate infection sarscov<NUMBER> resulting severe disease <NUMBER> <NUMBER> furthermore ace<NUMBER> gene polymorphism linked increased risk diabetes cardiovascular disease may also predict susceptibility severe cov infection <NUMBER> contrast upregulated ace<NUMBER> may increase levels angiotensin<NUMBER> mounting antiinflammatory effect however low angiotensin ii levels due acei inhibition may mitigate benefit thus still unclear balance benefit risk might continuing stopping ace inhibition <NUMBER> following incubation period <NUMBER> days median <NUMBER> days majority people covid<NUMBER> present role ace<NUMBER> pathogenesis coronavirus diseases ace<NUMBER> converts angiotensin angiotensin ii angiotensin<NUMBER> angiotensin<NUMBER> respectively ace<NUMBER> also expressed lung kidney heart pancreas acts facilitator coventry cells use aceiarbs increases angiotensin levels upregulates ace<NUMBER> gene expression facilitates excess viral entry host cells causing organ injury insulin deficiency contributing hyperglycaemia upregulated ace<NUMBER> may convert angiotensin ii angiotensin<NUMBER> latter acts mas<NUMBER> receptor trigger antiinflammatory effects inhibits at<NUMBER> receptor cause vasodilation however least acei users angiotensin ii levels low net benefit ace<NUMBER> upregulation uncertain cov infection downregulates ace<NUMBER> expression thereby reducing angiotensin<NUMBER> levels reduces antiinflammatory effects potentially worsens organ vulnerability infection angiotensin rbd receptor binding domain figure available part downloadable slideset cough fever shortness breath less commonly nausea diarrhoea <NUMBER> late phase sudden deterioration observed patients <NUMBER> days fever characterised sudden deterioration oxygen saturation people diabetes develop similar symptoms however initial manifestation could milder fever may less common <NUMBER> vs <NUMBER> p <NUMBER> deterioration could occur rapidly later stages <NUMBER> deteriorating glycaemic control hyperglycaemic emergencies may presenting feature type <NUMBER> diabetes may present diabetic ketoacidosis dka <NUMBER> realtime reverse transcription pcr rrtpcr remains gold standard diagnosis sarscov<NUMBER> infection <NUMBER> however use limited cost need technology expertise limited availability resourcepoor settings igmbased rapid diagnostic tests elisabased serological tests developed key limitation poorer early sensitivity typically takes <NUMBER> <NUMBER> days patients seroconvert <NUMBER> tests viral antigen detection also developed people diabetes need timely integrated interventions prevent acquiring disease enhanced selfmanagement supportive healthcare services public health measures need place fig <NUMBER> illness contracted promptly recognised supportive measures instituted specific attention glycaemic control advice found easd elearning portal httpseasdelearningorgcovid<NUMBER> covid<NUMBER> pandemic far solely medical phenomenon disrupts personal professional lives severely affects people societies several levels key strategies promoted containment outbreak isolation social distancing lockdown cities significant impact health lifestyle individual management chronic disease diabetes requires dietary modification regular exercise good adherence medications poses many complex challenges maintaining healthy diet may challenging limited access appropriate food careful portion selection adjusting mealtime insulin according carbohydrate intake continues best strategy particularly patients multipledose insulin regimens adopting regular exercise plan might feasible owing social distancing restrictions outdoor activities concerns high risk disease spread gyms sports centres many closed lockdown depending regional restrictions activities indoor walking gardening stationary high intensity activities may suitable alternatives maintain active lifestyle regular monitoring blood glucose important continuous glucose monitoring cgm flash glucose monitoring systems useful allow remote monitoring healthcare providers however see management patients diabetes covid<NUMBER> possible concerns regarding use paracetamolacetaminophen alongside cgm patients type <NUMBER> diabetes monitoring ketone levels particularly people persistently hyperglycaemic vigilance development symptoms dka important also important people diabetes adequate supply medications home fact increased incidence dka among children type <NUMBER> diabetes observed due delay seeking medical treatment providing routine healthcare newly developed symptoms patients afraid contracting covid<NUMBER> healthcare settings <NUMBER> routine clinic visits overcrowding hospitals minimised reduce disease spread among people diabetes measures telemedicine consultations telephone advice issue medication caregivers lower risk online coordination drug delivery dispensing medications extended periods considered healthcare providers nonemergency routine evaluations foot disease retinopathy etc deferred close contact healthcare providers patients may lead increased risk covid<NUMBER> transmission patients limbthreatening visionthreatening complications triaged immediate attention time uncertainty fear helplessness strong emotions may increase stress patients important ensure psychological wellbeing stress may adversely affect glycaemic control recommends minimising reading listening news could cause distress anxiety regular sleep routines important relaxation techniques meditation help people stress anxiety maintaining contact relatives friends neighbours via telephone conversations using online communication platforms help reduce effects social isolation <NUMBER> employers consider work home strategies furlough employees poorly controlled diabetes cardiac renal complications particularly high risk occupations frontline healthcare work similar high risk jobs especially areas high covid<NUMBER> prevalence setting general considerations majority people covid<NUMBER> develop mild disease managed home according local guidelines patients diabetes developing symptoms suggestive covid<NUMBER> infection immediately notify local healthcare services determine need diagnostic evaluation assessment severity isolation need hospitalisation higher risk adverse outcomes patients diabetes preferentially managed hospitals settings close monitoring disease progression possible managed home regular telephone contact healthcare services followup crucial recognise deterioration glycaemic control development hyperglycaemic emergencies deterioration clinical status frequent glucose monitoring healthy diet adequate hydration dose titration glucoselowering medication liaison healthcare providers prioritised patients may take symptomatic therapy including paracetamolacetaminophen preferred antipyretic agent <NUMBER> however paracetamol may interfere accuracy certain cgm sensors <NUMBER> situations serial capillary blood sugar monitoring adopted <NUMBER> use nonsteroidal antiinflammatory drugs nsaids including ibuprofen symptom relief raised several concerns suppressive effect immune response thought delay recovery salt water retention could worsen lung injury <NUMBER> nsaids also thought upregulate ace<NUMBER> see previous section ace<NUMBER> sarscov<NUMBER> diabetes <NUMBER> glycaemic control importance good glycaemic control covid<NUMBER> pandemic emphasised <NUMBER> new viral infection data limited expert recommendations conform strategies used similar epidemics <NUMBER> patients mild covid<NUMBER> managed usual glucoselowering agents long able eat drink satisfactorily patients adhere sick day rules people diabetes <NUMBER> frequent monitoring capillary glucose important patients develop severe illness likely need treatment modifications multiple factors including glycaemic status haemodynamic stability nutritional status renal function risk hypoglycaemia drug interactions availability medications influence decision making specific concerns relation glucoselowering agents used patients covid<NUMBER> table <NUMBER> metformin may stopped patients hospitalised acutely ill owing risk lactic acidosis <NUMBER> severe covid <NUMBER> infection hypoxic state may increase risk lactic acidosis although specific data sodiumglucose cotransporter <NUMBER> sglt<NUMBER> inhibitor use covid<NUMBER> infection advisable withhold acute illness increased risk dehydration euglycaemic ketoacidosis <NUMBER> <NUMBER> well difficulties maintaining usual perineal hygiene glucagonlike peptide<NUMBER> receptor agonist glp<NUMBER>ra therapy probably temporarily discontinued patients haemodynamic instability compromises absorption subcutaneous sites renal dysfunction gastrointestinal dysfunction prevents adequate oral intake treatment glp<NUMBER>ras may cause gastrointestinal side effects predisposing volume depletion aspiration <NUMBER> dipeptidyl peptidase<NUMBER> dpp<NUMBER> inhibitors associated low risk hypoglycaemia relatively safe across wide range renal functions dpp<NUMBER> inhibitors added basal insulin improve glycaemic control without increasing risk hypoglycaemia even among hospitalised patients <NUMBER> however agents likely less therapeutic benefit patients severe covid<NUMBER> patients mild symptoms could continue dpp<NUMBER> inhibitors omitted acute severe illness replaced insulin becomes necessary severe illness fine control blood glucose difficult using sulfonylureas patients sulfonylureas replaced insulin caution sulfonylureas also needs exercised chloroquine considered risk hypoglycaemia thiazolidinediones eg pioglitazone less favourable option inhospital management acutely ill patients fluid retention oedema contraindicated patients haemodynamic instability hepatic cardiac dysfunction may seen severe covid<NUMBER> infection <NUMBER> existing evidence favours insulin glucoselowering agents glycaemic control hospitalised patients noncritically ill hospitalised patients subcutaneous insulin therapy basal intermediateacting insulin given twice day along mealtime boluses shortor rapidacting insulin preferred strategy glycaemic management <NUMBER> sliding scale therapy probably practiced results greater fluctuations poor overall control <NUMBER> critically ill patients insulin therapy initiated glycaemic target <NUMBER> mmoll <NUMBER> mgdl <NUMBER> less stringent glycaemic control target glucose concentrations <NUMBER> mmoll <NUMBER> mgdl may acceptable terminally ill patients patients severe comorbidities patient care settings frequent glucose monitoring close nursing supervision feasible less aggressive insulin regimens aimed simply minimising glucosuria dehydration electrolyte disturbances may justifiable patients although strict guidelines regarding insulin regimen glycaemic control critically ill patients intravenous insulin infusions short rapidacting insulin boluses may used disease severity nutritional status concomitant medications trend glycaemic fluctuations considered determining insulin dosage <NUMBER> patients type <NUMBER> diabetes covid<NUMBER> hyperglycaemia important monitor blood glucose ketone levels maintain hydration continue insulin therapy strict infection control measures implemented covid<NUMBER> patients diabetes irrespective treated considering vulnerability acquiring secondary bacterial infections potential serious consequences medical therapy comorbidities aceiarbs essential management hypertension heart failure diabetic nephropathy considering contrasting effects ace<NUMBER> cov infection inflammatory lung injury see fig <NUMBER> difficult predict possible clinical outcomes date clear evidence exists use aceiarbs people diabetes risk infected sarscov<NUMBER> despite speculations potential adverse effects <NUMBER> clear competing risks stopping since control hypertension protection renal disease may compromised present international organisations recommended continuation aceiarbs unless explicit contraindications hypotension acute kidney injury <NUMBER> <NUMBER> clear evidence risks associated continuing aspirin although myocardial injury wellknown serious manifestation covid<NUMBER> acute myocardial ischaemia clearly described concerns atherosclerotic plaque accidents increased acute ischaemic strokes exist <NUMBER> <NUMBER> data available would appropriate continue aspirin patients indication secondary prevention unless specific individual concerns gastrointestinal bleeding noted present direct evidence continuation statins patients diabetes covid<NUMBER> preliminary reports raised liver enzymes muscle enzymes associated covid<NUMBER> although severe liver disease rhabdomyolysis characteristic <NUMBER> therefore suggest individualised decision considering indication statin therapy well possible drug interactions antiviral agents several authorities proposed guidelines protocols management covid<NUMBER> electronic supplementary material esm table <NUMBER> however dedicated guidance management covid<NUMBER> people diabetes formulated guidelines suggest treatment limited patients virologically confirmed covid<NUMBER> esm table <NUMBER> although drug robust evidence specific antiviral efficacy clinical outcomes treatment covid<NUMBER> several medications used basis limited clinical data tested clinical trials safety concerns candidate agents weighed relative benefit specific concerns relation agents people diabetes table <NUMBER> situations compassionate label anticovid<NUMBER> therapy considered best done within systematic clinical trials immunomodulators cytokine release syndrome cytokine storm thought central pathogenesis rapid deterioration multiorgan dysfunction patients covid<NUMBER> therefore immunomodulatory agents postulated benefit <NUMBER> chloroquinehydroxychloroquine two antimalarial agents attracted much attention treatment covid<NUMBER> basis limited clinical experience well due political reasons chloroquine shown antiviral antiinflammatory properties previous experimental studies <NUMBER> hydroxychloroquine shown superior potency compared chloroquine experimental studies <NUMBER> favourable safety profile probably lower level tissue accumulation <NUMBER> study france involving <NUMBER> virologically confirmed patients covid<NUMBER> showed chloroquine dose <NUMBER> mg day <NUMBER> days reduced virus carriage significantly <NUMBER> days therapy compared standard care <NUMBER> however nonrandomised study recruited less estimated sample size underpowered assessment clinical outcomes differences intervention control groups older mean age higher azithromycin use intervention group higher dropout rate intervention arm due <NUMBER> icu admissions <NUMBER> death <NUMBER> withdrawals consent emphasising need cautious interpretation systematic review literature cortegiani et al concluded evidence limited experimental vitro studies showing antiviral potency chloroquine hydroxychloroquine <NUMBER> <NUMBER> ongoing randomised clinical trials investigating utility agents solidarity trial hydroxychloroquine remdesivir nct<NUMBER> several studies china <NUMBER> minnesota university covid<NUMBER> pep trial hydroxychloroquine postexposure prophylaxis preemptive therapy covid<NUMBER> nct<NUMBER> specific safety concerns people diabetes hypoglycaemia known adverse effect chloroquine hydroxychloroquine treatment suggested mechanisms decreased intracellular insulin degradation increased insulinmediated glucose transport increased insulin release enhanced insulin sensitivity <NUMBER> therefore extra caution exercised used glucose lowering agents dose reduction may become necessary prolongation qt interval serious cardiac arrhythmias known albeit rare dosedependent adverse effects chloroquinehydroxychloroquine risk greater preexisting cardiac disorders especially comorbid coronary artery disease diminished cardiac reserve covid<NUMBER> known induce myocardial injury adding risk regular ecg monitoring therapy recommended guidelines recommend combining qt prolonging agents azithromycin lopinavirritonavir others recommend cautious use esm table <NUMBER> <NUMBER> glucocorticoids although glucocorticoids used treatment severe acute respiratory distress syndrome ards data use ards caused viral pneumonia minimal therefore recommended routine use covid<NUMBER> <NUMBER> place glucocorticoids treatment covid<NUMBER> investigated nct<NUMBER> used patients diabetes hyperglycaemia may worsen necessitating escalation insulin therapy antivirals fda authorised emergency use remdesivir although affecting mortality significantly shortens course disease <NUMBER> studies progress evaluate treatment well antiviral agents esm tables <NUMBER> <NUMBER> proven effective among patients without diabetes likely patients diabetes would also benefit therapeutic agents although caution always exercised patients multimorbidity glucoselowering agents potential therapeutic option covid <NUMBER> <NUMBER> metformin yu et al showed metformin reversed lipopolysaccharideinduced pulmonary oedema vascular leakage neutrophil accumulation reduced levels tnfα il<NUMBER>β il<NUMBER> il<NUMBER> ards model <NUMBER> patients severe sarscov<NUMBER> develop ards mediated dysregulated immune response producing cytokine storm however hypoxia severe disease limits use due risk lactic acidosis research needed regarding role metformin hostdirected treatment severe covid <NUMBER> <NUMBER> <NUMBER> incretin based therapies dpp<NUMBER> ubiquitous type ii transmembrane glycoprotein expressed many cells including alveolar epithelium inflammatory cells merscov uses dpp<NUMBER> gain entry host cells <NUMBER> dpp<NUMBER> inhibition mitigated inflammatory response experimental studies <NUMBER> known sarscov<NUMBER> uses dpp<NUMBER> cell entry date neither benefit harm shown humans dpp<NUMBER> inhibitors cov infections therefore dpp<NUMBER> inhibitors could continued least mild cases covid<NUMBER> potential benefit treating cov infection remains studied <NUMBER> similarly glp<NUMBER>ras known antiinflammatory effects shown potential therapeutic benefit acute lung injury <NUMBER> however data limited experimental models benefit best remains speculative general precautions mandatory patients caregivers prevent contracting covid<NUMBER> text box general precautions prevent covid<NUMBER> people diabetes chemoprophylaxis preand postexposure vaccines strategies evaluation agent approved far preor postexposure chemoprophylaxis evidence randomised clinical trials urgently needed chloroquine demonstrated antiviral activity five seven known human coronaviruses including covid<NUMBER> <NUMBER> leading candidate prophylactic use <NUMBER> ongoing trials china yielded encouraging preliminary findings <NUMBER> data generally contentious several trials progress phydra trial nct<NUMBER> copcov study nct<NUMBER> patients diabetes also included studies clusterrandomised controlled trial planned evaluate use lopinavirritonavir postexposure prophylaxis nct<NUMBER> safe potent vaccine would obviously useful high risk individuals diabetes cardiovascular disease elderly several vaccines investigated apicth trial recombinant novel coronavirus vaccine adenovirus type <NUMBER> vector nct<NUMBER> mrna<NUMBER> vaccine nct<NUMBER> artificial antigenpresenting cells aapcs vaccine nct<NUMBER> covid<NUMBER> emerged one greatest challenges humankind second world war identification effective preventive treatment strategies urgently needed people diabetes related comorbidities shown fare worse although pathophysiological molecular mechanisms behind link yet fully understood researchers authorities worldwide take urgent steps answer critical questions prevention management covid<NUMBER> protection people diabetes text box unanswered questions imperative establish standard case definitions data collection recording sharing strategies operational guidelines allow comparison analysis data standardisation research protocols identification research priorities essential utilise time resources productively role pharmaceutical agents prevention treatment covid<NUMBER> terms efficacy safety cost effectiveness evaluated priority data needed especially looking effects aceiarbs sglt<NUMBER> inhibitors infected well severely ill healthcare systems adopt strategies case detection treatment maintaining care supply essential medicines people chronic diseases diabetes reduce morbidity mortality risk due diseases period strategic utilisation human resources healthcare services safeguarding health timely need current challenge healthcare systems opportunity improve service provision learn successful regional global strategies prepare future hygiene social distancing widely recommended continue regular medication regular glucose monitoring consider dose adjustments match diet physical activity ketone level monitoring patients type <NUMBER> diabetes insulintreated type <NUMBER> diabetes especially persistently hyperglycaemic healthy diet ensure regular meals follow advice healthy eating diabetes limit refined sugars carbohydrates consume adequate vegetables fruit green leaves nuts physical activity indoor exercise walking minimise sedentarysitting time online exercise programmes regular active breaks avoid smoking minimise avoid alcohol general precautions prevent covid<NUMBER> people diabetes challenges greater magnitude pandemic also highlights need joinedup public health measures careforall policies coronavirus disease <NUMBER> caused severe acute respiratory syndromecoronavirus<NUMBER> sarscov<NUMBER> virus become pandemic within months first described hubei province china time writing affected <NUMBER> individuals <NUMBER> countries territories worldwide causing <NUMBER> deaths <NUMBER> usa certain regions europe currently experiencing highest disease burden apparently coming control china <NUMBER> covid<NUMBER> highly transmissible person person respiratory secretions virus enters mucous membranes upper respiratory tract later affecting lungs <NUMBER> majority cases covid<NUMBER> mild illness people develop severe disease characterised respiratory compromise dyspnoea respiratory rate ≥ <NUMBER> breaths per minute blood oxygen saturation ≤ <NUMBER> pao <NUMBER> fio <NUMBER> <NUMBER> andor pulmonary infiltrates <NUMBER> lung fields radiological imaging <NUMBER> minority patients develop critical disease septic shock respiratory andor multiorgan failure fewer <NUMBER> affected develop serious critical illness <NUMBER> likely overestimate since subclinical infection rates community unknown secondary pneumonic bacterial infection additional problem type <NUMBER> type <NUMBER> diabetes increase susceptibility infections complications <NUMBER> neutrophil dysfunction reduced cell response disordered humoral immunity contributory <NUMBER> bacterial viral respiratory people diabetes developing covid<NUMBER> increased risk complications mortality adherence healthy diet lifestyle access healthcare limited infection control measures community lockdown selfisolation quarantine general precautions prevent covid<NUMBER> infection critical people diabetes families patients multiple comorbidities need extra caution continuation good dietary practices safe physical activities regular glucose monitoring encouraged measures telemedicine services drug dispensing extended durations home delivery adopted reduce exposure diabetes patients ensuring uninterrupted continuity care people diabetes develop covid<NUMBER> continue routine medications unless illness severe severe covid<NUMBER> diabetes patients glycaemic control best achieved insulin sglt<NUMBER> inhibitors best discontinued unless illness mild ace inhibitorsarbs continued unless contraindications develop evidence emerges use individualised decisions taken continuing aspirin statins research pharmacological therapies treatment prevention covid<NUMBER> people diabetes urgently needed key points tract infections particularly common <NUMBER> diabetes associated increased morbidity mortality risk pneumonia <NUMBER> hyperglycaemia admission pneumonia <NUMBER> mmoll predicts poor outcome <NUMBER> sars epidemic <NUMBER> diabetes independent predictor mortality risk <NUMBER> <NUMBER> ci <NUMBER> <NUMBER> p <NUMBER> <NUMBER> presence comorbidities including diabetes also increased mortality risk independent age middle east respiratory syndromecoronavirus merscov epidemic <NUMBER> adjusted hr <NUMBER> <NUMBER> ci <NUMBER> <NUMBER> <NUMBER> another study diabetes strongest impact mortality risk among merscov patients <NUMBER> similarly among young patients novel influenza h<NUMBER>n<NUMBER> <NUMBER> diabetes increased risk intensive care unit icu admissions adjusted <NUMBER> <NUMBER> ci <NUMBER> <NUMBER> <NUMBER> increased risk severe disease according available evidence people diabetes higher susceptibility sarscov<NUMBER> infection <NUMBER> however observations recent covid<NUMBER> pandemic comparable epidemics higher rates complications mortality among patients diabetes hypertension diabetes coronary artery disease cerebrovascular disease main associations severe disease present <NUMBER> <NUMBER> <NUMBER> <NUMBER> respectively people severely affected covid<NUMBER> <NUMBER> mortality rate <NUMBER> <NUMBER> <NUMBER> <NUMBER> respectively people died infection <NUMBER> immunocompromised state obesity tobacco smoking risk factors severe disease death <NUMBER> <NUMBER> <NUMBER> larger study <NUMBER> patients covid<NUMBER> china indicated patients diabetes threefold higher mortality rate compared mortality rate covid<NUMBER> patients overall <NUMBER> vs <NUMBER> <NUMBER> italy overall case fatality rate higher <NUMBER> compared <NUMBER> china among group <NUMBER> covid<NUMBER> fatalities <NUMBER> diabetes <NUMBER> ischaemic heart disease <NUMBER> older age presence two comorbidities obesity also predict poor prognosis among covid<NUMBER> patients <NUMBER> <NUMBER> common associations diabetes may contribute least part observed increased risk nevertheless nationwide study <NUMBER> covid<NUMBER> patients china adjusting age smoking comorbidities diabetes independent risk factor composite outcome increased icu admission need ventilation death hr <NUMBER> <NUMBER> ci <NUMBER> <NUMBER> p <NUMBER> <NUMBER> far published data available disease severity among younger patients type <NUMBER> diabetes although experts field observed similar without <NUMBER> similar previous studies among patients influenza bacterial pneumonia elevated serum ferritin lactate dehydrogenase creactive protein crp procalcitonin erythrocyte sedimentation rate esr predicted severe disease among patients covid<NUMBER> <NUMBER> <NUMBER> may indicate secondary bacterial infection exacerbating covid<NUMBER> increased serum ferritin particular might suggest severe secondary bacterial infection among patients thereby making useful costeffective prognostic marker <NUMBER> <NUMBER> lymphopaenia also associated severe disease <NUMBER> <NUMBER> raised ddimer levels observed severe illness suggesting possible consumptive coagulopathy <NUMBER> anticoagulation linked decreased mortality rate covid<NUMBER> patients <NUMBER> among <NUMBER> covid<NUMBER> patients wuhan china people diabetes greater inflammatory response higher crp esr il<NUMBER> relative neutrophilia lymphopaenia higher incidence coagulopathy higher ddimer levels metabolic derangements hyperglycaemia transaminitis severe pneumonia higher radiological scores higher mortality rate compared without <NUMBER> however people diabetes study older higher prevalence cardiovascular disease noteworthy diabetes proinflammatory prothrombotic state <NUMBER> data indicate covid<NUMBER> least severe forms state severe inflammation thrombotic tendency diabetes may predisposed intense immune dysfunction resulting severe late disease supported observation renal cardiovascular comorbidities add proinflammatory state worsen outcome <NUMBER> elevated nterminal probraintype natriuretic peptide ntprobnp cardiac troponin ctni significantly correlated severe disease suggesting covid<NUMBER> may lead myocardial injury impair cardiac function <NUMBER> people diabetes preexisting ischaemic heart disease limited cardiac reserve may increase morbidity mortality risk receptor binding domain sarscov<NUMBER> uses host ace<NUMBER> fusion viral host cell membranes <NUMBER> ace<NUMBER> type <NUMBER> integral glycoprotein highly expressed kidney endothelium lungs heart <NUMBER> ace<NUMBER> converts angiotensin ii angiotensin<NUMBER> angiotensin<NUMBER> respectively fig <NUMBER> latter acts vasodilator antiinflammatory cardioprotective effects according animal studies expression ace<NUMBER> lung tissues low normal conditions <NUMBER> upregulated lung injury <NUMBER> fact animal studies <NUMBER> pilot studies humans <NUMBER> suggested potential therapeutic role ace<NUMBER> inflammatory acute lung injury furthermore sarscov virus responsible <NUMBER> sars epidemic appears downregulate ace<NUMBER> expression infected cells thought perpetuate inflammatory injury <NUMBER> <NUMBER> patients sars higher rates hyperglycaemia admission nonsars pneumonia patients irrespective premorbid glycaemic status disease severity glucocorticoid use <NUMBER> subsequently sarscov shown bind ace<NUMBER> pancreatic islet cells damage cause acute hyperglycaemia possibly contributing excessive mortality rate even among people without diabetes <NUMBER> similar mechanism may operate sarscov<NUMBER> infection contributing hyperglycaemia excess complications mortality rate although ace<NUMBER> shares characteristics ace<NUMBER> inhibited ace inhibitors acei fact acei angiotensin receptor blockers arbs upregulate ace<NUMBER> expression <NUMBER> therefore postulated aceiarb use might facilitate infection sarscov<NUMBER> resulting severe disease <NUMBER> <NUMBER> furthermore ace<NUMBER> gene polymorphism linked increased risk diabetes cardiovascular disease may also predict susceptibility severe cov infection <NUMBER> contrast upregulated ace<NUMBER> may increase levels angiotensin<NUMBER> mounting antiinflammatory effect however low angiotensin ii levels due acei inhibition may mitigate benefit thus still unclear balance benefit risk might continuing stopping ace inhibition <NUMBER> following incubation period <NUMBER> days median <NUMBER> days majority people covid<NUMBER> present role ace<NUMBER> pathogenesis coronavirus diseases ace<NUMBER> converts angiotensin angiotensin ii angiotensin<NUMBER> angiotensin<NUMBER> respectively ace<NUMBER> also expressed lung kidney heart pancreas acts facilitator coventry cells use aceiarbs increases angiotensin levels upregulates ace<NUMBER> gene expression facilitates excess viral entry host cells causing organ injury insulin deficiency contributing hyperglycaemia upregulated ace<NUMBER> may convert angiotensin ii angiotensin<NUMBER> latter acts mas<NUMBER> receptor trigger antiinflammatory effects inhibits at<NUMBER> receptor cause vasodilation however least acei users angiotensin ii levels low net benefit ace<NUMBER> upregulation uncertain cov infection downregulates ace<NUMBER> expression thereby reducing angiotensin<NUMBER> levels reduces antiinflammatory effects potentially worsens organ vulnerability infection angiotensin rbd receptor binding domain figure available part downloadable slideset cough fever shortness breath less commonly nausea diarrhoea <NUMBER> late phase sudden deterioration observed patients <NUMBER> days fever characterised sudden deterioration oxygen saturation people diabetes develop similar symptoms however initial manifestation could milder fever may less common <NUMBER> vs <NUMBER> p <NUMBER> deterioration could occur rapidly later stages <NUMBER> deteriorating glycaemic control hyperglycaemic emergencies may presenting feature type <NUMBER> diabetes may present diabetic ketoacidosis dka <NUMBER> realtime reverse transcription pcr rrtpcr remains gold standard diagnosis sarscov<NUMBER> infection <NUMBER> however use limited cost need technology expertise limited availability resourcepoor settings igmbased rapid diagnostic tests elisabased serological tests developed key limitation poorer early sensitivity typically takes <NUMBER> <NUMBER> days patients seroconvert <NUMBER> tests viral antigen detection also developed people diabetes need timely integrated interventions prevent acquiring disease enhanced selfmanagement supportive healthcare services public health measures need place fig <NUMBER> illness contracted promptly recognised supportive measures instituted specific attention glycaemic control advice found easd elearning portal httpseasdelearningorgcovid<NUMBER> covid<NUMBER> pandemic far solely medical phenomenon disrupts personal professional lives severely affects people societies several levels key strategies promoted containment outbreak isolation social distancing lockdown cities significant impact health lifestyle individual management chronic disease diabetes requires dietary modification regular exercise good adherence medications poses many complex challenges maintaining healthy diet may challenging limited access appropriate food careful portion selection adjusting mealtime insulin according carbohydrate intake continues best strategy particularly patients multipledose insulin regimens adopting regular exercise plan might feasible owing social distancing restrictions outdoor activities concerns high risk disease spread gyms sports centres many closed lockdown depending regional restrictions activities indoor walking gardening stationary high intensity activities may suitable alternatives maintain active lifestyle regular monitoring blood glucose important continuous glucose monitoring cgm flash glucose monitoring systems useful allow remote monitoring healthcare providers however see management patients diabetes covid<NUMBER> possible concerns regarding use paracetamolacetaminophen alongside cgm patients type <NUMBER> diabetes monitoring ketone levels particularly people persistently hyperglycaemic vigilance development symptoms dka important also important people diabetes adequate supply medications home fact increased incidence dka among children type <NUMBER> diabetes observed due delay seeking medical treatment providing routine healthcare newly developed symptoms patients afraid contracting covid<NUMBER> healthcare settings <NUMBER> routine clinic visits overcrowding hospitals minimised reduce disease spread among people diabetes measures telemedicine consultations telephone advice issue medication caregivers lower risk online coordination drug delivery dispensing medications extended periods considered healthcare providers nonemergency routine evaluations foot disease retinopathy etc deferred close contact healthcare providers patients may lead increased risk covid<NUMBER> transmission patients limbthreatening visionthreatening complications triaged immediate attention time uncertainty fear helplessness strong emotions may increase stress patients important ensure psychological wellbeing stress may adversely affect glycaemic control recommends minimising reading listening news could cause distress anxiety regular sleep routines important relaxation techniques meditation help people stress anxiety maintaining contact relatives friends neighbours via telephone conversations using online communication platforms help reduce effects social isolation <NUMBER> employers consider work home strategies furlough employees poorly controlled diabetes cardiac renal complications particularly high risk occupations frontline healthcare work similar high risk jobs especially areas high covid<NUMBER> prevalence setting general considerations majority people covid<NUMBER> develop mild disease managed home according local guidelines patients diabetes developing symptoms suggestive covid<NUMBER> infection immediately notify local healthcare services determine need diagnostic evaluation assessment severity isolation need hospitalisation higher risk adverse outcomes patients diabetes preferentially managed hospitals settings close monitoring disease progression possible managed home regular telephone contact healthcare services followup crucial recognise deterioration glycaemic control development hyperglycaemic emergencies deterioration clinical status frequent glucose monitoring healthy diet adequate hydration dose titration glucoselowering medication liaison healthcare providers prioritised patients may take symptomatic therapy including paracetamolacetaminophen preferred antipyretic agent <NUMBER> however paracetamol may interfere accuracy certain cgm sensors <NUMBER> situations serial capillary blood sugar monitoring adopted <NUMBER> use nonsteroidal antiinflammatory drugs nsaids including ibuprofen symptom relief raised several concerns suppressive effect immune response thought delay recovery salt water retention could worsen lung injury <NUMBER> nsaids also thought upregulate ace<NUMBER> see previous section ace<NUMBER> sarscov<NUMBER> diabetes <NUMBER> glycaemic control importance good glycaemic control covid<NUMBER> pandemic emphasised <NUMBER> new viral infection data limited expert recommendations conform strategies used similar epidemics <NUMBER> patients mild covid<NUMBER> managed usual glucoselowering agents long able eat drink satisfactorily patients adhere sick day rules people diabetes <NUMBER> frequent monitoring capillary glucose important patients develop severe illness likely need treatment modifications multiple factors including glycaemic status haemodynamic stability nutritional status renal function risk hypoglycaemia drug interactions availability medications influence decision making specific concerns relation glucoselowering agents used patients covid<NUMBER> table <NUMBER> metformin may stopped patients hospitalised acutely ill owing risk lactic acidosis <NUMBER> severe covid <NUMBER> infection hypoxic state may increase risk lactic acidosis although specific data sodiumglucose cotransporter <NUMBER> sglt<NUMBER> inhibitor use covid<NUMBER> infection advisable withhold acute illness increased risk dehydration euglycaemic ketoacidosis <NUMBER> <NUMBER> well difficulties maintaining usual perineal hygiene glucagonlike peptide<NUMBER> receptor agonist glp<NUMBER>ra therapy probably temporarily discontinued patients haemodynamic instability compromises absorption subcutaneous sites renal dysfunction gastrointestinal dysfunction prevents adequate oral intake treatment glp<NUMBER>ras may cause gastrointestinal side effects predisposing volume depletion aspiration <NUMBER> dipeptidyl peptidase<NUMBER> dpp<NUMBER> inhibitors associated low risk hypoglycaemia relatively safe across wide range renal functions dpp<NUMBER> inhibitors added basal insulin improve glycaemic control without increasing risk hypoglycaemia even among hospitalised patients <NUMBER> however agents likely less therapeutic benefit patients severe covid<NUMBER> patients mild symptoms could continue dpp<NUMBER> inhibitors omitted acute severe illness replaced insulin becomes necessary severe illness fine control blood glucose difficult using sulfonylureas patients sulfonylureas replaced insulin caution sulfonylureas also needs exercised chloroquine considered risk hypoglycaemia thiazolidinediones eg pioglitazone less favourable option inhospital management acutely ill patients fluid retention oedema contraindicated patients haemodynamic instability hepatic cardiac dysfunction may seen severe covid<NUMBER> infection <NUMBER> existing evidence favours insulin glucoselowering agents glycaemic control hospitalised patients noncritically ill hospitalised patients subcutaneous insulin therapy basal intermediateacting insulin given twice day along mealtime boluses shortor rapidacting insulin preferred strategy glycaemic management <NUMBER> sliding scale therapy probably practiced results greater fluctuations poor overall control <NUMBER> critically ill patients insulin therapy initiated glycaemic target <NUMBER> mmoll <NUMBER> mgdl <NUMBER> less stringent glycaemic control target glucose concentrations <NUMBER> mmoll <NUMBER> mgdl may acceptable terminally ill patients patients severe comorbidities patient care settings frequent glucose monitoring close nursing supervision feasible less aggressive insulin regimens aimed simply minimising glucosuria dehydration electrolyte disturbances may justifiable patients although strict guidelines regarding insulin regimen glycaemic control critically ill patients intravenous insulin infusions short rapidacting insulin boluses may used disease severity nutritional status concomitant medications trend glycaemic fluctuations considered determining insulin dosage <NUMBER> patients type <NUMBER> diabetes covid<NUMBER> hyperglycaemia important monitor blood glucose ketone levels maintain hydration continue insulin therapy strict infection control measures implemented covid<NUMBER> patients diabetes irrespective treated considering vulnerability acquiring secondary bacterial infections potential serious consequences medical therapy comorbidities aceiarbs essential management hypertension heart failure diabetic nephropathy considering contrasting effects ace<NUMBER> cov infection inflammatory lung injury see fig <NUMBER> difficult predict possible clinical outcomes date clear evidence exists use aceiarbs people diabetes risk infected sarscov<NUMBER> despite speculations potential adverse effects <NUMBER> clear competing risks stopping since control hypertension protection renal disease may compromised present international organisations recommended continuation aceiarbs unless explicit contraindications hypotension acute kidney injury <NUMBER> <NUMBER> clear evidence risks associated continuing aspirin although myocardial injury wellknown serious manifestation covid<NUMBER> acute myocardial ischaemia clearly described concerns atherosclerotic plaque accidents increased acute ischaemic strokes exist <NUMBER> <NUMBER> data available would appropriate continue aspirin patients indication secondary prevention unless specific individual concerns gastrointestinal bleeding noted present direct evidence continuation statins patients diabetes covid<NUMBER> preliminary reports raised liver enzymes muscle enzymes associated covid<NUMBER> although severe liver disease rhabdomyolysis characteristic <NUMBER> therefore suggest individualised decision considering indication statin therapy well possible drug interactions antiviral agents several authorities proposed guidelines protocols management covid<NUMBER> electronic supplementary material esm table <NUMBER> however dedicated guidance management covid<NUMBER> people diabetes formulated guidelines suggest treatment limited patients virologically confirmed covid<NUMBER> esm table <NUMBER> although drug robust evidence specific antiviral efficacy clinical outcomes treatment covid<NUMBER> several medications used basis limited clinical data tested clinical trials safety concerns candidate agents weighed relative benefit specific concerns relation agents people diabetes table <NUMBER> situations compassionate label anticovid<NUMBER> therapy considered best done within systematic clinical trials immunomodulators cytokine release syndrome cytokine storm thought central pathogenesis rapid deterioration multiorgan dysfunction patients covid<NUMBER> therefore immunomodulatory agents postulated benefit <NUMBER> chloroquinehydroxychloroquine two antimalarial agents attracted much attention treatment covid<NUMBER> basis limited clinical experience well due political reasons chloroquine shown antiviral antiinflammatory properties previous experimental studies <NUMBER> hydroxychloroquine shown superior potency compared chloroquine experimental studies <NUMBER> favourable safety profile probably lower level tissue accumulation <NUMBER> study france involving <NUMBER> virologically confirmed patients covid<NUMBER> showed chloroquine dose <NUMBER> mg day <NUMBER> days reduced virus carriage significantly <NUMBER> days therapy compared standard care <NUMBER> however nonrandomised study recruited less estimated sample size underpowered assessment clinical outcomes differences intervention control groups older mean age higher azithromycin use intervention group higher dropout rate intervention arm due <NUMBER> icu admissions <NUMBER> death <NUMBER> withdrawals consent emphasising need cautious interpretation systematic review literature cortegiani et al concluded evidence limited experimental vitro studies showing antiviral potency chloroquine hydroxychloroquine <NUMBER> <NUMBER> ongoing randomised clinical trials investigating utility agents solidarity trial hydroxychloroquine remdesivir nct<NUMBER> several studies china <NUMBER> minnesota university covid<NUMBER> pep trial hydroxychloroquine postexposure prophylaxis preemptive therapy covid<NUMBER> nct<NUMBER> specific safety concerns people diabetes hypoglycaemia known adverse effect chloroquine hydroxychloroquine treatment suggested mechanisms decreased intracellular insulin degradation increased insulinmediated glucose transport increased insulin release enhanced insulin sensitivity <NUMBER> therefore extra caution exercised used glucose lowering agents dose reduction may become necessary prolongation qt interval serious cardiac arrhythmias known albeit rare dosedependent adverse effects chloroquinehydroxychloroquine risk greater preexisting cardiac disorders especially comorbid coronary artery disease diminished cardiac reserve covid<NUMBER> known induce myocardial injury adding risk regular ecg monitoring therapy recommended guidelines recommend combining qt prolonging agents azithromycin lopinavirritonavir others recommend cautious use esm table <NUMBER> <NUMBER> glucocorticoids although glucocorticoids used treatment severe acute respiratory distress syndrome ards data use ards caused viral pneumonia minimal therefore recommended routine use covid<NUMBER> <NUMBER> place glucocorticoids treatment covid<NUMBER> investigated nct<NUMBER> used patients diabetes hyperglycaemia may worsen necessitating escalation insulin therapy antivirals fda authorised emergency use remdesivir although affecting mortality significantly shortens course disease <NUMBER> studies progress evaluate treatment well antiviral agents esm tables <NUMBER> <NUMBER> proven effective among patients without diabetes likely patients diabetes would also benefit therapeutic agents although caution always exercised patients multimorbidity glucoselowering agents potential therapeutic option covid <NUMBER> <NUMBER> metformin yu et al showed metformin reversed lipopolysaccharideinduced pulmonary oedema vascular leakage neutrophil accumulation reduced levels tnfα il<NUMBER>β il<NUMBER> il<NUMBER> ards model <NUMBER> patients severe sarscov<NUMBER> develop ards mediated dysregulated immune response producing cytokine storm however hypoxia severe disease limits use due risk lactic acidosis research needed regarding role metformin hostdirected treatment severe covid <NUMBER> <NUMBER> <NUMBER> incretin based therapies dpp<NUMBER> ubiquitous type ii transmembrane glycoprotein expressed many cells including alveolar epithelium inflammatory cells merscov uses dpp<NUMBER> gain entry host cells <NUMBER> dpp<NUMBER> inhibition mitigated inflammatory response experimental studies <NUMBER> known sarscov<NUMBER> uses dpp<NUMBER> cell entry date neither benefit harm shown humans dpp<NUMBER> inhibitors cov infections therefore dpp<NUMBER> inhibitors could continued least mild cases covid<NUMBER> potential benefit treating cov infection remains studied <NUMBER> similarly glp<NUMBER>ras known antiinflammatory effects shown potential therapeutic benefit acute lung injury <NUMBER> however data limited experimental models benefit best remains speculative general precautions mandatory patients caregivers prevent contracting covid<NUMBER> text box general precautions prevent covid<NUMBER> people diabetes chemoprophylaxis preand postexposure vaccines strategies evaluation agent approved far preor postexposure chemoprophylaxis evidence randomised clinical trials urgently needed chloroquine demonstrated antiviral activity five seven known human coronaviruses including covid<NUMBER> <NUMBER> leading candidate prophylactic use <NUMBER> ongoing trials china yielded encouraging preliminary findings <NUMBER> data generally contentious several trials progress phydra trial nct<NUMBER> copcov study nct<NUMBER> patients diabetes also included studies clusterrandomised controlled trial planned evaluate use lopinavirritonavir postexposure prophylaxis nct<NUMBER> safe potent vaccine would obviously useful high risk individuals diabetes cardiovascular disease elderly several vaccines investigated apicth trial recombinant novel coronavirus vaccine adenovirus type <NUMBER> vector nct<NUMBER> mrna<NUMBER> vaccine nct<NUMBER> artificial antigenpresenting cells aapcs vaccine nct<NUMBER> covid<NUMBER> emerged one greatest challenges humankind second world war identification effective preventive treatment strategies urgently needed people diabetes related comorbidities shown fare worse although pathophysiological molecular mechanisms behind link yet fully understood researchers authorities worldwide take urgent steps answer critical questions prevention management covid<NUMBER> protection people diabetes text box unanswered questions imperative establish standard case definitions data collection recording sharing strategies operational guidelines allow comparison analysis data standardisation research protocols identification research priorities essential utilise time resources productively role pharmaceutical agents prevention treatment covid<NUMBER> terms efficacy safety cost effectiveness evaluated priority data needed especially looking effects aceiarbs sglt<NUMBER> inhibitors infected well severely ill healthcare systems adopt strategies case detection treatment maintaining care supply essential medicines people chronic diseases diabetes reduce morbidity mortality risk due diseases period strategic utilisation human resources healthcare services safeguarding health timely need current challenge healthcare systems opportunity improve service provision learn successful regional global strategies prepare future hygiene social distancing widely recommended continue regular medication regular glucose monitoring consider dose adjustments match diet physical activity ketone level monitoring patients type <NUMBER> diabetes insulintreated type <NUMBER> diabetes especially persistently hyperglycaemic healthy diet ensure regular meals follow advice healthy eating diabetes limit refined sugars carbohydrates consume adequate vegetables fruit green leaves nuts physical activity indoor exercise walking minimise sedentarysitting time online exercise programmes regular active breaks avoid smoking minimise avoid alcohol general precautions prevent covid<NUMBER> people diabetes challenges greater magnitude pandemic also highlights need joinedup public health measures careforall policies <NUMBER> pandemic coronavirus affected three million people <NUMBER> countries causing two hundred thousand deaths end april <NUMBER> <NUMBER> etiologic agent disease severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> transmitted contact infected persons contaminated fluids <NUMBER> <NUMBER> several risk factors associated disease multicenter cohort study advanced age found significantly correlated overall covid<NUMBER> prevalence consistent higher incidence observed older adults <NUMBER> sex another risk factor higher prevalence seen men women <NUMBER> studies shown presence comorbidity increases chances covid<NUMBER> infection causing respiratory failure death patients <NUMBER> another study reports patients admitted intensive care unit icu higher number comorbidities <NUMBER> admitted icu <NUMBER> <NUMBER> hence comorbidities considered risk factor fatality data reports show <NUMBER> prevalence comorbidities fatal cases <NUMBER> cardiovascular diseases diabetes hypertension chronic obstructive pulmonary disease prevalent known comorbidities covid<NUMBER> cases <NUMBER> currently several published studies describe epidemiological clinical characteristics patients mortality cases affected covid<NUMBER> different parts world reason aim metaanalysis estimate prevalence geographical distribution comorbidities patients admitted icu mortality cases affected covid<NUMBER> using previously published data protocol systematic review published international prospective registry systematic reviews prospero <NUMBER> crd<NUMBER> implementation protocol final report developed based cochrane manual systematic reviews interventions <NUMBER> prevalence comorbidities patients patients admitted icu fatal cases affected new coronavirus covid<NUMBER> review considered studies conducted epidemiological clinical descriptions patients fatal cases different parts world order determine prevalence geographic distribution comorbidities patients affected covid<NUMBER> initial search limited medline performed using mesh index terms related keywords search followed analysis words text title abstract index terms used describe articles second search using identified keywords index terms conducted may <NUMBER> <NUMBER> using following databases latin american caribbean health sciences literature lilacs bibliographic database us national medicine medline elsevier database embase web science scopus mesh index term search included covid<NUMBER> sarscov<NUMBER> prevalence comorbidity covid<NUMBER> recent topic thesis dissertation papers yet published evaluated articles selected data recovery analyzed two independent reviewers assessed methodological validity text inclusion review quality publications included evaluated based criteria derived grading recommendations assessment development evaluation method grade points awarded studies present limitations study design execution risk bias inconsistency results evidence based indirect data imprecision publication bias score four five points considered high quality three points moderate quality zero two points low quality data added review manager revman <NUMBER> analysis data extraction table created assess quality demographic data study location sample size number cases number positives diagnostic test randomeffect model metaanalysis method used analyze pooled prevalence comorbidities patients fatal cases affected covid<NUMBER> different parts world heterogeneity among studies analyzed using higgins test <NUMBER> shows percentage variation among studies analyses compiled using stata software version <NUMBER> statacorp llc texas usa odds ratio test <NUMBER> confidence interval <NUMBER> ci calculated measure likelihood death patient comorbidity compared patient without comorbidities applying eligibility exclusion criteria duplicate texts articles related topics text excluded review criteria method quality <NUMBER> studies considered analyses <NUMBER> <NUMBER> <NUMBER> <NUMBER> used calculate total prevalence comorbidities patients affected covid<NUMBER> six used calculate prevalence comorbidities patients admitted icu <NUMBER> used calculate comorbidity prevalence fatal cases characteristics studies included metaanalysis shown table <NUMBER> results search strategy shown prisma flow chart figure <NUMBER> data extracted final selection shown supplementary table s<NUMBER> according criteria applied based grade studies met selection criteria presented high methodological quality score five <NUMBER> test indicated low heterogeneity among studies publication bias evaluated currently available methods considered useful studies proportions summaries methodological quality bias risk applicability study among included studies shown supplementary figures s<NUMBER> s<NUMBER> <NUMBER> studies used calculate pooled prevalence comorbidities <NUMBER> patients affected covid<NUMBER> analyzed <NUMBER> <NUMBER> presented one comorbidities <NUMBER> <NUMBER> admitted icu <NUMBER> <NUMBER> patients died patients age range <NUMBER> <NUMBER> years among studies one conducted usa <NUMBER> included large number patients <NUMBER> segregate patients according sex <NUMBER> studies <NUMBER> patients registered total <NUMBER> <NUMBER> males <NUMBER> <NUMBER> females reported comorbidities included hypertension heart disease diabetes cancer chronic obstructive pulmonary disease asthma chronic diseases liver kidneys digestive system autoimmune disorders immunodeficiencies stroke others one study specified diseases included category others regarding geographical distribution studied patients <NUMBER> <NUMBER> usa <NUMBER> analysis general population affected covid<NUMBER> indicated <NUMBER> pooled prevalence comorbidities <NUMBER> ci <NUMBER> weight <NUMBER> china geographical distribution analysis showed <NUMBER> prevalence comorbidities <NUMBER> ci <NUMBER> weight <NUMBER> followed usa <NUMBER> <NUMBER> ci <NUMBER> weight <NUMBER> india <NUMBER> <NUMBER> ci <NUMBER> weight <NUMBER> singapore <NUMBER> <NUMBER> ci <NUMBER> <NUMBER> weight <NUMBER> figure <NUMBER> among one previous diseases total <NUMBER> comorbidities hypertension prevalent <NUMBER> <NUMBER> ci <NUMBER> weight <NUMBER> followed diabetes <NUMBER> <NUMBER> ci <NUMBER> weight <NUMBER> heart disease <NUMBER> <NUMBER> ci <NUMBER> weight <NUMBER> chronic obstructive pulmonary disease copd <NUMBER> <NUMBER> ci <NUMBER> weight <NUMBER> addition comorbidities also assessed kidney disease <NUMBER> cancer <NUMBER> asthma <NUMBER> liver disease <NUMBER> stroke <NUMBER> immunodeficiencies <NUMBER> others <NUMBER> pooled prevalence <NUMBER> ci values disease shown table <NUMBER> six studies conducted descriptions epidemiological clinical profiles patients admitted icu five divided data according sex five studies <NUMBER> patients described <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> among patients <NUMBER> <NUMBER> male <NUMBER> <NUMBER> female age range <NUMBER> <NUMBER> years clinical characteristics <NUMBER> patients also described indicating <NUMBER> <NUMBER> one comorbidities total <NUMBER> comorbidities among patients admitted icu pooled prevalence comorbidities icu patients <NUMBER> <NUMBER> ci <NUMBER> weight <NUMBER> geographical distribution analysis showed <NUMBER> prevalence comorbidities <NUMBER> ci <NUMBER> weight <NUMBER> china followed italy <NUMBER> <NUMBER> ci <NUMBER> weight <NUMBER> usa <NUMBER> <NUMBER> ci <NUMBER> weight <NUMBER> forest plot randomeffect metaanalysis comorbidities patients admitted icus covid<NUMBER> shown supplementary figure s<NUMBER> prevalent comorbidities icu population hypertension <NUMBER> <NUMBER> ci <NUMBER> weight <NUMBER> heart disease <NUMBER> <NUMBER> ci <NUMBER> weight <NUMBER> diabetes <NUMBER> <NUMBER> ci <NUMBER> weight <NUMBER> others <NUMBER> <NUMBER> ci <NUMBER> weight <NUMBER> addition diseases patients copd <NUMBER> cancer <NUMBER> kidney disease <NUMBER> liver disease <NUMBER> stroke <NUMBER> also evaluated pooled prevalence <NUMBER> ci values disease shown table <NUMBER> eleven studies included descriptions epidemiological clinical profiles total <NUMBER> cases mortality studies <NUMBER> patients males <NUMBER> females age range <NUMBER> <NUMBER> years among <NUMBER> fatal cases <NUMBER> patients one previous diseases totaling <NUMBER> comorbidities pooled prevalence comorbidities among fatal cases <NUMBER> <NUMBER> ci <NUMBER> weight <NUMBER> two countries analyzed geographical distribution china <NUMBER> <NUMBER> ci <NUMBER> weight <NUMBER> korea <NUMBER> <NUMBER> ci <NUMBER> weight <NUMBER> figure <NUMBER> prevalent comorbidities population hypertension <NUMBER> <NUMBER> ci <NUMBER> weight <NUMBER> diabetes <NUMBER> <NUMBER> ci <NUMBER> weight <NUMBER> heart disease <NUMBER> <NUMBER> ci <NUMBER> weight <NUMBER> copd <NUMBER> <NUMBER> ci <NUMBER> weight <NUMBER> addition diseases patients cerebrovascular accident <NUMBER> cancer <NUMBER> kidney disease <NUMBER> liver disease <NUMBER> <NUMBER> also evaluated pooled prevalence <NUMBER> ci values disease shown table <NUMBER> probability patient comorbidity dying covid<NUMBER> significance associations using fishers exact test calculated number patients comorbidities died survived addition patients without comorbidities died survived used calculate odds ratio <NUMBER> <NUMBER> ci <NUMBER> fishers exact test value p <NUMBER> metaanalysis based <NUMBER> studies including large number descriptions china united states studies conducted india italy united kingdom south korea singapore also analyzed higher prevalence male patients infected covid<NUMBER> observed compared females predisposition male sex also observed diseases merscov sarsco also caused viruses coronavirus family <NUMBER> <NUMBER> pooled prevalence comorbidities general population patients affected new coronavirus covid<NUMBER> <NUMBER> <NUMBER> ci <NUMBER> china country highest prevalence although also studies analyzed country however important highlight two studies united states resulted contrasting prevalence values <NUMBER> <NUMBER> since united states country leads statistics far highest number confirmed cases one million deaths coronavirus seventy thousand may <NUMBER> <NUMBER> utmost importance publish data clinical characteristics disease country results study confirm prevalence comorbidities increases patients clinical conditions worsens general population affected covid<NUMBER> prevalence comorbidities <NUMBER> <NUMBER> among patients admitted icu <NUMBER> among fatal cases males affected three groups hand mean age also increases compare group patients general group fatal cases previously described among risk factors age sex comorbidities <NUMBER> <NUMBER> <NUMBER> <NUMBER> regarding comorbidities three groups analyzed general population admission icu fatal cases hypertension prevalent comorbidity accounting <NUMBER> <NUMBER> <NUMBER> respectively general population diabetes secondmost prevalent <NUMBER> comorbidity followed heart disease <NUMBER> copd <NUMBER> however patients admitted icu diabetes <NUMBER> heart disease <NUMBER> showed similar values phenomenon observed fatal cases diabetes <NUMBER> heart disease <NUMBER> showing similar values considering type <NUMBER> diabetes mellitus usually manifests childhood adolescence type <NUMBER> diabetes frequently manifests adults heart diseases prevalent older patients one may think earlier onset diabetes may account rank second among comorbidities general population affected covid<NUMBER> hand group fatal cases composed predominantly older adults population hypertension diabetes heart disease prevalent odds ratio comorbidity <NUMBER> <NUMBER> ci <NUMBER> statistical significance p <NUMBER> words patient comorbidity <NUMBER> times chance dying covid<NUMBER> compared patient without comorbidity may explain high prevalence comorbidities among fatal cases developing study encountered several limitations firstly studies segregated epidemiological clinical data age sex percentage comorbidity patients hospitalized icu secondly studies classified comorbidities category one study described diseases comprised category thirdly since china primary focus rise pandemic studies included country studies africa oceania latin america found finally metaanalyses recommended publication bias always assessed statistical methods however currently available methods funnel plot egger regression test considered useful tools studies proportions <NUMBER> one conclude existence comorbidities increases probability dying covid<NUMBER> <NUMBER> times compared preexisting conditions relevant comorbidities shown hypertension heart disease diabetes thus comorbidities prevalent group mortality cases compared general population group however conclusions based evidence obtained mostly studies conducted china reason studies describing epidemiological clinical profiles covid<NUMBER> cases africa oceania latin america recommended clarify behavior disease regions thus able apply effective measures aimed safeguarding populations risk oae asz contributed create design study analyze interpret data write first final version manuscript efa fgl tam pfb contributed analyze data wrote first version manuscript authors approved final version manuscript responsible aspects work including ensuring accuracy integrity provide explicit statement questions addressed reference participants interventions comparisons outcomes study design picos methods review question indicate review protocol exists accessed eg web address available provide registration information including registration number specify study characteristics eg picos length followup report characteristics eg years considered language publication status used criteria eligibility giving rationale information sources <NUMBER> describe information sources eg databases dates coverage contact study authors identify additional studies search date last searched state process selecting studies ie screening eligibility included systematic review applicable included metaanalysis data collection process <NUMBER> describe method data extraction reports eg piloted forms independently duplicate processes obtaining confirming data investigators data items <NUMBER> list define variables data sought eg picos funding sources assumptions simplifications made methods data extractionquality assessment describe methods used assessing risk bias individual studies including specification whether done study outcome level information used data synthesis additional file figure s<NUMBER> additional file figure s<NUMBER> describe methods additional analyses eg sensitivity subgroup analyses metaregression done indicating prespecified give numbers studies screened assessed eligibility included review reasons exclusions stage ideally flow diagram study characteristics <NUMBER> study present characteristics data extracted eg study size picos followup period provide citations table <NUMBER> risk bias within studies <NUMBER> present data risk bias study available outcome level assessment see item <NUMBER> additional file figure s<NUMBER> figure s<NUMBER> outcomes considered benefits harms present study simple summary data intervention group b effect estimates confidence intervals ideally forest plot results additional file figure s<NUMBER> give results additional analyses done eg sensitivity subgroup analyses metaregression see item <NUMBER> summarize main findings including strength evidence main outcome consider relevance key groups eg healthcare providers users policy makers discuss limitations study outcome level eg risk bias reviewlevel eg incomplete retrieval identified research reporting bias discussion provide general interpretation results context evidence implications future research conclusion describe sources funding systematic review support eg supply data role funders systematic review na figure s<NUMBER> methodological quality summary bias risk concern applicability study methodological quality summary bias risk concern applicability across included studies december <NUMBER> new coronavirus causing severe acute respiratory syndrome sarscov<NUMBER> emerged wuhan china virus spread rapidly <NUMBER> countries time writing march <NUMBER>th <NUMBER> affected <NUMBER> individuals causing almost <NUMBER> deaths <NUMBER> suggested diabetes mellitus one common comorbidities infected people exact prevalence unclear show results metaanalysis studies reporting prevalence diabetes among people infected sarscov<NUMBER> impact disease severity progression retrieved <NUMBER> studies reporting data <NUMBER> chinese patients confirmed sarscov<NUMBER> infection data supplement mean age <NUMBER> years prevalence diabetes <NUMBER> fig <NUMBER>a comparison nationwide prevalence diabetes china <NUMBER> <NUMBER> overall <NUMBER> among people aged <NUMBER> <NUMBER> march <NUMBER>th <NUMBER> italy second country affected sarscov<NUMBER> n <NUMBER> individuals confirmed sarscov<NUMBER> university hospital padova located centre outbreak among <NUMBER> hospitalized patients confirmed sarscov<NUMBER> infection mean age <NUMBER> years <NUMBER> preexisting diabetes yielding prevalence <NUMBER> <NUMBER> ci <NUMBER> comparison prevalence diabetes region <NUMBER> <NUMBER> overall <NUMBER> among people aged <NUMBER> years mean <NUMBER> <NUMBER> relatively low prevalence diabetes among sarscov<NUMBER> infected people could due underreporting chance biological phenomenon dipeptidyl peptidase<NUMBER> dpp<NUMBER> discovered receptor middleeast respiratory syndrome coronavirus sarscov<NUMBER> appears use preferentially angiotensinconverting enzyme <NUMBER> enter cell <NUMBER> however since dpp<NUMBER> inhibitors popular glucoselowering medications worldwide interest explore whether might protect sarscov<NUMBER> infection six metaanalysed studies chinese patients reported prevalence diabetes according disease severity outcome n <NUMBER> patients pooled rate ratio diabetes among patients adverse disease course compared favourable course <NUMBER> <NUMBER> ci <NUMBER> fig <NUMBER>b supplemental table <NUMBER> march <NUMBER>th median age <NUMBER> italian patients died infected sarscov<NUMBER> <NUMBER> iqr <NUMBER> <NUMBER> men among <NUMBER> deceased patients available information comorbidities diabetes prevalence <NUMBER> <NUMBER> <NUMBER> diabetes prevalence among italian citizens age range sex distribution <NUMBER> <NUMBER> thus rate ratio diabetes among patients died sarscov<NUMBER> infection compared general population <NUMBER> based data conclude diabetes may increase risk sarscov<NUMBER> infection worsen outcome new coronavirus disease finding consistent association diabetes excess mortality acute chronic condition including infections <NUMBER> situation rapidly evolving close monitoring data important correct communication patients healthcare providers fig <NUMBER> review riddell colleagues httpsdoiorg<NUMBER> s<NUMBER> specifically focus competitive athlete type <NUMBER> diabetes explain challenges athletes type <NUMBER> diabetes face trying maintain normal glucose levels training travel competition challenges may overcome use insulin pumps continuous glucose monitors addition discuss adjustment carbohydrate intake improve performance athletes type <NUMBER> diabetes exercise training also improve glycaemic control individuals type <NUMBER> diabetes known training regime likely elicit benefit regards review savikj zierath httpsdoiorg<NUMBER>s<NUMBER> discuss exercise type intensity modality affects impact exercise glycaemic control individuals type <NUMBER> diabetes also discuss impact nutritional status exerciseassociated benefits indicating training low carbohydrate availability may improve cardiorespiratory function skeletal muscle oxidative capacity vs conventional training conclude like competitive athletes individuals type <NUMBER> diabetes encouraged adopt training regimens improve fitness metabolism figures reviews available downloadable slideset gemmink et al slideset thyfault bergouignan slideset riddell et al slideset savikj zierath slideset competition publication diabetologia continues grow less <NUMBER> papers accepted highquality papers appear months issue want draw attention articles think particularly interesting articles summarised publisher springer kindly made full text papers freely available hope enjoy reading diabetes shown major comorbidity affects severity coronavirus disease<NUMBER> however precise data regarding diabetes characteristics prognostic relevance inpatients covid<NUMBER> still lacking issue cariou hadjadj wargny et al httpsdoiorg<NUMBER> s<NUMBER>x report first results coronavirus sarscov<NUMBER> diabetes outcomes coronado study observational multicentric <NUMBER> centres french nationwide study prespecified design protocol coronado study aims explore phenotypes diabetic individuals covid<NUMBER> authors found patients diabetes requiring hospital admission covid<NUMBER> likely elderly mean age <NUMBER> years <NUMBER> ≥<NUMBER> years old male <NUMBER> commonly type <NUMBER> <NUMBER> type <NUMBER> diabetes <NUMBER> one ten patients <NUMBER> died day <NUMBER> following hospital admission age advanced diabetic complications independently associated mortality day <NUMBER> admission thus people profile follow rules avoid infection severe acute respiratory syndrome coronavirus<NUMBER> sarscov<NUMBER> addition severe forms covid<NUMBER> associated macrovascular complications indicated previously also microvascular complications established first time study longterm glycaemic control hba <NUMBER>c showed obvious association prognosis however increased bmi appeared independent prognostic factor covid<NUMBER> severity hence authors suggest individuals high bmi require special attention complex interaction fasting glucose body mass index age sex allcause mortality cohort study <NUMBER> million korean adults lean diabetes diabetes people low bmi <NUMBER> kg <NUMBER> emerging pathological condition associated higher mortality risk excessive weight grade obese diabetes however clear whether low bmi hyperglycaemia joint effect mortality whether combined associations fasting glucose levels bmi mortality differ age sex issue jung et al https doiorg<NUMBER>s<NUMBER> use korean cohort study report <NUMBER> adverse effects hyperglycaemia mortality risk marked leaner overweight individuals particularly young men middleaged women <NUMBER> interpretation mortality risk associated fasting blood glucosebmi subgroups straightforward complex interactions fasting glucose bmi age sex example people fasting glucose level <NUMBER> mmoll lower normal weight bmi <NUMBER> kgm <NUMBER> similar higher mortality risk people fasting glucose level <NUMBER> mmoll bmi ≥<NUMBER> kgm <NUMBER> obese people diabetes higher mortality risk overweight people diabetes authors state study calls sophisticated management patients according detailed metabolic profiles individual including fasting glucose bmi well sex age achieve better health outcomes luciana mateus gonçalves elizabeth pereira joão pedro werneck de castro ernesto bernalmizrachi joana almaça vascular fibrosis common lesion islets individuals type <NUMBER> diabetes aetiology yet determined mouse models enable us study role dysfunctional islet microvasculature diabetes pathogenesis available issue mateus gonçalves et al httpsdoiorg<NUMBER>s<NUMBER> report transgenic mouse model beta cell expansion akttg mouse exhibits increased deposition extracellular matrix proteins around islet blood vessels allowing study cellular mechanisms lead islet vascular fibrosis functional consequences found islet pericytes proliferated extensively model converted profibrotic myofibroblasts vascular alterations associated diminished islet blood perfusion impaired islet vascular responses noradrenaline glucose led decrease glucosestimulated insulin secretion per beta cell unit transgenic mice authors conclude akttg mouse model used conduct studies aimed elucidating role insulin beta cell secretory products determining number phenotype function islet pericytes state elucidating crosstalk pericytes beta cells necessary fully understand pathogenesis islet adaptation diabetes coronaviridae family several members continuously circulate among humans lead mild respiratory diseases <NUMBER> contrast severe acute respiratory syndrome novel sarscov emerged wuhan china patients pneumonia identified sars pathogen virus denoted severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> disease denoted covid<NUMBER> typical symptoms covid<NUMBER> illness onset fever dry cough myalgia dyspnea <NUMBER> patients might suffer headaches dizziness diarrhea nausea vomiting however people underlying diseases hypertension diabetes cardiovascular disease may develop severe neurological disorders including acute cerebrovascular disease <NUMBER> <NUMBER> <NUMBER> based clinical data advised caution covid<NUMBER> infection among smokers patients underlying clinical symptoms including cardiovascular disease <NUMBER> zhou et al reported sarscov<NUMBER> shares receptor ace<NUMBER> sarscov <NUMBER> however use another coronavirus receptor dipeptidyl peptidase <NUMBER> dpp<NUMBER> whereas merscov <NUMBER> increasing evidence supports idea sprotein sarscov<NUMBER> binds ace<NUMBER> studies suggest cellular entry sarscov<NUMBER> mediated ace<NUMBER> since sarscov<NUMBER> infection causes severe lung injury sarscov<NUMBER> virus may use ace<NUMBER> expressed pneumocytes epithelial alveolar lining infect subjects however increasing clinical studies shown sarscov<NUMBER> observed organs endothelial dysfunction <NUMBER> also postmortem brain <NUMBER> since cells express ace<NUMBER> potentially risk sarscov<NUMBER> infection ace<NUMBER> expression profiling various conditions brain help understand process covid<NUMBER> cardiovascular complications including neurological diseases among patients covid<NUMBER> newonset cvd increases individuals risk factors including smoking diabetes chinese center disease control prevention reported covid<NUMBER> patients diabetes higher mortality <NUMBER> south korea kcdc reported april <NUMBER> <NUMBER> deaths occurred <NUMBER> deaths underlying disease among mortality rate covid<NUMBER> patients underlying disease metabolic disease cardiovascular diseases diabetes stroke hypertension <NUMBER> clinical data characterizing patients covid<NUMBER> give evidence cvd risk factors including smoking diabetes likely associated negative progression adverse outcomes covid<NUMBER> <NUMBER> recently high level ace<NUMBER> observed brains smokers <NUMBER> hence consider smoking diabetes might increase ability sarscov<NUMBER> enter infect brain based high expression ace<NUMBER> present study investigated alteration ace<NUMBER> expression brains ischemic stroke well effect cvd risk factors including cse diabetes ace<NUMBER> expression showed ace<NUMBER> expression altered cortex penumbra ischemic injuries addition ace<NUMBER> expression highly increased brain microvessels exposed cse endothelial cells derived patients diabetes antiace<NUMBER> antibody nbp<NUMBER> purchased novus littleton co usa heparin dimethyl sulfoxide dmso bicinchoninic acid chemicals purchased sigma st louis mo usa c<NUMBER>blksj dbdb male mice used type <NUMBER> diabetes mellitus model mice c<NUMBER>blksj male db mice used control mice mice obtained slc hamamatsu japan animal experimental procedures conducted according institutional guidelines care use laboratory animals permission granted kcdcinstitutional animal care use committee kcdciacuc approval number kcdc<NUMBER>a mice <NUMBER> weeks old housed temperatureand humiditycontrolled environment <NUMBER> h lightdark cycle allowed free access water standard mouse chow <NUMBER> weeks <NUMBER>weekold male c<NUMBER>blksj dbdb db mice sacrificed mice anesthetized tissue weighed immediately snapfrozen liquid nitrogen stored <NUMBER> °c analysis primary human brain microvascular endothelial cells hbmvecs obtained cell systems kirkland wa usa maintained csc complete medium <NUMBER> fetal bovine serum fbs gibco carlsbad ca usa <NUMBER> penicillinstreptomycin gibco cultureboost cell systems primary hbmvec cultures used passages <NUMBER> <NUMBER> cells grown attachment factorcoated plates csc complete serumfree medium cell systems m<NUMBER> medium supplemented <NUMBER> fbs <NUMBER> ngml recombinant human fibroblast growth factorbasic fgfb millipore temecula ca usa <NUMBER> uml heparin <NUMBER> penicillinstreptomycin humidified atmosphere <NUMBER> co <NUMBER> <NUMBER> °c healthy diseased human aortic endothelial cells haecs type ii diabetes obtained lonza walkersville md usa cells grown attachment factorcoated plates cell growth medium egm<NUMBER> lonza full supplements egm<NUMBER> bullet kit <NUMBER> fbs <NUMBER> hfgf<NUMBER> <NUMBER> vegf <NUMBER> r<NUMBER>igf<NUMBER> <NUMBER> hegf <NUMBER> hydrocortisone <NUMBER> ascorbic acid <NUMBER> heparin <NUMBER>ga<NUMBER> humidified atmosphere <NUMBER> co <NUMBER> <NUMBER> °c c<NUMBER> astrocyte cells maintained dulbeccos modified eagles medium dmem gibco supplemented <NUMBER> fbs <NUMBER> penicillinstreptomycin cells maintained <NUMBER> °c humidified atmosphere <NUMBER> air <NUMBER> co <NUMBER> cse generated described previously <NUMBER> total particulate matter tpm collected cambridge filter pads final concentration <NUMBER> mgml tpm extracted dmso shaking <NUMBER> min solution filtered stored <NUMBER> ℃ anesthetized ketamine <NUMBER> mgkg xylazine <NUMBER> mgkg body weight mixture surgery occlusion right middle carotid artery induced <NUMBER>h advancing nylon suture <NUMBER> ailee busan korea heatinduced bulb tip <NUMBER> mm diameter along internal carotid artery <NUMBER>mm bifurcation external carotid artery followed reperfusion thermoregulated heating pad heating lamp used maintain rectal temperature <NUMBER>±<NUMBER>°c surgery animals randomly allocated sham mcao groups follows <NUMBER> sham control group animals underwent surgery subjected mcao n<NUMBER> <NUMBER> mcao groups animals subjected mcao sacrificed <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> days postmcao n<NUMBER> mcao group animals sacrificed <NUMBER> <NUMBER> <NUMBER> <NUMBER> days postmcao brain tissues immediately extracted brain tissues containing cortex penumbra two animals used per sample total rna purified using rneasy mini kit qiagen hilden germany according manufacturers instructions total mrnaseq commercially commissioned ebiogen ebiogen seoul south korea brief data generated hiseq x<NUMBER> ngs <NUMBER>g read pairedend sequencing bbduk run obtain read data fastq format tophat used map reads rn<NUMBER> reference transcript genome counted samples reads mapped gene rn<NUMBER> analyzed results differential expression genes exdega ebiogen seoul south korea cells plates washed phosphatebuffered saline pbs lysed radioimmunoprecipitation ripa buffer <NUMBER> nonidet p<NUMBER> <NUMBER> mm nacl <NUMBER> mm trishcl ph <NUMBER> <NUMBER> sodium dodecyl sulfate <NUMBER> mm phenylmethylsulfonyl fluoride <NUMBER> mm na <NUMBER> vo <NUMBER> <NUMBER> μgml leupeptin cell lysate collected centrifugation <NUMBER> rpm <NUMBER> min <NUMBER>°c protein concentrations determined using bicinchoninic acid method equivalent amounts protein separated nupage <NUMBER> <NUMBER> invitrogen carlsbad ca usa gels transferred polyvinylidene difluoride membranes membranes blocked <NUMBER> skim milk trisbuffered saline tbs <NUMBER> tween<NUMBER> incubated primary antibody overnight <NUMBER>°c immune complexes detected using enhanced chemiluminescence system amersham buckinghamshire uk results expressed mean ± se students ttest applied analysis significant differences groups analyze gene expression pattern cerebral ischemic damage performed total mrnaseq cortical penumbra rat transient mcao model fig <NUMBER>a <NUMBER> mapped genes cortical penumbra mcao groups <NUMBER> <NUMBER> <NUMBER> <NUMBER> days post mcao sham control identified <NUMBER> differentially expressed genes degs fold change <NUMBER> sham control mcao group including <NUMBER> <NUMBER> <NUMBER> contraregulated genes fig <NUMBER>b comparing gene sham control mcao groups <NUMBER> <NUMBER> days post mcao gene expressions ace<NUMBER> dpp<NUMBER> cerebral ischemic brain upregulated mcao fig <NUMBER>c heat map cluster analysis degs representing virus receptor activity showed alteration ace<NUMBER> mrna expression ischemic injury validated immunoblotting analysis shown figure <NUMBER>c increase ace<NUMBER> protein levels began <NUMBER> days ischemic injury maximum increase observed <NUMBER> days previous study found cse induces brain inflammation <NUMBER> brain ace<NUMBER> mainly expressed microvessels astrocytes <NUMBER> since recent study showed high expression ace<NUMBER> smoker groups investigated effect cse expression ace<NUMBER> human brain microvessels astrocytes cells treated cse indicated times <NUMBER> <NUMBER> <NUMBER> h shown figure <NUMBER>a ace<NUMBER> protein expression significantly increased cse hbmvec increase also observed astrocytes treated cse fig <NUMBER>b furthermore cse elevated level icam<NUMBER> risk factor bloodbrain barrier bbb disruption hbmvec blood vessel damage found patients type ii diabetes <NUMBER> wondered whether ace<NUMBER> expression altered blood vessels patients diabetes compared ace<NUMBER> levels endothelial cells healthy humans subjects type ii diabetes shown figure <NUMBER> found ace<NUMBER> protein levels slightly significantly increased endothelial cells patients type ii diabetes compared healthy controls using type ii diabetes dbdb mice confirmed ace<NUMBER> expression increased brains mice type ii diabetes data demonstrate ace<NUMBER> functional receptor sarscov<NUMBER> upregulated brain cvd risk factors diabetes cigarette smoke although detailed clinical studies using large populations needed making conclusive claim diabetes patients stroke patients smokers identified groups susceptible sarscov<NUMBER> infection order provide adequate protection care ace<NUMBER> expressed tissues including lungs arteries heart kidneys intestines brain regulates blood pressure hydrolysis angiotensin ii vasoconstrictor angiotentin<NUMBER> vasodilator excessive angiotensin ii activates diverse cellular signaling pathways related inflammation free radical generation recruitment inflammatory cells thus deficiency ace<NUMBER> causes increase angiotensin leads organ injury aberrant production reactive oxidative stress inflammation <NUMBER> ace<NUMBER> deficiency associated exacerbation hypertension cardiac hypertrophy induced angiotensin ii <NUMBER> several studies shown loss ace<NUMBER> involved progression strokes alzheimers disease ad <NUMBER> hypertension <NUMBER> conversely overexpression ace<NUMBER> blocks proinflammatory responsiveness related pathogenesis ad therefore deficiency ace<NUMBER> progression disease may cause unregulated cytokine production suggests smoking diabetes highrisk factors covid<NUMBER> infection led us investigate ace<NUMBER> expression patterns cvd highrisk groups present data showed ace<NUMBER> mrna protein levels gradually increased reoxygenation stroke protein levels significantly increased <NUMBER> days ischemic injury compared sham control fig <NUMBER> study supporting data ace<NUMBER> angiotensin<NUMBER>mas receptor signaling axis activated ischemic stroke ace<NUMBER> expression increased <NUMBER> may play therapeutic role vasodilatation antiinflammatory responses <NUMBER> administration ang <NUMBER> derived ace<NUMBER> reduced improve neurological deficits following ischemic stroke reducing oxidative stress inflammation <NUMBER> <NUMBER> thus present data increased ace<NUMBER> subacute chronic stages ischemic injury likely beneficial effects beyond repairing injured cells lowering blood pressure words indicates ace<NUMBER> levels may elevated brains stroke patients individuals previously experienced stroke however induced ace<NUMBER> expression follows ischemic injuries may lead covid<NUMBER> susceptibility vivo study regulation ace<NUMBER> expression sarscovmediated internalization predicted worsen lung failure <NUMBER> hence stroke patients might need take extra caution covid<NUMBER> pandemic covid<NUMBER> causes newonset cvd individuals risk factors smoking diabetes however date enough evidence know covid<NUMBER> evokes cvd including strokes recent reports suggest possibility covid<NUMBER> triggers inflammation involved pathological progression cvd clot formation blood <NUMBER> blood clotting formed cellular components histones <NUMBER> hmgb<NUMBER> <NUMBER> microparticles <NUMBER> secreted granule proteins <NUMBER> degraded profibrinolytic agents released endothelial cells <NUMBER> thus surface endothelial dysfunctions cellular protein materials congregate produce blood clot consequence <NUMBER> particular regarding disease increase blood clots bbb disruption observed patients type ii diabetes <NUMBER> present data showed increase vascular ace<NUMBER> levels t<NUMBER>d t<NUMBER>d patients compared healthy controls fig <NUMBER> results support possibility cellular entry sarscov<NUMBER> ace<NUMBER> onto vessels makes vessels weaker onset diabetes may disrupt blood supply brain via clot blocking however exact mechanism underlying covid<NUMBER>induced cvd required like diabetes smoking known risk factor cvd well lung diseases including chronic obstructive pulmonary disease copd deleterious effects cse bbb known upregulate inflammationrelated genes including icam<NUMBER> vcam<NUMBER> blood vessels increase icam<NUMBER> vcam<NUMBER> response proinflammatory cytokines plays crucial role adhesion leukocytes including neutrophils macrophages resulting bbb disruption brain inflammation however ace<NUMBER> expression cigarette smoking controversial recent clinical study showed ace<NUMBER> expression increased airways smokers correlates expression α<NUMBER> subtype nicotine acetylcholine receptors <NUMBER> contrast nicotine component cigarette smoking reduced ace<NUMBER> expression primary neurons glial cells cvd <NUMBER> nonetheless study clearly showed upregulation ace<NUMBER> following cse brain endothelial cells astrocytes fig <NUMBER> conditions cse increased icam<NUMBER> protein levels primary human brain vessels fig <NUMBER> furthermore previous study provided evidence cse induces brain inflammation via astrocyte reactivation <NUMBER> taken together results suggest weaker vascular system among covid<NUMBER> patients history smoking makes vulnerable severe symptoms <NUMBER> study demonstrated ace<NUMBER> expression increased brain stroke mouse brain human blood vessels diabetes ace<NUMBER> expression upregulated showed vitro effect cse ace<NUMBER> expression blood vessels finally although vivo relevance data needs verified using human population caution may warranted covid<NUMBER> among individuals underlying diseases strokes diabetes smoking de changes ace<NUMBER> protein levels examined immunoblotting <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> days mcao αtubulin used control tissue lysates prepared asterisked regions figure <NUMBER>a results representative three independent experiments p <NUMBER> p <NUMBER> vs sham control exposure hbmvecs exposed <NUMBER> μgml cse indicated time <NUMBER> <NUMBER> h lysed ripa buffer lysates probed antibodies ace<NUMBER> icam<NUMBER> βactin used loading control lysates b c<NUMBER> cells exposed <NUMBER> μgml cse lysed ripa buffer lysates probed antibodies ace<NUMBER> βactin used loading control lysates since late december <NUMBER> newly recognized novel coronavirus disease caused severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> spread rapidly china around world <NUMBER> according report world health organization may <NUMBER> <NUMBER> total number confirmed cases risen sharply <NUMBER> <NUMBER> countries <NUMBER> <NUMBER> deceased cases <NUMBER> population generally susceptible sarscov<NUMBER> infection however several epidemiological studies described older adults certain underlying diseases vulnerable disease diabetes mellitus dm one frequent comorbidities <NUMBER> <NUMBER> <NUMBER> estimated <NUMBER> million adults living diabetes worldwide <NUMBER> individuals higher risk infection may worse outcomes population without diabetes infected <NUMBER> <NUMBER> previous studies demonstrated diabetes independent risk factor mortality patients severe acute respiratory syndrome coronavirus sarscov pandemic influenza h<NUMBER>n<NUMBER> middle east respiratory syndrome coronavirus merscov <NUMBER> <NUMBER> <NUMBER> angiotensinconverting enzyme <NUMBER> ace<NUMBER> functional receptor sarscov expressed pancreatic islets among others aggravate diabetes progression <NUMBER> notably sarscov<NUMBER> also bind target cells ace<NUMBER> affinity <NUMBER> <NUMBER> times higher sarscov <NUMBER> therefore covid<NUMBER> patients diabetes might higher disease severity poor prognosis however available information regarding covid<NUMBER> patients diabetes inadequate present hence study aimed analyze detailed clinical characteristics laboratory findings hrct features explore risk factors inhospital death complications covid<NUMBER> patients diabetes retrospective cohort study carried two hospitals hubei province china wuhan union hospital tongji medical college jinyintan hospital patients preexisting diabetes diagnosed sarscov<NUMBER> pneumonia according interim guidance <NUMBER> died discharged hospital dec <NUMBER> <NUMBER> apr <NUMBER> <NUMBER> included study study approved institutional review boards two hospitals informed consent waived retrospective study admission data obtained patients electronic medical records reviewed two physicians jin gu yue cui information extracted included demographic data exposure history comorbidities symptoms treatments inhospital complications outcomes laboratory results chest ct images based fasting blood glucose fbg levels admission two groups patients designated group <NUMBER> fbg ≤<NUMBER>mmoll group <NUMBER> fbg <NUMBER>mmoll primary outcomes included intensive care unit icu entry inhospital death secondary outcomes inhospital complications including sarscov<NUMBER>related ards acute cardiac injury acute kidney injury secondary infection ards diagnosed based guidance covid<NUMBER> <NUMBER> acute cardiac injury identified serum highsensitivity cardiac troponin level upper limit <NUMBER> th percentile reference <NUMBER> acute kidney injury diagnosed according clinical practice guidelines kdigo <NUMBER> secondary infection identified patient positive culture new pathogen obtained lower respiratory tract specimens blood samples admission <NUMBER> chest ct scans obtained using either following ct scanners somatom definition somatom spirit somatom perspective siemens healthineers forchheim germany parameters used scanning protocol described previous study <NUMBER> initial ct images assessed three radiologists heshui shi jin gu yanqing fan <NUMBER> years experience thoracic radiology predominant three ct findings included ground glass opacity ggo crazypaving pattern consolidation ct characteristics described basis previous studies covid<NUMBER> patients <NUMBER>， <NUMBER> extent pulmonary involvement abnormalities lung lobe evaluated using semiquantitative scoring system <NUMBER> ct score three findings <NUMBER> lung lobes scored <NUMBER> <NUMBER> total score <NUMBER> lobe scored follows <NUMBER> involvement <NUMBER> ≤<NUMBER> involvement <NUMBER> <NUMBER> involvement <NUMBER> <NUMBER> involvement <NUMBER> <NUMBER> involvement <NUMBER> <NUMBER> involvement kolmogorovsmirnov test used check normality data expressed mean ± sd median iqr n normally nonnormally continuous variables categorical variables respectively differences two groups stratified fbg assessed using independentsample students test mannwhitney test χ² test fishers exact test appropriate univariate multivariate logistic regression models used explore risk factors associated inhospital death complications twosided p value <NUMBER> considered statistically significant analyses performed using spss software version <NUMBER> ibm chicago il usa dec <NUMBER> <NUMBER> apr <NUMBER> <NUMBER> total <NUMBER> consecutive confirmed covid<NUMBER> patients diabetes admitted hospital <NUMBER> excluded due lack serum glucose test results <NUMBER> excluded missing ct images key information medical records table <NUMBER> study cohort median age <NUMBER> years iqr <NUMBER> <NUMBER> <NUMBER> patients male <NUMBER> patients <NUMBER> type <NUMBER> diabetes median disease duration <NUMBER> years iqr <NUMBER> common symptoms onset fever <NUMBER> <NUMBER> cough <NUMBER> <NUMBER> followed shortness breath <NUMBER> sputum <NUMBER> median time onset symptoms hospital admission <NUMBER> days iqr<NUMBER> half patients least one comorbidity hypertension common <NUMBER> followed cardiovascular <NUMBER> cerebrovascular diseases <NUMBER> among <NUMBER> patients <NUMBER> <NUMBER> patients received high flow nasal cannula oxygen therapy <NUMBER> <NUMBER> patients needed noninvasive respiratory support <NUMBER> <NUMBER> patients required endotracheal intubation addition patients received antiviral <NUMBER> antibiotic treatments <NUMBER> patients taken corticosteroids <NUMBER> intravenous immunoglobulin <NUMBER> antifungal agents <NUMBER> compared group<NUMBER> patients group <NUMBER> likely need systematic corticosteroid treatment fever sputum longer disease duration lower oxygen saturation significant differences age gender characteristics table <NUMBER> admissionlaboratory test results patients subgroups presented table <NUMBER> patients abnormal ct imaging features presented table <NUMBER> according semiquantitative scoring system median total ct score pulmonary involvement <NUMBER> iqr <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> compared group <NUMBER> patients group <NUMBER> higher total ct score <NUMBER> iqr <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> vs <NUMBER> iqr <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> p <NUMBER> figure <NUMBER> f ct score left upper lobe bilateral lower lobes group <NUMBER> patients also greater patients group <NUMBER> significant differences baseline ct characteristics mentioned table <NUMBER> compared group <NUMBER> patients group <NUMBER> higher death rate <NUMBER> vs <NUMBER> p <NUMBER> likely require icu care <NUMBER> vs <NUMBER> p <NUMBER> inhospital complications including ards <NUMBER> vs <NUMBER> p <NUMBER> acute cardiac injury <NUMBER> vs <NUMBER> p <NUMBER> risk factors associated inhospital death complications shown supplemental table s<NUMBER> according univariable analysis admission glucose absolute lymphocyte count ddimer associated increased risk inhospital death complications total ct score pulmonary involvement white blood cell count albumin ldh myoglobin highsensitivity troponin procalcitonin also associated odds inhospital complications considering relatively small number inhospital deaths n<NUMBER> complications n <NUMBER> study avoid overfitting model chosen age hypertension total ct score pulmonary involvement median age covid <NUMBER> <NUMBER> fever cough common symptom consistent previous reports <NUMBER> <NUMBER> recent multicentered study showed patients fbg <NUMBER> mmoll multiple organ injury higher mortality rate individuals fbg levels <NUMBER> <NUMBER> mmoll <NUMBER> similarly study patients poorlycontrolled fbg <NUMBER>mmoll greater incidence acute cardiac injury ards icu entry higher death rate fbg ≤<NUMBER> mmoll additionally previous study reported plasma glucose level independent predictor morbidity mortality sars <NUMBER> present study showed fbg <NUMBER>mmoll associated increased risk death complications covid<NUMBER> patients diabetes similarly large cohort study kornum et al <NUMBER> found admission fbg <NUMBER>mmoll predictor mortality type <NUMBER> diabetic patients communityacquired pneumonia cap proposed hyperglycemia may impair normal endothelial function hinder phagocytosis delay chemotaxis reduce microbiocidal capacity <NUMBER> <NUMBER> <NUMBER> abnormalities prone progress glucose level greater <NUMBER> mmoll improved better glycemic control <NUMBER> <NUMBER> <NUMBER> recent publication covid<NUMBER> patients showed although glucose level higher admission subsequently decreased continued increase deceased patients <NUMBER> therefore timely blood glucose testing better glycemic control play key role covid<NUMBER> patients prognosis described recent studies <NUMBER> <NUMBER> <NUMBER> <NUMBER> coagulation abnormalities common severe covid<NUMBER> patients marked elevated ddimer concentrations study ddimer ≥<NUMBER> μgml associated higher odds death similar previous report <NUMBER> state hypoxia severe pneumonia lead hypercoagulable state blood activating exogenous coagulation pathway also stimulate thrombus formation increasing blood viscosity <NUMBER> addition chronic hyperglycemia cause vascular injury oxidative stress inflammation lead formation atherosclerosis thrombus <NUMBER> therefore severe sarscov<NUMBER> infection diabetes likely cause coagulopathy resultant poor outcome present study found hrct score ≥<NUMBER> associated increased odds inhospital complications ct important inspection tool covid<NUMBER> score lesions involvement lung correlated histopathology <NUMBER> study patients fbg <NUMBER> mmoll significantly higher ct score fbg ≤<NUMBER> mmoll present study several limitations first retrospective study findings might limited small sample size second laboratory results missing electronic medical records may led selection bias identifying risk factors adverse outcomes third study assess nondiabetic patients since numerous descriptive studies clinical imaging characteristics general population conclusion study suggested covid<NUMBER> patients poorlycontrolled fbg <NUMBER>mmoll worse outcomes admission fbg <NUMBER>mmoll risk factor death complications covid<NUMBER> patients diabetes elevated ddimer hrct score also contributed adverse outcomes findings may provide useful information management special population guide strategies targeted intervention improve prognosis data expressed n mean sd median iqr p values reflect comparisons group <NUMBER> group <NUMBER> supplemental lockdown implemented covid<NUMBER> coronavirus disease <NUMBER> pandemic caused sarscov<NUMBER> severe acute respiratory syndrome coronavirus <NUMBER> <NUMBER> may slowed progression disease caused restriction movement resulting decreased exercise also dietary indiscretion patients type <NUMBER> diabetes <NUMBER> <NUMBER> previously reported impact lockdown worsening glycated hemoglobin hba<NUMBER>c associated complications type <NUMBER> diabetes mellitust<NUMBER>dm <NUMBER> probably due restriction movement limited exercise improper diet psychological stress <NUMBER> lack exercise improper diet caused poor availability healthy food may lead significant weight gain important note patients covid <NUMBER> obesity associated worse inhospital outcomes mortality rates requirement mechanical ventilation increased presence obesity patients diagnosed covid<NUMBER> <NUMBER> <NUMBER> generated data patients type <NUMBER> diabetes paucity data apparently nondiabetic population indications unhealthy weight gain especially children imposed restrictions akin weight gain seen summer recess <NUMBER> important gather data nondiabetic adults assess risk developing t<NUMBER>dm comorbidities associated especially important asian indians rate conversion t<NUMBER>dm prediabetes state higher whites <NUMBER> increment number patients diabetes india would catastrophic addition large pool patients analysis therefore undertaken estimate risk diabetes due lockdown baseline demographic clinical examination parameters collected online <NUMBER> household members t<NUMBER>d patients registered tertiary care diabetes centre <NUMBER> <NUMBER> days lockdown telephonic interviews conducted trained diabetes educator predesigned questionnaire people household known patient t<NUMBER>dm follow total interview time <NUMBER> minutes individual refused interview approached importantly none individuals documented history t<NUMBER>d data prior lockdown <NUMBER> days postlockdown collected file comma separated values csv format twoprong analytical strategy undertaken first phase involved performing simple demographic analysis looking individual risk parameters second phase involved analyzing impact lockdown weight well risk developing t<NUMBER>d risk developing diabetes based validated american diabetes association risk score table <NUMBER> components risk score age sex history gestational diabetes first degree relative diabetes selfreported hypertension selfreported physical activity bmi variables identified using value score combined score ≥<NUMBER> considered significant risk t<NUMBER>d undergo screening analysis performed using xlstat statistical software windows <NUMBER> <NUMBER> bits usa <NUMBER> score ≥<NUMBER> indication diabetes screening data hundred healthy individuals analyzed sequential fashion singlecentre data collection electronically <NUMBER>kg<NUMBER> kg increase weight <NUMBER> individuals figure<NUMBER> <NUMBER> recruited population weight gain range <NUMBER> kg weight remained unchanged <NUMBER> population varying degree weight loss <NUMBER> individuals figure <NUMBER> risk score diabetes calculated using bmi <NUMBER> population diabetes risk score increased baseline <NUMBER> remained unchanged figure<NUMBER> <NUMBER> population risk score decreased chance crossing total score <NUMBER> hence higher risk developing t<NUMBER>d <NUMBER> table <NUMBER> individuals recruited analysis predominantly young <NUMBER> <NUMBER> years age female gender <NUMBER> figure<NUMBER> males higher risk t<NUMBER>dm females individuals age <NUMBER> years risk age <NUMBER> years associated increased risk t<NUMBER>dm per decade individuals <NUMBER> years age comprising <NUMBER> population highest risk designated risk score <NUMBER> history t<NUMBER>d firstdegree relatives present <NUMBER> population also considered risk score <NUMBER> comparison figure <NUMBER> <NUMBER> individuals exercised least <NUMBER> days week <NUMBER> group risk developing t<NUMBER>d score <NUMBER> <NUMBER> percent group obese baseline <NUMBER> days lockdown <NUMBER> cohort gained weight <NUMBER> gaining <NUMBER> <NUMBER> kg weight baseline <NUMBER> individuals bmi greater <NUMBER> kgm <NUMBER> study show increased risk development t<NUMBER>dm apparently nondiabetic individuals predominantly ascribed weight gain covid<NUMBER> pandemic weight gain hold paramount importance individual current era first increases risk t<NUMBER>dm hypertension dyslipidemia furthermore increases mortality risk covid<NUMBER> previously research focusing enhanced risk diabetes lockdown particularly important india asian indians heightened propensity develop t<NUMBER>dm <NUMBER> adequate data implicating weight gain significant factor development metabolic disorders weight gain background obesity results expansion visceral fat resulting activation inflammatory response adipocytes <NUMBER> also inverse relationship body mass index brown adipose tissue bat increase bmi baseline results decrease bat consequent increase white adipose tissues wat responsible worsening insulin resistance associated metabolic complications another study group showed marked decrease physical activity increased intake carbohydrates snacking reasons could add weight gain destabilize metabolism <NUMBER> ford et al documented <NUMBER>kg weight gain baseline could result <NUMBER> increased risk developing t<NUMBER>d <NUMBER> addition gaining weight background preexisting obesity could increase risk t<NUMBER>dm <NUMBER> indicating risk t<NUMBER>d increases continuously per every kilogram weight gained <NUMBER> adverse impact weight gain study documented <NUMBER> us adults followed period <NUMBER> years addition robust evidence illustrating weight loss effective means preventing t<NUMBER>dm prediabetic stage collectively information accentuates need aggressively pursue weight control prevent t<NUMBER>d <NUMBER> stated previously analysis first india globally document impact externally imposed restrictive lifestyle weight effects weight gain risk developing t<NUMBER>d findings indicate immediate need address important aspect table <NUMBER> summary weight diabetes risk score data preand postlockdown bmi body mass index ada american diabetes association diabetes risk additional <NUMBER> increase highrisk diabetes score could add substantially patients t<NUMBER>dm increase burden complications spelling disastrous consequences health beleaguered economy nation <NUMBER> addition also expect increase weight gainrelated morbidities hypertension dyslipidemia cardiovascular disease exacerbating epidemic noncommunicable diseases india present cohort since individuals relatives t<NUMBER>d patients registered recruiting clinic based risk profile blood glucose monitoring assessment t<NUMBER>d done phasewise manner later absence evidence hypothesis investigated difficulty collecting data current scenario first best available data addition baseline age gender distribution cohort matches demographics country thereby degree generalization findings could permitted finally importantly since indian diabetes risk score required measurement waist circumference possible conduct due technical difficulties bmi cutoff measured higher indian criteria suggesting estimates underestimated rather overestimation scenario acceptable limitation risk overestimation major challenge analyzing smaller populations single centre study conducted tertiary centre hence reproducibility automatically assumed without larger multicentric studies moreover diabetes risk assessment identifies atrisk necessarily diabetes hence assumed increment t<NUMBER>d prevalence provide conclusive evidence risk assessment followed blood glucose measurement done study addition small number patients studied could skewed data finally indian diabetes risk score would appropriate instead ada criteria due difference criteria defining obesity based bmi weight gain important determinant far development worsening metabolic disorders concerned lockdown implemented sarscov<NUMBER> pandemic may negatively impact weight predispose individuals risk metabolic decompensation analysis first document weight gain period <NUMBER> days post lockdown along tendency towards increased risk developing type <NUMBER> diabetes novel coronavirus disease covid <NUMBER> rampage ever since outbreak december <NUMBER> wuhan china date disease affected <NUMBER> million people inflicting <NUMBER> casualties <NUMBER> nations worldwide <NUMBER> although overall mortality rate covid<NUMBER> ranges <NUMBER> <NUMBER> <NUMBER> <NUMBER> patients underlying comorbidities like diabetes mellitus dm tend severe disease acute respiratory distress syndrome ards increased mortality <NUMBER> <NUMBER> people type <NUMBER> diabetes mellitus t<NUMBER>dm type <NUMBER> diabetes mellitus t<NUMBER>dm high risk poor outcomes covid<NUMBER> <NUMBER> thus people dm need overly cautious amid ongoing pandemic must stringently follow social distancing ensure proper hand hygiene maintain good glycemic control avoid contracting disease <NUMBER> <NUMBER> <NUMBER> however peoples adherence control measures largely affected awareness disease means preventing proper awareness likely translate effective preventive practices however crosssectional survey conducted among <NUMBER> adults one underlying chronic conditions nearly onethird participants could correctly identify symptoms covid<NUMBER> ways prevent infection <NUMBER> nationwide lockdowns imposed governments world made things difficult people dm recent study china shown elderly subjects t<NUMBER>dm experienced worsening glycemic control ongoing covid<NUMBER> pandemic manifesting higher fasting blood glucose limitation physical activity altered diet restricted availability antidiabetic medications stress due lockdown lack inclinic followups could contributing factors <NUMBER> dietary adherence physical activity cornerstones management t<NUMBER>dm well <NUMBER> <NUMBER> besides stress frequency clinic visits important predictors glucose control people t<NUMBER>dm <NUMBER> <NUMBER> thus aforementioned factors could resulted suboptimal glucose control elderly individuals t<NUMBER>dm might also play role contributing worsening glycemic profile people t<NUMBER>dm amid lockdown present study conducted intent assess awareness amongst young adults t<NUMBER>dm regarding covid<NUMBER> problems faced amid ongoing lockdown india telephonebased narrative interviews crosssectional survey conducted april <NUMBER> <NUMBER> may <NUMBER> <NUMBER> amid nationwide lockdown india feasible perform communitybased facetoface survey period conducted telephonebased qualitative interview study young adults t<NUMBER>dm similar qualitative interview studies used past assess experiences perceptions behaviors psychosocial aspects people living diabetes mellitus <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> although telephonebased qualitative interview generally considered inferior inperson interviews <NUMBER> using telephone qualitative interviews carries logistic practical advantages improved access geographically dispersed interviewees reduced costs increased interviewer safety <NUMBER> besides methodological strengths telephonebased qualitative interviews include perceived anonymity increased privacy respondents reduced distraction interviewees selfconsciousness interviewers interviewers take notes interviews <NUMBER> <NUMBER> <NUMBER> moreover telephone interviews may less intrusive compared facetoface interviews thereby confer greater control interviewees terms negotiating interviews suit schedules well rescheduling interrupting ending interview <NUMBER> <NUMBER> young adults t<NUMBER>dm selected database maintained aditi association diabetes tricity north indiabased social support group working children adolescents young adults t<NUMBER>dm north india inclusion criteria age ≥<NUMBER> years ≤<NUMBER> years residence union territory chandigarh north india diagnosis t<NUMBER>dm least <NUMBER> year back last followup least within prior <NUMBER> months ability understand speak english hindi punjabi local language aditi uptodate database comprising <NUMBER> people t<NUMBER>dm amongst <NUMBER> people young adults aged <NUMBER> years <NUMBER> young adults t<NUMBER>dm residing chandigarh fulfilling inclusion criteria choose <NUMBER> patients purposive sampling based chronology enrolment aditi database demographic characteristics treatmentrelated details participants retrieved aditi database actual interview participants called explained details study verbal consent participation obtained elucidating fact participation entirely voluntary anonymity confidentiality would strictly maintained participants providing positive consent asked availability spare time upcoming <NUMBER> days preferred language future communication subsequently called particular date time final telephonic interview additional permission recording call taken every participant study approved institute ethics committee two members research team uy av fluency english hindi punjabi conducted interviews uy av trained interviewing received regular feedback rp skb interview conduct data collection based recordings average <NUMBER> interviews conducted per day interview lasting <NUMBER>−<NUMBER> min interviews narrative participants asked <NUMBER> openended questions five pertaining awareness covid<NUMBER> included knowledge covid<NUMBER> modes transmission symptoms additional risks associated covid<NUMBER> patient diabetes means protection covid<NUMBER> rest <NUMBER> questions catered problems patients facing concerning dietary adherence physical activity ongoing treatment result prevailing lockdown participants allowed answer question freely without interruption interviewer participant completed answering one question hisher due permission interviewer would move onto next question first two interviews served pilot interviews reconfirmed order questions would presented audience interviews recorded initially transcribed interviewers uy av native language interview verbatim transcripts translated english prior content analysis throughout process data collection conducted interim analyses gain understanding potential saturation responses thus conclusion data collection transcripts analyzed manually using qualitative content analysis <NUMBER> <NUMBER> transcript read several times relevant parts extracted employed primary question overarching category deductive coding broad categories broken subcategories based findings emerged analyses transcripts inductive coding answers question bearing meaning content assembled ascribed common code initially uy analyzed transcripts generate initial series codes <NUMBER> primary questions next rp skb independently coded interviews reviewed transcripts well codes assigned uy analyses discussed consensus meetings uy rp skb differences interpretation discussed resolved thereafter second round analyses independently undertaken uy rp skb wherein ascribed codes reviewed followed final discussion among team members initially selected <NUMBER> young adults t<NUMBER>dm aditi database three individuals provide consent hence total <NUMBER> participants interviewed however two interviews excluded due poor recording quality thus <NUMBER> interviews finally contentanalyzed characteristics participants detailed table <NUMBER> mean age ±sd participants <NUMBER> ± <NUMBER> years range <NUMBER> years malefemale ratio <NUMBER> participants literate <NUMBER> educated <NUMBER>th standard median duration t<NUMBER>dm <NUMBER> years interquartile range <NUMBER> years mean hba <NUMBER>c ±sd participants estimated least last <NUMBER> months <NUMBER> ± <NUMBER> mean ±sd duration interview <NUMBER> ± <NUMBER> min codes ascribed <NUMBER> primary questions frequency please cite article press r pal et al awareness regarding covid<NUMBER> problems faced young adults type <NUMBER> diabetes mellitus amid nationwide lockdown india qualitative interview study prim care diab <NUMBER> httpsdoiorg<NUMBER>jpcd<NUMBER> longacting insulin analogue regular insulin <NUMBER> <NUMBER> longacting insulin analogue rapidacting insulin analogue <NUMBER> <NUMBER> ultra longacting insulin analogue rapidacting insulin analogue <NUMBER> <NUMBER> longacting insulin analogue ultra rapidacting insulin analogue <NUMBER> <NUMBER> use metformin <NUMBER> <NUMBER> participants response matching code summarized tables <NUMBER> <NUMBER> following findings emerged data participants said coronavirus diseasecovid<NUMBER> viral disease classified pandemic respiratory disease highly contagious disease fatal disease one participant described disease originated wuhan initial source infection bats another participant narrated disease caused laboratorymade virus majority participants <NUMBER> said coronavirus spreads via inhalation respiratory droplets forty percent participants described fomites mode transmission however <NUMBER> participants <NUMBER> could recount respiratory droplets fomites potential modes transmission commonly encountered response fever <NUMBER> followed cough cold difficulty breathing tiredness cough characterized dry <NUMBER> participants <NUMBER> <NUMBER> participants <NUMBER> mention three cardinal symptoms namely fever cough difficulty breathing one participant mention loss smell taste symptom well two participants <NUMBER> aware symptoms seven participants <NUMBER> aware additional risks associated covid<NUMBER> patients diabetes mellitus twenty participants <NUMBER> opined patients diabetes mellitus increased risk infection coronavirus twelve believed weak immune system persons diabetes mellitus underlying reason <NUMBER> participants correct knowledge stated patients diabetes mellitus increased risk complications respiratory problems fatal outcomes get infected coronavirus participants believed staying indoors maintaining social distancing wearing facemasks going outside regular hand washing soap water regular use hand sanitizers necessary precautions required protect coronavirus infection total <NUMBER> participants <NUMBER> mentioned <NUMBER> major modes protection namely staying indoors maintaining social distance regular hand wash soap water importance touching ones face pointed one participant one participant felt need good glucose control ward infection ninety percent participants recounted diet remained unaltered amid prevailing circumstances one believed diet improved getting homecooked food time <NUMBER> participants believed ongoing lockdown brought changes routine diet one coexisting celiac disease able procure glutenfree oats another participant worried able get usual fruits namely papaya guava golden apple low glycemic indices however feel need fruits boost immune system hence replace readily available like watermelon ripe bananas high glycemic indices lockdown affected routine physical activityexercise schedule lockdown <NUMBER> participants performing form physical activity ranging yoga walk outdoor games resistance exercises gym interviewed participants <NUMBER> said routine physical activityexercise reduced amid lockdown amongst participants <NUMBER> resorted form physical activity like walking terrace garden front house wearing masks however believed duration intensity physical activity got reduced ten participants <NUMBER> admitted performing form physical activity ever since commencement lockdown <NUMBER> female participants <NUMBER> confident able perform extent physical activity performing prior lockdown one regularly carrying yoga home second woman used skip ropes morning recently started performing yoga guided youtube videos third woman used perform aerobic dance workout home <NUMBER> min every day amid lockdown <NUMBER> participants <NUMBER> finding difficult procure prescribed insulin preparation one voluntarily reduced dose insulin due nonavailability nearby pharmacies participants stocked insulin vialscartridges home prior commencement lockdown lockdown one participant used perform selfmonitoring capillary blood glucose smbg home ongoing lockdown <NUMBER> participants <NUMBER> reduced frequency smbg six due limited availability glucose strips pharmacies two due financial constraints rest two believed frequent smbg would make anxious amid prevailing circumstances seventytwo percent participants stated current selfmonitored blood glucose recordings higher prior lockdown addition <NUMBER> participants one documented episodes hypoglycemia one participant episode severe hypoglycemia requiring hospital admission <NUMBER> days date interview besides <NUMBER> participants concerned unable visit physicians routine followups one participant touch diabetes educators aditi group via social platforms best knowledge first study examining awareness problems faced people t<NUMBER>dm amid ongoing covid<NUMBER> pandemic qualitative interview study comprising <NUMBER> young adults t<NUMBER>dm found lacunae knowledge awareness covid<NUMBER> participants able continue routine diet prescribed treatment however <NUMBER> individuals complained higher blood glucose based selfmonitored capillary blood glucose recordings likely reduced physical activity reported majority participants <NUMBER> although people diabetes mellitus dm higher risk infection covid<NUMBER> compared nondiabetic population presence underlying dm portends poor prognosis patients covid<NUMBER> terms severe disease ards increased mortality <NUMBER> <NUMBER> <NUMBER> study comprising <NUMBER> covid<NUMBER> patients china dm found independent predictor admission icu invasive ventilation death hazard ratio <NUMBER> <NUMBER> ci <NUMBER> <NUMBER> hence people dm must realize fact take necessary precautions protect would however possible aware disease possible modes transmission measures protect besides people dm ensure good glycemic control would strengthen host innate immune response <NUMBER> <NUMBER> however amid nationwide lockdowns imposed governments world glycemic control expected take backseat possible explanations include alteration routine diet limitation physical activity restricted availability antidiabetic medications lack followups constant stress anxiety amid ongoing pandemic prevailing lockdown <NUMBER> situation expected worse people t<NUMBER>dm obligatory insulin therapy interruption treatment routine schedule lead lifethreatening complications form diabetic ketoacidosis hypoglycemia awareness participants regarding covid<NUMBER> assessed found major lacunae <NUMBER> participants mentioned respiratory droplets fomites possible modes transmission similarly fever stated common symptom covid<NUMBER> <NUMBER> participants <NUMBER> <NUMBER> participants could recount three cardinal symptoms namely fever cough difficulty breathing besides two participants aware symptoms addition <NUMBER> <NUMBER> participants aware three principal means protection covid<NUMBER> namely staying indoors maintaining social distance regular hand wash soap water likely <NUMBER> participants must properly abiding necessary precautions lastly <NUMBER> participants unaware additional risks associated covid<NUMBER> people diabetes mellitus thereby implying feel need take extra precautions expected people dm contrary <NUMBER> participants misconception people dm higher risk infection still acceptable expected take extra precautions protect covid<NUMBER> recently conducted crosssectional survey united states america amongst <NUMBER> adults aged <NUMBER> years living <NUMBER> chronic conditions found nearly onethird participants able identify symptoms correctly describe ways prevent <NUMBER> online crosssectional survey examining knowledge attitude practices towards covid<NUMBER> among chinese residents using closedended questions found overall correct rate knowledge questionnaire <NUMBER> however participants belonged relatively high socioeconomic status welleducated results could generalized entire chinese population <NUMBER> socioeconomic status important determinant knowledge awareness regard communicable noncommunicable diseases <NUMBER> higher socioeconomic status also correlates improved awareness disease preventive behavior covid<NUMBER> <NUMBER> <NUMBER> similarly educational status wellknown factor affecting disease awareness higher educational status correlating better disease knowledge viceversa <NUMBER> <NUMBER> <NUMBER> <NUMBER> participants study relatively well educated <NUMBER> educated <NUMBER>th standard higher still witnessed major lacunae awareness covid<NUMBER> overall literacy rate india <NUMBER> <NUMBER> expected scenario likely worse illiterate less educated sections society deficit immediately addressed easiest effective means would improve awareness covid<NUMBER> using types broadcast print social media addition nongovernmental organizations take responsibility improve cognizance among highrisk groups like people t<NUMBER>dm using various social platforms like whatsapp facebook instagram etc matter fact soon results index study available aditi started awareness program via whatsapp amongst members believe endeavor improve knowledge awareness people t<NUMBER>dm enquired problems faced participants amid lockdown common response reduction physical activity reported <NUMBER> individuals addition <NUMBER> participants complained high glucose recordings since commencement lockdown majority participants difficulty procuring insulin maintaining healthy diet thus apparent worsening blood glucose reported participants could resulted reduction physical activity moreover <NUMBER> participants one episodes hypoglycemia <NUMBER> concerned inability physically followup physicians lack inclinic visits subsequent modulation insulin doses could also contributory factor worsening glucose control herein comes crucial role teleconsultations daytoday diabetes care <NUMBER> <NUMBER> smartphones norm households seems dearth scope teleconsultations present era patients keep touch routine physicians andor diabetes educators via teleconsultations aided patient specified smbg values physicians help finetune insulin doses thereby avoiding prolonged periods sustained hyperglycemia well recurrent episodes hypoglycemia fact use telemedicine persons t<NUMBER>dm shown provide similar efficacy safety outcomes facetoface visits <NUMBER> addition teleconsultations means imparting diabetes selfmanagement education people dm amid ongoing pandemic physicians could help people t<NUMBER>dm choose type nature physical activity guide sharing sample exercise videos reinforce need remain physically active virtual interaction <NUMBER> minor recommendation would perform total <NUMBER> min physical activityday <NUMBER> could divided aerobic activity musclestrengthening activity simple aerobic activities pursued home include brisk walking terrace lawn balcony treadmills available stationary cycling stationary jogging gardening could performed well similarly musclestrengthening activities could performed home include bodyweight exercises like pushups squats situps resistance exercises form lifting lightweights like buckets halffilled water bags filled sand <NUMBER> respect limitations study first used qualitative method interview using openended questions rather taking help closedended questionnaires commonly employed surveys however using closedended questions would limited responses participants would missed responses absence relevant questions would relevant enquiring problems faced patients reallife setting using openended questions ensured able obtain wide range responses participants second recruited young adults t<NUMBER>dm children adolescents <NUMBER> years ensured could obtain viewpoints patients per se parentscaregivers third results study based interviews conducted <NUMBER> young adults t<NUMBER>dm residing city north india hence findings cannot generalized people t<NUMBER>dm residing parts country fourth compare absolute smbg values lockdown lastly assess psychological health participants people dm already tend varying degrees negative emotions depression anxiety expected get aggravated amid stress ongoing pandemic <NUMBER> <NUMBER> unhealthy emotions would turn worsen glycemic control amid covid<NUMBER> pandemic <NUMBER> conclusion young adults t<NUMBER>dm lack robust awareness covid<NUMBER> patients finding difficult maintain good glycemic control spite major changes diet treatment regime suboptimal glucose profile could explained based limitation physical activity reported majority participants increasing awareness imparting diabetes selfmanagement education via digitalprint media well via virtual clinics dire need hour research received specific grant funding agency public commercial notforprofit sectors authors declare conflict interest ongoing outbreak corona virus disease <NUMBER> covid <NUMBER> infection posed significant threats international health economy <NUMBER> <NUMBER> <NUMBER> <NUMBER> january <NUMBER> world health organization declared public health emergency international concern <NUMBER> march <NUMBER> <NUMBER> countries <NUMBER> cases covid<NUMBER> <NUMBER> deaths reported world number confirmed patients china gradually decreased increasing rapidly countries especially italy south korea iran lots doctors engaged combating <NUMBER> <NUMBER> sarscov<NUMBER> first reported samples bronchoalveolar lavage fluid three patients wuhan jinyintan hospital confirmed cause covid<NUMBER> january <NUMBER> <NUMBER> <NUMBER> deep examining fulllength genome found virus belongs betacoronavirus <NUMBER>b lineage phylogenetic tree <NUMBER> new humaninfecting betacoronavirus previously detected humans animals named covid<NUMBER> sarscov<NUMBER> international committee taxonomy viruses similar coronavirus responsible severe acute respiratory syndrome sarscov <NUMBER> shares <NUMBER> identity sequencing bat sarslike coronavirus shares <NUMBER> identity nucleotide original sars epidemic virus <NUMBER> <NUMBER> <NUMBER> coronavirus spike glycoproteins promote entry cells main target antibodies bind high affinity angiotensinconverting enzyme <NUMBER> ace<NUMBER> receptor humans manner similar sarscov <NUMBER> <NUMBER> <NUMBER> however sarscov<NUMBER> glycoprotein harbors furin cleavage site boundary s<NUMBER>s<NUMBER> subunits processed biogenesis sets virus apart sarscov sarsrelated covs <NUMBER> <NUMBER> present research reports incubation period people range <NUMBER> <NUMBER> days median <NUMBER> days incubation period may even long <NUMBER> days <NUMBER> reproductive number r<NUMBER> sarscov<NUMBER> although still preliminary estimated <NUMBER> <NUMBER> suggesting higher pandemic potential sars <NUMBER> fever cough may major symptom asymptomatic individuals also identified potential sources infection <NUMBER> present think new coronavirus mainly transmitted respiratory droplets close contact transmission asymptomatic carrier appears possible <NUMBER> report <NUMBER> pregnant patients suggests perinatal transmission unlikely larger studies needed confirm finding <NUMBER> although viral rna found stool whether transmitted fecaloral route still needs confirmed subsequent investigations <NUMBER> <NUMBER> recently patients found repositive treated negative nucleic acid tests twice symptoms disappeared difficult us decrease severity covid<NUMBER> owing complex structure unclear physiological mechanism increasing number confirmed cases clinical investigation patients antiviral treatment solution insufficient urgent need find alternative methods control spread disease order prove accurate conclusions prevalence comorbidity relation clinical characteristics mortality patients covid<NUMBER> searched relevant literatures carried single arm metaanalysis describe epidemiological clinical characteristics complications outcomes patients confirmed <NUMBER>ncov infection compare severity diabetes hypertension nondiabetes nonhypertension patients findings provide vital guidance current clinical work prevention treatment <NUMBER>ncov infection ethical approval patient consent required present study review previously published articles fulltext articles obtained detailed evaluation eligible studies included systematic review inclusion criteria following randomized controlled trial clinical trials series cases patients either sex diagnosed covid<NUMBER> patients laboratoryidentified sarscov<NUMBER> infection realtime reversetranscriptase polymerasechainreaction detection sarscov<NUMBER> nucleic acid positive throat swabs lower respiratory tract ct scanning lung inclusion epidemiological clinical characteristics laboratory radiological characteristics treatment outcome clear description clinical characteristics comorbidities including hypertension diabetes cardiovascular disease malignancy signs symptoms fever cough fatigue dyspnea clear description outcomes including major complications acute respiratory distress syndrome ards acute cardiac injuryaci acute kidney injuryaki shock incidence severity mortality exclusion criteria following absence clinical characteristics treatment outcome clinical experience case reports two authors independently extracted data reviewing titles abstracts searched papers disagreement choice literature exists third evaluator join make decision following information recorded included trials first author year publication number participants residence patients basic data gender age diagnosis extracted analyzed evaluate proportion comorbidity diabetes hypertension cardiovascular disease malignancy proportion symptoms fever cough fatigue dyspnea proportion clinical complications including ards aci aki shock severity mortality two readers independently extracted reviewed data enrolled studies ensure consistency quality included studies assessed newcastleottawa scale order objectively evaluate publication bias included studies egger test p <NUMBER> existence publication bias performed larger values considered publication bias single arm metaanalysis proportions <NUMBER> ci calculated clinical symptoms complication outcome selected comorbidities using stata <NUMBER> presence heterogeneity among identified studies cochrans q extent heterogeneity <NUMBER> index examined described previously original data included literature first transformed double arcsine method make conform normal distribution analyzed stata initial conclusion obtained metaanalysis restored using formula psintp<NUMBER> <NUMBER> reach final conclusion performed sensitivity analysis assess stability results investigate influence study omitting single study sequentially using egger test found evidence bias lag periods initial <NUMBER> citations identified based study subject summary literature <NUMBER> articles thereafter excluded duplication reviewing title abstract remaining <NUMBER> studies <NUMBER> fulltext studies evaluated assessment <NUMBER> obviously irrelevant records excluded eventually <NUMBER> clinical studies <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> consistent inclusion requirements detailed study flowdiagram shown fig <NUMBER> basic characteristics quality included studies illustrated table <NUMBER> twentyone studies selected total <NUMBER> patients <NUMBER> male <NUMBER> females representing approximately <NUMBER> confirmed one clinical trial investigated characteristics patients singapore others came china mainly wuhan systematic analysis studies describing epidemiological demographic clinical features covid<NUMBER> cases reporting prevalence number chronic diseases infectious disease undertaken number cases selected studies varied approximately <NUMBER>fold ranged <NUMBER> <NUMBER> cases sex ratio male female <NUMBER> overall average age subjects greater <NUMBER> years fortyone cases reported jinyintan hospital earliest confirmed cases patients treated wenzhou hospital almost mild xiaobo yang et al reported <NUMBER> cases covid<NUMBER> critical patients studies detailed pretreatment biochemical characteristics subsequent treatment eighteen studies reported comorbidity diabetes <NUMBER> introduced proportion severity <NUMBER> studies reported hypertension <NUMBER> introduced proportion severity <NUMBER> studies reported malignant <NUMBER> studies reported cad regard symptoms <NUMBER> studies recorded fever cough <NUMBER> studies reported fatigue <NUMBER> studies reported dyspnea seven studies recorded complication ards aci shock recorded <NUMBER> <NUMBER> studies respectively fifteen studies showed critical patients <NUMBER> research reported mortality studies provided incidence data least one kind comorbidity symptom complication sixteen forest plots used illustrate prevalence comorbidities covid<NUMBER> selected studies inspect heterogeneity individual findings metaanalysis identified studies showed prevalent clinical symptoms fever <NUMBER> <NUMBER>ci <NUMBER> cough <NUMBER> <NUMBER>ci <NUMBER> followed fatigue <NUMBER> <NUMBER>ci <NUMBER> shortness breath <NUMBER> <NUMBER>ci <NUMBER> fig <NUMBER> significant heterogeneity cochrans q estimates clinical symptoms among examined studies p <NUMBER> <NUMBER> index varying <NUMBER> <NUMBER> prevalence diabetes hypertension comorbidities <NUMBER> <NUMBER>ci <NUMBER> <NUMBER> <NUMBER>ci <NUMBER> respectively incidence cardiovascular disease malignancy <NUMBER> <NUMBER>ci <NUMBER> <NUMBER> <NUMBER>ci <NUMBER> respectively fig <NUMBER> case complications including ards risk ranged <NUMBER> <NUMBER> pooled estimate <NUMBER> acute cardiac injury <NUMBER> <NUMBER>ci <NUMBER> acute kidney injury <NUMBER> <NUMBER>ci <NUMBER> shock <NUMBER> <NUMBER>ci <NUMBER> also present fig <NUMBER> risks severity mortality rate ranged <NUMBER> <NUMBER> <NUMBER> <NUMBER> pooled estimates <NUMBER> <NUMBER> respectively percentage severe cases diabetes hypertension cases <NUMBER> <NUMBER>ci <NUMBER> fig <NUMBER> sensitivity analysis performed assess stability pooled results among <NUMBER> studies significant results obviously altered sequentially omitting study pooled results comparing incidence mortality excluding report chaolin huang et al heterogeneity decreased significantly <NUMBER> <NUMBER> ci <NUMBER> p <NUMBER> i² <NUMBER> showed significant difference preventing ards rate two groups hence regarded result heterogeneity likewise studies considered source heterogeneity heterogeneity significantly changed showed significant difference preventing ards two groups studies excluded pooled results comparing incidence ards sensitivity analysis conducted determine whether exclusion study would alter result exclusion study metaanalysis substantially influence results part study ards used assess publication bias egger test results showed pr jzj <NUMBER> therefore believe risk publication bias low metaanalysis outbreak covid<NUMBER> declared public health emergency international concern march <NUMBER> <NUMBER> epidemic spread <NUMBER> countries around world accordance experience china surgical masks widespread use beneficial prevent acquisition covid<NUMBER> addition italy started taking measures block traffic lockdown villages rising incidence covid<NUMBER> world feasible effective messaging clinical characteristics covid<NUMBER> greatly needed therefore focus analysis evaluate prevalence symptoms comorbidity complications different outcomes china singapore metaanalysis identified <NUMBER> published studies assessed proportion published rcts rapid development epidemic limited medical resources addition presence uncontrollable risk treatment much evidence effects cannot adequately studied randomized trials longterm rare outcomes therefore analyzed retrospective studies study main results found cases reported date suggest older adults difference susceptibility male female fever common symptom patients <NUMBER>ncov infection prevalent comorbidities hypertension diabetes associated rapid development severe illness ards aci may main obstacles patients treatment recovery severity mortality patients <NUMBER>ncov infection lower severe acute respiratory syndrome sars middle east respiratory syndrome mers prevalence covid<NUMBER> much higher sars mers two coronaviruses previously caused significant outbreaks associated critical disease sars coronavirus <NUMBER> middle east respiratory syndrome coronavirus emerged <NUMBER> <NUMBER> <NUMBER> <NUMBER> lot studies reported clinical characteristics patients covid<NUMBER> lack studies relation severity mortality comorbidity similarly metaanalysis published complications patients covid<NUMBER> infected therefore novel systematic review metaanalysis due inadequate evidence present metaanalysis consolidating multiple studies enable enhanced clinical decision making future report cohort patients laboratoryconfirmed <NUMBER>ncov infection patients serious sometimes fatal complications admitted designated hospital clinical presentations greatly resemble sarscov patients severe illness developed ards aki aci shock required icu admission oxygen therapy however despite comprehensive analysis also many limitations taken consideration metaanalysis first studies included metaanalysis rcts second literatureincluded studies treatment every hospital completely similar third owing treatment grading mild ordinary critical severity patients different hospitals varies greatly addition cause physio pathological mechanism unknown onset emerging infections treatment wuhan based clinical experience leading higher complication mortality fourth partial missing information articles may lead biased results attempted contact investigators study sponsors verify key study characteristics obtain missing numerical outcome data moreover clinical methodological heterogeneities observed several parameters metaanalysis given variation intervention techniques patient composition preferences among different cities true heterogeneity poor methodological quality could also lead asymmetric plot future larger higher quality clinical trials conducted conduct detailed subgroup analysis explore sources heterogeneity obtain reliable conclusion effort made answer questions future studies covid<NUMBER> emerging infectious disease global public health concern results note similarity clinical symptoms complications covid<NUMBER> previous betacoronavirus infections incidence severity mortality covid<NUMBER> much higher ordinary influenza prevalence chronic diseases including diabetes hypertension rising populations age lifestyle dietary habits change addition found diabetes hypertension closely related severity mortality improving protection covid<NUMBER> persons chronic disorders essential last least need limit humantohuman transmission including reducing secondary infections among close contacts healthcare workers thus preventing transmission amplification events preventing international spread authors declare known competing financial interests personal relationships could appeared influence work reported paper agencies public commercial notforprofit sectors governments around world imposed lockdown residents coordinated effort control covid<NUMBER> infection rate late march united kingdom government passed legislation impose restrictions peoples movements activities regulations stipulated people would allowed leave home certain specific reasons included buying food seeking health care exercise day people chronic underlying health conditions aged <NUMBER> years older known high risk catch coronavirus advised stay home least <NUMBER> weeks shielding home instructed avoid contact others except essential medical treatment support many older adults voluntarily chose practice strict isolation keep safe measures alongside closure leisure community facilities enforced limitations physical activity appeared particularly evident greatest risk <NUMBER> physical activity key factor prevention treatment multitude chronic health conditions physically active lowest rates chronic disease <NUMBER> <NUMBER> lowest mortality<NUMBER> remain productive longer <NUMBER> associated subsequently lower healthcare costs <NUMBER> <NUMBER> <NUMBER> conversely least physically active higher rates chronic disease contributes greater reliance healthcare systems higher healthcare costs society health benefits regular activity lost surprisingly quickly example withdrawal exercise <NUMBER> weeks result physiological effects changes glucose homeostasis<NUMBER> thus plausible <NUMBER> weeks inactivity may exacerbate existing conditions risk factors <NUMBER> <NUMBER> indirect health effects lockdown widely discussed popular scientific press often concentrating reduced attendance emergency departments general practice<NUMBER> little discussion adverse effects isolation physical health <NUMBER> type <NUMBER> diabetes major risk factor cardiovascular disease renal failure stroke united kingdom treatment type <NUMBER> diabetes complications costs nhs around £<NUMBER> billion per year <NUMBER> prevalence diabetes england risen <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> strong evidence physical activity along weight loss healthy diet integral reducing risk developing diabetes <NUMBER> <NUMBER> <NUMBER> <NUMBER> paper seeks estimate effect inactivity lockdown diabetes risk elderly subsequent healthcare costs managing increased incidence diabetes associated complications diabetes often preceded prediabetes recently referred nondiabetic hyperglycaemia ndh andor impaired glucose tolerance prediabetes refers raised blood glucose levels reference range diabetes includes impaired fasting glucose defined glucose levels <NUMBER>mmoll world health organisation<NUMBER> <NUMBER>mmoll nice <NUMBER> uk nhs diabetes prevention programme <NUMBER> andor glycated haemoglobin hba<NUMBER>c values <NUMBER>mmolmol <NUMBER> estimate additional incident cases diabetes elderly due lockdown chose focus elderly prediabetes thereby indicating high risk developing type <NUMBER> diabetes <NUMBER> using identical approach previously employed public health england <NUMBER> recent health survey england hse data <NUMBER> adults aged <NUMBER> years older england classified ndh prediabetes individuals would progressed diabetes regardless covid<NUMBER> thus assumed background conversion rate <NUMBER> <NUMBER> risk group therefore represents <NUMBER> elderly prediabetes unlikely progressed diabetes within year determine effect inactivity imposed lockdown active elderly sought estimate proportion elderly population prediabetes physically active estimate relative risk diabetes using data hse pooled <NUMBER> ensure large enough sample estimated proportion active elderly hba<NUMBER>c <NUMBER>mmolmol <NUMBER> reported least <NUMBER> minutes moderate vigorous physical activity mvpa previous week note definition aligns national guidelines <NUMBER> assumed active elderly risk diabetes prevalence exposed cases <NUMBER> estimate similar estimates overall elderly population <NUMBER> estimate effect inactivity diabetes risk used data large diabetes prevention programme compared metformin lifestyle intervention individuals risk diabetes <NUMBER> trial looked effect increasing physical activity necessary estimate inverse effect reducing physical activity calculating relative risk inactivity conversion rates diabetes knowler et al reported <NUMBER> new diabetes cases <NUMBER> year exercise group n<NUMBER> <NUMBER> new diabetes cases sedentary control n<NUMBER> assuming sedentary controls ie metformin group treated exposed lifestyle group treated control estimated relative risk rr <NUMBER> <NUMBER> ci <NUMBER> <NUMBER> <NUMBER> conservative approach using data multiple trials gives near identical rr <NUMBER> <NUMBER> ci <NUMBER> <NUMBER> relative risk allowed us estimate population attributable fraction paf given proportion elderly active prevalence exposed cases <NUMBER> estimated paf <NUMBER> eg <NUMBER> elderly prediabetes would likely develop type <NUMBER> diabetes next <NUMBER> months due effect transitioning inactivity lockdown <NUMBER> approach allowed us estimate number new cases diabetes elderly due lockdown order understand cost used estimates hex et al <NUMBER> hex colleagues used topdown approach estimate total current future burden type <NUMBER> type <NUMBER> diabetes using prevalence estimates <NUMBER> estimated unit cost additional burden primary care eg cost screening testing subsequent treatment management cost complications secondary tertiary care providers inflated costs <NUMBER> prices<NUMBER> minimum would expect newly diagnosed elderly individuals diabetes tested screened managed primary care proportion individuals develop complications modelled hex et al estimates <NUMBER> combining costs new cases diabetes provides estimate additional cost diabetes due inactivity lockdown tested sensitivity estimates including confidence interval bounds rr analysis additionally tested assumption inactivity lockdown modelling effect conservative estimates <NUMBER> elderly remain active <NUMBER> remain active <NUMBER> remain active table <NUMBER> presents various parameters used analysis office national statistics estimated <NUMBER> individuals aged <NUMBER> uk mid<NUMBER> <NUMBER> estimated <NUMBER> million <NUMBER> years olds uk hba<NUMBER>c values make high risk diabetes eg prediabetes models made assumption government advice stay home lockdown measures resulted active elderly prediabetes becoming inactive result inactivity <NUMBER> new cases diabetes <NUMBER> age group may expected screening testing patients primary care estimated cost £<NUMBER>m subsequent treatment management primary care including prescribing antidiabetic drugs cost £<NUMBER>m largest cost component individuals progressing diabetes cost complications estimated £<NUMBER>m newly diagnosed cohort patients diabetes ccbyncnd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted june <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint total cost inactivity nhs estimated £<NUMBER> billion notably include indirect costs social care costs lost productivity due mortality results various sensitivity analyses presented table <NUMBER> conservative estimate suggests despite lockdown government advice <NUMBER> elderly remain active <NUMBER> transition diabetes cost £<NUMBER> million extreme lockdown constrained activity relative risk diabetes conversion due inactivity higher <NUMBER> elderly individuals develop diabetes cost £<NUMBER> billion estimate excess healthcare costs related new diagnoses diabetes previously active adults <NUMBER> years age england become inactive due covid<NUMBER> lockdown may exceed £<NUMBER> billion costs national health service treating patients covid<NUMBER> predicted run billions pounds indirect healthcare costs covid<NUMBER> pandemic likely substantial yet unknown numerous unintended healthcare consequences covid<NUMBER> begun emerge including excess mortality due early discharge<NUMBER> widespread delays routine operations <NUMBER> reduced attendance emergency departments<NUMBER> delays diagnosing serious illness<NUMBER> either people reluctant seek medical attention normal services including screening suspended carry significant indirect cost burden met government likely breadth impact covid<NUMBER> across economy mean costsavings need made across nhs challenge determine made annual cost treating type <NUMBER> diabetes account nearly nine per cent nhs budget <NUMBER> every year around <NUMBER> <NUMBER> people develop diabetes uk <NUMBER> findings current study suggest possibility least <NUMBER> additional new cases diabetes may occur result lockdown applying conservative estimates potential <NUMBER> new cases latter estimate represents doubling annual incidence diabetes additional £<NUMBER> billion healthcare costs indirect effect covid<NUMBER> ccbyncnd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted june <NUMBER> <NUMBER> diabetes preventable condition mainly behavioural interventions exercise healthy diet <NUMBER> <NUMBER> <NUMBER> lockdown exercise widely discussed media context allowing people leave homes rarely context prevention chronic disease changing emphasis towards encouraging exercise maintenance good health prevention chronic diseases may slow conversion prediabetes diabetes additionally considerable evidence shows physical activity cost effective means preventing managing range long term conditions<NUMBER> thus physical activity promotion physical activity play role generating much needed efficiency gains postcovid healthcare system important highlight exercising home compatible government lockdown regulations probable inactivity due lockdown similar effects chronic diseases used diabetes conversion prediabetes model demonstrate potential health economic effects common condition well described precursor syndrome <NUMBER> study makes several assumptions first assumption adults <NUMBER> years reduced even stopped exercise lockdown whilst found ways exercise safely outdoors emerging data found many either limited access open spaces concerned venturing outside home higher chance encountering coronavirus <NUMBER> second assumption inactivity result lockdown last least <NUMBER> weeks longer sufficient time observe adverse physiological effects inactivity glycaemic control although currently cautious moves allow people opportunities leave home <NUMBER> likely older adults advised remain home longer working age restrictions eventually lifted likely many <NUMBER> remain cautious going outside exercise <NUMBER> thus effects lockdown physical activity group may persist beyond formal end lockdown regulations alongside physical activity<NUMBER> healthy diet key reducing risk developing diabetes diabetes prevention trials include dietary intervention combination structured exercise weight loss <NUMBER> <NUMBER> <NUMBER> <NUMBER> risk estimates inactivity diabetes drawn trials thus difficult tease apart effects diet weight loss exercise study assumes calorie consumption diet alcohol lockdown unchanged compared prelockdown made assumptions weight gain true dietary effects lockdown multifactorial time effects closing restaurants cafes limiting access supermarkets developing diabetes become clear assumed risk developing diabetes evenly spread across population adults <NUMBER> years age subsequent risk complications similarly evenly spread acknowledge previously active develop diabetes related inactivity less likely suffer early complications previously inactive however datasets describe figures available despite limitations approach sufficiently robust enable useful estimate health cost implications inactivity lockdown unintended indirect healthcare costs coronavirus stayathome lockdown regulations may significant inactivity previously active older adults may contribute £<NUMBER> billion additional healthcare costs potential increase incidence diabetes simple measures clear advice importance physical activity vulnerable adults may reduce potential economic burden global pandemics populations required stay home furthermore advice promote exercise home compatible government lockdown regulations foreseeable future coronavirus disease <NUMBER> covid<NUMBER> caused severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> first reported december <NUMBER> wuhan hubei province china <NUMBER> disease spread rapidly regions around world including western pacific europe eastern mediterranean americas southeast asia world health organization declared covid<NUMBER> pandemic march <NUMBER> <NUMBER> april <NUMBER> <NUMBER> approximately <NUMBER> million cases diagnosed <NUMBER> deaths worldwide although <NUMBER> covid<NUMBER> cases mild <NUMBER> severe <NUMBER> critical fatality rate <NUMBER> critical cases <NUMBER> number factors associated severe covid<NUMBER> identified china older age male sex presence comorbidities low oxygen saturation abnormal lab findings high lactate dehydrogenase ldh high procalcitonin low cd<NUMBER> cell count low albumin level shown risk factors severe however patientand diseaserelated factors vary region region factors may associated clinical severity covid <NUMBER> studies regarding prognostic factors severe disease covid<NUMBER> patients korea study performed identify prognostic factors severe disease patients covid<NUMBER> daegu korea retrospective observational study <NUMBER> patients confirmed covid<NUMBER> yeungnam university medical center daegu korea february <NUMBER> <NUMBER> april <NUMBER> <NUMBER> study period adult patients age ≥ <NUMBER> years covid<NUMBER> hospitalized via emergency room outpatient department eligible inclusion demographic clinical laboratory treatment outcome data collected electronic medical records participants demographic clinical data included age sex comorbidities symptoms vital signs admission treatment hospital laboratory data consisted complete blood count blood biochemistry infectionrelated biomarkers peripheral oxygen saturation measured pulse oximetry immediately hospitalization patient inhospital case fatality rate monitored final date followup data collected analyzed authors severe disease defined composite outcome acute respiratory distress syndrome ards intensive care unit care death ards diagnosed according berlin definition <NUMBER> sarscov<NUMBER> infection confirmed realtime reverse transcription polymerase chain reaction assay nose andor throat swap samples continuous variables expressed means ± standard deviation compared students ttest mannwhitney u test categorical variables described number compared χ <NUMBER> test fishers exact test univariable logistic regression analysis performed identify prognostic factors severe covid<NUMBER> multivariable logistic regression analysis conducted variables showed p <NUMBER> univariable analysis excluded variables univariable analysis number events small calculation marked difference two groups analyses twotailed p <NUMBER> taken indicate statistical significance statistical analyses performed using spss software ver <NUMBER> spss inc chicago il usa study conducted accordance tenets declaration helsinki reviewed approved institutional review board irb yeungnam university hospital yuh irb <NUMBER> requirement informed consent waived retrospective study design final followup date april <NUMBER> <NUMBER> excluding seven patients transferred hospitals <NUMBER> hospitalized patients confirmed covid<NUMBER> included study fig <NUMBER> baseline characteristics patients summarized table <NUMBER> mean age <NUMBER> ± <NUMBER> <NUMBER> patients <NUMBER> women fortynine patients <NUMBER> comorbidities hypertension common <NUMBER> followed diabetes mellitus <NUMBER> frequently presenting symptoms fever <NUMBER> cough <NUMBER> patients severe group significantly older patients nonsevere group <NUMBER> ± <NUMBER> vs <NUMBER> ± <NUMBER> respectively p <NUMBER> severe group significantly likely diabetes mellitus <NUMBER> vs <NUMBER> respectively p <NUMBER> hypertension <NUMBER> vs <NUMBER> respectively p <NUMBER> admission body temperature <NUMBER>°c ± <NUMBER>°c vs <NUMBER>°c ± <NUMBER>°c respectively p <NUMBER> respiration rate <NUMBER> ± <NUMBER> vs <NUMBER> ± <NUMBER> breaths per minute respectively p <NUMBER> significantly higher severe group nonsevere group peripheral oxygen saturation significantly lower severe group nonsevere group <NUMBER> ± <NUMBER> vs <NUMBER> ± <NUMBER> respectively p <NUMBER> difficult detect meaningful differences radiologic findings patients severe group laboratory findings hospital admission summarized table <NUMBER> complete blood counts white blood cell count <NUMBER> ± <NUMBER> vs <NUMBER> ± <NUMBER> respectively p <NUMBER> neutrophil count <NUMBER> ± <NUMBER> vs <NUMBER> ± <NUMBER> respectively p <NUMBER> higher severe group nonsevere group lymphocyte count <NUMBER> ± <NUMBER> vs <NUMBER> ± <NUMBER> respectively p <NUMBER> platelet count <NUMBER> ± <NUMBER> vs <NUMBER> ± <NUMBER> respectively p <NUMBER> significantly lower severe group nonsevere group regard blood chemistry albumin level significantly lower severe group nonsevere group <NUMBER> ± <NUMBER> vs <NUMBER> ± <NUMBER> gdl respectively p <NUMBER> concentrations aspartate aminotransferase total bilirubin blood urea nitrogen ldh creatine kinasemb ckmb significantly higher <NUMBER> httpsjkmsorg httpsdoiorg<NUMBER>jkms<NUMBER>e<NUMBER> severe group n nonsevere group n patients hospitalized covid patients enrolled transferred severe group nonsevere group regard infectionrelated markers creactive protein level significantly higher severe group nonsevere group <NUMBER> ± <NUMBER> vs <NUMBER> ± <NUMBER> mgl respectively p <NUMBER> although procalcitonin level significantly different two groups <NUMBER> ± <NUMBER> vs <NUMBER> ± <NUMBER> ngml respectively p <NUMBER> three cases bacterial coinfection <NUMBER> cases klebsiella pneumonia <NUMBER> case clostridium difficile identified nonsevere group duration viral shedding different two groups multivariable analysis using variables p <NUMBER> univariable analysis table <NUMBER> rates severe disease increased patients diabetes mellitus body temperature ≥ <NUMBER>°c peripheral oxygen saturation ≤ <NUMBER> ckmb <NUMBER> fig <NUMBER> likelihood development severe covid<NUMBER> increased increasing number prognostic factors p <NUMBER> test trend fig <NUMBER> among <NUMBER> patients covid<NUMBER> <NUMBER> <NUMBER> severe disease inhospital case fatality rate <NUMBER> study showed presence diabetes mellitus body temperature ≥ <NUMBER>°c peripheral oxygen saturation <NUMBER> ckmb <NUMBER> independent predictors severe disease hospitalized covid<NUMBER> patients knowledge first study evaluate prognostic factors severe covid<NUMBER> korea diabetes mellitus major public health issue estimated global prevalence <NUMBER> <NUMBER> <NUMBER> populationbased cohort study showed type <NUMBER> diabetes increased risk death associated pneumonia hyperglycemia admission associated increased mortality diabetic nondiabetic patients communityacquired pneumonia <NUMBER> yang et al <NUMBER> reported diabetes ambient hyperglycemia independent risk factors death morbidity sars patients diabetes also results immune dysregulation severe prolonged lung pathology middle east respiratory syndrome <NUMBER> main mechanisms underlying poorer clinical outcomes cases infections associated diabetes mellitus follows <NUMBER> decreased lymphocyte response <NUMBER> decreased neutrophil function <NUMBER> disorders humoral immunity <NUMBER> depression antioxidant system <NUMBER> recent study covid<NUMBER> patients without comorbidities diabetes shown greater risk severe disease assessed organ damage inflammatory factors hypercoagulability addition covid<NUMBER> patients diabetes high risk disease progression <NUMBER> results present study suggested progression covid<NUMBER> influenced diabetes mellitus physicians pay close attention whether diabetic patients covid<NUMBER> show rapid clinical deterioration body temperature one variables included pneumonia severity index <NUMBER> systemic inflammatory response syndrome sirs <NUMBER> predict clinical outcomes pneumonia febrile response thought mediated endogenous factors called endogenous pyrogens pyrogenic cytokines tumor necrosis factor tnf interleukin il<NUMBER> il<NUMBER> interferons ifns released response exogenous stimuli bacterial viral products toxins <NUMBER> covid<NUMBER> levels proinflammatory cytokines il<NUMBER>β il<NUMBER> il<NUMBER> il<NUMBER> ifnγ tnfα significantly higher severe cases mild cases <NUMBER> results present study suggested critical covid<NUMBER> patients elevated levels inflammatory cytokines increase body temperature low peripheral oxygen saturation shown independent prognostic factor severe covid<NUMBER> <NUMBER> many covid<NUMBER> patients experience rapid respiratory failure hypoxemia without signs dyspnea referred silent hypoxemia <NUMBER> unique characteristic covid<NUMBER> makes difficult predict clinical deterioration accurately using traditional scores quick sequential organ failure assessment sirs covid<NUMBER> highly contagious infectious disease medical staff tend less contact patients therefore discovery worsening condition patients may delayed viewpoint peripheral oxygen saturation measured immediately upon hospitalization pulse oximetry used convenient accurate marker prediction clinical deterioration covid<NUMBER> cardiac injury associated death severity covid<NUMBER> associated acute cardiac injury systemic review <NUMBER> studies <NUMBER> confirmed covid<NUMBER> patients severe covid<NUMBER> infection associated high cardiac injury related markers troponin ckmb myoglobin also cardiac injury covid<NUMBER> related higher mortality <NUMBER> <NUMBER> ci <NUMBER> p <NUMBER> <NUMBER> known sarscov<NUMBER> invades human cells via receptor angiotensin converting enzyme ii ace<NUMBER> ace<NUMBER> expressed lung heart esophagus kidney bladder ileum thus organs express ace<NUMBER> vulnerable sarscov<NUMBER> infection <NUMBER> therefore measurement cardiac damage markers admission needed patients covid<NUMBER> predict prognosis covid<NUMBER> several chinese studies demonstrating risk factors severity covid<NUMBER> li et al <NUMBER> reported elder age hypertension high cytokine levels high ldh levels associated severe covid<NUMBER> inpatients wuhan study anhui china revealed low fingertip oxygen saturation decreased cd<NUMBER> cell count independent risk factors severe covid<NUMBER> patients <NUMBER> diabetes maximum body temperature admission risk factors progression covid<NUMBER> <NUMBER> <NUMBER> predictors severe disease progression korean patients chinese patients much different study several limitations first retrospective study conducted single center korea subjected hospitalized patients therefore results cannot generalized covid<NUMBER> patients second antiviral agents corticosteroid usage included variables study research focused baseline clinical characteristics laboratory findings related worsening patients condition due severe disease treatment third selection bias could avoided populationbased data used disease severity patients may vary hospitals region fourth proinflammatory cytokines early cd<NUMBER> tcell response associated disease severity measured study conclusion found presence diabetes mellitus body temperature ≥ <NUMBER>°c peripheral oxygen saturation <NUMBER> ckmb <NUMBER> independent predictors severe disease hospitalized covid<NUMBER> patients likelihood progression severe covid<NUMBER> increased increasing number prognostic factors appropriate assessment prognostic factors close monitoring provide necessary interventions appropriate time highrisk patients may reduce case fatality rate covid<NUMBER> found repeatedly prior studies china italy patients diabetes similar risk infected coronavirus subjects general population figure <NUMBER> <NUMBER> <NUMBER> however moment covid<NUMBER>positive patients preexistent diabetes hospitalized clinical course often complicated subsequently higher morbidity mortality rate <NUMBER> theoretically explained expression ace<NUMBER> receptors lungs hyperglycaemic states diabetes animal models <NUMBER> vitro models showed higher facilitated entrance coronavirus ace<NUMBER> receptors rodent diabetes models level expression ace<NUMBER> receptors regulated differently among distinctive organs eg expression kidney cortex compared heart upregulated expression state glycaemia <NUMBER> however administration insulin lower high glycaemic states decrease tissue ace<NUMBER> receptor expression lung circulating ace<NUMBER> protein decreased <NUMBER> translating rodentderived results towards human conditions easy make still ongoing actual research however first rodentderived results motivated us prevent hyperglycaemia patients admitted covid<NUMBER> ward preventing respiratory failure covid<NUMBER> wards patients start recording capillary daytime glucose levels first <NUMBER> hours admission hba<NUMBER>c measurement performed covid<NUMBER> patients disturbed glycaemic level <NUMBER> mgdl <NUMBER> mmoll order diagnose preexistent type<NUMBER> diabetes define glucose control patients covid<NUMBER> glucose levels strictly titrated subcutaneous basalbolus insulin therapy line adaaace endocrine society guidelines <NUMBER> <NUMBER> dealing hospital glucose control seriously ill patients avoidance glycaemia less stopping oral antidiabetic drugs several considerations due significant acute chronic decrease kidney function clearance <NUMBER> mlmin many hospitalized patients biguanides glucoselowering drugs discontinued elderly sulfonylurea better avoided especially acute disease malnutrition possible increased risk pneumonia using ddpivs part discussion <NUMBER> patients covid<NUMBER> therapeutic use steroids restricted therefore steroidassociated glycaemia rare phenomenon covid<NUMBER> ward patients using glucose sensor medtronic stop measuring glycaemia modality paracetamol even low dose <NUMBER> g could hinder accurate measurements always start measure capillary glucose levels use finger prick paracetamol often used covid<NUMBER> ward known patients diabetes exert disturbed daytime glucose profile expected prior literature almost third inhospital patients disturbed daytime glucose level diagnosed de novo diabetes hba<NUMBER>c admission <NUMBER> using hba<NUMBER>c diagnostic cool always possible active phase covid<NUMBER> infection large amount patients displayed significant anaemia due systemic proinflammation one case report anaemia successfully corrected erythropoietin infusion <NUMBER> another large group patients ward displayed stressassociated hyperglycaemia covid<NUMBER> f g u r e <NUMBER> covid presentation patients diabetesendocrine disease corona virus entering alveolar space interacts ace<NUMBER> receptors ace<NUMBER>r hyperglycemia gives higher expression ace<NUMBER>r alveolar endothelium making entrance possible local damage virus replication initiation cytokine storm afterwards immune response impaired lesscontrolled diabetic conditions amount thoracic fat functionally hindering respiratory function combined factors make patient diabetes vulnerable clinical covidcourse b course disease covid<NUMBER> first stable clinicl phase could followed rapidly progressive clinically unstable <NUMBER>nd phase population last group frequently overrepresented known whether acute rise glucose levels could affect ace<NUMBER> receptor expression alveolar endothelium whether chronic hyperglycaemic conditions needed due lack knowledge treated similar insulin therapy stay ward case respiratory failure ward transition icu performed subcutaneous insulin changed intravenously administered insulin patients remained however covid<NUMBER> ward week went home insulin could stopped almost patients still limited experience covid<NUMBER> patients preexistent diabetes wellcontrolled glycaemia hba<NUMBER>c admission transfer icu moderate improvement insulin sensitivity lipid profile observed starting antimalarial drug hydroxychloroquine <NUMBER> therefore closely monitoring daytime glucose levels recommended especially insulin therapy line fact one case report described patient type<NUMBER> diabetes severe hypoglycaemia <NUMBER> covid<NUMBER> ward observe accidents due hypoglycaemia hydroxychloroquine started course disease another challenge reopening society presence viral clusters low continuous viraemia amid general population lot patients limited visits caregivers hospital active period covid<NUMBER> pandemic neglected alarming symptoms high glucose levels fear infected daring contact hospitals <NUMBER> instance experienced higher rate patients presenting complicated sepsis diabetic foot mentioning active coronary signs serious delay telemedicine telephone consultations always prevent late presentations complicated disease making us reconsider real effectiveness applications daily clinic especially patients low health literacy native speaking despite encouraged governmentrelated bodies commercial companies first period reopening society patients diabetes hospitalized covid<NUMBER> treated intensively order achieve distinctive metabolic targets hba<NUMBER>c blood pressure ldlcholesterol et cetera prevent cardiovascular risk used today also prevent complicated course next coming covid<NUMBER> outbreaks immunization influenza immune host response respiratory viral infections showed different patterns multiomics associations insulinsensitive persons insulinresistant persons prediabetes suggesting impaired immune capacity tackling viral respiratory infections <NUMBER> long efficient vaccine subsequent group protection obtained covid<NUMBER> outbreaks could foreseen cochrane analysis however showed vaccines preventing influenza elderly diabetes living longterm care facilities community could significantly effective reduces mortal complications total mortality reduction bacterial pneumonia hospitalizations <NUMBER> covid<NUMBER> viral pneumonia rarely complicated bacterial infection making comparison prior incoherent literature concerning vaccines covid<NUMBER> elderly diabetes even challenge certain doubt may simple panacea recent observations current antibody levels coronavirus general dutch population preselected belgium population passing <NUMBER> first corona peak marchapril <NUMBER> underlines need original fundamental research covid<NUMBER> trust replicate prior concepts may lead towards fast therapeutic achievements patients low health literacy found among worse clinical outcomes <NUMBER> netherland found <NUMBER> patients type<NUMBER> diabetes express less health literacy <NUMBER> prior studies dealing covid<NUMBER> pandemic patients presentation emergency room delayed compared higher health literacy public information later translated applied group patients giving serious patients delay patients lower health literacy supported others daily life activities daily diabetes management covid<NUMBER> pandemic availability supporting person much less present due kind local measures restricting social contact quarantine closure schools children home hindering visiting mum dad suffering diabetes <NUMBER> necessitate social restrictions covid<NUMBER> pandemic certainly affect negatively patients low health literacy risk run complications patients adrenal insufficiency rare among patients entering covid<NUMBER> ward however one underestimate hidden part patients partial adrenal insufficiency instance patients used high cumulative dose steroids rheumatoid disease chronic obstructive pulmonary disease could present disturbed stress response symptoms due impaired adrenal function especially severe infectious stress could initial course <NUMBER> specific background special groups patients forgotten instance patients high need morphinelike drugs secondary adrenal insufficiency recently treated new anticancer drugs immunemodulators hypophysitis secondary side effect secondary adrenal insufficiency <NUMBER> patients could safely tested synacthen test covid<NUMBER> ward case urgency fast hemodynamic deterioration intravenous solucortef <NUMBER> mg three times day could started immediately without synacthen test patients primary secondary adrenal insufficiency already take hydrocortisone substitution admission switched intravenously administered hydrocortisone <NUMBER> mg three times day <NUMBER> diarrhoea vomiting without fever may symptoms related covid<NUMBER> infection case diabetes insipidus disease neuropituitary salt water balance full attention covid<NUMBER> patients one wants avoid hypervolemic condition therefore <NUMBER> hours volume composition applied intravenous solutions strictly motivated aiming achieve cumulative <NUMBER> hours nil balance dose desmopressin adjusted accordingly disturbed thyroid function could negatively affect heart function covid<NUMBER> cytokine storm troponins often elevated suggesting significant cardiac stress controlling thyroid function mandatory acute phase deterioration thyroid function due nonthyroid illness need thyroxin substitution use amiodarone mostly gives significant orientation stay covid<NUMBER> ward hyperthyroidism mostly due toxic adenoma dealt according current guidelines patients covid<NUMBER> admitted ward serious challenge junior senior doctors numerous pathologies mastered order improve outcomes demand multidisciplinary approach metabolic disorders often present diagnosed treated background covid<NUMBER>related cytokine storm characterizing initial phase disease new coronavirus disease <NUMBER> cov<NUMBER> coronavirus severe cases covid<NUMBER> rapidly progress acute respiratory <NUMBER> distress syndrome ards septic shock multiple organ dysfunction syndrome mods <NUMBER> ultimately patient death <NUMBER> covid<NUMBER> patients diabetes mellitus dm one <NUMBER> main comorbidities associated severe disease ards increased mortality <NUMBER> <NUMBER> relationship due part fact patients diabetes permanent pro<NUMBER> inflammatory state makes susceptible inflammatory cytokine storm <NUMBER> often innate immune system compromised also underlying <NUMBER> hypercoagulable prothrombotic state meanwhile covid<NUMBER> worsen insulin resistance <NUMBER> making difficult control glucose people diabetes also promotes strong <NUMBER> inflammatory coagulation processes <NUMBER> <NUMBER> since establishing early prognosis patients <NUMBER> diabetes infected sarscov<NUMBER> could help treatment decisions <NUMBER> present work analyzed laboratory parameters showed differences could predict <NUMBER> good bad resolution disease <NUMBER> carry electronic search using different search engines medline pubmed <NUMBER> interface scopus web science via raven google scholar using keywords <NUMBER> diabetes covid<NUMBER> diabetes sarscov<NUMBER> without date june <NUMBER> <NUMBER> <NUMBER> language restrictions titles abstracts full texts articles identified <NUMBER> according criteria analyzed considering metaanalysis <NUMBER> reported prognostic data patients covid<NUMBER> diabetes defined <NUMBER> without need enter intensive care unit survivors nonsurvivors alive <NUMBER> deceased <NUMBER> four studies considered metaanalysis <NUMBER> laboratory parameters <NUMBER> appear articles analyzed mean standard deviation extrapolated <NUMBER> median range sample size previously described <NUMBER> analyzed whether <NUMBER> significant differences p <NUMBER> values age glycated hemoglobin hba<NUMBER>c <NUMBER> white blood cell wbc count neutrophils neu lymphocytes lym platelets plt d<NUMBER> dimer cardiac troponin ctni alanine aminotransferase alt creatinine cr creactive <NUMBER> protein crp neutrophiltolymphocyte ratio nlr procalcitonin pct <NUMBER> patients survived presented complications died metaanalysis <NUMBER> performed using comprehensive metaanalysis software version <NUMBER> <NUMBER> biostat <NUMBER> englewood nj calculating standardized mean difference smd <NUMBER> <NUMBER> confidence interval <NUMBER> ci parameters <NUMBER> studies conducted chinese population considering total <NUMBER> patients <NUMBER> covid<NUMBER> diabetes <NUMBER> <NUMBER> recovered without complications <NUMBER> <NUMBER> <NUMBER> complications died samples studies ranged <NUMBER> <NUMBER> <NUMBER> patients smd parameter summarized figure <NUMBER> parameters <NUMBER> random effects model used since heterogeneity <NUMBER> statistics exceeded <NUMBER> <NUMBER> exception wbc cr less therefore fixed effects model <NUMBER> ones presented greatest differences groups <NUMBER> diabetes mellitus significantly associated mortality risk patients <NUMBER> <NUMBER> <NUMBER> general patients covid<NUMBER> diabetes presented poor <NUMBER> prognosis showed higher levels inflammatory parameters time <NUMBER> immunocompromise due significant reduction number lymphocytes <NUMBER> likewise parameters associated coagulation cardiac activity increased <NUMBER> patients complications died parameter could identified clearly <NUMBER> different covid<NUMBER> patients diabetes without although blood <NUMBER> glucose control reported reduce risk death detrimental complications <NUMBER> <NUMBER> found significant difference hba<NUMBER>c values possibly due good patient control <NUMBER> prior sarscov<NUMBER> infection coronado study reported prior glucose control <NUMBER> impact severity covid<NUMBER> people diabetes <NUMBER> <NUMBER> important mention presence obesity reported studies <NUMBER> analyzed influence bmi could investigated included data antidiabetic <NUMBER> therapy baseline treatment considered unknown <NUMBER> percentage population uncontrolled diabetes <NUMBER> falr recipient doctoral scholarship application number <NUMBER>nacf<NUMBER> <NUMBER> national council science technology conacyt <NUMBER> authors declare conflict interest <NUMBER> research receive specific grant funding agencies public <NUMBER> commercial notforprofit sectors december <NUMBER> many cases unknown pneumonia reported wuhan china <NUMBER> subsequently betacoronavirus named severe acute respiratory syndrome coronavirus<NUMBER> sarscov<NUMBER> isolated lower respiratory tract samples infected patients disease later declared world health organization pandemic termed novel coronavirus disease<NUMBER> covid<NUMBER> clinical spectrum covid<NUMBER> varies widely majority patients present mild form disease severe cases may develop acute respiratory distress syndrome ards multiple organ failure even death <NUMBER> <NUMBER> <NUMBER> currently diagnosis covid<NUMBER> confirmed realtime reverse transcriptase polymerase chain reaction rtpcr however chest computed tomography ct imaging played major role diagnosis management suspected confirmed cases covid<NUMBER> <NUMBER> <NUMBER> addition various ct scores designed assess severity disease <NUMBER> <NUMBER> <NUMBER> studies reporting imaging findings covid<NUMBER> chest ct imaging indicated common findings groundglass opacities ggo consolidation mainly peripheral distribution <NUMBER> <NUMBER> moreover chest ct severity scores higher among severe cases covid<NUMBER> compared patients mild disease <NUMBER> <NUMBER> <NUMBER> according literature patients comorbidities diabetes hypertension cardiovascular disease well older patients prone worse clinical outcomes higher rates complications associated covid<NUMBER> <NUMBER> <NUMBER> <NUMBER> studies previous pandemics including influenza h<NUMBER>n<NUMBER> sarscov merscov pandemics indicated diabetes uncontrolled glycemia significantly associated disease severity mortality infected patients <NUMBER> <NUMBER> <NUMBER> example study evaluating <NUMBER> pandemic influenza h<NUMBER>n<NUMBER> virus found fasting plasma glucose fpg level h<NUMBER>n<NUMBER> patients admission significantly associated disease severity <NUMBER> point role glycemic control prognosis patients coexistent diabetes covid<NUMBER> clear study aimed compare clinical outcomes imaging findings covid<NUMBER> patients wellcontrolled diabetes poorlycontrolled diabetes conducted retrospective singlecenter study patients admitted tertiary care hospital tehran iran suspicion covid<NUMBER> infection total <NUMBER> patients covid<NUMBER> admitted february <NUMBER> april <NUMBER> <NUMBER> <NUMBER> patients type <NUMBER> diabetes mellitus dm included study diabetes mellitus confirmed reviewing patients medical records exclusion criteria considered study included patients classified patients wellcontrolled poorlycontrolled dm according hemoglobin a<NUMBER>c hba<NUMBER>c levels recommended american diabetes association <NUMBER> patients hba<NUMBER>c level <NUMBER> regarded patients poorlycontrolled dm hba<NUMBER>c level equal less <NUMBER> considered patients wellcontrolled dm due unavailability rtpcr kits detection sarscov<NUMBER> early outbreak iran patients clinical features chest ct findings highly suggestive covid<NUMBER> considered positive cases thus included study study approved ethics committee shahid beheshti university medical sciences baseline demographics patients retrieved collecting data patients electronic medical records study assessed underlying comorbidities hypertension cardiovascular disease duration diabetes smoking history medications insulin oral hypoglycemic agents ohas angiotensinconverting enzyme inhibitorangiotensin ii receptor blockers aceiarbs statin diuretics participants individuals ceased smoking <NUMBER> years earlier considered nonsmokers laboratory tests included total count leukocytes lymphocytes hba<NUMBER>c lactate dehydrogenase ldh creactive protein crp magnesium mg phosphorus p calcium ca cardiac troponin procalcitonin pct ddimer <NUMBER>ohvitd zinc addition rtpcr assay performed nasopharyngeal specimens sarscov<NUMBER> detection patients taqman® premix takara takara dalian china considering protocols provided manufacturer patients underwent chest ct examinations admission ct scans reported radiologist years experience ct imaging reduce potential bias chest ct severity score defined summation individual scores <NUMBER> lung lobes scores <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> respectively assigned lobe pulmonary involvement <NUMBER> less <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> region range total severity score <NUMBER> involvement <NUMBER> maximum involvement predominant patterns chest ct imaging classified five groups ggo consolidation ggoconsolidation mixed reverse halo sign crazypaving secondary ct findings cavity nodule pleural effusion pericardial effusion lymphadenopathy lap <NUMBER>mm also recorded distribution lung lesions grouped three categories peripheral peribronchovascular perihilar also lung opacifications fell three different categories terms morphology round linear nonspecific opacities nonnormally distributed continuous data expressed median interquartile range iqr categorical data presented number percentage normal distribution evaluated using shapirowilk test chisquare test used comparison proportions groups differences parametric nonparametric continuous data compared groups using independent samples ttest mannwhitney u test respectively statistical analyses performed using spss software version <NUMBER> spss inc chicago il usa pvalues less <NUMBER> considered statistically significant study included <NUMBER> patients covid<NUMBER> preexisting type <NUMBER> dm prevalence diabetes among patients covid<NUMBER> <NUMBER> totally <NUMBER> <NUMBER> patients male median age <NUMBER> years iqr <NUMBER> years among total population patients diabetes <NUMBER> <NUMBER> patients poorcontrolled diabetes <NUMBER> <NUMBER> patients wellcontrolled diabetes approximately <NUMBER> included patients tested positive sarscov<NUMBER> rtpcr clinical laboratory findings patients demonstrated table <NUMBER> shown patients wellcontrolled dm significantly older poorlycontrolled dm p<NUMBER> also distribution male female patients differed significantly two groups p<NUMBER> majority patients wellcontrolled dm group females male patients constituted higher percentage among patients poorlycontrolled dm median hba<NUMBER>c value among patients diabetes <NUMBER> iqr <NUMBER> comparing comorbidities two groups significant difference observed among patients coexistent diabetes covid<NUMBER> <NUMBER> <NUMBER> patients hypertension duration diabetes statistically different patients wellcontrolled poorlycontrolled dm p<NUMBER> approximately half patients recovered covid<NUMBER> <NUMBER> patients died hospitalization addition <NUMBER> experienced ards course disease clinical outcomes however significantly different patients wellcontrolled poorlycontrolled dm p<NUMBER> considering medications used patients underlying diabetes use aceiarbs insulin differ two groups p<NUMBER> p<NUMBER> respectively among laboratory parameters <NUMBER> <NUMBER> patients total population lymphocytopenia admission calcium <NUMBER>ohvitd levels differed significantly two groups p<NUMBER> imaging findings patients chest ct presented table <NUMBER> median total ct severity score <NUMBER> <NUMBER> among patients wellcontrolled poorlycontrolled dm respectively p<NUMBER> highest ct scores observed right lower lobes patients groups common chest ct pattern ggo <NUMBER> followed consolidation <NUMBER> addition <NUMBER> cases lesions peripheral distribution ct imaging whereas perihilar distribution detected patient terms morphology linear opacities frequently seen patients poorlycontrolled dm however finding borderline significance p<NUMBER> among <NUMBER> patients covid<NUMBER> diabetes <NUMBER> <NUMBER> <NUMBER> <NUMBER> patients pleural effusion hyperinflation ct imaging respectively comparing proportion patients fatal outcome receiving aceiarbs receive medications found patients using aceiarbs significantly higher rates death lower rates recovery p<NUMBER> ards also common among patients using aceiarbs although borderline significance p<NUMBER> study investigated clinical outcomes laboratory parameters imaging findings patients coexistent diabetes covid<NUMBER> admitted hospital february <NUMBER> april <NUMBER> previous studies reported comorbidities diabetes associated increased risk death among patients covid<NUMBER> <NUMBER> <NUMBER> <NUMBER> addition argued glycemic control may great value prognosis patients coexistent diabetes covid<NUMBER> <NUMBER> <NUMBER> <NUMBER> mortality rate hospitalized patients coexistent covid<NUMBER> diabetes <NUMBER> study likewise study united states mortality rate among patients diabetes andor uncontrolled hyperglycemia approximately <NUMBER> <NUMBER> mortality rates higher observed among general population covid<NUMBER> <NUMBER> several hypotheses exist role hyperglycemia progression viral respiratory infections elevated blood glucose levels may negatively impact pulmonary function well suppressing immune system increasing production inflammatory cytokines <NUMBER> <NUMBER> <NUMBER> <NUMBER> addition angiotensinconverting enzyme <NUMBER> ace<NUMBER> one main receptors sarscov<NUMBER> expressed within pancreas suggesting novel coronavirus directly damage pancreatic islets <NUMBER> nevertheless impact hyperglycemia covid<NUMBER> progression requires investigation recently zhu et al investigated association blood glucose control clinical outcomes largescale study <NUMBER> patients confirmed covid<NUMBER> <NUMBER> diabetes found <NUMBER> patients diabetes male similar results study <NUMBER> also reported prevalence <NUMBER> diabetes among total population patients covid<NUMBER> whereas study found slightly lower prevalence <NUMBER> iran diabetes estimated prevalence <NUMBER> among <NUMBER>yearolds <NUMBER> another study italy prevalence diabetes among patients covid<NUMBER> <NUMBER> <NUMBER> recent metaanalysis also reported pooled prevalence <NUMBER> diabetes among patients covid<NUMBER> <NUMBER> study zhu et al patients diabetes relatively lower median age compared study <NUMBER> versus <NUMBER> years respectively could due exclusion patients older <NUMBER> years mentioned study line study higher percentage patients wellcontrolled dm female patients poorlycontrolled dm male patients constituted higher percentage besides parallel study showed findings chest ct imaging similar two groups however chest ct imaging evaluations limited bilateralunilateral lesions study <NUMBER> patients diabetes developed ards study similarly zhu et al reported ards occurred <NUMBER> patients diabetes major difference two studies however remains definition wellcontrolled poorlycontrolled dm zhu colleagues divided patients diabetes two groups based glycemic variability range study patients diabetes classified longterm glycemic control hba<NUMBER>c values varying definition might explain differences outcomes found study zhu et al study hospital death rate compared poorlycontrolled blood glucose however study failed demonstrate significant difference clinical outcomes recovery death two groups another possible reason paradoxical findings two studies might ethnical geographical variations chinese iranian population findings supported recent study inpatients covid<NUMBER> diabetes coronado study hba<NUMBER>c values associated death primary outcome mechanical ventilation andor death patients covid<NUMBER> <NUMBER> although hba<NUMBER>c serves reliable test measuring blood glucose values period three months hba<NUMBER>c values greater <NUMBER> indicate impaired glycemic control unknown whether hba<NUMBER>c values fpg levels dominant role determining prognosis patients covid<NUMBER> acute viral respiratory tract infections associated diminished insulin sensitivity <NUMBER> <NUMBER> therefore fpg levels may probably increase hospitalization even patients diabetes hba<NUMBER>c values lower <NUMBER> could possibly explain insignificant differences clinical outcomes patients wellcontrolled poorlycontrolled dm since emergence sarscov<NUMBER> december <NUMBER> chest ct imaging played major role evaluation patients covid<NUMBER> ct severity scores soon developed assess disease severity imaging <NUMBER> <NUMBER> studies showed ct scores significantly higher severe cases compared mild cases covid<NUMBER> <NUMBER> <NUMBER> <NUMBER> date one study investigated difference ct scores general population diabetes study found chest ct scores significantly higher among patients diabetes compared patients without diabetes <NUMBER> nevertheless study evaluated ct scores among patients wellcontrolled poorlycontrolled dm yet observed significant difference chest ct scores patients wellcontrolled poorlycontrolled dm addition linear opacities frequently observed among patients poorlycontrolled dm wellcontrolled dm linear opacities also seen commonly among patients severe disease <NUMBER> <NUMBER> cases pulmonary lesions peripheral distribution observed consistent findings previously published studies <NUMBER> <NUMBER> currently considerable uncertainty use antihypertensive medications patients covid<NUMBER> underlying comorbidities researches recommended continued use aceiarbs patients covid<NUMBER> <NUMBER> <NUMBER> others turned use medications <NUMBER> <NUMBER> <NUMBER> results demonstrated patients diabetes receiving aceiarbs markedly higher rates death lower rates recovery compared take medications although finding intriguing caution used interpretation results comprehensive studies larger populations needed study several limitations first number cases group markedly different necessitates careful interpretation results larger prospective studies among different populations needed explore association diabetes either wellcontrolled poorlycontrolled imaging findings clinical outcomes also mentioned earlier evaluate patients blood glucose tests hospitalization assumption glycemic control patients diabetes solely based hba<NUMBER>c values retrospective singlecenter study showed patients wellcontrolled poorlycontrolled diabetes significantly differ terms clinical outcomes chest ct severity scores funding research receive specific grant funding agencies public commercial notforprofit sectors hba<NUMBER>c <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> coronavirus disease <NUMBER> caused severe acute respiratory syndrome coronavirus<NUMBER> sarscov<NUMBER> ongoing public health emergency international significance <NUMBER> although fatality sarscov<NUMBER> infection appears less observed sarscov merscov infections new virus possesses strong transmissibility <NUMBER> <NUMBER> april <NUMBER> rd <NUMBER> approximately <NUMBER> laboratory confirmed patients presented <NUMBER> countriesregions around world moreover virus led deaths <NUMBER> people mostly elderly underlying chronic diseases <NUMBER> therefore identification risk factors severity fatality sarscov<NUMBER> infection urgently needed better understand prevent public health epidemic worldwide accumulative clinical studies suggested diabetic patients acute viral respiratory infections often lead severe complications pneumonia acute respiratory distress syndrome organ failure even death <NUMBER> <NUMBER> <NUMBER> example yang et al reported known history diabetes mellitus independent predictor fatality sarscov infection importantly normalization blood glucose levels possible suppression ketosis using intravenous article protected copyright rights reserved insulinglucose infusion intensive insulin therapy shown reduce mortality morbidity diabetic patients admitted intensive care unit <NUMBER> addition garbati et al reported <NUMBER> merscovinfected diabetic patients poor outcomes compared <NUMBER> individuals type nondiabetic comorbidity merscov infection suggesting diabetes mellitus particular major contributor mers severity <NUMBER> one important public health problemsin <NUMBER> st century diabetes mellitus affects <NUMBER> million adults around world <NUMBER> however effects diabetes mellitus severity fatality sarscov<NUMBER> infection investigated limited therefore first objective study explore association diabetes mellitus covid<NUMBER> severity hospitalized patients combined results previously published studies metaanalysis assessment helpful management diabetic patients sarscov<NUMBER> infection jan <NUMBER> mar <NUMBER> <NUMBER> total <NUMBER> covid<NUMBER> patients admitted huaian fourth peoples hospital sole hospital caring covid<NUMBER> patients huaian city huaian city located hinterland northern jiangsu demographic clinical features extracted electronic medical records using standardized data collection form data checked team trained physicians present study laboratory tests examined within <NUMBER> hours hospital admission sarscov<NUMBER> rna isolated pharyngeal swab specimen amplified using qrtpcr kits bgi genomics beijing china recommended chinese center disease control prevention cdc routine laboratory tests including lymphocyte counts neutrophil counts serum levels ast aspartate aminotransferase alt alanine aminotransferase fpg fasting plasma glucose ck creatine kinase crp creactive protein tc total cholesterol tg triglyceride measured using commercial reagents according manufactures introductions article protected copyright rights reserved line american diabetes association guidelines patients identified diabetes mellitus currently treated insulin oral hypoglycemic agents fpg concentration ≥<NUMBER> mmoll least two separate occasions <NUMBER> present study mildmoderate severecritical covid<NUMBER> cases classified nonsevere severe groups respectively continuous variables expressed mean ± sd median interquartile range categorical variables expressed numbers unpaired ttest χ² test fishers exact test used compare characteristics covid<NUMBER> patients without diabetes mellitus appropriate logistic regression analysis used estimate risk covid<NUMBER> severity severecritical infection calculating odds ratios <NUMBER> confidence intervals cis statistical analyses performed using sas <NUMBER> software sas institute cary nc usa twosided p value <NUMBER> defined statistically significant based guidelines preferred reporting items systematic reviews metaanalyses prisma <NUMBER> metaanalysis conducted combining results present study previous studies reported effects diabetes mellitus severity fatality hospitalized covid<NUMBER> cases exclusion criteria following <NUMBER> repeated articles letters comments editorials expert opinions <NUMBER> case reports <NUMBER> review metaanalysis articles <NUMBER> studies without available data first searched relevant studies pubmed embase medrxiv cochrane library cnki databases articles published <NUMBER> using following terms covid<NUMBER> sarscov<NUMBER> <NUMBER>ncov ncip diabetes diabetes mellitus included metaanalysis article protected copyright rights reserved associations diabetes mellitus covid<NUMBER> severity study <NUMBER> grouping patients covid<NUMBER> based disease severity <NUMBER> show available data number diabetic patients sarscov<NUMBER> infection <NUMBER> published english chinese <NUMBER> including least <NUMBER> cases searched reference lists relevant publications manually identify studies finally twelve studies met criteria <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> second searched relevant studies metaanalysis relationship diabetes mellitus covid<NUMBER> fatality described included articles <NUMBER> show available data number diabetic patients <NUMBER> show available data number deaths sarscov<NUMBER> infected diabetic patients <NUMBER> published english chinese <NUMBER> including least <NUMBER> cases total six studies satisfied criteria <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> quality included studies evaluated using newcastleottawa scale nos table s<NUMBER> figure s<NUMBER> depicted flow study selection process two authors jw jz independently extracted data disagreements discussed third author cd extracted information authors date publication sample size range age number diabetes mellitus cases number severe fatality cases effect size potential heterogeneity studies examined using <NUMBER> judgment model <NUMBER> <NUMBER> means heterogeneity among included studies fixedeffects model selected otherwise means results independent studies due sampling errors randomeffects model must selected <NUMBER> funnel plot eggers test used examine potential publication bias <NUMBER> metaanalysis performed using package meta r software r version <NUMBER> reported p values twotailed <NUMBER> considered statistically significant unless otherwise specified article protected copyright rights reserved <NUMBER> diabetic <NUMBER> nondiabetic cases among <NUMBER> hospitalized covid<NUMBER> patients included study results shown seven cases <NUMBER> diagnosed severe sarscov<NUMBER> infections diabetic patients significantly higher nondiabetic group <NUMBER> <NUMBER> p<NUMBER> compared nondiabetic covid<NUMBER> cases diabetic patients sarscov<NUMBER> infection likely higher levels crp p<NUMBER> neutrophil counts p<NUMBER> admission expected mean bmi <NUMBER> ± <NUMBER> kgm <NUMBER> diabetic patients significantly higher nondiabetic cases <NUMBER> ± <NUMBER> kgm <NUMBER> p<NUMBER> however significant differences observed characteristics two groups table <NUMBER> results shown table <NUMBER> <NUMBER> estimated effect sizes similar sensitivity analysis regardless exclusion single study oneatatime figure<NUMBER>b furthermore subgroup analysis results revealed pooled <NUMBER> <NUMBER> ci <NUMBER> patients aged <NUMBER> years <NUMBER> <NUMBER> ci <NUMBER> patients aged ≥<NUMBER> years respectively fig <NUMBER> addition funnel plots eggers test t<NUMBER> p <NUMBER> show existence potential publication bias present metaanalysis figure s<NUMBER>a <NUMBER> sensitivity analysis showed exclusion single study oneatatime alter direction statistical difference figure <NUMBER>b similarly funnel plots eggers test t<NUMBER> p <NUMBER> show existence potential publication bias present study figure s<NUMBER> b knowledge first study address effect diabetes mellitus covid<NUMBER> severity first metaanalysis investigate associations diabetes mellitus severity fatality sarscov<NUMBER> infection results shown among hospitalized cases severity rate sarscov<NUMBER> article protected copyright rights reserved infection diabetic patients <NUMBER> much higher nondiabetic covid<NUMBER> patients <NUMBER> present metaanalysis diabetic patients covid<NUMBER> showed <NUMBER>and <NUMBER>fold higher risks severity fatality compared nondiabetic covid<NUMBER> patients respectively indeed chronic conditions influencing severity sarscov<NUMBER> diabetes hypertension obesity also addressed respiratory illnesses sars mers example yang et al reported prevalence known diabetes among dead sars patients much higher <NUMBER> survivors <NUMBER> <NUMBER> addition severe merscov infection reported range <NUMBER> <NUMBER> diabetic subjects <NUMBER> <NUMBER> although exact interaction diabetes mellitus virus infection well understood results previous studies could partially explain findings first host defense virus infection largely mediated innate immunity synthesis related cytokines interleukins interferon etc <NUMBER> however diabetes related conditions downregulate immune system impairing function innate immunity chemotaxis phagocytosis activity neutrophils macrophages lead severe illnesses <NUMBER> second recent studies reported many patients severe particularly fatal course covid<NUMBER> seemed die small pulmonary embolithrombosis <NUMBER> <NUMBER> considering diabetic mellituswas significantly associated development myocardial infarction cerebrovascular thromboses rational hypothesize diabetes mellitus might increase poor outcomes srascov<NUMBER> infection inducing hypercoagulable state covid<NUMBER> patient third similar sarscov sarscov<NUMBER> infection mediated binding spike protein cellular receptor angiotensinconverting enzyme <NUMBER> ace<NUMBER> also plays pivotal role development diabetes article protected copyright rights reserved mellitus <NUMBER> <NUMBER> furthermore addition heart lung ace<NUMBER> expressed brain liver placenta kidneys providing potential mechanism severity symptoms multiorgan dysfunction observed severe covid<NUMBER> patients <NUMBER> last results previous studies reported influenza virus sarscov infection could induce transient elevation fpg levels <NUMBER> <NUMBER> although similar effects sarscov<NUMBER> infection observed patients cannot conclude sarscov<NUMBER> infection affect fpg level limited sample size present study recently increasing clinical studies noticed circulating crp levels lymphocyte neutrophil counts significantly associated covid<NUMBER> severity example zhang et als study wuhan reported median crp level <NUMBER> mgl iqr <NUMBER>mgl severe covid<NUMBER> patients much higher nonsevere patients <NUMBER> crp well known asa sensitive acutephase reactant plays instructive role acquired immune response <NUMBER> additionally neutrophil lymphocyte counts significant predictors crp sarscov infections <NUMBER> similarly results showed crp levels neutrophilcounts clearly increased diabetic patients sarscov<NUMBER> infection however significant difference lymphocyte counts observed covid<NUMBER> patients without diabetes mellitus addition present results showed adjustment lymphocyte count crp could significantly affect associations diabetes mellitus covid<NUMBER> severity table s<NUMBER> indicating studies conducted explore characteristics inflammation induced sarscov<NUMBER> infection diabetic patient pooling studies together larger sample size observed significant association diabetes mellitus severity fatality sarscov<NUMBER> infection sensitivity analysis exclusion studies one one change article protected copyright rights reserved results materially suggesting included study might particularly strong influence results however limitations study discussed first publication bias inevitable metaanalysis relevant articles may missed included englishand chinesewritten studies second studies lacked information necessary properly evaluated example researchers explain exact date biomarkers measurement viral load lymphocyte counts crp alt ast etc additionally potential impact antidiabetic drugs outcomes included diabetic patients addressed studies might weak interpretation findings third due limited number patients outcomes study adjustment might cause overfitting issue multivariable model therefore studies large samples conducted validate findings although adjustment potential confounding oneatatime alter direction statistical difference except lymphocyte count crp table s<NUMBER> last given included studies retrospective study design may bias regarding collecting medical information retrospective manner therefore caution considered interpret findings however would difficult conduct randomized controlled trials ethical issues summary present findings provided new evidence diabetes mellitus could significantly increase risks severity fatality sarscov<NUMBER> infection article protected copyright rights reserved past two decades pandemics severe acute respiratory infections sari serious threats global health causing significant morbidity mortality reassorted novel strains influenza viruses coronaviruses continue arise rendering vaccinations developed less useful posing increased risks humans two prominent viruses <NUMBER> influenza h<NUMBER>n<NUMBER> middle east respiratory syndrome coronavirus merscov markedly affected humans h<NUMBER>n<NUMBER> since <NUMBER> pandemic caused <NUMBER> deaths directly via respiratory infections indirectly cardiovascular diseases secondary bacterial infections <NUMBER> addition merscov since first emergence <NUMBER> infected <NUMBER> individuals causing <NUMBER> deaths reported <NUMBER> countries although vast majority reported cases originated arabian peninsula <NUMBER> h<NUMBER>n<NUMBER> merscov target respiratory tract share many similar clinical symptoms common symptoms fever cough shortness breath sore throat <NUMBER> followed always gastrointestinal symptoms nausea vomiting diarrhea <NUMBER> <NUMBER> <NUMBER> <NUMBER> diseases often lead complications pneumonia acute respiratory distress syndrome organ failure even death <NUMBER> <NUMBER> <NUMBER> complications mostly lie within respiratory system organ failure commonly noted respiratory system followed renal cardiovascular systems <NUMBER> individuals infected h<NUMBER>n<NUMBER> usually belong aged <NUMBER> <NUMBER> years <NUMBER> <NUMBER> mean age early <NUMBER>s <NUMBER> <NUMBER> merscov hand mostly infects older adults median age <NUMBER> years <NUMBER> difference hypothesized related development crossreactive antibodies influenza viruses previous exposures seasonal influenza elder people <NUMBER> another difference h<NUMBER>n<NUMBER> merscov relates length incubation period h<NUMBER>n<NUMBER> short incubation period <NUMBER> <NUMBER> days <NUMBER> whereas merscov much longer period <NUMBER> days <NUMBER> many infected individuals exhibit comorbidities eg diabetes hypertension asthma obesity rendering susceptible complications <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> diabetes one known documented contributing hostrelated risk factor h<NUMBER>n<NUMBER> merscov severe cases frequent individuals developing fatal disease complications <NUMBER> <NUMBER> <NUMBER> <NUMBER> observation may suggest etiological relationship diabetes acute viral respiratory infections diabetes related conditions downregulate innate humoral immune systems reducing function cells neutrophils <NUMBER> hyperglycemia impairs critical components innate immunity vitro chemotaxis phagocytosis bactericidal activity neutrophils macrophages lead secondary infections <NUMBER> direct influence diabetes however acute respiratory infections outbreaks <NUMBER> influenza h<NUMBER>n<NUMBER> middle east respiratory syndrome coronavirus merscov presented considerable global public health threat past years evidence suggest infected subjects also diabetic likely susceptible severe outcome h<NUMBER>n<NUMBER> merscov systematic analysis <NUMBER> h<NUMBER>n<NUMBER> cases <NUMBER> merscov cases indicated overall prevalence <NUMBER> <NUMBER> diabetes h<NUMBER>n<NUMBER> merscov cases respectively may suggest possible etiological relationship diabetes two infectious conditions introduction effective public health vaccination intervention strategies severe acute respiratory infections developed target subjects chronic disorders diabetes obesity cardiovascular conditions article still needs research estimate frequency diabetes severe viral conditions elucidate etiologic role diabetes disease severity <NUMBER> present study undertaken conduct systematic review metaanalysis published literature describe prevalence diabetes two emerging severe acute respiratory infections h<NUMBER>n<NUMBER> merscov explore possible contribution severity complication two viral conditions search conducted pubmed ovid medline embase embase classic databases last week july <NUMBER> using search terms mesh h<NUMBER>n<NUMBER> merscov middle east respiratory syndrome coronavirus diabetes search resulted <NUMBER> articles selected title abstract review satisfied selection criteria see limited studies humans excluded reports published review articles letters case studies editorials conference abstracts vaccination trials familybased studies eliminating duplicate listings considering articles full text total <NUMBER> peerreviewed original studies selected full text review full article review resulted exclusion <NUMBER> reports documenting prevalence diabetes h<NUMBER>n<NUMBER> merscov ie association studies examining small number travellers case report n<NUMBER> subjects reporting seasonal influenza alone reviewing already reported cases merscov simply documenting national surveys bibliography search remaining articles identified two additional studies total <NUMBER> peerreviewed articles <NUMBER> studies h<NUMBER>n<NUMBER> <NUMBER> <NUMBER> merscov <NUMBER> identified article figure <NUMBER> abstracts identified studies independently reviewed two readers ab sj differences resolved discussions consensus reached percentage agreement cohens kappa k statistic <NUMBER> calculated interpreted accordance landis kochs benchmarks <NUMBER> assessing agreement reviewers poor <NUMBER> slight <NUMBER> fair <NUMBER> moderate <NUMBER> substantial <NUMBER> excellent <NUMBER> agreement inclusion two reviewers <NUMBER> k<NUMBER> <NUMBER> ci <NUMBER> methodological quality study evaluated previously described <NUMBER> modification quality study based four criteria number study subjects n least median <NUMBER> h<NUMBER>n<NUMBER> <NUMBER> merscov b comprehensive reporting patients demographic information c describing minimum <NUMBER> diseaseassociated symptoms reporting least <NUMBER> comorbidities addition diabetes criterion study given score <NUMBER> <NUMBER> <NUMBER> fulfilling criteria total score calculated study score range <NUMBER> quality scores <NUMBER> <NUMBER> <NUMBER> <NUMBER> considered poor fair good good respectively data extracted selected studies included first authors name publication date country dates recruitment ethnicity total sample size divided males females age prevalence symptoms including fever shortness breath sore throat cough acute physiology chronic health evaluation ii apacheii percentage comorbidities time presentation including obesity immunosuppression hiv heart conditions hypertension cardiovascular diseases andor coronary arterial diseases tables <NUMBER> <NUMBER> weighted average used calculate average age overall prevalence clinical symptoms comorbidities publication bias assessed visual inspection funnel plot figure <NUMBER> eggers test eggers test widely used assess tendency effects estimated small sample size studies differ estimated larger studies results eggers test presented terms bias coefficient measure prevalence diabetes two viral conditions extracted proportion disease reported cases severe respiratory infections subgroup analysis carried region h<NUMBER>n<NUMBER> studies table <NUMBER> region subgroup analysis merscov doable since identified studies conducted saudi populations one study pooled analysis regioncountry designation possible primary outcome measure evaluate prevalence diabetes h<NUMBER>n<NUMBER> merscov cases metaanalysis proportions <NUMBER> cis calculated identified studies figure <NUMBER> subgroup analysis within region table <NUMBER> metaanalysis tests conducted using openmeta analyst version <NUMBER> free crossplatform opensource program <NUMBER> used binary randomeffects model since assumed relationship diabetes severe respiratory infection varied across populations ttest used compare average age h<NUMBER>n<NUMBER> merscov since factor normally distributed two sets studies mannwhitney utest employed compare prevalence clinical symptoms comorbidities two diseases conditions normally distributed assess whether true heterogeneity among selected studies studies evaluating effect used q test <NUMBER> q test informs presence versus absence heterogeneity report extent heterogeneity therefore calculated <NUMBER> index complement q test quantify degree heterogeneity among studies <NUMBER> given poor power q test detect true heterogeneity among small number studies also quantified true heterogeneity estimating betweenstudy variance randomeffects model τ <NUMBER> previously described <NUMBER> p<NUMBER> considered statistically significant forest plots used illustrate prevalence diabetes h<NUMBER>n<NUMBER> merscov severity selected studies inspect heterogeneity individual findings present systematic review examines relationship diabetes h<NUMBER>n<NUMBER> merscov total <NUMBER> studies report prevalence diabetes h<NUMBER>n<NUMBER> n<NUMBER> cases <NUMBER> studies table <NUMBER> merscov n<NUMBER> cases <NUMBER> studies table <NUMBER> selected funnel plot figure <NUMBER> demonstrated nonsymmetrical distribution effect size study either side pooled estimate seemingly nonsymmetrical appearance plot suggested evidence publication bias eggers test also supported notion particularly merscov studies bias coefficient statistically significant given assumption evidence smallstudy effects based p<NUMBER> p<NUMBER> h<NUMBER>n<NUMBER> studies p<NUMBER> merscov studies findings supported significant heterogeneity p<NUMBER> among selected studies see according quality scoring criteria see majority studies fair score <NUMBER> <NUMBER> reports good score <NUMBER> <NUMBER> reports quality <NUMBER> studies fulfilled quality scoring criteria score <NUMBER> good within selected studies sexratio malefemale majority h<NUMBER>n<NUMBER> reports <NUMBER> whereas <NUMBER> merscov cases <NUMBER>±<NUMBER> vs <NUMBER>±<NUMBER> combined frequencies cardiovascular diseases hypertension cardioartillery diseases <NUMBER>fold higher merscov cases h<NUMBER>n<NUMBER> <NUMBER>±<NUMBER> vs <NUMBER>±<NUMBER> p<NUMBER> metaanalyses proportion diabetes h<NUMBER>n<NUMBER> merscov shown figures <NUMBER> <NUMBER> respectively overall proportion diabetes h<NUMBER>n<NUMBER> <NUMBER> <NUMBER> ci <NUMBER> <NUMBER>fold lower proportion merscov <NUMBER> <NUMBER>ci <NUMBER> two sets studies displayed significant heterogeneity p<NUMBER> among selected studies q test <NUMBER> h<NUMBER>n<NUMBER> vs <NUMBER> merscov additionally degree heterogeneity among studies statistically significant p<NUMBER> comparable two sets studies <NUMBER> index <NUMBER> h<NUMBER>n<NUMBER> vs <NUMBER> merscov betweenstudy variance randomeffects model markedly lower among h<NUMBER>n<NUMBER> studies τ <NUMBER> <NUMBER> merscov reports τ <NUMBER> <NUMBER> subgroup analysis region h<NUMBER>n<NUMBER> studies table <NUMBER> showed frequency diabetes h<NUMBER>n<NUMBER> asia north america <NUMBER> p<NUMBER> <NUMBER>fold higher prevalence cases recruited europe south america <NUMBER> p<NUMBER> cases africa <NUMBER> showed nonsignificant slightly lower diabetes prevalence compared asia north america noted however frequency estimate africa developed two studies compared <NUMBER> <NUMBER> studies asia north america respectively <NUMBER> studies europe south america heterogeneity tests studies included regional subanalyses exhibited significant overall heterogeneity q test p≤<NUMBER> degree heterogeneity among studies <NUMBER> index betweenstudy variance randomeffects model τ <NUMBER> test present systematic review evaluates frequency diabetes sari conditions h<NUMBER>n<NUMBER> merscov observed large difference volume literature total number subjects evaluated condition identified <NUMBER> studies h<NUMBER>n<NUMBER> <NUMBER> subjects <NUMBER> merscov <NUMBER> patients <NUMBER> selected studies <NUMBER> <NUMBER> quality score good good tables <NUMBER> <NUMBER> indicates large set studies sufficient enough number subjects substantiate outcome provided comprehensive reporting patients demographic information furthermore majority selected studies reported set diseaseassociated symptoms comorbidities permitted developing comprehensive profile infectious disease complication difference reflects discrepancy two diseases global h<NUMBER>n<NUMBER> versus regional merscov spread period emerged immediately following outbreak <NUMBER> h<NUMBER>n<NUMBER> triple reassortant swine influenza viruses contained genes avian swine human influenza viruses <NUMBER> <NUMBER> sustained rapid betweenhuman transmission spread globally <NUMBER> hand <NUMBER> emergence merscov great extent contained within arabian peninsula <NUMBER> dromedary camels identified intermediate host <NUMBER> closely related virus sequences found bats <NUMBER> apart number nosocomial outbreaks involving healthcare workers caring merscov patients little evidence initially reported sustained persontoperson transmission <NUMBER> however <NUMBER> merscov outbreak republic korea demonstrated among <NUMBER> cases <NUMBER> transmission events linked <NUMBER> superspreaders pneumonia presentation contacted hundreds people adding evidence persontoperson transmission merscov <NUMBER> characteristic pattern transmission spread h<NUMBER>n<NUMBER> merscov may resulted distinctive sexratio condition merscov cases exhibited sexratio malefemale <NUMBER> twice noted h<NUMBER>n<NUMBER> cases tables <NUMBER> <NUMBER> male predominance merscov reflects higher likelihood exposure infectious agent males females middle eastern cultures addition males tested positive virus died also underlying medical conditions could explain severity cases older males <NUMBER> agreement merscov cases significantly older <NUMBER>±<NUMBER> years h<NUMBER>n<NUMBER> <NUMBER>±<NUMBER> years counterparts average age h<NUMBER>n<NUMBER> patients similar h<NUMBER>n<NUMBER> cases <NUMBER> percent subjects <NUMBER> years younger <NUMBER> noted h<NUMBER>n<NUMBER> cases estimated <NUMBER> elder people may residual immunity h<NUMBER>n<NUMBER> flu strain following lifetime exposures multiple influenza outbreaks <NUMBER> <NUMBER> <NUMBER> <NUMBER> immunogenicity apply coronaviruses may explain younger average age h<NUMBER>n<NUMBER> cases compared merscov cases indeed proposed <NUMBER> years ago repeated exposures antigenic variants influenza viruses may result antibodies recognizing large number common flu antigens develop reinforced immunity lower risk infection newly emerging variants <NUMBER> clinical presentations sari generally include respiratory symptoms fever new onset exacerbation cough breathing difficulty sore throat severe illnesses may vary pneumonia acute respiratory distress syndrome encephalitis myocarditis severe lifethreatening complications <NUMBER> frequency fever shortness breath sore throat cough similar h<NUMBER>n<NUMBER> merscov cases contrast underlying medical conditions comorbidities varied significantly two viral conditions patients merscov <NUMBER>fold higher rates obesity p<NUMBER> <NUMBER>fold higher combined frequencies cardiovascular diseases hypertension cardioartillery diseases p<NUMBER> tables <NUMBER> <NUMBER> varying rates comorbidities h<NUMBER>n<NUMBER> merscov cases may relate different patterns regional spread cardiovascular diseases highly prevalent middle east <NUMBER> many regions world <NUMBER> <NUMBER> observation also applies obesity although lower prevalence obesity males arabian peninsula versus females <NUMBER> higher predominance merscov patients see together may combined render occurrence obesity merscov nonsignificantly different h<NUMBER>n<NUMBER> increased risk developing severe h<NUMBER>n<NUMBER> merscov complications people underlying chronic diseases similarly reported seasonal influenza recent study noted compared subjects comorbidities severe cases influenza likely manifest obesity mortality <NUMBER> <NUMBER>ci <NUMBER> cardiovascular diseases <NUMBER> <NUMBER> hypertension <NUMBER> <NUMBER> neuromuscular disease <NUMBER> <NUMBER> <NUMBER> studies examining link sari metabolic syndromerelated complications obesity cardiovascular conditions needed evaluate contribution severity infectious diseases overall proportion diabetes <NUMBER>fold higher merscov cases <NUMBER> h<NUMBER>n<NUMBER> counterparts <NUMBER> figures <NUMBER> <NUMBER> agreement odds ratio severe h<NUMBER>n<NUMBER> diabetic subjects ranging <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER>fold lower severe merscov ranging <NUMBER> <NUMBER> <NUMBER> although varying extents findings implicate diabetes risk factor sever merscov h<NUMBER>n<NUMBER> one reason difference may relate higher average age merscov cases given older age known risk factor type <NUMBER> diabetes <NUMBER> although younger middle eastern populations rates diabetes risk factors <NUMBER> higher older populations disease prevalence increased across age groups rather older adults region <NUMBER> another possible explanation attributed high prevalence diabetes middle east arabian peninsula <NUMBER> merscov originated spread compared prevalence world regions <NUMBER> similar increased rates tuberculosis noted regions high diabetes prevalence <NUMBER> additionally subgroup analysis region demonstrated diabetes frequency h<NUMBER>n<NUMBER> cases asia north america <NUMBER>fold higher europe south america table <NUMBER> coincides high prevalence diabetes asia north america <NUMBER> compared europe south central america <NUMBER> <NUMBER> however despite lines evidence suggesting influence region viral spread diabetes proportion severe cases sari rate diabetes merscov still <NUMBER>fold higher h<NUMBER>n<NUMBER> cases asia <NUMBER> <NUMBER> ci <NUMBER> p<NUMBER> table <NUMBER> diabetes rates comparable regions merscov observation suggests higher prevalence diabetes merscov cases h<NUMBER>n<NUMBER> may simply related regional differences viral spread etiologic role diabetes severe merscov cases may exist distinctive h<NUMBER>n<NUMBER> diabetes impair innate immune system <NUMBER> render individuals susceptible range infectious diseases severe illnesses <NUMBER> <NUMBER> <NUMBER> example seasonal influenza outbreaks compared healthy subjects diabetic patients shown <NUMBER>fold higher risk becoming critically ill acquire hospitalization <NUMBER>fold increased rates pneumoniarelated hospitalizations <NUMBER>fold elevated likelihood dying complications <NUMBER> diabetes share several common features infectious disorders complication endothelial dysfunction proinflammatory state attenuation innate immune response <NUMBER> cytokine overload related th<NUMBER> microbicidal action ifn th<NUMBER> antiinflammatory il<NUMBER> <NUMBER> <NUMBER> <NUMBER> shift severe viral infection accompanied increased cytokine levels arising diabetes detrimental endothelium lead range subsequent complications <NUMBER> dampened innate immunity shift th<NUMBER> th<NUMBER> responses implicated linking high prevalence allergy observed fatal viral infections eg dengue fever <NUMBER> furthermore diabetes impair macrophage lymphocyte functions subsequent status reduced immune response <NUMBER> individuals become increased risk severe infectious disease outcome support diabetesassociated hyperglycemia cellular insulinopenia known impair macrophage lymphocyte functions subsequent status reduced immune response <NUMBER> furthermore levels hba<NUMBER>c ≥<NUMBER> linked <NUMBER> increased risk pneumoniarelated complications hospitalization due lower immune response <NUMBER> host defense infection largely mediated cellular immunity synthesis related cytokines ifnand interleukins downregulated diabetes <NUMBER> <NUMBER> present study several limitations inspection funnel plot figure <NUMBER> eggers test indicates publication bias may derived smallstudy effect ie possibility including small studies spuriously overstated estimates ignoring without statistically significant effects may lower possibility published furthermore identified reports shown <NUMBER>fold amongstudies variance diabetes proportion h<NUMBER>n<NUMBER> <NUMBER> figure <NUMBER> merscov <NUMBER> figure <NUMBER> cases interstudy differences may contributed significant heterogeneity observed report additional sources heterogeneity may relate large variation among studies sample size <NUMBER> <NUMBER> h<NUMBER>n<NUMBER> cases <NUMBER> <NUMBER> merscov patients ethnic diversity study populations particularly within h<NUMBER>n<NUMBER> studies collected <NUMBER> counties furthermore heterogeneous methodologies due different study designs may influenced interstudy variation observation may levy limitations estimated contribution diabetes severe h<NUMBER>n<NUMBER> merscov cases render results guide generate accurate estimates national international intervention strategies severe sari conditions diabetic subjects furthermore although prevalence diabetes <NUMBER> severe h<NUMBER>n<NUMBER> cases <NUMBER> merscov may implicate causality warrants studies identify nature extent coexistence diabetes two respiratory infections another limitation low number merscov cases narrow geographic region recruited compared h<NUMBER>n<NUMBER> cases rendered subgroup analysis region unattainable merscov cases particular limitation may add weight suggestion stipulating difference diabetes prevalence h<NUMBER>n<NUMBER> merscov attributable regional difference spread small number merscov studies highlights need develop international collaborations include cases countries arabian peninsula eg korea recent cases emerged recently single study <NUMBER> examined merscov cases pooled various countries findings still limited small population size reports identified present study distinguish prevalence type <NUMBER> andor type <NUMBER> diabetes h<NUMBER>n<NUMBER> merscov cases exception three studies h<NUMBER>n<NUMBER> merscov <NUMBER> <NUMBER> <NUMBER> identified reports combined types diabetes despite different characteristics etiological factors clinical features cortes garcia et al <NUMBER> koegelenberg et al <NUMBER> clearly stated diabetic cases h<NUMBER>n<NUMBER> series type <NUMBER> cases jimenezgarcia et al <NUMBER> hand compared demographic characteristics underlying medical conditions inhospital case fatality risk cfr type <NUMBER> prevalence <NUMBER> type <NUMBER> prevalence <NUMBER> diabetic patients reported <NUMBER>fold higher cfr type <NUMBER> cases type <NUMBER> <NUMBER> given paucity information challenging distinguish two types diabetes role viral disease severity complication conclusion present study provides evidence greater prevalence diabetes merscov severity compared h<NUMBER>n<NUMBER> relationship causal however substantial proportion diabetes two infections suggests introducing effective strategies diabetes prevention may reduce severity significant number sari conditions specific systematic vaccination intervention strategies sari diseases also considered patients metabolic syndrome related disorders diabetes obesity cardiovascular conditions <NUMBER> viewed key public health strategy preventing sariassociated morbidity mortality <NUMBER> <NUMBER> pandemic response substantial morbidity mortality us surgeon general recommended annual influenza vaccination individuals chronic debilitating disease people aged ≥<NUMBER> years pregnant women <NUMBER> highrisk groups first recommendation national universal seasonal influenza vaccination established <NUMBER> advisory committee immunization practices acip <NUMBER> recently influenza vaccination demonstrated associated preventing allcause hospitalization infected subjects <NUMBER> however despite numerous recommendations several public health organizations across world eg cdc etc administer sari vaccines eg influenza annually diabetic patients vaccination rate vulnerable subpopulation remains low <NUMBER> <NUMBER> <NUMBER> current level vaccination falls far short <NUMBER> national health objectives call <NUMBER> rate elderly people ≥<NUMBER> years age <NUMBER> younger people risk factors eg diabetes <NUMBER> prevalence chronic diseases rising middleand lowincome countries populations age lifestyles diets change studies undertaken evaluate prevalence comorbidities h<NUMBER>n<NUMBER> merscov subsequent introduction effective public health vaccination intervention approaches strategies necessary improve protection sari subjects chronic disorders diabetes obesity cardiovascular conditions diabetes one important comorbidities linked severity three known human pathogenic coronavirus infections including severe acute respiratory syndrome coronavirus <NUMBER> patients diabetes increased risk severe complications including adult respiratory distress syndrome multiorgan failure depending global region <NUMBER> patients coronavirus disease <NUMBER> covid<NUMBER> pandemic diabetes given importance link covid<NUMBER> diabetes formed international panel experts field diabetes endocrinology provide guidance practical recommendations management diabetes pandemic aim briefly provide insight potential mechanistic links novel coronavirus infection diabetes present practical management recommendations elaborate differential needs several patient groups practical recommendations management diabetes patients covid<NUMBER> editor bidirectional relationship covid<NUMBER> diabetes one hand diabetes associated increased risk severe covid<NUMBER> hand newonset diabetes severe metabolic complications preexisting diabetes including diabetic ketoacidosis hyperosmolarity exceptionally high doses insulin warranted observed patients covid<NUMBER> manifestations diabetes pose challenges clinical management suggest complex pathophysiology covid<NUMBER>–related diabetes severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> virus causes covid<NUMBER> binds angiotensinconverting enzyme <NUMBER> ace<NUMBER> receptors expressed key metabolic organs tissues including pancreatic beta cells adipose tissue small intestine kidneys<NUMBER> thus plausible sarscov<NUMBER> may cause pleiotropic alterations glucose metabolism could complicate pathophysiology preexisting diabetes lead new mechanisms disease also several precedents viral cause ketosisprone diabetes including coronaviruses bind ace<NUMBER> receptors<NUMBER> greater incidences fasting glycemia acuteonset diabetes reported among patients sars coronavirus <NUMBER> pneumonia among nonsars pneumonia<NUMBER> aggregate observations provide support hypothesis potential diabetogenic effect covid<NUMBER> beyond wellrecognized stress response associated severe illness however whether alterations glucose metabolism occur sudden onset severe covid<NUMBER> persist remit infection resolves unclear frequent phenomenon newonset diabetes classic type <NUMBER> type <NUMBER> diabetes new type diabetes patients remain higher risk diabetes diabetic ketoacidosis patients preexisting diabetes covid<NUMBER> change underlying pathophysiology natural history disease answering questions order inform immediate clinical care followup monitoring affected patients priority address issues international group leading diabetes researchers participating covidiab project established global registry patients covid<NUMBER>–related diabetes covidiabedendritecom goal registry establish extent phenotype newonset diabetes defined hyperglycemia confirmed covid<NUMBER> negative history diabetes history normal glycated hemoglobin level registry expanded include patients preexisting diabetes present severe acute metabolic disturbance may also used investigate epidemiologic features pathogenesis covid<NUMBER>–related diabetes gain clues regarding appropriate care patients course covid<NUMBER> given short history human infection sarscov<NUMBER> understanding covid<NUMBER>–related diabetes develops natural history disease appropriate management helpful study covid<NUMBER>–related diabetes may also uncover novel mechanisms disease blockers arbs considered firstline agents diabetics due nephroprotective effects <NUMBER> administration drugs leads upregulation angiotensinconvertingenzyme<NUMBER> ace<NUMBER> <NUMBER> responsible viral entry severeacuterespiratorydistresssyndrome coronavirus<NUMBER> sarscov<NUMBER> <NUMBER> data lacking determine pulmonary effects aceisarbs may patients diabetes <NUMBER> could relevant management patients infected sarscov<NUMBER> study aim <NUMBER> assess prevalence pulmonary adverse drug effects ades diabetic patients taking acei <NUMBER> arbs help provide guidance medications could affect outcomes acute respiratory <NUMBER> illness sarscov<NUMBER> infection <NUMBER> <NUMBER>data unique data platform resulting collaboration across veterinary human healthcare <NUMBER> utilized intelligent medicine recommender system <NUMBER>drugassist developed using several national <NUMBER> international databases evaluate ades reported fda patients diabetes taking aceis <NUMBER> arbs <NUMBER> significantly higher incidence pulmonary ades compared aceis p <NUMBER> well arbs <NUMBER> p <NUMBER> though specific drugs also important pulmonary ades associated use <NUMBER> analyses suggest pharmacists clinicians need consider specific medications adverse <NUMBER> event profile particularly captopril profile may affect infections acute disease <NUMBER> states alter pulmonary function covid<NUMBER> <NUMBER> late <NUMBER> outbreak pneumonia later found caused severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> occurred wuhan china covid<NUMBER> patient symptomatology includes <NUMBER> fever dyspnea myalgia pneumonia also progress acute respiratory distress syndrome <NUMBER> ards acute cardiac injury well acute kidney injury death <NUMBER> study evaluating <NUMBER> patients <NUMBER> covid<NUMBER> found <NUMBER> patients comorbid conditions including <NUMBER> diabetes <NUMBER> <NUMBER> statistically significant difference p value <NUMBER> mortality patients <NUMBER> comorbid conditions including diabetes compared without <NUMBER> known long term <NUMBER> hyperglycemia deleterious effects many organ systemsmost notably eyes kidneys nerves <NUMBER> heart however less research described pathophysiologic effects diabetes may <NUMBER> respiratory system light recent covid<NUMBER> outbreak research needed understand <NUMBER> effects diabetes including medications prescribed patients diabetes may respiratory <NUMBER> system could impact management diseases covid<NUMBER> <NUMBER> reninangiotensin system ras implicated pathophysiology numerous disease states <NUMBER> including diabetic nephropathy hypertension drugs affecting system explored <NUMBER> manage nephropathy occurring patients diabetes angiotensinconverting enzyme inhibitors <NUMBER> aceis angiotensinii receptor blockers arbs currently recommended use patients <NUMBER> diabetes <NUMBER> currently available aceis differ based potency pharmacokinetics especially tissue <NUMBER> distribution whether molecule prodrug aceis also delineated three structural <NUMBER> classes based functional group responsible binding ace <NUMBER> although aceis arbs <NUMBER> generally considered similar adverse event profiles evaluation postmarketing adverse drug <NUMBER> events ades may shed light minute differences could important clinical impacts membranebound receptor involved ras found hostcell receptor responsible <NUMBER> viral entry also true sarscov lead outbreak <NUMBER> administration <NUMBER> aceis arbs well thiazolidinediones ibuprofen leads upregulated expression ace<NUMBER> <NUMBER> <NUMBER> upregulation ace<NUMBER> receptors theoretically puts patients higher risk infection sars<NUMBER> cov<NUMBER> target host receptors would available cellular virus entry conversely ace<NUMBER> <NUMBER> presence found protective lung tissue animal models due conversion angiotensin <NUMBER> ii angiotensin <NUMBER> vasodilatory properties animal models shown increase ace <NUMBER> concentration result pulmonary fibrosis asthma ards effects ace inhibiting <NUMBER> medications lower activity ace therefore concentration angiotensin ii <NUMBER> would theoretically protective patients developing ards <NUMBER> led hypothesis <NUMBER> aceisarbs may detrimental early sarscov<NUMBER> infection paradoxically protective later <NUMBER> stages ras exceedingly complex conflicting data available regarding contribution aceis <NUMBER> arbs mortality morbidity covid<NUMBER> patients <NUMBER> <NUMBER> study aimed assess individual aceisarbs particularly serious pulmonary adverse <NUMBER> event profiles could either place diabetics increased risk sarscov<NUMBER> infection due <NUMBER> diminished lung function may affect management patients <NUMBER> <NUMBER>data partnership university missourikansas city kansas state university <NUMBER> led development platform share human animal healthcare data <NUMBER> partnership public databases integrated <NUMBER>data database www<NUMBER>datalife study used <NUMBER> assess incidence ades related aceis arbs patients diabetes <NUMBER> data used study curated multiple publicly available data sources patients <NUMBER> includes pertinent data disease information drug information adverse drug event data <NUMBER> demographic information well outcome data <NUMBER> internationally ades terminologies reported similar process meddra database <NUMBER> ades terminologies hierarchically structured regulate information medical products global <NUMBER> level data structure terms organized accordance meddra terminology well use quantitative signal detection methods prr purpose able correct <NUMBER> analysis applying logistic regression known covariates age weight gender <NUMBER> combine approach prr improve analyses drug effects using diabetes data sets <NUMBER> found factors play significant role analysis data significantly found <NUMBER> important ades pulmonary edema dyspnea dysphonia cough bronchitis pleurisy therefore proceeded specific pairwise analysis captopril see distinctions <NUMBER> found thirteen different pulmonary ades selected assess related variation due <NUMBER> adverse event differences percent incidence reported pulmonary ades drug found <NUMBER> table <NUMBER> friedman tests also shows <NUMBER> captopril statistically significant increases pulmonary ades patients diabetes compared <NUMBER> aceis p <NUMBER> well compared arbs p <NUMBER> multiple comparison among <NUMBER> groups using test captopril vs acei<NUMBER> drugs vs arb drugs p value <NUMBER> seen <NUMBER> indicating significant differences pulmonary ades occurrences two drug groups compared <NUMBER> lower confidence interval <NUMBER> applying criteria captopril reportable <NUMBER> incidences majority reported pulmonary ades patients diabetes drugs including <NUMBER> arbs met criteria pulmonary ades supplementary table <NUMBER> show <NUMBER> trends across multiple ades depicted captopril <NUMBER> evaluation collated databases revealed captopril first acei approved back <NUMBER> <NUMBER> higher incidence pulmonary ades patients diabetes compared acei drugs p <NUMBER> <NUMBER> well statistically significant difference pulmonary events compared arbs p <NUMBER> <NUMBER> table <NUMBER> <NUMBER> captoprils high incidence pulmonary ades highlights fact drugs class identical figure <NUMBER> relative percentages reported pulmonary adverse events aceis arbs faers meddra databases organized drug march <NUMBER>th <NUMBER> coronavirus disease <NUMBER> covid <NUMBER> designated global pandemic world health organization <NUMBER>th may <NUMBER> confirmed cases reported ∼<NUMBER> deaths globally <NUMBER> countries <NUMBER> matter months escalated unprecedented public health well economic crisis several studies confirmed patients covid<NUMBER> show distinctive relatively significant comorbidities diabetes obesity cardiovascular disease cvd <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> furthermore covid<NUMBER> patients diabetes obesity cvd conditions higher risk morbidity mortality <NUMBER> <NUMBER> <NUMBER> conversely patients diabetes cvd obesity also higher risk contracting covid<NUMBER> infection <NUMBER> <NUMBER> <NUMBER> broadly speaking cvd diabetes obesity associated poor clinical outcomes <NUMBER> <NUMBER> therefore milieu covid<NUMBER> public health systems carers healthcare providers must take appropriate measures mitigate infection risks population consider health system reorganization adoption technologies sustain ongoing management <NUMBER> <NUMBER> <NUMBER> frontline healthcare workers triaging managing covid<NUMBER> patients consider various risks compounding effects prognoses patients cvd diabetes andor obesity independent medical problems cvd patients diabetes elevated risk infection covid<NUMBER> <NUMBER>to<NUMBER> fold <NUMBER> may attributed reduced functioning immune system caused high blood glucose levels <NUMBER> moreover diabetes often accompanied cvd obesity old age known increase risk infection <NUMBER> outcomes infection covid<NUMBER> also poor population <NUMBER> patients chinese center disease control prevention case series case fatality rate cfr elevated among diabetes cvd <NUMBER> <NUMBER> respectively compared overall cfr <NUMBER> <NUMBER> outcomes worse people poorly controlled diabetes additional chronic medical conditions cvd obesity <NUMBER> <NUMBER> recent metaanalysis eight studies china including <NUMBER> infected patients showed prevalent comorbidities high blood pressure <NUMBER> ± <NUMBER> <NUMBER> ci <NUMBER> diabetes <NUMBER> ± <NUMBER> <NUMBER> ci <NUMBER> followed cvd <NUMBER> ± <NUMBER> <NUMBER> ci <NUMBER> <NUMBER> time though mechanism associations remains unclear potential explanations include cvd prevalent advancing age functionally impaired immune system elevated levels angiotensinconverting enzyme <NUMBER> ace<NUMBER> predisposition covid<NUMBER> cvd <NUMBER> significant overlap risk factors cvd venous thromboembolism vte cvd risk factors older age smoking adiposity associated high vte risk <NUMBER> recent chinese study <NUMBER> covid<NUMBER> patients reported <NUMBER> n <NUMBER> high risk venous thromboembolism highrisk patients didnt receive prophylactic therapy <NUMBER> developed venous thromboembolism <NUMBER> <NUMBER>th april <NUMBER> intensive care national audit research centre icnarc united kingdom uk received notification <NUMBER> covid<NUMBER> positive cases requiring critical care <NUMBER> analysis data suggest significantly greater number covid<NUMBER> positive cases seasonal noncovid viral pneumonia patients obese body mass index bmi ≥<NUMBER> kgm <NUMBER> <NUMBER> compared <NUMBER> chisquare <NUMBER> p <NUMBER> requirement ventilatory support equal obese nonobese patients <NUMBER> <NUMBER> cases respectively p <NUMBER> obesity associated higher mortality rates critical care compared normal underweight covid<NUMBER> positive patients <NUMBER> compared <NUMBER> chisquare <NUMBER> p <NUMBER> data derive icnarc case mix programme database case mix programme national clinical audit patient outcomes adult critical care coordinated icnarc information representativeness quality data encourage readers contact icnarc <NUMBER> setting covid<NUMBER> specialist cardiologists endocrinologists confronted number critical issues management treatment cvd speculation regarding risk associated use ace inhibitors acei angiotensin receptor blockers arbs patients covid<NUMBER> <NUMBER> <NUMBER> particularly relevant patients diabetes cvd many rely pharmacotherapy treatment retinopathy nephropathy hypertension <NUMBER> though acei arb commonly used management cvds hypertension coronary artery disease congestive heart failure diabetes conflicting data studies <NUMBER> <NUMBER> <NUMBER> demonstrating increase minimal effect ace<NUMBER> levels <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> poor glycaemic index known cause immune suppression impaired neutrophil degranulation deficient complement system phagocytosis <NUMBER> coexistence cvd diabetes known risk factor several serious respiratory viral illnesses influenza <NUMBER> poor glycaemic control correlated worse prognosis diabetic patients infected covid<NUMBER> glucose control key prevention infection minimizing severity morbidity caused infection <NUMBER> however swift transition primary health care provision inperson teleconsultations led many patients unable access services regular checkups presumably due lack literacy access appropriate technology moreover increasing number physicians reported sudden decrease incidence myocardial infarction stroke acute conditions <NUMBER> <NUMBER> given prevalence conditions would invariably elevated circumstances indicates problematic decline number patients presenting hospital critical conditions likewise increasing concerns related postponement elective cardiac vascular surgeries pressure building available beds imminent select group patients clinical indication surgery cannot postponed receive therapy <NUMBER> furthermore impact postponement eventually receive prolonged delayed surgery vis vis longterm morbidity known patients diabetes cvd obesity physical exercise critical improving patient outcomes <NUMBER> implementation selfisolation however ability motivation engage physical exercise greatly diminished healthcare workers responsible care patients diabetes cardiovascular disorders infected covid<NUMBER> face threats wellbeing risk exposure high viral load <NUMBER> time critical acute myocardial cerebral infarction given reorganization healthcare services additional pressure frontline services covid<NUMBER> cases repurposing physicians meet demand additional resources limitations realized across spectrum delivering timecritical reperfusion therapy <NUMBER> likely reperfusion services also timeconstrained service hours due palpable risks covid<NUMBER> positive patients healthcare workers delivering reperfusion therapy significant negative impact delays reperfusion therapy patients acute neurocardiovascular events including acute myocardial infarction ami acute ischemic stroke ais may recommended follow overarching covid<NUMBER> protocol screen positive cases order minimize risk healthcare workers <NUMBER> refugees undocumented immigrants members aboriginal communities also limited provisions access medical relief pandemic situations due structural factors poor socioeconomic conditions put compounded risk due cardiovascular diabetes comorbidities professional societies american association clinical endocrinologists <NUMBER> european society endocrinology <NUMBER> agreement need people diabetes prevent prepare spread covid<NUMBER> taking regular precautions staying home much possible washing hands regularly guidelines also advise people continue taking medication order maintain glucose control stock additional <NUMBER>day supply medication supplies monitoring blood glucose levels home however specific guidelines targeted individuals multiple comorbidities obesity cvd per guidance given international diabetes federation context covid<NUMBER> pandemic people diabetes among high risk categories serious illness like flu get virus best rush hospital avoid transmitting virus others allow priority arrangements made medical personnel needed instead wait line <NUMBER> international society pediatric adolescent diabetes ispad updated guidelines recently <NUMBER> march <NUMBER> amidst recent covid<NUMBER> pandemic <NUMBER> nhs clinical guidelines management diabetic patients covid<NUMBER> recommend expedition treatment discharge inpatients use virtual clinics teleconsultations primary secondary care settings <NUMBER> however guidelines fail address need extra measures taken care patients poor access literacy regards technology moreover elderly patients chronic disability living nursing homes aged care facilities heightened risk infection patients often high prevalence comorbid cardiovascular diabetes risk factors makes vulnerable pandemic covid<NUMBER> increasing reports acts microaggression xenophobia discrimination surfacing since inception pandemic particularly relevant specific populations southasians high rates diabetes <NUMBER> current approaches management population aim continue care patients covid<NUMBER> minimizing risk transmission healthcare workers patients current protocol academic medical centers china acute myocardial infarction involves compulsory screening fever respiratory symptoms patients stemi suspected confirmed infection treated emergency intravenous thrombolysis absence contraindications <NUMBER> cardiologists operating theater strict guidelines regarding hand hygiene personal protective equipment ppe followed number people operating theater minimized <NUMBER> american college cardiology urges implementation telehealth cardiology clinics <NUMBER> societies including european society cardiology british cardiovascular society cardiac society australian new zealand csanz high blood pressure research council australia hbprca australian national heart foundation nhf australian new zealand society cardiac thoracic surgeons anzscts also recommend use telehealth services <NUMBER> <NUMBER> <NUMBER> regard use acei arbs several societies highlighted due limited nature evidence matter advisable ongoing management medication may continue patients diabetes hypertension unless otherwise clinically contraindicated per case profile <NUMBER> <NUMBER> <NUMBER> ongoing studies bring clarity use acei arbs covid<NUMBER> patients diabetes hypertension recent study reported higher prevalence cvd <NUMBER> patients suffer myocardial injury infection <NUMBER> critically ill <NUMBER> though ace<NUMBER> serves main gateway infection role acei arbs requires investigation myocardial injury present quarter critical cases presents two patterns acute myocardial injury dysfunction presentation myocardial injury develops severity illness intensifies <NUMBER> <NUMBER> <NUMBER> <NUMBER> continuation clinically indicated acei arb medications recommended based available evidence time though number promising treatments investigation none proven clinical efficacy date covid<NUMBER> proved pose challenge heart transplantation impacting donor selection immunosuppression posttransplant management <NUMBER> general sick day diabetes management principles modified ispad guidelines <NUMBER> frequent blood glucose ketone blood urine monitoring <NUMBER> aim blood glucose level <NUMBER> <NUMBER> mmoll <NUMBER> mgdl blood ketones <NUMBER> mmoll child ill <NUMBER> never stop insulin fever insulin needs usually higher <NUMBER> monitor maintain hydration adequate salt water balance <NUMBER> treat underlying illness symptoms fever urgent specialist advicereferral emergency <NUMBER> fever vomiting persists andor weight loss continues suggesting worsening dehydration potential circulatory compromise <NUMBER> fruity breath odor acetone persists worsens blood ketones remain elevated <NUMBER> mmoll urine ketones remain large despite extra insulin hydration <NUMBER> patient becoming exhausted confused hyperventilating kussmaul breathing severe abdominal pain <NUMBER> identify covid<NUMBER> patients highrisk venous thromboembolism vte including prolonged immobility overlapping cardiovascular disease cvd risk factors adiposity age smoking high estrogen levels including exogenous hormone therapy consider initiating appropriate prophylaxis higher risk bleeding due anticoagulation adjust anticoagulation dose duration well use mechanical compression <NUMBER> patients body mass index bmi <NUMBER> kgm <NUMBER> higher considered high risk given association patients significantly higher mortality covid<NUMBER> infection patients need close monitoring teleconsultation <NUMBER> patients increased risk qtc interval prolongation lifethreatening cardiac arrhythmic events andor sudden cardiac death eg covid<NUMBER> positive patients history diabetes andor cvd andor b postexposure prophylaxis treatment covid<NUMBER> using offlabel drugs hydroxychloroquine azithromycin lopinavirritonavir growing evidence suggests covid<NUMBER> burdened higher risk lifethreatening cardiac arrhythmic events especially group patients diabetes andor obesity important implications survival <NUMBER> lifethreatening arrhythmias also related inflammation increase duration ventricular repolarization qtc interval <NUMBER> particular attention inflammation arrhythmias important patients frequently affected qtc prolongation <NUMBER> <NUMBER> therefore key electrocardiogram ecg parameters qtc interval monitored subgroup patients surveillance qtc could potentially reduce number druginduced ventricular arrhythmias sudden cardiac deaths <NUMBER> particularly relevant offlabel agents hydroxychloroquine azithromycin lopinavirritonavir increasingly used postexposure prophylaxis treatment covid<NUMBER> patients <NUMBER> <NUMBER> drugs proven increase risk qtc interval prolongation ventricular tachycardia torsades de pointes sudden cardiac death <NUMBER> patients diabetes multiple comorbidities obesity cvd take extra precaution prevention possible infection risk due covid<NUMBER> recommended virtual contact primary health carers maintain glycaemic control diligence ensure maintenance adequate glucose control exceptional circumstances recommended primary health care physicians take additional interestresponsibility reach patients presented regular checkups main recommendations pediatric adolescents diabetes cvd summarized table <NUMBER> due alarming decline patients presenting emergent conditions hospitals outpatient clinics without indications fall prevalence conditions would request public health professions take extra measures reaching patients regarding safety coming hospitals medical need benefit getting timely acute reperfusion therapy eligible patients given aggravated risks propose novel triage management protocol takes account risks cvd diabetes figure <NUMBER> virtual delivery group exercise classes could organized patients diabetes cvd obesity currently restricted social isolation crossdepartment peertopeer interspecialty professional collaboration communication recommended adapt existing pandemic preparedness response strategies manage patients neuro cardiovascular emergencies special protection must observed interventions produce aerosol cardiopulmonary resuscitation may lower risk infection healthcare workers patients cardiovascular experts may brace deployments different settings limited extended repurposed causes mobility staff covid<NUMBER> treatment units patient facing consultation limited avoid opportunities nosocomial transmission covid<NUMBER> patients cvd diabetes obesity impact compounding negative dimensions patients increased risk covid<NUMBER> related hospitalization morbidity death covid<NUMBER> also show propensity increasing emergent acute cardiovascular events important identify covid<NUMBER> patients high risk vte appropriate prophylaxis treatment could initiated <NUMBER> <NUMBER> anticoagulation considered vte prophylaxis given high risk bleeding covid<NUMBER> patients high vte risk considerations include adjustments anticoagulant dose duration well use mechanical compressions <NUMBER> obesity associated severe covid<NUMBER> <NUMBER> <NUMBER> <NUMBER> moreover obesity higher bmi known associated higher risk cvd diabetes hypertensionwhich independent predictors poor outcomes covid<NUMBER> <NUMBER> <NUMBER> analyses icnarc data suggest bmi≥<NUMBER> kgm <NUMBER> used prognostic indicator mortality critical care settings due covid<NUMBER> <NUMBER> another recent study found significant association prevalence obesity defined bmi≥<NUMBER> kgm <NUMBER> severe covid<NUMBER> <NUMBER> recommend clinicians consider bmi≥<NUMBER> estimating risks stratifying patients early ongoing intervention center disease control prevention cdc united states also list obesity although relatively higher bmi cutoff ≥<NUMBER> kgm <NUMBER> independent risk factor severe illness covid<NUMBER> <NUMBER> concerns bmi cutoff ≥<NUMBER> kgm <NUMBER> might mislead compromise safety obese people lower bmis <NUMBER> current consortium recommends bmi cutoff <NUMBER> kgm <NUMBER> identifying patients adverse covid<NUMBER> prognosis surveillance ecg parameters recommended potentially reduce risk lifethreatening arrhythmic events sudden cardiac death covid<NUMBER> positive patients especially history diabetes andor obesity andor postexposure prophylactic treatment <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> addition clinical management public health interventions must adhered masks preferably n<NUMBER> washing hands social distancing new england journal medicine study showed efficacy face masks preventing transmission coronavirus symptomatic individuals <NUMBER> evident guidance currently issued world health organization cdc united states canadian standards association canadian federal guidance canada uk differences exist advice healthcare workers use respirators opposed surgical face masks <NUMBER> <NUMBER> <NUMBER> uk initially advocated covid<NUMBER> classified airborne high consequence infectious disease uk instructed ensure staff assessing caring suspected covid<NUMBER> cases familiar ffp<NUMBER> respirator conforming en<NUMBER> protection level higher n<NUMBER> fit testing undertaken using equipment <NUMBER> current uk position aligns guidance although recommending figure <NUMBER> proposed cardiovascular disease diabetes riskadjusted stagewise tele inhospital triage management protocol <NUMBER> patients seeking outpatient inhospital appointment except emergency cases must dial hospital triage telephone risk assessment covid<NUMBER> cases prior consultation triage carried relevant department officer comprise brief screening signs symptoms risk factors covid<NUMBER> questions address recent travel history fever cough sore throat shortness breath fatigue aches pains headaches runny stuffy nose diarrhea sneezing loss smell patients screened body mass index bmi bmi ≥ <NUMBER> closely monitored strongly advised selfisolate follow public health guidelines patients bmi ≥ <NUMBER> significant risk mortality covid<NUMBER> infection <NUMBER> patients despite risk factors symptoms asked attend compulsory teleconsultation order minimize harm patient consultant consultation assessment covid<NUMBER> symptoms made potential impact underlying diabetescardiovascular disease assessed <NUMBER>a selfreported acute emergency patient need immediate medical attention per clinical judgement physician patient asked continued figure <NUMBER> present emergency department b immediate medical assessment required management carried via teleconsultation <NUMBER> emergency department relevant steward must carry secondary screening covid<NUMBER> symptoms screening patients undergo diagnostic testing covid<NUMBER> drivethrough testing facilities deployed patients minimize exposure health systems health workers community imaging also carried patients extra precautions taken ensure proper cleaning equipment imaging covid<NUMBER> positive patients <NUMBER>a patients require surgery acute management plan invoked patient covid<NUMBER> positive measures must taken protect healthcare workers involved minimal number staff involved direct interface riskminimization ensured perisurgical procedures might involve aerosol production covid<NUMBER> negative patients routine management plan followed b surgery required nonacute management plan invoked <NUMBER> plan made ensure proper quarantine patients discharge could include home isolation telemonitoring patients advised follow hand hygiene wear masks practice social distancing risk assessment individual healthcare worker within guidance framework situation lowand middleincome countries made difficult lack resources uncertain availability respiratory ppe often intended single use recently cdc recommended wearing cloth face coverings public settings social distancing measures difficult maintain eg grocery stores pharmacies especially areas significant communitybased transmission <NUMBER> coronavirus like influenza rhinovirus possibly spread short range aerosol transmission exhaled breath therefore study reinforces need individual public health strategies adoption using face masks preventive intervention american academy ophthalmology aao recommends contact lens wearers switch wearing glasses limit risk covid<NUMBER> infection <NUMBER> pandemics like covid<NUMBER> sars spanish flu invoke irrational heightened fear could linked incidents xenophobia discrimination <NUMBER> public health crisis scale quickly mutate social political crisis therefore warranted political health systems leadership must continue transparent open respectful communication communities special consideration communities marginalized vulnerable backgrounds tend disproportionately poor cardiovascular metabolic profile <NUMBER> also subgroup patients often relatively poor access health services compromised provision medical supplies exacerbated public health crisis situation sustained period case pandemics covid<NUMBER> estimated mortality <NUMBER> however recent evidence suggests rates still evolving <NUMBER> <NUMBER> patients comorbid cvd diabetes obesity potentially vulnerable pandemic <NUMBER> <NUMBER> <NUMBER> must considered significant number healthcare workers vulnerabilities due preexisting health conditions therefore institutional policies provide redeployment away covid<NUMBER> patient direct contact furlough jurisdictions developed national policy workplace sector guidance others likely duty care law healthcare providers health systems political leadership must account heterogeneity compounded infection fatality risks longterm complications special considerations ongoing management well socioeconomic factors may interfere health wellbeing patients cvd diabetes andor obesity technological innovation telemedicine along public health strategies may mitigate risks original contributions presented study included articlesupplementary material inquiries directed corresponding authors authors note † covid<NUMBER> pandemic causing unprecedented public health crisis impacting healthcare systems healthcare workers communities covid<NUMBER> pandemic health system resilience program reprogram consortium thinktank leading international healthcare physicians researchers policymakers formed champion safety healthcare workers policy development advocacy global pandemic preparedness action sbh devised project main conceptual ideas proof outline sbh ar wrote first draft manuscript sbh encouraged ar investigate supervised findings work authors discussed results recommendations contributed final manuscript would like acknowledge reprogram consortium members worked tirelessly last days contributing various guidelines recommendations policy briefs ongoing discussions unprecedented challenging times despite incredibly short timeframe would like dedicate work healthcare workers died due covid<NUMBER> serving patients frontline continue serve challenging times despite lack personal protective equipment middle east respiratory syndrome mers respiratory disease caused novel coronavirus identified <NUMBER> saudi arabia aleanizy et al <NUMBER> assiri et al <NUMBER> raj et al <NUMBER> associated <NUMBER> mortality rate primarily due multiorgan failure rivers et al <NUMBER> zumla et al <NUMBER> middle east respiratory syndromecoronavirus merscov transmitted either nonhuman human dromedary camels major reservoir host virus human human transmission requires close contact cotten et al <NUMBER> de groot et al <NUMBER> many studies suggested merscov male predominance prevalence median age <NUMBER> years illness onset aleanizy et al <NUMBER> chan et al <NUMBER> chen et al <NUMBER> data showed underlying immunodeficiency immunosuppressant medications therapies diabetes mellitus strongly associated increased morbidity mortality aleanizy et al <NUMBER> chen et al <NUMBER> summary <NUMBER> directed development stringent screening criteria implemented different health care systems saudi arabia including ministry health hospitals suspected case defined instance admission health care facility clinical symptoms suggest infection history contact established cases trigger laboratory merscov testing using realtime polymerase chain reaction rtpcr test merscov swab samples collected admission aleanizy et al <NUMBER> although many studies suggested prognosis confirmed merscov contribution underlying comorbidities severity disease yet studies highlighted characteristics tested positive rtpcr test among suspected cases especially contribution medications thus intent paper identify factors associated merscov confirmation among suspected cases impact medications history virus transmission subjects suspected merscov infection confirmed cases merscov included final analysis suspected cases identified medical record university hospital confirmed cases identified university hospital ministray health data covers patient admitted period september <NUMBER> december <NUMBER> suspect cases defined incidence hospitalization two following clinical symptoms temperature <NUMBER>°c signs upper respiratory infection cough shortness breath sore throat etc runny nose low level consciousness confirmed cases defined suspected case laboratoryconfirmed merscov infection basis positive realtime polymerase chain reaction rtpcr results merscov swab samples subjects excluded missing data prevent final analysis study approved institution review board committee collected subjects data suspected cases confirmed cases demographic data include age gender collected also collected data existing comorbidities including diabetes chronic heart disease defined ischemic heart disease myocardial infarction acute coronary syndrome medications point screening collected including metformin sulfonylureas dipeptidyl peptidase<NUMBER> dpp<NUMBER> inhibitors angiotensinconverting enzyme inhibitors ace inhibitors beta blockers diuretics descriptive statistics used report demographic data percentages frequencies used summarize categorical variables means standard deviations calculated continuous variables chisquare fishers exact test required twosample ttests used summarize relationships demographic variables outcome serological test categorical continuous data respectively logistic regression model used assess risk merscov infection among suspected cases value p <NUMBER> considered statistically significant data entered analyzed using ibm spss windows version <NUMBER> ibm corp armonk ny usa total <NUMBER> suspected cases included study <NUMBER> <NUMBER> confirmed laboratory infection another tested negative rtpcr mean age suspected cases <NUMBER> year age mean age confirmed cases <NUMBER> year age majority confirmed cases male <NUMBER> comorbidities common among confirmed group including hypertension diabetes compared suspected cases sample characteristics see table <NUMBER> <NUMBER> suspected cases complete data analyzed <NUMBER> assess factors independently associated merscov infection merscov infection associated age adjusted odds ratio aor <NUMBER> <NUMBER> ci <NUMBER> pvalue <NUMBER> male gender aor <NUMBER> <NUMBER> ci <NUMBER> pvalue <NUMBER> diabetes aor <NUMBER> <NUMBER> ci <NUMBER> pvalue <NUMBER> significant association comorbidities medication history associated increase decrease likelihood infection table <NUMBER> study evaluated characteristics confirmed mers infection reported smaller studies age male sex comorbidities likely associated infection aleanizy et al <NUMBER> chen et al <NUMBER> guery et al <NUMBER> variables less likely suggest mers infection term medication history analyzed sample found statical differences suggest increase decrease likelihood mers infection however subjects received dipeptidyl peptidase<NUMBER> dpp<NUMBER> inhibitors tested negative may suggest underlying mechanism prevents transmission virus medications include metformin angiotensinconvertingenzyme inhibitors ace inhibitors beta blockers associated increase decrease likelihood mesra infection like studies suggested mers infection predominance male found statistical association confirmed aleanizy et al <NUMBER> chen et al <NUMBER> guery et al <NUMBER> although study large female representation sample due likelihood sharp increase health care workerswhich likely female screening upon exposure patient possible history mers infection reason many health care institutions became strict screening testing suspected cases prevent mers infection outbreaks increase female detection study suggests gender difference associated increase likelihood mers infection also study suggests diabetic patient likely confirmed mers infection compared nondiabetic patients also reported previously literature zumla et al <NUMBER> one unique sides study look impact medications mers infection knowledge first study look association patients medication history risk infection found many medications include chronic diseases associated increase decrease likelihood mers infection although many diabetic patients metformin analysis shows effect mers infection similarly sulfonylureas associated increase decrease likelihood infection diabetic medication patient ddp<NUMBER> inhibitors less likely mers infection entry receptor merscov identified dipeptidyl peptidase receptor ddp<NUMBER> expressed surface human airway blockage enzyme may interfere virus transmission similar study looked demographics patients mers infection many studies suggested infection common patients comorbidities primarily diabetes chronic kidney diseases moreover severity infection increased risk mortality likely older patients patients diabetes chronic kidney diseases findings suggest benefit screening suspected infection may suggest future preventive therapy limitations study include following first missing data demographics data limit analysis draw better understanding infection second retrospective analysis inherited flow nature finally outcome infection severity disease reported study merscov infection common male advanced age diabetes medications associated increase decrease likelihood infection except dpp<NUMBER> inhibitors shown less likely mers infection important focus screening detection patient population authors declare potential conflicts interest withrespect research authorship publication article middle east respiratory syndrome mers respiratory disease caused novel coronavirus identified <NUMBER> saudi arabia aleanizy et al <NUMBER> assiri et al <NUMBER> raj et al <NUMBER> associated <NUMBER> mortality rate primarily due multiorgan failure rivers et al <NUMBER> zumla et al <NUMBER> middle east respiratory syndromecoronavirus merscov transmitted either nonhuman human dromedary camels major reservoir host virus human human transmission requires close contact cotten et al <NUMBER> de groot et al <NUMBER> many studies suggested merscov male predominance prevalence median age <NUMBER> years illness onset aleanizy et al <NUMBER> chan et al <NUMBER> chen et al <NUMBER> data showed underlying immunodeficiency immunosuppressant medications therapies diabetes mellitus strongly associated increased morbidity mortality aleanizy et al <NUMBER> chen et al <NUMBER> summary <NUMBER> directed development stringent screening criteria implemented different health care systems saudi arabia including ministry health hospitals suspected case defined instance admission health care facility clinical symptoms suggest infection history contact established cases trigger laboratory merscov testing using realtime polymerase chain reaction rtpcr test merscov swab samples collected admission aleanizy et al <NUMBER> although many studies suggested prognosis confirmed merscov contribution underlying comorbidities severity disease yet studies highlighted characteristics tested positive rtpcr test among suspected cases especially contribution medications thus intent paper identify factors associated merscov confirmation among suspected cases impact medications history virus transmission subjects suspected merscov infection confirmed cases merscov included final analysis suspected cases identified medical record university hospital confirmed cases identified university hospital ministray health data covers patient admitted period september <NUMBER> december <NUMBER> suspect cases defined incidence hospitalization two following clinical symptoms temperature <NUMBER>°c signs upper respiratory infection cough shortness breath sore throat etc runny nose low level consciousness confirmed cases defined suspected case laboratoryconfirmed merscov infection basis positive realtime polymerase chain reaction rtpcr results merscov swab samples subjects excluded missing data prevent final analysis study approved institution review board committee collected subjects data suspected cases confirmed cases demographic data include age gender collected also collected data existing comorbidities including diabetes chronic heart disease defined ischemic heart disease myocardial infarction acute coronary syndrome medications point screening collected including metformin sulfonylureas dipeptidyl peptidase<NUMBER> dpp<NUMBER> inhibitors angiotensinconverting enzyme inhibitors ace inhibitors beta blockers diuretics descriptive statistics used report demographic data percentages frequencies used summarize categorical variables means standard deviations calculated continuous variables chisquare fishers exact test required twosample ttests used summarize relationships demographic variables outcome serological test categorical continuous data respectively logistic regression model used assess risk merscov infection among suspected cases value p <NUMBER> considered statistically significant data entered analyzed using ibm spss windows version <NUMBER> ibm corp armonk ny usa total <NUMBER> suspected cases included study <NUMBER> <NUMBER> confirmed laboratory infection another tested negative rtpcr mean age suspected cases <NUMBER> year age mean age confirmed cases <NUMBER> year age majority confirmed cases male <NUMBER> comorbidities common among confirmed group including hypertension diabetes compared suspected cases sample characteristics see table <NUMBER> <NUMBER> suspected cases complete data analyzed <NUMBER> assess factors independently associated merscov infection merscov infection associated age adjusted odds ratio aor <NUMBER> <NUMBER> ci <NUMBER> pvalue <NUMBER> male gender aor <NUMBER> <NUMBER> ci <NUMBER> pvalue <NUMBER> diabetes aor <NUMBER> <NUMBER> ci <NUMBER> pvalue <NUMBER> significant association comorbidities medication history associated increase decrease likelihood infection table <NUMBER> study evaluated characteristics confirmed mers infection reported smaller studies age male sex comorbidities likely associated infection aleanizy et al <NUMBER> chen et al <NUMBER> guery et al <NUMBER> variables less likely suggest mers infection term medication history analyzed sample found statical differences suggest increase decrease likelihood mers infection however subjects received dipeptidyl peptidase<NUMBER> dpp<NUMBER> inhibitors tested negative may suggest underlying mechanism prevents transmission virus medications include metformin angiotensinconvertingenzyme inhibitors ace inhibitors beta blockers associated increase decrease likelihood mesra infection like studies suggested mers infection predominance male found statistical association confirmed aleanizy et al <NUMBER> chen et al <NUMBER> guery et al <NUMBER> although study large female representation sample due likelihood sharp increase health care workerswhich likely female screening upon exposure patient possible history mers infection reason many health care institutions became strict screening testing suspected cases prevent mers infection outbreaks increase female detection study suggests gender difference associated increase likelihood mers infection also study suggests diabetic patient likely confirmed mers infection compared nondiabetic patients also reported previously literature zumla et al <NUMBER> one unique sides study look impact medications mers infection knowledge first study look association patients medication history risk infection found many medications include chronic diseases associated increase decrease likelihood mers infection although many diabetic patients metformin analysis shows effect mers infection similarly sulfonylureas associated increase decrease likelihood infection diabetic medication patient ddp<NUMBER> inhibitors less likely mers infection entry receptor merscov identified dipeptidyl peptidase receptor ddp<NUMBER> expressed surface human airway blockage enzyme may interfere virus transmission similar study looked demographics patients mers infection many studies suggested infection common patients comorbidities primarily diabetes chronic kidney diseases moreover severity infection increased risk mortality likely older patients patients diabetes chronic kidney diseases findings suggest benefit screening suspected infection may suggest future preventive therapy limitations study include following first missing data demographics data limit analysis draw better understanding infection second retrospective analysis inherited flow nature finally outcome infection severity disease reported study merscov infection common male advanced age diabetes medications associated increase decrease likelihood infection except dpp<NUMBER> inhibitors shown less likely mers infection important focus screening detection patient population authors declare potential conflicts interest withrespect research authorship publication article gestational diabetes mellitus gdm defined hyperglycemia onset first recognition pregnancy severity less occur overt diabetes <NUMBER> <NUMBER> gdm highrisk condition adverse maternal neonatal outcomes <NUMBER> <NUMBER> identification treatment gdm improve pregnancy outcomes thus requiring earlier therapeutic intervention <NUMBER> different approaches screening gestational diabetes mellitus significant impact management gestational diabetes future complications <NUMBER> however still many controversies surrounding gdm diagnosis management <NUMBER> first prenatal visit considered best time screen gestational diabetes majority health organizations <NUMBER> <NUMBER> aims early screening identifying women overt diabetes mainly diagnose women low high risk gestational diabetes <NUMBER> obtain diagnosis fasting plasma glucose fpg random plasma glucose rpg glucose glycosylated hemoglobin a<NUMBER>c hba<NUMBER>c commonly used approaches <NUMBER> grams two hours ogtt <NUMBER> weeks gestation recommended iadpsg standard test diagnosis gdm <NUMBER> early postpartum followup women history gdm provides opportunity assess health status mothers offspring <NUMBER> international guidelines recommend early screening glucose status prevention diabetes <NUMBER> weeks postpartum using <NUMBER> g <NUMBER> h ogtt <NUMBER> <NUMBER> lifestyle changes essential component management gestational diabetes mellitus recommended many national clinical practice guidelines interventions including advice healthy eating increase physical activity selfmonitoring blood sugar training use glucose meter interpreting glucose readings insulin added may play essential roles promoting health women gestational diabetes children <NUMBER> covid<NUMBER> pandemic impaired routine prenatal care disrupted traditionally facetoface communication patients reduced access laboratory testing <NUMBER> moreover patient refusal long time waiting standard test due fear illness shows necessity revision clinical guidelines current epidemic need compare benefits standard routine care testing risks exposure novel coronavirus performed narrative review using keywords covid<NUMBER> gestational diabetes guideline novel coronavirus gestational diabetes clinical practices recommendation first searched multiple databases inception till may <NUMBER> documents related gestational diabetes screening management including guidelines national institute health clinical excellence nice database national guidelines clearinghouse ngc evidencebased clinical practice guidelines united states medline embase database guidelines international networks library gray literature conducted professional societies organizations field diabetes obstetrics standard guideline covid<NUMBER> crisis <NUMBER> list guidelines available website sent email request updated guideline six national guidelines canada united kingdom australia new zealand australia health agencies identified one guideline provided australasian diabetes pregnancy society adips australian diabetes society ads australian diabetes educators association adea diabetes australia da duplicate version queensland guideline focused original recommendation published queensland clinical guidelines searches limited guidelines english language summaries national temporary clinical guidelines gestational diabetes screening management covid<NUMBER> presented table <NUMBER> pregnant women preexisting diabetes hba<NUMBER>c andor fbg nonfasting random plasma glucose test recommended early testing gdm done solely women higher risk overt diabetes one risk factors gdm cutoff thresholds fbg hba<NUMBER>c random plasma glucose different covid<NUMBER> canadian guideline recommend changes screen overt diabetes early pregnancy latest guideline canada released <NUMBER> <NUMBER> indicates early testing done women risk overt diabetes hba<NUMBER>c fasting plasma glucose recommended a<NUMBER>c unreliable women negative testing rescreened <NUMBER> weeks gestation society ads last updated guideline <NUMBER> april <NUMBER> outlined threephase system gdm testing pandemic based contagion risk local state government alternative method first trimester testing gdm amber red status risk contagion moderate high random blood glucose rbg hba<NUMBER>c advised cutoff point diagnosis gdm hba<NUMBER>c ≥<NUMBER> random blood glucose rbg ≥<NUMBER> mmoll ranzcog guideline emphasized necessity early pregnancy screening merely highrisk pregnant women first trimester antenatal serology testing hba<NUMBER>c recommended test guideline cutoff <NUMBER> considered gdm diagnosis queensland clinical guidelinerecommended hba<NUMBER>c <NUMBER> mmolmol <NUMBER> gdm diagnosis pregnant women risk factor ignored ogtt testing first trimester temporarily united kingdon according royal college obstetrics gynecology hba<NUMBER>c ≥<NUMBER> mmolmol random plasma glucose≥<NUMBER>mmoll diagnosed type <NUMBER> diabetes women borderline hba<NUMBER>c <NUMBER> mmolmol history gdm previous pregnancy managed gdm hba<NUMBER>c fasting rbg repeated highrisk pregnant women <NUMBER> weeks gestation strong agreement observed updated guidelines <NUMBER>hour ogtt important screening test gdm diagnosis <NUMBER> weeks gestation guidelines agreement perform testing pandemic fbg rpg a<NUMBER>c commonly selected alternatives based canadas clinical guideline women a<NUMBER>c ≥ <NUMBER> random plasma glucose ≥ <NUMBER>mmoll identified gdm ranzcog guideline considered fbg <NUMBER> weeks <NUMBER>mmoll diagnostic gdm adips ads recommended performance fbg <NUMBER> weeks ≥ <NUMBER> mmoll ogtt women fbg <NUMBER> <NUMBER> mmoll based guideline risk contagion high fbg alone may enough based queensland clinical guidelines <NUMBER> weeks gestation irrespective covid<NUMBER> status ogtt required fbg <NUMBER> <NUMBER> mmol fbg <NUMBER> mmoll higher require ogtt considered gdm women hba<NUMBER>c ≥<NUMBER> mmolmol fbg ≥<NUMBER> mmoll random plasma glucose ≥nine mmoll diagnosed gdm based united kingdom guidelines furthermore glycosuria suspicion diabetes due clinical symptom pregnancy polyhydramnios large gestational age screened gdm regardless months pregnancy deferred delay postpartum screening women gdm recent pregnancy recommended available national guidelines pandemic post partum screening postponed <NUMBER> months delivery uk hba<NUMBER>c queensland clinical guideline australia recommended delaying postpartum ogtt <NUMBER> months postpartum ogtt performed child turns <NUMBER> months old next pregnancy continued selfmonitoring mother greater risk type <NUMBER> diabetes hba<NUMBER>c test <NUMBER> months postpartum may also appropriate based guideline virtual management gestational diabetes using telehealth advised published national guidelines covid<NUMBER> outbreaks canadian guideline suggested video phone call reduces facetoface communication initial followup visits methods communication follows sharing critical clinical data including blood pressure weight obtained inperson visits obstetricians diabetes team virtual visits asking individuals send result blood glucose testing via email use video conference virtual classes teaching insulin injections ranzcog recommends following telehealth phone consultation obstetricians gynecologists temporary allocation medicare benefits schedule listing medicare services subsidized australian government selfblood glucose monitoring selfinsulin monitoring virtual consultation dietary exercise plans delaying gdm testing women positive covid<NUMBER> test isolation performing ultrasound screening <NUMBER> weeks suspected macrosomia fetal growth restriction cases united kingdom health authorities recommendations patients inclusive <NUMBER> educational video calls diabetes midwifenurse ensure safe selfmonitoring glucose meter proper dieting <NUMBER> hospital visits ultrasound scans <NUMBER> contacting diabetic health team blood glucose higher target level moreover uk health authorities emphasize training community midwives check mothers blood glucose readings remotely furthermore women gdm taking metformin insulin require obstetric evaluation <NUMBER> <NUMBER> weeks gestation cases inperson visit necessary appointment shall include opportunity ultrasound appointment planning birth recommended <NUMBER> weeks gestation feasible almost guidelines emphasize importance making decision based contamination risk ability local laboratories arrange social distancing available resources remote management also remind us temporary alternatives replace standard care rationales suggestion temporary measures shortening screening test process reduce risk exposure covid<NUMBER> laboratories reducing burden pathology centers diabetes care providers obstetrics team minimizing number visits duration stay hospital pregnant women reducing inperson visit replacing visits remote communication patients although poor specificity fbg test makes inappropriate test screening first trimester <NUMBER> furthermorethere conflicting evidence accuracy rpg <NUMBER> use <NUMBER>g <NUMBER>hour ogtt considered goldenstandard test diagnosis gdm <NUMBER> weeks gestation updated guidelines preferred screening tests fbg hba<NUMBER>c rpg flexibility quick turn around would feasible easily available would require fasting would conducted minimal laboratory facilities table <NUMBER> poor specificity high falsepositive fbg restrict efficiency gdm screening however useful decision making need oggt test reduce number required ogtts half <NUMBER> alsohba<NUMBER>c recommended screening gdm international guidelines <NUMBER> weeks pregnancy useful alternative ogtt pregnant women <NUMBER> furthermorethere conflicting evidence accuracy rpg limited pieces evidence accuracy rpg excellent predecessor gdm based systematic review single random glucose measurement inadequate screen gdm <NUMBER> performance ogtt also standard test postpartum diabetes screening women gdm recent pregnancy however screening postpartum diabetes patients gdm challenge worldwide <NUMBER> <NUMBER> <NUMBER> currently covid<NUMBER> epidemic require compare benefits performance <NUMBER> weeks postpartum screening tests standard routine test versus deferral test interestingly differences types tests cutoff values gdm diagnosis instance canadas guideline recommends women hba<NUMBER>c ≥ <NUMBER> rbg ≥ <NUMBER>mmoll identified gdm <NUMBER> weeks gestation united kingdom guideline considers following thresholds hba<NUMBER>c <NUMBER> rbg <NUMBER>o mmoll fpg <NUMBER> mmoll <NUMBER> value indexes gdm screening remains uncertain <NUMBER> challenges faced new temporary recommendations alternative screening strategies identify women highest risk miss many women lower glucose intolerance may affect shortand longterm health status mothers children furthermore new approaches recommendations covid<NUMBER> epidemic evidencebased hence cause adverse health impacts moreover implantation new strategies management gdm may suitable women living poornations inadequateresources roadblocks application telemedicine <NUMBER> <NUMBER> outlined based available resources one limitations review restricted sources could find guidelines asian countries high incidence corvid<NUMBER> outbreak developing countries lowincome another limitation limiting search english language despite limitation first narrative review collectively provides information challenges limitations clinical guidelines screening management gdm emergency crisis appropriate universal gdm testing management protocol provided base risk exposure viral epidemic available resources seems spite many old controversies screening treatment followup gestational diabetes world near unanimous agreement crisis situation immune system acts upon inflammation occurs adipose tissue due obesity increasing vulnerability infections <NUMBER> increased circulating levels many cytokines proteins released adipocytes associated inflammation obese individuals <NUMBER> inflammation adipose tissue generates chronic systemic metabolic alterations leading dyslipidemia hypertension cvd diabetes thus increasing risk infection severe acute respiratory syndromecoronavirus<NUMBER> sarscov<NUMBER> <NUMBER> thought sarscov<NUMBER> sarscov merscov suppress antiviral type ifnγ responses early stage infection leading uncontrolled viral replication mechanism later leads influx neutrophils monocytesmacrophages resulting hyperproduction proinflammatory cytokines damage lung tissue ie pneumonia acute respiratory distress syndrome specific th<NUMBER>th<NUMBER> cells may activated contribute increased inflammation facts higher mortality covid<NUMBER> observed underlying diseases indicates immune response determining factor covid<NUMBER> outcome <NUMBER> according phylogenetic analyses sarscov<NUMBER> related existing respiratory infections sarscov middle east respiratory syndromecoronavirus merscov <NUMBER> sarscov infection accounted <NUMBER> cases <NUMBER> deaths <NUMBER> countries <NUMBER> meanwhile merscov infection identified <NUMBER> countries <NUMBER> confirmed cases <NUMBER> deaths <NUMBER> observed covid<NUMBER> merscov infection also caused severe complications older immunocompromised patients history diabetes renal failure lung diseases <NUMBER> according genome sequencing sarscov<NUMBER> <NUMBER> identical bat sarslikecovzxc<NUMBER> <NUMBER> identical human sarscov <NUMBER> merscov <NUMBER> <NUMBER> several phylogenetic analyses suggests bat probable animal reservoir sarscov<NUMBER> sarscov merscov transmitted bats palm civets dromedary camels humans possible though another animal plays role intermediate host bat human sarscov<NUMBER> infection <NUMBER> viruses structural protein spike glycoprotein responsible binding host cells <NUMBER> according hoffman <NUMBER> protein primed human serine protease tmprss<NUMBER> recognized cell receptor recent study described liu <NUMBER> shows sarscov entering respiratory tract depends receptorbinding domain rbd bind host protein two trimers bind heterodimer angiotensinconverting enzyme ii ace<NUMBER> synthetic sarscov<NUMBER> rbd analysis indicated virus enters host cell ace<NUMBER> binding however merscov binds specifically another receptor dipeptidil peptidase <NUMBER> dpp<NUMBER> <NUMBER> <NUMBER> therefore since sarscov<NUMBER> analogous sarscov suggested use ace<NUMBER> main mechanism cell entry pathophysiology sarscov<NUMBER> yet well understood known cause acute lung injury condition resembles sarscov results aggressive inflammation initiated viral replication <NUMBER> review tried discuss report possible mechanisms inflammatory responses mediated sarscov<NUMBER> individuals preexisting cardiometabolic diseases speculate possible therapeutic target applied obtain better immune response reduce proinflammatory profile consequently reduce critical levels disease systematically searched pubmed database april <NUMBER> <NUMBER> using keywords covid<NUMBER> sarscov<NUMBER> treatment coronavirus following terms diabetes mellitus obesity hypertension arterial aceinhibitors cytokine storms immune response vitamin database research results accessed relevant cross references made proposed mini review approximately <NUMBER> adult population <NUMBER> years metabolic syndrome ms percentage increases population ages reaching <NUMBER> population <NUMBER> years age <NUMBER> appreciation ms presence due finding relationship cardiovascular chronic diseases present ms increases twice mortality patients type <NUMBER> diabetes three times mortality due cvds <NUMBER> <NUMBER> ms controlled direct action reninangiotensinaldosterone system raas normal functioning body system acts regulation blood pressure <NUMBER> <NUMBER> angiotensinconverting enzyme ace counterpart ace<NUMBER> main enzymes system main role ace conversion angiotensin angi angiotensin ii angii allowing vasoconstriction positive regulation blood pressure <NUMBER> <NUMBER> role ace<NUMBER> conversion angiotensin angiotensin <NUMBER> ang <NUMBER> converted ace angiotensin vasodilator peptide <NUMBER> ang <NUMBER> ace<NUMBER> also regulates conversion angii ang <NUMBER> negative regulation blood pressure occurs <NUMBER> multifactorial complex process affected individual must present <NUMBER> associated clinical characteristics better understanding processes trigger metabolic syndrome next sections clarify clinical characteristics involved related sarscov<NUMBER> immune system plays important role inflammation occurs adipose tissue due obesity increases vulnerability infections inflammation adipose tissue generates metabolic alterations cause comorbidities dyslipidemia hypertension cardiovascular diseases diabetes thus increasing risk infection sarscov<NUMBER> <NUMBER> overexpression inflammatory adipokines visceral fat deposits affect immune response impair chemotaxis alter differentiation macrophages imbalance secretion antiand proinflammatory adipokines thoracic visceral fat deposits epicardium mediastinal may also play role cytokine storm described patients severe sarscov<NUMBER> study demonstrated active role macrophages morbid obesity relationship inflammatory processes concluding disease chronic inflammation initiated adipose tissue consequence insulin resistance <NUMBER> hyperleptinemia tissue dysfunction low antioxidant defenses chronic inflammation generation postprandial ros factors involved development obesity oxidative stress participates <NUMBER> increase oxidative stress accumulated fat least part underlying cause adipocytokine dysregulation development metabolic syndrome <NUMBER> known obesity induces oxidative stress various mechanisms chronic inflammation endothelial dysfunction mitochondrial dysfunction <NUMBER> interestingly reported adiponectin predicted mortality critically ill patients admission intensive care unit icu innate inflammatory response visceral fat deposits cause positive regulation greater release inflammatory cytokines il<NUMBER> <NUMBER> addition adipose tissue serves reservoir several viruses influenza hiv cytomegalovirus may also infected covid<NUMBER> virus <NUMBER> important source il<NUMBER> receptor il<NUMBER>r therefore adipose tissue serve reservoir activation il<NUMBER> cascade signaling viral infection spread viruses organs affected adjacent adipose tissue take days prolonged viral shedding also contributing delay cytokine storm consequent tissue damage patients covid<NUMBER> <NUMBER> <NUMBER> diabetes mellitus dm major risk factor severity mortality individuals infected sarscov<NUMBER> similar risk evidence among people diabetes reported previous two glycemic homeostasis requires close quantitative temporal regulation glucose flow different organs circulating glucose body stable configuration similar biochemical characteristics cell wall commensal bacteria found individual <NUMBER> immune system hostpathogen hosthost interactions take place recognition binding oligosaccharides socalled c type lectin receptors clrs induce specific immune response several c type lectins recognize oligosaccharides rich sugars mannose fucose similar chemical structure glucose <NUMBER> sarscov<NUMBER> recognition protein glycoprotein may well increase inflammatory processes <NUMBER> thiazidetype diuretics calcium channel blockers ccb βblockers angiotensin converting enzyme inhibitors acei angiotensin ii type receptor blockers arb antihypertensive drugs distinct targets lower blood pressure acei arb drugs targets renin angiotensin system ras also used diabetes treatment leading increased ace<NUMBER> expression suggested fang <NUMBER> risk increaser severity covid<NUMBER> since sarscov<NUMBER> uses ace<NUMBER> enter cells contrast study meng <NUMBER> hypertensive chinese population covid<NUMBER> treatment aceiarb drugs displayed attenuated inflammatory response inhibiting il<NUMBER> cytokine levels achieved better clinical result higher cd<NUMBER> cd<NUMBER> cell counts peripheral blood lower viral load peak comparison antihypertensive drugs addition hospitalization <NUMBER> patients nonaceiarb group <NUMBER> considered severe one patient died versus aceiarb group <NUMBER> severe patients <NUMBER> deaths therefore evidence increased ace<NUMBER> expression drugs indeed harmful studies needed clarify effects covid<NUMBER> infection also il<NUMBER> controlled levels leading better clinical results showed equilibrated inflammatory response determining better outcome covid<NUMBER> disease reported patients severe symptoms covid<NUMBER> present cytokine storm <NUMBER> <NUMBER> <NUMBER> anhui china clinical trial chictr<NUMBER> using il<NUMBER> receptortargeted monoclonal antibody mab tocilizumab reported improvement respiratory function rapid fever control <NUMBER> patients severe covid<NUMBER> patients recovered discharged hospital including two critical condition <NUMBER> indicates need targeting antiinflammatory strategies treatment covid<NUMBER> demonstrates balanced immune host response crucial eliminate sarscov<NUMBER> infection successfully given need balanced immune response vitamin stands action mediated binding active form <NUMBER>αdihydroxyvitamin <NUMBER> vd <NUMBER> receptor vdr expressed several immune cells <NUMBER> <NUMBER> vd <NUMBER> genomic binding site vdrgp transcriptional complex formed modulating expression genes ace vdr <NUMBER> according sassi <NUMBER> individuals respiratory infections sepsis exacerbated symptoms reduced vd <NUMBER> levels using vd <NUMBER> experimental treatment protocol patients respiratory infections observed infection reduction modulation proinflammatory cytokines il<NUMBER>β il<NUMBER> produced helper th<NUMBER> cells <NUMBER> besides acting immune system hormone plays important role metabolic disorders pathophysiology diabetes modulating expression insulin reducing systemic inflammation regulating blood pressure reninangiotensinaldosterone system raas obesity regulating adipogenesis production release adipokines cytokines vd <NUMBER> connected various metabolic pathways immune system response becomes important identify therapeutic target <NUMBER> individuals cardiometabolic diseases prone sarscov<NUMBER> infection due immune response dysregulation inflammatory response occur immediately role medications generally used individuals affected diabetes hypertension cardiovascular diseases especially ace inhibitors debatable since drugs lead ace<NUMBER> receptor overexpression associated sarscov<NUMBER> cells entry virus entry cell multiplies reaches many copies generating acute late inflammatory response thus storm cytokines occurs end harming healthy cells order regulate inflammation reduce damage healthy cells vd modulate favorable immune response could hypothetically reduce levels associated complications december <NUMBER> series pneumonia cases unknown cause reported wuhan hubei china shortly novel coronavirus isolated respiratory tract samples named sarscov<NUMBER> severe acute respiratory syndrome coronavirus<NUMBER> new virus rapidly spread globally resulting pandemic sarscov<NUMBER> belongs betacoronavirus severev<NUMBER> belongs betacoronavirus severe acute respiratory syndrome sars middle east respiratory syndrome mers viruses responsible serious outbreaks china <NUMBER> <NUMBER> middle east <NUMBER> respectively <NUMBER> patients <NUMBER> diabetes also associated increased risk complications <NUMBER> pandemic influenza h<NUMBER>n<NUMBER> infection <NUMBER> despite higher transmissibility sarscov<NUMBER> appears lower case fatality rate sarscov <NUMBER> middle east respiratory syndrome merscov <NUMBER> higher influenza <NUMBER> <NUMBER> prevalence diabetes patients covid<NUMBER> depends size characteristics study population early estimates came china multicenter study <NUMBER> patients hospitalized covid<NUMBER> illness china overall prevalence diabetes <NUMBER> <NUMBER> metaanalysis <NUMBER> studies including <NUMBER> patients china diabetes second common comorbidity following hypertension present <NUMBER> patients <NUMBER> another metaanalysis <NUMBER> studies mainly china hypertension diabetes prevalent comorbidities present <NUMBER> <NUMBER> respectively among <NUMBER> patients covid<NUMBER> <NUMBER> retrospective study <NUMBER> critically ill patients admitted icu lombardy region italy hypertension common comorbidity <NUMBER> followed cardiovascular disorders <NUMBER> hypercholesterolemia <NUMBER> diabetes <NUMBER> <NUMBER> observational studies far indicate diabetes associated higher morbidity mortality patients covid<NUMBER> diabetic patients higher risk develop complications covid<NUMBER> admitted intensive care unit <NUMBER> study evaluating metabolic cardiovascular comorbidities patients covid<NUMBER> found hypertension cardiacerebrovascular disease diabetes present <NUMBER> <NUMBER> <NUMBER> respectively among <NUMBER> patients overall proportion hypertension cardiacerebrovascular diseases diabetes <NUMBER>fold <NUMBER>fold <NUMBER>fold respectively higher intensive care unit icusevere cases nonicusevere counterparts diabetes accounted <NUMBER> nonicusevere cases <NUMBER> icusevere cases study <NUMBER> metaanalysis <NUMBER> covid<NUMBER> patients <NUMBER> studies diabetes independent risk factor disease progression <NUMBER> p <NUMBER> along hypertension <NUMBER> p <NUMBER> chronic obstructive pulmonary disease copd <NUMBER> p <NUMBER> cardiovascular disease <NUMBER> p <NUMBER> cerebrovascular disease or<NUMBER> p <NUMBER> <NUMBER> diabetes also significantly increased risk icu admission <NUMBER> <NUMBER> ci <NUMBER> p <NUMBER> among <NUMBER> patients covid<NUMBER> <NUMBER> diabetic patients higher mortality risk <NUMBER> <NUMBER> ci <NUMBER> p <NUMBER> analysis <NUMBER> patients <NUMBER> larger metaanalysis <NUMBER> patients <NUMBER> studies diabetic patients increased risk death rr <NUMBER> p <NUMBER> severe covid<NUMBER> rr <NUMBER> p <NUMBER> acute respiratory distress syndrome ards rr <NUMBER> p <NUMBER> disease progression rr <NUMBER> p <NUMBER> <NUMBER> study included <NUMBER> cases covid<NUMBER> chinese center disease control prevention overall casefatality rate cfr <NUMBER> patients diabetes <NUMBER>fold higher mortality rate without diabetes <NUMBER> vs <NUMBER> <NUMBER> overall fatality rate persons confirmed covid<NUMBER> italian population <NUMBER> substantially higher china <NUMBER> difference may partly explained due older age patients italy <NUMBER> study included <NUMBER> patients hospitalized covid<NUMBER> <NUMBER> hospitals new york city common comorbidities hypertension <NUMBER> obesity <NUMBER> diabetes <NUMBER> mortality high <NUMBER> required mechanical ventilation among died patients diabetes likely received invasive mechanical ventilation <NUMBER> vs <NUMBER> icu care <NUMBER> vs <NUMBER> compared nondiabetics moreover patients diabetes likely develop acute kidney injury without <NUMBER> vs <NUMBER> among discharged patients <NUMBER> pathophysiological mechanisms implicated increased frequency severity covid<NUMBER> people diabetes yet elucidated several hypotheses explain covid<NUMBER> frequent diabetes associated worse outcomes general diabetes associated increased risk various infections including viral ones <NUMBER> alterations innate immunity play major role increased susceptibility infections diabetics humoral immunity appears relatively unaffected hyperglycemia depresses neutrophil chemotaxis phagocytosis opsonization adherence vascular endothelium intracellular bactericidal activity <NUMBER> presence diabetic complications vascular insufficiency peripheral neuropathy may also predispose infections <NUMBER> moreover poor glycemic control contributes increased risk infections people diabetes <NUMBER> diabetes obesity associated low grade subclinical chronic inflammation due increased secretion adipose tissue hormones cytokines contribute development insulin resistance leptin tumor necrosis factora tnfa interleukin<NUMBER> il<NUMBER> <NUMBER> moreover diabetes insulin resistance associated endothelial dysfunction enhanced platelet aggregation activation predispose development hypercoagulable prothrombotic state <NUMBER> lowgrade chronic inflammation along hypercoagulable state diabetes may promote cytokine storm complication severe covid<NUMBER> characterized excessive production inflammatory cytokines il<NUMBER> il<NUMBER> tnfa <NUMBER> guo et al compared laboratory parameters <NUMBER> diabetic <NUMBER> nondiabetic covid<NUMBER> patients found absolute counts neutrophils creactive protein crp ddimers serum ferritin erythrocyte sedimentation rate esr il<NUMBER> fibrinogen significantly higher p <NUMBER> diabetes compared nondiabetes group <NUMBER> possible higher inflammatory hypercoagulable state may contribute development cytokine storm rapid deterioration covid<NUMBER> patients diabetes <NUMBER> studies also demonstrated enhanced inflammation response diabetic patients severe covid<NUMBER> compared patients without diabetes yan et al compared clinical characteristics outcomes <NUMBER> severe covid<NUMBER> patients diabetes <NUMBER> patients severe covid<NUMBER> without diabetes retrospective observational study china <NUMBER> white cell count neutrophil count crp il<NUMBER>r il<NUMBER> il<NUMBER> ddimer lactate dehydrogenase ldh well nterminal probtype natriuretic peptide ntprobnp higher diabetics patients diabetes likely receive mechanical ventilation admitted icu die <NUMBER> similarly multicenter study <NUMBER> cases covid<NUMBER> china patients diabetes significantly higher incidence lymphopenia higher leukocytes neutrophil counts peripheral blood higher inflammation markers like creactive protein procalcitonin increased ddimers compared nondiabetic patients <NUMBER> interestingly diabetic patients well controlled glycemia experienced less severe inflammatory response poorly controlled glycemia highlighting importance good glycemic control prior covid<NUMBER> <NUMBER> pulmonary dysfunction another aspect may contribute worse outcomes covid<NUMBER> patients diabetes several functional abnormalities respiratory tract reported patients diabetes reduced lung function low fev<NUMBER> reduced forced vital capacity peripheral airway obstruction pathophysiology diabetic lung complex includes hyperglycemia hyperinsulinemia autonomic neuropathy oxidative stress micromacroangiopathy alveolar capillaries pulmonary arterioles glycosylation tissue proteins collagen elastin changes alteration connective tissue surfactant dysfunction malfunction respiratory muscles <NUMBER> obesity major risk factor diabetes diabetics overweight obese obesity appears independent risk factor severe illness covid<NUMBER> thus presence obesity diabetes poses poor prognosis <NUMBER> study <NUMBER> chinese patients obese patients <NUMBER>fold odds developing severe disease <NUMBER> <NUMBER> ci <NUMBER> p <NUMBER> compared patients normal weight even adjusting comorbidities risk factors <NUMBER> similarly obese patients <NUMBER>fold greater likelihood <NUMBER> <NUMBER> ci <NUMBER> progressing severe disease matched cohort study <NUMBER> chinese patients adjustment clinical characteristics including presence diabetes <NUMBER> chronic inflammation obesity impairs immune response moreover obesity associated decreased expiratory reserve volume functional capacity respiratory system compliance predisposing worse outcomes retrospective study obesity increased risk invasive ventilation patients covid<NUMBER> <NUMBER> severe obesity bmi ≥ <NUMBER> kgm <NUMBER> also independently associated mortality among <NUMBER> patients hospitalized covid<NUMBER> tertiary hospital new york <NUMBER> presence multiple comorbidities correlates greater disease severity adverse outcomes covid<NUMBER> infection <NUMBER> high incidence diabetes severe cases covid<NUMBER> could reflect frequent coexistence comorbidities cardiovascular disease older age previous study concurrent cardiovascular disease increased risk infectionrelated death patients diabetes <NUMBER> retrospective study involving <NUMBER> covid<NUMBER> patients diabetes compared age sexmatched patients without diabetes multivariable analyses showed age <NUMBER> years hr <NUMBER> <NUMBER> ci <NUMBER> hypertension hr <NUMBER> <NUMBER> ci <NUMBER> independent risk factors inhospital death patients diabetes <NUMBER> another study identified older age independent predictor death among diabetic patients covid<NUMBER> <NUMBER> sarscov<NUMBER> sarscov<NUMBER> entry target cells primarily lung alveolar epithelial cells binding angiotensinconverting enzyme <NUMBER> ace<NUMBER> ace<NUMBER> enzyme degrades angiotensin ii angiotensin <NUMBER> angiotensin angiotensin <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> ace<NUMBER> also expressed many tissues heart kidneys intestinal epithelium pancreas <NUMBER> suggested aceis arbs widely used antihypertensives diabetic patients result upregulation ace<NUMBER> thus possibly increasing risk severity covid<NUMBER> infection <NUMBER> experimental animal models provided mixed results regarding effects aceis ace<NUMBER> levels studies humans inconclusive results <NUMBER> present clinical evidence supporting use aceis arbs aggravate susceptibility severity covid<NUMBER> contrary arbs shown potentially protective pulmonary effect experimental models <NUMBER> sarscov<NUMBER> infection alveolar ace<NUMBER> appears downregulated resulting decreased levels protective angiotensin <NUMBER> <NUMBER> context ongoing study evaluating effect recombinant human angiotensinconverting enzyme <NUMBER> rhace<NUMBER> another study losartan treatment patients covid<NUMBER> therefore speculated increased ace<NUMBER> expression raas inhibitors treatment may actually beneficial course sarscov<NUMBER> infection <NUMBER> according several scientific societies including european society cardiology <NUMBER> european society hypertension <NUMBER> american heart association american college cardiology <NUMBER> aceisarbs withheld stable patients risk infected covid<NUMBER> data available withdrawal aceisarbs may result clinical instability especially highrisk patients prior myocardial infarction heart failure impaired left ventricular function proteinuric chronic kidney disease indeed findings observational studies support current recommendations treating hypertension covid<NUMBER> pandemic retrospective study china difference severity complications risk death covid<NUMBER> patients aceisarbs compared treated medications <NUMBER> similarly case control study italy use aceis arbs influence risk covid<NUMBER> <NUMBER> international expert panel published practical recommendations diabetes management patients covid<NUMBER> hospital setting <NUMBER> people diabetes follow general preventive measures including frequent hand hygiene strict social distancing telemedicine encouraged possible order avoid unnecessary routine clinical visits prevent persontoperson transmission <NUMBER> people diabetes intensify treatment optimize glycemic control better diabetes control associated improvement cellular immunity <NUMBER> better control hypertension dyslipidemia also encouraged order achieve optimal metabolic control outpatient diabetics mild covid<NUMBER> follow sick day rules including frequent glucose monitoring adequate hydration monitor ketones insulin therapy frequent medical contact order identify possible clinical deterioration <NUMBER> cases mild infection diabetes medications continued special attention paid sodiumglucose transporter <NUMBER> sglt<NUMBER> inhibitors risk euglycemic diabetic ketoacidosis dehydration acute illness however well established sglt<NUMBER>i exert cardioprotective renoprotective effects patients type<NUMBER> diabetes heart failure reduced ejection fraction chronic kidney disease thus hypothesized sglt<NUMBER>i may actually beneficial patients covid<NUMBER> frequently develop cardiovascular complications acute myocardial injury andor acute kidney injury randomized doubleblind placebocontrolled phase <NUMBER> dapagliflozin respiratory failure patients covid<NUMBER> dare<NUMBER> study ongoing evaluate effect dapagliflozin reducing disease progression complications allcause mortality hospitalized patients mildmoderate covid<NUMBER> type <NUMBER> diabetes cardiovascular disease andor mildmoderate chronic kidney disease ckd <NUMBER> metformin may stopped acute illness dehydration minimize risk lactic acidosis glucagonlike peptide<NUMBER> receptor agonist glp<NUMBER>ra therapy may continued noncritically ill patients however gastrointestinal side effects may predispose volume depletion pioglitazone discontinued critically ill patients <NUMBER> concern raised pioglitazone liraglutide associated upregulation ace<NUMBER> animal studies however aceisarbs currently absence clinical evidence harm people affected covid<NUMBER> <NUMBER> dipeptidyl peptidase<NUMBER> dpp<NUMBER> inhibitors associated low risk hypoglycaemia may continued noncritically ill patients dpp<NUMBER> receptor mers <NUMBER> hypothesized dpp<NUMBER> inhibitors might therapeutic strategy preventing infection decreasing severity covid<NUMBER> however currently evidence dpp<NUMBER> serves receptor sarscov<NUMBER> <NUMBER> doses antihyperglycemic drugs sulfonylureas insulin may adjusted depending blood glucose levels frequent selfmonitoring bloodglucose necessary especially insulin used careful adjustment insulin dose patients type <NUMBER> diabetes monitor ketone levels vigilant development symptoms dka <NUMBER> indeed registry patients type <NUMBER> diabetes covid<NUMBER> almost one third patients developed dka <NUMBER> insulin treatment choice hospitalized covid<NUMBER> patients according american diabetes association guidelines basal insulin basal plus bolus correction insulin regimen preferred treatment noncritically ill hospitalized patients continuous intravenous insulin infusion preferred critically ill patients icu target glucose range <NUMBER>−<NUMBER> mgdl <NUMBER> <NUMBER> mmoll recommended critically ill patients noncritically ill patients <NUMBER> optimizing glycemic control hospitalized patients requires multiple daily glucose measurements health care providers implementation diabetes technology ie continuous glucose monitoring cgm helpful minimizing staff exposure covid<NUMBER> pandemic data remotely accessed proven effective maintaining blood glucose control <NUMBER> <NUMBER> uks national diabetes inpatient covid response team released guidelines management inpatient hyperglycemia covid<NUMBER> patients diabetes <NUMBER> emphasized covid<NUMBER> increases risk diabetes emergencies dka hyperosmolar hyperglycaemic state moreover markedly increased insulin resistance detected icu setting patients requiring markedly elevated insulin drip rates <NUMBER> uh <NUMBER> guidance also provided regarding use subcutaneous insulin treatment dka infusion pumps available noteworthy patients evaluated diabetes admission evidence sarscov<NUMBER> predisposes new onset diabetes <NUMBER> ace<NUMBER> widely expressed several extrapulmonary tissues including liver pancreatic islets infection beta cells sarscov<NUMBER> could result impaired insulin secretion contribute exacerbation preexisting development new diabetes acutely ill patients covid<NUMBER> <NUMBER> well established inpatient hyperglycemia contributes significant increase morbidity mortality better glycemic control may improve clinical outcomes <NUMBER> improving glycemic control also correlates better outcomes patients diabetes covid<NUMBER> zhu et al showed among <NUMBER> confirmed covid<NUMBER> cases china diabetics better glucose control glycemic variability within <NUMBER>−<NUMBER> mgdl <NUMBER> mmoll lower mortality rate diabetics poor control upper limit glycemic variability <NUMBER> mgdl <NUMBER> mmoll <NUMBER> noteworthy patients wellcontrolled group also lower inflammatory coagulation markers crp procalcitonin ddimers required significantly less treatment antivirals antibiotics antifungals systemic corticosteroids immunoglobin vasoactive drugs less need oxygen supplementation well invasive noninvasive ventilation <NUMBER> retrospective study <NUMBER> patients <NUMBER> us hospitals showed patients covid<NUMBER> diabetes andor uncontrolled hyperglycaemia longer length hospital stay markedly higher mortality patients without diabetes andor uncontrolled hyperglycaemia subset analysis patients without evidence diabetes prior admission developed hyperglycemia hospital mortality <NUMBER>fold greater thus raising possibility acute hyperglycemia independent risk factor mortality covid<NUMBER> <NUMBER> hyperglycemia admission also associated worse prognosis optimal glycemic control hospitalization associated significant reduction inflammatory cytokines procoagulative status risk severe disease death patients covid<NUMBER> <NUMBER> people diabetes increased risk disease progression developing covid<NUMBER> complications ards icu admission mechanical ventilation death diabetic patients demonstrate severe inflammatory response prone develop cytokine storm syndrome optimal glycemic control crucial covid<NUMBER> era improves prognosis management patients diabetes covid<NUMBER> challenging prevention treatment strategies urgently required decrease morbidity mortality highrisk population research receive specific grant funding agencies public commercial notforprofit sectors burden severe acute respiratory syndromecoronavirus<NUMBER> sarscov<NUMBER> known covid<NUMBER> increasing worldwide according world health organisation covid<NUMBER> declared epidemic <NUMBER>th march <NUMBER> <NUMBER> date <NUMBER> cases reported united arab emirates uae <NUMBER> deaths <NUMBER> recent studies suggested diabetes major risk factor contributing severity illness mortality covid<NUMBER> <NUMBER> example metaanalysis seven trials china showed <NUMBER> <NUMBER> patients covid<NUMBER> diabetes <NUMBER> diabetes also major risk factor development severe pneumonia clinical course due covid<NUMBER> infection occurs around <NUMBER> patients <NUMBER> addition poor glycaemic control whether related diabetes stress hyperglycemia also known associated poor patient outcomes including hospitalisation death <NUMBER> large populationbased study england <NUMBER> covid<NUMBER> related deaths reported one third occurred people diabetes <NUMBER> <NUMBER>•<NUMBER> type <NUMBER> <NUMBER> <NUMBER>•<NUMBER> type <NUMBER> diabetes <NUMBER> aim dubaibased singlecentre crosssectional study assess clinical characteristics outcomes patients diabetes admitted moderate severe covid<NUMBER> illness study design crosssectional observational study hospitalised patients diabetes laboratory andor radiological confirmed covid<NUMBER> disease <NUMBER> th march <NUMBER> th june <NUMBER> mediclinic parkview hospital dubai uae diagnosis covid<NUMBER> confirmed either positive covid<NUMBER> rtpcr testing andor consistent imaging findings chest xray chest hrct scan ie pathognomonic changes ground glass radiological features covid<NUMBER> purposes study diabetes confirmed either prior diagnosis admission hba<NUMBER>c ≥ <NUMBER> prediabetes defined either prior diagnosis andor admission hba<NUMBER>c <NUMBER> uncontrolled diabetes defined admission hba<NUMBER>c ≥ <NUMBER> patients discharged hospital clinically well two negative laboratory confirmed nasopharyngeal swabs covid<NUMBER> rtpcr admission laboratory tests defined tests done within <NUMBER> hours hospital admission ccbynd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity certified peer review copyright holder preprint version posted july <NUMBER> <NUMBER> data collected electronic medical records bayanaty® information extracted basic demographics nationalities laboratory data imaging results ie chest xray chest hrct capillary blood glucose done admission ethical approvals taken local mediclinic institutional research board dubai scientific research ethics committee dubai health authority dubai uae total <NUMBER> patients admitted hospital confirmed covid<NUMBER> diabetes timeframe <NUMBER> patients overall admitted covid<NUMBER> infection gives total proportion persons admitted covid<NUMBER> infection coexistent diabetesprediabetes <NUMBER> <NUMBER> n<NUMBER> covid<NUMBER> diabetes cohort male patients admitted covid<NUMBER> diabetes represented <NUMBER> different ethnicities <NUMBER> n<NUMBER> asians <NUMBER> n<NUMBER> arab countries mean age sd <NUMBER> ±<NUMBER> years <NUMBER> n<NUMBER> comorbidities including hypertension ischaemic heart disease dyslipidaemia chronic kidney disease shown table <NUMBER> <NUMBER> patients acei <NUMBER> patients arb admission continued per individual clinical circumstances admission obvious adverse effects ccbynd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted july <NUMBER> <NUMBER> arb <NUMBER> <NUMBER> one disease possible per patient ccbynd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted july <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint <NUMBER> patients <NUMBER> patients <NUMBER> type <NUMBER> diabetes <NUMBER> patients <NUMBER> type <NUMBER> diabetes <NUMBER> patients newly diagnosed type <NUMBER> diabetes admission <NUMBER> patients <NUMBER> prediabetes <NUMBER> new diagnosis admission patients known diabetes diagnosis <NUMBER> patients basal insulin regimen <NUMBER> patients basal bolus insulin regimen table <NUMBER> ccbynd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted july <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint pneumonia radiologically <NUMBER> patients normal chest xray <NUMBER> confirmed pneumonia chest hrct <NUMBER> <NUMBER> patients negative laboratory rtpcr radiologically confirmed covid<NUMBER> pathognomonic changes ccbynd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted july <NUMBER> <NUMBER> <NUMBER> patients needed insulin admission required average <NUMBER> units insulin per <NUMBER> hours <NUMBER> patients documented hypoglycaemia defined blood glucose level <NUMBER> mmoll capillary blood glucose admission <NUMBER> hydroxychloroquine <NUMBER> insulin one end stage renal disease total death icu <NUMBER> <NUMBER> <NUMBER> patients died icu <NUMBER> asian origin <NUMBER> males <NUMBER> females <NUMBER> known type <NUMBER> diabetes <NUMBER> new diagnosis prediabetes admission <NUMBER> obese one end stage renal disease known breast cancer pneumonia <NUMBER> developed acute respiratory distress syndrome septic shock average length stay hospital <NUMBER> days ccbynd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted july <NUMBER> <NUMBER> survival curve figure <NUMBER> showed <NUMBER> deaths occurring among <NUMBER> patients <NUMBER> among group treated treatments hydroxychloroquine glucocorticoids might anticipated based severity illness median time death <NUMBER> <NUMBER> <NUMBER> days one drugs ccbynd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted july <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint subset analysis subanalysed laboratory data patients admission maximum results length stay fibrinogen ddimer crp increased statistically significantly course hospital stay table <NUMBER> among <NUMBER> patients admitted diabetesprediabetes covid<NUMBER> <NUMBER> needed icu care cohort admission levels fibrinogen ddimer ferritin crp statistically significantly higher p<NUMBER> managed wardbased care table <NUMBER> ccbynd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted july <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint singlecentre study dubai <NUMBER> patients n<NUMBER> admitted covid<NUMBER> also diabetesprediabetes <NUMBER> study cohort new diagnosis diabetesprediabetes admission according international diabetes federation idf prevalence diabetes uae <NUMBER> <NUMBER> data reflects high background prevalence diabetes patients admitted hospital covid<NUMBER> disease males <NUMBER> n<NUMBER> agrees emerging studies showing men covid<NUMBER> higher risk developing severe outcomes including death women <NUMBER> <NUMBER> <NUMBER> patients admitted covid<NUMBER> diabetes represented <NUMBER> different ethnicities dubai multinational society <NUMBER> nationalities <NUMBER> n<NUMBER> asians <NUMBER> n<NUMBER> arab countries finding also consistent studies suggest people black asian minority ethnic bame populations increased risk predisposed worser clinical courses outcomes covid<NUMBER> infection caucasian counterparts <NUMBER> addition many individuals bame origin also likely diabetesprediabetes also keeping recent studies patients cohort diabetesprediabetes covid<NUMBER> infection important comorbidities n<NUMBER> <NUMBER> finding consistent diabetes cardiovascular disease key components metabolic syndrome <NUMBER> metabolic syndrome also associated proinflammatory prothrombotic states may important implications persons affected covid<NUMBER> complications especially common troublesome <NUMBER> laboratory data shown fibrinogen ddimer ferritin crp levels admission higher subsequently requiring intensive care treatment reflective inflammatory cytokine response covid<NUMBER> acute hyperglycaemia shown upregulation ace<NUMBER> gene facilitates entry virus inside cells hyperglycaemia long periods time downregulates ace<NUMBER> expression making cells vulnerable inflammatory effects virus <NUMBER> laboratory tests used admission decide severity illness level care required patient ie risk stratification limitations study include small sample size retrospective nature analysis therefore studies large sample size would help guidance another limitation study control group patients without diabetes compare knowing absolute numbers total patients admitted covid<NUMBER> timeframe addition emergent nature many new sick patients presenting covid<NUMBER> healthcare facility short timeframe accurate characterisation overweightobese status unavailable majority patients thus reported comorbidities singlecentre study dubai <NUMBER> patients admitted covid<NUMBER> also diabetesprediabetes diabetes patients admitted hospital covid<NUMBER> disease males asian origin <NUMBER> new diagnosis diabetesprediabetes admission majority patients diabetesprediabetes covid<NUMBER> infection important comorbidities n<NUMBER> <NUMBER> <NUMBER> patients negative covid<NUMBER> rtpcr ccbynd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity certified peer review copyright holder preprint version posted july <NUMBER> <NUMBER> pathognomonic changes covid<NUMBER> radiologically comprehensive laboratory analysis revealed distinct abnormal patterns biomarkers associated poor prognosis fibrinogen ddimer ferritin crp levels statistically significantly higher p<NUMBER> presentation patients subsequently needed icu care compared patients remained wardbased <NUMBER> overall needed icu admission <NUMBER> patients died studies larger sample sizes needed compare data covid<NUMBER> patients admitted without diabetes within uae region none none ccbynd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity certified peer review copyright holder preprint version posted july <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint recent experimental epidemiologic data generated growing interest possibility viral infections may involved pathogenesis diabetes mellitus scattered case reports suggested human diabetes may follow viral diseases mumps <NUMBER> <NUMBER> <NUMBER> congenital rubella <NUMBER> <NUMBER> craighead coworkers <NUMBER> <NUMBER> provided experimental evidence mice infected strain encephalomyocarditis emc virus may develop damage <NUMBER>cells pancreatic islets resultant diabeticlike state furthermore gamble coworkers <NUMBER> reported coxsackie b viruses picornaviruses similar emc virus may associated human diabetes gambles data included higher prevalence antibody coxsackie b viruses individuals juvenile diabetes recent onset controls longterm diabetics early <NUMBER> group pediatricians pinellas county florida noted large number new cases juvenile diabetes report describes results epidemiologic laboratory investigation cases background pinellas county lies along gulf coast florida north mouth tampa bay flat lowlands <NUMBER> county covered contiguous urban suburban areas <NUMBER> per cent countys half million residents live <NUMBER> census largest cities st petersburg population <NUMBER> clearwater population <NUMBER> tourism main industry county socioeconomically residents middle class county situated peninsula excellent medical care available county pinellas county residents generally seek medical care within pinellas county medical records seven hospitals pinellas county children usually admitted reviewed records individuals age <NUMBER> admitted january <NUMBER> march <NUMBER> cases diabetes mellitus examined new case juvenile diabetes defined illness <NUMBER> diagnosed diabetes child previously known disease <NUMBER> characterized glycosuria hyperglycemia blood glucose least <NUMBER> mg<NUMBER> ml <NUMBER> treated insulin time hospital discharge incidence juvenile diabetes mellitus pediatric age group estimated plotting new cases month hospitalization effort made identify new cases older age groups new cases persons hospitalized investigation cases diabetic children hospitalized early <NUMBER> investigated detail consent childs parents detailed medical history taken family member family questioned concerning associations families diabetic children review public health records physicians reports viral diseases county health department examined time period november <NUMBER> march <NUMBER> records positive viral cultures positive viral serologic tests pinellas county also reviewed period laboratory midmarch <NUMBER> rectal throat swabs taken newly diabetic children members households specimens placed tryptose phosphate broth <NUMBER> per cent gelatin frozen dry ice laboratory specimens processed inoculation onto two strains human diploid lung fibroblast ru<NUMBER> wi<NUMBER> one line human epithelium hep<NUMBER> primary rhesus monkey kidney cell mkc cultures previously described <NUMBER> specimens also inoculated <NUMBER>day embryonated eggs <NUMBER> specimen passaged least three times total incubation period four weeks single convalescent serum specimens collected venipuncture midmarch newly diabetic children members households control group children pinellas county history diabetes nondiabetic controls matched newly diabetic children age sex serum samples stored <NUMBER> c tested sera tested antibodies prototype strains large number respiratory viruses complementfixation cf hemagglutinationinhibition hi indirect hemagglutination iha serum neutralization sn tests appropriate particular virus sera heatinactivated <NUMBER> c <NUMBER> minutes serologic tests antibodies influenza b parainfluenza <NUMBER> <NUMBER> <NUMBER> soluble viral antigens mumps virus groupspecific hexon antigen adenovirus respiratory syncytial virus rsv mycoplasma pneumoniae herpes simplex <NUMBER> cytomegalovirus cmv assayed standardized cf test overnight fixation <NUMBER> units complement <NUMBER> antibodies influenza c parainfluenza <NUMBER>a <NUMBER>b coronavirus oc <NUMBER> assayed standardized hi test <NUMBER> phosphatebuffered saline diluent spectrophotometrically standardized <NUMBER> per cent mammalian <NUMBER> per cent avian red blood cells <NUMBER> <NUMBER> hemagglutinating antigens parainfluenza <NUMBER>a <NUMBER>b prepared use hi test described killgore dowdle <NUMBER> antibodies herpes simplex <NUMBER> cmv determined iha procedures bernstein stewart <NUMBER> <NUMBER> coronavirus <NUMBER>e antibodies measured similar iha test <NUMBER> neutralizing antibodies six coxsackie b viruses assayed sn tests mkc tissue culture <NUMBER> neutralizing antibody titers emc virus r variant assayed plaque neutralization tests lcell tissue culture generously provided dr john e craighead university vermont epidemiologic thirtyfive cases juvenile diabetes diagnosed children january <NUMBER> march <NUMBER> presented month hospital admission figure <NUMBER> <NUMBER> months prior january <NUMBER> <NUMBER> new diabetics hospitalized average incidence one new case every <NUMBER> months maximum number consecutive <NUMBER>month period four <NUMBER> february march <NUMBER> <NUMBER> cases occurred based expected rate four new cases fewer <NUMBER>month period occurrence <NUMBER> cases rare event p <NUMBER> investigation cases nine <NUMBER> patients hospitalized february march families agreed participate detailed case investigations nine children newly diagnosed diabetes included five males four females ages <NUMBER> <NUMBER> mean age <NUMBER> although nine hospitalized either two hospitals central pinellas county places residence scattered throughout county diabetic child family acquainted child family none associated educational religious occupational recreational activities medication toxic exposure common nine summary data case investigations shown table <NUMBER> onset diabetic symptoms preceded hospitalization <NUMBER> <NUMBER> weeks mean <NUMBER> weeks two factors com mon majority diabetics family history diabetes illness <NUMBER> months preceding hospitalization considered patients physician possible viral etiology seven nine families knew relatives diabetes information concerning diabetic relatives unavailable two diabetic relatives reported onset disease young adulthood others apparently adult onset insulinindependent diabetics eight diabetics histories preceding illness possible viral etiology etiology illnesses determined seven illnesses respiratory ranging simple upper respiratory febrile lower respiratory illnesses four eight cases however illness precede onset diabetic symptoms review public health records search viral illnesses prevalent pinellas county prior cluster cases juvenile diabetes reports county health department viral diseases reviewed outbreak measles occurred clearwater december <NUMBER> influenza recognized throughout county january <NUMBER> outbreaks reportable viral illnesses including mumps rubella occurred influenza confirmed isolation ahong kong<NUMBER> h<NUMBER>n<NUMBER> strains positive serologic studies positive serologic tests also obtained parainfluenza adenovirus echo<NUMBER> coxsackie a<NUMBER> isolated individual patients addition coxsackie b<NUMBER> echo<NUMBER> isolated sewage effluents exception influenza however norre agents known associated significant morbidity laboratory cultures rectal throat swabs taken eight newly diabetic children nine family members yielded virus isolates time attempted isolation midmarch respiratory illness individuals tested isolation attempts therefore made chance might still virus excretion preceding illness single serum samples taken nine diabetic patients within <NUMBER> weeks hospitalization within <NUMBER> weeks onset symptoms unfortunately earlier sera either respiratory diabetes illnesses available single serum specimens also collected <NUMBER> family members contacts <NUMBER> matched <NUMBER> unmatched control children time table <NUMBER> sera tested antibody <NUMBER> common respiratory viruses pneumoniae antibody levels case contact matched control groups tabulated numbers persons significantly high antibody titers table <NUMBER> geometric mean titers gmt table <NUMBER> significant antibody titers defined levels antibody serum endpoint dilutions considered diagnostic experience test procedures used suggestive recent infection prevalence significantly high titers antibody <NUMBER> viruses pneumoniae quite similar diabetics controls agents except coxsackie b<NUMBER> table <NUMBER> three nine diabetics <NUMBER> per cent significant titers <NUMBER> virus whereas <NUMBER> <NUMBER> matched nondiabetic controls <NUMBER> per cent similar titers difference table <NUMBER> age sex characteristics study population diabetics family contacts controls matched controls total borderline statistical significance p <NUMBER> fishers exact test family members diabetics diverse group <NUMBER> adults nine children therefore compared control group except general terms elevated titers adenovirus herpesvirus coxsackie virus b<NUMBER> prevalent among family members serologic data expressed gmts <NUMBER> viral antigens reveal single agent diabetics possessed significantly higher mean titer table <NUMBER> gmt diabetics coxsackie b<NUMBER> almost two dilutions higher controls statistically difference significant ttest p <NUMBER> gmts family members despite age sex diversity similar diabetics controls agents except coxsackie b<NUMBER> gmt family members coxsackie b<NUMBER> approximately one dilution greater gmt diabetics controls results gmts nine additional viral antigens diabetics selected family members unmatched group non diabetic children shown table <NUMBER> table <NUMBER> antibody levels viruses typical pediatric groups gmt cmv somewhat high diabetics nonetheless quite similar nondiabetic group unusual range cf iha tests herpes cmv measure different aspects infection neither test indicated viruses associated respiratory illnesses diabetics hospitalized antibody levels six coxsackie b viruses presented nine cases together serologic identification possible recent respiratory illnesses provide summary salient serologic data table <NUMBER> pattern seen summary one total randomness virtually case serologic evidence infection different virus preceding four six months therefore apparent one coxsackie b viruses one <NUMBER> viruses tested could account outbreak diabetes discussion heredity accepted major determinant occurrence diabetes mellitus exact mode inheritance yet clarified <NUMBER> investigators concluded genetic environmental determinants involved <NUMBER> among characteristics suggestive environmental determinants seasonality onset juvenile diabetes <NUMBER> study patients north central united states <NUMBER> <NUMBER> analysis english diabetics <NUMBER> described nadir incidence late spring early summer broad peak late summer early spring data collected pinellas county also hinted seasonal pattern <NUMBER> <NUMBER> cases identified <NUMBER> <NUMBER> figure <NUMBER> hospitalized months januaryapril approximately time <NUMBER> peak many viral respiratory infections similar seasonal pattern characteristic suggested possible cause seasonality juvenile diabetes although case reports indicated diabetic state may follow diseases mumps congenital rubella <NUMBER> reports remained incidental observations present firm evidence one specific viral illness plays significant part pathogenesis human diabetes mellitus convincing data suggesting viral etiology diabetes come experiments carried craighead coworkers using mouse model strain emc virus <NUMBER> <NUMBER> mice strain virus caused necrosis <NUMBER>cells islets release insulin cases diabeticlike state characterized hyperglycemia similar findings recently reported investigators <NUMBER> <NUMBER> genetic factors also seem determinants model virusinduced diabetes certain strains mice infected develop lesions suggestive diabetes <NUMBER> fact emc virus common human pathogen appears preclude possibility emc virus involved human diabetes one study conducted craighead et al showed <NUMBER> per cent incidence emc antibody panamanian population <NUMBER> later survey random population hospitalized children new england states revealed <NUMBER> per cent incidence emc antibody <NUMBER> indeed present study <NUMBER> per cent persons tested measurable levels emc antibody none diabetic children attention focused therefore upon similar group picornaviruses coxsackie b viruses extremely frequent human pathogens coxsackie b viruses like emc may cause pancreatitis <NUMBER> even diabetes <NUMBER> experimental mice addition may attack human pancreas certain infant infections <NUMBER> although published case reports diabetes humans following proven coxsackie b infections epidemiologic serologic data gamble coworkers <NUMBER> aroused considerable interest possible relation viruses human diabetes gamble et al reported insulindependent diabetics within <NUMBER> months onset higher serum neutralization titers coxsackie b viruses especially b<NUMBER> nondiabetic controls longstanding diabetics <NUMBER> controls study however closely matched age sex residence time collection serum also comparison diabetics controls low complementfixation titers <NUMBER> coxsackie b viruses considered positive experience test suggests many sera <NUMBER> dilution fix complement crude coxsackie b antigens nonspecifically hence <NUMBER> titers might genuine indicators past infection separate study gamble taylor showed statistical correlation annual number isolates coxsackie b<NUMBER> virus number new cases juvenile diabetes <NUMBER> correlation seen coxsackie b viruses however attempts show temporal correlation diabetes viral infections common season made thus temporal relationship remains open question diabetes mellitus related etiologically specific viral illness one might expect see cases clustered time following outbreak viral illness population one study following coxsackie b<NUMBER> b<NUMBER> mixed outbreak upper respiratory infection recently completed cases diabetes found among <NUMBER> children four years outbreak <NUMBER> purpose present investigation determine <NUMBER> cases diabetes pinellas county represented unusually high incidence look retrospectively evidence single viral agent may associated cluster previous reports suggesting relationship diabetes viral infections dealt primarily juvenile form disease likewise confined investigation cases juvenile diabetes specifically pediatric population number reasons feel evidence supporting unusual incidence juvenile diabetes early <NUMBER> valid firstly definition new case juvenile diabetes quite strict included analysis new cases little doubt diagnosis cases modern medical community would hospitalized secondly county investigation took place somewhat isolated geographically excellent medical facilities available within county feel unlikely cases would hospitalized elsewhere thirdly case finding techniques viz review medical records equally sensitive throughout <NUMBER>month period investigated finally rather comparing incidence early <NUMBER> statistically expected incidence <NUMBER>year period compared previous maximum incidence since maximum occurred <NUMBER> pinellas county population stable growth pediatric population could likely explain peak cases observed <NUMBER> detailed investigation nine <NUMBER> cases comprised outbreak early <NUMBER> revealed geographic clustering cases within county personal association families involved single exposure common cases although seven diabetics family histories diabetes history diabetes immediate families relatives diabetes apparently adult onset disease none diabetics experienced recent viral illness measles mumps whose etiology could identified furthermore none experienced abdominal symptoms characteristic pancreatitis illnesses possible viral etiology reported eight diabetics illnesses general similar common winter respiratory illnesses infections preceded symptoms diabetes four cases could relate illnesses onset diabetes lack viral isolates diabetic children family members unexpected samples taken weeks recent virallike illnesses onsets diabetes time individuals tested recovered respiratory illnesses therefore necessary rely upon serologic testing single convalescent serum specimens search evidence recent viral infection results sera diabetic children revealed elevated viral antibody titers common high titers individual patients number different viruses observed influenza parainfluenza <NUMBER> respiratory syncytial virus coxsackie b<NUMBER> coxsackie b<NUMBER> parainfluenza<NUMBER>b cytomegalovirus coronavirus <NUMBER>e eight nine diabetics least one high titer suggestive recent viral infection whether clinical infections inapparent infections could determined evidence recent mumps emc infection diabetics comparison nondiabetic controls matched closely time serum collection residence age sex antibody one virus appeared prevalent diabetics three nine diabetics high titers coxsackie b<NUMBER> although prevalence high titers significantly greater diabetics gmt group significantly different matched controls family members diabetics possessed high titers related virus coxsackie b<NUMBER> since antibody coxsackie b viruses remain elevated years following infection significance elevated b<NUMBER> b<NUMBER> sn titers observed study much questionable antibody levels viruses perhaps coxsackie b infections related cases diabetes evidence coxsackie b viruses responsible outbreak diabetes furthermore cases diabetes investigation occurred six months usual late summerearly fall peak coxsackie b infections <NUMBER> temporally cluster cases diabetes followed closely communitywide influenza outbreak usual season winter respiratory viral infections cluster cases diabetic ketoacidosis influenza epidemic winter <NUMBER> previously reported <NUMBER> six <NUMBER> cases described report <NUMBER> individuals previously unknown diabetics despite temporal association study able demonstrate elevated titer influenza one diabetic three family members results therefore implicate particular virus outbreak diabetes viruses indeed etiologically involved data suggest effect multiple viruses rather single entity upon genetically predisposed individuals cases coronavirus disease <NUMBER> covid<NUMBER> rapidly increasing globally april <NUMBER> <NUMBER> <NUMBER> million cases confirmed <NUMBER> deaths reported <NUMBER> countries <NUMBER> several studies rapidly provided crucial data eg incubation period related various aspects novel coronavirus sarscov<NUMBER> severe acute respiratory syndrome coronavirus <NUMBER> infection <NUMBER> however risk factors severity prognosis covid<NUMBER> poorly understood information critical identify high risk patients facilitate planning eg forecasting need hospital beds mechanical ventilators risk factors also implications workforce allocation eg assignment healthcare providers specific risk factors positions reduced risk exposure date several studies reported history cardiovascular disease cvd traditional cvd risk factors eg age male sex current smoking hypertension diabetes associated severe covid<NUMBER> however age results inconsistent furthermore studies accounted potential confounding age sex evaluated potential risk factors example studies reported hypertension risk factor severe covid<NUMBER> observations may simply reflect fact hypertension common older adults <NUMBER> nonetheless despite lack robust evidence observation together fact sarscov<NUMBER> uses angiotensinconverting enzyme <NUMBER> entry human body <NUMBER> raised concern continued use reninangiotensin system increase among clinicians researchers <NUMBER> <NUMBER> context conducted systematic review studies reporting cardiovascular risk factors relation severe manifestation covid<NUMBER> ie death acute respiratory distress syndrome ards need mechanical ventilator support admission intensive care unit icu particular interest studies adjusted key confounders age sex ccbyncnd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted april <NUMBER> <NUMBER> conducted systematic review following prisma statement according predetermined protocol systematically searched pubmed embase eligible reports search terms listed web appendix <NUMBER> included full reports letters original data written english eligible study designs cohort study crosssectional case series clinical trials conducted literature search march <NUMBER> <NUMBER> restricted publications december <NUMBER> <NUMBER> review included studies reported adult patients aged <NUMBER> years older restriction respect gender raceethnicity comorbidities primary outcome interest severe covid<NUMBER> defined following allcause mortality icu admission ards need mechanical ventilation included studies reporting least <NUMBER> cases severe covid<NUMBER> obtain reliable estimates enough number outcomes considering clinical cascade eg death final outcome one study reported results multiple outcomes prioritized composite outcome followed icu admission ards need mechanical ventilation mortality potential risk factors interest preexisting cvd including cardiac disease cerebrovascular disease traditional risk factors recognized major cvd clinical guidelines age sex smoking hypertension diabetes found one study reporting severity covid<NUMBER> lipids lowdensity lipoprotein categorized risk factors sociodemographic factors age sex smoking clinical factors hypertension diabetes preexisting cvd ccbyncnd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity certified peer review copyright holder preprint version posted april <NUMBER> <NUMBER> eight reviewers collected relevant data elements identified publication recorded microsoft excel microsoft corporation redmond washington usa overall quality based newcastle ottawa quality assessment scale nos <NUMBER> includes eight items selection comparability outcome web appendix <NUMBER> nos score cohorts studies ranges <NUMBER> <NUMBER> score greater <NUMBER> considered highquality crosssectional studies applied adapted form nos <NUMBER> maximum score <NUMBER> <NUMBER> points used identify studies high qualitythe paired reviewers resolved conflicts related data collection quality assessment summarized relative risk estimates odds ratios hazard ratios association risk factor primary outcome relevant studies pooled estimates using randomeffects metaanalysis studies report measures association prevalence risk factors interest outcome status eg survivors vs nonsurvivors calculated crude odds ratios <NUMBER> cis process cell zero count added <NUMBER> cell appropriate <NUMBER> ccbyncnd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity certified peer review copyright holder preprint version posted april <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint potential confounding age sex relevant prior cvd hypertension diabetes since comorbidities become prevalent increased age <NUMBER> studies report adjusted risk estimates comorbidities ran metaregression randomeffects log odds ratio log hazard ratio comorbidities difference mean median age vs without primary outcome across eligible studies obtain reliable estimates conducted metaregression analyses least five studies also depicted funnel plots visually checked possibility publication bias heterogeneity study estimates assessed <NUMBER> statistic <NUMBER> <NUMBER> considered high heterogeneity <NUMBER> pvalue <NUMBER> considered statistically significant analyses conducted stata <NUMBER> <NUMBER> statacorp llc college station texas usa systematic review identified <NUMBER> potentially eligible publications removing duplicate publications figure <NUMBER> <NUMBER> publications excluded screening titles abstracts remaining <NUMBER> publications reviewed fulltext screening excluded <NUMBER> publications meet inclusion criteria leaving <NUMBER> publications <NUMBER> qualitative quantitative analyses publications considered high quality web table <NUMBER> included studies death reported <NUMBER> studies icu admission <NUMBER> studies ards <NUMBER> studies mechanical ventilation <NUMBER> studies two studies reported composite outcome studies reported covid<NUMBER> patients china <NUMBER> studies small sample size <NUMBER> <NUMBER> studies table <NUMBER> studies included confirmed covid<NUMBER> patients laboratory tests total <NUMBER> covid<NUMBER> patients included studies <NUMBER> ccbyncnd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted april <NUMBER> <NUMBER> table <NUMBER> case fatality rate three databases exceeded <NUMBER> around age <NUMBER> years <NUMBER> <NUMBER> years <NUMBER> years italy two studies reported relative risk age unadjusted multivariable models studies observed effect size age materially changed adjustment comorbidities <NUMBER> <NUMBER> studies showed higher risk severe covid<NUMBER> men women pooled crude relative risk estimate severe covid<NUMBER> men women <NUMBER> <NUMBER> ci <NUMBER> figure <NUMBER>a metaregression demonstrated consistent results regardless differences mean median age vs without severe covid<NUMBER> web figure <NUMBER> funnel plot indicate major publication bias web figure <NUMBER>a three studies reported associations current smoking severe covid<NUMBER> one study reaching statistical significance figure <NUMBER>b pooled estimate relative risk severe covid<NUMBER> <NUMBER> <NUMBER> ci <NUMBER> one study reported association across three categories current smoking odds ratio <NUMBER> <NUMBER> former smoking <NUMBER> <NUMBER> <NUMBER> vs never smoking <NUMBER> corresponding funnel plot shown web figure <NUMBER>b clinical factors hypertension diabetes prior cvd ccbyncnd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted april <NUMBER> <NUMBER> diabetes <NUMBER> study cancer chronic obstructive pulmonary disease similar independent associations severe covid<NUMBER> metaregression analyses demonstrated studies greater age difference vs without severe covid<NUMBER> tended greater relative risk according presence hypertension diabetes preexisting cvd indicating levels potential confounding age figure <NUMBER> although none analyses reached statistical significance similar pattern seen cvd difference proportion male sex vs without severe covid<NUMBER> web figure <NUMBER> hand meta ccbyncnd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted april <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint regression indicate higher proportion male sex confounded association hypertension diabetes severe covid<NUMBER> knowledge first systematic review metaanalysis focusing relationship severe covid<NUMBER> cvd risk factors confirmed robust association age male sex severe covid<NUMBER> contributions likely independent studies demonstrated positive associations current smoking severe covid<NUMBER> several studies reported preexisting cvd hypertension diabetes also associated severe covid<NUMBER> however two studies reported estimates comorbidities adjusted age andor sex one study found association coronary heart disease severe covid<NUMBER> longer statistically significant age adjustment <NUMBER> whereas showed independent associations hypertension diabetes severe covid<NUMBER> analyses adjusted age comorbidities <NUMBER> although primary estimate statistically significant metaregression analyses indicated degree confounding age necessarily sex associations hypertension diabetes prior cvd severe covid<NUMBER> positive association sociodemographic factors age male sex smoking severe covid<NUMBER> consistent reports infectious diseases eg influenza virus sars <NUMBER> <NUMBER> <NUMBER> <NUMBER> several plausible mechanisms older age linked reduced immune reaction comorbidities limited organ reserve <NUMBER> <NUMBER> <NUMBER> male sex related higher prevalence comorbidities less frequency washing hands immunological disadvantage given xchromosome coding proteins immune system <NUMBER> whereas smoking damage respiratory system <NUMBER> metaanalysis confirmed overall positive crude associations cvd hypertension diabetes severe covid<NUMBER> pooled relative risk estimates around <NUMBER> ccbyncnd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted april <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint <NUMBER> important question whether associations independent major confounders particularly age although could obtain definite answer studies ran multivariable models metaregression analysis indicated degree confounding age one study zhou et al showed substantial attenuation association coronary heart disease severe covid<NUMBER> hand liang et al showed independent associations hypertension diabetes severe covid<NUMBER> relatively large sample size <NUMBER> patients also biologic plausibility hypertension diabetes leading risk factors cvd kidney diseases evidence covid<NUMBER> damages organs <NUMBER> <NUMBER> available studies provide scant evidence related hypothesized adverse effect reninangiotensin system inhibitors severity covid<NUMBER> infection noted biological plausibility potential associations covid<NUMBER> hypertension diabetes two comorbidities associated use reninangiotensin system inhibitors one study reported prevalence reninangiotensin system inhibitors use <NUMBER> study <NUMBER> patients reported prevalent hypertension <NUMBER> patients taking reninangiotensin system inhibitors <NUMBER> thus reasonable many expert organizations recommend continuing category medications better evidence becomes available <NUMBER> results potentially used guide decisionmaking lack discrete age thresholds severe covid<NUMBER> complicates process data case fatality rates three countries web table <NUMBER> suggest age older <NUMBER> <NUMBER> years confers high risk severe covid<NUMBER> relative risk <NUMBER> compared <NUMBER> years results also indicate male sex independent risk factor pooled relative risk <NUMBER> although likely pooled crude relative risk <NUMBER> hypertension diabetes cvd overestimate impact beyond age sex may confer <NUMBER> times greater risk thus using factors possible estimate least crudely risk severe covid<NUMBER> example man aged <NUMBER> years old either hypertension diabetes prior cvd would ccbyncnd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted april <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint risk <NUMBER> fold higher risk approximation <NUMBER> x <NUMBER> x <NUMBER> compared woman younger <NUMBER> years without clinical factors information could used inform decisions testing covid<NUMBER> clinical management covid<NUMBER> workforce planning study limitations first reflecting fact outbreak started china studies china however given similar casefatality rates clinical manifestations across different countries seems likely results largely generalizable nonetheless need acknowledge regional variations risk factors eg <NUMBER>fold difference prevalence smoking men vs women china <NUMBER> thus future investigations different regions would valuable second include nonenglish publications third studies reported odds ratios known overestimate risk ratio prevalence exposures relatively high fourth cannot deny possibility patients included multiple studies especially china cdc report <NUMBER> chinese studies nonetheless pooled estimates largely similar analyses excluded china cdc data data shown finally literature covid<NUMBER> growing rapidly thus lag time literature search publication hand systematic review several strengths indepth review cvd risk factors clinically relevant definitions severe covid<NUMBER> minimize subjective reporting metaregression explore potential confounding relatively short elapsed time <NUMBER> weeks literature search manuscript submission conclusion systematic review metaanalysis found robust associations older age male sex risk factors severe covid<NUMBER> studies reported association current smoking severe covid<NUMBER> unadjusted analyses hypertension diabetes prior cvd significantly associated severe covid<NUMBER> however twostudies conducted ageadjusted analyses one relatively large study showing independent contributions hypertension diabetes severe covid<NUMBER> study explicitly assessed relationship reninangiotensin system inhibitors covid<NUMBER> ccbyncnd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted april <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint results suggest combination age male sex cvd risk factors identify substantial gradient risk developing severe covid<NUMBER> compared without factors ccbyncnd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted april <NUMBER> <NUMBER> ccbyncnd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted april <NUMBER> <NUMBER> studies published <NUMBER> abbreviations covid<NUMBER> coronavirus disease <NUMBER> cvd cardiovascular disease htn hypertension nr reported authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted april <NUMBER> <NUMBER> authorfunder granted medrxiv license display preprint perpetuity certified peer review copyright holder preprint version posted april <NUMBER> <NUMBER> ccbyncnd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity certified peer review copyright holder preprint version posted april <NUMBER> <NUMBER> ccbyncnd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity certified peer review copyright holder preprint version posted april <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint struggling understand human catastrophe coronavirus disease<NUMBER> covid <NUMBER> epidemic <NUMBER> cases documented covid<NUMBER> infection united states <NUMBER> deaths <NUMBER> economy except limited sectors come complete halt practice physical distancing try mitigate effects pandemic <NUMBER> weeks since covid<NUMBER> began accelerate flurry information corners expected unexpected help us understanding rapid publication peerreviewed data defined possible risk factors covid<NUMBER> clinical course possible epidemiology unusual time public health emergency numerous nonpeerreviewed manuscripts uploaded preprint servers unreviewed data conclusions must evaluated spirit nevertheless data published preprint form point tantalizing hypothesis covid<NUMBER> infection severity explained concentration glycosylated severe acute respiratory syndromecoronavirus <NUMBER> sarscov<NUMBER> viral particles lung epithereceptor <NUMBER> ace<NUMBER> lung epithelium degree control pulmonary immune response sarscov<NUMBER> spike protein approximately day <NUMBER> <NUMBER> symptom onset may related ace<NUMBER> appears primary receptor entry sarscov<NUMBER> various epithelial tissues envelope anchored spike protein allows entry coronaviruses host cells binding host receptor fusing viral host membranes <NUMBER> analysis sarscov betacoronavirus similar sarscov<NUMBER> responsible severe acute respiratory syndrome sars <NUMBER> defined receptorbinding domain rbd sarscov spike protein specifically recognized ace<NUMBER> <NUMBER> susceptibility sars appears primarily dependent affinity spike rbd bind host ace<NUMBER> target tissues initial viral attachment step differences affinity rbd ace<NUMBER> may determine zoonotic host epidemiology spread <NUMBER> protein crystal structure analysis sarscov rbd complexed ace<NUMBER> demonstrated differential binding affinity resides critical receptorbinding motif spike receptor protein particular composition amino acids <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> determine affinity human ace<NUMBER> opposed hosts <NUMBER> predicted protein structural analysis critical five residues sarscov<NUMBER> analogous sarscov suggested increased binding affinity human ace<NUMBER> sarscov<NUMBER> <NUMBER> synthetic sarscov<NUMBER> rbd found vitro bind enter cells transfected human ace<NUMBER> receptor known coronavirus targets dpp<NUMBER> target merscov <NUMBER> therefore rational assume like sarscov sarscov<NUMBER> uses ace<NUMBER> receptor target tissues primary mechanism entry recent work cryo electron microscopy ace<NUMBER> bound spike protein fragment sarscov<NUMBER> <NUMBER> suggests viral spike protein trimer one trimer rbd sites exposed bind ace<NUMBER> additional structurefunction studies <NUMBER> also appear indicate viral spike protein sarscov<NUMBER> highly glycosylated protein cleaved proteases two subunits s<NUMBER> s<NUMBER> s<NUMBER> subunit divided sa sb domains sb domain predicted bind human ace<NUMBER> s<NUMBER> subunit responsible fusion virusace<NUMBER> complex cell membrane highly glycosylated evolutionarily conserved sites <NUMBER> tempting speculate alterations glycosylation spike protein well ace<NUMBER> modulate viral binding also tempting speculate alterations highly glycosylated evolutionarily conserved viral fusion subunit could modulate proteinace<NUMBER> complex fusion cell membrane potentially attenuate human human transmission importance ace<NUMBER> binding sarscov<NUMBER> covid<NUMBER> underscored observation anosmia dysgeusia recently observed patients covid<NUMBER> <NUMBER> ace<NUMBER> expression recently found high oropharynx tongue <NUMBER> binding ace<NUMBER> sarscov<NUMBER> covid<NUMBER> also suggests prolonged uncontrolled hyperglycemia history diabetes mellitus may important pathogenesis disease known history diabetes dm ambient hyperglycemia found independent risk factors morbidity mortality sars <NUMBER> followup analysis <NUMBER> patients high fasting plasma glucose fpg independent predictor sars mortality <NUMBER> diabetes found <NUMBER> cohort hospitalized covid<NUMBER> patients appeared risk factor severity disease <NUMBER> history diabetes associated <NUMBER> covid<NUMBER> intensive care unit icu admissions vs <NUMBER> nonicu admissions one case series <NUMBER> another recent icu case series reported <NUMBER> <NUMBER> <NUMBER> history diabetes <NUMBER> mortality covid<NUMBER> patients diabetes found <NUMBER> vs <NUMBER> patients comorbidities <NUMBER> possible explanation link hyperglycemia ace<NUMBER> levels severity covid<NUMBER> disease could explained several clinical observations sars preclinical observations nod diabetic mouse noted potential changes glycosylation ace<NUMBER> well glycosylation viral spike protein possibly induced uncontrolled hyperglycemia may alter binding viral spike protein ace<NUMBER> degree immune response virus subset <NUMBER> patients prior diabetes received steroid treatment hospitalization survived sars fpg levels hospitalization found decrease discharge <NUMBER> twenty <NUMBER> <NUMBER> patients diabetes hospitalization <NUMBER> suggested could cause harm <NUMBER> interesting note article going press another group expressed similar hypothesis <NUMBER> potentially high aberrantly glycosylated ace<NUMBER> lung nasal airways tongue oropharynx uncontrolled hyperglycemia could also serve increased sarscov<NUMBER> viral binding sites thus leading higher propensity covid<NUMBER> infection higher disease severity interestingly high ace<NUMBER> protective effect various organs <NUMBER> ace<NUMBER> gene expression increased estrogen mouse model <NUMBER> potential protective factor sarscov<NUMBER> infection pathogenicity men likely women acquire covid<NUMBER> severe disease recent survey studies found ace<NUMBER> gene expression higher tissues women younger adults inverse correlation disease severity <NUMBER> possible explanation discrepancy gene expression experiments cannot measure posttranslational modifications protein glycosylation nod diabetic mouse model ace<NUMBER> activity lung rise fall insulin administration amount ace<NUMBER> protein apparently <NUMBER> consistent rise glycosylated ace<NUMBER> opposed total ace<NUMBER> since antibody binding proteins measured western blot analysis could affected glycosylation <NUMBER> therefore likely amount glycosylated ace<NUMBER> receptor simply amount ace<NUMBER> alone responsible virus binding fusion true argues better glycemic control patients prediabetes diabetes potential mechanism slow covid<NUMBER> spread reduce severity symptoms additionally since <NUMBER> american population without history diabetes prediabetes hemoglobin a<NUMBER>c <NUMBER> random sampling <NUMBER> appears coincident peak viral load measured nasopharyngeal swabs day <NUMBER> symptom onset sars <NUMBER> timing ards sars also corresponded timing immunoglobulin g igg seroconversion <NUMBER> additionally neutralizing antibody nab response sarscov spike protein patients died sars occurred earlier course disease <NUMBER> days symptom onset vs survived <NUMBER> days nab antibody titer higher died sars survived <NUMBER> notably viral load covid<NUMBER> severe cases appears remain high <NUMBER> days symptom onset <NUMBER> tempting hypothesize similar mechanism applies sarscov<NUMBER> acute onset lung inflammation sars resulting ards appears tightly associated monocytemacrophage polarization function <NUMBER> acute infection macrophages display classically activated inflammatory m<NUMBER> phenotype express cytokines interleukin<NUMBER> il<NUMBER> high il<NUMBER> levels associated brufsky <NUMBER> increased mortality series <NUMBER> hospitalized patients tempting consider mechanism acts covid<NUMBER> sars overactive macrophage m<NUMBER> inflammatory response neutralizing antibodies sarscov<NUMBER> spike protein form day <NUMBER> <NUMBER> results ards susceptible patients also allows consideration agents may interfere overly brisk macrophage inflammatory response perhaps influence course disease particular blunt completely abrogate m<NUMBER> m<NUMBER> balance macrophage polarization well viral load sars appears temporally related onset ards interest mouse model asthma macrophage m<NUMBER> polarization increased estrogen <NUMBER> additionally estrogen also accelerates acquisition m<NUMBER> phenotype monocyte cell culture model <NUMBER> vitro concentrations achievable human lung tissue <NUMBER> chloroquine related compound inhibits sarscov replication spread cell culture possibly reducing glycosylation ace<NUMBER> receptor <NUMBER> interestingly computer simulations suggest hydroxychloroquine chloroquine predicted bind active site enzyme udpnacetylglucosamine <NUMBER>epimerase catalyzes rate determining step sialic acid biosynthesis pathway <NUMBER> thus rational basis assume hydroxychloroquine interfere terminal glycosylation proteins golgi apparatus small unrandomized clinical cohort <NUMBER> patients combination hydroxychloroquine azithromycin shown rapidly reduce viral load covid<NUMBER> patients ameliorate clinical symptoms majority patients <NUMBER> another small randomized hydroxychloroquine also act oral hypoglycemic agent patients diabetes taking hydroxychloroquine rheumatologic diseases significant reduction hemoglobin a<NUMBER>c compared methotrexate <NUMBER> thus serve reduce hyperglycemia possible covid<NUMBER> risk factor disease severity studies mixed topic balance m<NUMBER> m<NUMBER> macrophage polarization may differ depending local microenvironment hydroxychloroquine shown least one study block polarization macrophages m<NUMBER> inflammatory subtype <NUMBER> await larger randomized studies analysis patient subtypes determine anyone benefit hydroxychloroquine context theoretical framework covid<NUMBER> infection results date supportive although much caution used interpretation early small clinical trials regardless results larger clinical trials hydroxychloroquine covid<NUMBER> hoped analysis provide testable theoretical framework allow advances understanding control deadly viral epidemic december <NUMBER> outbreak pneumonia caused <NUMBER> novel coronavirus disease first observed wuhan china <NUMBER> feb <NUMBER> <NUMBER> world health organization officially named disease coronavirus disease <NUMBER> covid <NUMBER> feb <NUMBER> <NUMBER> total <NUMBER> <NUMBER> cases covid <NUMBER> china reported <NUMBER> <NUMBER> death <NUMBER> although patients covid<NUMBER> mild symptoms good prognosis <NUMBER> accumulating evidence indicated high mortality covid<NUMBER> patients <NUMBER> <NUMBER> <NUMBER> resembling severe acute respiratory syndrome coronavirus sarscov infection <NUMBER> patients rapidly developed severe pneumonia acute respiratory distress syndrome cardiac injury multiple organ failure died <NUMBER> however data clinical characteristics patients covid<NUMBER> limited underlying mechanism clear yet therefore early identification severity covid<NUMBER> important public health nonalcoholic fatty liver disease <NUMBER> might predict development cardiovascular events <NUMBER> patients cardiometabolic disorders may susceptible infection covid<NUMBER> becoming severe case partly due abnormal metabolism systemic inflammation state thus patients might higher risk poor outcome sense studies evaluate relationship tyg index severity mortality covid<NUMBER> urgently needed study investigated patients confirmed covid<NUMBER> admitted wuhan tongji hospital purpose study explore association tyg index levels clinical outcomes patients covid<NUMBER> provide ideas improving covid<NUMBER> prognosis study retrospectively analysed confirmed covid<NUMBER> jan <NUMBER> <NUMBER> feb <NUMBER> <NUMBER> tongji hospital huazhong university science technology wuhan china patients enrolled study diagnosed covid<NUMBER> according interim guidance <NUMBER> patients missing data clinical characteristics excluded considering complexity disease well uncertainty course treatment <NUMBER> patients completed medical records follow data included study approved ethics commission tongji hospital participants provided oral informed consent reviewed epidemiological demographic clinical laboratory data patients medical records two researchers checked data collected independently collected information socioeconomic characteristics age sex exposure history smoking chronic medical histories diabetes hypertension cardiovascular disease cerebrovascular disease chronic kidney disease chronic pulmonary disease chronic liver disease clinical symptoms fever cough expectoration dyspnoea chest pain diarrhea headache hypodynamia anorexia nausea vomiting vital signs temperature heart rate respiratory rate oxygen saturation blood pressure laboratory data complete blood count liver renal function fasting plasma glucose fpg hemoglobin a<NUMBER>c hba<NUMBER>c lipid highsensitivity creactive protein crp ferritin tumor necrosis factor α tnfα well living status study period tyg index calculated formula ln fasting triglycerides mgdl × fpg mgdl<NUMBER> patients divided <NUMBER> tertiles according tyg index levels t<NUMBER> n <NUMBER> <NUMBER> ≤ tyg index ≤ <NUMBER> t<NUMBER> n <NUMBER> <NUMBER> ≤ tyg index ≤ <NUMBER> t<NUMBER> n <NUMBER> <NUMBER> ≤ tyg index ≤ <NUMBER> diabetes defined selfreported medical history diabetes use antidiabetic drugs hypertension defined selfreported history hypertension use antihypertensive drugs chronic diseases cardiovascular disease cerebrovascular disease chronic kidney disease chronic pulmonary disease chronic liver disease diagnosed according selfreported medical history severity disease staged according guidelines diagnosis treatment covid<NUMBER> trial sixth edition published national health commission china february <NUMBER> <NUMBER> severe case defined including one criterion follow <NUMBER> respiratory rate <NUMBER>min <NUMBER> oxygen saturation ≤ <NUMBER> <NUMBER> pao<NUMBER>fio<NUMBER> <NUMBER> patients developed either shock respiratory failure requiring mechanical ventilation combined organ failure admission intensive care unit icu presented continuous variables mean ± standard deviation sd normally distributed data median interquartile range iqr data skew distribution categorical variables frequencies percentage assessed differences mild severe cases using twosample test mannwhitney u test depending parametric nonparametric data continuous variables chi square test categorical variables comparisons among tyg index groups assessed analysis variance anova kruskalwallis test univariate multivariate logistic regression analyses used evaluate associations tyg index severity mortality covid<NUMBER> associations tyg index severity covid<NUMBER> subgroups classified age <NUMBER> vs ≥ <NUMBER> years sex male vs female medical history chronic disease presence vs absence including diabetes mellitus hypertension also studied using logistic regression analysis used spss software version <NUMBER> spss inc chicago il usa analyses statistically significant p <NUMBER> total <NUMBER> admitted hospital patients included study mean age <NUMBER> ± <NUMBER> years old <NUMBER> <NUMBER> patients males regarding history chronic diseases <NUMBER> hypertension <NUMBER> diabetes <NUMBER> cardiovascular disease <NUMBER> cerebrovascular disease <NUMBER> chronic kidney disease <NUMBER> chronic pulmonary disease <NUMBER> chronic liver disease prevalent symptoms fever <NUMBER> cough <NUMBER> fatigue <NUMBER> population <NUMBER> <NUMBER> patients severe cases <NUMBER> <NUMBER> patients died hospital baseline characteristics patients according severity shown table <NUMBER> severe patients older males likely hypertension diabetes compared mild patients prevalence dyspnea anorexia fatigue severe group higher mild group p <NUMBER> moreover severe patients significantly higher value respiratory rate systemic blood pressure sbp mortality andor likely receive auxiliary ventilation invasive mechanical ventilation p <NUMBER> markedly difference parameters laboratory findings patients according severity shown table <NUMBER> blood routine examination severe patients obviously higher values white blood cell wbc count neutrophil count neu notably lower levels lymphocytes count mild patients p <NUMBER> regarding blood biochemical indicators severe group higher levels aspartate aminotransferase ast lactate dehydrogenase ldh creatinine uric acid ua crp fpg compared mild group p <NUMBER> addition levels ferritin tnfα also elevated severe ones p <NUMBER> notably tyg index calculated triglycerides glucose markedly higher severe cases mild ones p <NUMBER> table <NUMBER> showed baseline characteristics among covid<NUMBER> patients divided according tyg index tertiles compared first tertile tyg index patients highest tertile tyg presented higher levels wbc neu ast ldh crp ferritin yet lower levels lymphocytes count p <NUMBER> importantly patients increasing level tyg index higher incidence severe covid<NUMBER> case death p <NUMBER> <NUMBER> respectively shown fig <NUMBER> continuous data expressed mean ± sd median interquartile range p values indicate differences mild severe cases p <NUMBER> considered statistically significant additionally association tyg index severity covid<NUMBER> confirmed logistic regression table <NUMBER> adjustment age sex sbp hba<NUMBER>c tyg index independently associated severity covid<NUMBER> patients odds ratio <NUMBER> <NUMBER> confidence interval ci <NUMBER> however significant association observed adjusting crp tnfα <NUMBER> <NUMBER> ci <NUMBER> next studied correlations tyg crp tnfα using pearson correlation analysis observed controlling age sex hba<NUMBER>c sbp tyg levels positively correlated crp r <NUMBER> p <NUMBER> tnfα r <NUMBER> p <NUMBER> assessed effect tyg index particular subsets patients covid<NUMBER> table <NUMBER> similar results observed subgroups analysis adjustment age sex sbp hba<NUMBER>c positively association tyg index severity observed subgroups men women age ≥ <NUMBER> patients diabetes <NUMBER> <NUMBER> ci <NUMBER> <NUMBER> <NUMBER> ci <NUMBER> <NUMBER> <NUMBER> ci <NUMBER> <NUMBER> <NUMBER> ci <NUMBER> however adjusted association statistically significant observed adding crp tnfα model <NUMBER> <NUMBER> <NUMBER> ci <NUMBER> <NUMBER> <NUMBER> ci <NUMBER> <NUMBER> <NUMBER> ci <NUMBER> <NUMBER> <NUMBER> ci <NUMBER> additionally associations significant patients age <NUMBER> years without diabetes hypertension moreover results showed tyg index level significantly higher death group survivor vs deceased <NUMBER> ± <NUMBER> vs <NUMBER> ± <NUMBER> p <NUMBER> used logistic regression model evaluate association tyg index mortality covid<NUMBER> found tyg index risk factor increased mortality covid<NUMBER> patients <NUMBER> <NUMBER> ci <NUMBER> adjustment age sex sbp hba<NUMBER>c table <NUMBER> notably association statistically significant observed additionally adjustment crp tnfα <NUMBER> <NUMBER> ci <NUMBER> finally performed receiver operating characteristic roc curve analysis test ability tyg predict severity mortality covid<NUMBER> optimal cutoff value tyg derived point maximum youden index area roc curve auroc tyg predicting severe covid<NUMBER> patients <NUMBER> <NUMBER> ci <NUMBER> p <NUMBER> optimal cutoff point tyg <NUMBER> sensitivity <NUMBER> specificity <NUMBER> moreover auroc tyg predicting mortality covid<NUMBER> <NUMBER> <NUMBER>ci <NUMBER> p <NUMBER> optimal cutoff point tyg <NUMBER> yielding sensitivity specificity <NUMBER> <NUMBER> respectively study evaluated role tyg index identifying severe cases mortality covid<NUMBER> patients demonstrated first time incidence severe covid<NUMBER> case higher among patients increasing level tyg index adjusting confounding factors tyg index closely associated increased risk severe patients covid<NUMBER> addition tyg index also valuable predictor mortality covid<NUMBER> epidemiological evidence shown high mortality morbidity diabetic patients develop covid<NUMBER> <NUMBER> data also observed high prevalence diabetes covid<NUMBER> patients notably found tyg index reliable surrogate marker ir predictive severe cases mortality covid<NUMBER> patients previous studies shown tyg index may predict development type <NUMBER> diabetes mellitus <NUMBER> metabolic syndrome <NUMBER> reported tyg index positively associated higher prevalence subclinical coronary artery disease cad <NUMBER> symptomatic cad metabolic behavioral risk factors <NUMBER> arterial stiffness nephric microvascular damage <NUMBER> moreover higher tyg index correlated increased risk main adverse cardiovascular cerebrovascular events macce acute stelevation myocardial infarction stemi patients tyg index might valuable predictor clinical outcomes stemi patients undergoing percutaneous coronary intervention <NUMBER> moreover elevated tyg index significantly associated higher risk arterial stiffness nephric microvascular damage positive association tyg index increased risk developing severe cases risk mortality confirmed covid<NUMBER> patients could attributed roles ir metabolic disorder altered inflammation profile cardiovascular disease risk factors findings support significance tyg index valuable predictor poorer outcomes covid<NUMBER> patients remind physicians intensive attention paid patients high level tyg index virus covid<NUMBER> classified betacoronavirus highly pathogenicity similar sarscov middle east respiratory syndrome coronavirus merscov could cause severe respiratory syndrome humans <NUMBER> <NUMBER> <NUMBER> yet fundamental pathophysiology covid<NUMBER> remains unknown previous studies shown increased concentrations proinflammatory cytokines serum eg il<NUMBER>b il<NUMBER> il<NUMBER> ifnγ il<NUMBER> tnfα induced patients sars <NUMBER> mers <NUMBER> considering large amount cytokines induced sarscov merscov cytokine storm body might play crucial role pulmonary inflammation extensive lung damage patients covid<NUMBER> early studies covid<NUMBER> also reported induce increased secretion thelper<NUMBER> th<NUMBER> cytokines eg il<NUMBER> il<NUMBER> suppress inflammation <NUMBER> noted severe patients covid<NUMBER> high amounts inflammatory indicators ferritin tnfα severe patients mild ones suggesting cytokine storm associated disease severity consistent previous reported older patients susceptible covid<NUMBER> <NUMBER> infected patients men <NUMBER> present study similar results observed age yet difference prevalence male female total patients covid<NUMBER> notably present study also emphasized greater number men among severe cases compared mild cases findings suggest older male patients likely worse prognosis addition elderly males found patients history diabetes hypertension increased risk severe covid<NUMBER> mortality agreement previous studies <NUMBER> <NUMBER> nevertheless observed higher prevalence diabetes hypertension reported study high prevalence comorbid conditions may expected tongji hospital designated hospital severe cases found tyg index closely associated mortality covid<NUMBER> may useful predict poor outcome infected patients although attempted adjust many confounders difficult assess independently cause death among <NUMBER> dead cases causes death may respiratory failure heart failure inflammation storm sepsis disseminated intravascular coagulation multiple organ failure acute kidney injury malignant arrhythmia diabetic ketoacidosis even sudden death uncertain events taken together easy identify relationship tyg index cause death world study several strengths first covid<NUMBER> first observed wuhan china large number patients suffering covid<NUMBER> city provided us opportunity evaluate epidemic affair second benefited obtaining accurate thorough clinical data patients tongji hospital designated hospital responsible treatments moderatesevere covid<NUMBER> patients wuhan third authors first line doctors could directly observe participants several limitations study also addressed first considering complexity disease well limited information course disease number samples relatively small second compared published paper percentage severe cases high study may explained tongji hospital designated hospital moderatesevere cases third people hospitalized treatment pneumonia resulting metabolic disorders easily overlooked thus could observe association metabolic control prognosis covid<NUMBER> fourth tyg index predicted death covid<NUMBER> study might affected change triglycerides glucose levels factors inflammation also taken consideration predicting death patient summary study illustrated tyg index notably high severe dead patients covid<NUMBER> moreover study unveiled tyg index independent predictor increased risk poor outcome patients covid<NUMBER> findings also highlighted high risk severe condition death among patients metabolic disorders despite understanding mechanisms underlying interaction tyg index covid<NUMBER> allow drug development aimed treatment andor preventing severe condition <NUMBER> covid<NUMBER> inpatients included study <NUMBER> discharged <NUMBER> dead hospital <NUMBER> <NUMBER> dead patients complicated chronic comorbidities <NUMBER> patients <NUMBER> <NUMBER> combined chronic comorbidities showed cfr <NUMBER> times patients without underlying disease number patients hypertension accounted three fourths concomitant underlying diseases univariable regression revealed patients simple hypertension group showed overall risk higher simple diabetes mellitus group agegrouped research patients hypertension senile group proved highest risk might associated level ldh egfr retrospective cohort study <NUMBER> <NUMBER> patients hypertension took ccb hospitalization odds ratio cfr patients hypertension taking ccb group <NUMBER> p <NUMBER> compared data shows clinical manifestations hospitalized patients covid<NUMBER> actually systemic syndromes although covid<NUMBER> defined novel coronavirus pneumonia china hypertension chronic underlying comorbidity also risk factor affecting severity covid<NUMBER> play critical role worsening patients clinical outcomes therefore hypertension management patients covid<NUMBER> regarded major challenge diagnostic therapeutic strategies including optimal management blood pressure pathophysiological status recent outbreak covid<NUMBER> rapidly spread worldwide large proportion covid<NUMBER> patients chronic underlying complications reported severe condition show unpromising clinical outcomes whether chronic comorbidities risk factors affecting severity covid<NUMBER> well described included covid<NUMBER> patients admitted tongji hospital tongji medical college hust wuhan china january <NUMBER> <NUMBER> march <NUMBER> <NUMBER> retrospective cohort study final date followup march <NUMBER> <NUMBER> patients diagnosed covid<NUMBER> according prevention control schemefor novel coronavirus pneumonia published national health commission peoples republic china interim demographic data medical history clinical symptoms signs laboratory findings chest computed tomography ct treatment clinical outcomes extracted electronic medical records standardized data collection forms compared among different groups <NUMBER> covid<NUMBER> inpatients included study <NUMBER> discharged <NUMBER> dead hospital <NUMBER> <NUMBER> dead patients complicated chronic comorbidities <NUMBER> patients <NUMBER> <NUMBER> combined chronic comorbidities showed cfr <NUMBER> times patients without underlying disease number patients hypertension accounted three fourths concomitant underlying diseases univariable regression revealed patients simple hypertension group showed overall risk higher simple diabetes mellitus group agegrouped research patients hypertension senile group proved highest risk might associated level ldh egfr retrospective cohort study <NUMBER> <NUMBER> patients hypertension took ccb hospitalization odds ratio cfr patients hypertension taking ccb group <NUMBER> p <NUMBER> compared data shows clinical manifestations hospitalized patients covid<NUMBER> actually systemic syndromes although covid<NUMBER> defined novel coronavirus pneumonia china hypertension chronic underlying comorbidity also risk factor affecting severity covid<NUMBER> play critical role improving patients clinical outcomes therefore hypertension management patients covid<NUMBER> major challenge diagnostic therapeutic strategies including optimal management blood pressure pathophysiological status infection covid<NUMBER> swiftly spread worldwide clinical spectrum covid<NUMBER> patients appears wide ranging asymptomatic infection mild critical illness <NUMBER> <NUMBER> significant portion covid<NUMBER> patients reported least one underlying complication admitted hospital hypertension diabetes mellitus cardiovascular diseases common <NUMBER> <NUMBER> covid<NUMBER> patients abruptly progressing mild normal condition severe critical illness critical determinants remain identified early detection early prediction early treatment identifying factors biological indicators particular early warning value development disease progression prognosis critical clinical decision making medical resource allocation article conducted indepth retrospective analysis covid<NUMBER> inpatients received treated intensively early stage pandemic aim reveal factors great influence predictive value covid<NUMBER> progression medical history laboratory indicators prognosis outcomes retrospective cohort study included <NUMBER> covid<NUMBER> inpatients tongji hospital tongji medical college hust wuhan china patients diagnosed covid<NUMBER> according prevention control scheme novel coronavirus pneumonia <NUMBER> th edition published national health commission peoples republic china <NUMBER> interim guidance confirmed case covid<NUMBER> defined positive result serum antibody realtime reversetranscriptasepolymerasechainreaction rtpcr assay nasal pharyngeal swab specimens admission date hospitalized patients january <NUMBER> <NUMBER> march <NUMBER> <NUMBER> date cutoff study march <NUMBER> <NUMBER> study designed investigators conducted accordance principles declaration helsinki institutional review board tongji hospital wuhan china approved retrospective study written informed consent waived tjc<NUMBER> data analyzed interpreted authors obtained raw data regarding <NUMBER> hospitalized covid<NUMBER> patients tongji hospital demographic data medical history clinical symptoms signs laboratory ccbynd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity certified peer review copyright holder preprint version posted june <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint findings chest computed tomography ct treatment clinical outcomes extracted electronic medical records standardized data collection forms hospitalized covid<NUMBER> patients data doubled checked two experienced physicians ensure accuracy data collection disagreement two major reviewers adjudicated third reviewer demographic data included age sex clinical symptoms signs included fever cough dyspnea myalgia diarrhea chest congestion heart rate blood pressure oos laboratory findings laboratory information system consist complete blood count ldh pt aptt scr egfr alt ast serum albumin ddimer ntprobnp tni crp esr il<NUMBER> sarscov<NUMBER> igg sarscov<NUMBER> igm sarscov<NUMBER> nucleic acid detection chest ct report data obtained image acquisition communication systems smoking history baseline comorbidities hypertension dm chd copd aki stroke cancer extracted medical history drug use condition antihypertension anticoronary drugs antiviral drugs antibiotics corticosteroids gamma globulin traditional chinese medicine mechanical interventions noninvasive ventilator tracheal intubation ecmo crrt covid<NUMBER> patients hospitalization collected medical advice information time symptom onset admission hospital severity illness normalsevere clinical outcome discharge death obtained electronic medical system according diagnosis treatment scheme novel coronavirus pneumonia trial <NUMBER> th edition published national health commission peoples republic china <NUMBER> severity covid<NUMBER> inpatients classified mild common severe critically ill acute cardiac injury aci diagnosed serum levels tni <NUMBER> μgl males <NUMBER> μgl females acute kidney injury aki diagnosed egfr less <NUMBER> mlmin composite endpoint occurrence aci aki use tracheal intubation different groups divided basis collected medical history patients hypertension included hypertension group patients without hypertension included nonhypertension group simple hypertension group referred patients hypertension without diabetes mellitus simple diabetes mellitus group referred patients diabetes mellitus without hypertension hypertension diabetes mellitus group referred patients hypertension diabetes mellitus others group referred patients without hypertension diabetes mellitus patients without hypertension dm chd copd cancer included nonunderlying disease group <NUMBER> continuous variables presented medians standard deviation sd compared independent sample test categorical variables summarized counts percentages n compared pearson χ² test missing data ccbynd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted june <NUMBER> <NUMBER> removed used univariable multivariable logistic regression models look insights risk factors associated incidence critically ill cases fatality cases composite endpoint twosided α less <NUMBER> considered statistically significant analyses performed using spss software version <NUMBER> <NUMBER> patients chronic comorbidities total <NUMBER> covid<NUMBER> inpatients accounting <NUMBER> two thirds one chronic comorbidities cfr <NUMBER> patients chronic comorbidities <NUMBER> times patients underlying disease <NUMBER> difference cfr among patients different number chronic comorbidities <NUMBER> discharged patients <NUMBER> dead patients total <NUMBER> covid<NUMBER> inpatients clinical characteristics prognosis conditions including demographic data clinical symptoms signs chronic comorbidities drug therapy two groups listed table <NUMBER> among dead patients <NUMBER> chronic comorbidities table <NUMBER> <NUMBER> <NUMBER> hypertension diabetes mellitus appendix table <NUMBER> <NUMBER> hypertension table <NUMBER> <NUMBER> patients included others group others <NUMBER> simple hypertension group htn <NUMBER> simple diabetes mellitusgroup dm <NUMBER> hypertension diabetes mellitus group htndm multiple indicators including ccir cfr incidence aci aki tracheal intubation use noninvasive ventilator ecmo crrt compared among four groups figure <NUMBER> ccir cfr relatively higher groups chronic comorbidities compared others group various prognostic indicators significantly higher htn group dm group patients htndm group showed higher incidence aci aki tracheal intubation use noninvasive ventilator odds ratio three major prognostic indicators incidence severe cases fatality cases cases composite endpoint adjusted age figure <NUMBER> covid<NUMBER> inpatients htn dm htndm group showed simple hypertension higher risk simple diabetes mellitus odds ratio occurrence composite endpoint <NUMBER> htn group p<NUMBER> <NUMBER> p<NUMBER> htndm group figure <NUMBER> appendix table <NUMBER> total <NUMBER> covid<NUMBER> inpatients divided four groups ie hypertension discharged group <NUMBER> patients hypertension dead group <NUMBER> patients nonhypertension discharged group <NUMBER> patients nonhypertension dead group <NUMBER> patients demographic data clinical signs oos hr sbp map laboratory indicators crp、ddimer、ldh、scr、egfr compared among four groups shown table <NUMBER> significant difference discharged dead ccbynd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted june <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint patients hypertension nonhypertension group age sex oos many laboratory indicators however indicator egfr significantly lower hypertension dead group nonhypertension dead group <NUMBER>±<NUMBER> vs <NUMBER>±<NUMBER> p<NUMBER> <NUMBER> patients nonhypertension nonsenile group <NUMBER> patients hypertension nonsenile patients <NUMBER> patients nonhypertension senile group <NUMBER> patients hypertension senile group patients hypertension divided according age age <NUMBER> demographic data clinical signs sbp dbp map oos laboratory indicators ldh egfr ccir cfr<NUMBER> cfr<NUMBER> compared among four groups appendix table <NUMBER> results showed ccir hypertension senile group significantly higher nonhypertension senile group <NUMBER> vs <NUMBER> p＜<NUMBER> different nonsenile patients senile patients showed significantly difference indicator crp ldh hypertension group nonhypertension group comparing probability survival among four groups figure <NUMBER> probability survival hypertension senile group continuously declined start hospitalization lowest among four groups due various reasons chinese hypertensive patients insisting antihypertensive therapy taking long acting calcium channel blockers ccb accounting nearly half <NUMBER> total number patients hypertension hypertensive patients using reninangiotensinaldosterone system inhibitors rasi less severe disease condition accounting nearly one eighth <NUMBER> comparison demographic data clinical signs oos hr sbp dbp map laboratory indicators crp ldh egfr cfr hypertensive patients taking ccb listed appendix table <NUMBER> age proved show significant difference two groups univariable multivariable logistic regression analyses revealed odds ratio death hypertensive patients taking ccb compared <NUMBER> p <NUMBER> appendix table <NUMBER> ccbynd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted june <NUMBER> <NUMBER> ccbynd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted june <NUMBER> <NUMBER> ccbynd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted june <NUMBER> <NUMBER> clinical manifestations covid<NUMBER> patients range asymptomatic infection mild critical illness requiring ventilators even ecmo sustain lives <NUMBER> <NUMBER> wuhan scholars china first reported half patients severe infection complicated chronic comorbidities hypertension diabetes mellitus coronary heart disease <NUMBER> among infected underlying diseases <NUMBER> progressed severe cases <NUMBER> <NUMBER> severe cases chronic comorbidities died hospital <NUMBER> however whether chronic comorbidities regarded risk factor affecting severity covid<NUMBER> remains controversial time recently many reports age concomitant diseases might aggravate disease progression affect clinical outcomes among covid<NUMBER> patients covid<NUMBER> patients preexisting complications observed show higher cfr<NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> patients cardiovascular disease diabetes mellitus chronic respiratory disease hypertension cancer respectively <NUMBER> reported greater number underlying diseases combined greater severity covid<NUMBER> <NUMBER> retrospective analyses covid<NUMBER> patients zhejiang province <NUMBER> province across mainland china revealed underlying hypertension independent risk factor severe cases even adjustment age <NUMBER> <NUMBER> among <NUMBER> covid<NUMBER> patients admitted icu available data italy <NUMBER> underlying hypertension excluding patients still icu deadline study cfr ccbynd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted june <NUMBER> <NUMBER> patients without hypertension <NUMBER> <NUMBER> <NUMBER> result populationbased cohort study england supported patients hypertension included highrisk group <NUMBER> retrospective study found determinants severity covid<NUMBER> closely related age chronic comorbidities chronic comorbidities hypertension diabetes mellitus major risk factors affecting disease progression prognosis patients simple hypertension may higher risk simple diabetes mellitus senile hypertensive patients highest risk progression prognosis covid<NUMBER> chronic comorbidities hypertension increase risk disease progression prognosis important investigated article named viral host factors related clinical outcome covid<NUMBER> published online <NUMBER> analyze viral genome variation sample collection <NUMBER> patients shanghai public health center significant variation viral sequences observed severe cases covid<NUMBER> therefore ruling possibility mutation sarscov<NUMBER> multiple major laboratory indicators compared among discharged dead patients without hypertension significant difference observed general also significant difference found sbp map among four groups results suggest likely due pathophysiological status target organ damage patients hypertension ras system laboratory indicator egfr rather blood pressure makes hypertension risk factor illness development prognosis known infection sarscov<NUMBER> needs combination ace<NUMBER> tmprss<NUMBER> human alveolar epithelial cells type <NUMBER> tissues subsequent replication multiplication amount virus leads increased expression ace<NUMBER> neighboring cells affects macrophages inflammatory cytokines released <NUMBER> consequently increased expression activity ace<NUMBER> tissue could identified critical factor patients susceptibility disease progression huanggang study published online conducted serological tests ace<NUMBER> <NUMBER> covid<NUMBER> patients <NUMBER> noncovid<NUMBER> patients revealing serum level ace<NUMBER> increased <NUMBER> hours infection remained high <NUMBER> hours infection <NUMBER> expression ace<NUMBER> mildly expressed lung tissue healthy human however brazilian researchers recently found expression ace<NUMBER> lung tissue upregulated covid<NUMBER> patients underlying diseases <NUMBER> including hypertension might provide reasonable explanation increased severity covid<NUMBER> patients underlying complications knowledge study retrospective report mainly focusing patients hypertension accounts highest proportion covid<NUMBER> patients risk early targeted interventions prevent disease progressing reasonable management strategy hypertension necessary might help improve clinical outcomes hospitalized covid<NUMBER> patients high risk retrospective cohort study limitations firstly admission examination indicator egfr captured collected data overall level aki might therefore underestimated secondly information patients prior admission put medical history could determined whether patients continued take changed medication hospitalization thirdly national unified standard normal reference values laboratory indicators thus followed standards set hospital finally data entry underlying diseases based inquiries patients enrolled hospital might underestimated due influence awareness rate retrospective cohort study revealed <NUMBER> covid<NUMBER> inpatients <NUMBER> combined chronic comorbidities showed cfr <NUMBER> times patients without underlying disease <NUMBER> <NUMBER> dead patients complicated chronic comorbidities number patients hypertension accounted three fourths concomitant underlying diseases odds ratio occurrence composite endpoint covid<NUMBER> inpatients simple hypertension <NUMBER> p<NUMBER> indicating overall risk higher simple hypertension group simple diabetes mellitus group according agegrouped research found hypertension senile group highest risk suggests hypertension management patients covid<NUMBER> would major challenge therapeutic strategies including optimal management blood pressure pathophysiological status might help improve clinical outcomes hospitalized covid<NUMBER> patients high risk hesong zeng weizhong zhang yin shen conceived study design full access data take responsibility integrity data accuracy analysis xingwei yuxin du yan tong organised entered data tianlu zhang yuxin du xueli wang contributed data analyses hesong zeng weizhong zhang yin shen xingwei tianlu zhang participated discussion made crucial suggestions interpreting findings weizhong zhang tianlu zhang drafted manuscript authors approved final version article decalre competing interests study supported covid<NUMBER> emergency response project wuhan science technology department <NUMBER> ccbynd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity certified peer review copyright holder preprint version posted june <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint coronavirus disease covid<NUMBER> global pandemic significantly impacts individuals living diabetes china wu mcgoogan <NUMBER> reported people living diabetes contracted virus triple mortality rate <NUMBER> comparison <NUMBER> without diabetes figures align previous global pandemics also associated increased morbidity mortality people diabetes <NUMBER> <NUMBER> h<NUMBER>n<NUMBER> pandemic canadians living diabetes triple risk hospitalization quadruple risk intensive care unit admissions <NUMBER> <NUMBER> severe acute respiratory syndrome epidemic also resulted increased hospitalization disease severity people diabetes <NUMBER> <NUMBER> global pandemics continue occur prevalence diabetes increases <NUMBER> diabetes community increasingly confronted ongoing public health challenges <NUMBER> world health organization warned older adults preexisting medical conditions like diabetes higher risk covid<NUMBER> exposure complications death <NUMBER> since majority diabetes population older <NUMBER> multiple comorbidities obesity emphysema hypertension heart failure <NUMBER> <NUMBER> greater risk viral infection although data covid<NUMBER> presentation yet support increased risk viral contraction people living diabetes <NUMBER> <NUMBER> evidence suggests may worse outcomes contract virus <NUMBER> <NUMBER> poor glycemic control significant contributor covid<NUMBER> severity hyperglycemic events lead diabetes ketoacidosis lifethreatening condition interferes immune response mitigate sepsis recovery <NUMBER> coronaviruses also shown bind target cells angiotensin converting enzyme<NUMBER> ace<NUMBER> fang et al <NUMBER> proposed expression ace<NUMBER> substantially increased people managing diabetes ace inhibitors antihyperglycemic angiotensin ii typei receptor blockers <NUMBER> individuals may increased risk developing severe fatal covid<NUMBER> maintain adequate glycemic control people living diabetes normally encouraged eat well exercise maintain good mental health <NUMBER> <NUMBER> <NUMBER> however efforts minimize risk exposure covid<NUMBER> required social distancing quarantine practices may exacerbate insulin sensitivity lower levels physical activity abrupt changes social routine poor dietary diversity diabetes distress <NUMBER> <NUMBER> <NUMBER> <NUMBER> guidelines authored prominent diabetes societies encourage use insulin preferred treatment global pandemic <NUMBER> <NUMBER> however impact covid<NUMBER> global economy compromised insulin production access <NUMBER> people insulindependent risk insulin shortage delayed delivery deadly <NUMBER> health professionals recommending people <NUMBER>day supply diabetes medication supplies medical devices <NUMBER> advice may prove difficult heed growing population people urban <NUMBER> rural <NUMBER> settings experience socioeconomic disparities specifically lower income may able afford adhering guidelines <NUMBER> <NUMBER> <NUMBER> addition shortage commercial antibacterial products may impede sterilization techniques insulin injections blood glucose monitoring promote infection <NUMBER> significant decreases traditional inperson clinic availability require people adopt adjust receiving digital diabetes care <NUMBER> response social distancing guidance outpatient diabetes clinics family medicine practices greatly curtailed services urgent cases <NUMBER> even restrictions expected ease time continued caution visiting clinics light circumstances use previously restricted forms communication providers patients allowed forms audio video texting technology allowed jurisdictions relaxing privacy security requirements also reimbursing providers services even telephone calls become accepted modality conducting clinical visit allowing without sophisticated consumer devices like smartphones access services <NUMBER> <NUMBER> <NUMBER> living diabetes opportunity able access care greater convenience expose infection inperson clinic use virtual visits continues pandemic easesas expected <NUMBER> opens great opportunity provide timely access physician care services often scarce living diabetes <NUMBER> physical distances longer factor virtualizing care provided diabetes educators dieticians specialized mental health professionals could improve access previously possible inperson encounters <NUMBER> successes realized broader digital health inequities access literacy addressed within diabetes community <NUMBER> perhaps compelling improving access health services virtual care digital health apps also create greater agency selfcare series studies recent years demonstrated diabetes smartphone apps ability capture diabetes data selfreported factors produce clinically significant improvement glycemic control living type <NUMBER> diabetes type <NUMBER> diabetes <NUMBER> <NUMBER> <NUMBER> outcomes achieved without benefit provider facilitating care app additional studies since shown outcomes enhanced addition virtual care active use diabetes data sharing enhance diabetes coaching guidance <NUMBER> <NUMBER> despite positive enablers remote diabetes care ability share diabetes device data back clinic remains challenge <NUMBER> stands current landscape diabetes device data interoperability patchwork proprietary technologies open source tools restrictive electronic health record ehr policies end requires unnecessarily high level technical sophistication clinics part living diabetes routinely use diabetes device data clinic visits virtual otherwise <NUMBER> <NUMBER> <NUMBER> technical burden simply continue hamper efforts facilitate comprehensive virtual care continues challenge convince manufacturers diabetes devices ehr vendors create truly interoperable systems ease burden diabetes communities <NUMBER> hoped pandemic reveals flaws industrys business tactics maintain exclusivity slow response addressing needs diabetes community world comes together fight covid<NUMBER> pandemic close collaboration among global diabetes community critical understand manage sustained impact pandemic people living diabetes figure <NUMBER> presents summary challenges covid<NUMBER> people living diabetes opportunities diabetes digital health support time need contribution access trusted diabetes resources communicate actionable insights status covid<NUMBER> needed support community challenging times <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> 